PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dusheiko, G; Burney, T				Dusheiko, Geoffrey; Burney, Tabinda			Hepatitis C treatment: interferon free or interferon freer?	LANCET			English	Editorial Material							VIRUS; POLYMERASE; THERAPY		[Dusheiko, Geoffrey; Burney, Tabinda] Royal Free Hosp, UCL Inst Liver & Digest Dis, London NW3 2PF, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Dusheiko, G (corresponding author), Royal Free Hosp, UCL Inst Liver & Digest Dis, London NW3 2PF, England.	g.dusheiko@ucl.ac.uk						Asselah T, 2013, LIVER INT, V33, P93, DOI 10.1111/liv.12076; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Dore GJ, 2012, HEPATOLOGY, V56, p558A; Furman PA, 2011, ANTIVIR RES, V91, P120, DOI 10.1016/j.antiviral.2011.05.003; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gilead Science, 2013, GIL ANN SUST VIR RES; Izumi N, 2012, HEPATOLOGY, V56, p310A; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Kowdley KV, 2013, LANCET; Lawitz E, 2013, LANCET INFECT DIS; Marcellin P, 2012, HEPATOLOGY, V56, p561A; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Osinusi A, 2012, HEPATOLOGY S, V56, pLB4; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Ross BS, 2011, J ORG CHEM, V76, P8311, DOI 10.1021/jo201492m; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Sofia Michael J., 2011, Antiviral Chemistry & Chemotherapy, V22, P23, DOI 10.3851/IMP1797; Sulkowski MS, 2012, HEPATOLOGY, V56, P1516	18	1	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2063	2065		10.1016/S0140-6736(13)60636-4	http://dx.doi.org/10.1016/S0140-6736(13)60636-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23499437				2022-12-28	WOS:000320924800008
J	Burns, T; Rugkasa, J; Molodynski, A; Dawson, J; Yeeles, K; Vazquez-Montes, M; Voysey, M; Sinclair, J; Priebe, S				Burns, Tom; Rugkasa, Jorun; Molodynski, Andrew; Dawson, John; Yeeles, Ksenija; Vazquez-Montes, Maria; Voysey, Merryn; Sinclair, Julia; Priebe, Stefan			Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial	LANCET			English	Article							INVOLUNTARY OUTPATIENT COMMITMENT	Background Compulsory supervision outside hospital has been developed internationally for the treatment of mentally ill people following widespread deinstitutionalisation but its efficacy has not yet been proven. Community treatment orders (CTOs) for psychiatric patients became available in England and Wales in 2008. We tested whether CTOs reduce admissions compared with use of Section 17 leave when patients in both groups receive equivalent levels of clinical contact but different lengths of compulsory supervision. Methods OCTET is a non-blinded, parallel-arm randomised controlled trial. We postulated that patients with a diagnosis of psychosis discharged from hospital on CTOs would have a lower rate of readmission over 12 months than those discharged on the pre-existing Section 17 leave of absence. Eligible patients were those involuntarily admitted to hospital with a diagnosis of psychosis, aged 18-65 years, who were deemed suitable for supervised outpatient care by their clinicians. Consenting patients were randomly assigned (1:1 ratio) to be discharged from hospital either on CTO or Section 17 leave. Randomisation used random permuted blocks with lengths of two, four, and six, and stratified for sex, schizophrenic diagnosis, and duration of illness. Research assistants, treating clinicians, and patients were aware of assignment to randomisation group. The primary outcome measure was whether or not the patient was admitted to hospital during the 12-month follow-up period, analysed with a log-binomial regression model adjusted for stratification factors. We did all analyses by intention to treat. This trial is registered, number ISRCTN73110773. Findings Of 442 patients assessed, 336 patients were randomly assigned to be discharged from hospital either on CTO (167 patients) or Section 17 leave (169 patients). One patient withdrew directly after randomisation and two were ineligible, giving a total sample of 333 patients (166 in the CTO group and 167 in the Section 17 group). At 12 months, despite the fact that the length of initial compulsory outpatient treatment differed significantly between the two groups (median 183 days CTO group vs 8 days Section 17 group, p<0.001) the number of patients readmitted did not differ between groups (59 [36%] of 166 patients in the CTO group vs 60 [36%] of 167 patients in the Section 17 group; adjusted relative risk 1.0 [95% CI 0.75-1.33]). Interpretation In well coordinated mental health services the imposition of compulsory supervision does not reduce the rate of readmission of psychotic patients. We found no support in terms of any reduction in overall hospital admission to justify the significant curtailment of patients' personal liberty.	[Burns, Tom; Rugkasa, Jorun; Yeeles, Ksenija] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Vazquez-Montes, Maria] Univ Oxford, Dept Primary Hlth Care Sci, Oxford OX3 7JX, England; [Voysey, Merryn] Univ Oxford, Ctr Stat Med, Oxford OX3 7JX, England; [Rugkasa, Jorun] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Molodynski, Andrew] Oxford Hlth NHS Fdn Trust, Oxford, England; [Dawson, John] Univ Otago, Fac Law, Otago, New Zealand; [Sinclair, Julia] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oslo; University of Otago; University of Southampton; University of London; Queen Mary University London	Burns, T (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	tom.burns@psych.ox.ac.uk	Rugkåsa, Jorun/ABI-6495-2020; Dawson, John/HDM-6702-2022; Sinclair, Julia/AAD-8049-2019	Sinclair, Julia/0000-0002-1905-2025; Rugkasa, Jorun/0000-0001-5842-2845; molodynski, andrew/0000-0002-3820-5955; Houston, Mary/0000-0002-8837-4503; Priebe, Stefan/0000-0001-9864-3394; Voysey, Merryn/0000-0001-6324-6559; Yeeles, Ksenija/0000-0002-7757-0154	National Institute of Health Research [RP-PG-0606-1006]; National Institute for Health Research [RP-PG-0606-1006] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial is funded by a Programme Grant for Applied Research from the National Institute of Health Research (RP-PG-0606-1006). It is adopted into the UKCRN and MHRN portfolios, and is registered with ISRCTN [ISRCTN73110773]. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Appelbaum PS, 2001, PSYCHIATR SERV, V52, P347, DOI 10.1176/appi.ps.52.3.347; Burns T, 2009, PSYCHOL MED, V39, P1583, DOI 10.1017/S0033291709005352; Burns T, 2010, PSYCHIATR BULL, V34, P361, DOI 10.1192/pb.bp.110.030254; Churchill R, 2007, INT EXPERIENCES USIN; Dawson J, 2011, MED LAW REV, V19, P1, DOI 10.1093/medlaw/fwq030; Dawson J., 2005, COMMUNITY TREATMENT; Dawson John, 2002, Med Law Rev, V10, P308, DOI 10.1093/medlaw/10.3.308; Gledhill K., 2007, J MENT HEALTH, VL, P149; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Kisely S, 2005, COCHRANE DB SYST REV, V3; Lukoff D, 1986, SCHIZOPHRENIA B, V12, P594, DOI DOI 10.1093/SCHBUL/12.4.578; Munetz MR, 2003, J AM ACAD PSYCHIATRY, V31, P173; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Romans S, 2004, AUST NZ J PSYCHIAT, V38, P836, DOI 10.1080/j.1440-1614.2004.01470.x; Royal College of Psychiatrists, 1993, CR18 ROYAL COLL PSYC; Steadman HJ, 2001, PSYCHIATR SERV, V52, P330, DOI 10.1176/appi.ps.52.3.330; Swartz MS, 1997, J MENT HEALTH ADMIN, V24, P35; Swartz MS, 1999, AM J PSYCHIAT, V156, P1968; Torrey E, 2008, SHORTAGE PUBLIC HOSP	19	232	234	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1627	1633		10.1016/S0140-6736(13)60107-5	http://dx.doi.org/10.1016/S0140-6736(13)60107-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23537605	Green Published			2022-12-28	WOS:000319112400029
J	Lipsman, N; Woodside, DB; Giacobbe, P; Hamani, C; Carter, JC; Norwood, SJ; Sutandar, K; Staab, R; Elias, G; Lyman, CH; Smith, GS; Lozano, AM				Lipsman, Nir; Woodside, D. Blake; Giacobbe, Peter; Hamani, Clement; Carter, Jacqueline C.; Norwood, Sarah Jane; Sutandar, Kalam; Staab, Randy; Elias, Gavin; Lyman, Christopher H.; Smith, Gwenn S.; Lozano, Andres M.			Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial	LANCET			English	Article							GLUCOSE-METABOLISM; EATING-DISORDERS; MORTALITY; SCALE; HYPOMETABOLISM; PREVALENCE; RECOVERY; OUTCOMES; ANXIETY; INSULA	Background Anorexia nervosa is characterised by a chronic course that is refractory to treatment in many patients and has one of the highest mortality rates of any psychiatric disorder. Deep brain stimulation (DBS) has been applied to circuit-based neuropsychiatric diseases, such as Parkinson's disease and major depression, with promising results. We aimed to assess the safety of DBS to modulate the activity of limbic circuits and to examine how this might affect the clinical features of anorexia nervosa. Methods We did a phase 1, prospective trial of subcallosal cingulate DBS in six patients with chronic, severe, and treatment-refractory anorexia nervosa. Eligible patients were aged 20-60 years, had been diagnosed with restricting or binge-purging anorexia nervosa, and showed evidence of chronicity or treatment resistance. Patients underwent medical optimisation preoperatively and had baseline body-mass index (BMI), psychometric, and neuroimaging investigations, followed by implantation of electrodes and pulse generators for continuous delivery of electrical stimulation. Patients were followed up for 9 months after DBS activation, and the primary outcome of adverse events associated with surgery or stimulation was monitored at every follow-up visit. Repeat psychometric assessments, BMI measurements, and neuroimaging investigations were also done at various intervals. This trial is registered with ClinicalTrials.gov, number NCT01476540. Findings DBS was associated with several adverse events, only one of which (seizure during programming, roughly 2 weeks after surgery) was serious. Other related adverse events were panic attack during surgery, nausea, air embolus, and pain. After 9 months, three of the six patients had achieved and maintained a BMI greater than their historical baselines. DBS was associated with improvements in mood, anxiety, affective regulation, and anorexia nervosa-related obsessions and compulsions in four patients and with improvements in quality of life in three patients after 6 months of stimulation. These clinical benefits were accompanied by changes in cerebral glucose metabolism (seen in a comparison of composite PET scans at baseline and 6 months) that were consistent with a reversal of the abnormalities seen in the anterior cingulate, insula, and parietal lobe in the disorder. Interpretation Subcallosal cingulate DBS seems to be generally safe in this sample of patients with chronic and treatment-refractory anorexia nervosa.	[Lipsman, Nir; Hamani, Clement; Elias, Gavin; Lozano, Andres M.] Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Woodside, D. Blake; Giacobbe, Peter; Carter, Jacqueline C.; Sutandar, Kalam] Univ Toronto, Toronto Gen Hosp, Dept Psychiat, Toronto, ON M5T 2S8, Canada; [Norwood, Sarah Jane] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [Staab, Randy] Credit Valley Hosp, Div Psychiat, Mississauga, ON, Canada; [Lyman, Christopher H.; Smith, Gwenn S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; York University - Canada; University of Toronto; Trillium Health Partners; Credit Valley Hospital; Johns Hopkins University	Lozano, AM (corresponding author), Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada.	lozano@uhnresearch.ca	Lozano, Andres M/A-5058-2012	Elias, Gavin/0000-0002-7495-550X; Lozano, Andres M./0000-0001-8257-3694	Klarman Family Foundation Grants Program in Eating Disorders Research; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086881] Funding Source: NIH RePORTER	Klarman Family Foundation Grants Program in Eating Disorders Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Klarman Family Foundation Grants Program in Eating Disorders Research and Canadian Institutes of Health Research.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bailer UF, 2004, NEUROPSYCHOPHARMACOL, V29, P1143, DOI 10.1038/sj.npp.1300430; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, PSYCHOL ASSESS; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; BOWDEN PK, 1989, BRIT J PSYCHIAT, V155, P196, DOI 10.1192/bjp.155.2.196; Bulik CM, 2005, INT J EAT DISORDER, V37, pS2, DOI 10.1002/eat.20107; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DeLong M, 2012, ANN NY ACAD SCI, V1265, P1, DOI 10.1111/j.1749-6632.2012.06608.x; Delvenne V, 1999, INT J EAT DISORDER, V25, P29, DOI 10.1002/(SICI)1098-108X(199901)25:1&lt;29::AID-EAT4&gt;3.0.CO;2-#; Delvenne V, 1997, PSYCHIAT RES-NEUROIM, V74, P83, DOI 10.1016/S0925-4927(97)02971-5; DELVENNE V, 1995, BIOL PSYCHIAT, V37, P161, DOI 10.1016/0006-3223(94)00189-A; Delvenne V, 1996, BIOL PSYCHIAT, V40, P761, DOI 10.1016/0006-3223(95)00522-6; Ellinson Z, 1998, LANCET, V352, P1192, DOI 10.1016/S0140-6736(05)60529-6; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Fichter MM, 1999, INT J EAT DISORDER, V26, P359; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Israel Mimi, 2010, Biol Psychiatry, V67, pe53, DOI 10.1016/j.biopsych.2009.11.016; Katzman DK, 2005, INT J EAT DISORDER, V37, pS52, DOI 10.1002/eat.20118; Kaye WH, 2011, CURR TOP BEHAV NEURO, V6, P37, DOI 10.1007/7854_2010_85; Keating C, 2010, NEUROSCI BIOBEHAV R, V34, P73, DOI 10.1016/j.neubiorev.2009.07.004; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kennedy SH, 2011, AM J PSYCHIAT, V168, P502, DOI 10.1176/appi.ajp.2010.10081187; Kojima S, 2005, PSYCHIAT RES-NEUROIM, V140, P251, DOI 10.1016/j.pscychresns.2005.08.002; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MAZURE CM, 1994, J PSYCHIATR RES, V28, P425, DOI 10.1016/0022-3956(94)90002-7; McLaughlin NCR, 2013, BIOL PSYCHIAT, V73, pE29, DOI 10.1016/j.biopsych.2012.09.015; Morris J, 2007, BMJ-BRIT MED J, V334, P894, DOI 10.1136/bmj.39171.616840.BE; Nico D, 2010, PSYCHOL MED, V40, P1531, DOI 10.1017/S0033291709991851; Noordenbos Greta, 2006, Eat Disord, V14, P41, DOI 10.1080/10640260500296756; Noordenbos Greta, 2011, Eat Disord, V19, P441, DOI 10.1080/10640266.2011.618738; Nunn K, 2008, EUR EAT DISORD REV, V16, P355, DOI 10.1002/erv.890; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Schaltenb G, 1998, ATLAS STEREOTAXY HUM; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Strober M, 2007, INT J EAT DISORDER, V40, pS46, DOI 10.1002/eat.20429; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tanaka H, 2001, PSYCHIAT CLIN NEUROS, V55, P389, DOI 10.1046/j.1440-1819.2001.00880.x; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Uher R, 2003, BIOL PSYCHIAT, V54, P934, DOI 10.1016/S0006-3223(03)00172-0; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Wu HM, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.06.039	62	174	183	0	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1361	1370		10.1016/S0140-6736(12)62188-6	http://dx.doi.org/10.1016/S0140-6736(12)62188-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23473846				2022-12-28	WOS:000317894800033
J	Chen, JS; Chan, WK; Tsai, KT; Hsu, HH; Lin, CY; Yuan, A; Chen, WJ; Lai, HS; Yang, PC				Chen, Jin-Shing; Chan, Wing-Kai; Tsai, Kung-Tsao; Hsu, Hsao-Hsun; Lin, Chien-Yu; Yuan, Ang; Chen, Wen-Jone; Lai, Hong-Shiee; Yang, Pan-Chyr			Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial	LANCET			English	Article							TUBE DRAINAGE; TETRACYCLINE PLEURODESIS; MANAGEMENT; PHYSICIANS; SURGERY	Background Simple aspiration and drainage is a standard initial treatment for primary spontaneous pneumothorax, but the rate of pneumothorax recurrence is substantial. We investigated whether additional minocycline pleurodesis after simple aspiration and drainage reduces the rate of recurrence. Methods In our open-label, parallel-group, prospective, randomised, controlled trial at two hospitals in Taiwan, patients were aged 15-40 years and had a first episode of primary spontaneous pneumothorax with a rim of air greater than 2 cm on chest radiographs, complete lung expansion without air leakage after pigtail catheter drainage, adequate haematological function, and normal renal and hepatic function. After simple aspiration and drainage via a pigtail catheter, patients were randomly assigned (1:1) to receive 300 mg of minocycline pleurodesis or no further treatment (control group). Randomisation was by computer-generated random numbers in sealed envelopes. Our primary endpoint was rate of pneumothorax recurrence at 1 year. This trial is registered with ClinicalTrials.gov (NCT00418392). Findings Between Dec 31, 2006, and June 30, 2012, 214 patients were randomly assigned-106 to the minocycline group and 108 to the control group (intention-to-treat population). Treatment was unsuccessful within 7 days of randomisation in 14 patients in the minocycline group and 20 patients in the control group. At 1 year, pneumothoraces had recurred in 31 of 106 (29.2%) patients in the minocycline group compared with 53 of 108 (49.1%) in the control group (p=0.003). We noted no procedure-related complications in either group. Interpretation Simple aspiration and drainage followed by minocycline pleurodesis is a safe and more effective treatment for primary spontaneous pneumothorax than is simple aspiration and drainage only. Minocycline pleurodesis should be an adjunct to standard treatment for primary spontaneous pneumothorax.	[Chen, Jin-Shing; Hsu, Hsao-Hsun; Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yuan, Ang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Wen-Jone] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan; [Chan, Wing-Kai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Tsai, Kung-Tsao] Far Eastern Mem Hosp, Dept Emergency Med, New Taipei City, Taiwan; [Lin, Chien-Yu] Natl Taiwan Univ, Acad Sinica, Inst Stat Sci, Taipei 100, Taiwan; [Lin, Chien-Yu] Natl Taiwan Univ, Ctr Genom Med, Microarray Core Facil, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Yang, PC (corresponding author), Natl Taiwan Univ, Coll Med, 1,Sect 1,Ren Ai Rd, Taipei 100, Taiwan.	pcyang@ntu.edu.tw		HSU, HSAO-HSUN/0000-0002-0376-1206; Chan, Wing-Kai/0000-0002-5328-548X; CHEN, WEN-JONE/0000-0002-2098-5922; Lai, Hong-Shiee/0000-0002-7958-2183; CHEN, JIN-SHING/0000-0001-5077-4483; YUAN, ANG/0000-0002-5664-1339; YANG, PAN-CHYR/0000-0001-6330-6048	Department of Health; National Science Council, Taiwan [NSC 100-2325-B-002-072]; Department of Health, Taiwan [DOH95-TD-I-111-012]	Department of Health; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	Department of Health and National Science Council, Taiwan.; We would like to acknowledge the contribution of Yung-Chie Lee, who was the principal investigator of this study before his death on Dec 30, 2010. This study was supported by research grants from the Department of Health, Taiwan (DOH95-TD-I-111-012) and National Science Council, Taiwan (NSC 100-2325-B-002-072).	ALFAGEME I, 1994, CHEST, V106, P347, DOI 10.1378/chest.106.2.347; ALMIND M, 1989, THORAX, V44, P627, DOI 10.1136/thx.44.8.627; ANDRIVET P, 1995, CHEST, V108, P335, DOI 10.1378/chest.108.2.335; Ayed AK, 2006, EUR RESPIR J, V27, P477, DOI 10.1183/09031936.06.00091505; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; British Thoracic Society Research Committee, 1993, THORAX, V48, P430; Chan L, 1997, AM J EMERG MED, V15, P368, DOI 10.1016/S0735-6757(97)90127-3; Chen JS, 2008, RESP MED, V102, P1004, DOI 10.1016/j.rmed.2008.02.006; Chen JS, 2006, AM J RESP CRIT CARE, V173, P548, DOI 10.1164/rccm.200509-1414OC; Chen JS, 2004, CHEST, V125, P50, DOI 10.1378/chest.125.1.50; Chen JS, 2003, ANN THORAC SURG, V75, P1080, DOI 10.1016/S0003-4975(02)04649-0; GOBBEL WG, 1963, J THORAC CARDIOV SUR, V46, P331, DOI 10.1016/S0022-5223(19)33666-9; HARVEY J, 1994, BRIT MED J, V309, P1338, DOI 10.1136/bmj.309.6965.1338; Henry M, 2003, THORAX S2, V58, P39, DOI DOI 10.1136/TH0RAX.58.SUPPL_21I39; Lichter J, 1971, THORAX, V25, P409; LIGHT RW, 1994, CHEST, V106, P577, DOI 10.1378/chest.106.2.577; LIGHT RW, 1990, JAMA-J AM MED ASSOC, V264, P2224, DOI 10.1001/jama.264.17.2224; LIGHT RW, 1993, AM REV RESPIR DIS, V148, P245, DOI 10.1164/ajrccm/148.1.245; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Margolis M, 2003, ANN THORAC SURG, V76, P1661, DOI 10.1016/S0003-4975(02)04816-6; Noppen M, 2002, AM J RESP CRIT CARE, V165, P1240, DOI 10.1164/rccm.200111-078OC; Noppen M, 2001, RESPIRATION, V68, P396, DOI 10.1159/000050533; Packham S, 2003, POSTGRAD MED J, V79, P345, DOI 10.1136/pmj.79.932.345; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; SEREMETIS MG, 1970, CHEST, V57, P65, DOI 10.1378/chest.57.1.65; Sodikot RT, 1997, THORAX, V52, P805; Tschopp JM, 2006, EUR RESPIR J, V28, P637, DOI 10.1183/09031936.06.00014206; Tschopp JM, 2002, EUR RESPIR J, V20, P1003, DOI 10.1183/09031936.02.00278202; VOGE VM, 1986, AVIAT SPACE ENVIR MD, V57, P939; Wakai A, 2007, COCHRANE DB SYST REV	30	64	73	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1277	1282		10.1016/S0140-6736(12)62170-9	http://dx.doi.org/10.1016/S0140-6736(12)62170-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23489754	Green Submitted			2022-12-28	WOS:000317351000030
J	Armstrong, PW; Gershlick, AH; Goldstein, P; Wilcox, R; Danays, T; Lambert, Y; Sulimov, V; Ortiz, FR; Ostojic, M; Welsh, RC; Carvalho, AC; Nanas, J; Arntz, HR; Halvorsen, S; Huber, K; Grajek, S; Fresco, C; Bluhmki, E; Regelin, A; Vandenberghe, K; Bogaerts, K; Van De Werf, F				Armstrong, Paul W.; Gershlick, Anthony H.; Goldstein, Patrick; Wilcox, Robert; Danays, Thierry; Lambert, Yves; Sulimov, Vitaly; Rosell Ortiz, Fernando; Ostojic, Miodrag; Welsh, Robert C.; Carvalho, Antonio C.; Nanas, John; Arntz, Hans-Richard; Halvorsen, Sigrun; Huber, Kurt; Grajek, Stefan; Fresco, Claudio; Bluhmki, Erich; Regelin, Anne; Vandenberghe, Katleen; Bogaerts, Kris; Van de Werf, Frans		STREAM Investigative Team	Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION STRATEGY; RANDOMIZED-TRIAL; MORTALITY; SURVIVAL; DELAYS	BACKGROUND It is not known whether prehospital fibrinolysis, coupled with timely coronary angiography, provides a clinical outcome similar to that with primary percutaneous coronary intervention (PCI) early after acute ST-segment elevation myocardial infarction (STEMI). METHODS Among 1892 patients with STEMI who presented within 3 hours after symptom onset and who were unable to undergo primary PCI within 1 hour, patients were randomly assigned to undergo either primary PCI or fibrinolytic therapy with bolus tenecteplase (amended to half dose in patients >= 75 years of age), clopidogrel, and enoxaparin before transport to a PCI-capable hospital. Emergency coronary angiography was performed if fibrinolysis failed; otherwise, angiography was performed 6 to 24 hours after randomization. The primary end point was a composite of death, shock, congestive heart failure, or reinfarction up to 30 days. RESULTS The primary end point occurred in 116 of 939 patients (12.4%) in the fibrinolysis group and in 135 of 943 patients (14.3%) in the primary PCI group (relative risk in the fibrinolysis group, 0.86; 95% confidence interval, 0.68 to 1.09; P = 0.21). Emergency angiography was required in 36.3% of patients in the fibrinolysis group, whereas the remainder of patients underwent angiography at a median of 17 hours after randomization. More intracranial hemorrhages occurred in the fibrinolysis group than in the primary PCI group (1.0% vs. 0.2%, P = 0.04; after protocol amendment, 0.5% vs. 0.3%, P = 0.45). The rates of nonintracranial bleeding were similar in the two groups. CONCLUSIONS Prehospital fibrinolysis with timely coronary angiography resulted in effective reperfusion in patients with early STEMI who could not undergo primary PCI within 1 hour after the first medical contact. However, fibrinolysis was associated with a slightly increased risk of intracranial bleeding. (Funded by Boehringer Ingelheim; ClinicalTrials.gov number, NCT00623623.)	[Armstrong, Paul W.] Univ Alberta, Canadian Virtual Coordinating Ctr Global Collabor, Edmonton, AB, Canada; [Welsh, Robert C.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Gershlick, Anthony H.] Univ Hosp Leicester Trust, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England; Univ Nottingham, Dept Cardiovasc Med, Nottingham NG7 2RD, England; Lille Univ Hosp, Emergency Dept, Lille, France; [Goldstein, Patrick] Lille Univ Hosp, SAMU, Lille, France; [Danays, Thierry] Boehringer Ingelheim GmbH & Co KG, Reims, France; [Lambert, Yves] Ctr Hosp Versailles, SAMU 78, Versailles, France; [Lambert, Yves] Mobile Intens Care Unit, Versailles, France; [Sulimov, Vitaly] First Moscow State Med Univ, Dept Internal Dis, Moscow, Russia; [Rosell Ortiz, Fernando] Empresa Publ Emergencias Sanitarias, Almeria, Spain; [Ostojic, Miodrag] Univ Belgrade, Sch Med, Belgrade, Serbia; [Carvalho, Antonio C.] Univ Fed Sao Paulo, Dept Med, Div Cardiol, Sao Paulo, Brazil; Univ Athens, Dept Cardiol 3, GR-10679 Athens, Greece; [Arntz, Hans-Richard] Benjamin Franklin Med Ctr, Charite, Berlin, Germany; Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Huber, Kurt] Wilhelminenhosp, Dept Med Cardiol & Emergency Med 3, Vienna, Austria; [Grajek, Stefan] Poznan Univ Med Sci, Dept Cardiol, Poznan, Poland; [Fresco, Claudio] Azienda Osped Univ Udine, Dept Cardiothorac Sci, Udine, Italy; [Bluhmki, Erich] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany; Boehringer Ingelheim GmbH & Co KG, Basel, Switzerland; [Vandenberghe, Katleen; Van de Werf, Frans] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Louvain, Belgium; [Bogaerts, Kris] Katholieke Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat, B-3000 Louvain, Belgium; [Bogaerts, Kris] Univ Hasselt, Hasselt, Belgium	University of Alberta; University of Alberta; University Hospitals of Leicester NHS Trust; University of Nottingham; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Boehringer Ingelheim; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Sechenov First Moscow State Medical University; University of Belgrade; Universidade Federal de Sao Paulo (UNIFESP); National & Kapodistrian University of Athens; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oslo; Wilhelminenspital; Poznan University of Medical Sciences; University of Udine; University Hospital of Udine; Boehringer Ingelheim; Boehringer Ingelheim; KU Leuven; Hasselt University; KU Leuven; Hasselt University	Van De Werf, F (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Sci, Herestr 49, B-3000 Louvain, Belgium.	frans.vandewerf@med.kuleuven.be	Fresco, Claudio/M-5203-2015; Boldueva, Svetlana/AAH-3862-2019; Ferrari, Emile/R-2917-2016; Welsh, Robert/ABH-3526-2021; Mendes Sant'Anna, Fernando/B-3508-2015; Neskovic, Aleksandar/P-5204-2015	Fresco, Claudio/0000-0001-7123-8153; Boldueva, Svetlana/0000-0002-1898-084X; Welsh, Robert/0000-0003-2613-9142; Baumbach, Andreas/0000-0001-7707-2254; Sinnaeve, Peter/0000-0003-4716-5892; Mendes Sant'Anna, Fernando/0000-0003-3998-8813; Armstrong, Paul/0000-0002-0460-3445; Neskovic, Aleksandar/0000-0001-8617-966X; Van de Werf, Frans/0000-0001-9479-7767; Lepper, Wolfgang/0000-0003-3707-3919; Rosell-Ortiz, Fernando/0000-0003-0260-9955; Bogaerts, Kris/0000-0003-0188-8665	Boehringer Ingelheim; Eli Lilly; Merck; Roche; Daiichi Sankyo; Medicines Company; AstraZeneca; Sanofi; Bayer; Schering-Plough; Sanofi-Aventis; Bristol-Myers Squibb; Abbott; Medtronic; Edwards Lifesciences; Servier; Pfizer	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); Merck(Merck & Company); Roche(Roche Holding); Daiichi Sankyo(Daiichi Sankyo Company Limited); Medicines Company; AstraZeneca(AstraZeneca); Sanofi; Bayer(Bayer AG); Schering-Plough(Merck & CompanySchering Plough Corporation); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Medtronic(Medtronic); Edwards Lifesciences; Servier(Servier); Pfizer(Pfizer)	Funded by Boehringer Ingelheim; Supported by Boehringer Ingelheim.; Dr. Armstrong reports receiving consulting fees from Eli Lilly, Merck, and Roche, payment for the development of educational presentations from AstraZeneca and Eli Lilly, and grant support through his institution from Merck; Dr. Goldstein, serving as a board member for Eli Lilly, Daiichi Sankyo, and the Medicines Company and receiving consulting fees from Eli Lilly, Daiichi Sankyo, the Medicines Company, and AstraZeneca, lecture fees from Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, AstraZeneca, the Medicines Company, Sanofi, and Bayer, and payment for the development of educational presentations from AstraZeneca and Boehringer Ingelheim; Dr. Wilcox, being a board member for and receiving consulting fees through his institution from Schering-Plough, Eli Lilly, Daiichi Sankyo, and AstraZeneca; Drs. Danays, Bluhmki, and Regelin, being employees of Boehringer Ingelheim; Dr. Lambert, receiving lecture fees from Boehringer Ingelheim; Dr. Sulimov, receiving lecture fees from Boehringer Ingelheim, Sanofi-Aventis, AstraZeneca, Bayer, Bristol-Myers Squibb, and Abbott; Dr. Rosell Ortiz, receiving lecture fees from Daiichi Sankyo and AstraZeneca; Dr. Welsh, receiving consulting fees from AstraZeneca, Eli Lilly, Roche, Medtronic, and Bayer, lecture fees from AstraZeneca and Eli Lilly, grant support from AstraZeneca and Edwards Lifesciences, and payment for the development of educational presentations from Bayer, AstraZeneca, and Eli Lilly; Dr. Nanas, receiving payment from Novartis, Sanofi-Aventis, and Actelion as principal investigator and to his institution for each patient enrolled in a multi-center trial; Dr. Halvorsen, receiving lecture fees from Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Boehringer Ingelheim, and Bayer, travel reimbursement from Bristol-Myers Squibb, Eli Lilly, and Bayer, and payment for the development of educational presentations from AstraZeneca; Dr. Grajek, receiving consulting fees and payment for manuscript preparation from AstraZeneca and Servier, lecture fees from AstraZeneca, Servier, and Bayer, and payment for the development of educational presentations from AstraZeneca, Servier, Bayer, Merck, Sanofi-Aventis, and Berlin-Chemie; Dr. Fresco, receiving consulting fees from Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, and the Medicines Company and lecture fees from Boehringer Ingelheim, Eli Lilly, the Medicines Company, Pfizer, Bristol-Myers Squibb, and AstraZeneca; Dr. Bogaerts, receiving consulting fees through his institution from Boehringer Ingelheim; and Dr. Van de Werf, receiving consulting and lecture fees from Boehringer Ingelheim and grant support through his institution from Boehringer Ingelheim. No other potential conflict of interest relevant to this article was reported.	Armstrong PW, 2011, ANN INTERN MED, V155, P389, DOI 10.7326/0003-4819-155-6-201109200-00008; Armstrong PW, 2010, AM HEART J, V160, P30, DOI 10.1016/j.ahj.2010.04.007; Armstrong PW, 2009, CIRCULATION, V119, P1293, DOI 10.1161/CIRCULATIONAHA.108.796383; Brouwer MA, 1996, AM J CARDIOL, V78, P497, DOI 10.1016/S0002-9149(96)00352-9; Harrell Jr FE, 2003, NEW ENGL J MED; Kaul S, 2005, J AM COLL CARDIOL, V46, P1986, DOI 10.1016/j.jacc.2005.07.062; Larson DM, 2012, EUR HEART J, V33, P1232, DOI 10.1093/eurheartj/ehr403; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pinto DS, 2011, CIRCULATION, V124, P2512, DOI 10.1161/CIRCULATIONAHA.111.018549; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Westerhout CM, 2011, AM HEART J, V161, P283, DOI 10.1016/j.ahj.2010.10.033; 2006, LANCET, V367, P569	14	448	494	2	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1379	1387		10.1056/NEJMoa1301092	http://dx.doi.org/10.1056/NEJMoa1301092			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23473396				2022-12-28	WOS:000317333600005
J	Heagerty, AM				Heagerty, Anthony M.			Scanning ancient history for evidence of modern diseases	LANCET			English	Editorial Material							ATHEROSCLEROSIS; LESIONS		Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester M13 9NT, Lancs, England	University of Manchester	Heagerty, AM (corresponding author), Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester M13 9NT, Lancs, England.	tony.heagerty@manchester.ac.uk		Heagerty, Anthony/0000-0002-9043-2119				David AR, 2010, LANCET, V375, P718, DOI 10.1016/S0140-6736(10)60294-2; HARRIS JE, 1980, XRAY ATLAS ROYAL MUM; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Ruffer MA, 1911, J PATHOL BACTERIOL, V15, P453, DOI 10.1002/path.1700150403; Shattock S G, 1909, Proc R Soc Med, V2, P122; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Thompson RC, 2013, LANCET; VIRMANI R, 1987, ARCH PATHOL LAB MED, V111, P972	9	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1165	1166		10.1016/S0140-6736(13)60639-X	http://dx.doi.org/10.1016/S0140-6736(13)60639-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23489749				2022-12-28	WOS:000317350100007
J	Kotchen, TA; Cowley, AW; Frohlich, ED				Kotchen, Theodore A.; Cowley, Allen W., Jr.; Frohlich, Edward D.			MEDICAL PROGRESS Salt in Health and Disease - A Delicate Balance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LEFT-VENTRICULAR MASS; LOWER BLOOD-PRESSURE; DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; SENSITIVE HYPERTENSION; OBSERVATIONAL DATA; URINARY SODIUM; HEART-FAILURE; REDUCTION; METAANALYSIS		[Kotchen, Theodore A.; Cowley, Allen W., Jr.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Frohlich, Edward D.] Ochsner Med Ctr, New Orleans, LA USA	Medical College of Wisconsin; Ochsner Health System	Kotchen, TA (corresponding author), Med Coll Wisconsin, Dept Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tkotchen@mcw.edu						Acelajado MC, 2010, HYPERTENSION, V56, P804, DOI 10.1161/HYPERTENSIONAHA.110.160960; Alderman MH, 2012, CURR HYPERTENS REP, V14, P193, DOI 10.1007/s11906-012-0275-6; Bayer R, 2012, HEALTH AFFAIR, V31, P2738, DOI 10.1377/hlthaff.2012.0554; Beeks E, 2004, J HYPERTENS, V22, P1243, DOI 10.1097/01.hjh.0000125443.28861.0d; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; BOEGEHOLD MA, 1991, HYPERTENSION, V17, pI158, DOI 10.1161/01.HYP.17.1_Suppl.I158; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Carey RM, 2012, HYPERTENSION, V60, P1359, DOI 10.1161/HYPERTENSIONAHA.112.196071; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Daniels D, 2004, PHYSIOL BEHAV, V81, P319, DOI 10.1016/j.physbeh.2004.02.013; Department of Health and Human Services/Department of Agriculture, 2005, DIET GUID AM; Dept. of Agriculture Dept. of Health and Human Services, 2010, DIET GUID AM; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; du Cailar G, 2010, HYPERTENSION, V56, P865, DOI 10.1161/HYPERTENSIONAHA.110.159277; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Frohlich ED, 2011, CIRCULATION, V124, P1882, DOI 10.1161/CIRCULATIONAHA.111.029371; FROST CD, 1991, BRIT MED J, V302, P815, DOI 10.1136/bmj.302.6780.815; Fujita T, 2010, HYPERTENSION, V55, P813, DOI 10.1161/HYPERTENSIONAHA.109.149062; Furberg CD, 2012, AM J HYPERTENS, V25, P21, DOI 10.1038/ajh.2011.203; Gardener H, 2012, STROKE, V43, P1200, DOI 10.1161/STROKEAHA.111.641043; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; GRIM CE, 1979, HYPERTENSION, V1, P583, DOI 10.1161/01.HYP.1.6.583; Gunn J. Peralez, 2010, Morbidity and Mortality Weekly Report, V59, P746; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Heagerty AM, 2012, AM J HYPERTENS, V25, P22, DOI 10.1038/ajh.2011.220; Hummel SL, 2012, HYPERTENSION, V60, P1200, DOI 10.1161/HYPERTENSIONAHA.112.202705; Institute of Medicine, 2010, STRAT RED SOD INT US; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jin Y, 2009, HYPERTENSION, V54, P489, DOI 10.1161/HYPERTENSIONAHA.109.130492; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Koleganova N, 2011, AM J PHYSIOL-RENAL, V301, pF344, DOI 10.1152/ajprenal.00626.2010; Kotchen T. A., 2006, MODERN NUTR HLTH DIS, P1095; Kotchen TA, 2009, HYPERTENSION, V54, P449, DOI 10.1161/HYPERTENSIONAHA.109.136226; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Lambers Heerspink HJ, 2012, NEPHROL DIAL TRANSPL, V27, P3435, DOI 10.1093/ndt/gfs354; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Leshem M, 2009, NEUROSCI BIOBEHAV R, V33, P1, DOI 10.1016/j.neubiorev.2008.07.007; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Liu YP, 1999, HYPERTENSION, V33, P686, DOI 10.1161/01.HYP.33.2.686; LUFT F, 1979, ENCOUNTER, V53, P60; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Matavelli LC, 2007, AM J PHYSIOL-HEART C, V292, pH814, DOI 10.1152/ajpheart.00671.2006; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; MILLER JZ, 1987, AM J EPIDEMIOL, V126, P822, DOI 10.1093/oxfordjournals.aje.a114719; Morris MJ, 2008, PHYSIOL BEHAV, V94, P709, DOI 10.1016/j.physbeh.2008.04.008; Nicholls MG, 2011, CURR HYPERTENS REP, V13, P325, DOI 10.1007/s11906-011-0216-9; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ott C, 2007, J HYPERTENS, V25, P1627, DOI 10.1097/HJH.0b013e3281cd40f5; Paterna S, 2009, AM J CARDIOL, V103, P93, DOI 10.1016/j.amjcard.2008.08.043; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Pimenta E, 2008, HYPERTENSION, V51, P339, DOI 10.1161/HYPERTENSIONAHA.107.100701; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Safar ME, 2009, HYPERTENSION, V54, P203, DOI 10.1161/HYPERTENSIONAHA.109.129585; Sanders PW, 2009, AM J PHYSIOL-RENAL, V297, pF237, DOI 10.1152/ajprenal.00027.2009; Siagman MC, 2011, BMJ-BRIT MED J, V343, pd4366; SimonsMorton DG, 1997, PEDIATR NEPHROL, V11, P244, DOI 10.1007/s004670050271; Simpson FO, 1990, HYPERTENSION PATHOPH, P205; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Susic D, 2011, J HYPERTENS, V29, P716, DOI 10.1097/HJH.0b013e3283440683; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; Vaidya A, 2009, AM J HYPERTENS, V22, P669, DOI 10.1038/ajh.2009.45; Varagic J, 2006, AM J PHYSIOL-HEART C, V290, pH1503, DOI 10.1152/ajpheart.00970.2005; Varagic J, 2008, AM J PHYSIOL-HEART C, V294, pH853, DOI 10.1152/ajpheart.00737.2007; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257	85	193	203	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1229	1237		10.1056/NEJMra1212606	http://dx.doi.org/10.1056/NEJMra1212606			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23534562				2022-12-28	WOS:000316869000010
J	Baldassarre, RL; Hughes, TH				Baldassarre, Randall L.; Hughes, Tudor H.			RATIONAL IMAGING Investigating suspected scaphoid fracture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE-SCINTIGRAPHY; MODALITIES; ACCURACY		[Baldassarre, Randall L.; Hughes, Tudor H.] Univ Calif San Diego, Dept Radiol, San Diego Med Ctr, San Diego, CA 92103 USA	University of California System; University of California San Diego	Hughes, TH (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego Med Ctr, 200 West Arbor Dr, San Diego, CA 92103 USA.	thughes@ucsd.edu		Hughes, Tudor/0000-0001-9385-6956				Beeres FJP, 2008, J BONE JOINT SURG BR, V90B, P1205, DOI 10.1302/0301-620X.90B9.20341; Beeres FJP, 2005, INJURY, V36, P1233, DOI 10.1016/j.injury.2005.02.009; Brydie A, 2003, BRIT J RADIOL, V76, P296, DOI 10.1259/bjr/19790905; DAFFNER RH, 1992, J HAND SURG-AM, V17A, P499, DOI 10.1016/0363-5023(92)90361-R; Groves AM, 2006, AM J ROENTGENOL, V187, P1453, DOI 10.2214/AJR.05.0686; Hauger O, 2002, AM J ROENTGENOL, V178, P1239, DOI 10.2214/ajr.178.5.1781239; Jenkins PJ, 2008, INJURY, V39, P768, DOI 10.1016/j.injury.2008.01.003; LARSEN CF, 1992, ACTA ORTHOP SCAND, V63, P216, DOI 10.3109/17453679209154827; Memarsadeghi M, 2006, RADIOLOGY, V240, P169, DOI 10.1148/radiol.2401050412; Platon A, 2011, SKELETAL RADIOL, V40, P869, DOI 10.1007/s00256-010-1086-y; The Royal College of Radiologists, 2012, IREFER MAK BEST US C; TIELVANBUUL MMC, 1993, J HAND SURG-BRIT EUR, V18B, P403, DOI 10.1016/0266-7681(93)90074-P; Yin ZG, 2012, J BONE JOINT SURG BR, V94B, P1077, DOI 10.1302/0301-620X.94B8.28998; [No title captured]	14	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f1370	10.1136/bmj.f1370	http://dx.doi.org/10.1136/bmj.f1370			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WT	23535257				2022-12-28	WOS:000316984500003
J	Prague, JK; May, S; Whitelaw, BC				Prague, Julia Kate; May, Stephanie; Whitelaw, Benjamin Cameron			EASILY MISSED? Cushing's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; DISEASE; EVENTS; RISK		[Prague, Julia Kate; Whitelaw, Benjamin Cameron] Kings Coll Hosp London, London SE5 9RS, England; [May, Stephanie] Stockwell Grp Practice, London SW9, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Whitelaw, BC (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	benjamin.whitelaw@nhs.net	Whitelaw, Benjamin/I-1726-2019	Whitelaw, Benjamin/0000-0002-7870-6666				ANDERSON GH, 1994, J HYPERTENS, V12, P609, DOI 10.1097/00004872-199405000-00015; Clayton RN, 2011, J CLIN ENDOCR METAB, V96, P632, DOI 10.1210/jc.2010-1942; Fardet L, 2007, BRIT J DERMATOL, V157, P142, DOI 10.1111/j.1365-2133.2007.07950.x; Fardet L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4928; Findling JW, 2005, ENDOCRIN METAB CLIN, V34, P385, DOI 10.1016/j.ecl.2005.02.001; Giraldi FP, 2007, J CLIN ENDOCR METAB, V92, P4123, DOI 10.1210/jc.2007-0596; GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; PLOTZ CM, 1952, AM J MED, V13, P597, DOI 10.1016/0002-9343(52)90027-2; Psaras T, 2011, EXP CLIN ENDOCR DIAB, V119, P21, DOI 10.1055/s-0030-1263104; Reimondo G, 2005, EUR J ENDOCRINOL, V153, P803, DOI 10.1530/eje.1.02042; ROSS EJ, 1982, LANCET, V2, P646; Tempark T, 2010, ENDOCRINE, V38, P328, DOI 10.1007/s12020-010-9393-6; Terzolo M, 2012, J CLIN ENDOCR METAB, V97, P3467, DOI 10.1210/jc.2012-1323; Wood PJ, 1997, ANN CLIN BIOCHEM, V34, P222, DOI 10.1177/000456329703400302	17	21	22	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f945	10.1136/bmj.f945	http://dx.doi.org/10.1136/bmj.f945			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WT	23535464				2022-12-28	WOS:000316984500012
J	Collins, M; Latimer, N				Collins, Marissa; Latimer, Nicholas			NICE's end of life decision making scheme: impact on population health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Collins, Marissa] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland; [Latimer, Nicholas] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England	Glasgow Caledonian University; University of Sheffield	Collins, M (corresponding author), Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland.	marissa.collins@gcu.ac.uk		Collins, Marissa/0000-0002-0896-6673; Latimer, Nicholas/0000-0001-5304-5585				[Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2011, NICE TECHN APPR GUID; [Anonymous], 2010, NICE TECHN APPR GUID; [Anonymous], 2011, NICE TECHN APPR GUID; [Anonymous], 2009, NICE TECHN APPR GUID; [Anonymous], 2009, NIC TECHN APPR GUID; Claxton K, 2013, 81 CHE; Department of Health, 2011, GUID SUPP OP CANC DR; Kerr M, 2012, CHRONIC KIDNEY DIS E; Linley WG, 2012, HLTH EC; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; NICE, 2004, GUID METH TECHN APPR; NICE, 2009, APPR LIF EXT END LIF; Raftery JP, 2009, BMJ-BRIT MED J, V338, P271; Shah K, 2012, VALUING HLTH END LIF, P56	18	36	37	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2013	346								f1363	10.1136/bmj.f1363	http://dx.doi.org/10.1136/bmj.f1363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MJ	23518274				2022-12-28	WOS:000316671800004
J	Opal, SM; Laterre, PF; Francois, B; LaRosa, SP; Angus, DC; Mira, JP; Wittebole, X; Dugernier, T; Perrotin, D; Tidswell, M; Jauregui, L; Krell, K; Pachl, J; Takahashi, T; Peckelsen, C; Cordasco, E; Chang, CS; Oeyen, S; Aikawa, N; Maruyama, T; Schein, R; Kalil, AC; Van Nuffelen, M; Lynn, M; Rossignol, DP; Gogate, J; Roberts, MB; Wheeler, JL; Vincent, JL				Opal, Steven M.; Laterre, Pierre-Francois; Francois, Bruno; LaRosa, Steven P.; Angus, Derek C.; Mira, Jean-Paul; Wittebole, Xavier; Dugernier, Thierry; Perrotin, Dominique; Tidswell, Mark; Jauregui, Luis; Krell, Kenneth; Pachl, Jan; Takahashi, Takeshi; Peckelsen, Claus; Cordasco, Edward; Chang, Chia-Sheng; Oeyen, Sandra; Aikawa, Naoki; Maruyama, Tatsuya; Schein, Roland; Kalil, Andre C.; Van Nuffelen, Marc; Lynn, Melvyn; Rossignol, Daniel P.; Gogate, Jogadish; Roberts, Mary B.; Wheeler, Janice L.; Vincent, Jean-Louis		ACCESS Study Grp	Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GRAM-NEGATIVE BACTEREMIA; ENDOTOXIN RESPONSE; TETRASODIUM E5564; INHIBITION; ILLNESS; PROTEIN; MURINE; SAFETY; SHOCK	Importance Eritoran is a synthetic lipid A antagonist that blocks lipopolysaccharide (LPS) from binding at the cell surface MD2-TLR4 receptor. LPS is a major component of the outer membrane of gram-negative bacteria and is a potent activator of the acute inflammatory response. Objective To determine if eritoran, a TLR4 antagonist, would significantly reduce sepsis-induced mortality. Design, Setting, and Participants We performed a randomized, double-blind, placebo-controlled, multinational phase 3 trial in 197 intensive care units. Patients were enrolled from June 2006 to September 2010 and final follow-up was completed in September 2011. Interventions Patients with severe sepsis (n=1961) were randomized and treated within 12 hours of onset of first organ dysfunction in a 2: 1 ratio with a 6-day course of either eritoran tetrasodium (105 mg total) or placebo, with n=1304 and n=657 patients, respectively. Main Outcome Measures The primary end point was 28-day all-cause mortality. The secondary end points were all-cause mortality at 3, 6, and 12 months after beginning treatment. Results Baseline characteristics of the 2 study groups were similar. In the modified intent-to-treat analysis (randomized patients who received at least 1 dose) there was no significant difference in the primary end point of 28-day all-cause mortality with 28.1% (366/1304) in the eritoran group vs 26.9% (177/657) in the placebo group (P=.59; hazard ratio, 1.05; 95% CI, 0.88-1.26; difference in mortality rate, -1.1; 95% CI, -5.3 to 3.1) or in the key secondary end point of 1-year all-cause mortality with 44.1% (290/657) in the eritoran group vs 43.3% (565/1304) in the placebo group, Kaplan-Meier analysis of time to death by 1 year, P=.79 (hazard ratio, 0.98; 0.85-1.13). No significant differences were observed in any of the prespecified subgroups. Adverse events, including secondary infection rates, did not differ between study groups. Conclusions and Relevance Among patients with severe sepsis, the use of eritoran, compared with placebo, did not result in reduced 28-day mortality. Trial Registration clinicaltrials.gov Identifier: NCT00334828 JAMA. 2013;309(11):1154-1162 www.jama.com	[Opal, Steven M.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Laterre, Pierre-Francois; Wittebole, Xavier] UCL, St Luc Univ Hosp, Brussels, Belgium; [Francois, Bruno] CHU, CIC 0801, Dupuytren Univ Hosp, INSERM, Limoges, France; [LaRosa, Steven P.] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Healthcare, Temple, TX USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Mira, Jean-Paul] Univ Paris 05, Cochin Univ Hosp, AP HP, Fac Med, Paris, France; [Dugernier, Thierry] St Pierre Hosp, Ottignies, Belgium; [Perrotin, Dominique] Univ Tours, CHU Bretonneau, Tours, France; [Tidswell, Mark] Baystate Med Ctr, Springfield, MA USA; [Jauregui, Luis] Mercy St Vincent Med Ctr, Toledo, OH USA; [Krell, Kenneth] Eastern Idaho Reg Med Ctr, Idaho Falls, ID USA; [Pachl, Jan] Charles Univ Prague, Sch Med 3, Prague, Czech Republic; [Takahashi, Takeshi] Vinohrady Teaching Hosp, Prague, Czech Republic; [Peckelsen, Claus] Harlaching Hosp, Munich Municipal Hosp Grp, Munich, Germany; [Cordasco, Edward] Remington Davis Inc, Columbus, OH USA; [Chang, Chia-Sheng] China Med Univ Hosp, Taichung, Taiwan; [Oeyen, Sandra] Ghent Univ Hosp, Ghent, Belgium; [Aikawa, Naoki; Maruyama, Tatsuya] Keio Univ, Sch Med, Tokyo, Japan; [Schein, Roland] Univ Miami, Miller Sch Med, Miama, FL USA; [Kalil, Andre C.] Univ Nebraska Med Ctr, Omaha, NE USA; [Van Nuffelen, Marc; Lynn, Melvyn; Rossignol, Daniel P.; Gogate, Jogadish; Wheeler, Janice L.] Eisai Inc, Woodcliff Lake, NJ USA; [Roberts, Mary B.] Brown Univ, Ctr Primary Care & Prevent, Pawtucket, RI 02860 USA; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Div Infect Dis, Pawtucket, RI 02860 USA; [Roberts, Mary B.] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA; [Vincent, Jean-Louis] Erasme Univ, Brussels, Belgium	Brown University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite de Tours; Baystate Medical Center; Charles University Prague; University Hospital Vinohrady; China Medical University Taiwan; China Medical University Hospital - Taiwan; Ghent University; Ghent University Hospital; Keio University; University of Nebraska System; University of Nebraska Medical Center; Eisai Co Ltd; Brown University; Brown University; Brown University; Universite Libre de Bruxelles	Opal, SM (corresponding author), Brown Univ, Mem Hosp Rhode Isl, Div Infect Dis, 111 Brewster St, Pawtucket, RI 02860 USA.	Steven_Opal@brown.edu	Wittebole, Xavier/ABC-2036-2021; Chan, Edward K. L./B-5671-2009; François, Bruno/O-8404-2016; Oeyen, Sandra/AAE-2838-2021; Angus, Derek C/E-9671-2012	Wittebole, Xavier/0000-0002-0621-8727; Chan, Edward K. L./0000-0003-3938-9503; François, Bruno/0000-0002-2531-1652; Vincent, Jean-Louis/0000-0001-6011-6951	Sirtris Pharmaceuticals; clinical coordinating center and the clinical evaluation committee; Agennix AG; Astra-Zeneca; Eisai Inc; Roche Diagnostics; MedImmune; Pfizer Inc; Idaho Technologies; Eisai Co.	Sirtris Pharmaceuticals; clinical coordinating center and the clinical evaluation committee; Agennix AG; Astra-Zeneca(AstraZeneca); Eisai Inc(Eisai Co Ltd); Roche Diagnostics; MedImmune(AstraZenecaMedimmune); Pfizer Inc(Pfizer); Idaho Technologies; Eisai Co.(Eisai Co Ltd)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Opal reports receipt of grant/research support from Sirtris Pharmaceuticals; serving as a consultant to Kenta Biotech, Arsanis, Agennix, and Astra-Zeneca; and serving on the clinical coordinating center and the clinical evaluation committee in support of this study. Dr Laterre reports serving as a consultant to Eisai Inc for the protocol design, serving on the speaker's bureau of Eisai Inc for the ISICEM, and being a member of the clinical evaluation committee of the ACCESS study for Eisai Inc. Dr Francois reports serving as a consultant to LillyTalecris. Dr LaRosa reports receipt of grant/research support from Agennix AG and Astra-Zeneca; serving as a consultant to Talecris Biopharmaceuticals; Dr La Rosa reports receipt of a grant to the institution and receipt of fees for participation in review activities such as data monitoring boards, statistical analysis, and end point committees from Eisai Inc; and serving as a consultant for ExThera Medical. Dr Angus reports receipt of a grant to the institution, consulting fees, and travel support from Eisai Inc; receipt of consultancy fees from Roche Diagnostics, MedImmune, Pfizer Inc, and Idaho Technologies; and serving on the data and safety monitoring board for Eli Lilly. Dr Mira reports serving as a consultant to Eisai Inc as amember of the clinical evaluation committee for the ACCESS study and as the national coordinator for France for this study. Dr Mira also reports serving as a consultant for Eli Lilly, Novartis, Astra-Zeneca, LFB Biotechnologies, and Merck. Dr Chang reports receipt of grant/research support from Eisai Inc. Dr Aikawa reports being a medical advisor for the eritoran phase 3 clinical trial sponsored by the Eisai Co. Dr Aikawa reports receipt of travel expenses from Eisai Inc. Dr Schein reports receipt of fees and travel support from Eisai Inc; receipt of fees for participation in review activities such as data monitoring boards, statistical analysis, and end point committees from Eisai Medical Research; and receipt of a grant to the institution form the University of Miami. Dr Kalil reports receipt of grant/research support from Eisai Inc. Dr Vincent reports receipt of grant/research support, serving as a consultant, and serving on the speaker's bureau for Eisai Inc.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dellinger RP, 2009, CRIT CARE MED, V37, P2929, DOI 10.1097/CCM.0b013e3181b0266c; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; GREENMAN RL, 1991, JAMA-J AM MED ASSOC, V266, P1097, DOI 10.1001/jama.266.8.1097; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; HURLEY JC, 1994, J CLIN MICROBIOL, V32, P2120, DOI 10.1128/JCM.32.9.2120-2127.1994; Kalil AC, 2011, SHOCK, V36, P327, DOI 10.1097/SHK.0b013e318227980e; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2011, CRIT CARE MED, V39, P2425, DOI 10.1097/CCM.0b013e31822572e3; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Lynn M, 2003, J INFECT DIS, V187, P631, DOI 10.1086/367990; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Rossignol DP, 2004, ANTIMICROB AGENTS CH, V48, P3233, DOI 10.1128/AAC.48.9.3233-3240.2004; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Vincent JL, 2010, CRIT CARE MED, V38, P283, DOI 10.1097/CCM.0b013e3181b785a2; WARREN HS, 1993, J EXP MED, V177, P89, DOI 10.1084/jem.177.1.89; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001	31	523	548	4	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1154	1162		10.1001/jama.2013.2194	http://dx.doi.org/10.1001/jama.2013.2194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512062	Green Published			2022-12-28	WOS:000316276500029
J	Storz-Pfennig, P; Schmedders, M; Dettloff, M				Storz-Pfennig, Philipp; Schmedders, Mechtild; Dettloff, Matthias			Trials are needed before new devices are used in routine practice in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH TECHNOLOGIES; MEDICAL DEVICES; COVERAGE; TRANSCATHETER; IMPLANTS; STENOSIS; ISSUES; ACCESS; CARE; FDA		[Storz-Pfennig, Philipp; Schmedders, Mechtild; Dettloff, Matthias] GKV Spitzenverband, Med, D-10117 Berlin, Germany		Storz-Pfennig, P (corresponding author), GKV Spitzenverband, Med, Mittelstr 51, D-10117 Berlin, Germany.	Philipp.Storz@gkv-spitzenverband.de						[Anonymous], 2006, GUIDANCE PUBLIC IND; [Anonymous], 2012, AQUA QUAL 2011; [Anonymous], 2011, BUNDESGESETZBLATT 1, VI, P2983; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; BRABANDT HV, 2012, BRIT MED J, V345; Broderick JP, 2011, NEW ENGL J MED, V365, P1054, DOI 10.1056/NEJMe1108394; Centers for Medicare and Medicaid Services, DEC MEM TRANSC AORT; Centers for Medicare and Medicaid Services, 2012, VIEW PUBL COMM CED P; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Claxton K, 2011, INFORM DECISION FRAM; Claxton K, 2011, UNCERTAINTY EVIDENCE; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7090; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Dhalla IA, 2009, INT J TECHNOL ASSESS, V25, P272, DOI 10.1017/S026646230999002X; Dobler K, 2012, Z HERZ THORAX GEFASS, V26, P86, DOI 10.1007/s00398-012-0911-0; European Commission, 2012, PROP REG EUR PARL CO; Figulla HR, 2009, KARDIOLOGE, V3, P199, DOI 10.1007/s12181-009-0183-4; Gottardi R, SYSTEMATISCHER REV; Greene JA, 2012, NEW ENGL J MED, V367, P1481, DOI 10.1056/NEJMp1210007; Hauser RG, 2010, NEW ENGL J MED, V366, P873; Haute Autorite de Sante, 2011, TRANSC AORT VALV IMP; Heneghan C, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e306; Institut fur angewandte Qualitatsforderung und Forschung im Gesundheitswesen, 2011, GERM HOSP QUAL REP 2; Klemp M, 2011, INT J TECHNOL ASSESS, V27, P77, DOI 10.1017/S0266462310001297; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V306, P1639, DOI 10.1001/jama.2011.1477; Lenzer J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4753; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Longworth L, 2013, PHARMACOECONOMICS, V31, P137, DOI 10.1007/s40273-012-0013-6; Miller FG, 2008, MED CARE, V46, P746, DOI 10.1097/MLR.0b013e3181789453; Mohr PE, 2010, PHARMACOECONOMICS, V28, P153, DOI 10.2165/11531050-000000000-00000; Nainggolan L, 2011, GERMANY TOPS TAVI TA; National Institute for Health and Care Excellence (NICE), 2012, TRANSC AORT VALV IMP; Neumann PJ, 2012, NEW ENGL J MED, V367, P1775, DOI 10.1056/NEJMp1208386; Neyt M, 2011, TRANSCATHETER AORTIC; Polisena J., 2018, HLTH TECHNOLOGY ASSE; Sehatzadeh S, 2012, TRANSCATHETER AORTIC; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stafinski T, 2011, CLINICOECONOMIC OUTC, V3, P117, DOI 10.2147/CEOR.S14407; Stafinski T, 2010, PHARMACOECONOMICS, V28, P113, DOI 10.2165/11530820-000000000-00000; Trueman P, 2010, INT J TECHNOL ASSESS, V26, P79, DOI 10.1017/S0266462309990882; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; US Food and Drug Administration, 2012, STRYK WINGSP STENT S	42	24	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2013	346								f1646	10.1136/bmj.f1646	http://dx.doi.org/10.1136/bmj.f1646			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113LR	23507537				2022-12-28	WOS:000316669700002
J	Adams, RL; Wente, SR				Adams, Rebecca L.; Wente, Susan R.			Uncovering Nuclear Pore Complexity with Innovation	CELL			English	Review							TRANSPORT; PROTEINS; CHANNEL	Advances in imaging and reductionist approaches have provided a high-resolution understanding of nuclear pore complex structure and transport, revealing unexpected mechanistic complexities based on nucleoporin functions and specialized import and export pathways.	[Adams, Rebecca L.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			National Institutes of Health [R37GM051219, T32HD007502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511, R01GM057438, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Joe Gall (Carnegie Institution for Science) and Markus Sauer (Julius-Maximilians-University Wurzburg) for permission to reprint the images in Figures 1A and 1B, and we thank Wente laboratory members and Elizabeth Bowman for discussion. Due to space constraints, we regret not being able to cite all primary references. The authors were supported by grants from the National Institutes of Health (R37GM051219 [S.R.W.] and T32HD007502 [R.L.A.]).	Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Bilokapic S, 2012, CURR OPIN CELL BIOL, V24, P86, DOI 10.1016/j.ceb.2011.12.011; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; Folkmann AW, 2011, NUCLEUS-PHILA, V2, P540, DOI 10.4161/nucl.2.6.17881; GALL JG, 1954, EXP CELL RES, V7, P197, DOI 10.1016/0014-4827(54)90054-3; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hayakawa A, 2012, J CELL BIOL, V196, P19, DOI 10.1083/jcb.201108124; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	23	70	70	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1218	1221		10.1016/j.cell.2013.02.042	http://dx.doi.org/10.1016/j.cell.2013.02.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498931	Green Accepted, Bronze			2022-12-28	WOS:000316192500004
J	Chan, PS; Nallamothu, BK; Krumholz, HM; Spertus, JA; Li, Y; Hammill, BG; Curtis, LH				Chan, Paul S.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Spertus, John A.; Li, Yan; Hammill, Bradley G.; Curtis, Lesley H.		Amer Heart Assoc Get Guidelines	Long-Term Outcomes in Elderly Survivors of In-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUSTRALIAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE-PROFESSIONALS; CAUSE READMISSION RATES; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; SOUTHERN-AFRICA; PERFORMANCE; STATEMENT; REGISTRY	BACKGROUND Little is known about the long-term outcomes in elderly survivors of in-hospital cardiac arrest. We determined rates of long-term survival and readmission among survivors of in-hospital cardiac arrest and examined whether these outcomes differed according to demographic characteristics and neurologic status at discharge. METHODS We linked data from a national registry of inpatient cardiac arrests with Medicare files and identified 6972 adults, 65 years of age or older, who were discharged from the hospital after surviving an in-hospital cardiac arrest between 2000 and 2008. Predictors of 1-year survival and of readmission to the hospital were examined. RESULTS One year after hospital discharge, 58.5% of the patients were alive, and 34.4% had not been readmitted to the hospital. The risk-adjusted rate of 1-year survival was lower among older patients than among younger patients (63.7%, 58.6%, and 49.7% among patients 65 to 74, 75 to 84, and >= 85 years of age, respectively; P<0.001), among men than among women (58.6% vs. 60.9%, P = 0.03), and among black patients than among white patients (52.5% vs. 60.4%, P = 0.001). The risk-adjusted rate of 1-year survival was 72.8% among patients with mild or no neurologic disability at discharge, as compared with 61.1% among patients with moderate neurologic disability, 42.2% among those with severe neurologic disability, and 10.2% among those in a coma or vegetative state (P<0.001 for all comparisons). Moreover, 1-year readmission rates were higher among patients who were black, those who were women, and those who had substantial neurologic disability (P<0.05 for all comparisons). These differences in survival and readmission rates persisted at 2 years. At 3 years, the rate of survival among survivors of in-hospital cardiac arrest was similar to that of patients who had been hospitalized with heart failure and were discharged alive (43.5% and 44.9%, respectively; risk ratio, 0.98; 95% confidence interval, 0.95 to 1.02; P = 0.35). CONCLUSIONS Among elderly survivors of in-hospital cardiac arrest, nearly 60% were alive at 1 year, and the rate of 3-year survival was similar to that among patients with heart failure. Survival and readmission rates differed according to the demographic characteristics of the patients and neurologic status at discharge. (Funded by the American Heart Association and the National Heart, Lung, and Blood Institute.)	[Chan, Paul S.; Spertus, John A.; Li, Yan] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Nallamothu, Brahmajee K.] Univ Michigan, VA Ann Arbor Healthcare Syst, Vet Affairs VA Hlth Serv Res & Dev Ctr, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Hammill, Bradley G.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University; Duke University; Duke University	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 5th Fl,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020		American Heart Association; National Heart, Lung, and Blood Institute [K23HL102224, 1U01HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224, U01HL105270] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the American Heart Association and by a Career Development Grant Award (K23HL102224, to Dr. Chan) from the National Heart, Lung, and Blood Institute. Dr. Krumholz was supported, in part, by a grant (1U01HL105270-02) from the National Heart, Lung, and Blood Institute to the Center for Cardiovascular Outcomes Research at Yale University.	Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Bloom HL, 2007, AM HEART J, V153, P831, DOI 10.1016/j.ahj.2007.02.011; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Herlitz J, 2000, RESUSCITATION, V45, P167, DOI 10.1016/S0300-9572(00)00187-8; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kalbag A, 2006, RESUSCITATION, V68, P79, DOI 10.1016/j.resuscitation.2005.06.003; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Kutsogiannis DJ, 2011, CAN MED ASSOC J, V183, P1589, DOI 10.1503/cmaj.100034; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Team RC., 2022, LANG ENV STAT COMP; Topjian AA, 2010, CRIT CARE MED, V38, P1254, DOI 10.1097/CCM.0b013e3181d8ca43; Zoch TW, 2000, ARCH INTERN MED, V160, P1969, DOI 10.1001/archinte.160.13.1969; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	112	113	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1019	1026		10.1056/NEJMoa1200657	http://dx.doi.org/10.1056/NEJMoa1200657			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484828	Green Accepted			2022-12-28	WOS:000315982100008
J	Downar, J; Kritek, PA				Downar, James; Kritek, Patricia A.			Family Presence during Cardiac Resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Downar, James] Univ Hlth Network, Toronto, ON, Canada; [Kritek, Patricia A.] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Toronto; University Health Network Toronto; University of Washington; University of Washington Seattle	Downar, J (corresponding author), Univ Hlth Network, Toronto, ON, Canada.							Aidman EV, 2006, PSYCHOL REP, V99, P569, DOI 10.2466/PR0.99.2.569-580; Compton S, 2011, J PALLIAT MED, V14, P715, DOI 10.1089/jpm.2010.0463; Curley MAQ, 2012, AM J RESP CRIT CARE, V186, P1133, DOI 10.1164/rccm.201205-0915OC; Dudley NC, 2009, ANN EMERG MED, V53, P777, DOI 10.1016/j.annemergmed.2008.10.002; Itzhaki M, 2012, J ADV NURS, V68, P1967, DOI 10.1111/j.1365-2648.2011.05883.x; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; O'Connell KJ, 2007, PEDIATRICS, V120, pE565, DOI 10.1542/peds.2006-2914	8	8	8	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1060	1062		10.1056/NEJMclde1301020	http://dx.doi.org/10.1056/NEJMclde1301020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104HF	23484836				2022-12-28	WOS:000315982100016
J	Kirchmair, G; Vlastakis, B; Leghtas, Z; Nigg, SE; Paik, H; Ginossar, E; Mirrahimi, M; Frupzio, L; Girvin, SM; Schoelkopf, RJ				Kirchmair, Gerhard; Vlastakis, Brian; Leghtas, Zaki; Nigg, Simon E.; Paik, Hanhee; Ginossar, Eran; Mirrahimi, Mazyar; Frupzio, Luigi; Girvin, S. M.; Schoelkopf, R. J.			Observation of quantum state collapse and revival due to the single-photon Kerr effect	NATURE			English	Article							TRAPPED ATOM; GENERATION; CIRCUIT; OPTICS; CAVITY; FIELD	To create and manipulate non-classical states of light for quantum information protocols, a strong, nonlinear interaction at the single-photon level is required. One approach to the generation of suitable interactions is to couple photons to atoms, as in the strong coupling regime of cavity quantum electrodynamic systems(1,2). In these systems, however, the quantum state of the light is only indirectly controlled by manipulating the atoms(3). A direct photon-photon interaction occurs in so-called Kerr media, which typically induce only weak nonlinearity at the cost of significant loss. So far, it has not been possible to reach the single-photon Kerr regime, in which the interaction strength between individual photons exceeds the loss rate. Here, using a three-dimensional circuit quantum electrodynamic architecture(4), we engineer an artificial Kerr medium that enters this regime and allows the observation, of new quantum effects. We realize a gedanken experiment(5) in which the collapse and revival of a coherent state can be observed. This time evolution is a consequence of the quantization of the light field in the cavity and the nonlinear interaction between individual photons. During the evolution, non-classical superpositions of coherent states (that is, multi-component 'Schrodinger cat' states) are formed. We visualize this evolution by measuring the Husimi Q function and confirm the non-classical properties of these transient states by cavity state tomography. The ability to create and manipulate superpositions of coherent states in such a high-quality-factor photon mode opens perspectives for combining the physics of continuous variables(6) with superconducting circuits. The single-photon Kerr effect could be used in quantum non-demolition measurement of photons(7), single-photon generation(8), autonomous quantum feedback schemes(9) and quantum logic operations(10).	[Kirchmair, Gerhard; Vlastakis, Brian; Nigg, Simon E.; Paik, Hanhee; Mirrahimi, Mazyar; Frupzio, Luigi; Girvin, S. M.; Schoelkopf, R. J.] Yale Univ, Dept Phys, New Haven, CT 06511 USA; [Kirchmair, Gerhard; Vlastakis, Brian; Nigg, Simon E.; Paik, Hanhee; Mirrahimi, Mazyar; Frupzio, Luigi; Girvin, S. M.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; [Leghtas, Zaki; Mirrahimi, Mazyar] INRIA Paris Rocquencourt, F-78153 Le Chesnay, France; [Ginossar, Eran] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Ginossar, Eran] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England	Yale University; Yale University; University of Surrey; University of Surrey	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06511 USA.	robert.schoelkopf@yale.edu	Frunzio, Luigi/C-3884-2009; Kirchmair, Gerhard/J-5218-2013; Frunzio, Luigi/O-1573-2019; Schoelkopf, Robert J/J-8178-2012	Kirchmair, Gerhard/0000-0003-4286-8839; Frunzio, Luigi/0000-0002-0272-5481; Mirrahimi, Mazyar/0000-0001-9471-6031; Leghtas, Zaki/0000-0002-9172-1537	National Science Foundation (NSF) [PHY-0969725]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office [W911NF-09-1-0369]; US Army Research Office [W911NF-09-1-0514]; NSF [DMR-1004406]; French Agence Nationale de la Recherche [ANR-09-JCJC-0070]; Swiss NSF; EPSRC [EP/I026231/1]; Engineering and Physical Sciences Research Council [EP/I026231/1] Funding Source: researchfish	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office; US Army Research Office; NSF(National Science Foundation (NSF)); French Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss NSF(Swiss National Science Foundation (SNSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. H. Devoret, M. D. Reed, M. Hatridge and A. Sears for discussions. This research was supported by the National Science Foundation (NSF) (PHY-0969725), the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office (W911NF-09-1-0369), and the US Army Research Office (W911NF-09-1-0514). Use of facilities was supported by the Yale Institute for Nanoscience and Quantum Engineering (YINQE) and the NSF (MRSECDMR 1119826). S.M.G. acknowledges support from the NSF (DMR-1004406). M.M. and Z.L. acknowledge support from French Agence Nationale de la Recherche under the project EPOQ2 (ANR-09-JCJC-0070). S.E.N. acknowledges support from-the Swiss NSF. E.G. acknowledges support from EPSRC (EP/I026231/1).	Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Bourassa J, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013814; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Eichler C, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032106; FISHER RA, 1969, APPL PHYS LETT, V14, P140, DOI 10.1063/1.1652749; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Haroche S., 2006, EXPLORING QUANTUM; Hoffman AJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053602; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Johnson BR, 2010, NAT PHYS, V6, P663, DOI 10.1038/NPHYS1710; Kerckhoff J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040502; Leghtas Z., 2012, PREPRINT; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; MILBURN GJ, 1986, PHYS REV A, V33, P674, DOI 10.1103/PhysRevA.33.674; MILBURN GJ, 1989, PHYS REV LETT, V62, P2124, DOI 10.1103/PhysRevLett.62.2124; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Saleh B. E. A., 1991, WILEY SERIES PURE AP; Shalibo Y., 2012, PREPRINT; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Solano E, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.013813; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Yin Y, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023826; YURKE B, 1988, PHYSICA B & C, V151, P298, DOI 10.1016/0378-4363(88)90181-7; YURKE B, 1988, PHYS REV LETT, V60, P764, DOI 10.1103/PhysRevLett.60.764	30	323	333	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					205	209		10.1038/nature11902	http://dx.doi.org/10.1038/nature11902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486059	Green Submitted			2022-12-28	WOS:000316652300044
J	Roberts, I; Jackson, R				Roberts, Ian; Jackson, Rod			Beyond disease burden: towards solution-oriented population health	LANCET			English	Editorial Material							PUBLIC-HEALTH; GLOBAL BURDEN; QUALITY		[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Jackson, Rod] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	University of London; London School of Hygiene & Tropical Medicine; University of Auckland	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Jackson, Rod/0000-0001-5914-6934				Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Chalabi Z, 2008, EUR J OPER RES, V191, P529, DOI 10.1016/j.ejor.2007.07.026; Chan M, 2012, LANCET, V380, P2054, DOI 10.1016/S0140-6736(12)62135-7; Claxton KP, 2006, PHARMACOECONOMICS, V24, P1055, DOI 10.2165/00019053-200624110-00003; Epstein DM, 2007, MED DECIS MAKING, V27, P128, DOI 10.1177/0272989X06297396; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; Jackson R, 2006, BMJ-BRIT MED J, V332, P617, DOI 10.1136/bmj.332.7542.617; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Kim JY, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62162-X; Lang T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5466; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; NHS Sustainable Development Unit, 2012, NHS ENGL CARB FOOTPR; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rose G., 1992, STRATEGY PREVENTIVE, P72; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Smith AJ, TOB CONTROL IN PRESS; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Williams A, 1999, HEALTH ECON, V8, P1; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	23	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2219	2221		10.1016/S0140-6736(13)60602-9	http://dx.doi.org/10.1016/S0140-6736(13)60602-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23489751				2022-12-28	WOS:000320925600038
J	Wacker, D; Wang, C; Katritch, V; Han, GW; Huang, XP; Vardy, E; McCorvy, JD; Jiang, Y; Chu, MH; Siu, FY; Liu, W; Xu, HE; Cherezov, V; Roth, BL; Stevens, RC				Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Xu, H. Eric; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.			Structural Features for Functional Selectivity at Serotonin Receptors	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PATHWAYS; AGONISTS	Drugs active at G protein-coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling. We report biochemical studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for beta-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor. To investigate the structural basis for biased signaling, we determined the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure. Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.	[Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, NIMH,Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Mat Med Ctr, Van Andel Res Inst,CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute	Roth, BL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, NIMH,Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu; stevens@scripps.edu	Katritch, Vsevolod/Q-8357-2016; Roth, Bryan L/F-3928-2010; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLT-1531-2022; Roth, Bryan/ABE-7032-2020; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Xu, H. Eric/ABD-7487-2021; Katritch, Vsevolod/Y-2721-2019	Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Roth, Bryan/0000-0002-0561-6520; Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Xu, H. Eric/0000-0002-6829-8144; Barabasi, Albert/0000-0002-4028-3522	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM094618]; NIH [P50 GM073197]; Jay and Betty Van Andel Foundation, Amway (China) [R01 DK071662]; Ministry of Science and Technology (China) [2012ZX09301001-005, 2012CB910403, U19 MH82441, R01 MH61887]; National Institute of Mental Health Psychoactive Drug Screening Program; Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship; Receptos; GPCR structure-based drug discovery company; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Office of Science of the U.S. Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation, Amway (China); Ministry of Science and Technology (China)(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Institute of Mental Health Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship(Boehringer Ingelheim); Receptos; GPCR structure-based drug discovery company; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-4) (V. K., V. C., and R. C. S.); NIH Common Fund in Structural Biology grant P50 GM073197 for technology development (V. C. and R. C. S.); the Jay and Betty Van Andel Foundation, Amway (China), grant R01 DK071662; Ministry of Science and Technology (China) grants 2012ZX09301001-005 and 2012CB910403 (H. E. X.); grants U19 MH82441, R01 MH61887, and the National Institute of Mental Health Psychoactive Drug Screening Program (X.-P. H., E. V., and B. L. R.); and the Michael Hooker Chair of Pharmacology (B. L. R.). D. W. is supported by a Boehringer Ingelheim Fonds Ph.D. Fellowship. R. C. S. is a founder and paid consultant for Receptos, a GPCR structure-based drug discovery company. We thank J. Velasquez for help on molecular biology; T. Trinh, K. Allin, and M. Chu for help on baculovirus expression; L. N. Collins for help on initial construct selection; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; I. Wilson for careful review and scientific feedback on the manuscript; T. Kenakin (University of North Carolina) for helpful discussions regarding the quantification of ligand bias; J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104. Use of the Advanced Photon Source was supported by the Office of Science of the U.S. Department of Energy. Coordinates and the structure factors of the 5-HT<INF>2B</INF>/ERG complex have been deposited in the Protein Data Bank under the accession code 4IB4.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Huang XP, 2009, MOL PHARMACOL, V76, P710, DOI 10.1124/mol.109.058057; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	27	643	675	9	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					615	619		10.1126/science.1232808	http://dx.doi.org/10.1126/science.1232808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23519215	Green Submitted, Green Accepted			2022-12-28	WOS:000318268900049
J	Kuhn, L; Coovadia, HM				Kuhn, Louise; Coovadia, Hoosen M.			Monitoring strategies for management of ART in children	LANCET			English	Editorial Material							HIV-INFECTED CHILDREN; CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; VIRAL LOAD; DISEASE PROGRESSION; NEVIRAPINE; INFANTS; ROUTINE; UGANDA; TRIAL		[Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Coovadia, Hoosen M.] Univ Witwatersrand, Maternal Adolescent & Child Hlth MATCH, ZA-4091 Durban, South Africa; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Durban, South Africa	Columbia University; Columbia University; University of Witwatersrand; University of Kwazulu Natal	Coovadia, HM (corresponding author), Univ Witwatersrand, Maternal Adolescent & Child Hlth MATCH, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za						ARROW Trial team, 2013, LANCET; Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Oliveira R, 2010, CLIN INFECT DIS, V51, P1325, DOI 10.1086/657119; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Walensky RP, 2010, CLIN INFECT DIS, V51, P85, DOI 10.1086/653119	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1343	1344		10.1016/S0140-6736(13)60284-6	http://dx.doi.org/10.1016/S0140-6736(13)60284-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23473849				2022-12-28	WOS:000317894800010
J	Feng, ZD; Hensley, L; McKnight, KL; Hu, FY; Madden, V; Ping, LF; Jeong, SH; Walker, C; Lanford, RE; Lemon, SM				Feng, Zongdi; Hensley, Lucinda; McKnight, Kevin L.; Hu, Fengyu; Madden, Victoria; Ping, LiFang; Jeong, Sook-Hyang; Walker, Christopher; Lanford, Robert E.; Lemon, Stanley M.			A pathogenic picornavirus acquires an envelope by hijacking cellular membranes	NATURE			English	Article							HEPATITIS-A VIRUS; CULTURE-ADAPTED VARIANT; LYSOSOMAL DEGRADATION; ALIX; MECHANISMS; INFECTION; REGIONS; ANTIGEN	Animal viruses are broadly categorized structurally by the presence or absence of an envelope composed of a lipid-bilayer membrane(1), attributes that profoundly affect stability, transmission and immune recognition. Among those lacking an envelope, the Picornaviridae are a large and diverse family of positive-strand RNA viruses that includes hepatitis A virus (HAV), an ancient human pathogen that remains a common cause of enterically transmitted hepatitis(2-4). HAV infects in a stealth-like manner and replicates efficiently in the liver(5). Virus-specific antibodies appear only after 3-4 weeks of infection, and typically herald its resolution(3,4). Although unexplained mechanistically, both anti-HAV antibody and inactivated whole-virus vaccines prevent disease when administered as late as 2 weeks after exposure(6), when virus replication is well established in the liver(5). Here we show that HAV released from cells is cloaked in host-derived membranes, thereby protecting the virion from antibody-mediated neutralization. These enveloped viruses ('eHAV') resemble exosomes(7), small vesicles that are increasingly recognized to be important in intercellular communications. They are fully infectious, sensitive to extraction with chloroform, and circulate in the blood of infected humans. Their biogenesis is dependent on host proteins associated with endosomal-sorting complexes required for transport (ESCRT)(8), namely VPS4B and ALIX. Whereas the hijacking of membranes by HAV facilitates escape from neutralizing antibodies and probably promotes virus spread within the liver, anti-capsid antibodies restrict replication after infection with eHAV, suggesting a possible explanation for prophylaxis after exposure. Membrane hijacking by HAV blurs the classic distinction between 'enveloped' and 'non-enveloped' viruses and has broad implications for mechanisms of viral egress from infected cells as well as host immune responses.	[Feng, Zongdi; Hensley, Lucinda; McKnight, Kevin L.; Hu, Fengyu; Ping, LiFang; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Madden, Victoria] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Jeong, Sook-Hyang] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, Gyeonggi Do, South Korea; [Walker, Christopher] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Walker, Christopher] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA; [Lanford, Robert E.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78227 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Texas Biomedical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lemon, SM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Feng, Zongdi/Y-7645-2019	Feng, Zongdi/0000-0001-7913-1027	National Institutes of Health [R01-AI103083]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103083, R37AI047367] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Duncan for helpful discussions; staff of the Michael Hooker Microscopy Facility for assistance with confocal microscopy; G. Kaplan for the gift of 190-4 antibody and GL37 cells; M. Fried for anti-HAV-negative human sera; A. Blikslager for porcine bile; and C. Rice for Huh-7.5 cells. This work was supported in part by a grant from the National Institutes of Health (R01-AI103083) and the University Cancer Research Fund.	ASHER LVS, 1995, J MED VIROL, V47, P260, DOI 10.1002/jmv.1890470312; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balasubramanian S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003200; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Cohen L, 2002, J VIROL, V76, P7495, DOI 10.1128/JVI.76.15.7495-7505.2002; Counihan NA, 2006, J VIROL METHODS, V133, P62, DOI 10.1016/j.jviromet.2005.10.023; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Feigelstock D, 1998, J VIROL, V72, P6218, DOI 10.1128/JVI.72.7.6218-6222.1998; Feng Z. D., 2010, The picornaviruses, P383, DOI 10.1128/ISBN978-1-55581-603-2.24; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Graff J, 1999, J VIROL, V73, P6015, DOI 10.1128/JVI.73.7.6015-6023.1999; Harrison SC, 2007, FIELDS VIROLOGY, P59; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; JANSEN RW, 1988, VIROLOGY, V163, P299, DOI 10.1016/0042-6822(88)90270-X; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lanford RE, 2011, P NATL ACAD SCI USA, V108, P11223, DOI 10.1073/pnas.1101939108; LEMON SM, 1982, J MED VIROL, V10, P25, DOI 10.1002/jmv.1890100105; LEMON SM, 1985, NEW ENGL J MED, V313, P1059, DOI 10.1056/NEJM198510243131706; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; LEMON SM, 1980, INFECT IMMUN, V28, P927; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Martin A, 2002, HEPATITIS VIRUSES, P23; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Ren XF, 2011, TRAFFIC, V12, P1282, DOI 10.1111/j.1600-0854.2011.01208.x; SCHULMAN AN, 1976, J INFECT DIS, V134, P80, DOI 10.1093/infdis/134.1.80; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; SHIMIZU YK, 1982, INFECT IMMUN, V36, P320, DOI 10.1128/IAI.36.1.320-324.1982; TAYLOR KL, 1993, J INFECT DIS, V168, P592, DOI 10.1093/infdis/168.3.592; Taylor MP, 2009, J VIROL, V83, P6599, DOI 10.1128/JVI.01819-08; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546; ZHANG HC, 1995, VIROLOGY, V212, P686, DOI 10.1006/viro.1995.1526	33	450	471	6	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					367	+		10.1038/nature12029	http://dx.doi.org/10.1038/nature12029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23542590	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000317599200039
J	Grubb, LK				Grubb, Laura K.			Lessons from Vermont's Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Grubb, LK (corresponding author), Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA.		Grubb, Laura/GPC-8678-2022	Grubb, Laura/0000-0003-1340-3952				Henry J., 2012, COST COVERAGE IMPLIC; Henry J., FACTS AT A GLANCE; Lunge R., 2012, VERMONT HLTH BENEFIT; Lunge R, 2013, FINANCING PLANS 2014; Panebaker A., 2012, SHUMLIN BENDS HLTH B	5	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1276	1277		10.1056/NEJMp1212974	http://dx.doi.org/10.1056/NEJMp1212974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550667				2022-12-28	WOS:000316989900004
J	Greer, SL; Hervey, TK; Mackenbach, JP; McKee, M				Greer, Scott L.; Hervey, Tamara K.; Mackenbach, Johan P.; McKee, Martin			Health law and policy in the European Union	LANCET			English	Article							PUBLIC-HEALTH; COMMUNICABLE DISEASE; AUSTERITY; DEVICES; FUTURE	From its origins as six western European countries coming together to reduce trade barriers, the European Union (EU) has expanded, both geographically and in the scope of its actions, to become an important supranational body whose policies affect almost all aspects of the lives of its citizens. This influence extends to health and health services. The EU's formal responsibilities in health and health services are limited in scope, but, it has substantial indirect influence on them. In this paper, we describe the institutions of the EU, its legislative process, and the nature of European law as it affects free movement of the goods, people, and services that affect health or are necessary to deliver health care. We show how the influence of the EU goes far beyond the activities that are most visible to health professionals, such as research funding and public health programmes, and involves an extensive body of legislation that affects almost every aspect of health and health care.	[Greer, Scott L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hervey, Tamara K.] Univ Sheffield, Sch Law, Sheffield, S Yorkshire, England; [Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England	University of Michigan System; University of Michigan; University of Sheffield; Erasmus University Rotterdam; Erasmus MC; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Hervey, Tamara/0000-0002-8310-9022; Greer, Scott Edward Lennarson/0000-0002-5288-0471	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This series was supported by the European Observatory on Health Systems and Policies.	Alvarez-Dardet C, 2006, J EPIDEMIOL COMMUN H, V60, P669, DOI 10.1136/jech.2005.038273; Briatte F, 2013, EUROPEAN UNION PUBLI, P51; Charlesworth K, 2011, EUR J PUBLIC HEALTH, V21, P404, DOI 10.1093/eurpub/ckp212; Chenet L, 1997, BRIT MED J, V314, P1142, DOI 10.1136/bmj.314.7088.1142; Cisneros Ornberg J, 2013, EUROPEAN UNION PUBLI, P168; Cohen D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4737; Cohen D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2748; Craig P., 2002, LAW SINGLE EUROPEAN, P1; De La Rosa S, 2012, COMMON MKT LAW REV, V49, P15; Dixon A, 2012, HEALTH ECON POLICY L, V7, P1, DOI 10.1017/S1744133111000247; Elliott HA, 2012, J HEALTH POLIT POLIC, V37, P935, DOI 10.1215/03616878-1813781; Ernst K, 2010, J HEALTH SERV RES PO, V15, P133, DOI 10.1258/jhsrp.2010.009115; European Commission, COM201284 EUR COMM; European Environment Agency, 2010, IMP SEL POL MEAS EUR; European Parliament, ORD LEG PROC; European Traffic Safety Council, 5 PIN EUR TRAFF SAF; European Union, 2007, TREAT FUNCT EUR UN; Fahy N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1712; Farrell Anne-Maree, 2012, POLITICS BLOOD ETHIC; Fraser AG, 2011, EUR HEART J, V32, P1673, DOI 10.1093/eurheartj/ehr171; Galsworthy MJ, 2012, LANCET, V380, P971, DOI 10.1016/S0140-6736(12)61528-1; Gilmore A, 2002, CLIN MED, V2, P335, DOI 10.7861/clinmedicine.2-4-335; Goldacre Ben, 2012, BAD PHARM; Greer SL, 2012, J HEALTH POLIT POLIC, V37, P1001, DOI 10.1215/03616878-1813817; Greer SL, 2013, HEALTH ECON POLICY L, V21, P1; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Hancher L., 2010, HLTH SYSTEMS GOVERNA, P635; Happich M, 2007, APPL ECON LETT, V14, P175, DOI 10.1080/13504850500425261; Hervey T, 2004, HLTH LAW EUROPEAN UN; Jarman H, 2012, J EUR INTEGRATION, V33, P385; Jelnikar E, 2006, INT C HUM EC RES IZM; Karanikolos M, 2013, LANCET; Kentikelenis A, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr190; Klomp J, 2009, SOC SCI MED, V69, P36, DOI 10.1016/j.socscimed.2009.03.033; Knudsen Ann-Christina L., 2009, FARMERS WELFARE MAKI; Kurzer P, 2013, EUROPEAN UNION PUBLI, P155; Kurzer P, 2011, J EUR SOC POLICY, V21, P107, DOI 10.1177/0958928710395047; Liverani M, 2012, J HLTH POLIT POLICY, V37, P1000; Lloyd-Williams F, 2008, B WORLD HEALTH ORGAN, V86, P535; MacLehose L, 2002, SCIENCE, V295, P2047, DOI 10.1126/science.1070025; MacMaolain C, 2008, COMMON MKT LAW REV, V45, P1147; McKee M, 2012, LANCET, V380, P1447, DOI 10.1016/S0140-6736(12)61774-7; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Meikle J, 2010, GUARDIAN; Mossialos E, 2010, HLTH SYSTEMS GOVERNA; Nicoll A, 2010, EUR J PUBLIC HEALTH, V20, P486, DOI 10.1093/eurpub/ckq114; Nixon J, 2000, CONVERGENCE HLTH CAR; Peeters Miek, 2010, HLTH SYSTEMS GOVERNA, P589; Permanand G, 2010, HLTH SYSTEMS GOVERNA, P589; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; Reintjes R, 2007, EUR J PUBLIC HEALTH, V17, P375, DOI 10.1093/eurpub/ckl256; Reintjes R, 2012, J HEALTH POLIT POLIC, V37, P955, DOI 10.1215/03616878-1813790; Smith KE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000202; Snell J, CAMB YEAR EURO LEGAL, V13, P415; Steffen M, 2012, J HEALTH POLIT POLIC, V37, P1057, DOI 10.1215/03616878-1813845; Studlar DT, 2013, EUROPEAN UNION PUBLI, P181; Sweet A. Stone, 2004, JUDICIAL CONSTRUCTIO, P153; Thompson M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4753; Titmuss R. M., 1970, GIFT RELATIONSHIP; US Food and Drug Administration, MED DEV PREM APPR; Veerman JL, 2006, EUR J PUBLIC HEALTH, V16, P31, DOI 10.1093/eurpub/cki166; Wismar M., 2011, HLTH PROFESSIONAL MO; Zeitlin J, 2008, EUROPEAN PERINATAL H	63	31	31	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1135	1144		10.1016/S0140-6736(12)62083-2	http://dx.doi.org/10.1016/S0140-6736(12)62083-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541054				2022-12-28	WOS:000317348900032
J	Zahn, LM; Travis, J				Zahn, Laura M.; Travis, John			A Medical Renaissance? INTRODUCTION	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2013	339	6127					1539	1539		10.1126/science.339.6127.1539	http://dx.doi.org/10.1126/science.339.6127.1539			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114HL	23539591				2022-12-28	WOS:000316731600033
J	Atianand, MK; Rathinam, VA; Fitzgerald, KA				Atianand, Maninjay K.; Rathinam, Vijay A.; Fitzgerald, Katherine A.			SnapShot: Inflammasomes	CELL			English	Editorial Material							AIM2 INFLAMMASOME; RECOGNITION; ACTIVATION; BACTERIA; IMMUNITY		[Atianand, Maninjay K.; Rathinam, Vijay A.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Atianand, MK (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.		Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020; Atianand, Maninjay/AAF-7823-2019	Rathinam, Vijay/0000-0002-8009-3977; Atianand, Maninjay/0000-0003-4135-2515; Fitzgerald, Kate/0000-0003-3175-609X				Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006	10	19	21	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					272	+		10.1016/j.cell.2013.03.009	http://dx.doi.org/10.1016/j.cell.2013.03.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540703	Bronze			2022-12-28	WOS:000316853700023
J	Zhang, LH; Malik, S; Pang, JJ; Wang, H; Park, KM; Yule, DI; Blaxall, BC; Smrcka, AV				Zhang, Lianghui; Malik, Sundeep; Pang, Jinjiang; Wang, Huan; Park, Keigan M.; Yule, David I.; Blaxall, Burns C.; Smrcka, Alan V.			Phospholipase C epsilon Hydrolyzes Perinuclear Phosphatidylinositol 4-Phosphate to Regulate Cardiac Hypertrophy	CELL			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; NUCLEAR-ENVELOPE; PHOSPHATASE SAC1; GOLGI-APPARATUS; CA2+ RELEASE; RECEPTOR; MYOCYTES; MAKAP; ACTIVATION	Phospholipase C epsilon (PLC epsilon) is a multifunctional enzyme implicated in cardiovascular, pancreatic, and inflammatory functions. Here we show that conditional deletion of PLC epsilon in mouse cardiac myocytes protects from stress-induced pathological hypertrophy. PLC epsilon small interfering RNA (siRNA) in ventricular myocytes decreases endothelin-1 (ET-1)-dependent elevation of nuclear calcium and activation of nuclear protein kinase D (PKD). PLC epsilon scaffolded to muscle-specific A kinase-anchoring protein (mAKAP), along with PKC epsilon and PKD, localizes these components at or near the nuclear envelope, and this complex is required for nuclear PKD activation. Phosphatidylinositol 4-phosphate (PI4P) is identified as a perinuclear substrate in the Golgi apparatus for mAKAP-scaffolded PLC epsilon. We conclude that perinuclear PLC epsilon, scaffolded to mAKAP in cardiac myocytes, responds to hypertrophic stimuli to generate diacylglycerol (DAG) from PI4P in the Golgi apparatus, in close proximity to the nuclear envelope, to regulate activation of nuclear PKD and hypertrophic signaling pathways.	[Zhang, Lianghui; Malik, Sundeep; Park, Keigan M.; Yule, David I.; Blaxall, Burns C.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Wang, Huan; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Pang, Jinjiang; Blaxall, Burns C.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, 601 Elmwood Ave, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu	Blaxall, Burns/ABD-8289-2021		National Institutes of Health [5R01GM053536, R01DE041756, R01 HL089885, R01 HL091475]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091475, R01HL089885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Tamas Balla for fluorescent phosphoinositide reporter fusion and PI5 ptase constructs and for valuable critical reading of this manuscript. We would also like to thank Peter Mayinger for providing the Sac1-K2A construct and Alexandra Newton for the nDKAR and DAG reporter constructs. This work was supported by National Institutes of Health grants 5R01GM053536 (A.V.S.), R01DE041756 (D.I.Y.), and R01 HL089885 and R01 HL091475 (B.C.B.).	Arantes LAM, 2012, J MOL CELL CARDIOL, V53, P475, DOI 10.1016/j.yjmcc.2012.06.017; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; COCCO L, 1989, BIOCHEM BIOPH RES CO, V159, P720, DOI 10.1016/0006-291X(89)90054-5; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Grubb DR, 2011, FASEB J, V25, P1040, DOI 10.1096/fj.10-171470; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Keune WJ, 2011, ADV ENZYME REGUL, V51, P91, DOI 10.1016/j.advenzreg.2010.09.009; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; KRONEBUSCH PJ, 1987, J CELL SCI, V88, P25; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	48	104	113	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					216	227		10.1016/j.cell.2013.02.047	http://dx.doi.org/10.1016/j.cell.2013.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540699	Bronze, Green Accepted			2022-12-28	WOS:000316853700018
J	Lin, SY; Erekosima, N; Kim, JM; Ramanathan, M; Suarez-Cuervo, C; Chelladurai, Y; Ward, D; Segal, JB				Lin, Sandra Y.; Erekosima, Nkiruka; Kim, Julia M.; Ramanathan, Murugappan; Suarez-Cuervo, Catalina; Chelladurai, Yohalakshmi; Ward, Darcy; Segal, Jodi B.			Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED EVALUATION; HOUSE-DUST-MITE; PARIETARIA-JUDAICA EXTRACT; GRASS-POLLEN EXTRACT; QUALITY-OF-LIFE; DOUBLE-BLIND; SWALLOW IMMUNOTHERAPY; RESPIRATORY ALLERGY; CONTROLLED-TRIAL; PERSISTENT ASTHMA	Importance Allergic rhinitis affects up to 40% of the US population. To desensitize allergic individuals, subcutaneous injection immunotherapy or sublingual immunotherapy may be administered. In the United States, sublingual immunotherapy is not approved by the Food and Drug Administration. However, some US physicians use aqueous allergens, off-label, for sublingual desensitization. Objective To systematically review the effectiveness and safety of aqueous sublingual immunotherapy for allergic rhinoconjunctivitis and asthma. Evidence Acquisition The databases of MEDLINE, EMBASE, LILACS, and the Cochrane Central Register of Controlled Trials were searched through December 22, 2012. English-language randomized controlled trials were included if they compared sublingual immunotherapy with placebo, pharmacotherapy, or other sublingual immunotherapy regimens and reported clinical outcomes. Studies of sublingual immunotherapy that are unavailable in the United States and for which a related immunotherapy is unavailable in the United States were excluded. Paired reviewers selected articles and extracted the data. The strength of the evidence for each comparison and outcome was graded based on the risk of bias (scored on allocation, concealment of intervention, incomplete data, sponsor company involvement, and other bias), consistency, magnitude of effect, and the directness of the evidence. Results Sixty-three studies with 5131 participants met the inclusion criteria. Participants' ages ranged from 4 to 74 years. Twenty studies (n=1814 patients) enrolled only children. The risk of bias was medium in 43 studies (68%). Strong evidence supports that sublingual immunotherapy improves asthma symptoms, with 8 of 13 studies reporting greater than40% improvement vs the comparator. Moderate evidence supports that sublingual immunotherapy use decreases rhinitis or rhinoconjunctivitis symptoms, with 9 of 36 studies demonstrating greater than 40% improvement vs the comparator. Medication use for asthma and allergies decreased by more than 40% in 16 of 41 studies of sublingual immunotherapy with moderate grade evidence. Moderate evidence supports that sublingual immunotherapy improves conjunctivitis symptoms (13 studies), combined symptom and medication scores (20 studies), and disease-specific quality of life (8 studies). Local reactions were frequent, but anaphylaxis was not reported. Conclusions and Relevance The overall evidence provides a moderate grade level of evidence to support the effectiveness of sublingual immunotherapy for the treatment of allergic rhinitis and asthma, but high-quality studies are still needed to answer questions regarding optimal dosing strategies. There were limitations in the standardization of adverse events reporting, but no life-threatening adverse events were noted in this review. JAMA. 2013; 309(12): 1278-1288 www.jama.com	[Kim, Julia M.] Johns Hopkins Univ, Sch Med, Div Gen Pediat & Adolescent Med, Baltimore, MD 21287 USA; [Lin, Sandra Y.; Ramanathan, Murugappan] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Erekosima, Nkiruka; Suarez-Cuervo, Catalina; Chelladurai, Yohalakshmi; Ward, Darcy; Segal, Jodi B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Kim, Julia M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lin, SY (corresponding author), Johns Hopkins Univ, Sch Med, 601 N Caroline St,Ste 6254, Baltimore, MD 21287 USA.	slin30@jhmi.edu			Agency for Healthcare Research and Quality (AHRQ) [HHSA 290 2007 10061]; Johns Hopkins University Evidence-based Practice Center [HHSA 290 2007 10061 I]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Johns Hopkins University Evidence-based Practice Center(Johns Hopkins University)	This study was funded by grant HHSA 290 2007 10061 I from the Agency for Healthcare Research and Quality (AHRQ) and is based on research conducted at the Johns Hopkins University Evidence-based Practice Center under contract HHSA 290 2007 10061 I.	Ahmadiafshar A, 2012, IRAN J ALLERGY ASTHM, V11, P175, DOI 011.02/ijaai.175181; Alvarez-Cuesta E, 2007, ALLERGY, V62, P1100, DOI 10.1111/j.1398-9995.2007.01520.x; Alvarez-Cuesta E, 2007, ALLERGY, V62, P810, DOI 10.1111/j.1398-9995.2007.01365.x; Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; Bahceciler NN, 2001, PEDIATR PULM, V32, P49, DOI 10.1002/ppul.1088; Bowen T, 2004, ANN ALLERG ASTHMA IM, V93, P425, DOI 10.1016/S1081-1206(10)61408-1; Bush RK, 2011, J ALLERGY CLIN IMMUN, V127, P1561; Bush RK, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Bush RK, 2011, J ALLERGY CLIN IMMUN, V127, P974, DOI 10.1016/j.jaci.2010.11.045; Calamita Z, 2006, ALLERGY, V61, P1162, DOI 10.1111/j.1398-9995.2006.01205.x; Calderon MA, 2011, CLIN EXP ALLERGY, V41, P1263, DOI 10.1111/j.1365-2222.2011.03835.x; Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x; Compalati E, 2009, ALLERGY, V64, P1570, DOI 10.1111/j.1398-9995.2009.02129.x; Cortellini G, 2010, ANN ALLERG ASTHMA IM, V105, P382, DOI 10.1016/j.anai.2010.08.007; Cox L, 2009, ANN ALLERG ASTHMA IM, V103, P451, DOI 10.1016/S1081-1206(10)60259-1; D'Ambrosio F P, 1996, Allergol Immunopathol (Madr), V24, P146; De Blay F, 2007, ANN ALLERG ASTHMA IM, V99, P453, DOI 10.1016/S1081-1206(10)60571-6; de Bot CMA, 2012, PEDIAT ALLERG IMM-UK, V23, P151, DOI 10.1111/j.1399-3038.2011.01219.x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Di Bona D, 2010, J ALLERGY CLIN IMMUN, V126, P558, DOI 10.1016/j.jaci.2010.06.013; Di Rienzo V., 2006, Clinical and Experimental Allergy Reviews, V6, P67, DOI 10.1111/j.1365-2222.2005.00102.x; Feliziani V, 1995, Allergol Immunopathol (Madr), V23, P224; Fujimura T, 2011, CLIN IMMUNOL, V139, P65, DOI 10.1016/j.clim.2010.12.022; Guez S, 2000, ALLERGY, V55, P369, DOI 10.1034/j.1398-9995.2000.00413.x; Hirsch T, 1997, PEDIATR ALLERGY IMMU, V8, P21, DOI 10.1111/j.1399-3038.1997.tb00138.x; Horak F, 1998, J INVEST ALLERG CLIN, V8, P165; Hordijk G J, 1998, Allergol Immunopathol (Madr), V26, P234; Horiguchi S, 2008, INT ARCH ALLERGY IMM, V146, P76, DOI 10.1159/000112506; Ippoliti F, 2003, PEDIATR ALLERGY IMMU, V14, P216, DOI 10.1034/j.1399-3038.2003.00025.x; La Rosa M, 1999, J ALLERGY CLIN IMMUN, V104, P425, DOI 10.1016/S0091-6749(99)70388-X; Larenas-Linnemann DE, 2008, ALLERGY ASTHMA PROC, V29, P130, DOI 10.2500/aap.2008.29.3093; Leonardi S, 2009, ANN ALLERG ASTHMA IM, V102, P259, DOI 10.1016/S1081-1206(10)60093-2; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lima MT, 2002, CLIN EXP ALLERGY, V32, P507, DOI 10.1046/j.0954-7894.2002.01327.x; Lue KH, 2006, PEDIAT ALLERG IMM-UK, V17, P408, DOI 10.1111/j.1399-3038.2006.00443.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Makino Y, 2010, J ALLERGY CLIN IMMUN, V126, P1163, DOI 10.1016/j.jaci.2010.06.031; Marogna M, 2005, J ALLERGY CLIN IMMUN, V115, P1184, DOI 10.1016/j.jaci.2005.02.031; Marogna M, 2004, ALLERGY, V59, P1205, DOI 10.1111/j.1398-9995.2004.00508.x; Marogna M, 2010, J INVEST ALLERG CLIN, V20, P146; Marogna M, 2008, ANN ALLERG ASTHMA IM, V101, P206, DOI 10.1016/S1081-1206(10)60211-6; Marogna M, 2007, ANN ALLERG ASTHMA IM, V98, P274, DOI 10.1016/S1081-1206(10)60718-1; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; Marogna M, 2009, ANN ALLERG ASTHMA IM, V102, P69, DOI 10.1016/S1081-1206(10)60111-1; Moreno-Ancillo A, 2007, J INVEST ALLERG CLIN, V17, P399; NELSON HS, 1993, J ALLERGY CLIN IMMUN, V92, P229, DOI 10.1016/0091-6749(93)90166-D; Niu CK, 2006, RESP MED, V100, P1374, DOI 10.1016/j.rmed.2005.11.016; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Okubo Kimihiro, 2008, Allergol Int, V57, P265, DOI 10.2332/allergolint.O-07-514; Ott H, 2009, ALLERGY, V64, P1394, DOI [10.1111/j.1398-9995.2008.01875.x, 10.1111/j.1398-9995.2009.02194.x]; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pajno GB, 2000, ALLERGY, V55, P842, DOI 10.1034/j.1398-9995.2000.00495.x; Pajno GB, 2004, ALLERGY, V59, P883, DOI 10.1111/j.1398-9995.2004.00578.x; Pajno GB, 2003, CLIN EXP ALLERGY, V33, P1641, DOI 10.1111/j.1365-2222.2003.01809.x; Pajno GB, 2011, PEDIAT ALLERG IMM-UK, V22, P803, DOI 10.1111/j.1399-3038.2011.01196.x; Panzner P, 2008, RESP MED, V102, P1296, DOI 10.1016/j.rmed.2008.03.024; Passalacqua G, 1999, J ALLERGY CLIN IMMUN, V104, P964, DOI 10.1016/S0091-6749(99)70076-X; Pfaar O, 2008, ANN ALLERG ASTHMA IM, V100, P256, DOI 10.1016/S1081-1206(10)60451-6; PIAZZA I, 1993, ANN ALLERGY, V71, P461; Pozzan M, 2010, CURR MED RES OPIN, V26, P2801, DOI 10.1185/03007995.2010.532201; Pradalier A, 1999, ALLERGY, V54, P819, DOI 10.1034/j.1398-9995.1999.00077.x; Purello-D'Ambrosio F, 1999, ALLERGY, V54, P968, DOI 10.1034/j.1398-9995.1999.00203.x; Radulovic Suzana, 2010, Cochrane Database Syst Rev, pCD002893, DOI 10.1002/14651858.CD002893.pub2; Roder E, 2007, J ALLERGY CLIN IMMUN, V119, P892, DOI 10.1016/j.jaci.2006.12.651; Rodriguez F, 2006, INT ARCH ALLERGY IMM, V140, P321, DOI 10.1159/000093710; SABBAH A, 1994, ALLERGY, V49, P309, DOI 10.1111/j.1398-9995.1994.tb02273.x; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Sambugaro R, 2003, Allergol Immunopathol (Madr), V31, P329, DOI 10.1157/13055212; Savolainen J, 2006, ALLERGY, V61, P1184, DOI 10.1111/j.1398-9995.2006.01206.x; Sieber J, 2012, EXPERT OPIN DRUG SAF, V11, P7, DOI 10.1517/14740338.2012.626765; Skoner D, 2010, J ALLERGY CLIN IMMUN, V125, P660, DOI 10.1016/j.jaci.2009.12.931; Stelmach I, 2012, ALLERGY, V67, P312, DOI 10.1111/j.1398-9995.2011.02758.x; Stelmach I, 2009, CLIN EXP ALLERGY, V39, P401, DOI 10.1111/j.1365-2222.2008.03159.x; Swamy RS, 2012, J ALLERGY CLIN IMMUN, V130, P215, DOI 10.1016/j.jaci.2012.04.021; Swamy RS, 2012, J ALLERGY CLIN IMMUN, V130, pe7; Tahamiler R, 2007, LARYNGOSCOPE, V117, P965, DOI 10.1097/MLG.0b013e31804f8141; TARI MG, 1990, ALLERGOL IMMUNOPATH, V18, P277; Tseng SH, 2008, ASIAN PAC J ALLERGY, V26, P105; Valovirta E, 2006, ALLERGY, V61, P1177, DOI 10.1111/j.1398-9995.2006.01190.x; Vervloet D, 2007, INT ARCH ALLERGY IMM, V142, P239, DOI 10.1159/000097026; Voltolini S, 2001, Allergol Immunopathol (Madr), V29, P103; Voltolini S, 2010, CURR MED RES OPIN, V26, P37, DOI 10.1185/03007990903431886; Vourdas D, 1998, ALLERGY, V53, P662, DOI 10.1111/j.1398-9995.1998.tb03952.x; Wahn U, 2012, J ALLERGY CLIN IMMUN, V130, pe5; Wahn U, 2012, J ALLERGY CLIN IMMUN, V130, P886, DOI 10.1016/j.jaci.2012.06.047; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x	87	174	179	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1278	1288		10.1001/jama.2013.2049	http://dx.doi.org/10.1001/jama.2013.2049			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532243				2022-12-28	WOS:000316625200028
J	Aghajafari, F; Nagulesapillai, T; Ronksley, PE; Tough, SC; O'Beirne, M; Rabi, DM				Aghajafari, Fariba; Nagulesapillai, Tharsiya; Ronksley, Paul E.; Tough, Suzanne C.; O'Beirne, Maeve; Rabi, Doreen M.			Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-D STATUS; FOR-GESTATIONAL-AGE; D DEFICIENCY; D INSUFFICIENCY; BACTERIAL VAGINOSIS; HIGH PREVALENCE; 1ST TRIMESTER; RISK; WOMEN; MOTHERS	Objective To assess the effect of 25-hydroxyvitamin D (25-OHD) levels on pregnancy outcomes and birth variables. Design Systematic review and meta-analysis. Data sources Medline (1966 to August 2012), PubMed (2008 to August 2012), Embase (1980 to August 2012), CINAHL (1981 to August 2012), the Cochrane database of systematic reviews, and the Cochrane database of registered clinical trials. Study selection Studies reporting on the association between serum 25-OHD levels during pregnancy and the outcomes of interest (pre-eclampsia, gestational diabetes, bacterial vaginosis, caesarean section, small for gestational age infants, birth weight, birth length, and head circumference). Data extraction Two authors independently extracted data from original research articles, including key indicators of study quality. We pooled the most adjusted odds ratios and weighted mean differences. Associations were tested in subgroups representing different patient characteristics and study quality. Results 3357 studies were identified and reviewed for eligibility. 31 eligible studies were included in the final analysis. Insufficient serum levels of 25-OHD were associated with gestational diabetes (pooled odds ratio 1.49, 95% confidence interval 1.18 to 1.89), pre-eclampsia (1.79, 1.25 to 2.58), and small for gestational age infants (1.85, 1.52 to 2.26). Pregnant women with low serum 25-OHD levels had an increased risk of bacterial vaginosis and low birthweight infants but not delivery by caesarean section. Conclusion Vitamin D insufficiency is associated with an increased risk of gestational diabetes, pre-eclampsia, and small for gestational age infants. Pregnant women with low 25-OHD levels had an increased risk of bacterial vaginosis and lower birth weight infants, but not delivery by caesarean section.	[Aghajafari, Fariba; Nagulesapillai, Tharsiya; Ronksley, Paul E.; Tough, Suzanne C.; Rabi, Doreen M.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada; [Aghajafari, Fariba; O'Beirne, Maeve] Univ Calgary, Dept Family Med, Calgary, AB T2N 4N1, Canada; [Ronksley, Paul E.] Univ Calgary, Calgary Inst Populat & Publ Hlth, Calgary, AB T2N 4N1, Canada; [Tough, Suzanne C.] Univ Calgary, Dept Paediat, Calgary, AB T2N 4N1, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Rabi, DM (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada.	Doreen.Rabi@albertahealthservices.ca			University of Calgary Institute for Public Health (Markin Fund for Health and Society); AISH (Alberta Innovate Health Solutions) population health investigator award; AISH; Canadian Institute of Health Research; Canadian Foundation for Healthcare Improvement	University of Calgary Institute for Public Health (Markin Fund for Health and Society); AISH (Alberta Innovate Health Solutions) population health investigator award; AISH; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Healthcare Improvement	FA and TN received studentship funding from the University of Calgary Institute for Public Health (Markin Fund for Health and Society); DMR is supported by an AISH (Alberta Innovate Health Solutions) population health investigator award; SCT is supported by an AISH salary support; and MO'B is supported by AISH, the Canadian Institute of Health Research, and the Canadian Foundation for Healthcare Improvement. These agencies did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Azar M, 2011, DIABETES CARE, V34, P1258, DOI 10.2337/dc10-2145; Baker AM, 2012, DIABETES-METAB RES, V28, P164, DOI 10.1002/dmrr.1282; Baker AM, 2010, J CLIN ENDOCR METAB, V95, P5105, DOI 10.1210/jc.2010-0996; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168; Bowyer L, 2009, CLIN ENDOCRINOL, V70, P372, DOI 10.1111/j.1365-2265.2008.03316.x; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005; Dijkstra SH, 2007, ARCH DIS CHILD, V92, P750, DOI 10.1136/adc.2006.105577; Egger M, 2001, SYSTEMATIC REV HLTH; Ertl R, 2012, FETAL DIAGN THER, V31, P103, DOI 10.1159/000333810; Farrant HJW, 2009, EUR J CLIN NUTR, V63, P646, DOI 10.1038/ejcn.2008.14; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Hensel KJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.013; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, AM J CLIN NUTR, V79, P717; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kaludjerovic J, 2010, J MIDWIFERY WOM HEAL, V55, P550, DOI 10.1016/j.jmwh.2010.02.016; Kolusari A, 2008, J INT MED RES, V36, P1335, DOI 10.1177/147323000803600622; Lee JM, 2007, CLIN PEDIATR, V46, P42, DOI 10.1177/0009922806289311; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; Makgoba M, 2011, DIABETES CARE, V34, P1091, DOI 10.2337/dc10-2264; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Nassar N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.058; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Parlea L, 2012, DIABETIC MED, V29, pE25, DOI 10.1111/j.1464-5491.2011.03550.x; Pike JW, 2008, ENDOCRINOLOGY, V149, P3656, DOI 10.1210/en.2008-0042; Poel YHM, 2012, EUR J INTERN MED, V23, P465, DOI 10.1016/j.ejim.2012.01.007; Powe CE, 2010, HYPERTENSION, V56, P758, DOI 10.1161/HYPERTENSIONAHA.110.158238; Robinson CJ, 2010, AM J OBSTET GYNECOL, V203, DOI [10.1016/j.ajog.2010.06.036, 10.1016/j.ajog.2010.03.045]; Savvidou MD, 2011, BJOG-INT J OBSTET GY, V118, P951, DOI 10.1111/j.1471-0528.2011.02982.x; Scholl TO, 2012, NUTRIENTS, V4, P319, DOI 10.3390/nu4040319; Soheilykhah S, 2010, NUTR CLIN PRACT, V25, P524, DOI 10.1177/0884533610379851; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Yu CKH, 2013, J HUM HYPERTENS, V27, P115, DOI 10.1038/jhh.2012.1; Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753	49	368	378	0	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1169	10.1136/bmj.f1169	http://dx.doi.org/10.1136/bmj.f1169			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WO	23533188	hybrid			2022-12-28	WOS:000316984000001
J	Fekete, DM; Noden, DM				Fekete, Donna M.; Noden, Drew M.			A Transition in the Middle Ear	SCIENCE			English	Editorial Material							NEURAL CREST; ORIGIN		[Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fekete, Donna M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Noden, Drew M.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University	Fekete, DM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dfekete@purdue.edu; dmn2@cornell.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246				Chapman SC, 2011, FRONT BIOSCI-LANDMRK, V16, P1675, DOI 10.2741/3813; JASKOLL TF, 1978, ANAT RECORD, V190, P177, DOI 10.1002/ar.1091900203; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; LELIEVRE CS, 1978, J EMBRYOL EXP MORPH, V47, P17; Mallo M, 2001, DEV BIOL, V231, P410, DOI 10.1006/dbio.2001.0154; MAROVITZ WF, 1971, ANN OTO RHINOL LARYN, V80, P384, DOI 10.1177/000348947108000313; McLaren A., 1984, CHIMERAS DEV BIOL; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; SCHWARZBART A, 1959, J Laryngol Otol, V73, P45, DOI 10.1017/S0022215100054906; Sienknecht UJ, 2013, HEARING RES, V301, P19, DOI 10.1016/j.heares.2013.01.019; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Thompson H, 2012, DEV DYNAM, V241, P1396, DOI 10.1002/dvdy.23831	12	3	3	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1396	1397		10.1126/science.1236645	http://dx.doi.org/10.1126/science.1236645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520103				2022-12-28	WOS:000316740700032
J	Meier, B; Kalesan, B; Mattle, HP; Khattab, AA; Hildick-Smith, D; Dudek, D; Andersen, G; Ibrahim, R; Schuler, G; Walton, AS; Wahl, A; Windecker, S; Juni, P				Meier, Bernhard; Kalesan, Bindu; Mattle, Heinrich P.; Khattab, Ahmed A.; Hildick-Smith, David; Dudek, Dariusz; Andersen, Grethe; Ibrahim, Reda; Schuler, Gerhard; Walton, Antony S.; Wahl, Andreas; Windecker, Stephan; Jueni, Peter		PC Trial Investigators	Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION/AMERICAN STROKE ASSOCIATION; PARADOXICAL EMBOLISM; MEDICAL THERAPY; CEREBROVASCULAR EVENTS; TRANSCATHETER CLOSURE; SURGICAL CLOSURE; HEALTH-CARE; PREVENTION; THROMBUS	Background The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or percutaneous closure of the patent foramen ovale. We investigated whether closure is superior to medical therapy. Methods We performed a multicenter, superiority trial in 29 centers in Europe, Canada, Brazil, and Australia in which the assessors of end points were unaware of the study-group assignments. Patients with a patent foramen ovale and is-che-mic stroke, transient ischemic attack (TIA), or a peripheral thromboembolic event were randomly assigned to undergo closure of the patent foramen ovale with the Amplatzer PFO Occluder or to receive medical therapy. The primary end point was a composite of death, nonfatal stroke, TIA, or peripheral embolism. Analysis was performed on data for the intention-to-treat population. Results The mean duration of follow-up was 4.1 years in the closure group and 4.0 years in the medical-therapy group. The primary end point occurred in 7 of the 204 patients (3.4%) in the closure group and in 11 of the 210 patients (5.2%) in the medical-therapy group (hazard ratio for closure vs. medical therapy, 0.63; 95% confidence interval [CI], 0.24 to 1.62; P=0.34). Nonfatal stroke occurred in 1 patient (0.5%) in the closure group and 5 patients (2.4%) in the medical-therapy group (hazard ratio, 0.20; 95% CI, 0.02 to 1.72; P=0.14), and TIA occurred in 5 patients (2.5%) and 7 patients (3.3%), respectively (hazard ratio, 0.71; 95% CI, 0.23 to 2.24; P=0.56). Conclusions Closure of a patent foramen ovale for secondary prevention of cryptogenic embolism did not result in a significant reduction in the risk of recurrent embolic events or death as compared with medical therapy. (Funded by St. Jude Medical; ClinicalTrials. gov number, NCT00166257.)	[Meier, Bernhard; Kalesan, Bindu; Khattab, Ahmed A.; Wahl, Andreas; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Mattle, Heinrich P.] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Kalesan, Bindu; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Kalesan, Bindu; Jueni, Peter] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Hildick-Smith, David] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England; [Dudek, Dariusz] Jagiellonian Univ, Univ Hosp, Coll Med, Krakow, Poland; [Andersen, Grethe] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Ibrahim, Reda] Univ Montreal, Montreal, PQ, Canada; [Schuler, Gerhard] Herzzentrum Leipzig, Leipzig, Germany; [Walton, Antony S.] Alfred Hosp, Melbourne, Vic, Australia	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; Brighton and Sussex University Hospitals NHS Trust; Jagiellonian University; Collegium Medicum Jagiellonian University; Aarhus University; Universite de Montreal; Heart Center Leipzig GMBH; Florey Institute of Neuroscience & Mental Health	Meier, B (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	bernhard.meier@insel.ch	Juni, Peter/Q-8700-2016; Pilgrim, Thomas/AAS-9120-2021; Ibrahim, Reda/AAX-7882-2021; Vanhooren, Geert/H-4433-2011; Böhm, Michael/C-3638-2011; Jensen, Troels Staehelin/A-3418-2009	Juni, Peter/0000-0002-5985-0670; Pilgrim, Thomas/0000-0001-8721-4068; Vanhooren, Geert/0000-0001-6818-9346; Jensen, Troels Staehelin/0000-0002-3487-6380; Wuttig, Helge/0000-0003-1877-8905; Andersen, Grethe/0000-0001-6807-2500	St. Jude Medical; Abbott; Cordis; Medtronic; Bayer; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Covidien; Genzyme; Merck Sharp Dohme-Chibret; Merck Serono; Novartis; Sanofi-Aventis; Servier; Teva; AstraZeneca; GlaxoSmithKline; Pfizer; Biosensors International; Biotronik; Boston Scientific; Ablynx; Amgen; Eisai; Eli Lilly; Exelixis; Geron; Gilead Sciences; Nestle; Novo Nordisk; Padma; Roche; Schering-Plough; Swiss Cardio Technologies	St. Jude Medical(St. Jude Medical); Abbott(Abbott Laboratories); Cordis; Medtronic(Medtronic); Bayer(Bayer AG); Biogen Idec(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Covidien; Genzyme(Sanofi-AventisGenzyme Corporation); Merck Sharp Dohme-Chibret(Merck & Company); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Teva(Teva Pharmaceutical Industries); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Biosensors International; Biotronik; Boston Scientific(Boston Scientific); Ablynx(Ablynx); Amgen(Amgen); Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Exelixis; Geron; Gilead Sciences(Gilead Sciences); Nestle(Nestle SA); Novo Nordisk(Novo Nordisk); Padma; Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Swiss Cardio Technologies	Dr. Meier reports receiving consulting fees from St. Jude Medical and grant support through his institution from Abbott, Cordis, and Medtronic. Dr. Mattle reports receiving consulting fees and lecture fees, as well as grant support through his institution, from Bayer; consulting fees and lecture fees, as well as grant support through his institution, from Biogen Idec; consulting fees, as well as grant support through his institution, from Boehringer Ingelheim; consulting fees, as well as grant support through his institution, from Bristol-Myers Squibb; lecture fees from Covidien; consulting fees from Genzyme; consulting fees, as well as grant support from his institution, from Merck Sharp & Dohme-Chibret; consulting fees and lecture fees, as well as grant support through his institution, from Merck Serono; consulting fees and lecture fees, as well as grant support through his institution, from Novartis; consulting fees and lecture fees, as well as grant support through his institution, from Sanofi-Aventis; consulting fees and lecture fees, as well as grant support through his institution, from Servier; consulting fees, as well as grant support through his institution, from Teva; and grant support through his institution from AstraZeneca, GlaxoSmithKline, Pfizer, and St. Jude Medical. Dr. Hildick-Smith reports receiving consulting fees through his institution from St. Jude Medical. Dr. Dudek and Dr. Wahl report receiving grant support through their institutions from St. Jude Medical. Dr. Andersen reports receiving lecture fees from St. Jude Medical. Dr. Windecker reports receiving lecture fees, as well as grant support through his institution, from Abbott; lecture fees, as well as grant support through his institution, from Medtronic; and grant support through his institution from Biosensors International, Biotronik, Boston Scientific, Cordis, and St. Jude Medical. Dr. Juni reports receiving grant support through his institution from Abbott, Ablynx, Amgen, AstraZeneca, Biosensors International, Biotronik, Boehringer Ingelheim, Eisai, Eli Lilly, Exelixis, Geron, Gilead Sciences, Nestle, Novartis, Novo Nordisk, Padma, Roche, Schering-Plough, St. Jude Medical, and Swiss Cardio Technologies. No other potential conflict of interest relevant to this article was reported.	Agarwal S, 2012, JACC-CARDIOVASC INTE, V5, P777, DOI 10.1016/j.jcin.2012.02.021; Almekhlafi MA, 2009, NEUROLOGY, V73, P89, DOI 10.1212/WNL.0b013e3181aa2a19; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; BRIDGES ND, 1992, CIRCULATION, V86, P1902, DOI 10.1161/01.CIR.86.6.1902; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Cohnheim J, 1877, THROMBOSE EMBOLIE VO; Devuyst G, 1996, NEUROLOGY, V47, P1162, DOI 10.1212/WNL.47.5.1162; Doufekias E, 2008, J AM COLL CARDIOL, V51, P1049, DOI 10.1016/j.jacc.2007.11.053; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Falk V, 1997, THORAC CARDIOV SURG, V45, P90, DOI 10.1055/s-2007-1013695; Fukumoto A, 2005, CIRCULATION, V112, pE143, DOI 10.1161/CIRCULATIONAHA.104.489906; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Khattab AA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-56; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Kizer JR, 2006, NEW ENGL J MED, V354, P2401; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; Koullias GJ, 2004, CIRCULATION, V109, P3056, DOI 10.1161/01.CIR.0000132371.91318.6D; Kutty S, 2012, J AM COLL CARDIOL, V59, P1665, DOI 10.1016/j.jacc.2011.09.085; Mascarenhas V, 2009, J AM COLL CARDIOL, V53, P1338, DOI 10.1016/j.jacc.2008.12.043; O'Gara PT, 2009, CIRCULATION, V119, P2743, DOI 10.1161/CIRCULATIONAHA.109.192272; Pavoni D, 2012, J AM COLL CARDIOL, V59, P1329, DOI 10.1016/j.jacc.2011.08.084; Ruchat P, 1997, EUR J CARDIO-THORAC, V11, P824, DOI 10.1016/S1010-7940(97)01175-5; Schuchlenz HW, 2005, INT J CARDIOL, V101, P77, DOI 10.1016/j.ijcard.2004.03.005; Wahl A, 2012, CIRCULATION, V125, P803, DOI 10.1161/CIRCULATIONAHA.111.030494	26	585	612	4	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1083	1091		10.1056/NEJMoa1211716	http://dx.doi.org/10.1056/NEJMoa1211716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514285	Green Published			2022-12-28	WOS:000316318600001
J	Payne, DC; Vinje, J; Szilagyi, PG; Edwards, KM; Staat, MA; Weinberg, GA; Hall, CB; Chappell, J; Bernstein, DI; Curns, AT; Wikswo, M; Shirley, SH; Hall, AJ; Lopman, B; Parashar, UD				Payne, Daniel C.; Vinje, Jan; Szilagyi, Peter G.; Edwards, Kathryn M.; Staat, Mary Allen; Weinberg, Geoffrey A.; Hall, Caroline B.; Chappell, James; Bernstein, David I.; Curns, Aaron T.; Wikswo, Mary; Shirley, S. Hannah; Hall, Aron J.; Lopman, Benjamin; Parashar, Umesh D.			Norovirus and Medically Attended Gastroenteritis in U.S. Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ROTAVIRUS-VACCINATION; IMPACT; SURVEILLANCE; SEASONALITY; OUTBREAKS; DECLINE; DISEASE; RATES	Background Cases of rotavirus-associated acute gastroenteritis have declined since the introduction of rotavirus vaccines, but the burden of norovirus-associated acute gastroenteritis in children remains to be assessed. Methods We conducted active surveillance for laboratory-confirmed cases of norovirus among children younger than 5 years of age with acute gastroenteritis in hospitals, emergency departments, and outpatient clinical settings. The children resided in one of three U.S. counties during the years 2009 and 2010. Fecal specimens were tested for norovirus and rotavirus. We calculated population-based rates of norovirus-associated acute gastroenteritis and reviewed billing records to determine medical costs; these data were extrapolated to the U.S. population of children younger than 5 years of age. Results Norovirus was detected in 21% of young children (278 of 1295) seeking medical attention for acute gastroenteritis in 2009 and 2010, with norovirus detected in 22% (165 of 742) in 2009 and 20% (113 of 553) in 2010 (P = 0.43). The virus was also detected in 4% of healthy controls (19 of 493) in 2009. Rotavirus was identified in 12% of children with acute gastroenteritis (152 of 1295) in 2009 and 2010. The respective rates of hospitalization, emergency department visits, and outpatient visits for the norovirus were 8.6, 146.7, and 367.7 per 10,000 children younger than 5 years of age in 2009 and 5.8, 134.3, and 260.1 per 10,000 in 2010, with an estimated cost per episode of $3,918, $435, and $151, respectively, in 2009. Nationally, we estimate that the average numbers of annual hospitalizations, emergency department visits, and outpatient visits due to norovirus infection in 2009 and 2010 among U.S. children in this age group exceeded 14,000, 281,000, and 627,000, respectively, with more than $273 million in treatment costs each year. Conclusions Since the introduction of rotavirus vaccines, norovirus has become the leading cause of medically attended acute gastroenteritis in U.S. children and is associated with nearly 1 million health care visits annually. (Funded by the Centers for Disease Control and Prevention.)	[Payne, Daniel C.; Curns, Aaron T.; Wikswo, Mary; Hall, Aron J.; Lopman, Benjamin; Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Epidemiol Branch, Atlanta, GA 30333 USA; [Vinje, Jan; Shirley, S. Hannah] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA 30333 USA; [Szilagyi, Peter G.; Weinberg, Geoffrey A.; Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Edwards, Kathryn M.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Chappell, James] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Chappell, James] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Staat, Mary Allen; Bernstein, David I.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Shirley, S. Hannah] Atlanta Res & Educ Fdn, Decatur, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Rochester; University of Rochester; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Payne, DC (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A34, Atlanta, GA 30333 USA.	dvp6@cdc.gov	Weinberg, Geoffrey A./W-7510-2019; Vinje, Jan/ABE-6336-2020	Weinberg, Geoffrey A./0000-0002-3900-379X; Vinje, Jan/0000-0002-1530-3675	GlaxoSmithKline; Merck; Luminex Molecular Diagnostics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Luminex Molecular Diagnostics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Staat reports receiving consulting and lecture fees from GlaxoSmithKline and Merck and grant support through her institution from GlaxoSmithKline; Dr. Chappell, receiving consulting fees and grant support from Luminex Molecular Diagnostics; and Dr. Bernstein, receiving royalties, both individually and through his institution, for the Rotarix vaccine from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; El-Kamary SS, 2011, J INFECT DIS, V203, P1036, DOI 10.1093/infdis/jiq151; Frey ST JJ, 2011, 49 ANN M INF DIS SOC; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Kilgore A, VACCINE IN PRESS; Lee N, 2007, EMERG INFECT DIS, V13, P1399, DOI 10.3201/eid1309.061535; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mast T Christopher, 2010, Pediatr Infect Dis J, V29, pe19, DOI 10.1097/INF.0b013e3181ca7e2e; Panozzo C. A., 2009, Morbidity and Mortality Weekly Report, V58, P1146; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Payne DC, 2009, PEDIATR INFECT DIS J, V28, P948, DOI 10.1097/INF.0b013e3181a6ad6e; Payne DC, 2008, PEDIATRICS, V122, P1235, DOI 10.1542/peds.2007-3378; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; VANBEEK J, 2013, EURO SURVEILL, V18; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vesikari T, 2011, 6 INT VACC ENT DIS C; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	29	409	433	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1121	1130		10.1056/NEJMsa1206589	http://dx.doi.org/10.1056/NEJMsa1206589			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514289	Green Accepted			2022-12-28	WOS:000316318600005
J	Sanyaolu, L; Farmer, S; Raza, A				Sanyaolu, Leigh; Farmer, Sarah; Raza, Ali			CASE REPORT A man with pain in his right ear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE OTITIS-EXTERNA		[Sanyaolu, Leigh; Farmer, Sarah; Raza, Ali] Royal Gwent Hosp, Ear Nose & Throat Dept, Newport NP20 2UB, Gwent, Wales	Royal Gwent Hospital	Sanyaolu, L (corresponding author), Royal Gwent Hosp, Ear Nose & Throat Dept, Newport NP20 2UB, Gwent, Wales.	lnsanyaolu@doctors.org.uk		Sanyaolu, Leigh/0000-0002-6762-6986				Kaushik V, 2010, COCHRANE DB SYST REV; Osguthorpe JD, 2006, AM FAM PHYSICIAN, V74, P1510; Pabla L, 2012, EUR ARCH OTO-RHINO-L, V269, P753, DOI 10.1007/s00405-011-1687-7; Roland PS, 2002, LARYNGOSCOPE, V112, P1166, DOI 10.1097/00005537-200207000-00005; Rosenfeld RM, 2006, OTOLARYNG HEAD NECK, V134, pS4, DOI [10.1177/0194599813517083, 10.1016/j.otohns.2006.02.014]; van Balen FAM, 2003, BRIT MED J, V327, P1201, DOI 10.1136/bmj.327.7425.1201	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2013	346								f1739	10.1136/bmj.f1739	http://dx.doi.org/10.1136/bmj.f1739			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MJ	23518275				2022-12-28	WOS:000316671800005
J	Noordally, ZB; Ishii, K; Atkins, KA; Wetherill, SJ; Kusakina, J; Walton, EJ; Kato, M; Azuma, M; Tanaka, K; Hanaoka, M; Dodd, AN				Noordally, Zeenat B.; Ishii, Kenyu; Atkins, Kelly A.; Wetherill, Sarah J.; Kusakina, Jelena; Walton, Eleanor J.; Kato, Maiko; Azuma, Miyuki; Tanaka, Kan; Hanaoka, Mitsumasa; Dodd, Antony N.			Circadian Control of Chloroplast Transcription by a Nuclear-Encoded Timing Signal	SCIENCE			English	Article							PLASTID SIGMA-FACTOR; LIGHT-RESPONSIVE PROMOTER; ARABIDOPSIS-THALIANA; RNA-POLYMERASE; HIGHER-PLANTS; KEY PATHWAYS; CLOCK; PSBD; GENE; RHYTHMS	Circadian timekeeping in plants increases photosynthesis and productivity. There are circadian oscillations in the abundance of many chloroplast-encoded transcripts, but it is not known how the circadian clock regulates chloroplast transcription or the photosynthetic apparatus. We show that, in Arabidopsis, nuclear-encoded SIGMA FACTOR5 (SIG5) controls circadian rhythms of transcription of several chloroplast genes, revealing one pathway by which the nuclear-encoded circadian oscillator controls rhythms of chloroplast gene expression. We also show that SIG5 mediates the circadian gating of light input to a chloroplast-encoded gene. We have identified an evolutionarily conserved mechanism that communicates circadian timing information between organelles with distinct genetic systems and have established a new level of integration between eukaryotic circadian clocks and organelles of endosymbiotic origin.	[Noordally, Zeenat B.] Univ Edinburgh, SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland; [Ishii, Kenyu; Kato, Maiko; Hanaoka, Mitsumasa] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Atkins, Kelly A.; Wetherill, Sarah J.; Walton, Eleanor J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Kusakina, Jelena; Dodd, Antony N.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Azuma, Miyuki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of Edinburgh; Chiba University; University of York - UK; University of Bristol; University of Tokyo; Tokyo Institute of Technology	Dodd, AN (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	antony.dodd@bristol.ac.uk	Tanaka, Kan/E-3724-2015; Hanaoka, Mitsumasa/M-9904-2015	Tanaka, Kan/0000-0001-7560-7884; Noordally, Zeenat/0000-0003-2817-1330	Royal Society; Royal Society Anglo-Japanese Daiwa Foundation; Biotechnology and Biological Sciences Research Council [BB/I005811/1]; Nuffield Foundation; University of York; Special Coordination Fund for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [21770034, 24117505, 24770037, 23120505, 24248061]; Japan Society for the Promotion of Science [21770034, 24117505, 24770037, 23120505, 24248061]; Sumitomo Foundation; BBSRC [BB/I005811/1, BB/I005811/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I005811/2, 1107454] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24117505] Funding Source: KAKEN	Royal Society(Royal Society of London); Royal Society Anglo-Japanese Daiwa Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nuffield Foundation; University of York(European Commission); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A.N.D. thanks the Royal Society for awarding a University Research Fellowship. Funding comprised a Royal Society Research Grant; a Royal Society Anglo-Japanese Daiwa Foundation International Joint Project (A.N.D. and M. H.); Biotechnology and Biological Sciences Research Council grant BB/I005811/1 (A.N.D.); the Nuffield Foundation (A.N.D. and K. A. A.); the University of York (A.N.D.); a Special Coordination Fund for Promoting Science and Technology (M. H.); Grants-in-Aid [21770034, 24117505, and 24770037 (M. H.); 23120505 and 24248061 (K. T.)] from the Ministry of Education, Culture, Sports, Science and Technology of Japan or Japan Society for the Promotion of Science, and the Sumitomo Foundation (M. H.). We thank A. Hall for delayed fluorescence advice and luciferase reporters; S. Penfield for period mutants; S. Kay for COSOPT; M. Kobayashi for technique development; and A. Webb, A. Hetherington, and K. Franklin for constructive criticism. The data described are in the main and supplementary figures. There are no conflicts of interest.	Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Favory JJ, 2005, NUCLEIC ACIDS RES, V33, P5991, DOI 10.1093/nar/gki908; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Hanaoka M, 2012, INT J MOL SCI, V13, P12182, DOI 10.3390/ijms131012182; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hassidim M, 2007, PLANT J, V51, P551, DOI 10.1111/j.1365-313X.2007.03160.x; Hoffer PH, 1997, PLANT PHYSIOL, V115, P213, DOI 10.1104/pp.115.1.213; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Ichikawa K, 2008, FEBS LETT, V582, P405, DOI 10.1016/j.febslet.2007.12.034; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kanamaru K, 2004, BIOSCI BIOTECH BIOCH, V68, P2215, DOI 10.1271/bbb.68.2215; Kanamaru K, 2001, PLANT CELL PHYSIOL, V42, P1034, DOI 10.1093/pcp/pce155; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mochizuki T, 2004, FEBS LETT, V571, P26, DOI 10.1016/j.febslet.2004.06.052; Nagashima A, 2004, PLANT CELL PHYSIOL, V45, P357, DOI 10.1093/pcp/pch050; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Onda Y, 2008, PLANT J, V55, P968, DOI 10.1111/j.1365-313X.2008.03567.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Tsunoyama Y, 2004, P NATL ACAD SCI USA, V101, P3304, DOI 10.1073/pnas.0308362101; Yao JL, 2003, PLANT PHYSIOL, V132, P739, DOI 10.1104/pp.102.017913	33	90	94	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1316	1319		10.1126/science.1230397	http://dx.doi.org/10.1126/science.1230397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493713				2022-12-28	WOS:000316053400037
J	Macilwain, C				Macilwain, Colin			The unlikely wisdom of Chairman Mao	NATURE			English	Editorial Material												colinmacilwain@googlemail.com							0	1	2	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					143	143		10.1038/495143a	http://dx.doi.org/10.1038/495143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486019	Bronze			2022-12-28	WOS:000316652300004
J	Chai-Coetzer, CL; Antic, NA; Rowland, LS; Reed, RL; Esterman, A; Catcheside, PG; Eckermann, S; Vowles, N; Williams, H; Dunn, S; McEvoy, RD				Chai-Coetzer, Ching Li; Antic, Nick A.; Rowland, L. Sharn; Reed, Richard L.; Esterman, Adrian; Catcheside, Peter G.; Eckermann, Simon; Vowles, Norman; Williams, Helena; Dunn, Sandra; McEvoy, R. Doug			Primary Care vs Specialist Sleep Center Management of Obstructive Sleep Apnea and Daytime Sleepiness and Quality of Life A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; POLYSOMNOGRAPHY; DIAGNOSIS; MODERATE; AUTOTITRATION; ASSOCIATION; OUTCOMES; SCALE; RISK; MEN	Importance Due to increasing demand for sleep services, there has been growing interest in ambulatory models of care for patients with obstructive sleep apnea. With appropriate training and simplified management tools, primary care physicians are ideally positioned to take on a greater role in diagnosis and treatment. Objective To compare the clinical efficacy and within-trial costs of a simplified model of diagnosis and care in primary care relative to that in specialist sleep centers. Design, Setting, and Patients A randomized, controlled, noninferiority study involving 155 patients with obstructive sleep apnea that was treated at primary care practices (n=81) in metropolitan Adelaide, 3 rural regions of South Australia or at a university hospital sleep medicine center in Adelaide, Australia (n=74), between September 2008 and June 2010. Interventions Primary care management of obstructive sleep apnea vs usual care in a specialist sleep center; both plans included continuous positive airway pressure, mandibular advancement splints, or conservative measures only. Main Outcome and Measures The primary outcome was 6-month change in Epworth Sleepiness Scale (ESS) score, which ranges from 0 (no daytime sleepiness) to 24 points (high level of daytime sleepiness). The noninferiority margin was < 2.0. Secondary outcomes included disease-specific and general quality of life measures, obstructive sleep apnea symptoms, adherence to using continuous positive airway pressure, patient satisfaction, and health care costs. Results There were significant improvements in ESS scores from baseline to 6 months in both groups. In the primary care group, the mean baseline score of 12.8 decreased to 7.0 at 6 months (P < .001), and in the specialist group, the score decreased from a mean of 12.5 to 7.0 (P < .001). Primary care management was noninferior to specialist management with a mean change in ESS score of 5.8 vs 5.4 (adjusted difference, -0.13; lower bound of 1-sided 95% CI, -1.5; P=. 43). There were no differences in secondary outcome measures between groups. Seventeen patients (21%) withdrew from the study in the primary care group vs 6 patients (8%) in the specialist group. Conclusions and Relevance Among patients with obstructive sleep apnea, treatment under a primary care model compared with a specialist model did not result in worse sleepiness scores, suggesting that the 2 treatment modes may be comparable.	[Chai-Coetzer, Ching Li; Antic, Nick A.; Rowland, L. Sharn; Catcheside, Peter G.; Vowles, Norman; McEvoy, R. Doug] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Adelaide, SA, Australia; [Chai-Coetzer, Ching Li; Antic, Nick A.; Rowland, L. Sharn; Reed, Richard L.; Catcheside, Peter G.; McEvoy, R. Doug] Flinders Univ S Australia, Dept Med, Adelaide, SA 5001, Australia; [Eckermann, Simon] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia; [Williams, Helena] Southern Adelaide Fleurieu Kangaroo Isl Medicare, Adelaide, SA, Australia; [Eckermann, Simon] Univ Wollongong, Australian Hlth Serv Res Inst, Wollongong, NSW, Australia; [Dunn, Sandra] Charles Darwin Univ, Sch Hlth, Darwin, NT 0909, Australia	Flinders University South Australia; Flinders University South Australia; University of South Australia; University of Wollongong; Charles Darwin University	Chai-Coetzer, CL (corresponding author), Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Daws Rd, Daw Pk, SA 5041, Australia.	chingli.chai-coetzer@health.sa.gov.au	McEvoy, Doug/ABB-8052-2020; Esterman, Adrian J/D-1042-2009	McEvoy, Doug/0000-0002-5759-0094; Catcheside, Peter/0000-0002-9372-6788; Reed, Richard/0000-0002-5115-4726; Esterman, Adrian/0000-0001-7324-9171	National Health and Medical Research Council of Australia; Flinders Medical Centre Clinicians Trust; Flinders Medical Centre Foundation; ResMed; Philips Respironics; SomnoMed; Fisher and Paykel; Gorman Promed Pty Ltd.; National Health and Medical Research Council of Australia [426744]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Flinders Medical Centre Clinicians Trust; Flinders Medical Centre Foundation; ResMed; Philips Respironics; SomnoMed; Fisher and Paykel; Gorman Promed Pty Ltd.; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chai-Coetzer reported that she has received research funding from the National Health and Medical Research Council of Australia, Flinders Medical Centre Clinicians Trust and Flinders Medical Centre Foundation, and equipment donations from ResMed, Philips Respironics, and SomnoMed. Dr Antic reported that he has received research funding from the National Health and Medical Research Council of Australia, Philips Respironics, and Fisher and Paykel, equipment donations from ResMed, Philips Respironics and SomnoMed, and lecture fees and payment for development of educational presentations from ResMed. Ms Rowland has reported that she has received research funding from the National Health and Medical Research Council of Australia and equipment donations from ResMed, Philips Respironics and SomnoMed. Dr Reed reported that he has received research funding from the National Health and Medical Research Council of Australia. Dr Catcheside has reported that he has received research funding from the National Health and Medical Research Council of Australia, and equipment support from Philips Respironics, Apnex Medical, and Gorman Promed Pty Ltd. Dr Williams has reported that she is Director on the Board of the Australian Commission for Safety and Quality in Health Care and Chair of the Primary Care Clinical Committee, is employed by the SAFKI Medicare Local as Executive Clinical Director, Southern Adelaide Local Health Network as the Presiding Member of the Governing Council, and the Russell Clinic where she is practicing as a general practitioner, and she has previously been employed by the Royal District Nursing Society of South Australia as the Chair of the Clinical Governance Committee. In addition, the National Prescribing Service has paid for her accommodation to attend the National Medicines Symposium 2012. Dr Dunn has reported that she has received research funding from the National Health and Medical Research Council of Australia and equipment donations from ResMed, Philips Respironics and SomnoMed. Dr McEvoy has reported that he has received research funding from the National Health and Medical Research Council of Australia, Philips Respironics, and Fisher and Paykel, equipment donations from ResMed, Philips Respironics and SomnoMed, and lecture fees from Philips Respironics. Drs Esterman, Eckermann, and Vowles have reported no conflicts of interest.; This study was funded by Project Grant 426744 from the National Health and Medical Research Council of Australia and a small grant from the Flinders Medical Centre Foundation. Research scholarship support was provided to Dr ChaiCoetzer by the Flinders Medical Centre Clinicians Trust. Equipment donations were received from ResMed (oximetry monitors and CPAP machines), Philips Respironics (CPAP machines), and SomnoMed (mandibular advancement splints).	Andreu AL, 2012, EUR RESPIR J, V39, P305, DOI 10.1183/09031936.00013311; Antic NA, 2009, AM J RESP CRIT CARE, V179, P501, DOI 10.1164/rccm.200810-1558OC; Association AMG, VIS SPEC SAT QUEST V; Ayas NT, 2011, SLEEP, V34, P691, DOI 10.5665/SLEEP.1026; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; Berry RB, 2008, SLEEP, V31, P1423; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Dixon T, 2003, GROWING PROBLEM TREN, P8; Engleman HM, 2004, THORAX, V59, P618, DOI 10.1136/thx.2003.015867; Goudge R, 2001, AM J RESP CRIT CARE, V163, pA933; Hukins CA, 2005, AM J RESP CRIT CARE, V171, P500, DOI 10.1164/rccm.200401-019OC; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Massie CA, 2003, AM J RESP CRIT CARE, V167, P20, DOI 10.1164/rccm.200201-022OC; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Netzer NC, 2003, CHEST, V124, P1406, DOI 10.1378/chest.124.4.1406; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; Siccoli MM, 2008, SLEEP, V31, P1551, DOI 10.1093/sleep/31.11.1551; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Weaver TE, 1997, SLEEP, V20, P835; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	28	136	139	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					997	1004		10.1001/jama.2013.1823	http://dx.doi.org/10.1001/jama.2013.1823			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483174	Bronze			2022-12-28	WOS:000315938700028
J	Wiggli, B; Imhof, E; Meier, CA; Laifer, G				Wiggli, Benedikt; Imhof, Edelbert; Meier, Christoph A.; Laifer, Gerd			Water, water, everywhere	LANCET			English	Editorial Material							INFECTION		[Wiggli, Benedikt; Meier, Christoph A.; Laifer, Gerd] Stadtspital Triemli, Dept Internal Med, Zurich, Switzerland; [Imhof, Edelbert] Stadtspital Triemli, Div Pulm Med, Zurich, Switzerland	Triemli Hospital; Triemli Hospital	Wiggli, B (corresponding author), Dept Internal Med, Birmensdorferstr 497, CH-8063 Zurich, Switzerland.	benedikt.wiggli@triemli.stzh.ch						ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; Moore TL, 2000, CURR OPIN RHEUMATOL, V12, P289, DOI 10.1097/00002281-200007000-00010; NAKAZAWA T, 1995, INTERNAL MED, V34, P163, DOI 10.2169/internalmedicine.34.163; Smith PT, 1998, CLIN INFECT DIS, V27, P164, DOI 10.1086/514629; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	5	6	6	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 2	2013	381	9868					776	776		10.1016/S0140-6736(12)61894-7	http://dx.doi.org/10.1016/S0140-6736(12)61894-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23472922				2022-12-28	WOS:000315570900032
J	Mariner, WK; Annas, GJ				Mariner, Wendy K.; Annas, George J.			Limiting "Sugary Drinks" to Reduce Obesity - Who Decides?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mariner, Wendy K.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Mariner, Wendy/0000-0001-5176-5917; Annas, George/0000-0001-5836-7831				Callahan D, 2013, HASTINGS CENT REP, V43, P34, DOI 10.1002/hast.114; Grynbaum MM, 2013, NEW YORK TIMES  0311, pA1; Mariner Wendy, 2007, J HLTH CARE LAW POLI, V10, P121	3	15	15	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1763	1765		10.1056/NEJMp1303706	http://dx.doi.org/10.1056/NEJMp1303706			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23550600	Green Published			2022-12-28	WOS:000318540000002
J	O'Sullivan, BP; Sassetti, CM				O'Sullivan, Brian P.; Sassetti, Christopher M.			Infection control in cystic fibrosis: share and share alike	LANCET			English	Editorial Material							MYCOBACTERIUM-ABSCESSUS; MASSILIENSE; COHORT		[O'Sullivan, Brian P.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	O'Sullivan, BP (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA.	osullivb@ummhc.org						Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Bryant JM, 2013, LANCET; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P835, DOI 10.1164/rccm.200207-679OC; Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; Saiman L, 2003, AM J INFECT CONTROL, V31, pS6, DOI 10.1067/mic.2003.78; Wang J, 2003, NAT GENET, V34, P80, DOI 10.1038/ng1139; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	10	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1517	1519		10.1016/S0140-6736(13)60740-0	http://dx.doi.org/10.1016/S0140-6736(13)60740-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23541536				2022-12-28	WOS:000318609600007
J	Buchholz, VR; Flossdorf, M; Hensel, I; Kretschmer, L; Weissbrich, B; Graf, P; Verschoor, A; Schiemann, M; Hofer, T; Busch, DH				Buchholz, Veit R.; Flossdorf, Michael; Hensel, Inge; Kretschmer, Lorenz; Weissbrich, Bianca; Graef, Patricia; Verschoor, Admar; Schiemann, Matthias; Hoefer, Thomas; Busch, Dirk H.			Disparate Individual Fates Compose Robust CD8(+) T Cell Immunity	SCIENCE			English	Article							TRANSCRIPTION FACTOR; CUTTING EDGE; MEMORY; EFFECTOR; PRECURSOR; SUBSETS; STEM; DIFFERENTIATION; EXPANSION; DIVISION	A core feature of protective T cell responses to infection is the robust expansion and diversification of naive antigen-specific T cell populations into short-lived effector and long-lived memory subsets. By means of in vivo fate mapping, we found a striking variability of immune responses derived from individual CD8(+) T cells and show that robust acute and recall immunity requires the initial recruitment of multiple precursors. Unbiased mathematical modeling identifies the random integration of multiple differentiation and division events as the driving force behind this variability. Within this probabilistic framework, cell fate is specified along a linear developmental path that progresses from slowly proliferating long-lived to rapidly expanding short-lived subsets. These data provide insights into how complex biological systems implement stochastic processes to guarantee robust outcomes.	[Buchholz, Veit R.; Hensel, Inge; Kretschmer, Lorenz; Weissbrich, Bianca; Graef, Patricia; Verschoor, Admar; Schiemann, Matthias; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Flossdorf, Michael; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Flossdorf, Michael; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, D-69120 Heidelberg, Germany; [Busch, Dirk H.] TUM, Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy &, D-81675 Munich, Germany; [Busch, Dirk H.] TUM, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-81675 Munich, Germany; [Busch, Dirk H.] Natl Ctr Infect Res DZIF, D-81675 Munich, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; German Center for Infection Research	Hofer, T (corresponding author), German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany.	t.hoefer@dkfz-heidelberg.de; dirk.busch@mikrobio.med.tum.de	Höfer, Thomas/G-5665-2013; Buchholz, Veit R./AAF-6966-2021	Höfer, Thomas/0000-0003-3560-8780; Buchholz, Veit R./0000-0003-0441-3913	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; EU-FP7 SYBILLA [201106]; BMBF ForSysPartner [0315267E]; National Science Foundation [NSF PHY11-25915];  [SFB TR 36 (TP-B10/13)];  [SFB 1054 (TP-B09)];  [SFB 914 (TP-B04)]	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; EU-FP7 SYBILLA; BMBF ForSysPartner(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF)); ; ; 	The authors thank L. Henkel for cell sorting; A. Muschaweckh and I. Drexler for providing Vaccinia-OVA and MVA-OVA; and K. Kerksiek, H. Wagner, C. Stemberger, F. Anderl, S. Dreher, and T. G. Grunewald for helpful discussion and/or critically reading the manuscript. The authors declare no conflict of interest. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the SFB TR 36 (TP-B10/13, TP-Z1), the SFB 1054 (TP-B09), the SFB 914 (TP-B04), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer, EU-FP7 SYBILLA (201106), BMBF ForSysPartner (0315267E), and by the National Science Foundation under grant NSF PHY11-25915.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	23	272	273	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					630	635		10.1126/science.1235454	http://dx.doi.org/10.1126/science.1235454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23493420				2022-12-28	WOS:000318268900053
J	Matthews, HD; Solomon, S				Matthews, H. Damon; Solomon, Susan			Irreversible Does Not Mean Unavoidable	SCIENCE			English	Editorial Material							CUMULATIVE CARBON; CLIMATE-CHANGE; EMISSIONS		[Matthews, H. Damon] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada; [Solomon, Susan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Concordia University - Canada; Massachusetts Institute of Technology (MIT)	Matthews, HD (corresponding author), Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada.	damon.matthews@concordia.ca; solos@mit.edu	/AAD-2430-2020	/0000-0003-3625-390X				Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; [Anonymous], 2012, WASHINGTON POST; Bolin B, 2001, P NATL ACAD SCI USA, V98, P4850, DOI 10.1073/pnas.081078998; Davis SJ, 2010, SCIENCE, V329, P1330, DOI 10.1126/science.1188566; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2012, PHILOS T R SOC A, V370, P4365, DOI 10.1098/rsta.2012.0064; Matthews HD, 2010, NAT GEOSCI, V3, P142, DOI 10.1038/ngeo813; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Parry M L, 2007, CLIMATE CHANGE 2007, P19; Solomon S., 2011, CLIMATE STABILIZATIO; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468; Victor D, 2011, GLOBAL WARMING GRIDL	14	40	40	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					438	439		10.1126/science.1236372	http://dx.doi.org/10.1126/science.1236372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131SQ	23539182	Green Accepted, Green Submitted			2022-12-28	WOS:000318016700028
J	Grupp, SA; Kalos, M; Barrett, D; Aplenc, R; Porter, DL; Rheingold, SR; Teachey, DT; Chew, A; Hauck, B; Wright, JF; Milone, MC; Levine, BL; June, CH				Grupp, Stephan A.; Kalos, Michael; Barrett, David; Aplenc, Richard; Porter, David L.; Rheingold, Susan R.; Teachey, David T.; Chew, Anne; Hauck, Bernd; Wright, J. Fraser; Milone, Michael C.; Levine, Bruce L.; June, Carl H.			Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ACUTE LYMPHOCYTIC-LEUKEMIA; DONOR LEUKOCYTE INFUSIONS; ADOPTIVE IMMUNOTHERAPY; CLINICAL-TRIAL; CHEMOTHERAPY; PERSISTENCE; MALIGNANCY; CHILDREN	Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whether chimeric antigen receptor T cells have clinical activity in acute lymphoblastic leukemia (ALL). Two children with relapsed and refractory pre-B-cell ALL received infusions of T cells transduced with anti-CD19 antibody and a T-cell signaling molecule (CTL019 chimeric antigen receptor T cells), at a dose of 1.4x10(6) to 1.2x10(7) CTL019 cells per kilogram of body weight. In both patients, CTL019 T cells expanded to a level that was more than 1000 times as high as the initial engraftment level, and the cells were identified in bone marrow. In addition, the chimeric antigen receptor T cells were observed in the cerebrospinal fluid (CSF), where they persisted at high levels for at least 6 months. Eight grade 3 or 4 adverse events were noted. The cytokine-release syndrome and B-cell aplasia developed in both patients. In one child, the cytokine-release syndrome was severe; cytokine blockade with etanercept and tocilizumab was effective in reversing the syndrome and did not prevent expansion of chimeric antigen receptor T cells or reduce anti-leukemic efficacy. Complete remission was observed in both patients and is ongoing in one patient at 11 months after treatment. The other patient had a relapse, with blast cells that no longer expressed CD19, approximately 2 months after treatment. Chimeric antigen receptor-modified T cells are capable of killing even aggressive, treatment-refractory acute leukemia cells in vivo. The emergence of tumor cells that no longer express the target indicates a need to target other molecules in addition to CD19 in some patients with ALL.	[Grupp, Stephan A.; Barrett, David; Aplenc, Richard; Rheingold, Susan R.; Teachey, David T.; Hauck, Bernd; Wright, J. Fraser] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Grupp, Stephan A.; Barrett, David; Aplenc, Richard; Rheingold, Susan R.; Teachey, David T.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Grupp, Stephan A.; Kalos, Michael; Aplenc, Richard; Porter, David L.; Rheingold, Susan R.; Teachey, David T.; Milone, Michael C.; Levine, Bruce L.; June, Carl H.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Kalos, Michael; Chew, Anne; Hauck, Bernd; Wright, J. Fraser; Milone, Michael C.; Levine, Bruce L.; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Porter, David L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Grupp, SA (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Oncol BMT CTRB 3006,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	grupp@email.chop.edu		June, Carl/0000-0003-0241-3557; Teachey, David/0000-0001-7373-8987	National Institutes of Health [1R01CA165206, R01CA102646, R01CA116660]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA116660, R01CA165206, R01CA102646, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants from the National Institutes of Health (1R01CA165206, to Dr. June; and R01CA102646 and R01CA116660, to Dr. Grupp) and the Leukemia and Lymphoma Society.	Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BARRETT AJ, 1994, NEW ENGL J MED, V331, P1253, DOI 10.1056/NEJM199411103311902; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Collins RH, 2000, BONE MARROW TRANSPL, V26, P511, DOI 10.1038/sj.bmt.1702555; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Huu DL, 2012, J INVEST DERMATOL, V132, P2752, DOI 10.1038/jid.2012.226; Drobyski WR, 2011, BIOL BLOOD MARROW TR, V17, P1862, DOI 10.1016/j.bbmt.2011.07.001; Garcia-Manero G, 2001, HEMATOL ONCOL CLIN N, V15, P163, DOI 10.1016/S0889-8588(05)70204-5; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; PULLEN J, 1993, J CLIN ONCOL, V11, P839, DOI 10.1200/JCO.1993.11.5.839; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Tang YM, 2008, BRIT J HAEMATOL, V143, P84, DOI 10.1111/j.1365-2141.2008.07298.x; Tawara I, 2011, CLIN CANCER RES, V17, P77, DOI 10.1158/1078-0432.CCR-10-1198; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969	26	2369	2704	90	723	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1509	1518		10.1056/NEJMoa1215134	http://dx.doi.org/10.1056/NEJMoa1215134			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23527958	Green Accepted, Bronze			2022-12-28	WOS:000317603300008
J	Ling, HQ; Zhao, SC; Liu, DC; Wang, JY; Sun, H; Zhang, C; Fan, HJ; Li, D; Dong, LL; Tao, Y; Gao, C; Wu, HL; Li, YW; Cui, Y; Guo, XS; Zheng, SS; Wang, B; Yu, K; Liang, QS; Yang, WL; Lou, XY; Chen, J; Feng, MJ; Jian, JB; Zhang, XF; Luo, GB; Jiang, Y; Liu, JJ; Wang, ZB; Sha, YH; Zhang, BR; Wu, HJ; Tang, DZ; Shen, QH; Xue, PY; Zou, SH; Wang, XJ; Liu, X; Wang, FM; Yang, YP; An, XL; Dong, ZY; Zhang, KP; Zhang, XQ; Luo, MC; Dvorak, J; Tong, YP; Wang, J; Yang, HM; Li, ZS; Wang, DW; Zhang, AM; Wang, J				Ling, Hong-Qing; Zhao, Shancen; Liu, Dongcheng; Wang, Junyi; Sun, Hua; Zhang, Chi; Fan, Huajie; Li, Dong; Dong, Lingli; Tao, Yong; Gao, Chuan; Wu, Huilan; Li, Yiwen; Cui, Yan; Guo, Xiaosen; Zheng, Shusong; Wang, Biao; Yu, Kang; Liang, Qinsi; Yang, Wenlong; Lou, Xueyuan; Chen, Jie; Feng, Mingji; Jian, Jianbo; Zhang, Xiaofei; Luo, Guangbin; Jiang, Ying; Liu, Junjie; Wang, Zhaobao; Sha, Yuhui; Zhang, Bairu; Wu, Huajun; Tang, Dingzhong; Shen, Qianhua; Xue, Pengya; Zou, Shenhao; Wang, Xiujie; Liu, Xin; Wang, Famin; Yang, Yanping; An, Xueli; Dong, Zhenying; Zhang, Kunpu; Zhang, Xiangqi; Luo, Ming-Cheng; Dvorak, Jan; Tong, Yiping; Wang, Jian; Yang, Huanming; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Wang, Jun			Draft genome of the wheat A-genome progenitor Triticum urartu	NATURE			English	Article							EVOLUTION; GENE; IDENTIFICATION; LOCI; MAP	Bread wheat (Triticum aestivum, AABBDD) is one of the most widely cultivated and consumed food crops in the world. However, the complex polyploid nature of its genome makes genetic and functional analyses extremely challenging. The A genome, as a basic genome of bread wheat and other polyploid wheats, for example, T. turgidum (AABB), T. timopheevii (AAGG) and T. zhukovskyi (AAGGA(m)A(m)), is central to wheat evolution, domestication and genetic improvement(1). The progenitor species of the A genome is the diploid wild einkorn wheat T. urartu(2), which resembles cultivated wheat more extensively than do Aegilops speltoides (the ancestor of the B genome(3)) and Ae. tauschii (the donor of the D genome(4)), especially in the morphology and development of spike and seed. Here we present the generation, assembly and analysis of a whole-genome shotgun draft sequence of the T. urartu genome. We identified protein-coding gene models, performed genome structure analyses and assessed its utility for analysing agronomically important genes and for developing molecular markers. Our T. urartu genome assembly provides a diploid reference for analysis of polyploid wheat genomes and is a valuable resource for the genetic improvement of wheat.	[Ling, Hong-Qing; Liu, Dongcheng; Wang, Junyi; Sun, Hua; Fan, Huajie; Dong, Lingli; Wu, Huilan; Li, Yiwen; Cui, Yan; Zheng, Shusong; Wang, Biao; Yu, Kang; Yang, Wenlong; Lou, Xueyuan; Zhang, Xiaofei; Luo, Guangbin; Zhang, Bairu; Tang, Dingzhong; Shen, Qianhua; Xue, Pengya; Zou, Shenhao; Liu, Xin; Wang, Famin; Yang, Yanping; An, Xueli; Dong, Zhenying; Zhang, Kunpu; Zhang, Xiangqi; Tong, Yiping; Li, Zhensheng; Wang, Daowen; Zhang, Aimin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Zhao, Shancen; Wang, Junyi; Zhang, Chi; Li, Dong; Tao, Yong; Gao, Chuan; Guo, Xiaosen; Liang, Qinsi; Chen, Jie; Feng, Mingji; Jian, Jianbo; Jiang, Ying; Liu, Junjie; Wang, Zhaobao; Sha, Yuhui; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518038, Peoples R China; [Zhao, Shancen] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Shancen] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Huajun; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of California System; University of California Davis; University of Copenhagen; King Abdulaziz University	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518038, Peoples R China.	hqling@genetics.ac.cn; zsli@genetics.ac.cn; dwwang@genetics.ac.cn; amzhang@genetics.ac.cn; wangj@genomics.cn	Sun, Hua/O-6729-2018; Liang, Qinsi/AAK-5234-2020; Ling, Hong-Qing/ABC-9451-2020; Tang, Dingzhong/AAZ-2500-2020; Wang, Xiu-Jie/L-1312-2019; wang, junyi/GYA-3213-2022; Shen, Qian-Hua/D-2734-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Sun, Hua/0000-0003-2169-0808; Tang, Dingzhong/0000-0001-8850-8754; Shen, Qian-Hua/0000-0002-9446-3086; wang, dao wen/0000-0002-6230-8735; Wang, Jun/0000-0002-2113-5874; Jian, Jianbo/0000-0003-2187-5490; Wang, Jun/0000-0002-8540-8931; Luo, Ming-Cheng/0000-0002-9744-5887; zhang, xiaofei/0000-0003-4516-9179	Ministry of Science and Technology of China [2010DFB33540, 2011CB100304, 2011AA100104, 2009CB118300]; Ministry of Science and Technology of China [2010DFB33540, 2011CB100304, 2011AA100104, 2009CB118300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank L. Goodman for assistance in editing the manuscript, and M. Bevan and Y.-B. Xue for critical reading of the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (the special fund for the State Key Laboratory of Plant Cell and Chromosome Engineering, 2010DFB33540, 2011CB100304, 2011AA100104 and 2009CB118300).	BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; DVORAK J, 1990, P NATL ACAD SCI USA, V87, P9640, DOI 10.1073/pnas.87.24.9640; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; FAOSTAT, 2011, FAOSTAT; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Ling H.-Q, 2013, GIGASCIENCE; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Ozkan H, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq015; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x	26	540	617	10	339	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					87	90		10.1038/nature11997	http://dx.doi.org/10.1038/nature11997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535596	Green Published, hybrid			2022-12-28	WOS:000316993400030
J	Debronkart, D				Debronkart, Dave			How the e-patient community helped save my life: an essay by Dave deBronkart	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE					dave@epatientdave.com						Christensen C, 2009, INNOVATORS PRESCRIPT; DeBronkart D., 2010, BACK FUTURE TOM FERG; e-Patient Dave, 2009, IM SOM HAD BEEN MAN; Ferguson T, 2004, BMJ-BRIT MED J, V328, P1148, DOI 10.1136/bmj.328.7449.1148; Ferguson T, 2000, BRIT MED J, V321, P1129, DOI 10.1136/bmj.321.7269.1129; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Meet e-Patient Dave, 2011, TEDX MAASTR FUT HLTH; Topol EJ, 2012, CREATIVE DESTRUCTION; Wangsness L, 2009, BOSTON GLOBE	11	30	30	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f1990	10.1136/bmj.f1990	http://dx.doi.org/10.1136/bmj.f1990			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SA	23550048	Bronze			2022-12-28	WOS:000317337200005
J	Li, C; Zhang, TN; Goldman, DI				Li, Chen; Zhang, Tingnan; Goldman, Daniel I.			A Terradynamics of Legged Locomotion on Granular Media	SCIENCE			English	Article							HYDRODYNAMICS	The theories of aero- and hydrodynamics predict animal movement and device design in air and water through the computation of lift, drag, and thrust forces. Although models of terrestrial legged locomotion have focused on interactions with solid ground, many animals move on substrates that flow in response to intrusion. However, locomotor-ground interaction models on such flowable ground are often unavailable. We developed a force model for arbitrarily-shaped legs and bodies moving freely in granular media, and used this "terradynamics" to predict a small legged robot's locomotion on granular media using various leg shapes and stride frequencies. Our study reveals a complex but generic dependence of stresses in granular media on intruder depth, orientation, and movement direction and gives insight into the effects of leg morphology and kinematics on movement.	[Li, Chen; Zhang, Tingnan; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Li, Chen] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Berkeley	Goldman, DI (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu	Li, Chen/A-4003-2013	Li, Chen/0000-0001-7516-3646	Burroughs Wellcome Fund; Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance; Army Research Office; NSF; Miller Institute for Basic Research in Science of the University of California, Berkeley	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance; Army Research Office; NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Science of the University of California, Berkeley	We thank Y. Ding, P. Umbanhowar, N. Gravish, G. Meirion-Griffith, S. Sharpe, H. Komsuoglu, D. Koditschek, and R. Full for discussions; J. Shen for assistance with robot modification; P. Masarati for multibody dynamic simulator support; S. Sharpe for measuring the angle of repose of 3-mm glass spheres and assistance with photography; P. Umbanhowar and H. Marvi for natural sand collection; and all the members of the Complex Rheology And Biomechanics Lab at Georgia Tech for general assistance. This work was supported by the Burroughs Wellcome Fund, the Army Research Laboratory Micro Autonomous Systems and Technology Collaborative Technology Alliance, the Army Research Office, and the NSF Physics of Living Systems program. C.L. was partially supported by a Miller Research Fellowship from the Miller Institute for Basic Research in Science of the University of California, Berkeley. The authors declare that they have no competing interests. C.L. designed the study, performed resistive force measurements, and performed robot experiments; C.L. and T.Z. performed model calculations; T.Z. performed robot simulation; D.I.G. oversaw the study; and C.L. and D.I.G. wrote the paper.	Bagnold RA, 2005, PHYS BLOWN SAND DESE; Bekker M, 1960, OFF THE ROAD LOCOMOT; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Brand LR, 1996, J PALEONTOL, V70, P1004, DOI 10.1017/S0022336000038701; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; Chaudhuri B, 2006, POWDER TECHNOL, V165, P105, DOI 10.1016/j.powtec.2006.04.001; Cho GC, 2006, J GEOTECH GEOENVIRON, V132, P591, DOI 10.1061/(ASCE)1090-0241(2006)132:5(591); Clack J. A., 2012, GAINING GROUND ORIGI; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Ding Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028001; Dudley R, 2002, BIOMECHANICS INSECT; Etkin B., 1972, DYNAMICS ATMOSPHERIC, V2nd ed.; FANCY SG, 1985, J WILDLIFE MANAGE, V49, P987, DOI 10.2307/3801384; Fearing R. S., 2000, IEEE INT C ROB AUT, V2000, P1509; Haynes G.C., 2011, 2011 IEEE SAF SEC RE, V2011, P134; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Kamrin K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.178301; Lauder GV, 2007, J EXP BIOL, V210, P2767, DOI 10.1242/jeb.000265; Lauder GV, 2002, INTEGR COMP BIOL, V42, P1009, DOI 10.1093/icb/42.5.1009; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Nedderman R.M., 1992, STATICS KINEMATICS G; Newman J.N., 2017, MARINE HYDRODYNAMICS; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Raibert M., 2008, IFAC P, V41, P10822, DOI [10.3182/20080706-5-KR-1001.01833, DOI 10.3182/20080706-5-KR-1001.01833]; Spenko M., 2010, IEEE AER C, V2010, P1; Vitt LJ, 2001, COPEIA, P401, DOI 10.1643/0045-8511(2001)001[0401:LOTLLT]2.0.CO;2; Vogel S, 2020, LIFE MOVING FLUIDS P; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Zhang TN, 2013, INT J ROBOT RES, V32, P859, DOI 10.1177/0278364913481690	32	244	253	13	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1408	1412		10.1126/science.1229163	http://dx.doi.org/10.1126/science.1229163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520106	Green Submitted			2022-12-28	WOS:000316740700036
J	Mackenbach, JP; Karanikolos, M; McKee, M				Mackenbach, Johan P.; Karanikolos, Marina; McKee, Martin			Health policy in Europe: factors critical for success	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHANGING LIFE EXPECTANCY; HEART-DISEASE MORTALITY; PUBLIC-HEALTH; SWEDEN; IMPACT		[Mackenbach, Johan P.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England	Erasmus University Rotterdam; Erasmus MC; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine	Mackenbach, JP (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.mackenbach@erasmusmc.nl	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Karanikolos, Marina/0000-0002-3824-8226				Albreht T, 2008, INT J PUBLIC HEALTH, V53, P150, DOI 10.1007/s00038-008-7032-2; Alesina A., 2004, FIGHTING POVERTY US; Allin S., 2004, MAKING DECISIONS PUB; Anderson P., 2012, ALCOHOL EUROPEAN UNI; Anttila A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-38; Armingeon K., 2011, COMP POLITICAL DATA; Balabanova D, 2011, GOOD HLTH LOW COST 2; BERG-SCFILOSSER D., 2004, J COMMUNIST STUDIES, V20, P28; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Bjorck L, 2011, J INTERN MED, V269, P452, DOI 10.1111/j.1365-2796.2010.02339.x; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bray FI, 2010, INT J CANCER, V126, P1454, DOI 10.1002/ijc.24855; Chenet L, 1996, J EPIDEMIOL COMMUN H, V50, P404, DOI 10.1136/jech.50.4.404; Chenet L, 1996, J PUBLIC HEALTH MED, V18, P329, DOI 10.1093/oxfordjournals.pubmed.a024514; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Gotzsche PC, 2012, CANCER CAUSE CONTROL, V23, P15, DOI 10.1007/s10552-011-9867-8; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; *INT AG RES CANC, 2005, CERV CANC SCREEN; Kunitz SJ, 2004, AM J PUBLIC HEALTH, V94, P1894, DOI 10.2105/AJPH.94.11.1894; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; MacGregor GA, 1996, BRIT MED J, V312, P1287, DOI 10.1136/bmj.312.7041.1287; Mackenbach JP., 2013, SUCCESSES FAILURES H; McKee M, 1996, HEALTH POLICY, V37, P117, DOI 10.1016/0168-8510(95)00829-2; Pagliccia N, 2012, INT J HEALTH SERV, V42, P77, DOI 10.2190/HS.42.1.h; Racioppi F., 2004, PREVENTING ROAD TRAF; RITSATAKIS A, 2009, GAINING HLTH ANAL PO; Rodriguez-Pose A, 2004, REG STUD, V38, P97, DOI 10.1080/00343400310001632226; Vallgarda S, 2007, SCAND J PUBLIC HEALT, V35, P205, DOI 10.1080/14034940600858433; Vallgarda S, 2011, SCAND J PUBLIC HEALT, V39, P6, DOI 10.1177/1403494810378922; WHO, 2012, HLTH 2020 EUR POL FR; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	39	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f533	10.1136/bmj.f533	http://dx.doi.org/10.1136/bmj.f533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516259	Green Submitted			2022-12-28	WOS:000316671500013
J	Awasthi, S; Peto, R; Read, S; Clark, S; Pande, V; Bundy, D				Awasthi, Shally; Peto, Richard; Read, Simon; Clark, Sarah; Pande, Vinod; Bundy, Donald		DEVTA Deworming Enhanced Vitamin A	Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial	LANCET			English	Article							CHILDHOOD MORTALITY; MORBIDITY; IMPACT	Background In north India, vitamin A deficiency (retinol <0.70 mu mol/L) is common in pre-school children and 2-3% die at ages 1.0-6.0 years. We aimed to assess whether periodic vitamin A supplementation could reduce this mortality. Methods Participants in this cluster-randomised trial were pre-school children in the defined catchment areas of 8338 state-staffed village child-care centres (under-5 population 1 million) in 72 administrative blocks. Groups of four neighbouring blocks (clusters) were cluster-randomly allocated in Oxford, UK, between 6-monthly vitamin A (retinol capsule of 200 000 IU retinyl acetate in oil, to be cut and dripped into the child's mouth every 6 months), albendazole (400 mg tablet every 6 months), both, or neither (open control). Analyses of retinol effects are by block (36 vs 36 clusters). The study spanned 5 calendar years, with 11 6-monthly mass-treatment days for all children then aged 6-72 months. Annually, one centre per block was randomly selected and visited by a study team 1-5 months after any trial vitamin A to sample blood (for retinol assay, technically reliable only after mid-study), examine eyes, and interview caregivers. Separately, all 8338 centres were visited every 6 months to monitor pre-school deaths (100 000 visits, 25 000 deaths at ages 1.0-6.0 years [the primary outcome]). This trial is registered at ClinicalTrials.gov, NCT00222547. Findings Estimated compliance with 6-monthly retinol supplements was 86%. Among 2581 versus 2584 children surveyed during the second half of the study, mean plasma retinol was one-sixth higher (0.72 [SE 0.01] vs 0.62 [0.01] mu mol/L, increase 0.10 [SE 0.01] mu mol/L) and the prevalence of severe deficiency was halved (retinol <0.35 mu mol/L 6% vs 13%, decrease 7% [SE 1%]), as was that of Bitot's spots (1.4% vs 3.5%, decrease 2.1% [SE 0.7%]). Comparing the 36 retinol-allocated versus 36 control blocks in analyses of the primary outcome, deaths per child-care centre at ages 1.0-6.0 years during the 5-year study were 3.01 retinol versus 3.15 control (absolute reduction 0.14 [SE 0.11], mortality ratio 0.96, 95% CI 0.89-1.03, p=0.22), suggesting absolute risks of death between ages 1.0 and 6.0 years of approximately 2.5% retinol versus 2.6% control. No specific cause of death was significantly affected. Interpretation DEVTA contradicts the expectation from other trials that vitamin A supplementation would reduce child mortality by 20-30%, but cannot rule out some more modest effect. Meta-analysis of DEVTA plus eight previous randomised trials of supplementation (in various different populations) yielded a weighted average mortality reduction of 11% (95% CI 5-16, p=0.00015), reliably contradicting the hypothesis of no effect.	[Awasthi, Shally; Pande, Vinod; DEVTA Deworming Enhanced Vitamin A] King Georges Med Univ, Lucknow, Uttar Pradesh, India; [Peto, Richard; Read, Simon; Clark, Sarah] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peto, Richard; Read, Simon; Clark, Sarah] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Bundy, Donald] World Bank, Human Dev Network, Washington, DC 20433 USA	King George's Medical University; University of Oxford; University of Oxford; The World Bank	Peto, R (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	rpeto@ctsu.ox.ac.uk	Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647	UK Medical Research Council; USAID; World Bank; USAID OMNI project; UK Medical Research Council (via CTSU); Helmut Horten cancer research award; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); USAID(United States Agency for International Development (USAID)); World Bank(The World Bank India); USAID OMNI project(United States Agency for International Development (USAID)); UK Medical Research Council (via CTSU)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Helmut Horten cancer research award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, USAID, World Bank (vitamin A donated by Roche).; This report is dedicated to Martin Frigg (1943-2010<SUP>28</SUP>). Our chief acknowledgment is to the anganwadi centre (AWC) workers, communities, and children in the 8338 participating AWCs; the seven district and 72 ICDS officials in the following districts and blocks (Lucknow: Mall, Malihabad, Bakshi Ka Talab, Chinhat, Sarojini Nagar, Kakori, Mohan Lal Ganj, Gosai Ganj; Unnao: S Karan, S Sirosi, Hasan Ganj, Miyan Ganj, Asoha, Auras, Safipur, Bangarmau, Fatehpur Chourasi, Bichhiya, Sumerpur, Bighapur, Purva, Ganjmuradabad; Kanpur: Kanpur Nagar I, Kanpur Nagar II, Sarsoul, Bilhour, Patara, Vidhnu, Choubepur, Kalyanpur; Sitapur: Mishrikh, Sakaran, Khairabad, Godlamau, Hargaon, Kasmanda, Machrehta, Biswan, Pahla; Lakhimpur Kheeri: Lakhimpur Kheeri, Nidyasan, Vijuva, Ishanagar, Dharora, Pasgawan, Mohammadi, Golagokaran Nath, Bakey Ganj, Mitouli, Paliya Kala, Nakha, Phool Behad, Behjam; Raibareli: Singhpur, Dalmau, Unchahar, Maharajganj, Bahadurpur, Salon, Harchanpur, Bachrawana, Khero, Tiloi; Hardoi: Kachhouna, Kothawa, Bilgram, Hariyawan, Pihani, Tadiawan, Sursa, Ahirori, Behinder); the Government of Uttar Pradesh Department of Health and Department of Woman and Child Welfare (with ICDS); and the Vice-Chancellor of King George's Medical University, M Bhandari. Rajiv Awasthi, Jill Boreham, Frances Davidson, Nilanthi de Silva, Martin Frigg, Andrew Hall, John Horton, Trudie Lang, Penny Nestel, Hongchao Pan, Lorenzo Savioli, and Sarman Singh helped to plan, execute, or comment on the study. Funding was received from USAID OMNI project, World Bank, and UK Medical Research Council (via CTSU). Albendazole (Zentel) was donated by SmithKlineBeecham (now GlaxoSmithKline), and vitamin A by Hoffman-La Roche via the Sight and Life Program. We acknowledge the CTSU's computing and other support in Oxford, including funds from the 1991 Helmut Horten cancer research award to Richard Peto and Richard Doll (1912-2005<SUP>29</SUP>).	[Anonymous], 2010, SIGHT LIFE, V3, P64; [Anonymous], 2000, REP NAT CONS BEN SAF; ARTHUR P, 1992, LANCET, V339, P361, DOI 10.1016/0140-6736(92)91677-Z; Awasthi S, 2007 MICR FOR IST; Baigent C, 2010, OXFORD TXB MED, P31; Beaton G., 1993, EFFECTIVENESS VITAMI; Beaton G, 1993, ACC SCN STATE ART SE; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Gogia S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b919; Gragnolati M, 2006, INDIAS UNDERNOURISHE; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Kapil U, 2004, AM J CLIN NUTR, V80, P1082, DOI 10.1093/ajcn/80.4.1082; Latham M., 2010, WORLD NUTR, V1; MUHILAL, 1988, AM J CLIN NUTR, V48, P1271, DOI 10.1093/ajcn/48.5.1271; Peto R, 2013, LANCET; Peto R, 2010, BIOGR MEMS FELL R SO, V56, P63; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; SOMMER A, 1986, LANCET, V1, P1169; Tonascia JA, 1993, PUBLIC HLTH SIGNIFIC; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; West Jr KP, 2010, WORLD NUTR, V1, P211; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6	29	102	104	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1469	1477		10.1016/S0140-6736(12)62125-4	http://dx.doi.org/10.1016/S0140-6736(12)62125-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23498849	Green Published			2022-12-28	WOS:000318607300036
J	Braveman, P				Braveman, Paula			Health in Europe-a view from across the Atlantic	LANCET			English	Editorial Material							UNITED-STATES; DISADVANTAGE; ENGLAND; US		Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Braveman, P (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94118 USA.	braveman@fcm.ucsf.edu						Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Crimmins EM, 2010, INT DIFFERENCES MORT; CUTLER D, 2005, WHAT EXPLAINS DIFFER; Institute ofMedicine and National Research Council, 2013, US HLTH INT PERSP SH; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Mackenbach JP, 2013, LANCET; Martinson ML, 2011, AM J EPIDEMIOL, V173, P858, DOI 10.1093/aje/kwq325; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Organisation for Economic Co-operation and Development, 2013, GDP GROWTH NAT ACC G; Pampel F., 2010, DIVERGENT PATTERNS S, P132; Rechel B, 2013, LANCET; Wilkinson R., 2010, SPIRIT LEVEL WHY GRE; [No title captured]	15	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1257	1259		10.1016/S0140-6736(13)60587-5	http://dx.doi.org/10.1016/S0140-6736(13)60587-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23541060	Bronze			2022-12-28	WOS:000317351000009
J	Katzman, M				Katzman, Michael			The Clock Doctor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Penn State Coll Med, Milton S Hershey Med Ctr, Dept Med, Div Infect Dis, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Katzman, M (corresponding author), Penn State Coll Med, Milton S Hershey Med Ctr, Dept Med, Div Infect Dis, Hershey, PA USA.	mkatzman@psu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1357	1358		10.1001/jama.2013.1560	http://dx.doi.org/10.1001/jama.2013.1560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549580				2022-12-28	WOS:000316934500024
J	Zhang, HB; Plutzky, J; Skentzos, S; Morrison, F; Mar, P; Shubina, M; Turchin, A				Zhang, Huabing; Plutzky, Jorge; Skentzos, Stephen; Morrison, Fritha; Mar, Perry; Shubina, Maria; Turchin, Alexander			Discontinuation of Statins in Routine Care Settings A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CHOLESTEROL GOALS; LDL CHOLESTEROL; ADHERENCE; THERAPY; SAFETY; ROSUVASTATIN; RISK; ATORVASTATIN; METAANALYSIS	Background: Systematic data on discontinuation of statins in routine practice of medicine are limited. Objective: To investigate the reasons for statin discontinuation and the role of statin-related events (clinical events or symptoms believed to have been caused by statins) in routine care settings. Design: A retrospective cohort study. Setting: Practices affiliated with Brigham and Women's Hospital and Massachusetts General Hospital in Boston. Patients: Adults who received a statin prescription between 1 January 2000 and 31 December 2008. Measurements: Information on reasons for statin discontinuations was obtained from a combination of structured electronic medical record entries and analysis of electronic provider notes by validated software. Results: Statins were discontinued at least temporarily for 57 292 of 107 835 patients. Statin-related events were documented for 18 778 (17.4%) patients. Of these, 11 124 had statins discontinued at least temporarily; 6579 were rechallenged with a statin over the subsequent 12 months. Most patients who were rechallenged (92.2%) were still taking a statin 12 months after the statin-related event. Among the 2721 patients who were rechallenged with the same statin to which they had a statin-related event, 1295 were receiving the same statin 12 months later, and 996 of them were receiving the same or a higher dose. Limitations: Statin discontinuations and statin-related events were assessed in practices affiliated with 2 academic medical centers. Utilization of secondary data could have led to missing or misinterpreted data. Natural-language-processing tools used to compensate for the low (30%) proportion of reasons for statin discontinuation documented in structured electronic medical record fields are not perfectly accurate. Conclusion: Statin-related events are commonly reported and often lead to statin discontinuation. However, most patients who are rechallenged can tolerate statins long-term. This suggests that many of the statin-related events may have other causes, are tolerable, or may be specific to individual statins rather than the entire drug class.	Chinese Acad Med Sci, Peking Union Med Coll Hosp, Minist Hlth, Key Lab Endocrinol, Beijing 100730, Peoples R China; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Partners HealthCare Syst, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System	Turchin, A (corresponding author), Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave, Boston, MA 02115 USA.	aturchin@partners.org	Zhang, Huabing/ABD-6216-2020; Plutzky, Jorge/V-3410-2019	Zhang, Huabing/0000-0001-6259-7584; 	National Library of Medicine [5RC1LM010460]; Diabetes Action Research and Education Foundation; Chinese National Key Program of Clinical Science; NATIONAL LIBRARY OF MEDICINE [RC1LM010460] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Diabetes Action Research and Education Foundation; Chinese National Key Program of Clinical Science; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Library of Medicine, Diabetes Action Research and Education Foundation, and Chinese National Key Program of Clinical Science.; From the National Library of Medicine (5RC1LM010460), the Diabetes Action Research and Education Foundation, and the Chinese National Key Program of Clinical Science.	Arca M, 2011, DIABETES METAB SYNDR, V4, P155, DOI 10.2147/DMSO.S11244; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Athyros VG, 2008, AM J CARDIOL, V101, P483, DOI 10.1016/j.amjcard.2007.09.096; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Backes JM, 2008, ANN PHARMACOTHER, V42, P341, DOI 10.1345/aph.1K604; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Blaier O, 2011, J CLIN PHARM THER, V36, P336, DOI 10.1111/j.1365-2710.2011.01254.x; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Brown AS, 1998, J AM COLL CARDIOL, V32, P665, DOI 10.1016/S0735-1097(98)00300-3; Brown Steven H, 2008, AMIA Annu Symp Proc, P71; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Campeau L, 1997, NEW ENGL J MED, V336, P153; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Fung Vicki, 2010, Perm J, V14, P4; Garavalia L, 2009, J CARDIOVASC NURS, V24, P371, DOI 10.1097/JCN.0b013e3181ae7b2a; Glueck CJ, 2006, CLIN THER, V28, P933, DOI 10.1016/j.clinthera.2006.06.004; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Law M., 2006, AM J CARDIOL, V17, P97, DOI DOI 10.1016/J.AMJCARD.2005.12.010; Maningat P, 2011, NEW ENGL J MED, V365, P2250, DOI 10.1056/NEJMp1112023; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Pasternak RC, 2002, STROKE, V33, P2337, DOI 10.1161/01.str.0000034125.94759.41; PEDERSEN TR, 1994, LANCET, V344, P1383; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Ruisinger JF, 2009, AM J CARDIOL, V103, P393, DOI 10.1016/j.amjcard.2008.09.095; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sandoval YHG, 2011, CURR PHARM DESIGN, V17, P3669, DOI 10.2174/138161211798220891; Skentzos Stephen, 2011, AMIA Annu Symp Proc, V2011, P1270; Stamler J, 1986, JAMA-J AM MED ASSOC; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Tziomalos K, 2008, CURR MED RES OPIN, V24, P3059, DOI [10.1185/03007990802469102, 10.1185/03007990802469102 ]; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	46	406	411	2	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					526	+		10.7326/0003-4819-158-7-201304020-00004	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546564	Green Accepted			2022-12-28	WOS:000317419400003
J	Dawson, SJ; Tsui, DWY; Murtaza, M; Biggs, H; Rueda, OM; Chin, SF; Dunning, MJ; Gale, D; Forshew, T; Mahler-Araujo, B; Rajan, S; Humphray, S; Becq, J; Halsall, D; Wallis, M; Bentley, D; Caldas, C; Rosenfeld, N				Dawson, Sarah-Jane; Tsui, Dana W. Y.; Murtaza, Muhammed; Biggs, Heather; Rueda, Oscar M.; Chin, Suet-Feung; Dunning, Mark J.; Gale, Davina; Forshew, Tim; Mahler-Araujo, Betania; Rajan, Sabrina; Humphray, Sean; Becq, Jennifer; Halsall, David; Wallis, Matthew; Bentley, David; Caldas, Carlos; Rosenfeld, Nitzan			Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIGITAL PCR; ACQUIRED-RESISTANCE; SOLID TUMORS; PLASMA DNA; CA 15-3; MUTATIONS; CELLS; GENOME; SERUM; EVOLUTION	BACKGROUND The management of metastatic breast cancer requires monitoring of the tumor burden to determine the response to treatment, and improved biomarkers are needed. Biomarkers such as cancer antigen 15-3 (CA 15-3) and circulating tumor cells have been widely studied. However, circulating cell-free DNA carrying tumor-specific alterations (circulating tumor DNA) has not been extensively investigated or compared with other circulating biomarkers in breast cancer. METHODS We compared the radiographic imaging of tumors with the assay of circulating tumor DNA, CA 15-3, and circulating tumor cells in 30 women with metastatic breast cancer who were receiving systemic therapy. We used targeted or whole-genome sequencing to identify somatic genomic alterations and designed personalized assays to quantify circulating tumor DNA in serially collected plasma specimens. CA 15-3 levels and numbers of circulating tumor cells were measured at identical time points. RESULTS Circulating tumor DNA was successfully detected in 29 of the 30 women (97%) in whom somatic genomic alterations were identified; CA 15-3 and circulating tumor cells were detected in 21 of 27 women (78%) and 26 of 30 women (87%), respectively. Circulating tumor DNA levels showed a greater dynamic range, and greater correlation with changes in tumor burden, than did CA 15-3 or circulating tumor cells. Among the measures tested, circulating tumor DNA provided the earliest measure of treatment response in 10 of 19 women (53%). CONCLUSIONS This proof-of-concept analysis showed that circulating tumor DNA is an informative, inherently specific, and highly sensitive biomarker of metastatic breast cancer. (Funded by Cancer Research UK and others.)	[Dawson, Sarah-Jane; Tsui, Dana W. Y.; Murtaza, Muhammed; Rueda, Oscar M.; Chin, Suet-Feung; Dunning, Mark J.; Gale, Davina; Forshew, Tim; Caldas, Carlos; Rosenfeld, Nitzan] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Dawson, Sarah-Jane; Tsui, Dana W. Y.; Murtaza, Muhammed; Rueda, Oscar M.; Chin, Suet-Feung; Dunning, Mark J.; Gale, Davina; Forshew, Tim; Caldas, Carlos; Rosenfeld, Nitzan] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Mahler-Araujo, Betania] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Histopathol, Cambridge, England; [Rajan, Sabrina; Wallis, Matthew] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Halsall, David] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England; [Dawson, Sarah-Jane; Biggs, Heather; Mahler-Araujo, Betania; Rajan, Sabrina; Wallis, Matthew; Caldas, Carlos] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England; [Caldas, Carlos] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge, England; [Humphray, Sean; Becq, Jennifer; Bentley, David] Illumina, Saffron Walden, England; [Dawson, Sarah-Jane] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Illumina; Peter Maccallum Cancer Center	Rosenfeld, N (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	carlos.caldas@cruk.cam.ac.uk	Rueda, Oscar/ABF-5479-2020; Caldas, Carlos/U-7250-2019; ravegnini, gloria/K-1330-2016; wang, edwin/G-5372-2010	Rueda, Oscar/0000-0003-0008-4884; Caldas, Carlos/0000-0003-3547-1489; ravegnini, gloria/0000-0002-7774-402X; Dunning, Mark/0000-0002-8853-9435; Forshew, Tim/0000-0003-2093-7020; Dawson, Sarah-Jane/0000-0002-8276-0374; chin, suet-feung/0000-0001-5697-1082; Murtaza, Muhammed/0000-0001-7557-2861	Cancer Research UK; Experimental Cancer Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre; Australian National Health and Medical Research Council-R.G. Menzies Early Career Fellowship; Cancer Research UK [16942, 11906, 22310] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Experimental Cancer Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Australian National Health and Medical Research Council-R.G. Menzies Early Career Fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by grants from Cancer Research UK, and the Experimental Cancer Medicine Centre and National Institute for Health Research Cambridge Biomedical Research Centre, and by an Australian National Health and Medical Research Council-R.G. Menzies Early Career Fellowship (to Dr. Dawson).	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chen XQ, 1999, CLIN CANCER RES, V5, P2297; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Efron B., 1994, MONOGRAPHS STAT APPL; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lauro S, 1999, ANTICANCER RES, V19, P3511; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lianidou ES, 2011, CLIN CHEM, V57, P1242, DOI 10.1373/clinchem.2011.165068; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Mego M, 2011, INT J CANCER, V129, P417, DOI 10.1002/ijc.25690; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nakamura T, 2011, J THORAC ONCOL, V6, P1639, DOI 10.1097/JTO.0b013e31822956e8; Otsuka J, 2004, INT J GYNECOL CANCER, V14, P459, DOI 10.1111/j.1048-891x.2004.014305.x; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pierga JY, 2012, ANN ONCOL, V23, P618, DOI 10.1093/annonc/mdr263; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	41	1525	1655	14	476	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1199	1209		10.1056/NEJMoa1213261	http://dx.doi.org/10.1056/NEJMoa1213261			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23484797				2022-12-28	WOS:000316869000007
J	Kenny, C				Kenny, Charles			What should follow the millennium development goals?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Ctr Global Dev, Washington, DC 20036 USA		Kenny, C (corresponding author), Ctr Global Dev, 1800 Massachusetts Ave NW, Washington, DC 20036 USA.	ckenny@CGDEV.ORG						Casabonne U, 2012, WORLD DEV, V40, P21, DOI 10.1016/j.worlddev.2011.05.009; Clemens MA, 2007, WORLD DEV, V35, P735, DOI 10.1016/j.worlddev.2006.08.003; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Fukuda-Parr Sakiko, 2008, MDGS PRIORITY DEV ST; Glassman A, 2012, 2015 DEV GOAL HLTH S; Kenny C, 2011, 278 CGD; Kenny C, 2012, FOREIGN POLICY; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Pritchett L., 2013, REBIRTH ED UNIVERSAL; Sumner A., 2012, 297 CGD; UN, 2012, GUARDIAN; UN Development Programme, 2012, ASS PROGR AFR MILL D; United Nations, MILL DEV GOALS REP; Von der Hoeven R, 2012, MDGS 2015 BEACONS TU; WHO, 2012, HLTH POST 2015 UN DE	15	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1193	10.1136/bmj.f1193	http://dx.doi.org/10.1136/bmj.f1193			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538917				2022-12-28	WOS:000316986200001
J	MacNeil, LT; Watson, E; Arda, HE; Zhu, LJ; Walhout, AJM				MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Zhu, Lihua Julie; Walhout, Albertha J. M.			Diet-Induced Developmental Acceleration Independent of TOR and Insulin in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; NUTRIENT RESPONSE; NUCLEAR RECEPTORS; GROWTH; GENES; INHIBITION; METABOLISM; NUTRITION; DISCOVERY	Dietary composition has major effects on physiology. Here, we show that developmental rate, reproduction, and lifespan are altered in C. elegans fed Comamonas DA1877 relative to those fed a standard E. coli OP50 diet. We identify a set of genes that change in expression in response to this diet and use the promoter of one of these (acdh-1) as a dietary sensor. Remarkably, the effects on transcription and development occur even when Comamonas DA1877 is diluted with another diet, suggesting that Comamonas DA1877 generates a signal that is sensed by the nematode. Surprisingly, the developmental effect is independent from TOR and insulin signaling. Rather, Comamonas DA1877 affects cyclic gene expression during molting, likely through the nuclear hormone receptor NHR-23. Altogether, our findings indicate that different bacteria elicit various responses via distinct mechanisms, which has implications for diseases such as obesity and the interactions between the human microbiome and intestinal cells.	[MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [MacNeil, Lesley T.; Watson, Emma; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu		Walhout, Marian/0000-0001-5587-3608; Zhu, Lihua/0000-0001-7416-0590	NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH grant [DK068429]; CIHR postdoctoral fellowship; American Heart Association fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Walhout laboratory and Amy Walker for discussion and critical reading of the manuscript. We thank Heidi Tissenbaum for RNAi clones and discussions. We thank Victor Ambros for discussions. Some nematode strains used in this work were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by NIH grant DK068429 to A.J.M.W., a CIHR postdoctoral fellowship to L.T.M., and an American Heart Association fellowship to E.W.	ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Avery L., 2012, C ELEGANS RES COMMUN, DOI 10.xxx/wormbook.1.7.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRENNER S, 1974, GENETICS, V77, P71; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EVANS TC, 2006, C ELEGANS RES COMMUN; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Korta DZ, 2012, DEVELOPMENT, V139, P859, DOI 10.1242/dev.074047; Kostrouchova M, 1998, DEVELOPMENT, V125, P1617; Kouns NA, 2011, BIOCHEM BIOPH RES CO, V413, P515, DOI 10.1016/j.bbrc.2011.08.124; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sommer RJ, 2011, CURR BIOL, V21, pR758, DOI 10.1016/j.cub.2011.06.034; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050	44	158	163	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					240	252		10.1016/j.cell.2013.02.049	http://dx.doi.org/10.1016/j.cell.2013.02.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540701	Green Accepted, Bronze			2022-12-28	WOS:000316853700020
J	Osheroff, DD				Osheroff, Douglas D.			Robert Richardson (1937-2013) OBITUARY	NATURE			English	Biographical-Item									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Osheroff, DD (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	osheroff@stanford.edu							0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					450	450		10.1038/495450a	http://dx.doi.org/10.1038/495450a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538823	Bronze			2022-12-28	WOS:000316682800029
J	Paul, S; Million-Weaver, S; Chattopadhyay, S; Sokurenko, E; Merrikh, H				Paul, Sandip; Million-Weaver, Samuel; Chattopadhyay, Sujay; Sokurenko, Evgeni; Merrikh, Houra			Accelerated gene evolution through replication-transcription conflicts	NATURE			English	Article							ESCHERICHIA-COLI; FLUCTUATION ANALYSIS; DNA-REPLICATION; LEADING-STRAND; LAGGING-STRAND; ESSENTIALITY; ORGANIZATION; MUTAGENESIS; EXPRESSION; MUTATIONS	Several mechanisms that increase the rate of mutagenesis across the entire genome have been identified; however, how the rate of evolution might be promoted in individual genes is unclear. Most genes in bacteria are encoded on the leading strand of replication(1-4). This presumably avoids the potentially detrimental head-on collisions that occur between the replication and transcription machineries when genes are encoded on the lagging strand(1-4). Here we identify the ubiquitous (core) genes in Bacillus subtilis and determine that 17% of them are on the lagging strand. We find a higher rate of point mutations in the core genes on the lagging strand compared with those on the leading strand, with this difference being primarily in the amino-acid-changing (nonsynonymous) mutations. We determine that, overall, the genes under strong negative selection against amino-acid-changing mutations tend to be on the leading strand, co-oriented with replication. In contrast, on the basis of the rate of convergent mutations, genes under positive selection for amino-acid-changing mutations are more commonly found on the lagging strand, indicating faster adaptive evolution in many genes in the head-on orientation. Increased gene length and gene expression amounts are positively correlated with the rate of accumulation of nonsynonymous mutations in the head-on genes, suggesting that the conflict between replication and transcription could be a driving force behind these mutations. Indeed, using reversion assays, we show that the difference in the rate of mutagenesis of genes in the two orientations is transcription dependent. Altogether, our findings indicate that head-on replication-transcription conflicts are more mutagenic than co-directional conflicts and that these encounters can significantly increase adaptive structural variation in the coded proteins. We propose that bacteria, and potentially other organisms, promote faster evolution of specific genes through orientation-dependent encounters between DNA replication and transcription.	[Paul, Sandip; Million-Weaver, Samuel; Chattopadhyay, Sujay; Sokurenko, Evgeni; Merrikh, Houra] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sokurenko, E (corresponding author), Univ Washington, Dept Microbiol, Hlth Sci Bldg J Wing, Seattle, WA 98195 USA.	evs@u.washington.edu; merrikh@uw.edu	Chattopadhyay, Sujay/AAA-5772-2022; Paul, Sandip/C-1224-2010	Chattopadhyay, Sujay/0000-0003-1785-2683; Paul, Sandip/0000-0001-7406-3598; Million-Weaver, Samuel/0000-0001-9057-6326	Department of Microbiology at the University of Washington; University of Washington Biophysics Training Grant; National Institutes of Health (NIH) [RC4 AI092828, R01 GM084318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084318, T32GM008268] Funding Source: NIH RePORTER	Department of Microbiology at the University of Washington; University of Washington Biophysics Training Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the work of others that has contributed to our understanding of the topic, which we were unable to cite here. We thank B. Brewer, J. Mougous, F. Fang, M. Parsek and S. Miller for reading the manuscript. We thank C. Merrikh for comments on the manuscript and technical help with sequencing of revertants. We thank E. Robleto for the auxotrophic YB955 strain. H. M. was supported by start-up funds from the Department of Microbiology at the University of Washington. S.M.-W. was supported by the University of Washington Biophysics Training Grant. E. S., S. P, and S. C. were supported by National Institutes of Health (NIH) grants RC4 AI092828 and R01 GM084318.	Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chattopadhyay S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-187; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Juurik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048511; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S19; Maliszewska-Tkaczyk M, 2000, P NATL ACAD SCI USA, V97, P12678, DOI 10.1073/pnas.220424697; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Price MN, 2005, NUCLEIC ACIDS RES, V33, P3224, DOI 10.1093/nar/gki638; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Suzuki Y, 2003, PHYLOGENETIC HDB PRA, P283; Szczepanik D, 2001, J MOL EVOL, V52, P426, DOI 10.1007/s002390010172; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; VEAUTE X, 1993, SCIENCE, V261, P598, DOI 10.1126/science.8342022	30	93	93	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					512	+		10.1038/nature11989	http://dx.doi.org/10.1038/nature11989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538833	Green Accepted			2022-12-28	WOS:000316682800046
J	Pijnappel, WWMP; Esch, D; Baltissen, MPA; Wu, GM; Mischerikow, N; Bergsma, AJ; van der Wal, E; Han, DW; vom Bruch, H; Moritz, S; Lijnzaad, P; Altelaar, AFM; Sameith, K; Zaehres, H; Heck, AJR; Holstege, FCP; Scholer, HR; Timmers, HTM				Pijnappel, W. W. M. Pim; Esch, Daniel; Baltissen, Marijke P. A.; Wu, Guangming; Mischerikow, Nikolai; Bergsma, Atze J.; van der Wal, Erik; Han, Dong Wook; vom Bruch, Hermann; Moritz, Soeren; Lijnzaad, Phillip; Altelaar, A. F. Maarten; Sameith, Katrin; Zaehres, Holm; Heck, Albert J. R.; Holstege, Frank C. P.; Schoeler, Hans R.; Timmers, H. T. Marc			A central role for TFIID in the pluripotent transcription circuitry	NATURE			English	Article							STEM-CELLS; NETWORK; MECHANISMS; SURVIVAL; GENES	Embryonic stem (ES) cells are pluripotent and characterized by open chromatin and high transcription levels, achieved through auto-regulatory and feed-forward transcription factor loops(1,2). ES-cell identity is maintained by a core of factors including Oct4 (also known as Pou5f1), Sox2, Klf4, c-Myc (OSKM) and Nanog(2-4), and forced expression of the OSKM factors can reprogram somatic cells into induced pluripotent stem cells (iPSCs) resembling ES cells(5,6). These gene-specific factors for RNA-polymerase-II-mediated transcription recruit transcriptional cofactors and chromatin regulators that control access to and activity of the basal transcription machinery on gene promoters(7,8). How the basal transcription machinery is involved in setting and maintaining the pluripotent state is unclear. Here we show that knockdown of the transcription factor IID (TFIID) complex affects the pluripotent circuitry in mouse ES cells and inhibits reprogramming of fibroblasts. TFIID subunits and the OSKM factors forma feed-forward loop to induce and maintain a stable transcription state. Notably, transient expression of TFIID subunits greatly enhanced reprogramming. These results show that TFIID is critical for transcription-factor-mediated reprogramming. We anticipate that, by creating plasticity in gene expression programs, transcription complexes such as TFIID assist reprogramming into different cellular states.	[Pijnappel, W. W. M. Pim; Baltissen, Marijke P. A.; Bergsma, Atze J.; Lijnzaad, Phillip; Sameith, Katrin; Holstege, Frank C. P.; Timmers, H. T. Marc] Univ Med Ctr Utrecht, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Pijnappel, W. W. M. Pim; Baltissen, Marijke P. A.; Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.; Timmers, H. T. Marc] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Pijnappel, W. W. M. Pim; van der Wal, Erik] Erasmus MC, Dept Pediat, NL-3015 GE Rotterdam, Netherlands; [Pijnappel, W. W. M. Pim; van der Wal, Erik] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Esch, Daniel; Wu, Guangming; van der Wal, Erik; Han, Dong Wook; vom Bruch, Hermann; Moritz, Soeren; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Altelaar, A. F. Maarten; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Max Planck Society; Utrecht University; Utrecht University	Timmers, HTM (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res, NL-3584 CG Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl	Heck, Albert/D-7098-2011; Holstege, Frank/AAM-9944-2021; , HS/AAB-4434-2019; Bergsma, Atze/AAV-6273-2020; Lijnzaad, Philip/ABE-4205-2021; Altelaar, Maarten/I-3845-2016	Heck, Albert/0000-0002-2405-4404; , HS/0000-0003-2643-5136; Bergsma, Atze/0000-0002-8733-5078; Lijnzaad, Philip/0000-0002-7535-583X; Altelaar, Maarten/0000-0001-5093-5945; Sameith, Katrin/0000-0003-4306-930X; Pijnappel, Pim/0000-0002-7042-2482	Netherlands Proteomics Centre, Netherlands Organization for Scientific Research [700.57.302]; Deutsche Forschungsgemeinschaft (DFG) [SPP 1356/2]; European Union [EUTRACC LSHG-CT-2006-037445]	Netherlands Proteomics Centre, Netherlands Organization for Scientific Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission)	This work is funded by the Netherlands Proteomics Centre, Netherlands Organization for Scientific Research (TOP#700.57.302), Deutsche Forschungsgemeinschaft (DFG Priority Program SPP 1356/2) and the European Union (EUTRACC LSHG-CT-2006-037445). We thank M. Groot Koerkamp and D. van Leenen for microarray analysis, M. de Bruijn and O. Kranenburg for advice on lentiviral knockdown experiments, F. Stewart for help with BAC recombineering, I. Davidson and R. Tjian for TAF cDNA constructs, N. Outchkourov for the GFP-tagging vector, B. Roeder, T. Oelgeschlager and G. Kops for antibodies, M. Stehling for help with the FACS analyses, A. Schambach and C. Baum for the lentiviral OSKM vector, M. Sgodda and T. Cantz for human fibroblasts, M. Radstaak for assistance with human iPSC culture and P. de Graaf, N. Jelluma and M. Vermeulen for critical reading of the manuscript.	Bieniossek C., 2013, NATURE; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Munoz J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.84; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voss AK, 2000, DEVELOPMENT, V127, P5449; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	29	59	62	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					516	519		10.1038/nature11970	http://dx.doi.org/10.1038/nature11970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23503660				2022-12-28	WOS:000316682800047
J	Habib, SJ; Chen, BC; Tsai, FC; Anastassiadis, K; Meyer, T; Betzig, E; Nusse, R				Habib, Shukry J.; Chen, Bi-Chang; Tsai, Feng-Chiao; Anastassiadis, Konstantinos; Meyer, Tobias; Betzig, Eric; Nusse, Roel			A Localized Wnt Signal Orients Asymmetric Stem Cell Division in Vitro	SCIENCE			English	Article							BETA-CATENIN; GROUND-STATE; CENTROSOME; PLURIPOTENCY; SPINDLE; NANOG	Developmental signals such as Wnts are often presented to cells in an oriented manner. To examine the consequences of local Wnt signaling, we immobilized Wnt proteins on beads and introduced them to embryonic stem cells in culture. At the single-cell level, the Wnt-bead induced asymmetric distribution of Wnt-beta-catenin signaling components, oriented the plane of mitotic division, and directed asymmetric inheritance of centrosomes. Before cytokinesis was completed, the Wnt-proximal daughter cell expressed high levels of nuclear beta-catenin and pluripotency genes, whereas the distal daughter cell acquired hallmarks of differentiation. We suggest that a spatially restricted Wnt signal induces an oriented cell division that generates distinct cell fates at predictable positions relative to the Wnt source.	[Habib, Shukry J.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA; [Habib, Shukry J.; Chen, Bi-Chang; Betzig, Eric] Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Tsai, Feng-Chiao; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Anastassiadis, Konstantinos] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Technische Universitat Dresden	Habib, SJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, 265 Campus Dr, Stanford, CA 94305 USA.	shabib@stanford.edu; rnusse@stanford.edu	Chen, Bi-Chang/F-3480-2014; Anastassiadis, Konstantinos/A-8944-2010	Chen, Bi-Chang/0000-0002-1876-7432; Anastassiadis, Konstantinos/0000-0002-9814-0559; Meyer, Tobias/0000-0003-4339-3804; Habib, Shukry/0000-0003-3132-2216; Tsai, Feng-Chiao/0000-0001-9615-6023	Howard Hughes Medical Institute; California Institute for Regenerative Medicine [RC1-00133-1, RB4-05825, TR1-02149]; NIH [GM063702, NS069375]; Center for Regenerative Therapies Dresden; Deutsche Forschungsgemeinschaft (DFG); Siebel scholarship;  [DFG-SPP1356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Therapies Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Siebel scholarship; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by the Howard Hughes Medical Institute and by grants RC1-00133-1, RB4-05825, and TR1-02149 from the California Institute for Regenerative Medicine to R.N.; by NIH grant GM063702 to T.M.; and by the Center for Regenerative Therapies Dresden and grant DFG-SPP1356 to K.A. We thank the Stanford Neuroscience Microscopy Service, supported by NIH NS069375. Patent applications are pending for the Bessel beam plane illumination microscopy (by E.B.) and for the Wnt, DKK, and R spondin1 immobilization technology and their applications (by S.J.H. and R.N.). We also thank M. Drukker, T. Schroeder, and T. Stearns for discussions. We appreciate discussions and comments on the manuscript by C. Logan and J. Nelson. S.J.H. was supported by a fellowship from the Deutsche Forschungsgemeinschaft (DFG) and a Siebel scholarship.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mogensen MM, 2000, J CELL SCI, V113, P3013; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sugioka K, 2011, CELL, V146, P941, DOI 10.1016/j.cell.2011.07.043; Surani A, 2012, NATURE, V487, P43, DOI 10.1038/487043a; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Werts AD, 2011, SEMIN CELL DEV BIOL, V22, P842, DOI 10.1016/j.semcdb.2011.07.011; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	29	222	230	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1445	1448		10.1126/science.1231077	http://dx.doi.org/10.1126/science.1231077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520113	Green Accepted			2022-12-28	WOS:000316740700046
J	Fattal, D; Peng, Z; Tran, T; Vo, S; Fiorentino, M; Brug, J; Beausoleil, RG				Fattal, David; Peng, Zhen; Tho Tran; Vo, Sonny; Fiorentino, Marco; Brug, Jim; Beausoleil, Raymond G.			A multi-directional backlight for a wide-angle, glasses-free three-dimensional display	NATURE			English	Article								Multiview three-dimensional (3D) displays can project the correct perspectives of a 3D image in many spatial directions simultaneously(1-4). They provide a 3D stereoscopic experience to many viewers at the same time with full motion parallax and do not require special glasses or eye tracking. None of the leading multiview 3D solutions is particularly well suited to mobile devices (watches, mobile phones or tablets), which require the combination of a thin, portable form factor, a high spatial resolution and a wide full-parallax view zone (for short viewing distance from potentially steep angles). Here we introduce a multi-directional diffractive backlight technology that permits the rendering of high-resolution, full-parallax 3D images in a very wide view zone (up to 180 degrees in principle) at an observation distance of up to a metre. The key to our design is a guided-wave illumination technique based on light-emitting diodes that produces wide-angle multiview images in colour from a thin planar transparent light-guide. Pixels associated with different views or colours are spatially multiplexed and can be independently addressed and modulated at video rate using an external shutter plane. To illustrate the capabilities of this technology, we use simple ink masks or a high-resolution commercial liquid-crystal display unit to demonstrate passive and active (30 frames per second) modulation of a 64-view backlight, producing 3D images with a spatial resolution of 88 pixels per inch and full-motion parallax in an unprecedented view zone of 90 degrees. We also present several transparent hand-held prototypes showing animated sequences of up to six different 200-view images at a resolution of 127 pixels per inch.	[Fattal, David; Peng, Zhen; Tho Tran; Vo, Sonny; Fiorentino, Marco; Brug, Jim; Beausoleil, Raymond G.] Hewlett Packard Labs, Palo Alto, CA 94304 USA	Hewlett-Packard	Fattal, D (corresponding author), Hewlett Packard Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA.	david.fattal@hp.com	Fiorentino, Marco/AAC-1479-2020; Brug, Johannes/A-8242-2018; Fiorentino, Marco/AAC-1473-2020	Fiorentino, Marco/0000-0001-8867-3098; Brug, Johannes/0000-0002-1904-7349; 				Astilean S, 1998, OPT LETT, V23, P552, DOI 10.1364/OL.23.000552; Blanche PA, 2010, NATURE, V468, P80, DOI 10.1038/nature09521; Dodgson NA, 2005, COMPUTER, V38, P31, DOI 10.1109/MC.2005.252; Dodgson NA, 2004, PROC SPIE, V5291, P36, DOI 10.1117/12.529999; Fu J., 2012, US patent, Patent No. [8,187 986, 8187986]; Kawakita M., 2012, P SPIE, V8288; KULICK JH, 1995, J OPT SOC AM A, V12, P73, DOI 10.1364/JOSAA.12.000073; Levoy M., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P31, DOI 10.1145/237170.237199; Lucente M., 1994, THESIS MIT; Okoshi T., 2011, 3 DIMENSIONAL IMAGIN; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Ramachandra V, 2011, IEEE T VIS COMPUT GR, V17, P642, DOI 10.1109/TVCG.2010.86; Takaki Y, 2010, OPT EXPRESS, V18, P8824, DOI 10.1364/OE.18.008824; vanBerkel C, 1997, P SOC PHOTO-OPT INS, V3012, P179, DOI 10.1117/12.274456; Wetzstein G., 2011, ACM T GRAPH SIGGRAPH, V30, P1; Wetzstein G, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185576; Zwicker M., 2006, EUR S REND	17	213	323	3	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					348	351		10.1038/nature11972	http://dx.doi.org/10.1038/nature11972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518562				2022-12-28	WOS:000316650500038
J	Agrawal, S; Taitsman, J; Cassel, C				Agrawal, Shantanu; Taitsman, Julie; Cassel, Christine			Educating Physicians About Responsible Management of Finite Resources	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Agrawal, Shantanu] Ctr Program Integr, Ctr Medicare Serv, Baltimore, MD 21244 USA; [Agrawal, Shantanu] Ctr Program Integr, Ctr Medicaid Serv, Baltimore, MD 21244 USA; [Taitsman, Julie] Dept Hlth & Human Serv, Off Inspector Gen, Washington, DC USA; [Cassel, Christine] Amer Board Internal Med, Philadelphia, PA USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; American Board of Internal Medicine	Agrawal, S (corresponding author), Ctr Program Integr, Ctr Medicare Serv, 7500 Secur Blvd,Mail Stop AR 18-50, Baltimore, MD 21244 USA.	shantanu.agrawal@cms.hhs.gov						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brunt CS, 2011, HEALTH ECON, V20, P831, DOI 10.1002/hec.1649; Cadieux G, 2008, HEALTH SERV RES, V43, P2223, DOI 10.1111/j.1475-6773.2008.00873.x; Department of Health and Human Services; Centers for Medicare & Medicaid Services, 2010, IMPL REC AUD CTR MED; Department of Health and Human Services; Centers for Medicare & Medicaid Services, 2011 MED FEE FOR SER; Office of Inspector General Office of Evaluation and Inspections, 2010, MED MED FRAUD AB TRA; Shah BR, 2011, JAMA-J AM MED ASSOC, V306, P1993, DOI 10.1001/jama.2011.1604; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858	8	32	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1115	1116		10.1001/jama.2013.1013	http://dx.doi.org/10.1001/jama.2013.1013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FF	23512056				2022-12-28	WOS:000316276500021
J	Spence, D				Spence, Des			Doctor in the house	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1809	10.1136/bmj.f1809	http://dx.doi.org/10.1136/bmj.f1809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516157				2022-12-28	WOS:000316671500014
J	Frances, A				Frances, Allen			PERSONAL VIEW The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOMATOFORM DISORDERS				Frances, A (corresponding author), 1820 Ave Mundo, Coronado, CA 92118 USA.	allenfrances@vzw.blackberry.net						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2012, DSM 5 DEV D IN PRESS; Brauser D., 2011, MEDSCAPE MED NEWS; Creed F, 2012, INT REV PSYCHIATR, V24, P556, DOI 10.3109/09540261.2012.741063; Dimsdale JE, 2012, AM PSYCH ASS 165 ANN; Dimsdale JE, 2011, PSYCHIAT CLIN N AM, V34, P511, DOI 10.1016/j.psc.2011.05.003; Goldberg DP, 2012, 21 CENTURY GLOBAL ME, P37; Szasz Thomas., 1997, MANUFACTURE MADNESS; WHO, ICD11 BETA IN PRESS	9	57	61	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f1580	10.1136/bmj.f1580	http://dx.doi.org/10.1136/bmj.f1580			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113LX	23511949				2022-12-28	WOS:000316670500014
J	Black, J				Black, Jeremy			Art of Medicine Occupation and reconstruction: a historical perspective	LANCET			English	Editorial Material									Univ Exeter, Dept Hist, Established Chair Hist, Exeter EX4 4RJ, Devon, England	University of Exeter	Black, J (corresponding author), Univ Exeter, Dept Hist, Established Chair Hist, Exeter EX4 4RJ, Devon, England.	jeremy@jeremyblack.co.uk							0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 16	2013	381	9870					898	899		10.1016/S0140-6736(13)60662-5	http://dx.doi.org/10.1016/S0140-6736(13)60662-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23509842	Bronze			2022-12-28	WOS:000316069700014
J	Bickmore, WA; van Steensel, B				Bickmore, Wendy A.; van Steensel, Bas			Genome Architecture: Domain Organization of Interphase Chromosomes	CELL			English	Review							EMBRYONIC STEM-CELLS; NUCLEAR LAMINA INTERACTIONS; RANGE DNA INTERACTIONS; GENE-EXPRESSION; DROSOPHILA GENOME; CHROMATIN DOMAINS; 3-DIMENSIONAL ARCHITECTURE; SPATIAL-ORGANIZATION; TRANSCRIPTOME MAP; X-INACTIVATION	The architecture of interphase chromosomes is important for the regulation of gene expression and genome maintenance. Chromosomes are linearly segmented into hundreds of domains with different protein compositions. Furthermore, the spatial organization of chromosomes is nonrandom and is characterized by many local and long-range contacts among genes and other sequence elements. A variety of genome-wide mapping techniques have made it possible to chart these properties at high resolution. Combined with microscopy and computational modeling, the results begin to yield a more coherent picture that integrates linear and three-dimensional (3D) views of chromosome organization in relation to gene regulation and other nuclear functions.	[Bickmore, Wendy A.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands	University of Edinburgh; Netherlands Cancer Institute	Bickmore, WA (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	wendy.bickmore@igmm.ed.ac.uk; b.v.steensel@nki.nl	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735	ERC Advanced grant [293662, 249956]; NWO-VICI; MRC; MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	ERC Advanced grant; NWO-VICI(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the van Steensel lab; Duncan Sproul, Nick Gilbert, and Colin Semple of IGMM for critical reading of the manuscript; an anonymous reviewer for many thoughtful suggestions; and Frank Alber, Elphege Nora, and Tyrone Ryba for help with figures. We are supported by ERC Advanced grant 293662 and NWO-VICI (B.v.S.) and by the MRC and ERC Advanced grant 249956 (W.A.B.).	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; Dietzel S, 1998, CHROMOSOME RES, V6, P25, DOI 10.1023/A:1009262223693; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dostie J, 2012, CURR OPIN GENET DEV, V22, P125, DOI 10.1016/j.gde.2011.12.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Filion GJ, 2010, NAT GENET, V42, P4, DOI 10.1038/ng0110-4; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Morey C, 2009, GENOME RES, V19, P1184, DOI 10.1101/gr.089045.108; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Noordermeer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000016; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Vogelmann J, 2011, NUCLEUS-PHILA, V2, P358, DOI 10.4161/nucl.2.5.17860; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Williamson I, 2011, DEV CELL, V21, P17, DOI 10.1016/j.devcel.2011.06.008; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	122	485	493	4	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1270	1284		10.1016/j.cell.2013.02.001	http://dx.doi.org/10.1016/j.cell.2013.02.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498936	Bronze			2022-12-28	WOS:000316192500009
J	Braunschweig, U; Gueroussov, S; Plocik, AM; Graveley, BR; Blencowe, BJ				Braunschweig, Ulrich; Gueroussov, Serge; Plocik, Alex M.; Graveley, Brenton R.; Blencowe, Benjamin J.			Dynamic Integration of Splicing within Gene Regulatory Pathways	CELL			English	Review							PRE-MESSENGER-RNA; C-TERMINAL DOMAIN; CELL-FREE FORMATION; SR-LIKE PROTEIN; POLYMERASE-II; NUCLEAR EXPORT; HISTONE H3; LYSINE 9; COUPLING TRANSCRIPTION; CHROMATIN SIGNATURES	Precursor mRNA splicing is one of the most highly regulated processes in metazoan species. In addition to generating vast repertoires of RNAs and proteins, splicing has a profound impact on other gene regulatory layers, including mRNA transcription, turnover, transport, and translation. Conversely, factors regulating chromatin and transcription complexes impact the splicing process. This extensive crosstalk between gene regulatory layers takes advantage of dynamic spatial, physical, and temporal organizational properties of the cell nucleus, and further emphasizes the importance of developing a multidimensional understanding of splicing control.	[Braunschweig, Ulrich; Gueroussov, Serge; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; [Gueroussov, Serge; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Plocik, Alex M.; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Toronto; University of Toronto; University of Connecticut	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, 400 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu; b.blencowe@utoronto.ca	Braunschweig, Ulrich/I-1070-2019; Graveley, Brenton R/C-3108-2013	Braunschweig, Ulrich/0000-0001-6653-0926; Graveley, Brenton/0000-0001-5777-5892; Plocik, Alex/0000-0001-9489-6466	NIH [R01 GM067842, R01 GM095296, U54 HG007005, U54 HG006994]; Canadian Institutes of Health Research; Canadian Cancer Society; Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Research Fund; European Molecular Biology Organization; Human Frontier Science Program Fellowships; NSERC Studentship; NRSA Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006994, U54HG007005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067842, R01GM095296, F32GM105264] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Research Fund; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Fellowships; NSERC Studentship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Graveley and Blencowe laboratories for helpful discussions. B.R.G. acknowledges support from NIH grants R01 GM067842, R01 GM095296, U54 HG007005, and U54 HG006994. B.J.B. acknowledges funding from the Canadian Institutes of Health Research, Canadian Cancer Society, Natural Sciences and Engineering Research Council of Canada (NSERC), and the Ontario Research Fund. U.B. was supported by European Molecular Biology Organization and Human Frontier Science Program Fellowships, S.G. was supported by an NSERC Studentship, and A.P. was supported by an NRSA Fellowship.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Bieberstein NI, 2012, CELL REP, V2, P62, DOI 10.1016/j.celrep.2012.05.019; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Close P, 2012, NATURE, V484, P386, DOI 10.1038/nature10925; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Cuenca-Bono B, 2011, NUCLEIC ACIDS RES, V39, P8599, DOI 10.1093/nar/gkr496; David CJ, 2011, TRANSCR-AUSTIN, V2, P221, DOI 10.4161/trns.2.5.17272; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Dermody JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003273; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012339; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Evsyukova I, 2013, RNA, V19, P103, DOI 10.1261/rna.035410.112; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Ghosh S, 2012, NAT STRUCT MOL BIOL, V19, P441, DOI 10.1038/nsmb.2257; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Khodor YL, 2012, RNA, V18, P2174, DOI 10.1261/rna.034090.112; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim S, 2011, N KOREAN REV, V7, P3; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; La Via L, 2013, NUCLEIC ACIDS RES, V41, P617, DOI 10.1093/nar/gks1223; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lamond AI, 2011, COLD SPRING HARB PER, V3; Langemeier J, 2012, EMBO J, V31, P4035, DOI 10.1038/emboj.2012.252; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LAWRENCE JB, 1993, COLD SPRING HARB SYM, V58, P807, DOI 10.1101/SQB.1993.058.01.088; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Millevoi S, 2002, EMBO REP, V3, P869, DOI 10.1093/embo-reports/kvf173; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Moehle EA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003101; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2012, CELL MOL LIFE SCI, V69, P3027, DOI 10.1007/s00018-012-0973-x; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Plocik AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002620; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Rosonina E, 2004, RNA, V10, P581, DOI 10.1261/rna.5207204; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schneider M, 2010, MOL CELL, V38, P223, DOI 10.1016/j.molcel.2010.02.027; Schor IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048084; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Smith KP, 1995, J CELL BIOCHEM, V59, P473, DOI 10.1002/jcb.240590408; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Waldholm J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-46; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weatheritt RJ, 2012, TRENDS BIOCHEM SCI, V37, P333, DOI 10.1016/j.tibs.2012.05.001; Wilhelm BT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r82; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Zeng CQ, 2000, MOL CELL BIOL, V20, P8290, DOI 10.1128/MCB.20.21.8290-8301.2000; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zraly CB, 2012, NUCLEIC ACIDS RES, V40, P5975, DOI 10.1093/nar/gks288	171	289	295	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1252	1269		10.1016/j.cell.2013.02.034	http://dx.doi.org/10.1016/j.cell.2013.02.034			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498935	Green Accepted, Bronze			2022-12-28	WOS:000316192500008
J	Thornicroft, G; Farrelly, S; Szmukler, G; Birchwood, M; Waheed, W; Flach, C; Barrett, B; Byford, S; Henderson, C; Sutherby, K; Lester, H; Rose, D; Dunn, G; Leese, M; Marshall, M				Thornicroft, Graham; Farrelly, Simone; Szmukler, George; Birchwood, Max; Waheed, Waquas; Flach, Clare; Barrett, Barbara; Byford, Sarah; Henderson, Claire; Sutherby, Kim; Lester, Helen; Rose, Diana; Dunn, Graham; Leese, Morven; Marshall, Max			Clinical outcomes of Joint Crisis Plans to reduce compulsory treatment for people with psychosis: a randomised controlled trial	LANCET			English	Article							EVALUATING COMPLEX INTERVENTIONS; ADVANCE DIRECTIVES; IMPLEMENTATION; FRAMEWORK	Background The CRIMSON (CRisis plan IMpact: Subjective and Objective coercion and eNgagement) study is an individual level, randomised controlled trial that compared the effectiveness of Joint Crisis Plans (JCPs) with treatment as usual for people with severe mental illness. The JCP is a negotiated statement by a patient of treatment preferences for any future psychiatric emergency, when he or she might be unable to express clear views. We assessed whether the additional use of JCPs improved patient outcomes compared with treatment as usual. Methods Patients were eligible if they had at least one psychiatric admission in the previous 2 years and were on the Enhanced Care Programme Approach register. The study was done with 64 generic and specialist community mental health teams in four English mental health care provider organisations (trusts). Hypotheses tested were that, compared with the control group, the intervention group would experience: fewer compulsory admissions (primary outcome); fewer psychiatric admissions; shorter psychiatric stays; lower perceived coercion; improved therapeutic relationships; and improved engagement. We stratified participants by centre. The research team but not participants nor clinical staff were masked to allocation. This study is registered with ClinicalTrials.gov, number ISRCTN11501328. Findings 569 participants were randomly assigned (285 to the intervention group and 284 to the control group). No significant treatment effect was seen for the primary outcome (56 [20%] sectioned in the control group and 49 [18%] in the JCP group; odds ratio 0.90 [95% CI 0.58-1.39, p=0.63]) or any secondary outcomes, with the exception of an improved secondary outcome of therapeutic relationships (17.3 [7.6] vs 16.0 [7.1]; adjusted difference -1.28 [95% CI -2.56 to -0.01, p=0.049]). Qualitative data supported this finding. Interpretation Our findings are inconsistent with two earlier JCP studies, and show that the JCP is not significantly more effective than treatment as usual. There is evidence to suggest the JCPs were not fully implemented in all study sites, and were combined with routine clinical review meetings which did not actively incorporate patients' preferences. The study therefore raises important questions about implementing new interventions in routine clinical practice.	[Thornicroft, Graham; Farrelly, Simone; Szmukler, George; Flach, Clare; Barrett, Barbara; Byford, Sarah; Henderson, Claire; Sutherby, Kim; Rose, Diana; Leese, Morven] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England; [Birchwood, Max] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Waheed, Waquas; Marshall, Max] Univ Manchester, Sch Med, Div Psychiat, Manchester, Lancs, England; [Flach, Clare; Dunn, Graham] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Lester, Helen] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of London; King's College London; University of Birmingham; University of Manchester; University of Manchester; University of Birmingham	Thornicroft, G (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England.	graham.thornicroft@kcl.ac.uk	Henderson, Claire/E-4664-2010; Thornicroft, Graham/B-4027-2010; Rose, Diana/HGE-8574-2022; Byford, Sarah/D-1699-2010; Rose, Diana S/D-1387-2010; Barrett, Barbara M/F-7606-2010; Birchwood, Max/E-3474-2017	Henderson, Claire/0000-0002-6998-5659; Thornicroft, Graham/0000-0003-0662-0879; Byford, Sarah/0000-0001-7084-1495; Rose, Diana S/0000-0002-6393-6389; Barrett, Barbara M/0000-0002-0270-6256; Birchwood, Max/0000-0002-7476-0171; Flach, Clare/0000-0001-7836-1744; Flach, Clare/0000-0002-3128-0952; Farrelly, Simone/0000-0001-8991-6178	National Institute for Health Research (NIHR); Maudsley NHS Foundation Trust; Guy's and St Thomas's Charitable Trust; Big Lottery Fund; Comic Relief; National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); Medical Research Council (MRC); MRC [G0601660] Funding Source: UKRI; Medical Research Council [G0601660] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10053] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Guy's and St Thomas's Charitable Trust; Big Lottery Fund; Comic Relief; National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC)(National Institute for Health Research (NIHR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	GT, DR, and CH are funded in relation to a National Institute for Health Research (NIHR) Applied Programme grant awarded to the South London and Maudsley NHS Foundation Trust (GT), and in relation to the NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London, and the South London and Maudsley NHS Foundation Trust. CH is funded by a grant from Guy's and St Thomas's Charitable Trust and a grant from the Big Lottery Fund and Comic Relief. MB is part-funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC). We thank all the patients and clinical staff who participated in this research. In particular we are grateful to: JCP Facilitators: Melanie De Castro, Betina Reid, Rangeni Zinyama, and Anita Davies; Research Assistants: Katie Selwood, Liz Doherty, Sam Treacy, Nicola Wright, Sarah Davis, Julia Cook, Gemma Clark, Catherine Finnecy, Gill Brown, and Adrine Woodham; Trial Steering Committee: Simon Gilbody, Mary Evans, Paul Farmer, Peter Campbell, and Genevra Richardson; Data Monitoring and Ethics Committee: Mike Crawford, Tim Croudace, and Ian Harvey; The Mental Health Research Network in each trust, specifically, Liz Hutt, Amy Mclachan, Mike Kelly, Carly Cooper, Juan Doblado Pavon, Siobhan Keogh, Rachael Clarke, Moira Winters, Maria Kaltsi, Polly Bidwell, Vicky Bell, and Deela Monji. This report is independent research funded by the Medical Research Council (MRC) and managed by the NIHR on behalf of the MRC-NIHR partnership. The views expressed in this publication are those of the authors and not necessarily those of the MRC, National Health Service, NIHR, or the Department of Health.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barbour R, 1999, DEV FOCUS GROUP RES; Bauer MS, 2002, HARVARD REV PSYCHIAT, V10, P138, DOI 10.1093/hrp/10.3.138; Bindman J, 1999, BRIT J PSYCHIAT, V175, P327, DOI 10.1192/bjp.175.4.327; Campbell LA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005963.pub2; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davies S, 1996, BRIT MED J, V312, P533, DOI 10.1136/bmj.312.7030.533; Department of Health, 1991, CAR PROGR APPR; Department of Health, 2011, OP FRAM NHS ENGL 201; Flood C, 2006, BRIT MED J, V333, P729, DOI 10.1136/bmj.38929.653704.55; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Hamilton S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-21; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; Henderson C, 2008, PSYCHIAT SERV, V59, P63, DOI 10.1176/ps.2008.59.1.63; Katsakou C, 2012, SOC PSYCH PSYCH EPID, V47, P1169, DOI 10.1007/s00127-011-0427-z; NEALE MS, 1995, PSYCHIATR SERV, V46, P719; Papageorgiou A, 2002, BRIT J PSYCHIAT, V181, P513, DOI 10.1192/bjp.181.6.513; Parker A, 2006, INT J RES METHOD EDU, V29, P23, DOI 10.1080/01406720500537304; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; Rose D, 2000, USERS VOICES PERSPEC; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; SILVERMAN D, 1997, INTERPRETING QUALITA; Sutherby K, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10914.x; Sutherby K, 1998, PSYCHIAT B, V22, P4; Swanson JW, 2006, AM J PSYCHIAT, V163, P1943, DOI 10.1176/appi.ajp.163.11.1943; Swartz MS, 2002, J AM ACAD PSYCHIATRY, V30, P207; Tait Lynda, 2002, J Ment Health, V11, P191, DOI 10.1080/09638230020023570-2; Tansella M, 2009, BRIT J PSYCHIAT, V195, P283, DOI 10.1192/bjp.bp.109.065565; Thornicroft G, 2011, PSYCHOL MED, V41, P2015, DOI 10.1017/S0033291711000109; Thornicroft G, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-102; WHO, 1996, MENT HLTH CAR LAW TE	33	105	105	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1634	1641		10.1016/S0140-6736(13)60105-1	http://dx.doi.org/10.1016/S0140-6736(13)60105-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23537606	Bronze			2022-12-28	WOS:000319112400030
J	Sarraf, SA; Raman, M; Guarani-Pereira, V; Sowa, ME; Huttlin, EL; Gygi, SP; Harper, JW				Sarraf, Shireen A.; Raman, Malavika; Guarani-Pereira, Virginia; Sowa, Mathew E.; Huttlin, Edward L.; Gygi, Steven P.; Harper, J. Wade			Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization	NATURE			English	Article							PHOSPHORYLATION ANALYSIS; PROTEIN-PHOSPHORYLATION; PINK1; DEGRADATION; MITOPHAGY; ACTIVATION; PROTEASOME; PROMOTES; VDAC1	The PARKIN ubiquitin ligase (also known as PARK2) and its regulatory kinase PINK1 (also known as PARK6), often mutated in familial early-onset Parkinson's disease, have central roles in mitochondrial homeostasis and mitophagy(1-3). Whereas PARKIN is recruited to the mitochondrial outer membrane (MOM) upon depolarization via PINK1 action and can ubiquitylate porin, mitofusin and Miro proteins on the MOM1,4-11, the full repertoire of PARKIN substrates-the PARKIN-dependent ubiquitylome-remains poorly defined. Here we use quantitative diGly capture proteomics (diGly)(12,13) to elucidate the ubiquitylation site specificity and topology of PARKIN-dependent target modification in response to mitochondrial depolarization. Hundreds of dynamically regulated ubiquitylation sites in dozens of proteins were identified, with strong enrichment for MOM proteins, indicating that PARKIN dramatically alters the ubiquitylation status of the mitochondrial proteome. Using complementary interaction proteomics, we found depolarization-dependent PARKIN association with numerous MOM targets, autophagy receptors, and the proteasome. Mutation of the PARKIN active site residue C431, which has been found mutated in Parkinson's disease patients, largely disrupts these associations. Structural and topological analysis revealed extensive conservation of PARKIN-dependent ubiquitylation sites on cytoplasmic domains in vertebrate and Drosophila melanogaster MOM proteins. These studies provide a resource for understanding how the PINK1-PARKIN pathway re-sculpts the proteome to support mitochondrial homeostasis.	[Sarraf, Shireen A.; Raman, Malavika; Guarani-Pereira, Virginia; Sowa, Mathew E.; Huttlin, Edward L.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Huttlin, Edward/0000-0002-1822-1173; raman, malavika/0000-0002-4773-8673; Sarraf, Shireen/0000-0001-8489-6198; Harper, Jeffrey/0000-0002-6944-7236	NIH [GM070565, GM095567, GM067945, CA139885]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL CANCER INSTITUTE [F32CA139885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM070565, R01GM095567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Kim for LC-MS and for development of QdiGly profiling, R. Kunz for peptide purification, J. Lydeard, S. Hayes and A. White for proteomics, M. Comb and S. Beausoleil (Cell Signaling Technologies) for antibodies, Nikon Imaging Center (Harvard Medical School) for microscopy, and D. Finley and B. Schulman for discussions. Supported by NIH grants GM070565 and GM095567 to J.W.H., GM067945 to S.P.G., CA139885 to M.R., and the Michael J. Fox Foundation for Parkinson's Research to J.W.H.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Onoue K, 2012, J CELL SCI; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	33	678	687	9	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					372	+		10.1038/nature12043	http://dx.doi.org/10.1038/nature12043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23503661	Green Accepted, Green Submitted			2022-12-28	WOS:000317599200040
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Mortality Rates for Medicare Beneficiaries Admitted to Critical Access and Non-Critical Access Hospitals, 2002-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							30-DAY MORTALITY; MYOCARDIAL-INFARCTION; QUALITY; CARE; OUTCOMES; COSTS	Importance Critical access hospitals (CAHs) provide inpatient care to Americans living in rural communities. These hospitals are at high risk of falling behind with respect to quality improvement, owing to their limited resources and vulnerable patient populations. How they have fared on patient outcomes during the past decade is unknown. Objective To evaluate trends in mortality for patients receiving care at CAHs and compare these trends with those for patients receiving care at non-CAHs. Design, Setting, and Patients Retrospective observational study using data from Medicare fee-for-service patients admitted to US acute care hospitals with acute myocardial infarction (1 902 586 admissions), congestive heart failure (4 488 269 admissions), and pneumonia (3 891 074 admissions) between 2002 and 2010. Main Outcome Measures Trends in risk-adjusted 30-day mortality rates for CAHs and other acute care US hospitals. Results Accounting for differences in patient, hospital, and community characteristics, CAHs had mortality rates comparable with those of non-CAHs in 2002 (composite mortality across all 3 conditions, 12.8% vs 13.0%; difference, -0.3% [95% CI, -0.7% to 0.2%]; P=.25). Between 2002 and 2010, mortality rates increased 0.1% per year in CAHs but decreased 0.2% per year in non-CAHs, for an annual difference in change of 0.3% (95% CI, 0.2% to 0.3%; P<.001). Thus, by 2010, CAHs had higher mortality rates compared with non-CAHs (13.3% vs 11.4%; difference, 1.8% [95% CI, 1.4% to 2.2%]; P<.001). The patterns were similar when each individual condition was examined separately. Comparing CAHs with other small, rural hospitals, similar patterns were found. Conclusions and Relevance Among Medicare beneficiaries with acute myocardial infarction, congestive heart failure, or pneumonia, 30-day mortality rates for those admitted to CAHs, compared with those admitted to other acute care hospitals, increased from 2002 to 2010. New efforts may be needed to help CAHs improve. JAMA. 2013;309(13):1379-1387 www.jama.com	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute, National Institutes of Health [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Ambardekar AV, 2010, AM J CARDIOL, V105, P139, DOI 10.1016/j.amjcard.2009.09.003; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Desai MM, 2009, 2009 MEASURES MAINTE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Institute of Medicine Committee on the Future of Rural Health Care Quality Board on Health Care Services., 2005, QUAL COLL FUT RUR HL; James PA, 2007, ANN FAM MED, V5, P105, DOI 10.1370/afm.625; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Li P, 2007, HEALTH SERV RES, V42, P2294; Li PX, 2007, HEALTH SERV RES, V42, P2089, DOI 10.1111/j.1475-6773.2007.00731.x; Li PX, 2009, J RURAL HEALTH, V25, P70, DOI 10.1111/j.1748-0361.2009.00201.x; Li PX, 2009, INQUIRY-J HEALTH CAR, V46, P46, DOI 10.5034/inquiryjrnl_46.01.46; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Medicare Payment Advisory Commission, 2008, C PAYM BAS CRIT ACC; MedPAC, 2005, C ISS MOD MED PROGR; Rosko MD, 2010, J HEALTH POLIT POLIC, V35, P95, DOI 10.1215/03616878-2009-042; Ross JS, 2008, HEALTH AFFAIR, V27, P1707, DOI 10.1377/hlthaff.27.6.1707; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Snyder C, 2005, JAMA-J AM MED ASSOC, V293, P2900, DOI 10.1001/jama.293.23.2900; Stensland J, 2004, 44 U MINN RUR HLTH R; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; Wang M, 2012, URBAN STUD, V49, P563, DOI 10.1177/0042098011404932; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2010, HEALTH AFFAIR, V29, P1319, DOI 10.1377/hlthaff.2008.0770; Yeh RW, 2012, CIRC-CARDIOVASC QUAL, V5, P197, DOI 10.1161/CIRCOUTCOMES.111.962456	29	60	60	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1379	1387		10.1001/jama.2013.2366	http://dx.doi.org/10.1001/jama.2013.2366			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EC	23549583	Bronze			2022-12-28	WOS:000316934500027
J	Juergens, N				Juergens, Norbert			The Biological Underpinnings of Namib Desert Fairy Circles	SCIENCE			English	Article							MYSTERIOUS CIRCLES	The sand termite Psammotermes allocerus generates local ecosystems, so-called fairy circles, through removal of short-lived vegetation that appears after rain, leaving circular barren patches. Because of rapid percolation and lack of evapotranspiration, water is retained within the circles. This process results in the formation of rings of perennial vegetation that facilitate termite survival and locally increase biodiversity. This termite-generated ecosystem persists through prolonged droughts lasting many decades.	Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany	University of Hamburg	Juergens, N (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	norbert.juergens@t-online.de	Juergens, Norbert/K-4792-2013	Juergens, Norbert/0000-0003-3211-0549	German Federal Ministry of Education and Research [01 LC 0024, 01 LC 0024A, 01 LC 0624A2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding of long-term monitoring was provided by the German Federal Ministry of Education and Research 01 LC 0024, 01 LC 0024A, and 01 LC 0624A2 [Biodiversity Monitoring Transect Analysis in Africa (BIOTA)-Southern Africa]. Data presented in this paper	Albrecht CF, 2001, S AFR J SCI, V97, P23; Grube S., 1997, THESIS FREIE U BERLI; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Kaffarnik S., 2009, THESIS U HAMBURG HAM; NAIMAN RJ, 1994, ECOLOGY, V75, P905, DOI 10.2307/1939415; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3	9	72	74	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1618	1621		10.1126/science.1222999	http://dx.doi.org/10.1126/science.1222999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539605				2022-12-28	WOS:000316731600052
J	Diegeler, A; Borgermann, J; Kappert, U; Breuer, M; Boning, A; Ursulescu, A; Rastan, A; Holzhey, D; Treede, H; Riess, FC; Veeckmann, P; Asfoor, A; Reents, W; Zacher, M; Hilker, M				Diegeler, Anno; Boergermann, Jochen; Kappert, Utz; Breuer, Martin; Boening, Andreas; Ursulescu, Adrian; Rastan, Ardawan; Holzhey, David; Treede, Hendrik; Riess, Friedrich-Christian; Veeckmann, Philippe; Asfoor, Amjad; Reents, Wilko; Zacher, Michael; Hilker, Michael		GOPCABE Study Grp	Off-Pump versus On-Pump Coronary-Artery Bypass Grafting in Elderly Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK PATIENTS; CARDIOPULMONARY BYPASS; LOGISTIC EUROSCORE; SURGERY; OUTCOMES; TRIAL; PATENCY; REVASCULARIZATION	BACKGROUND The benefits of coronary-artery bypass grafting (CABG) without cardiopulmonary bypass in the elderly are still undetermined. METHODS We randomly assigned patients 75 years of age or older who were scheduled for elective first-time CABG to undergo the procedure either without cardiopulmonary bypass (off-pump CABG) or with it (on-pump CABG). The primary end point was a composite of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy at 30 days and at 12 months after surgery. RESULTS A total of 2539 patients underwent randomization. At 30 days after surgery, there was no significant difference between patients who underwent off-pump surgery and those who underwent on-pump surgery in terms of the composite outcome (7.8% vs. 8.2%; odds ratio, 0.95; 95% confidence interval [CI], 0.71 to 1.28; P = 0.74) or four of the components (death, stroke, myocardial infarction, or new renal-replacement therapy). Repeat revascularization occurred more frequently after off-pump CABG than after on-pump CABG (1.3% vs. 0.4%; odds ratio, 2.42; 95% CI, 1.03 to 5.72; P = 0.04). At 12 months, there was no significant between-group difference in the composite end point (13.1% vs. 14.0%; hazard ratio, 0.93; 95% CI, 0.76 to 1.16; P = 0.48) or in any of the individual components. Similar results were obtained in a per-protocol analysis that excluded the 177 patients who crossed over from the assigned treatment to the other treatment. CONCLUSIONS In patients 75 years of age or older, there was no significant difference between on-pump and off-pump CABG with regard to the composite outcome of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy within 30 days and within 12 months after surgery. (Funded by Maquet; GOPCABE ClinicalTrials.gov number, NCT00719667.)	[Diegeler, Anno; Reents, Wilko; Zacher, Michael] Herz & Gefass Klin Bad Neustadt, Bad Neustadt an der Saale, Germany; [Boergermann, Jochen] Herz & Diabet Zentrum Bad Oeynhausen, Bad Oeynhausen, Germany; [Kappert, Utz] Herzzentrum Dresden, Dresden, Germany; [Breuer, Martin] Univ Klin Jena, Jena, Germany; [Boening, Andreas] Univ Klin Giessen, Giessen, Germany; [Ursulescu, Adrian] Robert Bosch Krankenhaus Stuttgart, Stuttgart, Germany; [Rastan, Ardawan; Holzhey, David] Herzzentrum Univ Leipzig, Leipzig, Germany; [Treede, Hendrik] Univ Klin Hamburg Eppendorf, Hamburg, Germany; [Riess, Friedrich-Christian] Albertinen Krankenhaus Hamburg, Hamburg, Germany; [Veeckmann, Philippe] Klinikum Herzchirurg Karlsruhe, Karlsruhe, Germany; [Asfoor, Amjad] Ruhr Univ Bochum, Bochum, Germany; [Hilker, Michael] Univ Klin Regensburg, Regensburg, Germany	Ruhr University Bochum; Technische Universitat Dresden; Friedrich Schiller University of Jena; Bosch; Robert Bosch Krankenhaus; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum; University of Regensburg	Diegeler, A (corresponding author), Cardiovasc Clin Bad Neustadt, Salzburger Leite 1, D-97616 Bad Neustadt an der Saale, Germany.	cachir@herzchirurgie.de	F, G/AAD-4585-2020; Treede, Hendrik/I-3630-2017	Holzhey, David/0000-0002-0613-4419	Maquet	Maquet	Supported by Maquet.	Badreldin AMA, 2011, THORAC CARDIOV SURG, V59, P399, DOI 10.1055/s-0030-1270944; Diegeler A, 2000, CIRCULATION, V102, P95; Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X; Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595; Hattler B, 2012, CIRCULATION, V125, P2827, DOI 10.1161/CIRCULATIONAHA.111.069260; Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kuss O, 2011, J THORAC CARDIOV SUR, V142, pE117, DOI 10.1016/j.jtcvs.2011.04.032; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Pintar Tatjana, 2003, Anesthesiol Clin North Am, V21, P453, DOI 10.1016/S0889-8537(03)00039-7; Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841; Puskas J, 2005, INNOVATIONS, V1, P3, DOI 10.1097/01243895-200500110-00002; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36	19	333	361	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1189	1198		10.1056/NEJMoa1211666	http://dx.doi.org/10.1056/NEJMoa1211666			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23477657				2022-12-28	WOS:000316869000006
J	Key, K; Constable, S; Liu, LJ; Pommier, A				Key, Kerry; Constable, Steven; Liu, Lijun; Pommier, Anne			Electrical image of passive mantle upwelling beneath the northern East Pacific Rise	NATURE			English	Article							MIDOCEAN RIDGES; MELT EXPERIMENT; REGION; HETEROGENEITY; GENERATION; PERIDOTITE; ASYMMETRY; DYNAMICS; BASALT; MODELS	Melt generated by mantle upwelling is fundamental to the production of new oceanic crust at mid-ocean ridges, yet the forces controlling this process are debated(1,2). Passive-flow models predict symmetric upwelling due to viscous drag from the diverging tectonic plates, but have been challenged by geophysical observations of asymmetric upwelling(3-5) that suggest anomalous mantle pressure and temperature gradients(2,6,7), and by observations of concentrated upwelling centres(8) consistent with active models where buoyancy forces give rise to focused convective flow(2). Here we use sea-floor magnetotelluric soundings at the fast-spreading northern East Pacific Rise to image mantle electrical structure to a depth of about 160 kilometres. Our data reveal a symmetric, high-conductivity region at depths of 20-90 kilometres that is consistent with partial melting of passively upwelling mantle(9-11). The triangular region of conductive partial melt matches passive-flow predictions, suggesting that melt focusing to the ridge occurs in the porous melting region rather than along the shallower base of the thermal lithosphere. A deeper conductor observed east of the ridge at a depth of more than 100 kilometres is explained by asymmetric upwelling due to viscous coupling across two nearby transform faults. Significant electrical anisotropy occurs only in the shallowest mantle east of the ridge axis, where high vertical conductivity at depths of 10-20 kilometres indicates localized porous conduits. This suggests that a coincident seismic-velocity anomaly(12) is evidence of shallow magma transport channels(13,14) rather than deeper off-axis upwelling. We interpret the mantle electrical structure as evidence that plate-driven passive upwelling dominates this ridge segment, with dynamic forces being negligible.	[Key, Kerry; Constable, Steven] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Liu, Lijun] Univ Illinois, Dept Geol, Coll Liberal Arts & Sci, Urbana, IL 61801 USA; [Pommier, Anne] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Illinois System; University of Illinois Urbana-Champaign; Arizona State University; Arizona State University-Tempe	Key, K (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	kkey@ucsd.edu	Key, Kerry W/B-1092-2008; Constable, Steven C/B-8959-2008; Key, Kerry/AAH-6949-2021	Key, Kerry/0000-0003-1169-6683; Constable, Steven/0000-0001-6324-3470	US NSF [OCE-0241597]; Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography	US NSF(National Science Foundation (NSF)); Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography	We thank the captain and crew of R/V Roger Revelle, members of the scientific party (J. Behrens, G. Boran, G. Heinson, J. King, A. Massarweh, L. Terzi and C. Weiss), and the technical team (C. Armerding, P. Cheng, C. Berger, G. Englehorn, G. Howe, K. Callaway and J. Lemire). We thank D. Myer for assistance with the data processing and R. Katz for reviewing the manuscript. This work was funded by US NSF award OCE-0241597 and the Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography.	AHARONOV E, 1995, J GEOPHYS RES-SOL EA, V100, P20433, DOI 10.1029/95JB01307; Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; BAKER ET, 1994, EARTH PLANET SC LETT, V128, P1, DOI 10.1016/0012-821X(94)90022-1; Berdichevsky MN, 2008, MODELS METHODS MAGNE, DOI [10.1007/978-3-540-77814-1, DOI 10.1007/978-3-540-77814-1]; Conder JA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000807; Constable S, 2006, GEOPHYS J INT, V166, P435, DOI 10.1111/j.1365-246X.2006.03041.x; CONSTABLE SC, 1987, GEOPHYSICS, V52, P289, DOI 10.1190/1.1442303; Danyushevsky LV, 2000, J PETROL, V41, P1329, DOI 10.1093/petrology/41.8.1329; Dasgupta R, 2007, GEOLOGY, V35, P135, DOI 10.1130/G22856A.1; Dunn RA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002217; Egbert GD, 1997, GEOPHYS J INT, V130, P475, DOI 10.1111/j.1365-246X.1997.tb05663.x; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Hammond WC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001789; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; Hirose K, 1997, GEOPHYS RES LETT, V24, P2837, DOI 10.1029/97GL02956; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Katz RF, 2012, EARTH PLANET SC LETT, V335, P226, DOI 10.1016/j.epsl.2012.04.042; Katz RF, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003282; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13945, DOI 10.1029/93JB00705; Key K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016035; Key K, 2011, GEOPHYS J INT, V186, P137, DOI 10.1111/j.1365-246X.2011.05025.x; Minarik WG, 1998, J PETROL, V39, P1965, DOI 10.1093/petrology/39.11.1965; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Scheirer DS, 1998, SCIENCE, V280, P1221, DOI 10.1126/science.280.5367.1221; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Toomey DR, 2007, NATURE, V446, P409, DOI 10.1038/nature05679; Toomey DR, 2002, EARTH PLANET SC LETT, V200, P287, DOI 10.1016/S0012-821X(02)00655-6; Wang Y, 2009, NATURE, V462, P499, DOI 10.1038/nature08552; WANNAMAKER PE, 1984, GEOPHYSICS, V49, P1517, DOI 10.1190/1.1441777; WENDLANDT RF, 1980, AM MINERAL, V65, P37; Yoshino T, 2012, PHYS EARTH PLANET IN, V194, P1, DOI 10.1016/j.pepi.2012.01.005; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	33	102	106	6	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					500	+		10.1038/nature11932	http://dx.doi.org/10.1038/nature11932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538832				2022-12-28	WOS:000316682800043
J	Li, L; Hanahan, D				Li, Leanne; Hanahan, Douglas			Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion	CELL			English	Article							MOUSE MODELS; PANCREATIC NEUROENDOCRINE; RECEPTOR TRAFFICKING; E-CADHERIN; CANCER; ANGIOGENESIS; CELLS; DISSEMINATION; ACTIVATION; EXPRESSION	Glutamate and its receptor N-methyl-D-aspartate receptor (NMDAR) have been associated with cancer, although their functions are not fully understood. Herein, we implicate glutamate-driven NMDAR signaling in a mouse model of pancreatic neuroendocrine tumorigenesis (PNET) and in selected human cancers. NMDAR was upregulated at the periphery of PNET tumors, particularly invasive fronts. Moreover, elevated coexpression of NMDAR and glutamate exporters correlated with poor prognosis in cancer patients. Treatment of a tumor-derived cell line with NMDAR antagonists impaired cancer cell proliferation and invasion. Flow conditions mimicking interstitial fluid pressure induced autologous glutamate secretion, activating NMDAR and its downstream MEK-MAPK and CaMK effectors, thereby promoting invasiveness. Congruently, pharmacological inhibition of NMDAR in mice with PNET reduced tumor growth and invasiveness. Therefore, beyond its traditional role in neurons, NMDAR may be activated in human tumors by fluid flow consequent to higher interstitial pressure, inducing an autocrine glutamate signaling circuit with resultant stimulation of malignancy.	[Li, Leanne; Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hanahan, D (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland.	douglas.hanahan@epfl.ch		Li, Leanne/0000-0002-1598-1564	EPFL	EPFL	We wish to thank M. Luisa Iruela-Arispe, Igor Allaman, and Anita Wolfer for advice, discussions, and insightful comments on the manuscript; Jessica Sordet-Dessimoz and Alessandra Piersigilli for pathology, Jacques Rougemont and Marion Leleu for statistical consultations; Ehud Drori, Mei-Wen Peng, and Jean-Paul Abbuhl for help with animal experiments; Yunyun Han, Hsin-Ying Huang, Sukhvinder Sidhu, and all Hanahan lab members for biological samples and discussions; Melody Swartz, Adrian C. Shieh, and Jacqueline Shields for advice and instruction on the modified invasion assay; Janet Iwasa for the schematic figure; and the EPFL School of Life Sciences technology cores and animal care facility. This research was supported by a core grant from EPFL. Some results are based on data generated by the TCGA pilot project.	Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Chun MGH, 2010, P NATL ACAD SCI USA, V107, P17268, DOI 10.1073/pnas.1012705107; Chun MGH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001120; Dafni H, 2002, CANCER RES, V62, P6731; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Grippo PJ, 2010, CANCER PREV RES, V3, P1382, DOI 10.1158/1940-6207.CAPR-10-0258; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Herner A, 2011, INT J CANCER, V129, P2349, DOI 10.1002/ijc.25898; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoletti F, 2007, TRENDS PHARMACOL SCI, V28, P206, DOI 10.1016/j.tips.2007.03.008; North WG, 2010, CLIN PHARMACOL-ADV A, V2, P31, DOI 10.2147/CPAA.S6262; North WG, 2010, BREAST CANCER RES TR, V122, P307, DOI 10.1007/s10549-009-0556-1; Olson P, 2011, P NATL ACAD SCI USA, V108, pE1275, DOI 10.1073/pnas.1111079108; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wegener N, 2011, NEUROSCI LETT, V503, P68, DOI 10.1016/j.neulet.2011.08.012; Wu JH, 2005, PSYCHOPHARMACOLOGY, V177, P256, DOI 10.1007/s00213-004-1944-1	44	92	100	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					86	100		10.1016/j.cell.2013.02.051	http://dx.doi.org/10.1016/j.cell.2013.02.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540692	Bronze, Green Submitted			2022-12-28	WOS:000316853700008
J	Altenburg, J; de Graaff, CS; Stienstra, Y; Sloos, JH; van Haren, EHJ; Koppers, RJH; van der Werf, TS; Boersma, WG				Altenburg, Josje; de Graaff, Casper S.; Stienstra, Ymkje; Sloos, Jacobus H.; van Haren, Eric H. J.; Koppers, Ralph J. H.; van der Werf, Tjip S.; Boersma, Wim G.			Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM AZITHROMYCIN; LOW-DOSE AZITHROMYCIN; MACROLIDE RESISTANCE; DOUBLE-BLIND; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; HEALTH-STATUS; CHILDREN; CORTICOSTEROIDS; ANTIBIOTICS	Importance Macrolide antibiotics have been shown beneficial in cystic fibrosis (CF) and diffuse panbronchiolitis, and earlier findings also suggest a benefit in non-CF bronchiectasis. Objective To determine the efficacy of macrolide maintenance treatment for adults with non-CF bronchiectasis. Design, Setting, and Participants The BAT (Bronchiectasis and Long-term Azithromycin Treatment) study, a randomized, double-blind, placebo-controlled trial conducted between April 2008 and September 2010 in 14 hospitals in the Netherlands among 83 outpatients with non-CF bronchiectasis and 3 or more lower respiratory tract infections in the preceding year. Interventions Azithromycin (250 mg daily) or placebo for 12 months. Main Outcome Measures Number of infectious exacerbations during 12 months of treatment. Secondary end points included lung function, sputum bacteriology, inflammatory markers, adverse effects, symptom scores, and quality of life. Results Forty-three participants (52%) received azithromycin and 40 (48%) received placebo and were included in the modified intention-to-treat analysis. At end of study, the median number of exacerbations in the azithromycin group was 0 (interquartile range [IQR], 0-1), compared with 2 (IQR, 1-3) in the placebo group (P<.001). Thirty-two (80%) placebo-treated vs 20 (46%) azithromycin-treated individuals had at least 1 exacerbation (hazard ratio, 0.29 [95% CI, 0.16-0.51]). In a mixed-model analysis, change in forced expiratory volume in the first second of expiration (percent of predicted) over time differed between groups (F-1,F-78.8 = 4.085, P=.047), with an increase of 1.03% per 3 months in the azithromycin group and a decrease of 0.10% per 3 months in the placebo group. Gastrointestinal adverse effects occurred in 40% of patients in the azithromycin group and in 5% in the placebo group (relative risk, 7.44 [95% CI, 0.97-56.88] for abdominal pain and 8.36 [95% CI, 1.10-63.15] for diarrhea) but without need for discontinuation of study treatment. A macrolide resistance rate of 88% was noted in azithromycin-treated individuals, compared with 26% in the placebo group. Conclusions and Relevance Among adults with non-CF bronchiectasis, the daily use of azithromycin for 12 months compared with placebo resulted in a lower rate of infectious exacerbations. This could result in better quality of life and might influence survival, although effects on antibiotic resistance need to be considered.	[Altenburg, Josje; de Graaff, Casper S.; Boersma, Wim G.] Med Ctr Alkmaar, Dept Pulm Dis, NL-1812 JD Alkmaar, Netherlands; [Sloos, Jacobus H.] Med Ctr Alkmaar, Reg Lab, NL-1812 JD Alkmaar, Netherlands; [Stienstra, Ymkje; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 AB Groningen, Netherlands; [van Haren, Eric H. J.] Atrium Med Ctr, Dept Pulm Dis, Heerlen, Netherlands; [Koppers, Ralph J. H.] Leeuwarden Med Ctr, Dept Pulm Dis, Leeuwarden, Netherlands	Medical Center Of Alkmaar; Medical Center Of Alkmaar; University of Groningen; Atrium Medical Center; Medical Center Leeuwarden	Altenburg, J (corresponding author), Med Ctr Alkmaar, Dept Pulm Dis, Wilhelminalaan 12, NL-1812 JD Alkmaar, Netherlands.	j.altenburg@mca.nl	Stienstra, Ymkje/F-2222-2010	Stienstra, Ymkje/0000-0002-8844-8859; van der Werf, Tjip/0000-0002-4824-1642	Foreest Medical School; GlaxoSmithKline	Foreest Medical School; GlaxoSmithKline(GlaxoSmithKline)	Dr Altenberg and Dr Boersma are supported by a research grant from the Foreest Medical School, an independent scientific institution based in the Alkmaar Medical Centre. This grant was used for paying salaries for the main researcher and research assistant, to provide logistical support, and for laboratory tests, pulmonary function testing, and imaging. This study was supported by an unrestricted research grant from GlaxoSmithKline. Teva Netherlands supplied the azithromycin tablets used in the study. No salaries or stipends were paid.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; Anwar GA, 2008, RESP MED, V102, P1494, DOI 10.1016/j.rmed.2008.06.005; Banerjee D, 2005, RESP MED, V99, P208, DOI 10.1016/j.rmed.2004.06.009; Bilton D, 2008, CURR OPIN PULM MED, V14, P595, DOI 10.1097/MCP.0b013e328312ed8c; Clement A, 2006, THORAX, V61, P895, DOI 10.1136/thx.2005.057950; Cole P J, 1986, Eur J Respir Dis Suppl, V147, P6; Cymbala Alicia A, 2005, Treat Respir Med, V4, P117, DOI 10.2165/00151829-200504020-00005; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Davies G, 2004, THORAX, V59, P540; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Hansen CR, 2009, J CYST FIBROS, V8, P58, DOI 10.1016/j.jcf.2008.09.001; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kasahara Kei, 2005, Journal of Infection and Chemotherapy, V11, P112, DOI 10.1007/s10156-005-0375-1; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Knottnerus JA, 2001, J CLIN EPIDEMIOL, V54, P109, DOI 10.1016/S0895-4356(00)00276-6; Koh YY, 1997, EUR RESPIR J, V10, P994, DOI 10.1183/09031936.97.10050994; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; McCormack J, 2007, EUR RESPIR J, V30, P487, DOI 10.1183/09031936.00163306; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Serisier DJ, 2011, RESP MED, V105, P946, DOI 10.1016/j.rmed.2011.01.009; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; ten Hacken NHT, 2007, BMJ-BRIT MED J, V335, P1089, DOI 10.1136/bmj.39384.657118.80; Tramper-Stranders GA, 2007, PEDIATR INFECT DIS J, V26, P8, DOI 10.1097/01.inf.0000247109.44249.ac; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Yalcin E, 2006, J CLIN PHARM THER, V31, P49, DOI 10.1111/j.1365-2710.2006.00708.x	36	325	340	2	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1251	1259		10.1001/jama.2013.1937	http://dx.doi.org/10.1001/jama.2013.1937			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532241	Bronze			2022-12-28	WOS:000316625200025
J	Zoghbi, WA; Holmes, DR				Zoghbi, William A.; Holmes, David R., Jr.			Improving Cardiovascular Health A Balance Between Discovery and Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Zoghbi, William A.; Holmes, David R., Jr.] Cardiol Fdn, Amer Coll, Washington, DC USA; [Holmes, David R., Jr.] Mayo Clin Fdn, Rochester, MN USA; [Zoghbi, William A.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA	Mayo Clinic; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Zoghbi, WA (corresponding author), Methodist DeBakey Heart & Vasc Ctr, Cardiovasc Imaging Inst, 6550 Fannin St,SM 677, Houston, TX 77030 USA.	wzoghbi@tmhs.org						Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; World Health Organization, GLOB ATL CARD DIS PR	4	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1117	1118		10.1001/jama.2013.2416	http://dx.doi.org/10.1001/jama.2013.2416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23475314				2022-12-28	WOS:000316276500022
J	Gundersen, GG; Worman, HJ				Gundersen, Gregg G.; Worman, Howard J.			Nuclear Positioning	CELL			English	Review							CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; MYOSIN-II; LAMIN-A/C; MEMBRANE PROTEIN; CELL-ADHESION; KASH DOMAIN; ACTIN FLOW; TAN LINES; ENVELOPE	The nucleus is the largest organelle and is commonly depicted in the center of the cell. Yet during cell division, migration, and differentiation, it frequently moves to an asymmetric position aligned with cell function. We consider the toolbox of proteins that move and anchor the nucleus within the cell and how forces generated by the cytoskeleton are coupled to the nucleus to move it. The significance of proper nuclear positioning is underscored by numerous diseases resulting from genetic alterations in the toolbox proteins. Finally, we discuss how nuclear position may influence cellular organization and signaling pathways.	[Gundersen, Gregg G.; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.	ggg1@columbia.edu; hjw14@columbia.edu			NIH [R01GM099481, R01NS059352, R01HD070713, R01AR048997]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Susumu Antoku, Wakam Chang, Edgar Gomes, Gant Luxton, and Alex Palazzo for their comments and Wakam Chang for Figures 1B and 2A. The authors are supported by NIH grants R01GM099481, R01NS059352, R01HD070713, and R01AR048997.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Borrego-Pinto J, 2012, J CELL SCI, V125, P1099, DOI 10.1242/jcs.087049; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Buchman JJ, 2008, CELL, V134, P912, DOI 10.1016/j.cell.2008.09.007; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Dupin I, 2011, J CELL SCI, V124, P865, DOI 10.1242/jcs.076356; Fan SS, 1997, DEVELOPMENT, V124, P1497; Folker ES, 2012, DEVELOPMENT, V139, P3827, DOI 10.1242/dev.079178; Folker ES, 2011, P NATL ACAD SCI USA, V108, P131, DOI 10.1073/pnas.1000824108; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Gladfelter A, 2009, NAT REV MICROBIOL, V7, P875, DOI 10.1038/nrmicro2249; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Godin JD, 2012, DEV CELL, V23, P729, DOI 10.1016/j.devcel.2012.08.006; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Horn HF, 2013, J CLIN INVEST, V123, P740, DOI 10.1172/JCI66911; Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2011, NUCLEUS-PHILA, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinsch S, 1998, J CELL SCI, V111, P2283; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	111	315	318	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1376	1389		10.1016/j.cell.2013.02.031	http://dx.doi.org/10.1016/j.cell.2013.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498944	Bronze, Green Accepted			2022-12-28	WOS:000316192500017
J	Morrow, M; Winograd, JM; Freer, PE; Eichhorn, JH				Morrow, Monica; Winograd, Jonathan M.; Freer, Phoebe E.; Eichhorn, John H.			Case 8-2013: A 48-Year-Old Woman with Carcinoma In Situ of the Breast Ductal carcinoma in situ of the breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACELLULAR DERMAL MATRIX; SKIN-SPARING MASTECTOMY; LOCAL RECURRENCE; CANCER; WOMEN; RISK; RADIOTHERAPY; TOMOSYNTHESIS; CONSERVATION; MULTICENTER		[Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Morrow, Monica] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Winograd, Jonathan M.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Freer, Phoebe E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Eichhorn, John H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Winograd, Jonathan M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Freer, Phoebe E.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Eichhorn, John H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Morrow, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.			Freer, Phoebe/0000-0001-6886-7100				Abe O., 2010, Journal of the National Cancer Institute Monographs, P162, DOI 10.1093/jncimonographs/lgq039; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; [Anonymous], 2007, J AM COLL SURGEONS, V205, P362, DOI 10.1016/j.jamcollurg.2007.02.057; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P679; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P180, DOI 10.1016/j.jamcollsurg.2009.04.010; Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7; Carlson GW, 2007, J AM COLL SURGEONS, V204, P1074, DOI 10.1016/j.jamcollsurg.2007.01.063; Chun YS, 2010, PLAST RECONSTR SURG, V125, P429, DOI 10.1097/PRS.0b013e3181c82d90; Colwell AS, 2011, PLAST RECONSTR SURG, V128, P1170, DOI 10.1097/PRS.0b013e318230c2f6; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Dunne C, 2009, J CLIN ONCOL, V27, P1615, DOI 10.1200/JCO.2008.17.5182; Gamboa-Bobadilla GM, 2006, ANN PLAS SURG, V56, P22, DOI 10.1097/01.sap.0000185460.31188.c1; Gao X, 2003, INT J RADIAT ONCOL, V56, P1038, DOI 10.1016/S0360-3016(03)00203-7; Greenway RM, 2005, AM J SURG, V190, P918, DOI 10.1016/j.amjsurg.2005.08.035; Hawley ST, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.6010; Holmberg L, 2008, J CLIN ONCOL, V26, P1247, DOI 10.1200/JCO.2007.12.7969; Hughes LL, 2009, J CLIN ONCOL, V27, P5319, DOI 10.1200/JCO.2009.21.8560; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; King TA, 2011, J CLIN ONCOL, V29, P2158, DOI 10.1200/JCO.2010.29.4041; Kobraei EM, 2012, PLAST RECONSTR SURG, V129, p234E, DOI 10.1097/PRS.0b013e31823aec7f; Kopans D, 2011, BREAST J, V17, P638, DOI 10.1111/j.1524-4741.2011.01152.x; Morrow M, 1998, ANN SURG, V227, P502, DOI 10.1097/00000658-199804000-00009; Morrow M, 2009, JAMA-J AM MED ASSOC, V302, P1551, DOI 10.1001/jama.2009.1450; Niklason LT, 1998, BREAST IMAGING, P151, DOI 10.3233/BD-1998-103-415; Niklason LT, 1997, RADIOLOGY, V205, P399, DOI 10.1148/radiology.205.2.9356620; Peters NHGM, 2011, EUR J CANCER, V47, P879, DOI 10.1016/j.ejca.2010.11.035; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Roostaeian J, 2011, PLAST RECONSTR SURG, V127, P1407, DOI 10.1097/PRS.0b013e318208d0ea; Rusby JE, 2010, BRIT J SURG, V97, P305, DOI 10.1002/bjs.6970; Salgarello M, 2010, PLAST RECONSTR SURG, V126, P1460, DOI 10.1097/PRS.0b013e3181ef8bce; Schiller DE, 2008, ANN SURG ONCOL, V15, P833, DOI 10.1245/s10434-007-9711-2; Skaane P., 2013, RADIOLOGY; Solin LJ, 1996, J CLIN ONCOL, V14, P754, DOI 10.1200/JCO.1996.14.3.754; Topol BM, 2008, ANN PLAS SURG, V61, P494, DOI 10.1097/SAP.0b013e31816d82d9; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027; Wu T, 2006, MED PHYS, V33, P2461, DOI 10.1118/1.2207127; Yang TIJ, 2010, INT J RADIAT ONCOL, V76, P79, DOI 10.1016/j.ijrobp.2009.01.039; Yao K, 2010, ANN SURG ONCOL, V17, P2554, DOI 10.1245/s10434-010-1091-3	40	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1046	1053		10.1056/NEJMcpc1214221	http://dx.doi.org/10.1056/NEJMcpc1214221			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484832				2022-12-28	WOS:000315982100012
J	Inaba, H; Greaves, M; Mullighan, CG				Inaba, Hiroto; Greaves, Mel; Mullighan, Charles G.			Acute lymphoblastic leukaemia	LANCET			English	Article							MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; CHILDRENS CANCER GROUP; EVENT-FREE SURVIVAL; T-CELL; STANDARD-RISK; RELAPSE RISK; INTRACHROMOSOMAL AMPLIFICATION; CLINICAL-SIGNIFICANCE; REMISSION INDUCTION	Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 and 5 years of age. Causation is multifactorial and exogenous or endogenous exposures, genetic susceptibility, and chance have roles. Survival in paediatric acute lymphoblastic leukaemia has improved to roughly 90% in trials with risk stratification by biological features of leukaemic cells and response to treatment, treatment modification based on patients' pharmacodynamics and pharmacogenomics, and improved supportive care. However, innovative approaches are needed to further improve survival while reducing adverse effects. Prognosis remains poor in infants and adults. Genome-wide profiling of germline and leukaemic cell DNA has identified novel submicroscopic structural genetic changes and sequence mutations that contribute to leukaemogenesis, define new disease subtypes, affect responsiveness to treatment, and might provide novel prognostic markers and therapeutic targets for personalised medicine.	[Inaba, Hiroto] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Greaves, Mel] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, Sutton, Surrey, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of London; Institute of Cancer Research - UK	Inaba, H (corresponding author), St Jude Childrens Res Hosp, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	hiroto.inaba@stjude.org	Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850	National Institutes of Health [CA21765]; Leukaemia and Lymphoma Research UK; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukaemia and Lymphoma Research UK; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Our work was supported in part by grants from the National Institutes of Health (CA21765; HI, CGM), Leukaemia and Lymphoma Research UK (MG), and the American Lebanese Syrian Associated Charities (HI, CGM). CGM is a Pew Scholar in the Biomedical Sciences and a St Baldrick's Scholar. These sponsors had no roles in writing of the Seminar. We thank Ching-Hon Pui for critical review and Sharon Naron for editing the manuscript.	Anderson R M, 1990, Lancet, V335, P641; Attarbaschi A, 2008, J CLIN ONCOL, V26, P3046, DOI 10.1200/JCO.2008.16.1117; Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bertrand Y, 2008, ASH ANN M, V112, P8; Bhatia S, 2012, J CLIN ONCOL, V30, P2094, DOI 10.1200/JCO.2011.38.9924; Boissel N, 2003, J CLIN ONCOL, V21, P774, DOI 10.1200/JCO.2003.02.053; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Buitenkamp TD, 2012, LEUKEMIA, V26, P2204, DOI 10.1038/leu.2012.84; Campana D, 2012, CURR OPIN HEMATOL, V19, P313, DOI 10.1097/MOH.0b013e3283543d5c; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; de Bont JM, 2004, LEUKEMIA, V18, P2032, DOI 10.1038/sj.leu.2403538; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; French D, 2009, BLOOD, V113, P4512, DOI 10.1182/blood-2008-07-172106; Gilham C, 2005, BMJ-BRIT MED J, V330, P1294, DOI 10.1136/bmj.38428.521042.8F; Gokbuget N, 2012, BLOOD, V120, P1868, DOI 10.1182/blood-2011-09-377713; Goldman JM, 1984, MECH VIRAL LEUKAEMOG; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M., 2000, CANC EVOLUTIONARY LE; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; GREAVES MF, 1988, LEUKEMIA, V2, P120; Harewood L, 2003, LEUKEMIA, V17, P547, DOI 10.1038/sj.leu.2402849; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Harrison CJ, 2009, BRIT J HAEMATOL, V144, P147, DOI 10.1111/j.1365-2141.2008.07417.x; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hoelzer D, 2011, HEMATOL-AM SOC HEMAT, P243, DOI 10.1182/asheducation-2011.1.243; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Iacobucci I, 2009, BLOOD, V114, P2159, DOI 10.1182/blood-2008-08-173963; Igarashi S, 2005, J CLIN ONCOL, V23, P6489, DOI 10.1200/JCO.2005.01.982; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kawamata N, 2009, INT J ONCOL, V34, P1603, DOI 10.3892/ijo_00000290; Kawedia JD, 2012, BLOOD, V119, P1658, DOI 10.1182/blood-2011-09-381731; Kendall G, 2011, LEUKEMIA RES, V35, P1039, DOI 10.1016/j.leukres.2011.01.023; Kinlen L, 2004, BRIT J CANCER, V91, P1, DOI 10.1038/sj.bjc.6601982; KINLEN L, 1988, LANCET, V2, P1323; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Kroll ME, 2006, J NATL CANCER I, V98, P417, DOI 10.1093/jnci/djj095; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Larsen E, 2011, J CLIN ONCOL, V29, p3s; Leung W, 2012, BLOOD, V120, P468, DOI 10.1182/blood-2012-02-409813; Leung W, 2011, BLOOD, V118, P223, DOI 10.1182/blood-2011-01-333070; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Marks DI, 2010, BLOOD, V116, P366, DOI 10.1182/blood-2010-01-264077; Matloub Y, 2006, BLOOD, V108, P1165, DOI 10.1182/blood-2005-12-011809; Matloub Y, 2011, BLOOD, V118, P243, DOI 10.1182/blood-2010-12-322909; Mattano LA, 2012, LANCET ONCOL, V13, P906, DOI 10.1016/S1470-2045(12)70274-7; Mikkelsen TS, 2011, J CLIN ONCOL, V29, P1771, DOI 10.1200/JCO.2010.32.5340; Miller C, 2008, BLOOD, V112, p293s; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Pui CH, 2011, J CLIN ONCOL, V29, P386, DOI 10.1200/JCO.2010.32.0325; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; RAIMONDI SC, 1993, BLOOD, V82, P576; Ramsey LB, 2012, GENOME RES, V22, P1, DOI 10.1101/gr.129668.111; Ravandi F, 2010, BLOOD, V116, P2070, DOI 10.1182/blood-2009-12-261586; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Robinson HM, 2007, GENE CHROMOSOME CANC, V46, P318, DOI 10.1002/gcc.20412; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rots Marianne G., 1999, Blood, V93, P1677; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Schafer ES, 2011, NAT REV CLIN ONCOL, V8, P417, DOI 10.1038/nrclinonc.2011.77; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Schrappe M, 2008, BLOOD, V112, p7s; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schuz J, 2011, PROG BIOPHYS MOL BIO, V107, P339, DOI 10.1016/j.pbiomolbio.2011.09.008; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Seibel NL, 2008, BLOOD, V111, P2548, DOI 10.1182/blood-2007-02-070342; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Silverman LB, 2010, BLOOD, V115, P1351, DOI 10.1182/blood-2009-09-245951; Skarby TVC, 2006, LEUKEMIA, V20, P1955, DOI 10.1038/sj.leu.2404404; Stanulla M, 2009, SEMIN HEMATOL, V46, P52, DOI 10.1053/j.seminhematol.2008.09.007; Stock W, 2008, BLOOD, V112, P1646, DOI 10.1182/blood-2008-01-130237; Stork LC, 2010, BLOOD, V115, P2740, DOI 10.1182/blood-2009-07-230656; Stow P, 2010, BLOOD, V115, P4657, DOI 10.1182/blood-2009-11-253435; Strefford JC, 2007, ONCOGENE, V26, P4306, DOI 10.1038/sj.onc.1210190; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Taylor GM, 1996, LEUKEMIA, P210; Thomas DA, 2010, J CLIN ONCOL, V28, P3880, DOI 10.1200/JCO.2009.26.9456; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Urayama KY, 2010, INT J EPIDEMIOL, V39, P718, DOI 10.1093/ije/dyp378; Van Vlierberghe P, 2008, LEUKEMIA, V22, P762, DOI 10.1038/sj.leu.2405082; van Vlierberghe P, 2006, LEUKEMIA, V20, P1245, DOI 10.1038/sj.leu.2404247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Veerman AJ, 2009, LANCET ONCOL, V10, P957, DOI 10.1016/S1470-2045(09)70228-1; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Virely C, 2010, LEUKEMIA, V24, P1200, DOI 10.1038/leu.2010.63; Vora A, 2006, LANCET, V368, P1339, DOI 10.1016/S0140-6736(06)69558-5; WARD G, 1917, BR J CHILD DIS, V14, P10; WHITEHEAD VM, 1992, BLOOD, V80, P1316; Willer A, 2011, BLOOD, V118, P5774, DOI 10.1182/blood-2011-07-367904; Winick N, 2011, J CLIN ONCOL S, V29, p586s; Xu H, 2012, J CLIN ONCOL, V30, P751, DOI 10.1200/JCO.2011.38.0345; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Yang W, 2010, LEUKEMIA, V24, P894, DOI 10.1038/leu.2009.277; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	142	678	713	7	155	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1943	1955		10.1016/S0140-6736(12)62187-4	http://dx.doi.org/10.1016/S0140-6736(12)62187-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23523389	Green Accepted			2022-12-28	WOS:000320319500035
J	Bryant, JM; Grogono, DM; Greaves, D; Foweraker, J; Roddick, I; Inns, T; Reacher, M; Haworth, CS; Curran, MD; Harris, SR; Peacock, SJ; Parkhill, J; Floto, RA				Bryant, Josephine M.; Grogono, Dorothy M.; Greaves, Daniel; Foweraker, Juliet; Roddick, Iain; Inns, Thomas; Reacher, Mark; Haworth, Charles S.; Curran, Martin D.; Harris, Simon R.; Peacock, Sharon J.; Parkhill, Julian; Floto, R. Andres			Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study	LANCET			English	Article							NONTUBERCULOUS MYCOBACTERIA; LUNG-TRANSPLANT; SP-NOV; MASSILIENSE; EPIDEMIOLOGY; GENE; PREVALENCE; RESISTANCE; INFECTION; BOLLETII	Background Increasing numbers of individuals with cystic fibrosis are becoming infected with the multidrug-resistant non-tuberculous mycobacterium (NTM) Mycobacterium abscessus, which causes progressive lung damage and is extremely challenging to treat. How this organism is acquired is not currently known, but there is growing concern that person-to-person transmission could occur. We aimed to define the mechanisms of acquisition of M abscessus in individuals with cystic fibrosis. Method Whole genome sequencing and antimicrobial susceptibility testing were done on 168 consecutive isolates of M abscessus from 31 patients attending an adult cystic fibrosis centre in the UK between 2007 and 2011. In parallel, we undertook detailed environmental testing for NTM and defined potential opportunities for transmission between patients both in and out of hospital using epidemiological data and social network analysis. Findings Phylogenetic analysis revealed two clustered outbreaks of near-identical isolates of the M abscessus subspecies massiliense (from 11 patients), differing by less than ten base pairs. This variation represents less diversity than that seen within isolates from a single individual, strongly indicating between-patient transmission. All patients within these clusters had numerous opportunities for within-hospital transmission from other individuals, while comprehensive environmental sampling, initiated during the outbreak, failed to detect any potential point source of NTM infection. The clusters of M abscessus subspecies massiliense showed evidence of transmission of mutations acquired during infection of an individual to other patients. Thus, isolates with constitutive resistance to amikacin and clarithromycin were isolated from several individuals never previously exposed to long-term macrolides or aminoglycosides, further indicating cross-infection. Interpretation Whole genome sequencing has revealed frequent transmission of multidrug resistant NTM between patients with cystic fibrosis despite conventional cross-infection measures. Although the exact transmission route is yet to be established, our epidemiological analysis suggests that it could be indirect.	[Grogono, Dorothy M.; Foweraker, Juliet; Haworth, Charles S.; Floto, R. Andres] Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge CB3 8RE, England; [Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Greaves, Daniel; Peacock, Sharon J.; Floto, R. Andres] Univ Cambridge, Dept Med, Cambridge CB2 0XY, England; [Curran, Martin D.] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Inns, Thomas] HPA, Norfolk, Suffolk, England; [Inns, Thomas] Hlth Protect Agcy, Field Epidemiol Training Programme, London, England	Papworth Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; Health Protection Agency; Health Protection Agency	Floto, RA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	parkhill@sanger.ac.uk; arf27@cam.ac.uk	Harris, Simon R/K-1318-2013; Grogono, Dorothy/Y-3306-2019; Peacock, Sharon J/ABE-6331-2020; Parkhill, Julian/G-4703-2011; Bryant, Josephine/ABC-8288-2021; Reacher, Mark/Y-6979-2018	Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Reacher, Mark/0000-0001-6871-7903; Bryant, Josephine/0000-0002-0149-5768; Grogono, Dorothy/0000-0002-3423-3158; Inns, Thomas/0000-0002-1218-958X; Peacock, Sharon/0000-0002-1718-2782	Illumina Inc.; Wellcome Trust [098051, 084953]; Papworth Hospital; NIHR Cambridge Biomedical Research Centre; UK Health Protection Agency; Medical Research Council; UKCRC Translational Infection Research Initiative; MRC [G1000803] Funding Source: UKRI; Medical Research Council [G1000803, 974668] Funding Source: researchfish	Illumina Inc.; Wellcome Trust(Wellcome Trust); Papworth Hospital; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKCRC Translational Infection Research Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JP has received funding for conference travel and accommodation from Illumina Inc. The other authors declare that they have no confl icts of interest.; This work was supported by The Wellcome Trust (grant numbers 098051 [JMB, SH, JP] and RAF [084953]), Papworth Hospital (DMG, CSH, JF, RAF), NIHR Cambridge Biomedical Research Centre (SP, RAF), The UK Health Protection Agency (JF, MDC, SP), Medical Research Council (JMB), and the UKCRC Translational Infection Research Initiative (SP, JP).	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; CF Foundation Patient Registry, 2011, ANN DAT REP CTR DIR; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cystic Fibrosis Trust, 2004, PSEUD AER INF PEOPL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Huang WC, 2010, J MED MICROBIOL, V59, P1203, DOI 10.1099/jmm.0.020586-0; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; Jeon K, 2009, AM J RESP CRIT CARE, V180, P896, DOI 10.1164/rccm.200905-0704OC; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; Stout JE, 2012, AM J RESP CRIT CARE, V186, P822, DOI 10.1164/rccm.201208-1500ED; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676; Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453; WENDT SL, 1980, AM REV RESPIR DIS, V122, P259; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104	36	439	450	3	85	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1551	1560		10.1016/S0140-6736(13)60632-7	http://dx.doi.org/10.1016/S0140-6736(13)60632-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23541540	Bronze, Green Published			2022-12-28	WOS:000318609600030
J	Jae, LT; Raaben, M; Riemersma, M; van Beusekom, E; Blomen, VA; Velds, A; Kerkhoven, RM; Carette, JE; Topaloglu, H; Meinecke, P; Wessels, MW; Lefeber, DJ; Whelan, SP; van Bokhoven, H; Brummelkamp, TR				Jae, Lucas T.; Raaben, Matthijs; Riemersma, Moniek; van Beusekom, Ellen; Blomen, Vincent A.; Velds, Arno; Kerkhoven, Ron M.; Carette, Jan E.; Topaloglu, Haluk; Meinecke, Peter; Wessels, Marja W.; Lefeber, Dirk J.; Whelan, Sean P.; van Bokhoven, Hans; Brummelkamp, Thijn R.			Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry	SCIENCE			English	Article							ALPHA-DYSTROGLYCAN; HUMAN-CELLS; MUTATIONS; RECEPTOR; ISPD; IDENTIFICATION; DISRUPTION; REQUIRES	Glycosylated alpha-dystroglycan (alpha-DG) serves as cellular entry receptor for multiple pathogens, and defects in its glycosylation cause hereditary Walker-Warburg syndrome (WWS). At least eight proteins are critical to glycosylate alpha-DG, but many genes mutated in WWS remain unknown. To identify modifiers of alpha-DG, we performed a haploid screen for Lassa virus entry, a hemorrhagic fever virus causing thousands of deaths annually that hijacks glycosylated alpha-DG to enter cells. In complementary screens, we profiled cells for absence of alpha-DG carbohydrate chains or biochemically related glycans. This revealed virus host factors and a suite of glycosylation units, including all known Walker-Warburg genes and five additional factors critical for the modification of alpha-DG. Our findings accentuate the complexity of this posttranslational feature and point out genes defective in dystroglycanopathies.	[Jae, Lucas T.; Blomen, Vincent A.; Velds, Arno; Kerkhoven, Ron M.; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Raaben, Matthijs; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Riemersma, Moniek; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Neurol, NL-6525 GA Nijmegen, Netherlands; [Riemersma, Moniek; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Lab Genet Endocrine & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Riemersma, Moniek; van Beusekom, Ellen; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Carette, Jan E.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Topaloglu, Haluk] Hacettepe Univ, Childrens Hosp, TR-06100 Ankara, Turkey; [Meinecke, Peter] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Wessels, Marja W.] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	Netherlands Cancer Institute; Harvard University; Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Stanford University; Hacettepe University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Erasmus University Rotterdam; Erasmus MC; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Whelan, SP (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	sean_whelan@hms.harvard.edu; H.vanBokhoven@gen.umcn.nl; t.brummelkamp@nki.nl	Jae, Lucas/AAH-5342-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Lefeber, Dirk DJ/A-2146-2014; TOPALOGLU, HALUK AYDIN/I-9318-2013; van Beusekom, Ellen/AAF-2687-2019; Jae, Lucas/AAY-3438-2021; blomen, vincent/AAE-1477-2020; van Bokhoven, Hans/D-8764-2012	Jae, Lucas/0000-0002-3531-1760; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Raaben, Matthijs/0000-0001-5989-289X; Whelan, Sean/0000-0003-1564-8590; Carette, Jan/0000-0002-5187-8070; Velds, Arno/0000-0003-4333-8872	Netherlands Genomics Initiative (NGI); Netherlands Organization for Scientific Research [Vidi-91711316]; European Research Council (ERC) [ERC- 2012-StG 309634]; Prinses Beatrix Fonds [W.OR09-15]; European Union [241995 GENCODYS]; NIH [AI081842, AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081842, R01AI081842, U54AI057159] Funding Source: NIH RePORTER	Netherlands Genomics Initiative (NGI); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission); Prinses Beatrix Fonds; European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, J. Roix, S. Mukherjee, S. Hill, and S. Nijman for discussions and S. Radoshitzky and M. Farzan for providing the plasmid encoding the LASV glycoprotein. Supported by The Netherlands Genomics Initiative (NGI), Netherlands Organization for Scientific Research (Vidi-91711316), and the European Research Council (ERC) starting grant (ERC- 2012-StG 309634) to T. R. B., Prinses Beatrix Fonds (W.OR09-15) to D. J. L. and H. V. B., European Union Framework Programme 7 Health Programme (241995 GENCODYS) to H. V. B., and NIH grants AI081842 and AI057159 to S. P. W. T. R. B. is a cofounder of Haplogen GmbH, S. P. W. is inventor on a patent describing the reverse-genetics system for VSV (International Patent no: 5,789,229), J. E. C. and T. R. B. are inventors on a patent on mutagenesis in haploid or near-haploid cells (U. S. Patent Application no: 2012/0190,011), and materials will be made available to the academic community under a Materials Transfer Agreement. The study was approved by the ethical board of the Radboud University Nijmegen Medical Centre, Commissie Mensgebonden Onderzoek Regio Arnhem-Nijmegen Approval 2011/155 (9612-1812). Deep sequencing data have been deposited in the NCBI Sequence Read Archive (www.ncbi.nlm.nih.gov/sra) under accession number SRP018361.	Buysse K., 2013, HUM MOL GENET; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hari R. J. L, 2005, CHEM BIOL HEPARIN HE; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	24	214	222	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					479	483		10.1126/science.1233675	http://dx.doi.org/10.1126/science.1233675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23519211	Green Accepted			2022-12-28	WOS:000318016700042
J	Caliskan, M; Bochkov, YA; Kreiner-Moller, E; Bonnelykke, K; Stein, MM; Du, GX; Bisgaard, H; Jackson, DJ; Gern, JE; Lemanske, RF; Nicolae, DL; Ober, C				Caliskan, Minal; Bochkov, Yury A.; Kreiner-Moller, Eskil; Bonnelykke, Klaus; Stein, Michelle M.; Du, Gaixin; Bisgaard, Hans; Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.; Nicolae, Dan L.; Ober, Carole			Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASDERMIN-LIKE GSDML; 17Q21 VARIANTS; SMOKE EXPOSURE; EXPRESSION; ORMDL3; ASSOCIATION; INFECTIONS; DISEASE; FAMILY	BACKGROUND Both genetic variation at the 17q21 locus and virus-induced respiratory wheezing illnesses are associated with the development of asthma. Our aim was to determine the effects of these two factors on the risk of asthma in the Childhood Origins of Asthma (COAST) and the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) birth cohorts. METHODS We tested genotypes at the 17q21 locus for associations with asthma and with human rhinovirus (HRV) and respiratory syncytial virus (RSV) wheezing illnesses and tested for interactions between 17q21 genotypes and HRV and RSV wheezing illnesses with respect to the risk of asthma. Finally, we examined genotype-specific expression of 17q21 genes in unstimulated and HRV-stimulated peripheral-blood mononuclear cells (PBMCs). RESULTS The 17q21 variants were associated with HRV wheezing illnesses in early life, but not with RSV wheezing illnesses. The associations of 17q21 variants with asthma were restricted to children who had had HRV wheezing illnesses, resulting in a significant interaction effect with respect to the risk of asthma. Moreover, the expression levels of ORMDL3 and of GSDMB were significantly increased in HRV-stimulated PBMCs, as compared with unstimulated PBMCs. The expression of these genes was associated with 17q21 variants in both conditions, although the increase with exposure to HRV was not genotype-specific. CONCLUSIONS Variants at the 17q21 locus were associated with asthma in children who had had HRV wheezing illnesses and with expression of two genes at this locus. The expression levels of both genes increased in response to HRV stimulation, although the relative increase was not associated with the 17q21 genotypes. (Funded by the National Institutes of Health.)	[Caliskan, Minal; Stein, Michelle M.; Du, Gaixin; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Bochkov, Yury A.; Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Med, Madison, WI USA; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Fac Hlth Sci, Gentofte, Denmark; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Bisgaard, Hans] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Copenhagen; University of Copenhagen	Caliskan, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	caliskan@uchicago.edu; c-ober@genetics.uchicago.edu	Du, Gaixin/M-9901-2014; Bisgaard, Hans/N-4761-2016	Du, Gaixin/0000-0002-4616-7725; Bisgaard, Hans/0000-0003-4131-7592; Ober, Carole/0000-0003-4626-9809; Caliskan, Minal/0000-0002-0942-7073; Nicolae, Dan/0000-0002-0918-4630; Bonnelykke, Klaus/0000-0003-2003-1018; Kreiner, Eskil/0000-0003-1204-2438; Bochkov, Yury/0000-0003-2618-4496; Stein, Michelle/0000-0002-7680-9012	National Institutes of Health [HL070831, AI070503]; KL2 from the National Institutes of Health [UL1TR00042]; Lundbeck Foundation; Danish Council for Strategic Research; Danish Pediatric Asthma Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KL2 from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Pediatric Asthma Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health.; Supported by grants (HL070831 and AI070503) from the National Institutes of Health. Dr. Jackson was supported by KL2 grant UL1TR000427 from the National Institutes of Health. The Lundbeck Foundation, Danish Council for Strategic Research, and Danish Pediatric Asthma Center provided the core funding for the COPSAC research unit.	Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Bisgaard H, 2010, BMJ-BRIT MED J, V341; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Flory JH, 2009, J ALLERGY CLIN IMMUN, V124, P605, DOI 10.1016/j.jaci.2009.05.047; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hyvarinen MK, 2005, PEDIATR PULM, V40, P316, DOI 10.1002/ppul.20273; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Smit LAM, 2010, EUR RESPIR J, V36, P57, DOI 10.1183/09031936.00154509; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; van der Valk RJP, 2012, ALLERGY, V67, P767, DOI 10.1111/j.1398-9995.2012.02819.x; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	29	341	353	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1398	1407		10.1056/NEJMoa1211592	http://dx.doi.org/10.1056/NEJMoa1211592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23534543	Green Accepted, Bronze			2022-12-28	WOS:000317333600007
J	Schmidt, H; Voigt, K; Emanuel, EJ				Schmidt, Harald; Voigt, Kristin; Emanuel, Ezekiel J.			The Ethics of Not Hiring Smokers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schmidt, Harald; Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Schmidt, Harald] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Off Vice Provost Global Initiat, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Voigt, Kristin] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Voigt, Kristin] McGill Univ, Dept Philosophy, Montreal, PQ, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; McGill University; McGill University	Schmidt, H (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.			Voigt, Kristin/0000-0002-6452-7712				Centers for Disease Control and Prevention Office on Smoking and Health and National Center for Chronic Disease Prevention and Health Promotion, SMOK TOB US FAST FAC; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Novotny T.E., 2000, TOBACCO CONTROL DEV, P287; Office on Smoking and Health, 2012, PREV TOB US YOUTH YO; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966	5	24	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1369	1371		10.1056/NEJMp1301951	http://dx.doi.org/10.1056/NEJMp1301951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122QT	23534544	Bronze			2022-12-28	WOS:000317333600001
J	Tracy, SW				Tracy, Sarah W.			HISTORY OF MEDICINE Something New under the Sun? The Mediterranean Diet and Cardiovascular Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Oklahoma, McClendon Honors Coll, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Tracy, SW (corresponding author), Univ Oklahoma, McClendon Honors Coll, Norman, OK 73019 USA.							Allbaugh LG, 1953, CRETE CASE STUDY UND; Datz T., 2011, HARVARD SERVES ITS O; GOFMAN H, 1951, LOW FAT LOW CHOLESTE; Gofman J. W., 1958, DIETARY PREVENTION T; Jacobs DR, 2007, NUTR REV, V65, P439, DOI [10.1111/j.1753-4887.2007.tb00269.x, 10.1301/nr.2007.oct.439-450]; NESTLE M, 1995, AM J CLIN NUTR, V61, p1313S, DOI 10.1093/ajcn/61.6.1313S; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673	7	18	18	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1274	1276		10.1056/NEJMp1302616	http://dx.doi.org/10.1056/NEJMp1302616			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550666				2022-12-28	WOS:000316989900003
J	McMullan, CJ; Schernhammer, ES; Rimm, EB; Hu, FB; Forman, JP				McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.			Melatonin Secretion and the Incidence of Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTED SLEEP DURATION; URINARY MELATONIN; PHYSICAL-ACTIVITY; PLASMA MELATONIN; CANCER-RISK; MELLITUS; INSULIN; VARIANTS; RECEPTOR; MTNR1B	Importance Loss-of-function mutations in the melatonin receptor are associated with insulin resistance and type 2 diabetes. Additionally, in a cross-sectional analysis of persons without diabetes, lower nocturnal melatonin secretion was associated with increased insulin resistance. Objective To study the association between melatonin secretion and the risk of developing type 2 diabetes. Design, Setting, and Participants Case-control study nested within the Nurses' Health Study cohort. Among participants without diabetes who provided urine and blood samples at baseline in 2000, we identified 370 women who developed type 2 diabetes from 2000-2012 and matched 370 controls using risk-set sampling. Main Outcome Measures Associations between melatonin secretion at baseline and incidence of type 2 diabetes were evaluated with multivariable conditional logistic regression controlling for demographic characteristics, lifestyle habits, measures of sleep quality, and biomarkers of inflammation and endothelial dysfunction. Results The median urinary ratios of 6-sulfatoxymelatonin to creatinine were 28.2 ng/mg (5%-95% range, 5.5-84.2 ng/mg) among cases and 36.3 ng/mg (5%-95% range, 6.9-110.8 ng/mg) among controls. Women with lower ratios of 6-sulfatoxymelatonin to creatinine had increased risk of diabetes (multivariable odds ratio, 1.48 [95% CI, 1.11-1.98] per unit decrease in the estimated log ratio of 6-sulfatoxymelatonin to creatinine). Compared with women in the highest ratio category of 6-sulfatoxymelatonin to creatinine, those in the lowest category had a multivariable odds ratio of 2.17 (95% CI, 1.18-3.98) of developing type 2 diabetes. Women in the highest category of melatonin secretion had an estimated diabetes incidence rate of 4.27 cases/1000 person-years compared with 9.27 cases/1000 person-years in the lowest category. Conclusions and Relevance Lower melatonin secretion was independently associated with a higher risk of developing type 2 diabetes. Further research is warranted to assess if melatonin secretion is a modifiable risk factor for diabetes within the general population. JAMA. 2013;309(13):1388-1396 www.jama.com	[McMullan, Ciaran J.; Forman, John P.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Div Renal, Boston, MA 02115 USA; [McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [McMullan, Ciaran J.; Schernhammer, Eva S.; Rimm, Eric B.; Hu, Frank B.; Forman, John P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	McMullan, CJ (corresponding author), 41 Ave Louis Pasteur,Ste 121, Boston, MA USA.	cmcmullan1@partners.org	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415	Merck; Walnut Commission; National Institutes of Health [DK58845, HL103607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	Merck(Merck & Company); Walnut Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hu reported serving as a consultant to Novo Nordisk; and receiving grants from Merck and the Walnut Commission. No other author reported disclosures.; This work was supported by National Institutes of Health grants DK58845 and HL103607.	Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Baskett JJ, 1998, J PINEAL RES, V24, P58, DOI 10.1111/j.1600-079X.1998.tb00366.x; Bertone ER, 2001, J NATL CANCER I, V93, P942, DOI 10.1093/jnci/93.12.942; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Broderick CR, 2012, JAMA-J AM MED ASSOC, V308, P1452, DOI 10.1001/jama.2012.12727; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Cuesta S, 2012, AGE DORDR; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Diethelm K, 2010, HORM RES PAEDIAT, V74, P390, DOI 10.1159/000303134; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Graham C, 1998, J PINEAL RES, V24, P230, DOI 10.1111/j.1600-079X.1998.tb00538.x; Griefahn B, 2001, ENDOCRINE, V15, P199, DOI 10.1385/ENDO:15:2:199; Hernandez C, 2007, EUR RESPIR J, V30, P496, DOI 10.1183/09031936.00051906; Hikichi T, 2011, CLIN OPHTHALMOL, V5, P655, DOI 10.2147/OPTH.S19559; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; LANG U, 1981, J CLIN ENDOCR METAB, V53, P645, DOI 10.1210/jcem-53-3-645; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mason JM, 2005, J HYPERTENS, V23, P1777, DOI 10.1097/01.hjh.0000177537.91527.09; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Peschke E, 2006, J PINEAL RES, V40, P135, DOI 10.1111/j.1600-079X.2005.00287.x; Peschke E, 2010, BEST PRACT RES CL EN, V24, P829, DOI 10.1016/j.beem.2010.09.001; Picinato MC, 2008, J PINEAL RES, V44, P88, DOI 10.1111/j.1600-079X.2007.00493.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prunet-Marcassus B, 2003, ENDOCRINOLOGY, V144, P5347, DOI 10.1210/en.2003-0693; Puchalski SS, 2003, ENDOCRINE, V21, P163, DOI 10.1385/ENDO:21:2:163; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Robeva R, 2008, J PINEAL RES, V44, P52, DOI 10.1111/j.1600-079X.2007.00527.x; Robeva R, 2006, ANDROLOGIA, V38, P216, DOI 10.1111/j.1439-0272.2006.00743.x; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Schernhammer ES, 2004, BRIT J CANCER, V90, P941, DOI 10.1038/sj.bjc.6601626; Schernhammer ES, 2009, CANCER EPIDEM BIOMAR, V18, P74, DOI 10.1158/1055-9965.EPI-08-0637; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; SHIMAKAWA T, 1993, DIABETES CARE, V16, P1356, DOI 10.2337/diacare.16.10.1356; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; WALDHAUSER F, 1985, ANN NY ACAD SCI, V453, P205, DOI 10.1111/j.1749-6632.1985.tb11811.x; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	51	215	229	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1388	1396		10.1001/jama.2013.2710	http://dx.doi.org/10.1001/jama.2013.2710			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549584	Green Accepted			2022-12-28	WOS:000316934500028
J	Treseder, KK; Holden, SR				Treseder, Kathleen K.; Holden, Sandra R.			Fungal Carbon Sequestration	SCIENCE			English	Editorial Material							LITTER DECOMPOSITION; MYCORRHIZAL FUNGI		[Treseder, Kathleen K.; Holden, Sandra R.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Treseder, KK (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	treseder@uci.edu	Treseder, Kathleen K/E-5148-2011	Treseder, Kathleen K/0000-0003-2847-6935				Allison SD, 2006, AM NAT, V167, P619, DOI 10.1086/503443; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Holden SR, 2013, ECOSYSTEMS, V16, P34, DOI 10.1007/s10021-012-9594-3; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Read DJ, 2004, CAN J BOT, V82, P1243, DOI [10.1139/b04-123, 10.1139/B04-123]; Treseder KK, 2000, NEW PHYTOL, V147, P189, DOI 10.1046/j.1469-8137.2000.00690.x; Wright SF, 1998, PLANT SOIL, V198, P97, DOI 10.1023/A:1004347701584	11	34	49	4	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1528	1529		10.1126/science.1236338	http://dx.doi.org/10.1126/science.1236338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539585				2022-12-28	WOS:000316731600026
J	Wilbanks, J				Wilbanks, John			A fool's errand	NATURE			English	Editorial Material									Sage Bionetworks, Seattle, WA 98109 USA		Wilbanks, J (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	john.wilbanks@sagebase.org		wilbanks, john/0000-0002-4510-0385					0	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					440	441		10.1038/495440a	http://dx.doi.org/10.1038/495440a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113QN	23538812	hybrid			2022-12-28	WOS:000316682800018
J	Pilling, S; Gould, N; Whittington, C; Taylor, C; Scott, S				Pilling, Stephen; Gould, Nick; Whittington, Craig; Taylor, Clare; Scott, Stephen		Guideline Dev Grp	GUIDELINES Recognition, intervention, and management of antisocial behaviour and conduct disorders in children and young people: summary of NICE-SCIE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pilling, Stephen; Whittington, Craig] UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Pilling, Stephen] UCL, Ctr Outcomes Res & Effectiveness, London WC1E 7HB, England; UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 7HB, England; [Gould, Nick] Social Care Inst Excellence, London SW1Y 5BH, England; [Gould, Nick] Univ Bath, Dept Social & Policy Sci, Bath BA2 7AY, Avon, England; [Gould, Nick] Griffith Univ, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia; [Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Scott, Stephen] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Scott, Stephen] Maudsley Hosp & Inst Psychiat, Natl Conduct Problems Clin, London BR3 3BX, England; [Scott, Stephen] Maudsley Hosp & Inst Psychiat, Natl Adopt & Fostering Clin, London BR3 3BX, England; [Scott, Stephen] Kings Coll London, Natl Acad Parenting Res, London SE5 8AF, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Bath; Griffith University; University of London; University College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London	Pilling, S (corresponding author), UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England.	s.pilling@ucl.ac.uk	Whittington, Craig/B-1380-2008	Whittington, Craig/0000-0002-1950-0334; Fonagy, Peter/0000-0003-0229-0091	National Institute for Health Research [NF-SI-0510-10228] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Barber Andrew J, 2006, J Child Health Care, V10, P9; Cohen DJ., 2006, DEV PSYCHOPATHOL, P570; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Green H., 2005, J RES SPEC EDUC NEED; National Collaborating Centre for Mental Health, 2010, ANT PERS DIS TREATM; National Collaborating Centre for Mental Health, ANT BEH COND DIS CHI; National Institute for Health and Clinical Excellence, 2013, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Scott S, 2007, BRIT MED J, V334, P646, DOI 10.1136/bmj.39161.370498.BE; Vostanis P, 2003, EUR CHILD ADOLES PSY, V12, P231, DOI 10.1007/s00787-003-0330-6	13	17	17	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f1298	10.1136/bmj.f1298	http://dx.doi.org/10.1136/bmj.f1298			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WT	23535256	Green Published			2022-12-28	WOS:000316984500002
J	Kakumanu, N; Rao, SD				Kakumanu, Naveen; Rao, Sudhaker D.			Skeletal Fluorosis Due to Excessive Tea Drinking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kakumanu, Naveen; Rao, Sudhaker D.] Henry Ford Hlth Syst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kakumanu, N (corresponding author), Henry Ford Hlth Syst, Detroit, MI 48202 USA.	srao1@hfhs.org	Rao, Sudhaker/ABG-8204-2021						0	29	31	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1140	1140		10.1056/NEJMicm1200995	http://dx.doi.org/10.1056/NEJMicm1200995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514291				2022-12-28	WOS:000316318600007
J	Lund, LH; Benson, L				Lund, Lars H.; Benson, Lina			Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PRESERVED EJECTION FRACTION; COHORT		[Lund, Lars H.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Benson, Lina] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lund, LH (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055				Feenstra H, 2001, ANN INTERN MED, V134, P569, DOI 10.7326/0003-4819-134-7-200104030-00010; Fu MQ, 2012, INT J CARDIOL, V155, P33, DOI 10.1016/j.ijcard.2011.01.081; Holland DJ, 2011, J AM COLL CARDIOL, V57, P1676, DOI 10.1016/j.jacc.2010.10.057; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Patel K, 2012, EUR J HEART FAIL, V14, P1179, DOI 10.1093/eurjhf/hfs101	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1107	1108		10.1001/jama.2013.1975	http://dx.doi.org/10.1001/jama.2013.1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512046				2022-12-28	WOS:000316276500011
J	Davidson, DJ; Andrews, J				Davidson, Debra J.; Andrews, Jeffrey			Not All About Consumption	SCIENCE			English	Editorial Material							ECONOMIC-GROWTH; OIL; POPULATION; EMISSIONS; IMPACT		[Davidson, Debra J.; Andrews, Jeffrey] Dept Resource Econ & Environm Sociol, Edmonton, AB T6G 2H1, Canada		Davidson, DJ (corresponding author), Dept Resource Econ & Environm Sociol, Edmonton, AB T6G 2H1, Canada.	debra.davidson@ualberta.ca						American Petroleum Institute, 2011, BAS PETR DAT BOOK PE, V31; [Anonymous], ST982012 EN RES CONS; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Clausen R, 2008, CONSERV BIOL, V22, P458, DOI 10.1111/j.1523-1739.2007.00851.x; Dietz T, 1997, P NATL ACAD SCI USA, V94, P175, DOI 10.1073/pnas.94.1.175; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fantazzini D, 2011, ENERG POLICY, V39, P7865, DOI 10.1016/j.enpol.2011.09.035; Jordaan SM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024004; Murphy DJ, 2011, ANN NY ACAD SCI, V1219, P52, DOI 10.1111/j.1749-6632.2010.05940.x; Ricardo D., 1966, EC ESSAYS EDITED INT; Wang JX, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014035; Yeh S, 2010, ENVIRON SCI TECHNOL, V44, P8766, DOI 10.1021/es1013278; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5	13	25	25	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1286	1287		10.1126/science.1234205	http://dx.doi.org/10.1126/science.1234205			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GC	23493704				2022-12-28	WOS:000316053400027
J	Huang, LE				Huang, L. Eric			How HIF-1 alpha Handles Stress	SCIENCE			English	Editorial Material							CELL-CYCLE ARREST; C-MYC; DNA-REPLICATION; HYPOXIA; PROLIFERATION; HIF; HIF-2-ALPHA		Univ Utah, Dept Oncol Sci, Dept Neurosurg, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Huang, LE (corresponding author), Univ Utah, Dept Oncol Sci, Dept Neurosurg, Salt Lake City, UT 84132 USA.	eric.huang@hsc.utah.edu		Huang, Eric/0000-0002-6444-1708	NCI NIH HHS [R01 CA131355] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Ilves I, 2012, P NATL ACAD SCI USA, V109, P13163, DOI 10.1073/pnas.1211525109; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; To KKW, 2006, EMBO J, V25, P4784, DOI 10.1038/sj.emboj.7601369	15	18	19	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1285	1286		10.1126/science.1236966	http://dx.doi.org/10.1126/science.1236966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493703				2022-12-28	WOS:000316053400026
J	Barnard, E; Johnston, A				Barnard, Edward; Johnston, Andrew			Blast Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barnard, Edward; Johnston, Andrew] Royal Ctr Def Med, Birmingham, W Midlands, England	Royal Centre for Defence Medicine	Barnard, E (corresponding author), Royal Ctr Def Med, Birmingham, W Midlands, England.	barnard@doctors.org.uk	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589					0	4	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1045	1045		10.1056/NEJMicm1203842	http://dx.doi.org/10.1056/NEJMicm1203842			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484831				2022-12-28	WOS:000315982100011
J	Dion, V; Gasser, SM				Dion, Vincent; Gasser, Susan M.			Chromatin Movement in the Maintenance of Genome Stability	CELL			English	Review							DOUBLE-STRAND BREAK; DNA-DAMAGE; CHROMOSOMAL TRANSLOCATIONS; POSITIONAL STABILITY; DYNAMICS; REPAIR; PROTEIN; MOTION; LOCALIZATION; ORGANIZATION	Mechanistic analyses based on improved imaging techniques have begun to explore the biological implications of chromatin movement within the nucleus. Studies in both prokaryotes and eukaryotes have shed light on what regulates the mobility of DNA over long distances. Interestingly, in eukaryotes, genomic loci increase their movement in response to double-strand break induction. Break mobility, in turn, correlates with the efficiency of repair by homologous recombination. We review here the source and regulation of DNA mobility and discuss how it can both contribute to and jeopardize genome stability.	[Dion, Vincent; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Gasser, Susan M.] Univ Basel, Fac Nat Sci, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch		Gasser, Susan/0000-0003-3610-9123; Dion, Vincent/0000-0003-4953-7637	Novartis Research Foundation; Swiss National Science Foundation; various EU Marie Curie Networks	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); various EU Marie Curie Networks	We thank Fisun Hamaratoglu, Michael Hauer, and Andrew Seeber for critical reading of the manuscript. Work in the Gasser laboratory is supported by the Novartis Research Foundation, the Swiss National Science Foundation, and various EU Marie Curie Networks.	Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; Agmon N, 2009, NUCLEIC ACIDS RES, V37, P5081, DOI 10.1093/nar/gkp495; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Aylon Y, 2003, MOL CELL BIOL, V23, P6585, DOI 10.1128/MCB.23.18.6585-6596.2003; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Berg, 2018, RANDOM WALKS BIOL; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Egecioglu D, 2011, CURR OPIN CELL BIOL, V23, P338, DOI 10.1016/j.ceb.2011.01.001; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gehlen LR, 2011, PROG THEOR PHYS SUPP, P20; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hediger F, 2006, EMBO J, V25, P857, DOI 10.1038/sj.emboj.7600976; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Neumann FR, 2012, GENE DEV, V26, P369, DOI 10.1101/gad.176156.111; Ngo HP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001072; Nielsen I, 2009, NAT METHODS, V6, P753, DOI [10.1038/NMETH.1372, 10.1038/nmeth.1372]; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Pliss A, 2009, CHROMOSOMA, V118, P459, DOI 10.1007/s00412-009-0208-6; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Savage JRK, 1996, MUTAT RES-REV GENET, V366, P81, DOI 10.1016/S0165-1110(96)90030-5; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Spehalski E, 2012, P NATL ACAD SCI USA, V109, P13728, DOI 10.1073/pnas.1202882109; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wiesmeijer K, 2008, DIFFERENTIATION, V76, P83, DOI 10.1111/j.1432-0436.2007.00234.x; WILSON JH, 1994, P NATL ACAD SCI USA, V91, P177, DOI 10.1073/pnas.91.1.177; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	81	153	158	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1355	1364		10.1016/j.cell.2013.02.010	http://dx.doi.org/10.1016/j.cell.2013.02.010			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498942	Bronze			2022-12-28	WOS:000316192500015
J	Van Bortle, K; Corces, VG				Van Bortle, Kevin; Corces, Victor G.			Spinning the Web of Cell Fate	CELL			English	Review							NUCLEAR LAMINA INTERACTIONS; HISTONE DEACETYLASE; GENOME; DIFFERENTIATION; HETEROCHROMATIN; REORGANIZATION; ORGANIZATION; METHYLATION; EXPRESSION; DROSOPHILA	Spatiotemporal changes in nuclear lamina composition underlie cell-type-specific chromatin organization and cell fate, suggesting that the lamina forms a dynamic framework critical for genome function, cellular identity, and developmental potential.	[Van Bortle, Kevin; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Corces, Victor/0000-0001-5140-4337	NIH [R01GM035463]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratory is supported by NIH award R01GM035463. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Eckersley-Maslin M.A., 2013, NUCLEUS, V4, P1; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Muck JS, 2012, J CELL BIOCHEM, V113, P2607, DOI 10.1002/jcb.24136; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051	19	17	17	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1213	1217		10.1016/j.cell.2013.02.052	http://dx.doi.org/10.1016/j.cell.2013.02.052			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498930	Bronze, Green Accepted			2022-12-28	WOS:000316192500003
J	Cimino, JJ				Cimino, James J.			Improving the Electronic Health Record-Are Clinicians Getting What They Wished For?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL RECORDS; TEACH; GUIDE		[Cimino, James J.] NIH, Lab Informat Dev, Ctr Clin, Bethesda, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Cimino, JJ (corresponding author), NIH, 10 Ctr Dr, Bethesda, MD 20852 USA.	james.cimino@nih.gov		Cimino, James/0000-0003-4101-1622	Intramural NIH HHS [Z99 CL999999] Funding Source: Medline; CLINICAL CENTER [ZIACL000904] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER		BARNETT GO, 1993, ANN INTERN MED, V119, P1046, DOI 10.7326/0003-4819-119-10-199311150-00014; Hirschtick RE, 2006, JAMA-J AM MED ASSOC, V295, P2335, DOI 10.1001/jama.295.20.2335; Hirschtick RE, 2012, JAMA-J AM MED ASSOC, V308, P463, DOI 10.1001/jama.2012.8331; Jennifer K, 2012, EHR ADOPTION MEANING; Mamykina L, 2012, J AM MED INFORM ASSN, V19, P1025, DOI 10.1136/amiajnl-2012-000901; Pitts SR, 2012, NEW ENGL J MED, V367, P2465, DOI 10.1056/NEJMp1211315; WEED LL, 1968, NEW ENGL J MED, V278, P652, DOI 10.1056/NEJM196803212781204; WEED LL, 1968, NEW ENGL J MED, V278, P593, DOI 10.1056/NEJM196803142781105; Weir CR, 2003, METHOD INFORM MED, V42, P61	9	46	46	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					991	992		10.1001/jama.2013.890	http://dx.doi.org/10.1001/jama.2013.890			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483171	Green Accepted			2022-12-28	WOS:000315938700025
J	Yasnoff, WA; Sweeney, L; Shortliffe, EH				Yasnoff, William A.; Sweeney, Latanya; Shortliffe, Edward H.			Putting Health IT on the Path to Success	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RECORDS		[Yasnoff, William A.] NHII Advisors, Arlington, VA USA; [Yasnoff, William A.] Johns Hopkins Univ, Baltimore, MD USA; [Sweeney, Latanya] Harvard Univ, Cambridge, MA 02138 USA; [Shortliffe, Edward H.] Arizona State Univ, Tempe, AZ USA; [Shortliffe, Edward H.] Columbia Univ, New York, NY USA	Johns Hopkins University; Harvard University; Arizona State University; Arizona State University-Tempe; Columbia University	Shortliffe, EH (corresponding author), Arizona State Univ, 500 N 2nd St, Phoenix, AZ 85004 USA.	ted@shortliffe.net		Shortliffe, Edward/0000-0001-5201-6176	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021726] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1237235] Funding Source: National Science Foundation; NIEHS NIH HHS [R01 ES021726] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adler-Milstein J, 2011, ANN INTERN MED, V154, P666, DOI 10.7326/0003-4819-154-10-201105170-00006; [Anonymous], HIE ARCH BUS MOD WHI; [Anonymous], ACC EL INF SHAR IMPR; Halamka JD, 2008, J AM MED INFORM ASSN, V15, P1, DOI 10.1197/jamia.M2562; Krist AH, 2011, JAMA-J AM MED ASSOC, V305, P300, DOI 10.1001/jama.2010.2011; Lapsia V, 2012, INT J MED INFORM, V81, P821, DOI 10.1016/j.ijmedinf.2012.08.008; Murphy J, 2012, AM MED INF ASS ANN C; President's Council of Advisors on Science and Technology, 2010, REAL FULL POT HLTH I, P40; Steinbrook R, 2008, NEW ENGL J MED, V358, P1653, DOI 10.1056/NEJMp0801736	9	26	26	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					989	990		10.1001/jama.2013.1474	http://dx.doi.org/10.1001/jama.2013.1474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483170	Green Accepted			2022-12-28	WOS:000315938700024
J	Wang, C; Jiang, Y; Ma, JM; Wu, HX; Wacker, D; Katritch, V; Han, GW; Liu, W; Huang, XP; Vardy, E; McCorvy, JD; Gao, X; Zhou, XE; Melcher, K; Zhang, CH; Bai, F; Yang, HY; Yang, LL; Jiang, HL; Roth, BL; Cherezov, V; Stevens, RC; Xu, HE				Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Bai, Fang; Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.; Xu, H. Eric			Structural Basis for Molecular Recognition at Serotonin Receptors	SCIENCE			English	Article							AGONIST; FENFLURAMINE; PHARMACOLOGY; MUTATION; LIGANDS; TARGETS; BINDING	Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiology through the 5-HT receptor family. We report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine. The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops. The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT. Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity. Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.	[Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Jiang, Yi; Zhang, Chenghai; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Mat Med Ctr, Van Andel Res Inst,CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Ma, Jinming; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, NIMH,Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA; [Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Bai, Fang] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, State Key Lab Technol, Dept Engn Mech, Dalian 116023, Peoples R China; [Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Dalian University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu; eric.xu@vai.org	Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLT-1531-2022; Roth, Bryan L/F-3928-2010; Ma, Jinming/D-5613-2015; Ma, Jinming/N-3704-2014; Stevens, Raymond/K-7272-2015; Roth, Bryan/ABE-7032-2020; Melcher, Karsten/AAZ-3861-2020; Katritch, Vsevolod/Y-2721-2019; Xu, H. Eric/ABD-7487-2021; Wu, Huixian/N-6353-2014; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022	Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Ma, Jinming/0000-0002-0019-8219; Ma, Jinming/0000-0002-7171-1059; Stevens, Raymond/0000-0002-4522-8725; Roth, Bryan/0000-0002-0561-6520; Melcher, Karsten/0000-0002-9125-4027; Wu, Huixian/0000-0003-1357-9747; Han, Gye Won/0000-0003-4107-835X; Xu, H. Eric/0000-0002-6829-8144; Bai, Fang/0000-0003-1468-5568	National Institute of General Medical Sciences (NIGMS) PSI: Biology grant [U54 GM094618, GPCR-118]; NIH Common Fund in Structural Biology grant [P50 GM073197]; Jay and Betty Van Andel Foundation [R01 DK071662]; Ministry of Science and Technology (China) [2012ZX09301001-005, 2012CB910403]; Amway (China) [R01 MH61887, U19 MH82441, R01 DA27170]; National Institute of Mental Health Psychoactive Drug Screening Program; Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; Office of Science of the U.S. Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) PSI: Biology grant; NIH Common Fund in Structural Biology grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Ministry of Science and Technology (China)(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); Amway (China); National Institute of Mental Health Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; Boehringer Ingelheim Fonds Ph.D. Fellowship(Boehringer Ingelheim); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of General Medical Sciences (NIGMS) PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-118) (V. K., V. C., and R. C. S.); NIH Common Fund in Structural Biology grant P50 GM073197 for technology development (V. C. and R. C. S.); the Jay and Betty Van Andel Foundation, R01 DK071662, Ministry of Science and Technology (China) grants 2012ZX09301001-005 and 2012CB910403, and Amway (China) (H. E. X.); R01 MH61887, U19 MH82441, R01 DA27170, and the National Institute of Mental Health Psychoactive Drug Screening Program (X.-P. H., E. V., J.D.M., and B. L. R.); and the Michael Hooker Chair of Pharmacology (B. L. R.). D. W. is supported by a Boehringer Ingelheim Fonds Ph.D. Fellowship. We thank J. Velasquez for help on molecular biology; T. Trinh, K. Allin, and M. Chu for help on baculovirus expression; I. Wilson for careful review and scientific feedback on the manuscript; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source (APS), which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104; and Z. Wawrzak and J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (Life Sciences Collaborative Access Team), which is funded in part by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817. Use of the APS was supported by the Office of Science of the U.S. Department of Energy. The coordinates and the structure factors have been deposited in the Protein Data Bank (PDB) under accession codes 4IAR (5-HT<INF>1B</INF>/ERG) and 4IAQ (5-HT<INF>1B</INF>/DHE). R.C.S. is a founder and paid consultant for Receptos, a GPCR structure-based drug discovery company.	ADHAM N, 1994, NEUROPHARMACOLOGY, V33, P387, DOI 10.1016/0028-3908(94)90068-X; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Braden MR, 2007, MOL PHARMACOL, V72, P1200, DOI 10.1124/mol.107.039255; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Goldenberg Marvin M, 2012, P T, V37, P499; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; HOYER D, 1994, PHARMACOL REV, V46, P157; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Mehrotra S, 2008, N-S ARCH PHARMACOL, V378, P371, DOI 10.1007/s00210-008-0322-7; NELSON DL, 1993, J PHARMACOL EXP THER, V265, P1272; OKSENBERG D, 1992, NATURE, V360, P161, DOI 10.1038/360161a0; Roth BL, 2004, PSYCHOPHARMACOLOGY, V174, P17, DOI 10.1007/s00213-003-1683-8; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2002, ANN INTERN MED, V136, P779, DOI 10.7326/0003-4819-136-10-200205210-00016; Rothman RB, 2002, PHARMACOL BIOCHEM BE, V71, P825, DOI 10.1016/S0091-3057(01)00669-4; Rothman RB, 2000, CIRCULATION, V102, P2836; Setola V, 2005, MOL PHARMACOL, V68, P20, DOI 10.1124/mol.104.009266; Shapiro DA, 2000, MOL PHARMACOL, V58, P877, DOI 10.1124/mol.58.5.877; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Villalon Carlos M., 2003, Current Vascular Pharmacology, V1, P71, DOI 10.2174/1570161033386826; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	27	372	381	8	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					610	614		10.1126/science.1232807	http://dx.doi.org/10.1126/science.1232807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23519210	Green Accepted, Green Submitted			2022-12-28	WOS:000318268900048
J	Southworth, MR; Reichman, ME; Unger, EF				Southworth, Mary Ross; Reichman, Marsha E.; Unger, Ellis F.			Dabigatran and Postmarketing Reports of Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Southworth, Mary Ross; Reichman, Marsha E.; Unger, Ellis F.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Southworth, MR (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; FDA Drug Safety Communication, FDA DRUG SAF COMM SA; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1	4	277	287	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1272	1274		10.1056/NEJMp1302834	http://dx.doi.org/10.1056/NEJMp1302834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23484796				2022-12-28	WOS:000316989900002
J	Murdoch, TB; Detsky, AS				Murdoch, Travis B.; Detsky, Allan S.			The Inevitable Application of Big Data to Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Murdoch, Travis B.] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Charles D., 2012, ELECT HLTH RECORD SY; Grimes S, 2008, UNSTRUCTURED DATA 80; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Reis BY, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3677; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273	7	862	891	11	508	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1351	1352		10.1001/jama.2013.393	http://dx.doi.org/10.1001/jama.2013.393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549579				2022-12-28	WOS:000316934500021
J	Chatterjee, S; Riaz, H				Chatterjee, Subhankar; Riaz, Haris			PUBLIC HEALTH Death by insecticide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PESTICIDE; PREVENTION; MANAGEMENT		[Chatterjee, Subhankar] RG Kar Med Coll & Hosp, Kolkata, India; [Riaz, Haris] Dow Univ Hlth Sci, Karachi, Pakistan	RG Kar Medical College & Hospital; Dow University of Health Sciences	Riaz, H (corresponding author), Dow Univ Hlth Sci, Karachi, Pakistan.	harisriaz73@yahoo.com						[Anonymous], 2013, BUSINESS STANDARD; Balali-Mood M, 2012, IRAN J MED SCI, V37, P74; Bigbee JW, 2000, BRAIN RES, V861, P354, DOI 10.1016/S0006-8993(00)02046-1; Burgess JL, 1999, ANN EMERG MED, V34, P205, DOI 10.1016/S0196-0644(99)70230-1; Dash SK, 2008, MED SCI LAW, V48, P241, DOI 10.1258/rsmmsl.48.3.241; Dharmani Chandrabhan, 2005, Reviews on Environmental Health, V20, P215; Eddleston M, 2004, J TOXICOL-CLIN TOXIC, V42, P865, DOI 10.1081/CLT-200035223; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Eddleston M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000104; Goel A, 2007, NATL MED J INDIA, V20, P182; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; MCCONNELL R, 1993, AM J PUBLIC HEALTH, V83, P1559, DOI 10.2105/AJPH.83.11.1559; Paudyal BP, 2008, J NEPAL MED ASSOC, V47, P251; Rao CS, 2005, TROP MED INT HEALTH, V10, P581, DOI 10.1111/j.1365-3156.2005.01412.x; Ravi G, 2007, 6 ANN C AS PAC ASS M; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Singh S, 2000, NEUROL INDIA, V48, P308; Stone DL, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-18; Sudakin DL, 2007, J TOXICOL ENV HEAL A, V70, P141, DOI 10.1080/15287390600755224; Times of India, 2013, TIMES INDIA 0916; van Heel W, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-32; ZWIENER RJ, 1988, PEDIATRICS, V81, P121	23	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f2029	10.1136/bmj.f2029	http://dx.doi.org/10.1136/bmj.f2029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23539101				2022-12-28	WOS:000316986200016
J	Svejstrup, JQ				Svejstrup, Jesper Q.			Synovial Sarcoma Mechanisms: A Series of Unfortunate Events	CELL			English	Editorial Material								Human synovial sarcoma is caused by a chromosome translocation, which fuses DNA encoding SSX to that encoding the SS18 protein. Kadoch and Crabtree now show that the resulting cellular transformation stems from disruption of the normal architecture and function of the human SWI/SNF (BAF) complex.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Svejstrup, Jesper/0000-0003-4964-6147	Cancer Research UK [11567] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Saha S., 2005, FUSION PROTEINS DIS; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Taki T, 2006, CURR OPIN ONCOL, V18, P62, DOI 10.1097/01.cco.0000198972.69541.04; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585	7	8	10	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					11	12		10.1016/j.cell.2013.03.015	http://dx.doi.org/10.1016/j.cell.2013.03.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540685	Bronze			2022-12-28	WOS:000316853700001
J	Kramer, CK; Zinman, B; Gross, JL; Canani, LH; Rodrigues, TC; Azevedo, MJ; Retnakaran, R				Kramer, Caroline K.; Zinman, Bernard; Gross, Jorge L.; Canani, Luis H.; Rodrigues, Ticiana C.; Azevedo, Mirela J.; Retnakaran, Ravi			Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-DISEASE; ASYMPTOMATIC INDIVIDUALS; RISK CLASSIFICATION; METABOLIC SYNDROME; PUBLICATION BIAS; PROGRESSION; CT; CALCIFICATION; ASSOCIATION	Objective To investigate the association of coronary artery calcium score with all cause mortality and cardiovascular events in people with type 2 diabetes. Design Systematic review and meta-analysis of observational studies. Data sources Studies were identified from Embase, PubMed, and abstracts from the 2011 and 2012 annual meetings of the American Diabetes Association, European Association for the Study of Diabetes, American College of Cardiology, and American Heart Association (2011). Eligibility criteria Prospective studies that evaluated baseline coronary artery calcium score in people with type 2 diabetes and subsequent all cause mortality or cardiovascular events (fatal and non-fatal). Data extraction Two independent reviewers extracted the data. The predictive value of the coronary artery calcium score was assessed by random effects model. Results Eight studies were included (n=6521; 802 events; mean follow-up 5.18 years). The relative risk for all cause mortality or cardiovascular events, or both comparing a total coronary artery calcium score of >= 10 with a score of <10 was 5.47 (95% confidence interval 2.59 to 11.53; I-2=82.4%, P<0.001). The overall sensitivity of a total coronary artery calcium score of >= 10 for this composite outcome was 94% (95% confidence interval 89% to 96%), with a specificity of 34% (24% to 44%). The positive and negative likelihood ratios were 1.41 (95% confidence interval 1.20 to 1.66) and 0.18 (0.10 to 0.30), respectively. For people with a coronary artery calcium score of <10, the post-test probability of the composite outcome was about 1.8%, representing a 6.8-fold reduction from the pretest probability. Four studies evaluated cardiovascular events as the outcome (n=1805; 351 events). The relative risk for cardiovascular events comparing a total coronary artery calcium score of >= 10 with a score of <10 was 9.22 (2.73 to 31.07; I-2=76.7%, P=0.005). The positive and negative likelihood ratios were 1.67 (1.30 to 2.17) and 0.11 (0.04 to 0.29), respectively. Conclusion In people with type 2 diabetes, a coronary artery calcium score of >= 10 predicts all cause mortality or cardiovascular events, or both, and cardiovascular events alone, with high sensitivity but low specificity. Clinically, the finding of a coronary artery calcium score of <10 may facilitate risk stratification by enabling the identification of people at low risk within this high risk population.	[Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON M5T 3L9, Canada; [Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Zinman, Bernard; Retnakaran, Ravi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Gross, Jorge L.; Canani, Luis H.; Rodrigues, Ticiana C.; Azevedo, Mirela J.] Univ Fed Rio Grande do Sul, Div Endocrinol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universidade Federal do Rio Grande do Sul	Retnakaran, R (corresponding author), Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St,Suite L5-025,Mailbox 21, Toronto, ON M5T 3L9, Canada.	rretnakaran@mtsinai.on.ca	Canani, Luis H/G-9686-2012; Retnakaran, Ravi/P-2002-2015; Kramer, Caroline K/L-9093-2018; Zinman, Bernard/E-7266-2013; Rodrigues, Ticiana C/V-9858-2019	Canani, Luis H/0000-0002-1813-4491; Retnakaran, Ravi/0000-0003-1989-027X; 	Canadian Diabetes Association; Sam and Judy Pencer family chair in diabetes research at Mount Sinai Hospital; University of Toronto; Ontario Ministry of Research and Innovation; Leadership Sinai Centre for Diabetes	Canadian Diabetes Association; Sam and Judy Pencer family chair in diabetes research at Mount Sinai Hospital; University of Toronto(University of Toronto); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Leadership Sinai Centre for Diabetes	CKK holds a Canadian Diabetes Association postdoctoral fellowship award. BZ holds the Sam and Judy Pencer family chair in diabetes research at Mount Sinai Hospital and the University of Toronto. RR holds an Ontario Ministry of Research and Innovation early researcher award. The study was supported by intramural funds from the Leadership Sinai Centre for Diabetes. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Agarwal S, 2011, DIABETES CARE, V34, P1219, DOI 10.2337/dc11-0008; Anand DV, 2006, EUR HEART J, V27, P713, DOI 10.1093/eurheartj/ehi808; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Broderick LS, 1996, AM J ROENTGENOL, V167, P439, DOI 10.2214/ajr.167.2.8686622; Chiu YW, 2010, KIDNEY INT, V77, P1107, DOI 10.1038/ki.2010.70; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dora JM, 2008, DIABETES CARE, V31, pe45; Dora Jose Miguel, 2008, Diabetes Care, V31, pe45, DOI 10.2337/dc08-0109; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Einstein AJ, 2009, NAT REV CARDIOL, V6, P436, DOI 10.1038/nrcardio.2009.53; Elkeles RS, 2008, EUR HEART J, V29, P2244, DOI 10.1093/eurheartj/ehn279; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Gilbert J, 2004, DIABETES CARE, V27, P990, DOI 10.2337/diacare.27.4.990; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2010, JAMA-J AM MED ASSOC, V303, P1646, DOI 10.1001/jama.2010.503; Jassal SK, 2012, AM J CARDIOL, V110, P1425, DOI 10.1016/j.amjcard.2012.06.053; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kramer CK, 2011, OBES REV, V12, pe338, DOI 10.1111/j.1467-789X.2010.00846.x; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Kramer CK, 2009, J CLIN ENDOCR METAB, V94, P5039, DOI 10.1210/jc.2009-1497; Kramer CK, 2009, DIABETES CARE, V32, P141, DOI 10.2337/dc08-1360; Kramer CK, 2013, LANCET DIABETES ENDO; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Malik S, 2011, DIABETES CARE, V34, P2285, DOI 10.2337/dc11-0816; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Orakzai RH, 2008, AM J CARDIOL, V101, P999, DOI 10.1016/j.amjcard.2007.11.059; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2005, HYPERTENSION, V46, P238, DOI 10.1161/01.HYP.0000164575.16609.02; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Rana JS, 2012, DIABETES CARE, V35, P1787, DOI 10.2337/dc11-2403; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; SHEMESH J, 1995, RADIOLOGY, V197, P779, DOI 10.1148/radiology.197.3.7480756; Shemesh J, 2012, AM J CARDIOL, V109, P844, DOI 10.1016/j.amjcard.2011.10.047; Silverman MG, 2012, DIABETES CARE, V35, P624, DOI 10.2337/dc11-1773; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	47	78	79	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2013	346								f1654	10.1136/bmj.f1654	http://dx.doi.org/10.1136/bmj.f1654			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117VT	23529983	hybrid, Green Published			2022-12-28	WOS:000316981900002
J	Olotu, A; Fegan, G; Wambua, J; Nyangweso, G; Awuondo, KO; Leach, A; Lievens, M; Leboulleux, D; Njuguna, P; Peshu, N; Marsh, K; Bejon, P				Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Awuondo, Ken O.; Leach, Amanda; Lievens, Marc; Leboulleux, Didier; Njuguna, Patricia; Peshu, Norbert; Marsh, Kevin; Bejon, Philip			Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE EFFICACY; CHILDREN	BACKGROUND The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but data on long-term outcomes are limited. METHODS For 4 years, we followed children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of RTS,S/AS01E vaccine (223 children) or rabies vaccine (224 controls). The end point was clinical malaria (temperature of >= 37.5 degrees C and Plasmodium falciparum parasitemia density of >2500 parasites per cubic millimeter). Each child's exposure to malaria was estimated with the use of the distance-weighted local prevalence of malaria. RESULTS Over a period of 4 years, 118 of 223 children who received the RTS,S/AS01E vaccine and 138 of 224 of the controls had at least 1 episode of clinical malaria. Vaccine efficacies in the intention-to-treat and per-protocol analyses were 29.9% (95% confidence interval [CI], 10.3 to 45.3; P = 0.005) and 32.1% (95% CI, 11.6 to 47.8; P = 0.004), respectively, calculated by Cox regression. Multiple episodes were common, with 551 and 618 malarial episodes in the RTS,S/AS01E and control groups, respectively; vaccine efficacies in the intention-to-treat and per-protocol analyses were 16.8% (95% CI, -8.6 to 36.3; P = 0.18) and 24.3% (95% CI, 1.9 to 41.6; P = 0.04), respectively, calculated by the Andersen-Gill extension of the Cox model. For every 100 vaccinated children, 65 cases of clinical malaria were averted. Vaccine efficacy declined over time (P = 0.004) and with increasing exposure to malaria (P = 0.001) in the per-protocol analysis. Vaccine efficacy was 43.6% (95% CI, 15.5 to 62.3) in the first year but was -0.4% (95% CI, -32.1 to 45.3) in the fourth year. Among children with a malaria-exposure index that was average or lower than average, the vaccine efficacy was 45.1% (95% CI, 11.3 to 66.0), but among children with a malaria-exposure index that was higher than average it was 15.9% (95% CI, -11.0 to 36.4). CONCLUSIONS The efficacy of RTS,S/AS01E vaccine over the 4-year period was 16.8%. Efficacy declined over time and with increasing malaria exposure. (Funded by the PATH Malaria Vaccine Initiative and Wellcome Trust; ClinicalTrials.gov number, NCT00872963.)	[Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Awuondo, Ken O.; Njuguna, Patricia; Peshu, Norbert; Marsh, Kevin; Bejon, Philip] Wellcome Trust Res Programme, Kenya Med Res Inst KEMRI, Ctr Geog Med Res, Kilifi, Kenya; [Fegan, Gregory; Marsh, Kevin; Bejon, Philip] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Leach, Amanda; Lievens, Marc] GlaxoSmithKline Biol, Wavre, Belgium; [Leboulleux, Didier] Malaria Vaccine Initiat, Program Appropriate Technol Hlth PATH, Bethesda, MD USA	Kenya Medical Research Institute; University of Oxford; GlaxoSmithKline	Olotu, A (corresponding author), KEMRI Wellcome Trust Res Programme, POB 230, Kilifi, Kenya.	aolotu@kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Leach, Amanda/AAS-1120-2020	Fegan, Greg W/0000-0002-2663-2765; Leach, Amanda/0000-0002-7114-9967	Program for Appropriate Technology in Health Malaria Vaccine Initiative; Wellcome Trust; Medical Research Council [G1002624] Funding Source: researchfish; MRC [G1002624] Funding Source: UKRI	Program for Appropriate Technology in Health Malaria Vaccine Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Program for Appropriate Technology in Health Malaria Vaccine Initiative and the Wellcome Trust.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Cheung YB, 2010, STAT MED, V29, P328, DOI 10.1002/sim.3783; Duncan CJA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7728; Greenwood B, 2005, CLIN INFECT DIS, V40, P1519, DOI 10.1086/429833; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; WHO, 2011, WORLD MALARIA REPORT 2011, P1	16	184	193	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1111	1120		10.1056/NEJMoa1207564	http://dx.doi.org/10.1056/NEJMoa1207564			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514288	Green Accepted, Bronze			2022-12-28	WOS:000316318600004
J	Kildishev, AV; Boltasseva, A; Shalaev, VM				Kildishev, Alexander V.; Boltasseva, Alexandra; Shalaev, Vladimir M.			Planar Photonics with Metasurfaces	SCIENCE			English	Review							VARIANT SUBWAVELENGTH GRATINGS; BROAD-BAND; PLASMONIC METASURFACES; ELECTROMAGNETIC-FIELDS; OPTICAL METAMATERIALS; PHASE DISCONTINUITIES; PANCHARATNAM PHASE; LIGHT; REFRACTION; REFLECTION	Metamaterials, or engineered materials with rationally designed, subwavelength-scale building blocks, allow us to control the behavior of physical fields in optical, microwave, radio, acoustic, heat transfer, and other applications with flexibility and performance that are unattainable with naturally available materials. In turn, metasurfaces-planar, ultrathin metamaterials-extend these capabilities even further. Optical metasurfaces offer the fascinating possibility of controlling light with surface-confined, flat components. In the planar photonics concept, it is the reduced dimensionality of the optical metasurfaces that enables new physics and, therefore, leads to functionalities and applications that are distinctly different from those achievable with bulk, multilayer metamaterials. Here, we review the progress in developing optical metasurfaces that has occurred over the past few years with an eye toward the promising future directions in the field.	[Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shalaev, VM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	shalaev@purdue.edu	Kildishev, Alexander V/GSN-3724-2022; Kildishev, Alexander V./L-5725-2019; Boltasseva, Alexandra/C-1674-2019; Shalaev, Vladimir M./B-9331-2019	Kildishev, Alexander V/0000-0002-8382-8422; Kildishev, Alexander V./0000-0002-8382-8422; Boltasseva, Alexandra/0000-0001-8905-2605; Shalaev, Vladimir M./0000-0001-8976-1102	Air Force Office of Scientific Research [FA9550-12-1-0024]; U.S. Army Research Office [57981-PH (W911NF-11-1-0359)]; NSF [DMR-1120923, 1205457]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Army Research Office; NSF(National Science Foundation (NSF))	We thank A. Sokolov, X. Ni, and G. Naik for useful discussions. This work was partially supported by Air Force Office of Scientific Research grant FA9550-12-1-0024, U.S. Army Research Office grant 57981-PH (W911NF-11-1-0359), NSF grant DMR-1120923, and NSF award Meta-PREM no. 1205457.	Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Aieta F, 2012, NANO LETT, V12, P1702, DOI 10.1021/nl300204s; BERRY MV, 1987, J MOD OPTIC, V34, P1401, DOI 10.1080/09500348714551321; Biener G, 2005, OPT LETT, V30, P1096, DOI 10.1364/OL.30.001096; Blanchard R, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155457; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Caiazzo M, 2004, IEEE ANTENN WIREL PR, V3, P261, DOI 10.1109/LAWP.2004.836576; Engheta N, 2011, SCIENCE, V334, P317, DOI 10.1126/science.1213278; Fan PY, 2012, NAT PHOTONICS, V6, P380, DOI [10.1038/NPHOTON.2012.108, 10.1038/nphoton.2012.108]; Feigenbaum E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.147402; Genevet P, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673334; Gorodetski Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.013901; Gorodetski Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125433; Hasman E, 2003, APPL PHYS LETT, V82, P328, DOI 10.1063/1.1539300; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Holloway CL, 2008, IET MICROW ANTENNA P, V2, P120, DOI 10.1049/iet-map:20060309; Holloway CL, 2005, IEEE T ELECTROMAGN C, V47, P853, DOI 10.1109/TEMC.2005.853719; Jacob Z, 2010, APPL PHYS B-LASERS O, V100, P215, DOI 10.1007/s00340-010-4096-5; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Jacob Z, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4710548; Jacob Z, 2011, SCIENCE, V334, P463, DOI 10.1126/science.1211736; Jacob Z, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3037208; Kang M, 2012, OPT EXPRESS, V20, P15882, DOI 10.1364/OE.20.015882; Krishnamoorthy HNS, 2012, SCIENCE, V336, P205, DOI 10.1126/science.1219171; Kuester EF, 2003, IEEE T ANTENN PROPAG, V51, P2641, DOI 10.1109/TAP.2003.817560; Larouche S, 2012, OPT LETT, V37, P2391, DOI 10.1364/OL.37.002391; Larouche S, 2012, NAT MATER, V11, P450, DOI [10.1038/NMAT3278, 10.1038/nmat3278]; Levy U, 2005, OPT LETT, V30, P2089, DOI 10.1364/OL.30.002089; Litchinitser NM, 2012, SCIENCE, V337, P1054, DOI 10.1126/science.1226204; Liu YM, 2010, NANO LETT, V10, P1991, DOI 10.1021/nl1008019; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Naik GV, 2012, P NATL ACAD SCI USA, V109, P8834, DOI 10.1073/pnas.1121517109; Naik GV, 2012, OPT MATER EXPRESS, V2, P478, DOI 10.1364/OME.2.000478; Naik GV, 2011, OPT MATER EXPRESS, V1, P1090, DOI 10.1364/OME.1.001090; Ni XJ, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.28; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Niv A, 2005, OPT COMMUN, V251, P306, DOI 10.1016/j.optcom.2005.03.002; Niv A, 2006, OPT EXPRESS, V14, P4208, DOI 10.1364/OE.14.004208; Noginov MA, 2010, OPT LETT, V35, P1863, DOI 10.1364/OL.35.001863; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; Papakostas A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.107404; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pozar DM, 1997, IEEE T ANTENN PROPAG, V45, P287, DOI 10.1109/8.560348; Prosvirnin SL, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/7/074002; Prosvirnin SL, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037603; Ryan CGM, 2010, IEEE T ANTENN PROPAG, V58, P1486, DOI 10.1109/TAP.2010.2044356; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Shitrit N, 2011, NANO LETT, V11, P2038, DOI 10.1021/nl2004835; Shu WX, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063840; Sievenpiper D, 1999, IEEE T MICROW THEORY, V47, P2059, DOI 10.1109/22.798001; Smith DR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.077405; Soukoulis CM, 2010, SCIENCE, V330, P1633, DOI 10.1126/science.1198858; Sun SL, 2012, NAT MATER, V11, P426, DOI [10.1038/nmat3292, 10.1038/NMAT3292]; Svirko Y, 2001, APPL PHYS LETT, V78, P498, DOI 10.1063/1.1342210; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Walther B, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3587622; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Xiao SM, 2010, NATURE, V466, P735, DOI 10.1038/nature09278; Yang XD, 2012, NAT PHOTONICS, V6, P450, DOI [10.1038/nphoton.2012.124, 10.1038/NPHOTON.2012.124]; Yu NF, 2012, NANO LETT, V12, P6328, DOI 10.1021/nl303445u; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1877; Zhao Y., 2011, METAMATERIALS, V5, P90, DOI DOI 10.1016/J.METMAT.2011.05.001; Zhao Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205428; Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]	66	2036	2105	175	1949	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125							1232009	10.1126/science.1232009	http://dx.doi.org/10.1126/science.1232009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493714				2022-12-28	WOS:000316053400029
J	Bamji, A				Bamji, Andrew			The art of medicine Faces of war	LANCET			English	Editorial Material									British Assoc Plast Reconstruct & Aesthet Surg, Rye TN31 7ES, England		Bamji, A (corresponding author), British Assoc Plast Reconstruct & Aesthet Surg, Norman House,West St, Rye TN31 7ES, England.	bamji@btinternet.com							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 2	2013	381	9868					718	719		10.1016/S0140-6736(13)60570-X	http://dx.doi.org/10.1016/S0140-6736(13)60570-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23479808	Bronze			2022-12-28	WOS:000315570900013
J	Gerlach, C; Rohr, JC; Perie, L; van Rooij, N; van Heijst, JWJ; Velds, A; Urbanus, J; Naik, SH; Jacobs, H; Beltman, JB; de Boer, RJ; Schumacher, TNM				Gerlach, Carmen; Rohr, Jan C.; Perie, Leila; van Rooij, Nienke; van Heijst, Jeroen W. J.; Velds, Arno; Urbanus, Jos; Naik, Shalin H.; Jacobs, Heinz; Beltman, Joost B.; de Boer, Rob J.; Schumacher, Ton N. M.			Heterogeneous Differentiation Patterns of Individual CD8(+) T Cells	SCIENCE			English	Article							INFECTION; EFFECTOR; FATES; ACTIVATION; PRECURSOR; DIVISION; SUBSETS	Upon infection, antigen-specific CD8(+) T lymphocyte responses display a highly reproducible pattern of expansion and contraction that is thought to reflect a uniform behavior of individual cells. We tracked the progeny of individual mouse CD8(+) T cells by in vivo lineage tracing and demonstrated that, even for T cells bearing identical T cell receptors, both clonal expansion and differentiation patterns are heterogeneous. As a consequence, individual naive T lymphocytes contributed differentially to short-and long-term protection, as revealed by participation of their progeny during primary versus recall infections. The discordance in fate of individual naive T cells argues against asymmetric division as a singular driver of CD8(+) T cell heterogeneity and demonstrates that reproducibility of CD8(+) T cell responses is achieved through population averaging.	[Gerlach, Carmen; Rohr, Jan C.; Perie, Leila; van Rooij, Nienke; van Heijst, Jeroen W. J.; Urbanus, Jos; Naik, Shalin H.; Beltman, Joost B.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Rohr, Jan C.] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Rohr, Jan C.] Univ Freiburg, D-79106 Freiburg, Germany; [Perie, Leila; Beltman, Joost B.; de Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands; [Velds, Arno] Netherlands Canc Inst, Cent Genom Facil, NL-1066 CX Amsterdam, Netherlands; [Jacobs, Heinz] Netherlands Canc Inst, Div Biol Stress Responses, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; University of Freiburg; University of Freiburg; Utrecht University; Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	de Boer, Rob/B-6050-2011; Naik, Shalin/AFD-5605-2022; Schumacher, Ton/Y-2432-2019	de Boer, Rob/0000-0002-2130-691X; Schumacher, Ton/0000-0003-0517-8804; Jacobs, Heinz/0000-0001-6227-9850; Velds, Arno/0000-0003-4333-8872; Perie, Leila/0000-0003-0798-4498; Naik, Shalin/0000-0003-0299-3301; Gerlach, Carmen/0000-0001-7889-2393	European Research Council AdG Life-his-T; Walter-Hitzig fellowship from the CCI [BMBF 01EO0803]; Deutsche Forschungsgemeinschaft [DFG RO 4120/1-1]; Marie Curie Intra European Fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant [916.86.080]; Leukemia and Lymphoma Society Career Development Fellowship	European Research Council AdG Life-his-T; Walter-Hitzig fellowship from the CCI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Intra European Fellowship(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant; Leukemia and Lymphoma Society Career Development Fellowship(Leukemia and Lymphoma Society)	The authors thank A. Pfauth and F. van Diepen for cell sorting; E. Borg for technical assistance; D. Zehn for provision of LM-OVA (T4); S. Harkema for helpful discussions; and G. Bendle, M. C. Wolkers, and E. A. Moseman for critically reading the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The authors declare no conflict of interest. This research was funded by European Research Council AdG Life-his-T to T.N.M.S., a Walter-Hitzig fellowship from the CCI (BMBF 01EO0803), a Deutsche Forschungsgemeinschaft (DFG RO 4120/1-1) research fellowship to J.C.R., a Marie Curie Intra European Fellowship to L. P., a Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni grant (916.86.080) to J.B.B., and a Leukemia and Lymphoma Society Career Development Fellowship to S.H.N.	Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schlub TE, 2009, EUR J IMMUNOL, V39, P67, DOI 10.1002/eji.200838554; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	18	245	250	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					635	639		10.1126/science.1235487	http://dx.doi.org/10.1126/science.1235487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23493421				2022-12-28	WOS:000318268900054
J	Tannahill, GM; Curtis, AM; Adamik, J; Palsson-McDermott, EM; McGettrick, AF; Goel, G; Frezza, C; Bernard, NJ; Kelly, B; Foley, NH; Zheng, L; Gardet, A; Tong, Z; Jany, SS; Corr, SC; Haneklaus, M; Caffrey, BE; Pierce, K; Walmsley, S; Beasley, FC; Cummins, E; Nizet, V; Whyte, M; Taylor, CT; Lin, H; Masters, SL; Gottlieb, E; Kelly, VP; Clish, C; Auron, PE; Xavier, RJ; O'Neill, LAJ				Tannahill, G. M.; Curtis, A. M.; Adamik, J.; Palsson-McDermott, E. M.; McGettrick, A. F.; Goel, G.; Frezza, C.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Zheng, L.; Gardet, A.; Tong, Z.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Caffrey, B. E.; Pierce, K.; Walmsley, S.; Beasley, F. C.; Cummins, E.; Nizet, V.; Whyte, M.; Taylor, C. T.; Lin, H.; Masters, S. L.; Gottlieb, E.; Kelly, V. P.; Clish, C.; Auron, P. E.; Xavier, R. J.; O'Neill, L. A. J.			Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha	NATURE			English	Article							RECEPTOR GPR91; HYPOXIA; ACTIVATION; LINKS; INHIBITION; METABOLISM; MECHANISM; PROMOTER; MUTATION; PROVIDES	Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis(1). Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1 beta but not tumour-necrosis factor-a in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and down-regulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (gamma-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1 alpha, an effect that is inhibited by 2-deoxyglucose, with interleukin-1 beta as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1 beta production during inflammation.	[Tannahill, G. M.; Curtis, A. M.; Palsson-McDermott, E. M.; McGettrick, A. F.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Kelly, V. P.; O'Neill, L. A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Adamik, J.; Auron, P. E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Goel, G.; Xavier, R. J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Richard B Simches Res Ctr, Boston, MA 02114 USA; [Frezza, C.; Zheng, L.; Gottlieb, E.] Beatson Inst Canc Res, Apoptosis & Tumour Physiol Lab, Glasgow G61 1BD, Lanark, Scotland; [Frezza, C.; Xavier, R. J.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0X2, England; [Gardet, A.; Pierce, K.; Clish, C.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Tong, Z.; Lin, H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Caffrey, B. E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Walmsley, S.; Whyte, M.] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England; [Beasley, F. C.; Nizet, V.] Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Pediat, V Nizet Lab, La Jolla, CA 92093 USA; [Cummins, E.; Taylor, C. T.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Masters, S. L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia	Trinity College Dublin; Duquesne University; Harvard University; Massachusetts General Hospital; Beatson Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Trinity College Dublin; University of Sheffield; University of California System; University of California San Diego; University College Dublin; Walter & Eliza Hall Institute	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	laoneill@tcd.ie	Kelly, Vincent P/I-2151-2017; Gottlieb, Eyal/G-6450-2010; Nizet, Victor/AAF-3190-2019; Masters, Seth L/N-2886-2013; Cummins, Eoin/S-7554-2019; Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Haneklaus, Moritz/AAE-4728-2020; Frezza, Christian/G-2174-2010	Kelly, Vincent P/0000-0001-7067-5407; Gottlieb, Eyal/0000-0002-9770-0956; Masters, Seth L/0000-0003-4763-576X; Cummins, Eoin/0000-0002-9346-8299; Clish, Clary B/0000-0001-8259-9245; Frezza, Christian/0000-0002-3293-7397; Corr, Sinead/0000-0001-9930-5039; Adamik, Juraj/0000-0002-3604-158X; Nizet, Victor/0000-0003-3847-0422; Kelly, Beth/0000-0002-3195-6860; Bernard, Nicholas/0000-0002-9483-7922; Walmsley, Sarah/0000-0001-9584-174X; Curtis, Annie/0000-0002-9601-9624; Zheng, Liang/0000-0002-5346-4111	European Research Council; Science Foundation Ireland; Health Research Board; European Union FP7 programme 'TIMER'; Wellcome Trust; National Institutes of Health; Helmsley Trust; Nestle Research Centre; VESKI; Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093451, R56AI090863, U54AI057153] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1101/3] Funding Source: researchfish; MRC [MC_UP_1101/3] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; European Union FP7 programme 'TIMER'; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Trust; Nestle Research Centre(Nestle SA); VESKI; Duquesne University Hunkele Dreaded Disease Award; Interleukin Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the European Research Council, Science Foundation Ireland, the Health Research Board, European Union FP7 programme 'TIMER', Wellcome Trust, National Institutes of Health, Helmsley Trust, Nestle Research Centre, VESKI, The Duquesne University Hunkele Dreaded Disease Award, The Interleukin Foundation and the National Health and Medical Research Council for funding. We also thank R. Thompson for assistance with Hif1a<SUP>-/-</SUP> mice and M. Murphy for discussions.	Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Choi S, 2002, J MED CHEM, V45, P4531, DOI 10.1021/jm020134i; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hobert JA, 2012, GENET MED, V14, P616, DOI 10.1038/gim.2011.63; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Pan H, 2012, BIOCHEM BIOPH RES CO, V420, P685, DOI 10.1016/j.bbrc.2012.03.069; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; ROTSTEIN OD, 1985, ARCH SURG-CHICAGO, V120, P146; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Walker SD, 2011, ACTA NEUROL SCAND, V124, P72, DOI 10.1111/j.1600-0404.2011.01602.x; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	30	2021	2106	25	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					238	+		10.1038/nature11986	http://dx.doi.org/10.1038/nature11986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535595	Green Submitted, Green Accepted			2022-12-28	WOS:000317346300045
J	Kurth, I; Georgescu, RE; O'Donnell, ME				Kurth, Isabel; Georgescu, Roxana E.; O'Donnell, Mike E.			A solution to release twisted DNA during chromosome replication by coupled DNA polymerases	NATURE			English	Article							LAGGING-STRAND SYNTHESIS; SLIDING CLAMPS; TOPOISOMERASE-I; FORK; MECHANISM; PROCESSIVITY; BACTERIAL; DYNAMICS; HOLOENZYME; VIABILITY	Chromosomal replication machines contain coupled DNA polymerases that simultaneously replicate the leading and lagging strands(1). However, coupled replication presents a largely unrecognized topological problem. Because DNA polymerase must travel a helical path during synthesis, the physical connection between leading- and lagging-strand polymerases causes the daughter strands to entwine, or produces extensive build-up of negative supercoils in the newly synthesized DNA(2-4). How DNA polymerases maintain their connection during coupled replication despite these topological challenges is unknown. Here we examine the dynamics of the Escherichia coli replisome, using ensemble and single-molecule methods, and show that the replisome may solve the topological problem independent of topoisomerases. We find that the lagging-strand polymerase frequently releases from an Okazaki fragment before completion, leaving single-strand gaps behind. Dissociation of the polymerase does not result in loss from the replisome because of its contact with the leading-strand polymerase. This behaviour, referred to as 'signal release', had been thought to require a protein, possibly primase, to pry polymerase from incompletely extended DNA fragments(5-7). However, we observe that signal release is independent of primase and does not seem to require a protein trigger at all. Instead, the lagging-strand polymerase is simply less processive in the context of a replisome. Interestingly, when the lagging-strand polymerase is supplied with primed DNA in trans, uncoupling it from the fork, high processivity is restored. Hence, we propose that coupled polymerases introduce topological changes, possibly by accumulation of superhelical tension in the newly synthesized DNA, that cause lower processivity and transient lagging-strand polymerase dissociation from DNA.	[Kurth, Isabel; Georgescu, Roxana E.; O'Donnell, Mike E.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, ME (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	odonnel@rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM 38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Langston, A. Libchaber and B. Michel for suggestions on the manuscript. We are also grateful to the National Institutes of Health (GM 38839) for supporting this work.	Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; BENYAJATI C, 1976, CELL, V9, P393, DOI 10.1016/0092-8674(76)90084-2; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Dorman Charles J., 2006, Science Progress, V89, P151, DOI 10.3184/003685006783238317; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kornberg A., 1992, DNA REPLICATION; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; Stockum A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-26; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Tanner NA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp006; Travers A, 2007, EMBO REP, V8, P147, DOI 10.1038/sj.embor.7400898; Ullsperger C. J., 1995, UNLINKING DNA TOPOIS, V9; VOLOGODSKII AV, 1979, NUCLEIC ACIDS RES, V6, P967, DOI 10.1093/nar/6.3.967; WU CA, 1992, J BIOL CHEM, V267, P4074; WYMAN C, 1995, CURR BIOL, V5, P334, DOI 10.1016/S0960-9822(95)00065-0; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	29	31	31	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					119	+		10.1038/nature11988	http://dx.doi.org/10.1038/nature11988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535600	Green Accepted			2022-12-28	WOS:000316993400037
J	McDonough, JE				McDonough, John E.			Budget Sequestration and the US Health Sector	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	McDonough, JE (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 2013, COMMUNICATION; [Anonymous], 2013, COMMUNICATION; Congressional Budget Office, 2013, BUDG EC OUTL FISC YE; Office of Management and Budget, 2013, OMB REP C JOINT COMM	4	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1269	1271		10.1056/NEJMp1303266	http://dx.doi.org/10.1056/NEJMp1303266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23514248				2022-12-28	WOS:000316989900001
J	Mackenbach, JP; Karanikolos, M; McKee, M				Mackenbach, Johan P.; Karanikolos, Marina; McKee, Martin			The unequal health of Europeans: successes and failures of policies	LANCET			English	Article							CHANGING LIFE EXPECTANCY; FORMER SOVIET-UNION; OLD-AGE MORTALITY; SOCIOECONOMIC INEQUALITIES; DISEASE MORTALITY; RISK-FACTORS; ROUTINE DATA; TRENDS; ALCOHOL; RUSSIA	Europe, with its 53 countries and divided history, is a remarkable but inadequately exploited natural laboratory for studies of the effects of health policy. In this paper, the first in a Series about health in Europe, we review developments in population health in Europe, with a focus on trends in mortality, and draw attention to the main successes and failures of health policy in the past four decades. In western Europe, life expectancy has improved almost continuously, but progress has been erratic in eastern Europe, and, as a result, disparities in male life expectancy between the two areas are greater now than they were four decades ago. The falls in mortality noted in western Europe are associated with many different causes of death and show the combined effects of economic growth, improved health care, and successful health policies (eg, tobacco control, road traffic safety). Less favourable mortality trends in eastern Europe show economic and health-care problems and a failure to implement effective health policies. The political history of Europe has left deep divisions in the health of the population. Important health challenges remain in both western and eastern Europe and signify unresolved issues in health policy (eg, alcohol, food) and rising health inequalities within countries.	[Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England	Erasmus University Rotterdam; Erasmus MC; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Karanikolos, Marina/0000-0002-3824-8226	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This paper was drafted during a residency at the Rockefeller Foundation in Bellagio, Italy and draws extensively from the work done during the residency, the result of which is due to be published as a book in late 2013. This Series was supported by the European Observatory on Health Systems and Policies.	Albrecht H.J., 2002, EUROPEAN J CRIME CRI, V10, P1, DOI DOI 10.1163/15718170220519506; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Armour-Marshall J, 2012, EUR J PUBLIC HEALTH, V22, P61, DOI 10.1093/eurpub/ckr004; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Atun RA, 2007, HEALTH POLICY, V81, P207, DOI 10.1016/j.healthpol.2006.05.021; Badurashvili I, 2001, PUBLIC HEALTH, V115, P394, DOI 10.1038/sj.ph.1900808; Balabanova D, 2012, HEALTH SERV RES, V47, P840, DOI 10.1111/j.1475-6773.2011.01323.x; Belin MA, 2012, INT J INJ CONTROL SA, V19, P171, DOI 10.1080/17457300.2011.635213; Berrino F, 2009, EUR J CANCER, V45, P901, DOI 10.1016/j.ejca.2009.01.018; Bevan G, 2010, J HEALTH SERV RES PO, V15, P67, DOI 10.1258/jhsrp.2010.009174; Borsch-Supan A, 2005, HEALTH AGEING AND RE; Bosetti C, 2007, J HEPATOL, V46, P827, DOI 10.1016/j.jhep.2007.01.025; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Chenet L, 1997, J EPIDEMIOL COMMUN H, V51, P510, DOI 10.1136/jech.51.5.510; Chenet L, 1996, J EPIDEMIOL COMMUN H, V50, P404, DOI 10.1136/jech.50.4.404; Chenet L, 1996, J PUBLIC HEALTH MED, V18, P329, DOI 10.1093/oxfordjournals.pubmed.a024514; Chiang CL, 1984, THE LIFE TABLE AND I; de Lorgeril M, 2008, CURR ATHEROSCLER REP, V10, P518, DOI 10.1007/s11883-008-0080-5; Delanty G., 1995, INVENTING EUROPE IDE; Dolea C, 2002, J EPIDEMIOL COMMUN H, V56, P444, DOI 10.1136/jech.56.6.444; Doyle Y, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3926; Elmadfa I, EUROPEAN NUTRITION A; Eurostat, 2009, HEALTH STATISTICS AT; Figes Orlando, 2002, NATASHAS DANCE A CUL; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Gene-Badia J, 2012, HEALTH POLICY, V106, P23, DOI 10.1016/j.healthpol.2012.02.001; Gil A, 2009, ALCOHOL CLIN EXP RES, V33, P79, DOI 10.1111/j.1530-0277.2008.00813.x; Gilmore AB, 2004, TOB CONTROL, V13, P151, DOI 10.1136/tc.2003.005207; Greer SL, 2013, LANCET; Gruning T, AM J PUBLIC HLTH, V96, P20; Hajioff S, 2000, J EPIDEMIOL COMMUN H, V54, P864, DOI 10.1136/jech.54.11.864; Herttua K, 2011, INT J EPIDEMIOL, V40, P441, DOI 10.1093/ije/dyp336; Jackson MC, 2000, ADDICTION, V95, pS597, DOI 10.1046/j.1360-0443.95.12s4.11.x; Janssen F, 2004, J CLIN EPIDEMIOL, V57, P203, DOI [10.1016/j.jclinepi.2003.07.005, 10.1016/j.clinepi.2003.07.005]; Jasilionis D, 2011, EUR J POPUL, V27, P403, DOI 10.1007/s10680-011-9243-0; Jeffreys B, FINLANDS U TURN ON A; Joossens L., 2011, THE TOBACCO CONTROL; Karanikolos M, 2013, LANCET; Karanikolos M, 2012, J EPIDEMIOL COMMUN H, V66, P1043, DOI 10.1136/jech-2011-200879; Karlsson K, 2006, SCALING ALCOHOL CONT; Karlsson T, 2006, COUNTRY REPORTS AND; Kosebalaban H, 2007, MEDITERR Q, V18, P87, DOI 10.1215/10474552-2007-027; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Levintova M, 2007, ALCOHOL ALCOHOLISM, V42, P500, DOI 10.1093/alcalc/agm040; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, SUCCESSES AND FAILUR; Marmot M., 2010, FAIR SOCIETY HEALTHY; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; McKee M, 2006, LANCET, V367, P1224, DOI 10.1016/S0140-6736(06)68520-6; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; McKee M., 2002, THE IMPACT OF EU LAW; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Mesle F, 2006, POPUL DEV REV, V32, P123, DOI 10.1111/j.1728-4457.2006.00108.x; Nolte E, 2002, SOC SCI MED, V55, P1905, DOI 10.1016/S0277-9536(01)00320-3; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Osterberg EL, 2011, DRUG ALCOHOL REV, V30, P124, DOI 10.1111/j.1465-3362.2010.00265.x; Perlman F, 2007, TOB CONTROL, V16, P299, DOI 10.1136/tc.2006.019455; Physicians for a Smoke-Free Canada, LESSONS FROM NORWAY; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Racioppi F., 2004, PREVENTING ROAD TRAF; Rechel B, 2011, MIGRATION AND HEALTH; Rechel B, 2013, LANCET; Richards M, 2009, LANCET ONCOL, V10, P311, DOI 10.1016/S1470-2045(09)70086-5; Riley J, 2001, RISING LIFE EXPECTAN; Roberts B, 2012, J EPIDEMIOL COMMUN H, V66, P1079, DOI 10.1136/jech-2011-200645; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Toshkov D, 2013, PUBLIC ADMIN, V91, P448, DOI 10.1111/j.1467-9299.2012.02075.x; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Velkova A, 1997, INT J EPIDEMIOL, V26, P75, DOI 10.1093/ije/26.1.75; Vitek CR, 1998, EMERG INFECT DIS, V4, P539, DOI 10.3201/eid0404.980404; Weijermars W. A. M., 2009, TIEN JAAR DUURZAAM V; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; Wolfe I, 2013, LANCET; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277	86	111	115	2	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1125	1134		10.1016/S0140-6736(12)62082-0	http://dx.doi.org/10.1016/S0140-6736(12)62082-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541053	Green Submitted			2022-12-28	WOS:000317348900031
J	McLeod, HL				McLeod, Howard L.			Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed	SCIENCE			English	Review							GENOME-WIDE ASSOCIATION; PLASMA-CONCENTRATIONS; LUNG-CANCER; TAMOXIFEN; CYP2D6; CHEMOTHERAPY; WOMEN	The past decade has brought together substantial advances in human genome analysis and a maturation of understanding of tumor biology. Although there is much progress still to be made, there are now several prominent examples in which tumor-associated somatic mutations have been used to identify cellular signaling pathways in tumors. This in turn has led to the development of targeted therapies, with somatic mutations serving as genomic predictors of tumor response and providing new leads for drug development. There is also a realization that germline DNA variants can help optimize cancer drug dosing and predict the susceptibility of patients to the adverse side effects of these drugs-knowledge that ultimately can be used to improve the benefit: risk ratio of cancer treatment for individual patients.	[McLeod, Howard L.] Univ N Carolina, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [McLeod, Howard L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [McLeod, Howard L.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [McLeod, Howard L.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	McLeod, HL (corresponding author), Univ N Carolina, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA.	hmcleod@unc.edu	McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	NIH [UL1 RR025747, P01CA142538, R01 CA161608, R01HL110380]; NATIONAL CANCER INSTITUTE [R01CA161608, P01CA142538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110380] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by NIH grants UL1 RR025747, P01CA142538, R01 CA161608, and R01HL110380. The author serves on the NIH NHGRI Advisory Council, FDA Clinical Pharmacology Committee, and Coriell Institute Pharmacogenomics Advisory Committee and is a scientific advisor to Gentris Corporation.	Ahmad A, 2010, CLIN PHARMACOL THER, V88, P814, DOI 10.1038/clpt.2010.196; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Brown CC, 2012, PHARMACOGENET GENOM, V22, P796, DOI 10.1097/FPC.0b013e3283589c50; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Eechoute K, 2012, CLIN CANCER RES, V18, P5780, DOI 10.1158/1078-0432.CCR-12-0490; Engstrom PF, 2011, J NATL COMPR CANC NE, V9, pS1; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Hertz DL, 2012, ONCOLOGIST, V17, P620, DOI 10.1634/theoncologist.2011-0418; Innocenti F, 2012, CLIN CANCER RES, V18, P577, DOI 10.1158/1078-0432.CCR-11-1387; Irvin WJ, 2011, J CLIN ONCOL, V29, P3232, DOI 10.1200/JCO.2010.31.4427; KALOW W, 1956, LANCET, V271, P576; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lee SY, 2011, J PATHOL, V223, P15, DOI 10.1002/path.2766; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peters EJ, 2011, PHARMACOGENOMICS, V12, P1407, DOI [10.2217/PGS.11.92, 10.2217/pgs.11.92]; Ratain MJ, 2006, CLIN CANCER RES, V12, p3612S, DOI 10.1158/1078-0432.CCR-06-9008; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Ross CJD, 2009, NAT GENET, V41, P1345, DOI 10.1038/ng.478; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; Walko CM, 2012, PHARMACOGENOMICS, V13, P691, DOI [10.2217/PGS.12.27, 10.2217/pgs.12.27]; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600	30	107	110	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1563	1566		10.1126/science.1234139	http://dx.doi.org/10.1126/science.1234139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539596	Green Accepted, Green Submitted			2022-12-28	WOS:000316731600038
J	Nakagome, S; Mano, S; Hasegawa, M				Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami			Comment on "Nuclear Genomic Sequences Reveal that Polar Bears Are an Old and Distinct Bear Lineage"	SCIENCE			English	Editorial Material							INFERENCE	Based on nuclear and mitochondrial DNA, Hailer et al. (Reports, 20 April 2012, p. 344) suggested early divergence of polar bears from a common ancestor with brown bears and subsequent introgression. Our population genetic analysis that traces each of the genealogies in the independent nuclear loci does not support the evolutionary model proposed by the authors.	[Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami] Inst Stat Math, Tachikawa, Tokyo 1808562, Japan; [Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Fudan University	Nakagome, S (corresponding author), Inst Stat Math, 10-3 Midori Cho, Tachikawa, Tokyo 1808562, Japan.	nakagome@ism.ac.jp		Nakagome, Shigeki/0000-0001-9613-975X				Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044	7	11	11	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2013	339	6127								10.1126/science.1227339	http://dx.doi.org/10.1126/science.1227339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539580	Green Submitted			2022-12-28	WOS:000316731600021
J	Le Grand, J				Le Grand, Julian			Will 1 April mark the beginning of the end of England's NHS? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPETITION		London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Le Grand, J (corresponding author), London Sch Econ, London WC2A 2AE, England.	J.Legrand@lse.ac.uk						Bevan G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6470; Bloom N, 983 CTR EC PERF; Bloom N, 2011, LANCET, V378, P2064, DOI 10.1016/S0140-6736(11)61708-X; Cookson R, 2012, J HEALTH SERV RES PO, V17, P55, DOI 10.1258/jhsrp.2011.011014; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Dixon A, 2011, UNDERSTANDING NEW LA, P191; Gaynor M., 2012, FREE CHOOSE REFORM D; Gaynor M, AM EC J EC IN PRESS; Le Grand J., 2006, MOTIVATION AGENCY PU; Pollock A, 2011, LANCET, V378, P2057, DOI 10.1016/S0140-6736(11)61553-5	10	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1975	10.1136/bmj.f1975	http://dx.doi.org/10.1136/bmj.f1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WO	23533191				2022-12-28	WOS:000316984000029
J	Schulz, TJ; Huang, P; Huang, TL; Xue, RD; McDougall, LE; Townsend, KL; Cypess, AM; Mishina, Y; Gussoni, E; Tseng, YH				Schulz, Tim J.; Huang, Ping; Huang, Tian Lian; Xue, Ruidan; McDougall, Lindsay E.; Townsend, Kristy L.; Cypess, Aaron M.; Mishina, Yuji; Gussoni, Emanuela; Tseng, Yu-Hua			Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat	NATURE			English	Article							ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; ADIPOCYTES; THERMOGENESIS; DISTINCT; REVEALS; MUSCLE; MICE; IDENTIFICATION; ACTIVATION	Maintenance of body temperature is essential for the survival of homeotherms. Brown adipose tissue (BAT) is a specialized fat tissue that is dedicated to thermoregulation(1). Owing to its remarkable capacity to dissipate stored energy and its demonstrated presence in adult humans(2-5), BAT holds great promise for the treatment of obesity and metabolic syndrome(1). Rodent data suggest the existence of two types of brown fat cells: constitutive BAT (cBAT), which is of embryonic origin and anatomically located in the imterscapular region of mice; and recruitable BAT (rBAT), which resides within white adipose tissue (WAT)(6) and skeletal muscle(7), and has alternatively been called beige(8), brite(9) or inducible BAT(10). Bone morphogenetic proteins (BMPs) regulate the formation and thermogenic activity of BAT(10-12). Here we use mouse models to provide evidence for a systemically active regulatory mechanism that controls whole-body BAT activity for thermoregulation and energy homeostasis. Genetic ablation of the type 1A BMP receptor (Bmpr1a) in brown adipogenic progenitor cells leads to a severe paucity of cBAT. This in turn increases sympathetic input to WAT, thereby promoting the formation of rBAT within white fat depots. This previously unknown compensatory mechanism, aimed at restoring total brown-fat-mediated thermogenic capacity in the body, is sufficient to maintain normal temperature homeostasis and resistance to diet-induced obesity. These data suggest an important physiological cross-talk between constitutive and recruitable brown fat cells. This sophisticated regulatory mechanism of body temperature may participate in the control of energy balance and metabolic disease.	[Schulz, Tim J.; Huang, Tian Lian; Xue, Ruidan; McDougall, Lindsay E.; Townsend, Kristy L.; Cypess, Aaron M.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Huang, Ping; Gussoni, Emanuela] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Huang, Ping; Gussoni, Emanuela] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Xue, Ruidan] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Div Endocrinol & Metab, Shanghai 200032, Peoples R China; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Tseng, Yu-Hua] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Fudan University; University of Michigan System; University of Michigan; Harvard University	Tseng, YH (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA.	yu-hua.tseng@joslin.harvard.edu	Gussoni, Emanuela/AAL-6150-2021; Tseng, Yu-Hua/G-7003-2015; Schulz, Tim/F-4842-2013	Gussoni, Emanuela/0000-0002-9915-3677; Schulz, Tim/0000-0002-8413-3972	National Institutes of Health (NIH) [R01 DK077097]; Joslin Diabetes Center's Diabetes Research Center (DRC from the NIDDK) [P30 DK036836]; Eli Lilly Research Foundation; Harvard Stem Cell Institute; Mary K. Iacocca Foundation; German Research Foundation (DFG) [SCHU2445/1-1]; American Heart Association [0730285N]; NIH [T32 DK007260, F32 DK091996]; National Natural Science Foundation of China [985III-YFX0302, NSFC81070680]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, T32DK007260, F32DK091996, K23DK081604, R01DK077097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center's Diabetes Research Center (DRC from the NIDDK); Eli Lilly Research Foundation(Eli Lilly); Harvard Stem Cell Institute; Mary K. Iacocca Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK077097 (Y.-H.T.), and Joslin Diabetes Center's Diabetes Research Center (DRC; P30 DK036836 from the NIDDK), a research grant from the Eli Lilly Research Foundation, and by funding from the Harvard Stem Cell Institute (to Y.-H.T.), T.J.S. was supported by the Mary K. Iacocca Foundation and the German Research Foundation (DFG; SCHU2445/1-1). P.H. was supported by a Scientist Development Grant from the American Heart Association (0730285N). K.L.T. was supported by NIH fellowships (T32 DK007260 and F32 DK091996). R.X. was supported by Project 985III-YFX0302 and NSFC81070680 from the National Natural Science Foundation of China. The authors thank Stryker Regenerative Medicine for the gift of recombinant BMP7. We acknowledge V. Kaartinen, B. Kahn, K. Lyons and P. Soriano for providing floxed Acvr1 mice, FABP4-Cre mice, Bmpr1b heterozygous mice and Myf5-Cre mice, respectively. The authors thank C. R. Kahn, L.J. Goodyear, E. Kokkotou and D. Breault for comments on the manuscript The authors wish to thank J. LaVecchio, G. Buruzula, A. Wakabayashi, A. Pinkhasov, A. Clermont, M. Mulvey, C. Cahill and G. Sankaranarayanan for technical assistance, and E. Caniano for editorial contributions.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BUCKINGHAM ME, 1992, CIBA F SYMP, V165, P111; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; ROTHWELL NJ, 1989, AM J PHYSIOL, V257, pR253, DOI 10.1152/ajpregu.1989.257.2.R253; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; SCHMID P, 1991, DEVELOPMENT, V113, P857; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	30	282	293	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					379	383		10.1038/nature11943	http://dx.doi.org/10.1038/nature11943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485971	Green Accepted, Green Submitted			2022-12-28	WOS:000316650500045
J	Raven, MC; Lowe, RA; Maselli, J; Hsia, RY				Raven, Maria C.; Lowe, Robert A.; Maselli, Judith; Hsia, Renee Y.			Comparison of Presenting Complaint vs Discharge Diagnosis for Identifying "Nonemergency" Emergency Department Visits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; ALGORITHM	Importance Reduction in emergency department (ED) use is frequently viewed as a potential source for cost savings. One consideration has been to deny payment if the patient's diagnosis upon ED discharge appears to reflect a "nonemergency" condition. This approach does not incorporate other clinical factors such as chief complaint that may inform necessity for ED care. Objective To determine whether ED presenting complaint and ED discharge diagnosis correspond sufficiently to support use of discharge diagnosis as the basis for policies discouraging ED use. Design, Setting, and Participants The New York University emergency department algorithm has been commonly used to identify nonemergency ED visits. We applied the algorithm to publicly available ED visit data from the 2009 National Hospital Ambulatory Medical Care Survey (NHAMCS) for the purpose of identifying all "primary care-treatable" visits. The 2009 NHAMCS data set contains 34 942 records, each representing a unique ED visit. For each visit with a discharge diagnosis classified as primary care treatable, we identified the chief complaint. To determine whether these chief complaints correspond to nonemergency ED visits, we then examined all ED visits with this same group of chief complaints to ascertain the ED course, final disposition, and discharge diagnoses. Main Outcomes and Measures Patient demographics, clinical characteristics, and disposition associated with chief complaints related to nonemergency ED visits. Results Although only 6.3% (95% CI, 5.8%-6.7%) of visits were determined to have primary care-treatable diagnoses based on discharge diagnosis and our modification of the algorithm, the chief complaints reported for these ED visits with primary care-treatable ED discharge diagnoses were the same chief complaints reported for 88.7% (95% CI, 88.1%-89.4%) of all ED visits. Of these visits, 11.1% (95% CI, 9.3%-13.0%) were identified at ED triage as needing immediate or emergency care; 12.5% (95% CI, 11.8%-14.3%) required hospital admission; and 3.4% (95% CI, 2.5%-4.3%) of admitted patients went directly from the ED to the operating room. Conclusions and Relevance Among ED visits with the same presenting complaint as those ultimately given a primary care-treatable diagnosis based on ED discharge diagnosis, a substantial proportion required immediate emergency care or hospital admission. The limited concordance between presenting complaints and ED discharge diagnoses suggests that these discharge diagnoses are unable to accurately identify nonemergency ED visits. JAMA. 2013;309(11):1145-1153 www.jama.com	[Raven, Maria C.; Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94707 USA; [Maselli, Judith] Univ Calif San Francisco, Dept Med, San Francisco, CA 94707 USA; [Hsia, Renee Y.] San Francisco Gen Hosp, Dept Emergency Med, San Francisco, CA 94110 USA; [Lowe, Robert A.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Lowe, Robert A.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97201 USA; [Lowe, Robert A.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Raven, MC (corresponding author), Univ Calif San Francisco, Dept Emergency Med, 505 Parnassus Ave, San Francisco, CA 94707 USA.	maria.raven@emergency.ucsf.edu	Lowe, Robert A/A-4926-2008	Lowe, Robert A/0000-0002-4732-9634	Emergency Medicine Foundation; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-Clinical and Translational Sciences Institute [KL2TR000143]; Robert Wood Johnson Foundation Physician Faculty; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Emergency Medicine Foundation; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-Clinical and Translational Sciences Institute; Robert Wood Johnson Foundation Physician Faculty(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported by the Emergency Medicine Foundation, as well as by grant KL2TR000143 from the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-Clinical and Translational Sciences Institute (Dr Hsia), and the Robert Wood Johnson Foundation Physician Faculty Scholars (Dr Hsia).	Abbuhl SB, 1996, ACAD EMERG MED, V3, P189, DOI 10.1111/j.1553-2712.1996.tb03416.x; [Anonymous], 2005, COMP ASS REP EM DEP; [Anonymous], 2004, NONEM PREV ED VIS; [Anonymous], 2012, KAISER HLTH NEW 0208; Ballard DW, 2010, MED CARE, V48, P58, DOI 10.1097/MLR.0b013e3181bd49ad; Billings J, 2000, ISSUE BRIEF EMERGENC; Billings J, 2000, EMERGENCY DEP USE NE; Birnbaum A, 1994, Acad Emerg Med, V1, P213; Blachly L, 2010, ACEP NEWS CLIN P MAY; Centers for Disease Control and Prevention, 2012, CTR DIS CONTR PREV A; Centers for Disease Control and Prevention, 2009, NAT SUMM FERT CLIN R, P23; Cheung PT, 2012, ANN EMERG MED, V60, P4, DOI 10.1016/j.annemergmed.2012.01.035; Cunningham PJ, 2006, HEALTH AFFAIR, V25, pW324, DOI 10.1377/hlthaff.25.w324; Dickinson Edward T, 2010, JEMS, V35, P62, DOI 10.1016/S0197-2510(10)70066-8; Dickinson ET, 2010, JEMS, V35, P71; Dickinson ET, 2010, JEMS, V35, P66; Dickinson ET, 2010, J EMERG MED SERV, V35, P68; Galewitz Phil, 2012, KAISER HLTH NEW 0220; Greci L. K., 2010, ISSUE BRIEF PROFILE; Kathleen A, 2012, DUNN MED DIRECTOR NE; Kellermann AL, 2012, NEW ENGL J MED, V366, P2141, DOI 10.1056/NEJMp1203247; Lowe RA, 2001, ANN EMERG MED, V37, P629, DOI 10.1067/mem.2001.115216; LOWE RA, 1994, ANN EMERG MED, V23, P286, DOI 10.1016/S0196-0644(94)70042-7; Lowe RA, 2012, EVALUATION WASHINGTO; Lowe RA, 2008, ACAD EMERG MED, V15, P506, DOI 10.1111/j.1553-2712.2008.00108.x; Lowe RA, 2011, ANN EMERG MED, V58, P235, DOI 10.1016/j.annemergmed.2011.03.054; Lowe RA, 2009, MED CARE, V47, P15, DOI 10.1097/MLR.0b013e3181844e1c; Many Pear R, 2013, NY TIMES; Matthews AW, 2012, WALL STREET J; MCCAIG L, 2006, ANAL DATA NAMCS NHAM; McCaig LF, 2012, ANN EMERG MED, V60, P716, DOI 10.1016/j.annemergmed.2012.07.010; Mortensen K, 2010, HEALTH AFFAIR, V29, P1643, DOI 10.1377/hlthaff.2009.0906; OBrien GM, 1996, ACAD EMERG MED, V3, P252, DOI 10.1111/j.1553-2712.1996.tb03429.x; PITTS SR, 2008, NATL HLTH STAT REPOR, V7, P1; Raman S, 2002, USING CATEGORIZATION; Schneider D, 1979, VITAL HLTH STAT, V78, pI; Smith V. K., 2011, MOVING AHEAD AMID FI; Sommers A.S., 2012, DISPELLING MYTHS EME; Tyrance PH, 1996, AM J PUBLIC HEALTH, V86, P1527, DOI 10.2105/AJPH.86.11.1527; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; Young GP, 1996, JAMA-J AM MED ASSOC, V276, P460, DOI 10.1001/jama.276.6.460; Young GP, 1997, ACAD EMERG MED, V4, P1129, DOI 10.1111/j.1553-2712.1997.tb03695.x	42	151	151	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1145	1153		10.1001/jama.2013.1948	http://dx.doi.org/10.1001/jama.2013.1948			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512061	Bronze, Green Accepted			2022-12-28	WOS:000316276500028
J	Dormuth, CR; Hemmelgarn, BR; Paterson, JM; James, MT; Teare, GF; Raymond, CB; Lafrance, JP; Levy, A; Garg, AX; Ernst, P				Dormuth, Colin R.; Hemmelgarn, Brenda R.; Paterson, J. Michael; James, Matthew T.; Teare, Gary F.; Raymond, Colette B.; Lafrance, Jean-Philippe; Levy, Adrian; Garg, Amit X.; Ernst, Pierre		CNODES	Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ROSUVASTATIN; METAANALYSIS; CHOLESTEROL; VALIDITY; OUTCOMES; FAILURE; DISEASE; WOMEN; MEN	Objective To quantify an association between acute kidney injury and use of high potency statins versus low potency statins. Design Retrospective observational analysis of administrative databases, using nine population based cohort studies and meta-analysis. We performed as treated analyses in each database with a nested case-control design. Rate ratios for different durations of current and past statin exposure to high potency or low potency statins were estimated using conditional logistic regression. Ratios were adjusted for confounding by high dimensional propensity scores. Meta-analytic methods estimated overall effects across participating sites. Setting Seven Canadian provinces and two databases in the United Kingdom and the United States. Participants 2 067 639 patients aged 40 years or older and newly treated with statins between 1 January 1997 and 30 April 2008. Each person hospitalized for acute kidney injury was matched with ten controls. Intervention A dispensing event was new if no cholesterol lowering drug or niacin prescription was dispensed in the previous year. High potency statin treatment was defined as >= 10 mg rosuvastatin, >= 20 mg atorvastatin, and >= 40 mg simvastatin; all other statin treatments were defined as low potency. Statin potency groups were further divided into cohorts with or without chronic kidney disease. Main outcome measure Relative hospitalization rates for acute kidney injury. Results Of more than two million statin users (2 008 003 with non-chronic kidney disease; 59 636 with chronic kidney disease), patients with similar propensity scores were comparable on measured characteristics. Within 120 days of current treatment, there were 4691 hospitalizations for acute kidney injury in patients with non-chronic kidney injury, and 1896 hospitalizations in those with chronic kidney injury. In patients with non-chronic kidney disease, current users of high potency statins were 34% more likely to be hospitalized with acute kidney injury within 120 days after starting treatment (fixed effect rate ratio 1.34, 95% confidence interval 1.25 to 1.43). Users of high potency statins with chronic kidney disease did not have as large an increase in admission rate (1.10, 0.99 to 1.23). chi(2) tests for heterogeneity confirmed that the observed association was robust across participating sites. Conclusions Use of high potency statins is associated with an increased rate of diagnosis for acute kidney injury in hospital admissions compared with low potency statins. The effect seems to be strongest in the first 120 days after initiation of statin treatment.	[Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Victoria, BC V8W 1Y2, Canada; [Hemmelgarn, Brenda R.; James, Matthew T.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Paterson, J. Michael] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Teare, Gary F.] Hlth Qual Council, Saskatoon, SK, Canada; [Raymond, Colette B.] Univ Manitoba, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Lafrance, Jean-Philippe] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Levy, Adrian] Dalhousie Univ, Halifax, NS, Canada; [Garg, Amit X.] Univ Western Ontario, Div Nephrol, London, ON, Canada; [Ernst, Pierre] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada	University of British Columbia; University of Calgary; University of Toronto; University of Manitoba; Universite de Montreal; Dalhousie University; Western University (University of Western Ontario); Lady Davis Institute; McGill University	Dormuth, CR (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Victoria, BC V8W 1Y2, Canada.	colin.dormuth@ti.ubc.ca	Lafrance, Jean-Philippe/C-9113-2013; Garg, Amit X/G-3295-2011	Lafrance, Jean-Philippe/0000-0001-7876-0446; Dormuth, Colin/0000-0001-8577-8783; Platt, Robert/0000-0002-5981-8443	Health Canada; Drug Safety and Effectiveness Network; Canadian Institutes for Health Research; Zeneca; Boehringer Ingelheim; Merck; Nycomed; Icon	Health Canada; Drug Safety and Effectiveness Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Zeneca; Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Nycomed; Icon	CNODES is funded by a grant from Health Canada, the Drug Safety and Effectiveness Network, and the Canadian Institutes for Health Research that oversaw the peer review and funding process.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from Health Canada, the Drug Safety and Effectiveness Network, and the Canadian Institutes for Health Research for the submitted work; PE receives consultancy and speaker's fees from Astra Zeneca, Boehringer Ingelheim, Merck, and Nycomed, and a research grant from Boehringer Ingelheim; AL receives consultancy fees from Oxford Outcomes (now Icon), a company that carries out contracted work for pharmaceutical companies; no other relationships or activities that could appear to have influenced the submitted work.	Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; [Anonymous], 2010, HIGH DIMENSIONAL PRO; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; *CAN PHARM ASS, 2004, COMP PHARM SPEC; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Rodriguez LAG, 2010, PHARMACOEPIDEM DR S, V19, P1218, DOI 10.1002/pds.2032; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Ishikawa A, 2011, CLIN EXP NEPHROL, V15, P30, DOI 10.1007/s10157-010-0350-8; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kiortsis DN, 2007, ATHEROSCLEROSIS, V195, P7, DOI 10.1016/j.atherosclerosis.2006.10.001; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; McMurray JJV, 2010, J AM COLL CARDIOL, V56, P1196, DOI 10.1016/j.jacc.2010.02.075; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Murugan R, 2012, CLIN J AM SOC NEPHRO, V7, P895, DOI 10.2215/CJN.07100711; Ouattara A, 2009, J CARDIOTHOR VASC AN, V23, P633, DOI 10.1053/j.jvca.2009.02.008; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Roberts MD, 2009, CRESTOR ROSUVASTATIN; Singh Ram B., 2000, Journal of Nutritional and Environmental Medicine (Abingdon), V10, P281, DOI 10.1080/13590840020013266; Sniderman A, 2012, J CLIN LIPIDOL, V6, P303, DOI 10.1016/j.jacl.2012.05.004; Suissa Samy, 2012, Open Med, V6, pe134; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6	26	162	166	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f880	10.1136/bmj.f880	http://dx.doi.org/10.1136/bmj.f880			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113LX	23511950	hybrid			2022-12-28	WOS:000316670500002
J	Sethmann, I				Sethmann, Ingo			Creating Flexible Calcite Fibers with Proteins	SCIENCE			English	Editorial Material							SPICULES		Tech Univ Darmstadt, Inst Angew Geowissensch, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Sethmann, I (corresponding author), Tech Univ Darmstadt, Inst Angew Geowissensch, Petersenstr 30, D-64287 Darmstadt, Germany.	sethmann@geo.tu-darmstadt.de	Sethmann, Ingo/AAF-1366-2020; Darmstadt, Electron microscopy EMC/D-8395-2016	Sethmann, Ingo/0000-0003-1852-4198; 				Aizenberg J, 1996, Connect Tissue Res, V34, P255, DOI 10.3109/03008209609005269; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Currey JD, 1999, J EXP BIOL, V202, P3285; Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135; Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003; Natalio F, 2013, SCIENCE, V339, P1298, DOI 10.1126/science.1216260; Sethmann I, 2006, J INORG BIOCHEM, V100, P88, DOI 10.1016/j.jinorgbio.2005.10.005; Wang XH, 2010, PURE APPL CHEM, V82, P175, DOI 10.1351/PAC-CON-09-01-07	8	1	1	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1281	1282		10.1126/science.1235357	http://dx.doi.org/10.1126/science.1235357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493701				2022-12-28	WOS:000316053400023
J	Peplow, M				Peplow, Mark			The accelerator	NATURE			English	Editorial Material																			0	18	18	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S10	S11		10.1038/495S10a	http://dx.doi.org/10.1038/495S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486095	Bronze			2022-12-28	WOS:000316652300030
J	Bishop, TF				Bishop, Tara F.			Pushing the Outpatient Quality Envelope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bishop, Tara F.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY 10021 USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University	Bishop, TF (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 E 67th St,Room LA 218, New York, NY 10021 USA.	tlfernan@med.cornell.edu			NATIONAL INSTITUTE ON AGING [K23AG043499] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG043499, K23AG043499] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Casalino LP, 1999, NEW ENGL J MED, V341, P1147, DOI 10.1056/NEJM199910073411511; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Insitute of Medicine, 2008, FUT NURS LEAD CHANG; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kupfer JM, 2012, JAMA-J AM MED ASSOC, V308, P139, DOI 10.1001/jama.2012.7381; The Joint Commission, 2012 NAT PAT SAF GOA; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Workgroup ACQA, 2005, REC START SET CLIN P	8	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1353	1354		10.1001/jama.2013.1220	http://dx.doi.org/10.1001/jama.2013.1220			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23519384	Green Accepted			2022-12-28	WOS:000316934500022
J	Ross, JS; Krumholz, HM				Ross, Joseph S.; Krumholz, Harlan M.			Ushering in a New Era of Open Science Through Data Sharing The Wall Must Come Down	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NHLBI NIH HHS [1U01HL105270-03] Funding Source: Medline; NIA NIH HHS [K08 AG032886] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; ClinicalTrials, TRENDS CHARTS MAPS; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Thomas K., 2012, NY TIMES	8	83	83	2	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1355	1356		10.1001/jama.2013.1299	http://dx.doi.org/10.1001/jama.2013.1299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23508736	Bronze			2022-12-28	WOS:000316934500023
J	Lafaurie-Janvore, J; Maiuri, P; Wang, I; Pinot, M; Manneville, JB; Betz, T; Balland, M; Piel, M				Lafaurie-Janvore, Julie; Maiuri, Paolo; Wang, Irene; Pinot, Mathieu; Manneville, Jean-Baptiste; Betz, Timo; Balland, Martial; Piel, Matthieu			ESCRT-III Assembly and Cytokinetic Abscission Are Induced by Tension Release in the Intercellular Bridge	SCIENCE			English	Article							MIDBODY; CONSTRICTION; RECRUITMENT; DYNAMICS; SPASTIN; FORCES	The last step of cell division, cytokinesis, produces two daughter cells that remain connected by an intercellular bridge. This state often represents the longest stage of the division process. Severing the bridge (abscission) requires a well-described series of molecular events, but the trigger for abscission remains unknown. We found that pulling forces exerted by daughter cells on the intercellular bridge appear to regulate abscission. Counterintuitively, these forces prolonged connection, whereas a release of tension induced abscission. Tension release triggered the assembly of ESCRT-III (endosomal sorting complex required for transport-III), which was followed by membrane fission. This mechanism may allow daughter cells to remain connected until they have settled in their final locations, a process potentially important for tissue organization and morphogenesis.	[Lafaurie-Janvore, Julie; Maiuri, Paolo; Pinot, Mathieu; Manneville, Jean-Baptiste; Piel, Matthieu] Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France; [Wang, Irene; Balland, Martial] Univ Grenoble 1, CNRS, LIPhy UMR 5588, F-38041 Grenoble, France; [Betz, Timo] Inst Curie, CNRS, UMR 168, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Piel, M (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.	matthieu.piel@curie.fr	Manneville, Jean-Baptiste/L-5914-2019; Pinot, Mathieu/P-8192-2014; Betz, Timo/ABF-9946-2021	Maiuri, Paolo/0000-0001-5079-445X; Betz, Timo/0000-0002-1548-0655; Manneville, Jean-Baptiste/0000-0002-8670-3940; Balland, martial/0000-0002-6585-9735	French ministerial fellowship; Fondation pour la Recherche Medicale fellowship; Ligue Contre le Cancer grant; Fondation Nanosciences RTRA;  [ANR-11-JSV5-0002]	French ministerial fellowship; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale); Ligue Contre le Cancer grant; Fondation Nanosciences RTRA; 	We thank D. Gerlich for the Hela Kyoto alpha-tubulin-EGFP histone2B-mCherry cell line and the alpha-tubulin plasmids; I. Poser and A. Hyman for the CHMP4B-GFP cell line; A. Roux, A. Echard, N. Minc, C. Janke, and members of the Piel lab for critical reading of the manuscript and C. Ainsworth for editing it; L. Sengmanivong, V. Fraisier, the Nikon Imaging Center, and the PICT-IBiSA of the Institut Curie for technical support in microscopy; C. Sykes; and E. Terriac and A. Jimenez for helpful discussions. Supported by a French ministerial fellowship (J.L.-J.), a Fondation pour la Recherche Medicale fellowship (J.L.-J. and P. M.), a Ligue Contre le Cancer grant (M. P.), ANR-11-JSV5-0002 (T. B.), and Fondation Nanosciences RTRA (M. B.). The data are contained in the manuscript and the supplementary materials.	Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Morin P, 2009, EUR J CELL BIOL, V88, P495, DOI 10.1016/j.ejcb.2009.04.005; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tanimoto H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248110; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	23	106	107	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1625	1629		10.1126/science.1233866	http://dx.doi.org/10.1126/science.1233866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539606				2022-12-28	WOS:000316731600054
J	Suva, ML; Riggi, N; Bernstein, BE				Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.			Epigenetic Reprogramming in Cancer	SCIENCE			English	Review							STEM-CELLS; SOMATIC MUTATIONS; SELF-RENEWAL; HISTONE H3; GENE; PLURIPOTENCY; EXPRESSION; COMPLEX; H3K27; REGULATORS	The demonstration of induced pluripotency and direct lineage conversion has led to remarkable insights regarding the roles of transcription factors and chromatin regulators in mediating cell state transitions. Beyond its considerable implications for regenerative medicine, this body of work is highly relevant to multiple stages of oncogenesis, from the initial cellular transformation to the hierarchical organization of established malignancies. Here, we review conceptual parallels between the respective biological phenomena, highlighting important interrelationships among transcription factors, chromatin regulators, and preexisting epigenetic states. The shared mechanisms provide insights into oncogenic transformation, tumor heterogeneity, and cancer stem cell models.	[Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Suva, Mario L.; Riggi, Nicolo; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	bernstein.bradley@mgh.harvard.edu	Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351	Howard Hughes Medical Institute; National Human Genome Research Institute; NIH Common Fund; National Heart, Lung, and Blood Institute; Harvard Stem Cell Institute; Burroughs Wellcome Fund; Medic Foundation; Nuovo Soldati Foundation; Swiss National Science Foundation; Oncosuisse; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harvard Stem Cell Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Medic Foundation; Nuovo Soldati Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Rheinbay, R. Ryan, M. Rivera, I. Bernstein, and A. Meissner for critical comments, and L. Gaffney for figure design. This work was supported by the Howard Hughes Medical Institute, the National Human Genome Research Institute, the NIH Common Fund, the National Heart, Lung, and Blood Institute, the Harvard Stem Cell Institute, the Burroughs Wellcome Fund, the Medic Foundation, the Nuovo Soldati Foundation, the Swiss National Science Foundation, and Oncosuisse.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lakshmikuttyamma A, 2010, ONCOGENE, V29, P576, DOI 10.1038/onc.2009.361; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Xu J, 2012, CELL, V151, P929, DOI 10.1016/j.cell.2012.11.007; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	64	509	523	8	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1567	1570		10.1126/science.1230184	http://dx.doi.org/10.1126/science.1230184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539597	Green Accepted			2022-12-28	WOS:000316731600039
J	Zheng, XT; O'Connor, J; Huchzermeyer, F; Wang, XL; Wang, Y; Wang, M; Zhou, ZH				Zheng, Xiaoting; O'Connor, Jingmai; Huchzermeyer, Fritz; Wang, Xiaoli; Wang, Yan; Wang, Min; Zhou, Zhonghe			Preservation of ovarian follicles reveals early evolution of avian reproductive behaviour	NATURE			English	Article							ALLIGATOR-MISSISSIPPIENSIS; DINOSAUR; CHINA; GROWTH; GENDER; SIZE	The two groups of archosaurs, crocodilians and birds, form an extant phylogenetic bracket for understanding the reproductive behaviour of dinosaurs. This behaviour is inferred from preserved nests and eggs, and even gravid individuals(1). Data indicate that many 'avian' traits were already present in Paraves-the clade that includes birds and their close relatives-and that the early evolution of the modern avian form of reproduction was already well on its way(2,3). Like living neornithine birds, non-avian maniraptorans had daily oviposition and asymmetrical eggs with complex shell microstructure, and were known to protect their clutches(4-6). However, like crocodilians, non-avian maniraptorans had two active oviducts (one present in living birds), relatively smaller eggs, and may not have turned their eggs in the way that living birds do(1,6). Here we report on the first discovery of fossilized mature or nearly mature ovarian follicles, revealing a previously undocumented stage in dinosaur reproduction: reproductively active females near ovulation. Preserved in a specimen of the long bony-tailed Jeholornis and two enantiornithine birds from the Early Cretaceous period lacustrine Jehol Biota in northeastern China, these discoveries indicate that basal birds only had one functional ovary, but retained primitive morphologies as a result of their lower metabolic rate relative to living birds. They also indicate that basal birds reached sexual maturity before skeletal maturity, as in crocodiles and paravian dinosaurs. Differences in follicular morphology between Jeholornis and the enantiornithines are interpreted as forming an evolutionary gradient from the reproductive condition in paravian dinosaurs towards neornithine birds. Furthermore, differences between the two enantiornithines indicate that this lineage might also have evolved advanced reproductive traits in parallel to the neornithine lineage.	[Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China; [Zheng, Xiaoting] Tianyu Nat Hist Museum Shandong, Pingyi 273300, Shandong, Peoples R China; [O'Connor, Jingmai; Wang, Min; Zhou, Zhonghe] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origin, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Huchzermeyer, Fritz] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Pretoria	O'Connor, J (corresponding author), Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China.	jingmai.oconnor@gmail.com; zhouzhonghe@ivpp.ac.cn	Xiaoli, Wang/H-1079-2014; Wang, Min/AAH-6782-2020	Wang, Min/0000-0001-8506-1213	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [41172020]; Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The specimens reported here are deposited in the Tianyu Natural History Museum, Shandong, China. We thank A. Shi for helping with illustrations, S. Zhang for help with the histological analysis and E. O'Connor for estimating body mass. The research was supported by the National Basic Research Program of China (973 Program, 2012CB821906), the National Natural Science Foundation of China (41172020) and the Chinese Academy of Sciences.	ASTHEIMER LB, 1989, COPEIA, P221, DOI 10.2307/1445632; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Clark James M., 1999, American Museum Novitates, V3265, P1; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; GILBERT AB, 1979, FORM FUNCTION BIRDS, V1, P237; GILL F. B., 2007, ORNITHOLOGY, P399; Girling JE, 2002, J EXP ZOOL, V293, P141, DOI 10.1002/jez.10105; GODFRAY HCJ, 1991, ANNU REV ECOL SYST, V22, P409, DOI 10.1146/annurev.es.22.110191.002205; LANCE VA, 1989, AM ZOOL, V29, P999; Liu Di, 2012, Vertebrata Palasiatica, V50, P39; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; OConnor, 2009, THESIS U SO CALIFORN; Richardson K. C., 2002, CROCODILES INSIDE OU, P96; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schweitzer MH, 2007, BONE, V40, P1152, DOI 10.1016/j.bone.2006.10.029; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; TAYLOR TG, 1970, SCI AM, V222, P88, DOI 10.1038/scientificamerican0370-88; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Zelenitsky D., 2006, P 2006 GOS INT DIN S, V22, P209; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2004, SCIENCE, V306, P653, DOI 10.1126/science.1100000	29	65	71	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					507	511		10.1038/nature11985	http://dx.doi.org/10.1038/nature11985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23503663	Green Submitted			2022-12-28	WOS:000316682800045
J	McCartney, M				McCartney, Margaret			Would doctors routinely asking older patients about their memory improve dementia outcomes? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Alzhemer's Society, ETH ISS REL COMM ORG; Armstrong R, 2012, COMMUNICATION; Boustani M, SCREENING DEMENTIA P; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; Nutricia Advanced Medical Nutrition, NEW APPR EARL ALZH D; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Social Market Foundation, 2012, FUT STAT MIND FAC DE; UK National Screening Committee, UK NSC POL ALZH DIS; UK Research and Innovation (UKRI), 2022, FRAMEWORK RESPONSIBL	9	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1745	10.1136/bmj.f1745	http://dx.doi.org/10.1136/bmj.f1745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WO	23532868				2022-12-28	WOS:000316984000012
J	Poulain, AJ; Barkay, T				Poulain, Alexandre J.; Barkay, Tamar			Cracking the Mercury Methylation Code	SCIENCE			English	Editorial Material							BIOLOGICAL METHYLATION; PRINCIPAL METHYLATORS; REDUCING BACTERIA; MODEL		[Poulain, Alexandre J.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Barkay, Tamar] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA	University of Ottawa; Rutgers State University New Brunswick	Poulain, AJ (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	apoulain@uottawa.ca	Poulain, Alexandre/C-1246-2009	Poulain, Alexandre/0000-0002-0488-3993				[Anonymous], 2013, DTI1636GE UN ENV PRO; Bergquist BA, 2007, SCIENCE, V318, P417, DOI 10.1126/science.1148050; Boto L, 2009, BIOL PHILOS, V24, P119, DOI 10.1007/s10539-007-9072-z; CHOI SC, 1994, APPL ENVIRON MICROB, V60, P4072, DOI 10.1128/AEM.60.11.4072-4077.1994; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Gilmour CC, 2011, APPL ENVIRON MICROB, V77, P3938, DOI 10.1128/AEM.02993-10; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; Hintelmann H, 2000, ENVIRON TOXICOL CHEM, V19, P2204, DOI [10.1897/1551-5028(2000)019&lt;2204:COMMAD&gt;2.3.CO;2, 10.1002/etc.5620190909]; JENSEN S, 1969, NATURE, V223, P753, DOI 10.1038/223753a0; Kerin EJ, 2006, APPL ENVIRON MICROB, V72, P7919, DOI 10.1128/AEM.01602-06; LANDNER L, 1971, NATURE, V230, P452, DOI 10.1038/230452a0; Lehnherr I, 2011, NAT GEOSCI, V4, P298, DOI [10.1038/ngeo1134, 10.1038/NGEO1134]; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; WOOD JM, 1968, NATURE, V220, P173, DOI 10.1038/220173a0	15	42	44	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1280	1281		10.1126/science.1235591	http://dx.doi.org/10.1126/science.1235591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493700				2022-12-28	WOS:000316053400022
J	Benoist, LBL; van Looij, MAJ				Benoist, Linda B. L.; van Looij, Marjolein A. J.			Melanoma of the Oral Cavity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Benoist, Linda B. L.; van Looij, Marjolein A. J.] Sint Lucas Andreas Hosp, Amsterdam, Netherlands	Sint Lucas Andreas Hospital	Benoist, LBL (corresponding author), Sint Lucas Andreas Hosp, Amsterdam, Netherlands.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					E14	E14		10.1056/NEJMicm1209977	http://dx.doi.org/10.1056/NEJMicm1209977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484850				2022-12-28	WOS:000315982100001
J	Asplund, CA; Best, TM				Asplund, Chad A.; Best, Thomas M.			Achilles tendon disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SHOCK-WAVE TREATMENT; NONOPERATIVE TREATMENT; RANDOMIZED-TRIAL; TENDINOPATHY; RUPTURE; EXERCISE; THERAPY; INJURY; RISK; ANATOMY		[Asplund, Chad A.] Eisenhower Army Med Ctr, Dept Family Med, Ft Gordon, GA 30905 USA; [Best, Thomas M.] Ohio State Univ, Dept Family Med, Div Sports Med, Columbus, OH 43221 USA	United States Department of Defense; United States Army; University System of Ohio; Ohio State University	Asplund, CA (corresponding author), Eisenhower Army Med Ctr, Dept Family Med, Ft Gordon, GA 30905 USA.	chad.asplund@gmail.com						Ahmed IM, 1998, J ORTHOPAED RES, V16, P591, DOI 10.1002/jor.1100160511; Alfredson H, 1998, AM J SPORT MED, V26, P360, DOI 10.1177/03635465980260030301; Alvarez-Nenegyei J, 2004, CLEV CLIN J MED, V73, P465; American Academy of Orthopaedic Surgeons, 2009, DIAGN TREATM AC ACH; ANDRES KH, 1985, ANAT EMBRYOL, V172, P145, DOI 10.1007/BF00319597; Aroen A, 2004, SCAND J MED SCI SPOR, V14, P30, DOI 10.1111/j.1600-0838.2004.00344.x; Benjamin M, 2004, ARTHRITIS RHEUM-US, V50, P3306, DOI 10.1002/art.20566; CANOSO JJ, 1988, ANN RHEUM DIS, V47, P910, DOI 10.1136/ard.47.11.910; Carcia CR, 2010, J ORTHOP SPORT PHYS, V40, pA1; Chen TM, 2009, CLIN ANAT, V22, P377, DOI 10.1002/ca.20758; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Corrao G, 2006, DRUG SAFETY, V29, P889, DOI 10.2165/00002018-200629100-00006; de Vos RJ, 2007, AM J SPORT MED, V35, P1696, DOI 10.1177/0363546507303116; Delgado GJ, 2002, RADIOLOGY, V224, P112, DOI 10.1148/radiol.2241011067; Doral MN, 2010, KNEE SURG SPORT TR A, V18, P638, DOI 10.1007/s00167-010-1083-7; Filardo Giuseppe, 2010, Orthopedics, V33, P120, DOI 10.3928/01477447-20100104-31; Forsgren S, 2005, REGUL PEPTIDES, V126, P173, DOI 10.1016/j.regpep.2004.09.008; Gambito ED, 2010, ARCH PHYS MED REHAB, V91, P1291, DOI 10.1016/j.apmr.2010.02.008; Garras DN, 2012, CLIN ORTHOP RELAT R, V470, P2268, DOI 10.1007/s11999-012-2355-y; Haims AH, 2000, SKELETAL RADIOL, V29, P640, DOI 10.1007/s002560000273; Hartgerink P, 2001, RADIOLOGY, V220, P406, DOI 10.1148/radiology.220.2.r01au41406; HELMS CA, 1995, RADIOLOGY, V195, P201, DOI 10.1148/radiology.195.1.7892469; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; Jonsson P, 2008, BRIT J SPORT MED, V42, P746, DOI 10.1136/bjsm.2007.039545; Kane TPC, 2008, AM J SPORT MED, V36, P1160, DOI 10.1177/0363546508314423; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Karjalainen PT, 2000, AM J ROENTGENOL, V175, P251, DOI 10.2214/ajr.175.1.1750251; Kearney R, 2010, FOOT ANKLE INT, V31, P689, DOI 10.3113/FAI.2010.0689; Keating JF, 2011, J BONE JOINT SURG BR, V93B, P1071, DOI 10.1302/0301-620X.93B8.25998; Khan KM, 2003, BRIT J SPORT MED, V37, P149, DOI 10.1136/bjsm.37.2.149; Khan RJK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003674.pub4; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; Kongsgaard M, 2005, J APPL PHYSIOL, V99, P1965, DOI 10.1152/japplphysiol.00384.2005; Kraemer R, 2012, ARCH ORTHOP TRAUM SU, V132, P847, DOI 10.1007/s00402-012-1476-9; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Leekam RN, 1999, AM J ROENTGENOL, V172, P185, DOI 10.2214/ajr.172.1.9888765; Longo UG, 2009, AM J SPORT MED, V37, P1400, DOI 10.1177/0363546509332250; Maffuli N, 2007, ACHILLES TENDON, P43; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Maffulli N, 2004, J ROY SOC MED, V97, P472, DOI 10.1258/jrsm.97.10.472; Maffulli N, 1998, AM J SPORT MED, V26, P266, DOI 10.1177/03635465980260021801; Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090; Mahieu NN, 2006, AM J SPORT MED, V34, P226, DOI 10.1177/0363546505279918; McMahon Samuel E, 2011, Foot Ankle Surg, V17, P211, DOI 10.1016/j.fas.2010.11.001; Nilsson-Helander K, 2010, AM J SPORT MED, V38, P2186, DOI 10.1177/0363546510376052; Nilsson-Helander K, 2009, KNEE SURG SPORT TR A, V17, P1234, DOI 10.1007/s00167-009-0727-y; Olsson N, 2011, KNEE SURG SPORT TR A, V19, P1385, DOI 10.1007/s00167-011-1511-3; Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301; Paavola Mika, 2005, Foot Ankle Clin, V10, P279, DOI 10.1016/j.fcl.2005.01.008; Rasmussen S, 2008, ACTA ORTHOP, V79, P249, DOI 10.1080/17453670710015058; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Rompe JD, 2008, J BONE JOINT SURG AM, V90A, P52, DOI 10.2106/JBJS.F.01494; Rompe JD, 2009, AM J SPORT MED, V37, P463, DOI 10.1177/0363546508326983; Roos EM, 2004, SCAND J MED SCI SPOR, V14, P286, DOI 10.1111/j.1600-0838.2004.378.x; Ryan M, 2009, FOOT ANKLE INT, V30, P1190, DOI 10.3113/FAI.2009.1190; Sampson S, 2011, INT J THER REHABIL, V18, P101, DOI 10.12968/ijtr.2011.18.2.101; SIMPSON SL, 1991, J HAND SURG-AM, V16A, P708; Sode J, 2007, EUR J CLIN PHARMACOL, V63, P499, DOI 10.1007/s00228-007-0265-9; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Suchak AA, 2008, J BONE JOINT SURG AM, V90A, P1876, DOI 10.2106/JBJS.G.01242; THOMPSON T C, 1962, Acta Orthop Scand, V32, P461, DOI 10.3109/17453676208989608; Twaddle BC, 2007, AM J SPORT MED, V35, P2033, DOI 10.1177/0363546507307503; van der Plas A, 2012, BRIT J SPORT MED, V46, P214, DOI 10.1136/bjsports-2011-090035; Willits K, 2010, J BONE JOINT SURG AM, V92A, P2767, DOI 10.2106/JBJS.I.01401; Woodley BL, 2007, BRIT J SPORT MED, V41, P188, DOI 10.1136/bjsm.2006.029769	66	39	39	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2013	346								f1262	10.1136/bmj.f1262	http://dx.doi.org/10.1136/bmj.f1262			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108VM	23482943				2022-12-28	WOS:000316324300006
J	Walshe, K; McKee, M; McCarthy, M; Groenewegen, P; Hansen, J; Figueras, J; Ricciardi, W				Walshe, Kieran; McKee, Martin; McCarthy, Mark; Groenewegen, Peter; Hansen, Johan; Figueras, Josep; Ricciardi, Walter			Health systems and policy research in Europe: Horizon 2020	LANCET			English	Editorial Material							PRIMARY-CARE; QUALITY		[Walshe, Kieran] European Hlth Management Assoc, B-1040 Brussels, Belgium; [McKee, Martin; Ricciardi, Walter] European Publ Hlth Assoc, Utrecht, Netherlands; [McCarthy, Mark] UCL, London, England; [Groenewegen, Peter] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Hansen, Johan] HSR Europe, Utrecht, Netherlands; [Figueras, Josep] European Observ Hlth Syst & Policies, Brussels, Belgium	University of London; University College London; Netherlands Institute for Health Services Research; European Observatory on Health Systems & Policies	Walshe, K (corresponding author), European Hlth Management Assoc, B-1040 Brussels, Belgium.	kieran.walshe@mbs.ac.uk	Ricciardi, Walter/K-3342-2018; Ricciardi, Walter/AAB-2056-2019; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	Ricciardi, Walter/0000-0002-5655-688X; McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683; Walshe, Kieran/0000-0002-0696-480X; Groenewegen, Peter/0000-0003-2127-8442	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albreht T, 2011, EUR J PUBLIC HEALTH, V21, P1, DOI 10.1093/eurpub/ckq196; Busse R, 2012, HEALTH ECON, V21, P1, DOI 10.1002/hec.2861; European Commission, 2012, COM211811 EUR COMM; Fahy N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1712; HSR-Europe, 2011, HLTH SERV RES EUR PO; Kringos DS, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-81; Legido-Quigley H, 2008, BMJ-BRIT MED J, V336, P920, DOI 10.1136/bmj.39538.584190.47; McCarthy M, 2011, PUBLIC HLTH RES EURO; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; OECD, 2012, HLTH GLANC 2012; Schafer WLA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-115; Suhrcke M, 2005, CONTRIBUTION HLTH EC; WHO, 2012, STRAT HLTH POL SYST	13	35	36	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 24	2013	382	9893					668	669		10.1016/S0140-6736(12)62195-3	http://dx.doi.org/10.1016/S0140-6736(12)62195-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206SI	23515143				2022-12-28	WOS:000323542400008
J	Katz, JN; Brophy, RH; Chaisson, CE; de Chaves, L; Cole, BJ; Dahm, DL; Donnell-Fink, LA; Guermazi, A; Haas, AK; Jones, MH; Levy, BA; Mandl, LA; Martin, SD; Marx, RG; Miniaci, A; Matava, MJ; Palmisano, J; Reinke, EK; Richardson, BE; Rome, BN; Safran-Norton, CE; Skoniecki, DJ; Solomon, DH; Smith, MV; Spindler, KP; Stuart, MJ; Wright, J; Wright, RW; Losina, E				Katz, Jeffrey N.; Brophy, Robert H.; Chaisson, Christine E.; de Chaves, Leigh; Cole, Brian J.; Dahm, Diane L.; Donnell-Fink, Laurel A.; Guermazi, Ali; Haas, Amanda K.; Jones, Morgan H.; Levy, Bruce A.; Mandl, Lisa A.; Martin, Scott D.; Marx, Robert G.; Miniaci, Anthony; Matava, Matthew J.; Palmisano, Joseph; Reinke, Emily K.; Richardson, Brian E.; Rome, Benjamin N.; Safran-Norton, Clare E.; Skoniecki, Debra J.; Solomon, Daniel H.; Smith, Matthew V.; Spindler, Kurt P.; Stuart, Michael J.; Wright, John; Wright, Rick W.; Losina, Elena			Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOME SCORE KOOS; KNEE OSTEOARTHRITIS; ARTHROSCOPIC SURGERY; LOWER-EXTREMITIES; RANDOMIZED-TRIAL; ELDERLY PERSONS; CLINICAL-TRIALS; UNITED-STATES; MENISCECTOMY; VALIDATION	BACKGROUND Whether arthroscopic partial meniscectomy for symptomatic patients with a meniscal tear and knee osteoarthritis results in better functional outcomes than nonoperative therapy is uncertain. METHODS We conducted a multicenter, randomized, controlled trial involving symptomatic patients 45 years of age or older with a meniscal tear and evidence of mild-to-moderate osteoarthritis on imaging. We randomly assigned 351 patients to surgery and postoperative physical therapy or to a standardized physical-therapy regimen (with the option to cross over to surgery at the discretion of the patient and surgeon). The patients were evaluated at 6 and 12 months. The primary outcome was the difference between the groups with respect to the change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) physical-function score (ranging from 0 to 100, with higher scores indicating more severe symptoms) 6 months after randomization. RESULTS In the intention-to-treat analysis, the mean improvement in the WOMAC score after 6 months was 20.9 points (95% confidence interval [CI], 17.9 to 23.9) in the surgical group and 18.5 (95% CI, 15.6 to 21.5) in the physical-therapy group (mean difference, 2.4 points; 95% CI, -1.8 to 6.5). At 6 months, 51 active participants in the study who were assigned to physical therapy alone (30%) had undergone surgery, and 9 patients assigned to surgery (6%) had not undergone surgery. The results at 12 months were similar to those at 6 months. The frequency of adverse events did not differ significantly between the groups. CONCLUSIONS In the intention-to-treat analysis, we did not find significant differences between the study groups in functional improvement 6 months after randomization; however, 30% of the patients who were assigned to physical therapy alone underwent surgery within 6 months. (Funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases; METEOR ClinicalTrials.gov number, NCT00597012.)	[Katz, Jeffrey N.; de Chaves, Leigh; Donnell-Fink, Laurel A.; Martin, Scott D.; Rome, Benjamin N.; Safran-Norton, Clare E.; Skoniecki, Debra J.; Solomon, Daniel H.; Wright, John; Losina, Elena] Brigham & Womens Hosp, Boston, MA 02115 USA; [Chaisson, Christine E.; Guermazi, Ali; Palmisano, Joseph] Boston Univ, Boston, MA 02215 USA; [Brophy, Robert H.; Haas, Amanda K.; Matava, Matthew J.; Smith, Matthew V.; Wright, Rick W.] Washington Univ, St Louis, MO 63130 USA; [Cole, Brian J.] Rush Univ, Chicago, IL 60612 USA; [Dahm, Diane L.; Levy, Bruce A.; Stuart, Michael J.] Mayo Clin, Rochester, MN USA; [Jones, Morgan H.; Miniaci, Anthony] Cleveland Clin, Cleveland, OH 44106 USA; [Mandl, Lisa A.; Marx, Robert G.] Hosp Special Surg, New York, NY 10021 USA; [Reinke, Emily K.; Richardson, Brian E.; Spindler, Kurt P.] Vanderbilt Univ, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Boston University; Washington University (WUSTL); Rush University; Mayo Clinic; Cleveland Clinic Foundation; Vanderbilt University	Katz, JN (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, 75 Francis St,BC-4016, Boston, MA 02115 USA.	jnkatz@partners.org	Brophy, Robert H/AAX-8562-2021; Cole, Brian/K-4268-2019; Jones, Morgan H/ABG-3503-2021	Brophy, Robert H/0000-0002-2912-8265; Jones, Morgan H/0000-0002-5466-0624; Chaisson, Christine/0000-0002-3207-9257; Rome, Benjamin/0000-0001-5776-3293; Losina, ELENA/0000-0002-3424-0892; Reinke, Emily/0000-0001-7629-8067	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR055557, K24AR057827, P60AR047782]; Orthopaedic Research and Education Foundation; Arthrex; Carticept; DJ Orthopedics; Genzyme; Johnson Johnson; DePuy Orthopedics; Regentis; Zimmer; Major League Baseball; Arthrosurface; Ossur; Smith and Nephew; Merck Serono; Pfizer; Allergan; Stryker; Breg; ISTO Technologies; Schwartz Biomedical; Ostesys; Arthrex and Breg; Arthrosurface and Stryker; DonJoy; National Football League; Flexion Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827, R01AR055557, P60AR047782] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Orthopaedic Research and Education Foundation; Arthrex; Carticept; DJ Orthopedics; Genzyme(Sanofi-AventisGenzyme Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); DePuy Orthopedics; Regentis; Zimmer; Major League Baseball; Arthrosurface; Ossur; Smith and Nephew; Merck Serono(Merck & Company); Pfizer(Pfizer); Allergan(AbbVieAllergan); Stryker; Breg; ISTO Technologies; Schwartz Biomedical; Ostesys; Arthrex and Breg; Arthrosurface and Stryker; DonJoy; National Football League; Flexion Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants (R01AR055557, K24AR057827, and P60AR047782) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.; Dr. Brophy reports receiving fees for providing expert testimony on behalf of Genzyme on the use of Synvisc and grant support through his institution from the Orthopaedic Research and Education Foundation. Dr. Cole reports receiving consulting fees from Arthrex, Carticept, DJ Orthopedics, Genzyme, Johnson & Johnson, DePuy Orthopedics, Regentis, and Zimmer, lecture fees from Genzyme, fees for providing expert testimony for medical malpractice defense and third-party liability cases on personal injury and product liability, and royalties from Arthrex, DJ Orthopedics, Elsevier, and W.B. Saunders, holding equity in Carticept and Regentis, receiving grant support through his institution from Major League Baseball, Arthrex, Zimmer, Arthrosurface, Johnson & Johnson, and Medipost and fellowship support through his institution from DJ Orthopedics, Ossur, and Smith and Nephew. Dr. Guermazi reports receiving consulting fees from Merck Serono, Pfizer, and Genzyme, and holding stock in Boston Imaging Core Lab. Dr. Jones reports receiving consulting fees from Allergan and grant support through his institution from DJ Orthopedics, Stryker, Smith and Nephew, Breg, and Arthrex. Dr. Levy reports receiving consulting fees from Arthrex and royalties from VOT Solutions and Arthrex. Dr. Matava reports receiving consulting fees from ISTO Technologies, Schwartz Biomedical, and Ostesys, and grant support through his institution from Arthrex and Breg. Dr. Miniaci reports receiving consulting fees from Arthrosurface and Stryker and lecture fees, payment for the development of educational presentations, and travel support from Arthrosurface, holding stock in Arthrosurface, and receiving royalties from Arthrosurface for granted and pending patents regarding retrograde delivery of resurfacing devices, an articular surface implant and delivery system, and a system and method for a retrograde procedure and grant support through his institution from DJ Orthopedics, Stryker, and Arthrex. Dr. Reinke reports receiving grant support through her institution from Smith and Nephew, DonJoy, and the National Football League. Dr. Smith reports receiving consulting fees from ISTO Technologies. Dr. Spindler reports receiving consulting fees from the National Football League and payment for patents from Connective Orthopedics on a biologic replacement for fibrin clots. Dr. Stuart reports receiving consulting fees and royalties from Arthrex and grant support through his institution from Stryker. Dr. J. Wright reports receiving consulting fees from DePuy Orthopedics. Dr. R. Wright reports receiving consulting fees from Flexion Therapeutics and ISTO Technologies, and grant support through his institution from Smith and Nephew. No other potential conflict of interest relevant to this article was reported.	Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Angst F, 2002, J RHEUMATOL, V29, P131; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Frobell RB, 2010, NEW ENGL J MED, V363, P893; Frobell RB, 2010, NEW ENGL J MED, V363, P331, DOI 10.1056/NEJMoa0907797; Guermazi A, 2012, SKELETAL RADIOL, V41, P179, DOI 10.1007/s00256-011-1142-2; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; Katz JN, 2012, CONTEMP CLIN TRIALS, V33, P1189, DOI 10.1016/j.cct.2012.08.010; Katz JN, 2011, J CLIN EPIDEMIOL, V64, P280, DOI 10.1016/j.jclinepi.2010.04.008; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Kirkley A, 2009, NEW ENGL J MED, V361, P2004; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mills PM, 2008, OSTEOARTHR CARTILAGE, V16, P1526, DOI 10.1016/j.joca.2008.04.014; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Niu NNN, 2011, ARTHRIT CARE RES, V63, P208, DOI 10.1002/acr.20354; Papalia R, 2011, BRIT MED BULL, V99, P89, DOI 10.1093/bmb/ldq043; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos EM, 1998, SCAND J MED SCI SPOR, V8, P439, DOI 10.1111/j.1600-0838.1998.tb00465.x; Sowers M, 2011, J BONE JOINT SURG AM, V93A, P241, DOI 10.2106/JBJS.I.00667; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136	31	404	411	9	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1675	1684		10.1056/NEJMoa1301408	http://dx.doi.org/10.1056/NEJMoa1301408			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23506518	Green Accepted			2022-12-28	WOS:000318214400001
J	Salmon, DA; Proschan, M; Forshee, R; Gargiullo, P; Bleser, W; Burwen, DR; Cunningham, F; Garman, P; Greene, SK; Lee, GM; Vellozzi, C; Yih, WK; Gellin, B; Lurie, N				Salmon, Daniel A.; Proschan, Michael; Forshee, Richard; Gargiullo, Paul; Bleser, William; Burwen, Dale R.; Cunningham, Francesca; Garman, Patrick; Greene, Sharon K.; Lee, Grace M.; Vellozzi, Claudia; Yih, W. Katherine; Gellin, Bruce; Lurie, Nicole		H1N1 GBS Meta-Anal Working Grp	Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis	LANCET			English	Article							UNITED-STATES; VACCINATION; SAFETY; IMMUNIZATION; DATALINK; SURVEILLANCE; RECEIPT; KINGDOM; COHORT; RISK	Background The influenza A (H1N1) 2009 monovalent vaccination programme was the largest mass vaccination initiative in recent US history. Commensurate with the size and scope of the vaccination programme, a project to monitor vaccine adverse events was undertaken, the most comprehensive safety surveillance agenda in the USA to date. The adverse event monitoring project identified an increased risk of Guillain-Barre syndrome after vaccination; however, some individual variability in results was noted. Guillain-Barre syndrome is a rare but serious health disorder in which a person's own immune system damages their nerve cells, causing muscle weakness, sometimes paralysis, and infrequently death. We did a meta-analysis of data from the adverse event monitoring project to ascertain whether influenza A (H1N1) 2009 monovalent inactivated vaccines used in the USA increased the risk of Guillain-Barre syndrome. Methods Data were obtained from six adverse event monitoring systems. About 23 million vaccinated people were included in the analysis. The primary analysis entailed calculation of incidence rate ratios and attributable risks of excess cases of Guillain-Barre syndrome per million vaccinations. We used a self-controlled risk-interval design. Findings Influenza A (H1N1) 2009 monovalent inactivated vaccines were associated with a small increased risk of Guillain-Barre syndrome (incidence rate ratio 2.35, 95% CI 1.42-4.01, p=0.0003). This finding translated to about 1.6 excess cases of Guillain-Barre syndrome per million people vaccinated. Interpretation The modest risk of Guillain-Barre syndrome attributed to vaccination is consistent with previous estimates of the disorder after seasonal influenza vaccination. A risk of this small magnitude would be difficult to capture during routine seasonal influenza vaccine programmes, which have extensive, but comparatively less, safety monitoring. In view of the morbidity and mortality caused by 2009 H1N1 influenza and the effectiveness of the vaccine, clinicians, policy makers, and those eligible for vaccination should be assured that the benefits of inactivated pandemic vaccines greatly outweigh the risks.	[Salmon, Daniel A.; Bleser, William; Gellin, Bruce] Dept Hlth & Human Serv, Natl Vaccine Program Off, Off Assistant Secretary Hlth, Washington, DC USA; [Lurie, Nicole] Dept Hlth & Human Serv, Washington, DC USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD 21205 USA; [Proschan, Michael] NIH, Bethesda, MD 20892 USA; [Forshee, Richard; Burwen, Dale R.] US FDA, Rockville, MD 20857 USA; [Gargiullo, Paul; Vellozzi, Claudia] Ctr Dis Control & Prevent, Atlanta, GA USA; [Cunningham, Francesca] US Dept Vet Affairs, Hines, IL USA; [Garman, Patrick] US Dept Def, Washington, DC 20305 USA; [Greene, Sharon K.; Lee, Grace M.; Yih, W. Katherine] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Greene, Sharon K.; Lee, Grace M.; Yih, W. Katherine] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; United States Department of Defense; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Salmon, DA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD 21205 USA.	dsalmon@jhsph.edu		Forshee, Richard/0000-0002-5805-2837; Greene, Sharon K./0000-0002-3509-2377; salmon, daniel/0000-0002-1035-4422; Jacobsen, Steven/0000-0002-8174-8533; Bleser, William/0000-0002-4640-8680	US Federal Government	US Federal Government	US Federal Government.	[Anonymous], 2011, MEDICINE, DOI DOI 10.17226/13164; Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; Borse RH, 2013, EMERG INFECT DIS, V19, P439, DOI 10.3201/eid1903.120394; BREMAN JG, 1984, AM J EPIDEMIOL, V119, P880, DOI 10.1093/oxfordjournals.aje.a113810; Burwen DR, 2012, AM J PUBLIC HEALTH, V102, P1921, DOI 10.2105/AJPH.2011.300510; Burwen DR, 2010, AM J PREV MED, V39, P296, DOI 10.1016/j.amepre.2010.05.022; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Greene SK, 2010, AM J EPIDEMIOL, V171, P177, DOI 10.1093/aje/kwp345; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Klein NP, 2010, PEDIATR INFECT DIS J, V29, P613, DOI 10.1097/INF.0b013e3181d581f9; Kramarz P, 2000, ARCH FAM MED, V9, P617, DOI 10.1001/archfami.9.7.617; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; National Vaccine Advisory Committee, 2012, H1N1 VACC SAF RISK A; Polakowski LL, AM J EPIDEM IN PRESS; Poland GA, 2012, VACCINE, V30, P5801, DOI 10.1016/j.vaccine.2012.06.093; Prothro C., 2010, Morbidity and Mortality Weekly Report, V59, P657; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Shaikh AG, 2012, VACCINE, V30, P3251, DOI 10.1016/j.vaccine.2012.03.013; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Stratton K, 2004, INFLUENZA VACCINE NE; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197	40	127	130	0	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1461	1468		10.1016/S0140-6736(12)62189-8	http://dx.doi.org/10.1016/S0140-6736(12)62189-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23498095				2022-12-28	WOS:000318607300035
J	Ohde, T; Yaginuma, T; Niimi, T				Ohde, Takahiro; Yaginuma, Toshinobu; Niimi, Teruyuki			Insect Morphological Diversification Through the Modification of Wing Serial Homologs	SCIENCE			English	Article							TEAD/TEF FAMILY; EVOLUTION; ULTRABITHORAX; INTEGRATION; EXPRESSION; COCKROACH; IDENTITY; ORIGIN; BEETLE	Fossil insects living some 300 million years ago show winglike pads on all thoracic and abdominal segments, which suggests their serial homology. It remains unclear whether winglike structures in nonwinged segments have been lost or modified through evolution. Here, we identified a ventral lateral part of the body wall on the first thoracic segment, the hypomeron, and pupal dorsolateral denticular outgrowths as wing serial homologs in the mealworm beetle Tenebrio molitor. Both domains transform into winglike structures under Hox RNA interference conditions. Gene expression and functional analyses revealed central roles for the key wing selector genes, vestigial and scalloped, in the hypomeron and the denticular outgrowth formation. We propose that modification, rather than loss, of dorsal appendages has provided an additional diversifying mechanism of insect body plan.	[Ohde, Takahiro; Yaginuma, Toshinobu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	niimi@agr.nagoya-u.ac.jp		Niimi, Teruyuki/0000-0003-3981-0177; Ohde, Takahiro/0000-0002-0870-9175	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Morita-Miwa for helping in the early stage of this study; T. Suzuki, M. Kobayashi, M. Ikeda, and L. van de Graaf for helpful discussions; and K. Kawakita for providing potatoes. This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science. Sequences are deposited in GenBank (accession nos. AB698919 to AB698923).	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Eisner Thomas, 1992, Psyche (Cambridge), V99, P265, DOI 10.1155/1992/54859; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HLAVAC T F, 1972, Psyche (Cambridge), V79, P123, DOI 10.1155/1972/31579; Hrycaj S, 2010, DEV BIOL, V341, P324, DOI 10.1016/j.ydbio.2010.02.018; Ichikawa T, 2009, ZOOL SCI, V26, P525, DOI 10.2108/zsj.26.525; Jockusch EL, 2004, J HERED, V95, P382, DOI 10.1093/jhered/esh064; KERRIDGE S, 1982, J EMBRYOL EXP MORPH, V68, P211; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Miko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030137; Niwa N, 2010, EVOL DEV, V12, P168, DOI 10.1111/j.1525-142X.2010.00402.x; Ohde T, 2009, INSECT MOL BIOL, V18, P571, DOI 10.1111/j.1365-2583.2009.00898.x; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Prud'homme B, 2011, NATURE, V473, P83, DOI 10.1038/nature09977; ROSS MARY H., 1964, AMER MIDLAND NAT, V71, P161, DOI 10.2307/2422693; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Tanaka A, 1997, ZOOL SCI, V14, P339, DOI 10.2108/zsj.14.339; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; WILSON MCL, 1971, J STORED PROD RES, V7, P21, DOI 10.1016/0022-474X(71)90034-8; WOOTTON R J, 1972, Palaeontology (Oxford), V15, P662; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yoshizawa K, 2012, SYST ENTOMOL, V37, P2, DOI 10.1111/j.1365-3113.2011.00606.x; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; [No title captured], DOI DOI 10.1111/J.1365-2311.1946.TB00273.X	28	48	49	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					495	498		10.1126/science.1234219	http://dx.doi.org/10.1126/science.1234219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23493422				2022-12-28	WOS:000318016700047
J	Pernigo, S; Lamprecht, A; Steiner, RA; Dodding, MP				Pernigo, Stefano; Lamprecht, Anneri; Steiner, Roberto A.; Dodding, Mark P.			Structural Basis for Kinesin-1: Cargo Recognition	SCIENCE			English	Article							LIGHT-CHAIN; DYNEIN; TRANSPORT; PROTEINS; SEQUENCE; AVIDITY; BINDING	Kinesin-mediated cargo transport is required for many cellular functions and plays a key role in pathological processes. Structural information on how kinesins recognize their cargoes is required for a molecular understanding of this fundamental and ubiquitous process. Here, we present the crystal structure of the tetratricopeptide repeat domain of kinesin light chain 2 in complex with a cargo peptide harboring a "tryptophan-acidic" motif derived from SKIP (SifA-kinesin interacting protein), a critical host determinant in Salmonella pathogenesis and a regulator of lysosomal positioning. Structural data together with biophysical, biochemical, and cellular assays allow us to propose a framework for intracellular transport based on the binding by kinesin-1 of W-acidic cargo motifs through a combination of electrostatic interactions and sequence-specific elements, providing direct molecular evidence of the mechanisms for kinesin-1: cargo recognition.	[Pernigo, Stefano; Lamprecht, Anneri; Steiner, Roberto A.; Dodding, Mark P.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Steiner, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	roberto.steiner@kcl.ac.uk; mark.dodding@kcl.ac.uk	Steiner, Roberto/AAZ-9582-2021	Steiner, Roberto/0000-0001-7084-9745; Dodding, Mark/0000-0001-8091-6534	Wellcome Trust; London Law Trust; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); London Law Trust; British Heart Foundation(British Heart Foundation)	Scientists of I24 beamline (Diamond Light Source, Didcot, UK) are gratefully acknowledged for their support during data collection. ARL8b-HA and myc-SKIP were a kind gift from S. Munro, (Laboratory of Molecular Biology-Medical Research Council, Cambridge). We thank T. Blundell and R. Nookala (University of Cambridge) for useful discussions. Coordinates and structure factor files for have been deposited in the Protein Data Bank under accession number 3ZFW. The authors declare no competing financial interests. M.P.D and A.L. are supported by a Wellcome Trust Research Career Development Fellowship to M.P.D. and a London Law Trust Medal Fellowship to M.P.D. S.P. is supported by a British Heart Foundation grant awarded to R.A.S.	Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Gindhart Joseph G., 2006, Briefings in Functional Genomics & Proteomics, V5, P74, DOI 10.1093/bfgp/ell002; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Mack ET, 2012, J AM CHEM SOC, V134, P333, DOI 10.1021/ja2073033; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943	21	56	59	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					356	359		10.1126/science.1234264	http://dx.doi.org/10.1126/science.1234264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23519214	Green Accepted			2022-12-28	WOS:000317657500057
J	Fukami, T				Fukami, Tadashi			Integrating Inquiry-Based Teaching with Faculty Research	SCIENCE			English	Editorial Material									Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Fukami, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	fukamit@stanford.edu	Fukami, Tadashi/A-2934-2010	Fukami, Tadashi/0000-0001-5654-4785	Direct For Biological Sciences [1149600] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		American Association for the Advancement of Science, 2010, VIS CHANG CALL ACT; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Brownell S.E., 2012, J COLL SCI TEACH, V41, P36; Brownell SE, 2012, CBE-LIFE SCI EDUC, V11, P339, DOI 10.1187/cbe.12-09-0163; Duncan RG, 2013, SCIENCE, V339, P396, DOI 10.1126/science.1228692; Kloser MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001174; Kloser MJ, 2013, J COLL SCI TEACH, V42, P90; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601	10	19	19	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1536	1537		10.1126/science.1229850	http://dx.doi.org/10.1126/science.1229850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114HL	23539590				2022-12-28	WOS:000316731600032
J	Michaelis, S; Hrycyna, CA				Michaelis, Susan; Hrycyna, Christine A.			A Protease for the Ages	SCIENCE			English	Editorial Material							PRELAMIN-A; ZMPSTE24		[Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Johns Hopkins University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Michaelis, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	michaelis@jhmi.edu; hrycyna@purdue.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041223] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM41223] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Gordon LB, 2012, J CELL BIOL, V199, P9, DOI 10.1083/jcb.201207072; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513	11	16	16	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1529	1530		10.1126/science.1236764	http://dx.doi.org/10.1126/science.1236764			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539586				2022-12-28	WOS:000316731600027
J	Quigley, A; Dong, YY; Pike, ACW; Dong, L; Shrestha, L; Berridge, G; Stansfeld, PJ; Sansom, MSP; Edwards, AM; Bountra, C; von Delft, F; Bullock, AN; Burgess-Brown, NA; Carpenter, EP				Quigley, Andrew; Dong, Yin Yao; Pike, Ashley C. W.; Dong, Liang; Shrestha, Leela; Berridge, Georgina; Stansfeld, Phillip J.; Sansom, Mark S. P.; Edwards, Aled M.; Bountra, Chas; von Delft, Frank; Bullock, Alex N.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.			The Structural Basis of ZMPSTE24-Dependent Laminopathies	SCIENCE			English	Article							HETEROZYGOUS ZMPSTE24 MUTATIONS; MANDIBULOACRAL DYSPLASIA; RESTRICTIVE DERMOPATHY; PRELAMIN-A; ZINC METALLOPROTEINASE; LAMIN-A; ACCUMULATION; PHENOTYPE	Mutations in the nuclear membrane zinc metalloprotease ZMPSTE24 lead to diseases of lamin processing (laminopathies), such as the premature aging disease progeria and metabolic disorders. ZMPSTE24 processes prelamin A, a component of the nuclear lamina intermediate filaments, by cleaving it at two sites. Failure of this processing results in accumulation of farnesylated, membrane-associated prelamin A. The 3.4 angstrom crystal structure of human ZMPSTE24 has a seven transmembrane a-helical barrel structure, surrounding a large, water-filled, intramembrane chamber, capped by a zinc metalloprotease domain with the catalytic site facing into the chamber. The 3.8 angstrom structure of a complex with a CSIM tetrapeptide showed that the mode of binding of the substrate resembles that of an insect metalloprotease inhibitor in thermolysin. Laminopathy-associated mutations predicted to reduce ZMPSTE24 activity map to the zinc metalloprotease peptide-binding site and to the bottom of the chamber.	[Quigley, Andrew; Dong, Yin Yao; Pike, Ashley C. W.; Dong, Liang; Shrestha, Leela; Berridge, Georgina; Bountra, Chas; von Delft, Frank; Bullock, Alex N.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Stansfeld, Phillip J.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Oxford; University of Oxford; University of Toronto; Structural Genomics Consortium	Carpenter, EP (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	liz.carpenter@sgc.ox.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011; Sansom, Mark S.P./C-5157-2009	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Carpenter, Liz/0000-0001-9138-2937; Pike, Ashley/0000-0001-9661-2607; Edwards, Aled/0000-0002-4782-6016; von Delft, Frank/0000-0003-0378-0017; Quigley, Andrew/0000-0002-5022-9845; Dong, Yin/0000-0001-8600-6988	AbbVie [1097737]; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Eli Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019855/1, B19456, BB/H000267/1, BBS/B/16011, BEP17032] Funding Source: researchfish	AbbVie(AbbVie); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Yang, S. Mukhopadhyay, C. Cooper, S. Goubin, Q. Li, A. Chaikuad, J. Kim, and A. Barr for help with this project, including preparation of insect cell cultures, screening constructs and crystals, purification, and help with crystal optimization. We thank J. Bray for construct design; B. Marsden for bioinformatics support; R. Chalk for mass spectrometry; H. Lingard for help with the mechanism figures; the staff at Diamond Light Source Ltd.; and, in particular, the microfocus beamline I24 staff D. Axford, R. Owen, and G. Evans. The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Eli Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, The Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust. Atomic coordinates and structure factors have been deposited with the Protein Data Bank under accession codes 4AW6 (P1 crystal form) and 2YPT (peptide complex). The authors declare no competing financial interests.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Agarwal AK, 2006, J INVEST MED, V54, P208, DOI 10.2310/6650.2006.05068; Ahmad Z, 2010, AM J MED GENET A, V152A, P2703, DOI 10.1002/ajmg.a.33664; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Ben Yaou R, 2011, EUR J HUM GENET, V19, P647, DOI 10.1038/ejhg.2010.256; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Cunningham VJ, 2010, BONE, V47, P591, DOI 10.1016/j.bone.2010.06.004; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Denecke J, 2006, HUM MUTAT, V27, P524, DOI 10.1002/humu.20315; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Kuzin A. P., 2008, PDB ENTRY 3C37, V3c37, DOI [10.2210/pdb3c37/pdb, DOI 10.2210/PDB3C37/PDB]; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Miyoshi Y, 2008, CLIN GENET, V73, P535, DOI 10.1111/j.1399-0004.2008.00992.x; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Shackleton S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029751; Thill M, 2008, ARCH GYNECOL OBSTET, V278, P201, DOI 10.1007/s00404-008-0676-6; WITT DR, 1986, AM J MED GENET, V24, P631, DOI 10.1002/ajmg.1320240408	31	69	74	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1604	1607		10.1126/science.1231513	http://dx.doi.org/10.1126/science.1231513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539603				2022-12-28	WOS:000316731600048
J	Kadoch, C; Crabtree, GR				Kadoch, Cigall; Crabtree, Gerald R.			Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; NEURAL DEVELOPMENT; SWI/SNF COMPLEXES; SOFT-TISSUE; GENES; SYT; POLYCOMB; GENOME; CELLS; SSX	Recent exon sequencing studies have revealed that over 20% of human tumors have mutations in subunits of mSWI/SNF (BAF) complexes. To investigate the underlying mechanism, we studied human synovial sarcoma (SS), in which transformation results from the translocation of exactly 78 amino acids of SSX to the SS18 subunit of BAF complexes. We demonstrate that the SS18-SSX fusion protein competes for assembly with wild-type SS18, forming an altered complex lacking the tumor suppressor BAF47 (hSNF5). The altered complex binds the Sox2 locus and reverses polycomb-mediated repression, resulting in Sox2 activation. Sox2 is uniformly expressed in SS tumors and is essential for proliferation. Increasing the concentration of wild-type SS18 leads to reassembly of wild-type complexes retargeted away from the Sox2 locus, polycomb-mediated repression of Sox2, and cessation of proliferation. This mechanism of transformation depends on only two amino acids of SSX, providing a potential foundation for therapeutic intervention.	[Kadoch, Cigall] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kadoch, Cigall; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	crabtree@stanford.edu		Crabtree, Robert/0000-0002-6639-8707	National Institutes of Health (NIH) [HD55391, RO1NS046789, R01CA163195]; National Science Foundation (Graduate Research Fellowship Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA163915, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (Graduate Research Fellowship Program)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health (NIH) (HD55391, RO1NS046789, and R01CA163195) (to G.R.C.). G.R.C. is an Investigator of the Howard Hughes Medical Institute. C.K. is supported by the National Science Foundation (Graduate Research Fellowship Program). The authors are grateful to Kazuyuki Itoh, Norifume Naka, and Satoshi Takenaka (Osaka University, Japan) for kindly providing the Aska-SS and Yamato-SS cell lines and cDNA clone of the SS18-SSX fusion. We are also grateful to Clara Lee for technical assistance and N. Hathaway, O. Bell, A. Shalizi, and J. Ronan for helpful discussions and their critical review of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sandberg AA, 2002, CANCER GENET CYTOGEN, V132, P1, DOI 10.1016/S0165-4608(01)00528-3; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith HA, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/150591; Takenaka S, 2010, INT J ONCOL, V36, P823, DOI 10.3892/ijo_00000559; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WEISS SW, 2001, ENZINGER WEISSS SOFT; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	44	289	300	4	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					71	85		10.1016/j.cell.2013.02.036	http://dx.doi.org/10.1016/j.cell.2013.02.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540691	Green Accepted, Bronze			2022-12-28	WOS:000316853700007
J	Kaelin, WG; McKnight, SL				Kaelin, William G., Jr.; McKnight, Steven L.			Influence of Metabolism on Epigenetics and Disease	CELL			English	Review							OFFSPRING DNA METHYLATION; ACETYL-COA SYNTHETASE; COMBINED FOLIC-ACID; HISTONE METHYLATION; OXIDATIVE STRESS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; S-ADENOSYLMETHIONINE; ESSENTIAL COFACTOR; TUMOR-SUPPRESSOR; GENE-EXPRESSION	Chemical modifications of histones and DNA, such as histone methylation, histone acetylation, and DNA methylation, play critical roles in epigenetic gene regulation. Many of the enzymes that add or remove such chemical modifications are known, or might be suspected, to be sensitive to changes in intracellular metabolism. This knowledge provides a conceptual foundation for understanding how mutations in the metabolic enzymes SDH, FH, and IDH can result in cancer and, more broadly, for how alterations in metabolism and nutrition might contribute to disease. Here, we review literature pertinent to hypothetical connections between metabolic and epigenetic states in eukaryotic cells.	[Kaelin, William G., Jr.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu; steven.mcknight@utsouthwestern.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA068490, R01 CA076120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076120, R01CA068490] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Andreeva VA, 2012, ARCH INTERN MED, V172, P540, DOI 10.1001/archinternmed.2011.1450; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Cai L, 2012, ANNU REV CELL DEV BI, V28, P59, DOI 10.1146/annurev-cellbio-092910-154010; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Cervera AM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-89; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gerhauser C, 2013, TOP CURR CHEM, V329, P73, DOI 10.1007/128_2012_360; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hardie DG, 2011, COLD SH Q B, V76, P155, DOI 10.1101/sqb.2011.76.010819; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim YI, 2004, AM J CLIN NUTR, V80, P1123, DOI 10.1093/ajcn/80.5.1123; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krebs H. A., 1969, ENERGY LEVEL METABOL, P329; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Langer MR, 2002, J BIOL CHEM, V277, P27337, DOI 10.1074/jbc.M203251200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; LIPMANN F, 1946, J BIOL CHEM, V162, P743; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Losman JA, 2013, SCIENCE; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Park J, 2012, P NATL ACAD SCI USA, V109, P21058, DOI 10.1073/pnas.1214400109; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; SAKATA SF, 1993, J BIOL CHEM, V268, P13978; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Song YQ, 2012, J NATL CANCER I, V104, P1562, DOI 10.1093/jnci/djs370; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stefanska B, 2012, BRIT J PHARMACOL, V167, P279, DOI 10.1111/j.1476-5381.2012.02002.x; Stover PJ, 2011, J NUTRIGENET NUTRIGE, V4, P293, DOI 10.1159/000334586; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; Tefferi A, 2009, NEW ENGL J MED, V361, P1117, DOI 10.1056/NEJMc091348; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	127	581	592	9	307	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					56	69		10.1016/j.cell.2013.03.004	http://dx.doi.org/10.1016/j.cell.2013.03.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540690	Green Accepted, Bronze			2022-12-28	WOS:000316853700006
J	Silverman, E				Silverman, Ed			DRUG COMPANIES Big brand pharma on the hook for generic problems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pharmalot@gmail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1978	10.1136/bmj.f1978	http://dx.doi.org/10.1136/bmj.f1978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538929				2022-12-28	WOS:000316986200013
J	Shnyrova, AV; Bashkirov, PV; Akimov, SA; Pucadyil, TJ; Zimmerberg, J; Schmid, SL; Frolov, VA				Shnyrova, Anna V.; Bashkirov, Pavel V.; Akimov, Sergey A.; Pucadyil, Thomas J.; Zimmerberg, Joshua; Schmid, Sandra L.; Frolov, Vadim A.			Geometric Catalysis of Membrane Fission Driven by Flexible Dynamin Rings	SCIENCE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; CONSTRICTION; REVEALS; FUSION; SHAPE	Biological membrane fission requires protein-driven stress. The guanosine triphosphatase (GTPase) dynamin builds up membrane stress by polymerizing into a helical collar that constricts the neck of budding vesicles. How this curvature stress mediates nonleaky membrane remodeling is actively debated. Using lipid nanotubes as substrates to directly measure geometric intermediates of the fission pathway, we found that GTP hydrolysis limits dynamin polymerization into short, metastable collars that are optimal for fission. Collars as short as two rungs translated radial constriction to reversible hemifission via membrane wedging of the pleckstrin homology domains (PHDs) of dynamin. Modeling revealed that tilting of the PHDs to conform with membrane deformations creates the low-energy pathway for hemifission. This local coordination of dynamin and lipids suggests how membranes can be remodeled in cells.	[Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, CSIC, Biophys Unit, Leioa, Spain; [Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa, Spain; [Bashkirov, Pavel V.; Akimov, Sergey A.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow 119071, Russia; [Akimov, Sergey A.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Schmid, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Frolov, Vadim A.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; National University of Science & Technology (MISIS); Indian Institute of Science Education & Research (IISER) Pune; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; Basque Foundation for Science	Frolov, VA (corresponding author), Univ Basque Country, CSIC, Biophys Unit, Leioa, Spain.	vadim.frolov@ehu.es	Frolov, Vadim/ABH-3889-2020; Bashkirov, Pavel V/Y-8464-2018; Akimov, Sergey A/L-2001-2013; Akimov, Sergey/AFV-4270-2022; Akimov, Sergey A./I-6432-2015; Pucadyil, Thomas/AAJ-3974-2020	Frolov, Vadim/0000-0002-0653-5669; Akimov, Sergey/0000-0002-7916-6032; Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024; Bashkirov, Pavel/0000-0003-2250-9759; Shnyrova, Anna/0000-0002-5329-348X	Spanish Ministry of Economy and Competitiveness [BFU2012-34885]; Basque Government [IE12-332]; Russian Foundation for Basic Research [11-04-02087]; Russian Academy of Science; Ministry of Education and Science of the Russian Federation [14.740.11.1409]; National Institute of Child Health and Human Development; NIH [GM42455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Rizo-Rey and P. Kuzmin for critical reading of the manuscript. This work was in part supported by Spanish Ministry of Economy and Competitiveness grant BFU2012-34885 (V.A.F.); the Basque Government Program Etortek, grant IE12-332 (V.A.F); Russian Foundation for Basic Research grant 11-04-02087 (P.V.B.); the Russian Academy of Science program "Molecular and Cell Biology" (P.V.B. and S.A.A.); the Ministry of Education and Science of the Russian Federation, grant 14.740.11.1409 (P.V.B.); the Intramural Program of the National Institute of Child Health and Human Development (J.Z); and NIH grant GM42455 (S.L.S.). Additional data are presented in the supplementary materials.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Frolov VA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004747; Frolov VA, 2010, FEBS LETT, V584, P1824, DOI 10.1016/j.febslet.2010.01.039; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8; Mattheyses AL, 2011, TRAFFIC, V12, P1394, DOI 10.1111/j.1600-0854.2011.01235.x; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2011, CURR TOP MEMBR, V68, P33, DOI 10.1016/B978-0-12-385891-7.00002-7; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	28	92	93	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1433	1436		10.1126/science.1233920	http://dx.doi.org/10.1126/science.1233920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520112	Green Accepted			2022-12-28	WOS:000316740700043
J	Tanji, H; Ohto, U; Shibata, T; Miyake, K; Shimizu, T				Tanji, Hiromi; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki			Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands	SCIENCE			English	Article							SINGLE-STRANDED RNA; INTERFERING RNA; RECOGNITION; ACTIVATION; RESPONSES; CELLS; TLR7; INDUCTION; VIRUSES	Toll-like receptor 7 (TLR7) and TLR8 recognize single-stranded RNA and initiate innate immune responses. Several synthetic agonists of TLR7-TLR8 display novel therapeutic potential; however, the molecular basis for ligand recognition and activation of signaling by TLR7 or TLR8 is largely unknown. In this study, the crystal structures of unliganded and ligand-induced activated human TLR8 dimers were elucidated. Ligand recognition was mediated by a dimerization interface formed by two protomers. Upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity. The loop between leucine-rich repeat 14 (LRR14) and LRR15 was cleaved; however, the N- and C-terminal halves remained associated and contributed to ligand recognition and dimerization. Thus, ligand binding induces reorganization of the TLR8 dimer, which enables downstream signaling processes.	[Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Ctr Expt Med & Syst Biol, Div Innate Immun,Lab Innate Immun,Inst Med Sci,Mi, Tokyo 1088639, Japan; [Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; University of Tokyo; RIKEN	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	The NF-kappa B luciferase reporter plasmid, pELAM1-luc, containing the human E-selectin promoter region was kindly provided by T. Muta. We thank the beamline staffs at Photon Factory and SPring-8 for their assistance with data collection. This work was supported by funding from a Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid (U.O., K.M., and T.S.), Takeda Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.). The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The coordinate and structure factor data of human TLR8 (unliganded form), TLR8-CL097, TLR8-CL075, TLR8-R848 (form1), TLR8-R848 (form2), and TLR8-R848 (form3) have been deposited to the Protein Data Bank (PDB) under the PDB IDs 3W3G, 3W3J, 3W3K, 3W3L, 3W3M, and 3W3N, respectively. We all declare that none of the authors have a financial interest related to this work.	Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	24	231	243	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1426	1429		10.1126/science.1229159	http://dx.doi.org/10.1126/science.1229159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520111				2022-12-28	WOS:000316740700041
J	Winnacker, EL				Winnacker, Ernst-Ludwig			A chance to drive forward Europe's science	NATURE			English	Editorial Material											Winnacker, EL (corresponding author), Human Frontier Sci Program Org, Strasbourg, France.	elwinnacker@gmail.com							0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					283	283		10.1038/495283a	http://dx.doi.org/10.1038/495283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EY	23518524	Bronze			2022-12-28	WOS:000316650500004
J	Butler, CC; Simpson, SA; Hood, K; Cohen, D; Pickles, T; Spanou, C; McCambridge, J; Moore, L; Randell, E; Alam, MF; Kinnersley, P; Edwards, A; Smith, C; Rollnick, S				Butler, Christopher C.; Simpson, Sharon A.; Hood, Kerenza; Cohen, David; Pickles, Tim; Spanou, Clio; McCambridge, Jim; Moore, Laurence; Randell, Elizabeth; Alam, M. Fasihul; Kinnersley, Paul; Edwards, Adrian; Smith, Christine; Rollnick, Stephen			Training practitioners to deliver opportunistic multiple behaviour change counselling in primary care: a cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PRIMARY-HEALTH-CARE; GENERAL-PRACTICE; PHYSICAL-ACTIVITY; COMMUNICATION-SKILLS; PATIENTS PERCEPTIONS; PRIMARY PREVENTION; RISK REDUCTION; INTERVENTIONS; SMOKING	Objectives To evaluate the effect of training primary care health professionals in behaviour change counselling on the proportion of patients self reporting change in four risk behaviours (smoking, alcohol use, exercise, and healthy eating). Design Cluster randomised trial with general practices as the unit of randomisation. Setting General practices in Wales. Participants 53 general practitioners and practice nurses from 27 general practices (one each at all but one practice) recruited 1827 patients who screened positive for at least one risky behaviour. Intervention Behaviour change counselling was developed from motivational interviewing to enable clinicians to enhance patients' motivation to change health related behaviour. Clinicians were trained using a blended learning programme called Talking Lifestyles. Main outcome measures Proportion of patients who reported making beneficial changes in at least one of the four risky behaviours at three months. Results 1308 patients from 13 intervention and 1496 from 14 control practices were approached: 76% and 72% respectively agreed to participate, with 831 (84%) and 996 (92%) respectively screening eligible for an intervention. There was no effect on the primary outcome (beneficial change in behaviour) at three months (362 (44%) v 404 (41%), odds ratio 1.12 (95% CI 0.90 to 1.39)) or on biochemical or biometric measures at 12 months. More patients who had consulted with trained clinicians recalled consultation discussion about a health behaviour (724/795 (91%) v 531/966 (55%), odds ratio 12.44 (5.85 to 26.46)) and intended to change (599/831 (72%) v 491/996 (49%), odds ratio 2.88 (2.05 to 4.05)). More intervention practice patients reported making an attempt to change (328 (39%) v 317 (32%), odds ratio 1.40 (1.15 to 1.70)), a sustained behaviour change at three months (288 (35%) v 280 (28%), odds ratio 1.36 (1.11 to 1.65)), and reported slightly greater improvements in healthy eating at three and 12 months, plus improved activity at 12 months. Training cost 1597 pound per practice. Discussion Training primary care clinicians in behaviour change counselling using a brief blended learning programme did not increase patients reported beneficial behaviour change at three months or improve biometric and a biochemical measure at 12 months, but it did increase patients' recollection of discussing behaviour change with their clinicians, intentions to change, attempts to change, and perceptions of having made a lasting change at three months. Enduring behaviour change and improvements in biometric measures are unlikely after a single routine consultation with a clinician trained in behaviour change counselling without additional intervention.	[Butler, Christopher C.; Moore, Laurence; Kinnersley, Paul; Edwards, Adrian; Rollnick, Stephen] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF14 4YS, S Glam, Wales; [Simpson, Sharon A.; Hood, Kerenza; Pickles, Tim; Randell, Elizabeth] Cardiff Univ, South East Wales Trials Unit, Sch Med, Cardiff CF14 4YS, S Glam, Wales; [Cohen, David; Alam, M. Fasihul] Univ Glamorgan, Fac Hlth Sport & Sci, Hlth Econ & Policy Res Unit, Pontypridd CF37 1DL, M Glam, Wales; [Spanou, Clio] Staffordshire Univ, Fac Sci, Ctr Hlth Psychol, Stoke On Trent ST4 2DE, Staffs, England; [Moore, Laurence] Cardiff Univ, Cardiff Inst Soc & Hlth, Sch Social Sci, Cardiff CF14 4YS, S Glam, Wales; [McCambridge, Jim] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9HS, England; [Smith, Christine] Cardiff Univ, Sch Nursing & Midwifery, Cardiff CF14 4YS, S Glam, Wales	Cardiff University; Cardiff University; University of South Wales; Staffordshire University; Cardiff University; University of London; London School of Hygiene & Tropical Medicine; Cardiff University	Butler, CC (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF14 4YS, S Glam, Wales.	ButlerCC@Cardiff.ac.uk	Alam, M Fasihul/AAD-7268-2020; Hood, Kerenza/C-2528-2008	Hood, Kerenza/0000-0002-5268-8631; Alam, M Fasihul/0000-0003-2590-851X; Moore, Laurence/0000-0003-2182-823X; Butler, Christopher/0000-0002-0102-3453; Simpson, Sharon Anne/0000-0002-6219-1768; Pickles, Timothy/0000-0001-7743-0234; McCambridge, Jim/0000-0002-5461-7001; Randell, Elizabeth/0000-0002-1606-3175	National Prevention Research Initiative; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Welsh Assembly Government; World Cancer Research Fund (NPRI) [G0501283]; National Institute for Social Care and Health Research (NISCHR); Wales School of Primary Care Research; NISCHR; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_PC_13027, G0501283] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0501283, MC_PC_13027] Funding Source: researchfish	National Prevention Research Initiative(Diabetes UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly Government; World Cancer Research Fund (NPRI); National Institute for Social Care and Health Research (NISCHR); Wales School of Primary Care Research; NISCHR; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the National Prevention Research Initiative (www.mrc.ac.uk/npri) with support from British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Welsh Assembly Government; and World Cancer Research Fund (NPRI, G0501283). The South East Wales Trials Unit is funded by the National Institute for Social Care and Health Research (NISCHR). Service support costs were provided by NISCHR. Support was also received by the Wales School of Primary Care Research, which is funded by NISCHR.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Ampt AJ, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-59; Anderson P, 2004, ALCOHOL ALCOHOLISM, V39, P351, DOI 10.1093/alcalc/agh072; [Anonymous], 1994, BMJ, V308, P313; Aveyard P, 2012, ADDICTION, V107, P1066, DOI 10.1111/j.1360-0443.2011.03770.x; BARON JA, 1990, BRIT J GEN PRACT, V40, P137; Brett T, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616337; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Butler CC, 1998, BMJ-BRIT MED J, V316, P1878; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cappuccio FP, 2003, NUTR METAB CARDIOVAS, V13, P12, DOI 10.1016/S0939-4753(03)80163-1; Carter B, 2010, STAT MED, V29, P2984, DOI 10.1002/sim.4050; Carter BR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-65; Cope G, 2000, ANN CLIN BIOCHEM, V37, P666, DOI 10.1258/0004563001899717; COULTER A, 1995, BRIT MED J, V310, P1099; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curtis L., 2009, UNIT COSTS HLTH SOCI; Dale RA, 2008, ANN PHARMACOTHER, V42, P633, DOI 10.1345/aph.1K688; de Boer AGEM, 2004, QUAL LIFE RES, V13, P311, DOI 10.1023/B:QURE.0000018499.64574.1f; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Douglas F, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-138; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Fleming P, 2008, CAN FAM PHYSICIAN, V54, P1706; Flodgren G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000984.pub2; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Foy R, 2002, J CLIN EPIDEMIOL, V55, P717, DOI 10.1016/S0895-4356(02)00403-1; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Goldstein MG, 2004, AM J PREV MED, V27, P61, DOI 10.1016/j.amepre.2004.04.023; Greenhalgh T, 2004, SPREAD GOOD IDEAS SY; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Healthy Ambitions, DEL HLTH AMB BETT LE; HIPPISLEYCOX J, 2008, TRENDS CONSULTATION; Hooper L, 2001, Cochrane Database Syst Rev, pCD002137, DOI 10.1002/14651858.CD002137; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; Huang J, 2004, ACAD MED, V79, P156, DOI 10.1097/00001888-200402000-00012; Jepson R, 2006, REV EFFECTIVENESS IN; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kastarinen MJ, 2002, J HYPERTENS, V20, P2505, DOI 10.1097/00004872-200212000-00031; Kehler D, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-50; KOZLOWSKI LT, 1994, DRUG ALCOHOL DEPEN, V34, P211, DOI 10.1016/0376-8716(94)90158-9; Lambert MJ, 2005, BERGIN GARFIELDS HDB; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lane C, 2005, PATIENT EDUC COUNS, V56, P166, DOI 10.1016/j.pec.2004.01.003; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Miller WR, 2004, J CONSULT CLIN PSYCH, V72, P1050, DOI 10.1037/0022-006X.72.6.1050; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Institute for Health and Clinical Excellence (NICE), 2007, BEH CHANG POP COMM I; Oliver I, 2012, IEEE IC COMP COM NET; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Phillips K, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616328; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Raab GM, 2001, STAT MED, V20, P351, DOI 10.1002/1097-0258(20010215)20:3<351::AID-SIM797>3.0.CO;2-C; Roderick P, 1997, BRIT J GEN PRACT, V47, P7; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Rollnick S, 2002, MED EDUC, V36, P377, DOI 10.1046/j.1365-2923.2002.01174.x; Rollnick S, 2001, ADDICTION, V96, P1769; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Rollnick S, 2002, MOTIVATIONAL INTERVI; Russell J, 2004, BRIT MED J, V328, P1174, DOI 10.1136/bmj.328.7449.1174; Salkeld G, 1997, HEALTH POLICY, V41, P105, DOI 10.1016/S0168-8510(97)00015-8; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Sim MG, 2009, AUST FAM PHYSICIAN, V38, P986; SMITH MS, 1995, HEALTH EDUC RES, V10, P51, DOI 10.1093/her/10.1.51; Spanou C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-69; Stafford RS, 2000, ARCH FAM MED, V9, P631, DOI 10.1001/archfami.9.7.631; Steptoe A, 1999, BRIT MED J, V319, P943, DOI 10.1136/bmj.319.7215.943; Svetkey LP, 2009, HYPERTENSION, V54, P1226, DOI 10.1161/HYPERTENSIONAHA.109.134874; Thijs GA, 2007, PATIENT EDUC COUNS, V67, P267, DOI 10.1016/j.pec.2007.05.002; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; WALKER A, 2001, LIVING BRITAIN RESUL; Wanless D., 2004, SECURING GOOD HLTH W; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	81	83	84	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f1191	10.1136/bmj.f1191	http://dx.doi.org/10.1136/bmj.f1191			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113LX	23512758	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000316670500003
J	Levy, BS; Sidel, VW				Levy, Barry S.; Sidel, Victor W.			Adverse health consequences of the Iraq War	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; RESPIRATORY HEALTH; SERVICE MEMBERS; ALCOHOL MISUSE; SUICIDAL IDEATION; MILITARY CHILDREN; AFGHANISTAN; COMBAT	The adverse health consequences of the Iraq War (2003-11) were profound. We conclude that at least 116 903 Iraqi non-combatants and more than 4800 coalition military personnel died over the 8-year course. Many Iraqi civilians were injured or became ill because of damage to the health-supporting infrastructure of the country, and about 5 million were displaced. More than 31 000 US military personnel were injured and a substantial percentage of those deployed suffered post-traumatic stress disorder, traumatic brain injury, and other neuropsychological disorders and their concomitant psychosocial problems. Many family members of military personnel had psychological problems. Further review of the adverse health consequences of this war could help to minimise the adverse health consequences of, and help to prevent, future wars.	[Levy, Barry S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sidel, Victor W.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Sidel, Victor W.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Sidel, Victor W.] Weill Cornell Med Coll, New York, NY USA	Tufts University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University	Levy, BS (corresponding author), POB 1230, Sherborn, MA 01770 USA.	blevy@igc.org						Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P733, DOI 10.1097/JOM.0b013e318253356c; Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P740, DOI 10.1097/JOM.0b013e318252969a; *AG TOX SUBST DIS, 1999, TOX PROF UR UPD; Ali MM, 2003, POP STUD-J DEMOG, V57, P217, DOI 10.1080/0032472032000097119; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; [Anonymous], 2011, NEW YORK TIMES  1125; [Anonymous], 2003, IRAQ WAT BORN DIS IN; [Anonymous], 2010, NY TIMES; Bahjat ST, 2006, EYES TRUTH; Baird CP, 2012, J OCCUP ENVIRON MED, V54, P717, DOI 10.1097/JOM.0b013e3182572e37; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bennis P, 2005, IRAQ QUAGMIRE MOUNTI; Bilmes Linda J., 2008, 3 TRILLION DOLLAR WA; Bloche MG, 2005, NEW ENGL J MED, V353, P6, DOI 10.1056/NEJMp058145; Breeze J, 2011, J LARYNGOL OTOL, V125, P13, DOI 10.1017/S0022215110002215; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Briner W, 2010, INT J ENV RES PUB HE, V7, P303, DOI 10.3390/ijerph7010303; Burkle Frederick M Jr, 2007, Lancet, V369, P104, DOI 10.1016/S0140-6736(07)60064-6; Burnham G, 2007, LANCET, V369, P103, DOI 10.1016/S0140-6736(07)60063-4; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Burnham Gilbert, 2012, World Health Popul, V13, P68; Burnham G, 2012, INT J HEALTH PLAN M, V27, pe51, DOI 10.1002/hpm.1091; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P734; Cost of War, COST WAR IR; Cumberland S, 2009, B WORLD HEALTH ORGAN, V87, P8, DOI 10.2471/BLT.09.030109; Dao J, 2013, NEW YORK TIMES  0113, p[1, 18]; Daponte BO, 2007, INT REV RED CROSS, V89, P943; Dau B, 2009, J REHABIL RES DEV, V46, P673, DOI 10.1682/JRRD.2008.09.0113; de Burgh HT, 2011, INT REV PSYCHIATR, V23, P192, DOI 10.3109/09540261.2011.560144; Donaldson RI, 2010, J TRAUMA, V69, P1379, DOI 10.1097/TA.0b013e318203190f; Doocy S, 2013, INT J HEALTH PLAN M, V28, pe1, DOI 10.1002/hpm.2119; Doocy S, 2011, SOC SCI MED, V72, P273, DOI 10.1016/j.socscimed.2010.10.023; Dougherty J, 2007, LANCET, V369, P102, DOI 10.1016/S0140-6736(07)60062-2; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Epstein RA, 2010, J REHABIL RES DEV, V47, P373, DOI 10.1682/JRRD.2009.03.0023; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; FEICKERT A, 2008, CLUSTER MUNITIONS BA; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gibbs DA, 2012, MIL MED, V177, P1178, DOI 10.7205/MILMED-D-12-00008; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Guha-Sapir D, 2007, LANCET, V369, P102, DOI 10.1016/S0140-6736(07)60061-0; Harvey SB, 2012, AM J EPIDEMIOL, V176, P1177, DOI 10.1093/aje/kws248; Harvey SB, 2011, ANN EPIDEMIOL, V21, P666, DOI 10.1016/j.annepidem.2011.05.004; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Helfer TM, 2011, AM J AUDIOL, V20, P33, DOI 10.1044/1059-0889(2011/10-0033); Hicks MHR, 2007, LANCET, V369, P101, DOI 10.1016/S0140-6736(07)60060-9; Hicks MHR, 2011, LANCET, V378, P906, DOI 10.1016/S0140-6736(11)61023-4; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hicks MHR, 2009, NEW ENGL J MED, V360, P1585, DOI 10.1056/NEJMp0807240; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper R, 2008, ADDICT BEHAV, V33, P1067, DOI 10.1016/j.addbeh.2008.03.010; iCasualties, OP IR FREED IR COAL; Ilgen MA, 2012, J CONSULT CLIN PSYCH, V80, P323, DOI 10.1037/a0028266; *INT ORG MIGR, IR DISPL 2007 YEAR R; Iraq Body Count, IR DEATHS VIOL 2003; Iraq Minist. Plann. Dev. Coop. U. N. Dev. Progr, 2005, IR LIV COND SURV 200, VII, P57; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Jha P, 2007, LANCET, V369, P101, DOI 10.1016/S0140-6736(07)60059-2; Johnson NF, 2008, J PEACE RES, V45, P653, DOI 10.1177/0022343308094325; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Kline A, 2011, J NERV MENT DIS, V199, P914, DOI 10.1097/NMD.0b013e3182392917; LeardMann CA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-437; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Levy BS, 2011, LANCET, V378, P944, DOI 10.1016/S0140-6736(11)60970-7; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; MARON DF, 2010, PENTAGON WEIGHS CLEA; Mateen FJ, 2012, J NEUROL, V259, P694, DOI 10.1007/s00415-011-6248-x; Morton MJ, 2008, JAMA-J AM MED ASSOC, V300, P727, DOI 10.1001/jama.300.6.727; Murray CK, 2011, J TRAUMA, V71, pS62, DOI 10.1097/TA.0b013e3182218c99; National Counterterrorism Center, 2007, REP TERR INC 2006; Norton-Taylor R, 2008, GUARDIAN LONDON 0419; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; Physicians for Human Rights, 2005, BREAK THEM SYST US P; ReliefWeb, 2008, INT DISPL UPD IR; Riviere LA, 2012, MIL MED, V177, P1169, DOI 10.7205/MILMED-D-12-00164; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Shen YC, 2012, AM J PUBLIC HEALTH, V102, pS80, DOI 10.2105/AJPH.2011.300425; Slaven-Lee PW, 2011, INT NURS REV, V58, P164, DOI 10.1111/j.1466-7657.2010.00860.x; SLEVIN P, 2004, WASHINGTON POST 0610; Smith B, 2012, J OCCUP ENVIRON MED, V54, P708, DOI 10.1097/JOM.0b013e31825107f9; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Spagat M, 2010, DEFENCE PEACE ECON, V21, P1, DOI 10.1080/10242690802496898; Squibb KS, 2012, J OCCUP ENVIRON MED, V54, P724, DOI 10.1097/JOM.0b013e31824fe138; Stinner DJ, 2010, MIL MED, V175, P1027, DOI 10.7205/MILMED-D-10-00102; Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tran M, 2008, GUARDIAN LONDON 0418; U. N. World Food Progr, 2008, COMPR FOOD SEC VULN, P1; UN Educational Scientific and Cultural Organization, 2010, UNESCO LAUNCH IN ID; UNHCR: The UN Refugee Agency, 2011, 2011 UNHCR COUNTR OP; UNHCR: The UN Refugee Agency, 2013, 2013 UNHCR COUNTR OP; UNHCR (U. N. Refug. Agency), 2007, UN NEWS CTR     0918; *UNICEF, IR STAT; United Nations Environmental Programmme, 2005, ASS ENV HOT SPOTS IR; US Department of Defense, OP IR FREED OIF US C; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; von Schreeb J, 2007, LANCET, V369, P101, DOI 10.1016/S0140-6736(07)60058-0; Weiss P, 2012, TERRORISM PUBLIC HLT, P362; White CJ, 2011, INT REV PSYCHIATR, V23, P210, DOI 10.3109/09540261.2011.560143; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wong E, 2006, NEW YORK TIMES  0405; World Bank, WORLD BANK IND; *WORLD VIS, IR CHILDR CAUGHT WAR	131	50	50	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					949	958		10.1016/S0140-6736(13)60254-8	http://dx.doi.org/10.1016/S0140-6736(13)60254-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499043				2022-12-28	WOS:000316069700030
J	el Barzouhi, A; Vleggeert-Lankamp, CLAM; Nijeholt, GJLA; Van der Kallen, BF; van den Hout, WB; Jacobs, WCH; Koes, BW; Peul, WC				el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.; van den Hout, Wilbert B.; Jacobs, Wilco C. H.; Koes, Bart W.; Peul, Wilco C.		Leiden Hague Spine Intervention	Magnetic Resonance Imaging in Follow-up Assessment of Sciatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BACK-PAIN; LUMBAR DISC HERNIATION; PROLONGED CONSERVATIVE TREATMENT; PERIDURAL SCAR; FUNCTIONAL STATUS; NATURAL-HISTORY; SURGERY; DISKECTOMY; MICRODISCECTOMY; ASSOCIATION	BACKGROUND Magnetic resonance imaging (MRI) is frequently performed during follow-up in patients with known lumbar-disk herniation and persistent symptoms of sciatica. The association between findings on MRI and clinical outcome is controversial. METHODS We studied 283 patients in a randomized trial comparing surgery and prolonged conservative care for sciatica and lumbar-disk herniation. Patients underwent MRI at baseline and after 1 year. We used a 4-point scale to assess disk herniation on MRI, ranging from 1 for "definitely present" to 4 for "definitely absent." A favorable clinical outcome was defined as complete or nearly complete disappearance of symptoms at 1 year. We compared proportions of patients with a favorable outcome among those with a definite absence of disk herniation and those with a definite, probable, or possible presence of disk herniation at 1 year. The area under the receiver-operating-characteristic (ROC) curve was used to assess the prognostic accuracy of the 4-point scores regarding a favorable or unfavorable outcome, with 1 indicating perfect discriminatory value and 0.5 or less indicating no discriminatory value. RESULTS At 1 year, 84% of the patients reported having a favorable outcome. Disk herniation was visible in 35% with a favorable outcome and in 33% with an unfavorable outcome (P = 0.70). A favorable outcome was reported in 85% of patients with disk herniation and 83% without disk herniation (P = 0.70). MRI assessment of disk herniation did not distinguish between patients with a favorable outcome and those with an unfavorable outcome (area under ROC curve, 0.48). CONCLUSIONS MRI performed at 1-year follow-up in patients who had been treated for sciatica and lumbar-disk herniation did not distinguish between those with a favorable outcome and those with an unfavorable outcome. (Funded by the Netherlands Organization for Health Research and Development and the Hoelen Foundation; Controlled Clinical Trials number, ISRCTN26872154.)	[el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Jacobs, Wilco C. H.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands; [van den Hout, Wilbert B.] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands; [Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.] Med Ctr Haaglanden, Dept Radiol, The Hague, Netherlands; [Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands; [Koes, Bart W.] Univ Med Ctr, Erasmus Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Haaglanden Medical Center; Erasmus University Rotterdam; Erasmus MC	Peul, WC (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, POB 9600, NL-2300 RC Leiden, Netherlands.	w.c.peul@lumc.nl	Jacobs, Wilco/H-7642-2013; Koes, Bart w/K-4614-2016; Vleggeert-Lankamp, Carmen/AGX-9660-2022	Jacobs, Wilco/0000-0002-8942-4525; Koes, Bart w/0000-0002-0450-9969; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; van den Hout, Wilbert B./0000-0002-6425-0135	Netherlands Organization for Health Research and Development; Hoelen Foundation; B. Braun Medical; Medtronic; Paradigm Spine; College voor zorgverzekeringen (CVZ, Dutch health care insurance board); B. Braun Aesculap; Zorgverzekeraars Nederland (Dutch association of insurance companies); CVZ	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Hoelen Foundation; B. Braun Medical; Medtronic(Medtronic); Paradigm Spine; College voor zorgverzekeringen (CVZ, Dutch health care insurance board); B. Braun Aesculap; Zorgverzekeraars Nederland (Dutch association of insurance companies); CVZ	Supported by a grant from the Netherlands Organization for Health Research and Development and the Hoelen Foundation.; Dr. Vleggeert-Lankamp reports receiving grant support from B. Braun Medical, Medtronic, and Paradigm Spine and lecture fees from B. Braun Medical. Dr. Peul reports receiving grant support from the Netherlands Organization for Health Research and Development, College voor zorgverzekeringen (CVZ, Dutch health care insurance board), Medtronic, B. Braun Aesculap, and Paradigm Spine, receiving lecture fees from Zorgverzekeraars Nederland (Dutch association of insurance companies) and CVZ, and providing legal expert testimony for medicolegal cases. No other potential conflict of interest relevant to this article was reported.	Arts MP, 2009, JAMA-J AM MED ASSOC, V302, P149, DOI 10.1001/jama.2009.972; Barth M, 2008, SPINE, V33, P273, DOI 10.1097/BRS.0b013e31816201a6; BODEN SD, 1992, RADIOLOGY, V182, P59, DOI 10.1148/radiology.182.1.1727310; Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002; BRANTZAWADZKI MN, 1995, SPINE, V20, P1257, DOI 10.1097/00007632-199506000-00010; Cheng F, 2010, CAN FAM PHYSICIAN, V56, pE323; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Jarvik JG, 1996, ACAD RADIOL, V3, P537, DOI 10.1016/S1076-6332(96)80214-5; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jensen TS, 2007, J MANIP PHYSIOL THER, V30, P98, DOI 10.1016/j.jmpt.2006.12.004; Komori H, 1996, SPINE, V21, P225, DOI 10.1097/00007632-199601150-00013; Kuijer W, 2005, CLIN REHABIL, V19, P488, DOI 10.1191/0269215505cr842oa; Lee YS, 2009, AM J NEURORADIOL, V30, P1062, DOI 10.3174/ajnr.A1497; Legrand E, 2007, JOINT BONE SPINE, V74, P530, DOI 10.1016/j.jbspin.2007.07.004; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Maroon JC, 1999, NEUROL RES, V21, pS43, DOI 10.1080/01616412.1999.11741026; Nygaard OP, 1999, ACTA NEUROCHIR, V141, P619, DOI 10.1007/s007010050351; Nygaard OP, 1997, ACTA NEUROCHIR, V139, P1095, DOI 10.1007/BF01410967; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Peul WC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-8; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Ronnberg K, 2008, EUR SPINE J, V17, P1714, DOI 10.1007/s00586-008-0805-8; Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053; Stafford MA, 2007, BRIT J ANAESTH, V99, P461, DOI 10.1093/bja/aem238; VanGoethem JWM, 1996, NEURORADIOLOGY, V38, pS90, DOI 10.1007/BF02278130; Vogelsang JP, 1999, EUR SPINE J, V8, P475, DOI 10.1007/s005860050208; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Vucetic N, 1999, CLIN ORTHOP RELAT R, P116; Wassenaar M, 2012, EUR SPINE J, V21, P220, DOI 10.1007/s00586-011-2019-8; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Yamashita K, 2006, SPINE, V31, P2602, DOI 10.1097/01.brs.0000240717.25787.7d	37	62	62	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					999	1007		10.1056/NEJMoa1209250	http://dx.doi.org/10.1056/NEJMoa1209250			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484826	Bronze			2022-12-28	WOS:000315982100006
J	Korbel, JO; Campbell, PJ				Korbel, Jan O.; Campbell, Peter J.			Criteria for Inference of Chromothripsis in Cancer Genomes	CELL			English	Article							STRUCTURAL VARIATION; DNA BREAKS; REARRANGEMENTS; CHROMOSOMES; MECHANISMS; EVOLUTION; MUTATION	Chromothripsis scars the genome when localized chromosome shattering and repair occurs in a one-off catastrophe. Outcomes of this process are detectable as massive DNA rearrangements affecting one or a few chromosomes. Although recent findings suggest a crucial role of chromothripsis in cancer development, the reproducible inference of this process remains challenging, requiring that cataclysmic one-off rearrangements be distinguished from localized lesions that occur progressively. We describe conceptual criteria for the inference of chromothripsis, based on ruling out the alternative hypothesis that stepwise rearrangements occurred. Robust means of inference may facilitate in-depth studies on the impact of, and the mechanisms underlying, chromothripsis.	[Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB22XY, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	jan.korbel@embl.de; pc8@sanger.ac.uk	Korbel, Jan O/G-6470-2012	Korbel, Jan O/0000-0002-2798-3794	European Commission [Health-F2-2010-260791]	European Commission(European CommissionEuropean Commission Joint Research Centre)	J.O.K. acknowledges funding from the European Commission (Health-F2-2010-260791). P.J.C. is a Wellcome Trust Senior Clinical Fellow. We thank Tobias Rausch, Stephanie Sungalee, Balca Mardin, Joachim Weischenfeldt, Christopher Buccitelli, and Wolfgang Huber for their thoughtful comments.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Hirsch D., 2012, CANC RES IN PRESS; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; McClintock B, 1941, GENETICS, V26, P234; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Onishi-Seebacher M, 2011, BIOESSAYS, V33, P840, DOI 10.1002/bies.201100075; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tubio JMC, 2011, NATURE, V470, P476, DOI 10.1038/470476a; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	44	319	325	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1226	1236		10.1016/j.cell.2013.02.023	http://dx.doi.org/10.1016/j.cell.2013.02.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498933	Bronze			2022-12-28	WOS:000316192500006
J	Daumit, GL; Dickerson, FB; Wang, NY; Dalcin, A; Jerome, GJ; Anderson, CAM; Young, DR; Frick, KD; Yu, AR; Gennusa, JV; Oefinger, M; Crum, RM; Charleston, J; Casagrande, SS; Guallar, E; Goldberg, RW; Campbell, LM; Appel, LJ				Daumit, Gail L.; Dickerson, Faith B.; Wang, Nae-Yuh; Dalcin, Arlene; Jerome, Gerald J.; Anderson, Cheryl A. M.; Young, Deborah R.; Frick, Kevin D.; Yu, Airong; Gennusa, Joseph V., III; Oefinger, Meghan; Crum, Rosa M.; Charleston, Jeanne; Casagrande, Sarah S.; Guallar, Eliseo; Goldberg, Richard W.; Campbell, Leslie M.; Appel, Lawrence J.			A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTIONS; PHYSICAL-ACTIVITY; MEDICAL COMORBIDITY; DIABETES-MELLITUS; BLOOD-PRESSURE; SCHIZOPHRENIA; OBESITY; PREVALENCE; DISORDERS	BACKGROUND Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness. METHODS We recruited overweight or obese adults from 10 community psychiatric rehabilitation outpatient programs and randomly assigned them to an intervention or a control group. Participants in the intervention group received tailored group and individual weight-management sessions and group exercise sessions. Weight change was assessed at 6, 12, and 18 months. RESULTS Of 291 participants who underwent randomization, 58.1% had schizophrenia or a schizoaffective disorder, 22.0% had bipolar disorder, and 12.0% had major depression. At baseline, the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 36.3, and the mean weight was 102.7 kg (225.9 lb). Data on weight at 18 months were obtained from 279 participants. Weight loss in the intervention group increased progressively over the 18-month study period and differed significantly from the control group at each follow-up visit. At 18 months, the mean between-group difference in weight (change in intervention group minus change in control group) was -3.2 kg (-7.0 lb, P = 0.002); 37.8% of the participants in the intervention group lost 5% or more of their initial weight, as compared with 22.7% of those in the control group (P = 0.009). There were no significant between-group differences in adverse events. CONCLUSIONS A behavioral weight-loss intervention significantly reduced weight over a period of 18 months in overweight and obese adults with serious mental illness. Given the epidemic of obesity and weight-related disease among persons with serious mental illness, our findings support implementation of targeted behavioral weight-loss interventions in this high-risk population. (Funded by the National Institute of Mental Health; ACHIEVE ClinicalTrials. gov number, NCT00902694.)	[Daumit, Gail L.; Wang, Nae-Yuh; Crum, Rosa M.; Charleston, Jeanne; Guallar, Eliseo; Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Daumit, Gail L.; Wang, Nae-Yuh; Dalcin, Arlene; Jerome, Gerald J.; Yu, Airong; Gennusa, Joseph V., III; Oefinger, Meghan; Charleston, Jeanne; Campbell, Leslie M.; Appel, Lawrence J.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Daumit, Gail L.; Crum, Rosa M.; Guallar, Eliseo; Appel, Lawrence J.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Daumit, Gail L.; Crum, Rosa M.; Guallar, Eliseo; Appel, Lawrence J.] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD USA; [Daumit, Gail L.; Frick, Kevin D.] Johns Hopkins Univ, Dept Hlth Policy & Management, Sch Med, Baltimore, MD 21218 USA; [Daumit, Gail L.; Crum, Rosa M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Wang, Nae-Yuh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Goldberg, Richard W.] Capitol Hlth Care Network VISN 5, Dept Vet Affairs, Mental Illness Educ & Clin Res Ctr, Baltimore, MD USA; [Goldberg, Richard W.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Dickerson, Faith B.] Towson Univ, Sheppard Pratt Hlth Syst, Towson, MD USA; [Jerome, Gerald J.] Towson Univ, Dept Kinesiol, Towson, MD USA; [Casagrande, Sarah S.] Social & Sci Syst, Silver Spring, MD USA; [Anderson, Cheryl A. M.] Univ Calif San Diego, Div Prevent Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Young, Deborah R.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res, Madrid, Spain	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; University System of Maryland; Towson University; University System of Maryland; Towson University; Social & Scientific Systems; University of California System; University of California San Diego; Kaiser Permanente; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Daumit, GL (corresponding author), Johns Hopkins Med Inst, 2024 E Monument St, Baltimore, MD 21287 USA.	gdaumit@jhmi.edu	Appel, Larry/GLT-2608-2022; Dickerson, Faith/C-8311-2019; Jerome, Gerald/R-2979-2018; Guallar, Eliseo/D-3807-2014	Dickerson, Faith/0000-0003-3800-2864; Jerome, Gerald/0000-0003-0612-2626; Guallar, Eliseo/0000-0002-4471-9565; Frick, Kevin/0000-0002-0178-5319; Wang, Nae-Yuh/0000-0001-6513-9730	National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080916, R01MH080964] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by the National Institute of Mental Health.	Agerbo E, 2004, ARCH GEN PSYCHIAT, V61, P28, DOI 10.1001/archpsyc.61.1.28; Allison DB, 2009, AM J PREV MED, V36, P341, DOI 10.1016/j.amepre.2008.11.020; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; American Heart Association National Heart, 1993, EX YOUR HEART GUID P; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bartels S, 2012, HLTH PROMOTION PROGR; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Cabassa LJ, 2010, PSYCHIAT SERV, V61, P774, DOI 10.1176/ps.2010.61.8.774; Carney CP, 2006, PSYCHOSOM MED, V68, P684, DOI 10.1097/01.psy.0000237316.09601.88; Carney CP, 2006, J GEN INTERN MED, V21, P1133, DOI 10.1111/j.1525-1497.2006.00563.x; Casagrande SS, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-108; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Coodin S, 2001, CAN J PSYCHIAT, V46, P549, DOI 10.1177/070674370104600610; Daumit GL, 2010, PSYCHIAT RES, V176, P242, DOI 10.1016/j.psychres.2009.01.006; Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60; Daumit GL, 2003, J NERV MENT DIS, V191, P799, DOI 10.1097/01.nmd.0000100923.20188.2d; *DEPR GUID PAN, 1993, AHCPR PUBL; Dickerson F, 2004, PSYCHIAT RES, V129, P45, DOI 10.1016/j.psychres.2004.07.002; Dickerson FB, 2006, ACTA PSYCHIAT SCAND, V113, P306, DOI 10.1111/j.1600-0447.2005.00637.x; Dipasquale S, 2013, J PSYCHIATR RES, V47, P197, DOI 10.1016/j.jpsychires.2012.10.005; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Eisen SV, 2004, MED CARE, V42, P1230, DOI 10.1097/00005650-200412000-00010; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Faulkner G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005148.pub2; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Green MF, 1999, SCHIZOPHRENIA BULL, V25, P309, DOI 10.1093/oxfordjournals.schbul.a033380; Heinssen RK, 1996, COGNITIVE REHABILITA, P395; Himelhoch S, 2004, AM J PSYCHIAT, V161, P2317, DOI 10.1176/appi.ajp.161.12.2317; Hinshaw S. P., 2007, MARK SHAME STIGMA ME; Hollis JF, 2008, AM J PREV MED, V35, P118, DOI 10.1016/j.amepre.2008.04.013; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Jerome GJ, 2009, SCHIZOPHR RES, V108, P252, DOI 10.1016/j.schres.2008.12.006; Lieberman JA, 2010, NEW ENGL J MED, V363, P1092; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Macrithie KA, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; McElroy SL, 2002, J CLIN PSYCHIAT, V63, P207, DOI 10.4088/JCP.v63n0306; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; McGinty EE, 2012, PSYCHIAT SERV, V63, P714, DOI 10.1176/appi.ps.201100169; McKibbin CL, 2006, SCHIZOPHR RES, V86, P36, DOI 10.1016/j.schres.2006.05.010; Mueser KT, 2002, PSYCHIAT SERV, V53, P1272, DOI 10.1176/appi.ps.53.10.1272; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; STAMLER R, 1989, JAMA-J AM MED ASSOC, V262, P3132; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Velligan DI, 2000, AM J PSYCHIAT, V157, P1317, DOI 10.1176/appi.ajp.157.8.1317; Verhaeghe N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-28; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wu MK, 2007, PSYCHIAT SERV, V58, P544, DOI 10.1176/appi.ps.58.4.544; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b	55	354	356	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1594	1602		10.1056/NEJMoa1214530	http://dx.doi.org/10.1056/NEJMoa1214530			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23517118	Green Accepted			2022-12-28	WOS:000317956300008
J	Boonen, E; Vervenne, H; Meersseman, P; Andrew, R; Mortier, L; Declercq, PE; Vanwijngaerden, YM; Spriet, I; Wouters, PJ; Vander Perre, S; Langouche, L; Vanhorebeek, I; Walker, BR; Van den Berghe, G				Boonen, Eva; Vervenne, Hilke; Meersseman, Philippe; Andrew, Ruth; Mortier, Leen; Declercq, Peter E.; Vanwijngaerden, Yoo-Mee; Spriet, Isabel; Wouters, Pieter J.; Vander Perre, Sarah; Langouche, Lies; Vanhorebeek, Ilse; Walker, Brian R.; Van den Berghe, Greet			Reduced Cortisol Metabolism during Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; APPARENT MINERALOCORTICOID EXCESS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; SEPTIC SHOCK; BILE-ACIDS; IN-VIVO; ADIPOSE-TISSUE; ADRENAL AXIS; ADRENOCORTICOTROPIN; HUMANS	BACKGROUND Critical illness is often accompanied by hypercortisolemia, which has been attributed to stress-induced activation of the hypothalamic-pituitary-adrenal axis. However, low corticotropin levels have also been reported in critically ill patients, which may be due to reduced cortisol metabolism. METHODS In a total of 158 patients in the intensive care unit and 64 matched controls, we tested five aspects of cortisol metabolism: daily levels of corticotropin and cortisol; plasma cortisol clearance, metabolism, and production during infusion of deuterium-labeled steroid hormones as tracers; plasma clearance of 100 mg of hydrocortisone; levels of urinary cortisol metabolites; and levels of messenger RNA and protein in liver and adipose tissue, to assess major cortisol-metabolizing enzymes. RESULTS Total and free circulating cortisol levels were consistently higher in the patients than in controls, whereas corticotropin levels were lower (P<0.001 for both comparisons). Cortisol production was 83% higher in the patients (P=0.02). There was a reduction of more than 50% in cortisol clearance during tracer infusion and after the administration of 100 mg of hydrocortisone in the patients (P <= 0.03 for both comparisons). All these factors accounted for an increase by a factor of 3.5 in plasma cortisol levels in the patients, as compared with controls (P<0.001). Impaired cortisol clearance also correlated with a lower cortisol response to corticotropin stimulation. Reduced cortisol metabolism was associated with reduced inactivation of cortisol in the liver and kidney, as suggested by urinary steroid ratios, tracer kinetics, and assessment of liver-biopsy samples (P <= 0.004 for all comparisons). CONCLUSIONS During critical illness, reduced cortisol breakdown, related to suppressed expression and activity of cortisol-metabolizing enzymes, contributed to hypercortisolemia and hence corticotropin suppression. The diagnostic and therapeutic implications for critically ill patients are unknown. (Funded by the Belgian Fund for Scientific Research and others; ClinicalTrials.gov numbers, NCT00512122 and NCT00115479; and Current Controlled Trials numbers, ISRCTN49433936, ISRCTN49306926, and ISRCTN08083905.)	[Boonen, Eva; Vervenne, Hilke; Vanwijngaerden, Yoo-Mee; Wouters, Pieter J.; Vander Perre, Sarah; Langouche, Lies; Vanhorebeek, Ilse; Van den Berghe, Greet] Katholieke Univ Leuven, Clin Div, B-3000 Louvain, Belgium; [Boonen, Eva; Vervenne, Hilke; Vanwijngaerden, Yoo-Mee; Wouters, Pieter J.; Vander Perre, Sarah; Langouche, Lies; Vanhorebeek, Ilse; Van den Berghe, Greet] Katholieke Univ Leuven, Lab Intens Care Med, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Meersseman, Philippe] Katholieke Univ Leuven, Med Intens Care Unit, Dept Internal Med, B-3000 Louvain, Belgium; [Spriet, Isabel] Katholieke Univ Leuven, Dept Pharm, B-3000 Louvain, Belgium; [Mortier, Leen; Declercq, Peter E.] Jessa Hosp, Dept Lab Med, Hasselt, Belgium; [Andrew, Ruth; Walker, Brian R.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	KU Leuven; KU Leuven; KU Leuven; KU Leuven; University of Edinburgh	Van den Berghe, G (corresponding author), Katholieke Univ Leuven, Clin Div, Herestr 49, B-3000 Louvain, Belgium.	greet.vandenberghe@med.kuleuven.be	Langouche, Lies/C-1098-2013; Marik, Paul E/U-9733-2019; Annane, Djillali/R-7947-2019; Van den Berghe, Greet/J-6788-2018; Andrew, Ruth/C-2727-2008	Langouche, Lies/0000-0002-8564-6809; Van den Berghe, Greet/0000-0002-5320-1362; Andrew, Ruth/0000-0002-6916-2994; Deprest, Jan/0000-0002-4920-945X; Vanhorebeek, Ilse/0000-0002-5261-5192	Belgian Fund for Scientific Research; British Heart Foundation; Methusalem Program; Flemish government; European Research Council Advanced Grant from the Ideas Program of the European Union 7th Framework Program [AdvG-2012-321670]; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); British Heart Foundation(British Heart Foundation); Methusalem Program; Flemish government(European Commission); European Research Council Advanced Grant from the Ideas Program of the European Union 7th Framework Program; British Heart Foundation(British Heart Foundation)	Supported by grants from the Belgian Fund for Scientific Research (to Dr. Van den Berghe) and the British Heart Foundation (to Dr. Walker); long-term structural research support from the Methusalem Program, funded by the Flemish government (to Dr. Van den Berghe through the Catholic University of Leuven); and a European Research Council Advanced Grant from the Ideas Program of the European Union 7th Framework Program (AdvG-2012-321670, to Dr. Van den Berghe).	Ackermann D, 1999, HEPATOLOGY, V30, P623, DOI 10.1002/hep.510300303; Andrew R, 1998, J CLIN ENDOCR METAB, V83, P1806, DOI 10.1210/jc.83.5.1806; Andrew R, 2002, J CLIN ENDOCR METAB, V87, P277, DOI 10.1210/jc.87.1.277; Andrew R, 2005, DIABETES, V54, P1364, DOI 10.2337/diabetes.54.5.1364; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2008, JAMA-J AM MED ASSOC, V300, P1652; Barquist E, 1997, J TRAUMA, V42, P27, DOI 10.1097/00005373-199701000-00006; Basu R, 2010, DIABETES, V59, P1283; Basu R, 2009, DIABETES, V58, P1936; Basu R, 2009, DIABETES, V58, P39, DOI 10.2337/db08-1079; Best R, 1997, CLIN ENDOCRINOL, V47, P231, DOI 10.1046/j.1365-2265.1997.2471061.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Fenske M, 2006, STEROIDS, V71, P1014, DOI 10.1016/j.steroids.2006.08.004; Hughes KA, 2012, DIABETES, V61, P1357, DOI 10.2337/db11-1345; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Langlois VS, 2010, GEN COMP ENDOCR, V166, P489, DOI 10.1016/j.ygcen.2009.08.004; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; Mericq MV, 1998, J CLIN ENDOCR METAB, V83, P682, DOI 10.1210/jc.83.2.682; Mesotten D, 2008, NAT CLIN PRACT ENDOC, V4, P496, DOI 10.1038/ncpendmet0921; Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x; Quattropani C, 2001, J CLIN INVEST, V108, P1299, DOI 10.1172/JCI200112745; SANDBERG AA, 1956, J CLIN ENDOCR METAB, V16, P1001, DOI 10.1210/jcem-16-8-1001; SELYE H, 1946, J CLIN ENDOCR METAB, V6, P117, DOI 10.1210/jcem-6-2-117; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stauffer AT, 2002, J BIOL CHEM, V277, P26286, DOI 10.1074/jbc.M201556200; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P3617, DOI 10.1210/jc.80.12.3617; Stimson RH, 2009, DIABETES, V58, P46, DOI 10.2337/db08-0969; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Trainer PJ, 1995, BARTS ENDOCRINE PROT, P52; ULICK S, 1992, J CLIN ENDOCR METAB, V74, P593, DOI 10.1210/jc.74.3.593; Vanhorebeek I, 2006, J CLIN ENDOCR METAB, V91, P3803, DOI 10.1210/jc.2005-2089; Vanwijngaerden YM, 2011, HEPATOLOGY, V54, P1741, DOI 10.1002/hep.24582; VERMES I, 1995, J CLIN ENDOCR METAB, V80, P1238, DOI 10.1210/jc.80.4.1238; Vermes I, 2001, BEST PRACT RES CL EN, V15, P495, DOI 10.1053/beem.2001.0166; Walker BR, 2000, CLIN ENDOCRINOL, V52, P401, DOI 10.1046/j.1365-2265.2000.00969.x; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354	43	284	300	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1477	1488		10.1056/NEJMoa1214969	http://dx.doi.org/10.1056/NEJMoa1214969			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23506003	Green Published, Green Accepted			2022-12-28	WOS:000317603300005
J	Chang, CZ; Zhang, JS; Feng, X; Shen, J; Zhang, ZC; Guo, MH; Li, K; Ou, YB; Wei, P; Wang, LL; Ji, ZQ; Feng, Y; Ji, SH; Chen, X; Jia, JF; Dai, X; Fang, Z; Zhang, SC; He, K; Wang, YY; Lu, L; Ma, XC; Xue, QK				Chang, Cui-Zu; Zhang, Jinsong; Feng, Xiao; Shen, Jie; Zhang, Zuocheng; Guo, Minghua; Li, Kang; Ou, Yunbo; Wei, Pang; Wang, Li-Li; Ji, Zhong-Qing; Feng, Yang; Ji, Shuaihua; Chen, Xi; Jia, Jinfeng; Dai, Xi; Fang, Zhong; Zhang, Shou-Cheng; He, Ke; Wang, Yayu; Lu, Li; Ma, Xu-Cun; Xue, Qi-Kun			Experimental Observation of the Quantum Anomalous Hall Effect in a Magnetic Topological Insulator	SCIENCE			English	Article								The quantized version of the anomalous Hall effect has been predicted to occur in magnetic topological insulators, but the experimental realization has been challenging. Here, we report the observation of the quantum anomalous Hall (QAH) effect in thin films of chromium-doped (Bi,Sb)(2)Te-3, a magnetic topological insulator. At zero magnetic field, the gate-tuned anomalous Hall resistance reaches the predicted quantized value of h/e(2), accompanied by a considerable drop in the longitudinal resistance. Under a strong magnetic field, the longitudinal resistance vanishes, whereas the Hall resistance remains at the quantized value. The realization of the QAH effect may lead to the development of low-power-consumption electronics.	[Chang, Cui-Zu; Zhang, Jinsong; Feng, Xiao; Zhang, Zuocheng; Guo, Minghua; Feng, Yang; Ji, Shuaihua; Chen, Xi; Jia, Jinfeng; Wang, Yayu; Xue, Qi-Kun] Tsinghua Univ, State Key Lab Low Dimens Quantum Phys, Dept Phys, Beijing 100084, Peoples R China; [Chang, Cui-Zu; Feng, Xiao; Shen, Jie; Li, Kang; Ou, Yunbo; Wei, Pang; Wang, Li-Li; Ji, Zhong-Qing; Dai, Xi; Fang, Zhong; He, Ke; Lu, Li; Ma, Xu-Cun] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China; [Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS; Stanford University	He, K (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China.	kehe@iphy.ac.cn; yayuwang@tsinghua.edu; qkxue@mail.tsinghua.edu.cn	Ou, Yunbo/AAJ-3559-2021; Chang, Cui-Zu/P-3049-2014; Fang, Zhong/D-4132-2009; Jia, Jinfeng/O-2356-2015; HE, KE/G-7538-2011; HE, KE/A-9078-2013; Wang, Lili/C-4156-2014; Feng, Xiao/W-4051-2017; Dai, Xi/C-4236-2008; Zhang, Shou-Cheng/B-2794-2010; Ji, Shuaihua/F-1743-2014; Dai, Xi/HCG-9886-2022; Feng, Xiao/AAJ-3617-2020	Ou, Yunbo/0000-0002-9350-8756; Jia, Jinfeng/0000-0002-9900-281X; Wang, Lili/0000-0001-6035-1660; Feng, Xiao/0000-0001-7982-0455; Dai, Xi/0000-0002-2396-0966; He, Ke/0000-0001-6787-3453; Shen, Jie/0000-0002-7205-5081; Zhang, Jinsong/0000-0002-3601-4995; Feng, Yang/0000-0002-3584-1227	National Science Foundation; Ministry of Science and Technology of China; Chinese Academy of Sciences	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank X. Xie, C. Yang, and X.-L. Qi for stimulating discussions and X.-C. Hong and S.-Y. Li for help with experiments. We are grateful to the National Science Foundation and Ministry of Science and Technology of China and the Chinese Academy of Sciences for financial support.	Buhmann H., 2012, B AM PHYS SOC, V57; Chang CZ, 2013, ADV MATER, V25, P1065, DOI 10.1002/adma.201203493; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hall E. H., 1881, PHILOS MAG, V12, P157, DOI DOI 10.1080/14786448108627086; Hall E.H., 1879, AM J MATH, V2, P287, DOI DOI 10.2307/2369245; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Jeckelmann B, 2001, REP PROG PHYS, V64, P1603, DOI 10.1088/0034-4885/64/12/201; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; Liu CX, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146802; Nomura K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166802; Onoda M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206601; Qi XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085308; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Qiao ZH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.161414; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang JS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1588	23	2229	2282	101	2084	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					167	170		10.1126/science.1234414	http://dx.doi.org/10.1126/science.1234414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23493424	Green Submitted			2022-12-28	WOS:000317341400047
J	Lloyd, KG; Schreiber, L; Petersen, DG; Kjeldsen, KU; Lever, MA; Steen, AD; Stepanauskas, R; Richter, M; Kleindienst, S; Lenk, S; Schramm, A; Jorgensen, BB				Lloyd, Karen G.; Schreiber, Lars; Petersen, Dorthe G.; Kjeldsen, Kasper U.; Lever, Mark A.; Steen, Andrew D.; Stepanauskas, Ramunas; Richter, Michael; Kleindienst, Sara; Lenk, Sabine; Schramm, Andreas; Jorgensen, Bo Barker			Predominant archaea in marine sediments degrade detrital proteins	NATURE			English	Article							AARHUS BAY; RNA GENES; ONE-CELL; BACTERIA; QUANTIFICATION; CLOSTRIPAIN; METAGENOME; INDICATORS; PHYLOGENY; ALGORITHM	Half of the microbial cells in the Earth's oceans are found in sediments(1). Many of these cells are members of the Archaea(2), single-celled prokaryotes in a domain of life separate from Bacteria and Eukaryota. However, most of these archaea lack cultured representatives, leaving their physiologies and placement on the tree of life uncertain. Here we show that the uncultured miscellaneous crenar-chaeotal group (MCG) and marine benthic group-D (MBG-D) are among the most numerous archaea in the marine sub-sea floor. Single-cell genomic sequencing of one cell of MCG and three cells of MBG-D indicated that they form new branches basal to the archaeal phyla Thaumarchaeota(3) and Aigarchaeota(4), for MCG, and the order Thermoplasmatales, for MBG-D. All four cells encoded extracellular protein-degrading enzymes such as gingipain and clostripain that are known to be effective in environments chemically similar to marine sediments. Furthermore, we found these two types of peptidase to be abundant and active in marine sediments, indicating that uncultured archaea may have a previously undiscovered role in protein remineralization in anoxic marine sediments.	[Lloyd, Karen G.; Schreiber, Lars; Petersen, Dorthe G.; Kjeldsen, Kasper U.; Lever, Mark A.; Schramm, Andreas; Jorgensen, Bo Barker] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus, Denmark; [Lloyd, Karen G.; Steen, Andrew D.] Univ Tennessee, Knoxville, TN 37996 USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Richter, Michael] Ribocon GmbH, D-28359 Bremen, Germany; [Kleindienst, Sara; Lenk, Sabine] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Aarhus University; University of Tennessee System; University of Tennessee Knoxville; Bigelow Laboratory for Ocean Sciences; Max Planck Society	Lloyd, KG (corresponding author), Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus, Denmark.	klloyd@utk.edu	Jorgensen, Bo B/C-2214-2013; Schramm, Andreas/AAE-1616-2022; Petersen, Dorthe/B-6063-2009; Schramm, Andreas/J-2655-2013; Schreiber, Lars/J-5937-2013; Kleindienst, Sara/O-9908-2016; Kjeldsen, Kasper U/A-4151-2011; Lever, Mark A/C-2134-2011	Jorgensen, Bo B/0000-0001-9398-8027; Schramm, Andreas/0000-0002-7614-9616; Schramm, Andreas/0000-0002-7614-9616; Schreiber, Lars/0000-0003-3411-0083; Kleindienst, Sara/0000-0001-8304-9149; Kjeldsen, Kasper U/0000-0002-7805-5605; Lever, Mark A/0000-0002-2046-8028; Stepanauskas, Ramunas/0000-0003-4458-3108; Lloyd, Karen/0000-0003-0914-6375; Steen, Andrew/0000-0003-4297-4332	Danish National Research Foundation; German Max Planck Society; NSF Center for Dark Energy Biosphere Investigations [NSF-157595]; Danish Council for Independent Research-Natural Sciences; Villum Kann Rasmussen Foundation; EU Marie Curie fellowship; German Research Foundation; USA National Science Foundation [EF-826924, OCE-821374, OCE-1019242]; Directorate For Geosciences [1232982] Funding Source: National Science Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); German Max Planck Society(Max Planck Society); NSF Center for Dark Energy Biosphere Investigations; Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden); EU Marie Curie fellowship(European Commission); German Research Foundation(German Research Foundation (DFG)); USA National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the captain and crew of the R/V Tyra for sampling; T. B. Sogaard, A. Stentebjerg and B. Poulsen for technical work; F. Loffler for laboratory space; and D. Kirchman and S. Hallam for sharing their unpublished metagenomic data sets. This work was funded by the Danish National Research Foundation, the German Max Planck Society, NSF Center for Dark Energy Biosphere Investigations NSF-157595 (K. G. L.), The Danish Council for Independent Research-Natural Sciences (D. G. P.), the Villum Kann Rasmussen Foundation, an EU Marie Curie fellowship (M. A. L.), the German Research Foundation (S. L.) and the USA National Science Foundation awards EF-826924, OCE-821374 and OCE-1019242 (R.S.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brochier-Armanet C, 2012, ISME J, V6, P227, DOI [10.1038/ismej.2011.145, 10.1038/ismej.2012.110]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Coolen MJL, 2000, APPL ENVIRON MICROB, V66, P2589, DOI 10.1128/AEM.66.6.2589-2598.2000; Dale AW, 2008, J MAR RES, V66, P127, DOI 10.1357/002224008784815775; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; HALL DO, 1971, NATURE, V233, P136, DOI 10.1038/233136a0; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Jarrell KF, 2011, MICROBIOL-SGM, V157, P919, DOI 10.1099/mic.0.047837-0; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Jorgensen B. B., 1996, COASTAL ESTUARINE ST, P137, DOI DOI 10.1029/CE052P0137; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KEMBHAVI AA, 1991, FEBS LETT, V283, P277, DOI 10.1016/0014-5793(91)80607-5; KING GM, 1986, APPL ENVIRON MICROB, V51, P373, DOI 10.1128/AEM.51.2.373-380.1986; Kjeldsen KU, 2007, FEMS MICROBIOL ECOL, V60, P287, DOI 10.1111/j.1574-6941.2007.00288.x; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Labrou NE, 2004, EUR J BIOCHEM, V271, P983, DOI 10.1111/j.1432-1033.2004.04000.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pedersen AGU, 2001, LIMNOL OCEANOGR, V46, P1358, DOI 10.4319/lo.2001.46.6.1358; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, 2009, R LANG ENV STAT COMP; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; RAUBER P, 1988, BIOCHEM J, V250, P871, DOI 10.1042/bj2500871; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schippers A, 2010, GEOMICROBIOL J, V27, P170, DOI 10.1080/01490450903456798; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schut GJ, 2001, METHOD ENZYMOL, V331, P144; Stahl D, 1991, DEV APPL NUCL ACID P, P205; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299	60	374	385	4	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					215	+		10.1038/nature12033	http://dx.doi.org/10.1038/nature12033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535597				2022-12-28	WOS:000317346300040
J	Greene, M; Justice, AC; Lampiris, HW; Valcour, V				Greene, Meredith; Justice, Amy C.; Lampiris, Harry W.; Valcour, Victor			Management of Human Immunodeficiency Virus Infection in Advanced Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER-ADULTS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; RISK-FACTORS; OF-LIFE; AIDS; CARE; MORTALITY; INDIVIDUALS; PREVENTION	Importance Human immunodeficiency virus (HIV)-positive patients treated with antiretroviral therapy now have increased life expectancy and develop chronic illnesses that are often seen in older HIV-negative patients. Objective To address emerging issues related to aging with HIV. Screening older adults for HIV, diagnosis of concomitant diseases, management of multiple comorbid medical illnesses, social isolation, polypharmacy, and factors associated with end-of-life care are reviewed. Evidence Acquisition Published guidelines and consensus statements were reviewed. PubMed and PsycINFO were searched between January 2000 and February 2013. Articles not appearing in the search that were referenced by reviewed articles were also evaluated. Findings The population of older HIV-positive patients is rapidly expanding. It is estimated that by 2015 one-half of the individuals in the United States with HIV will be older than age 50. Older HIV-infected patients are prone to having similar chronic diseases as their HIV-negative counterparts, as well as illnesses associated with co-infections. Medical treatments associated with these conditions, when added to an antiretroviral regimen, increase risk for polypharmacy. Care of aging HIV-infected patients involves a need to balance a number of concurrent comorbid medical conditions. Conclusions and Relevance HIV is no longer a fatal disease. Management of multiple comorbid diseases is a common feature associated with longer life expectancy in HIV-positive patients. There is a need to better understand how to optimize the care of these patients. JAMA. 2013;309(13):1397-1405 www.jama.com	[Greene, Meredith; Valcour, Victor] Univ Calif San Francisco, Dept Med, Div Geriatr Med, San Francisco, CA 94158 USA; [Lampiris, Harry W.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94158 USA; [Valcour, Victor] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94158 USA; [Justice, Amy C.] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA; [Justice, Amy C.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Lampiris, Harry W.] Dept Vet Affairs Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Valcour, V (corresponding author), Univ Calif San Francisco, Memory & Aging Ctr, MB 1207,675 Nelson Rising Ln, San Francisco, CA 94158 USA.	vvalcour@memory.ucsf.edu			National Institutes of Health (NIH) [T32-AG00212]; S. D. Bechtel Jr Foundation for Program for the Aging Century; NIH [U10-AA13566, U24-AA020794, U01-AA020790, AG032872, MH098759]; International Antiviral Society-USA (IAS-USA); UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research [P30-A1027763]; SCAN Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, K24MH098759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032872, T32AG000212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA013566, U01AA020790, U24AA020794] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); S. D. Bechtel Jr Foundation for Program for the Aging Century; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Antiviral Society-USA (IAS-USA); UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research; SCAN Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Greene reports receipt of salary support through the National Institutes of Health (NIH) (T32-AG00212) and research support from the S. D. Bechtel Jr Foundation for Program for the Aging Century. Dr Justice reports receipt of research support including salary from the NIH related to HIV/aging (U10-AA13566, U24-AA020794, U01-AA020790). Dr Valcour reports receipt of research support including salary from the NIH related to HIV/aging (AG032872 and MH098759); and board membership, speakers bureau participation, an honorarium for consulting, fees for development of educational presentations (eLearning for Africa), and support for travel to meetings from the International Antiviral Society-USA (IAS-USA). Drs Valcour and Greene report receipt of research support from the joint UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research (P30-A1027763).; The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Abrass CK, 2012, J AM GERIATR SOC, V60, P974, DOI 10.1111/j.1532-5415.2012.03948.x; Adekeye OA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043618; Akgun KM, 2013, JAIDS-J ACQ IMM DEF, V62, P52, DOI 10.1097/QAI.0b013e318278f3fa; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; [Anonymous], 2006, MMWR RECOMM REP; [Anonymous], GUID US ANT AG HIV 1; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Balderson BH, 2013, AIDS CARE, V25, P451, DOI 10.1080/09540121.2012.712669; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Bianco JA, 2011, AIDS BEHAV, V15, P1437, DOI 10.1007/s10461-010-9756-2; Braithwaite R Scott, 2009, Med Care, V47, P610, DOI 10.1097/MLR.0b013e31819748d5; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Chou R, 2011, EPIDEMIOL REV, V33, P7, DOI 10.1093/epirev/mxr001; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Crystal S, 2003, JAIDS-J ACQ IMM DEF, V33, pS76, DOI 10.1097/00126334-200306012-00004; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Desquilbet L, 2011, J GERONTOL A-BIOL, V66, P1030, DOI 10.1093/gerona/glr097; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emlet CA, 2006, HEALTH SOC WORK, V31, P299, DOI 10.1093/hsw/31.4.299; Emlet CA, 2011, GERONTOLOGIST, V51, P101, DOI 10.1093/geront/gnq060; Erlandson KM, 2012, JAMA INTERN MED, V15, P1124, DOI DOI 10.1001/JAMAINTERNMED.2013.3728; Erlandson KM, 2012, J PALLIAT MED, V15, P1124, DOI 10.1089/jpm.2011.0510; Furler MD, 2004, AIDS PATIENT CARE ST, V18, P568, DOI 10.1089/apc.2004.18.568; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; HANDFORD CD, 2006, COCHRANE DB SYST REV, V19; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Heckman TG, 2011, J BEHAV MED, V34, P102, DOI 10.1007/s10865-010-9292-6; Henderson SJ, 2004, J AM GERIATR SOC, V52, P1549, DOI 10.1111/j.1532-5415.2004.52421.x; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jacobs R, 2009, J WOMEN AGING, V21, P19, DOI 10.1080/08952840802633586; Johnson CJ, 2009, AIDS CARE, V21, P541, DOI 10.1080/09540120802385611; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Krentz HB, 2012, ANTIVIR THER, V17, P833, DOI 10.3851/IMP2076; Kwiatkowski CF, 2003, JAIDS-J ACQ IMM DEF, V33, pS131, DOI 10.1097/00126334-200306012-00010; LEE S, ESTIMATING PROGNOSIS; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Linley L, 2012, AM J PUBLIC HEALTH, V102, P1527, DOI 10.2105/AJPH.2011.300431; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; Milaszewski D, 2012, J EVID-INFORM SOC WO, V9, P213, DOI 10.1080/15433714.2010.494979; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Morgan EE, 2012, JAIDS-J ACQ IMM DEF, V61, P341, DOI 10.1097/QAI.0b013e31826bfc53; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; O'Brien K, 2010, COCHRANE DB SYST REV, V4; Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242; Owen G, 2012, CULT HEALTH SEX, V14, P59, DOI 10.1080/13691058.2011.621449; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Rhee MS, 2008, J CLIN PHARMACOL, V48, P1212, DOI 10.1177/0091270008322177; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Sankar A, 2011, AIDS CARE, V23, P1187, DOI 10.1080/09540121.2011.564115; Schensul JJ, 2003, JAIDS-J ACQ IMM DEF, V33, pS138, DOI 10.1097/00126334-200306012-00011; Selwyn Peter A, 2003, J Palliat Med, V6, P475, DOI 10.1089/109662103322144853; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Simms V, 2012, LANCET INFECT DIS, V12, P571, DOI 10.1016/S1473-3099(12)70085-3; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; University of Liverpool, DRUG INT CHARTS; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Waters L, 2012, INT J STD AIDS, V23, P546, DOI 10.1258/ijsa.2012.011412; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; WHO, ANT THER HIV INF AD; WOMACK JA, 2013, CLIN INFECT DIS; Yehia BR, 2012, JAMA-J AM MED ASSOC, V308, P339, DOI 10.1001/jama.2012.5927; Zablotsky D, 2003, JAIDS-J ACQ IMM DEF, V33, pS122, DOI 10.1097/00126334-200306012-00009	78	120	123	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1397	1405		10.1001/jama.2013.2963	http://dx.doi.org/10.1001/jama.2013.2963			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EC	23549585	Green Accepted			2022-12-28	WOS:000316934500029
J	Berkley, S; Chan, M; Dybul, M; Hansen, K; Lake, A; Osotimehin, B; Sidibe, M				Berkley, Seth; Chan, Margaret; Dybul, Mark; Hansen, Keith; Lake, Anthony; Osotimehin, Babatunde; Sidibe, Michel			A healthy perspective: the post-2015 development agenda	LANCET			English	Editorial Material									[Berkley, Seth] GAVI Alliance, CH-1202 Geneva, Switzerland; [Chan, Margaret] WHO, CH-1211 Geneva, Switzerland; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Hansen, Keith] World Bank, Washington, DC 20433 USA; [Lake, Anthony] UNICEF, New York, NY USA; [Osotimehin, Babatunde] UNFPA, New York, NY USA; [Sidibe, Michel] UNAIDS, Geneva, Switzerland	World Health Organization; The World Bank; UNICEF; United Nations Population Fund; UNAIDS	Berkley, S (corresponding author), GAVI Alliance, CH-1202 Geneva, Switzerland.	sberkley@gavialliance.org						[Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2012, GLOB REP UNAIDS REP; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Pruss-Ustun A., 2006, WORLD HEALTH; Singh S, 2012, ADDING IT COSTS BENE; The World Bank, 2012, MAL AFR; WHO, 2012, WORLD MALARIA REPORT 2012, P1	7	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1076	1077		10.1016/S0140-6736(13)60722-9	http://dx.doi.org/10.1016/S0140-6736(13)60722-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541052				2022-12-28	WOS:000317348900006
J	Rechel, B; Roberts, B; Richardson, E; Shishkin, S; Shkolnikov, VM; Leon, DA; Bobak, M; Karanikolos, M; McKee, M				Rechel, Bernd; Roberts, Bayard; Richardson, Erica; Shishkin, Sergey; Shkolnikov, Vladimir M.; Leon, David A.; Bobak, Martin; Karanikolos, Marina; McKee, Martin			Health and health systems in the Commonwealth of Independent States	LANCET			English	Article							FORMER SOVIET-UNION; HAZARDOUS ALCOHOL-DRINKING; INJECTING DRUG-USERS; EASTERN-EUROPE; ANTIRETROVIRAL TREATMENT; SMOKING PREVALENCE; INSURANCE-COVERAGE; RUSSIAN MORTALITY; CENTRAL-ASIA; CARE REFORM	The countries of the Commonwealth of Independent States differ substantially in their post-Soviet economic development but face many of the same challenges to health and health systems. Life expectancies dropped steeply in the 1990s, and several countries have yet to recover the levels noted before the dissolution of the Soviet Union. Cardiovascular disease is a much bigger killer in the Commonwealth of Independent States than in western Europe because of hazardous alcohol consumption and high smoking rates in men, the breakdown of social safety nets, rising social inequality, and inadequate health services. These former Soviet countries have embarked on reforms to their health systems, often aiming to strengthen primary care, scale back hospital capacities, reform mechanisms for paying providers and pooling funds, and address the overall shortage of public funding for health. However, major challenges remain, such as frequent private out-of-pocket payments for health care and underdeveloped systems for improvement of quality of care.	[Rechel, Bernd; Richardson, Erica; Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Rechel, Bernd; Roberts, Bayard; Richardson, Erica; Leon, David A.; Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Shishkin, Sergey] Higher Sch Econ, Moscow, Russia; [Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Lab Demog Data, Rostock, Germany; [Shkolnikov, Vladimir M.] New Econ Sch, Ctr Demog Res, Moscow, Russia; [Bobak, Martin] UCL, London, England	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; HSE University (National Research University Higher School of Economics); Max Planck Society; New Economic School; University of London; University College London	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	bernd.rechel@lshtm.ac.uk	Mckee, Martin/E-6673-2018; Leon, David A/G-2195-2010; Shkolnikov, Vladimir/D-2986-2017; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; Leon, David A/0000-0001-9747-1762; Shkolnikov, Vladimir/0000-0003-2259-5423; McKee, Marc D/0000-0001-8349-965X; Karanikolos, Marina/0000-0002-3824-8226; Bobak, Martin/0000-0002-2633-6851; Roberts, Bayard/0000-0003-4482-5859; Richardson, Erica/0000-0001-9400-0316; Rechel, Bernd/0000-0001-8020-3956	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This work was supported by the European Observatory on Health Systems and Policies.	Ahmedov M, 2007, INT J HEALTH PLAN M, V22, P301, DOI 10.1002/hpm.897; Aleshina N, 2003, 99 INN RES CTR; Allen E, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-238; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Andreev EM, 2011, POP STUD-J DEMOG, V65, P319, DOI 10.1080/00324728.2011.603428; Andreeva TI, 2007, TOB CONTROL, V16, P202, DOI 10.1136/tc.2006.019588; [Anonymous], 2011, GLOB TUB CONTR 2011; Atun R., 2008, HLTH SYSTEMS TRANSIT, V10, P1; Atun R, 2008, B WORLD HEALTH ORGAN, V86, P147, DOI 10.2471/BLT.06.034991; Balabanova DC, 2003, AM J PUBLIC HEALTH, V93, P2124, DOI 10.2105/AJPH.93.12.2124; Balabanova D, 2012, HEALTH SERV RES, V47, P840, DOI 10.1111/j.1475-6773.2011.01323.x; Belli Paolo, 2001, 10 YEARS HLTH REFORM; Bernitz B. L., 2006, HIV/AIDS in Europe: moving from death sentence to chronic disease management, P232; Bobak M, 2006, TOB CONTROL, V15, P131, DOI 10.1136/tc.2005.014274; Bobrova N, 2007, INT J DRUG POLICY, V18, P313, DOI 10.1016/j.drugpo.2007.01.015; Bobrova N, 2006, DRUG ALCOHOL DEPEN, V82, pS57, DOI 10.1016/S0376-8716(06)80010-4; Chanturidze T., 2009, HLTH SYSTEMS TRANSIT, V11, P1; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; COOPER R, 1982, BRIT MED J, V285, P549, DOI 10.1136/bmj.285.6341.549; Danichevski K, 2008, HEALTH POLICY, V85, P242, DOI 10.1016/j.healthpol.2007.08.001; Danishevski K, 2009, INT J HEALTH PLAN M, V24, P161, DOI 10.1002/hpm.934; Djibuti M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-222; Duke T, 2006, LANCET, V367, P919, DOI 10.1016/S0140-6736(06)68382-7; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Ensor T, 2004, SOC SCI MED, V58, P237, DOI 10.1016/S0277-9536(03)00007-8; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Field MG, 2004, NEW ENGL J MED, V351, P117, DOI 10.1056/NEJMp048066; Fuenzalida-Puelma HL., 2010, IMPLEMENTING HLTH FI, V21, P155; Gil A, 2010, EUR J PUBLIC HEALTH, V20, P588, DOI 10.1093/eurpub/ckq030; Gilmore AB, 2004, TOB CONTROL, V13, P151, DOI 10.1136/tc.2003.005207; Gilmore AB, 2004, TOB CONTROL, V13, P136, DOI 10.1136/tc.2002.002667; Gotsadze G, 2010, IMPLEMENTING HLTH FI, P187; Grassi G, 2011, EUR HEART J, V32, P218, DOI 10.1093/eurheartj/ehq394; Guillot M, 2011, DEMOGRAPHY, V48, P1081, DOI 10.1007/s13524-011-0036-1; Guindon GE, 2010, CAN MED ASSOC J, V182, pE362, DOI 10.1503/cmaj.081165; HAKOBYAN T, 2006, HLTH SYSTEMS TRANSIT, V8, P1; Holley J., 2004, HLTH CARE SYSTEMS TR; Ibrahimov Fuad, 2010, Health Syst Transit, V12, P1; Ibraimova A., 2011, Health Systems in Transition (European Observatory on Health Systems and Policies), V13; Khaltourina DA, 2008, EVAL HEALTH PROF, V31, P272, DOI 10.1177/0163278708320160; Khodjamurodov Ghafur., 2010, HLTH SYSTEMS TRANSIT, V12, P1; Krasovsky K, 2009, DRUG ALCOHOL REV, V28, P396, DOI 10.1111/j.1465-3362.2009.00034.x; Krementsov Nikolai, 1996, STALINIST SCI; Kutzin J, 2010, HEALTH ECON POLICY L, V5, P135, DOI 10.1017/S1744133110000010; Kutzin J, 2009, B WORLD HEALTH ORGAN, V87, P549, DOI 10.2471/BLT.07.049544; Latypov A, 2010, INT J DRUG POLICY, V21, P407, DOI 10.1016/j.drugpo.2010.01.013; Latypov A, 2009, INT J DRUG POLICY, V20, P387, DOI 10.1016/j.drugpo.2008.11.002; Lekhan V., 2007, UKRAINIAN HLTH FINAN; Lekhan Valery, 2010, Health Syst Transit, V12, P1; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Lewis M., 2000, WHO IS PAYING HLTH C; Lewis M, 2002, FUNDING HLTH CARE OP, P184; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mackenbach JP, 2013, LANCET; Marmot M., 2005, EUR REV, V13, P15, DOI DOI 10.1017/S1062798705000037; Marx FM, 2007, EUR J PUBLIC HEALTH, V17, P98, DOI 10.1093/eurpub/ckl098; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; Mir H, 2013, TOB CONTROL, V22, P231, DOI 10.1136/tobaccocontrol-2012-050567; Nemtsov A. V., 2011, CONT HIST ALCOHOL RU; Open Society Institute, HARM RED DEV COUNTR; Parfitt B, 2009, COLLEGIAN, V16, P35, DOI 10.1016/j.colegn.2009.01.002; Perlman F, 2007, TOB CONTROL, V16, P299, DOI 10.1136/tc.2006.019455; Pomerleau J, 2004, ADDICTION, V99, P1577, DOI 10.1111/j.1360-0443.2004.00885.x; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Popovich Larisa, 2011, Health Syst Transit, V13, P1; Preker A., 2002, FUNDING HLTH CARE OP, P80; Raikhel E, 2010, CULT MED PSYCHIAT, V34, P132, DOI 10.1007/s11013-009-9163-1; Raj A, 2009, AIDS BEHAV, V13, P310, DOI 10.1007/s10461-008-9383-3; Rechel B, 2012, HEALTH POLICY PLANN, V27, P281, DOI 10.1093/heapol/czr040; Rechel B, 2008, BMJ-BRIT MED J, V337, P236; Rechel Bernd, 2010, Central European Journal of Public Health, V18, P110; Rechel B, 2010, SOC SCI MED, V70, P1928, DOI 10.1016/j.socscimed.2010.02.029; Rechel B, 2009, LANCET, V374, P1186, DOI 10.1016/S0140-6736(09)61334-9; Rechel B, 2011, J PUBLIC HEALTH POL, V32, P293, DOI 10.1057/jphp.2011.18; Rese A, 2005, BMJ-BRIT MED J, V331, P204, DOI 10.1136/bmj.331.7510.204; Richardson E., 2008, HLTH SYSTEMS TRANSIT, V10, P1; Richardson E, 2012, HEALTH POLICY PLANN, V27, P204, DOI 10.1093/heapol/czr024; Roberts B, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-05024, DOI 10.1136/TOBACCOCONTROL-2011-05024]; Roberts B, 2012, J EPIDEMIOL COMMUN H, V66, P1079, DOI 10.1136/jech-2011-200645; Roberts B, 2012, AM J PUBLIC HEALTH, V102, P1320, DOI 10.2105/AJPH.2011.300547; Roberts B, 2012, J EPIDEMIOL COMMUN H, V66, P482, DOI 10.1136/jech.2010.111377; Sarang A, 2007, INT J DRUG POLICY, V18, P129, DOI 10.1016/j.drugpo.2006.11.007; Sheiman I, 2010, IMPLEMENTING HLTH FI, P187; Shishkin S., 2008, EVALUATION MOLDOVAS; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; Somanathan A., 2019, STRENGTHENING INTEGR; Stachowiak J, 2006, HIV AIDS RUSSIA EURA, V1, P57; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; Treisman D, 2010, ECON TRANSIT, V18, P281, DOI 10.1111/j.1468-0351.2009.00382.x; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2010, GLOB REP UNAIDS REP; *UNICEF, 2003, SOC MON 2003 SOC TRE; Vishnevskiy A., 2006, ROSSIYSKOE ZDRAVOOKH; Vlassov VV, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-15; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Watson N, 2004, LANCET, V364, P1745, DOI 10.1016/S0140-6736(04)17419-9; Webb CPM, 2007, PUBLIC HEALTH, V121, P663, DOI 10.1016/j.puhe.2006.11.017; WHO, 2012, EUR HLTH ALL DAT AUG; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; World Health Organization, 2019, WHO REPORT GLOBAL TO; Yeganyan R, 2001, DEMOGR RES, V5, P217, DOI DOI 10.4054/DEMRES.2001.5.7; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	110	40	43	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1145	1155		10.1016/S0140-6736(12)62084-4	http://dx.doi.org/10.1016/S0140-6736(12)62084-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541055				2022-12-28	WOS:000317348900033
J	Kilpivaara, O; Aaltonen, LA				Kilpivaara, O.; Aaltonen, L. A.			Diagnostic Cancer Genome Sequencing and the Contribution of Germline Variants	SCIENCE			English	Review							COLORECTAL-CANCER; P53 MUTATIONS; HIGH-RISK; ORIGIN; INDIVIDUALS; LANDSCAPE; REVEALS	Whole-genome sequencing (WGS) is revolutionizing medical research and has the potential to serve as a powerful and cost-effective diagnostic tool in the management of cancer. We review the progress to date in the use of WGS to reveal how germline variants and mutations may be associated with cancer. We use colorectal cancer as an example of how the current level of knowledge can be translated into predictions of predisposition. We also address challenges in the clinical implementation of the variants in germline DNA identified through cancer genome sequencing. We call for the international development of standards to facilitate the clinical use of germline information arising from diagnostic cancer genome sequencing.	[Aaltonen, L. A.] Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, FI-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Aaltonen, LA (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, POB 63 Haartmaninkatu 8, FI-00014 Helsinki, Finland.	lauri.aaltonen@helsinki.fi	Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286	Academy of Finland, Finnish Center of Excellence Program (Center of Excellence in Cancer Genetics Research) [137680]; EU FP7 Project SYSCOL	Academy of Finland, Finnish Center of Excellence Program (Center of Excellence in Cancer Genetics Research); EU FP7 Project SYSCOL	Supported by the Academy of Finland, Finnish Center of Excellence Program 2012-2017 (Center of Excellence in Cancer Genetics Research), postdoctoral grant 137680 (O.K.), and EU FP7 Project SYSCOL.	Aittomaki K., 2013, FINN MED CONV HELS 1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Bleiker EMA, 2005, GASTROENTEROLOGY, V128, P280, DOI 10.1053/j.gastro.2004.11.002; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Chang VY, 2013, PEDIATR BLOOD CANCER, V60, P570, DOI 10.1002/pbc.24316; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Lubbe SJ, 2012, AM J EPIDEMIOL, V175, P1, DOI 10.1093/aje/kwr285; Maher B, 2009, NATURE, V459, P146, DOI 10.1038/459146b; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Nekrutenko A, 2012, NAT REV GENET, V13, P667, DOI 10.1038/nrg3305; P. C. for the Study of Bioethical Issues, 2012, PRIVACY PROGR WHOLE; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Solomon BD, 2012, MOL SYNDROMOL, V3, P59, DOI 10.1159/000341253; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tomlinson IPM, 2012, MUTAGENESIS, V27, P219, DOI 10.1093/mutage/ger070; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	50	40	41	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1559	1562		10.1126/science.1233899	http://dx.doi.org/10.1126/science.1233899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539595				2022-12-28	WOS:000316731600037
J	Winkler, JR				Winkler, Jay R.			FRETting over the Spectroscopic Ruler	SCIENCE			English	Editorial Material							ELECTRON; TRYPTOPHAN; UV		CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology	Winkler, JR (corresponding author), CALTECH, Beckman Inst, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	winklerj@caltech.edu	Winkler, Jay R/B-7372-2009		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019038] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK019038] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beierlein FR, 2006, J AM CHEM SOC, V128, P5142, DOI 10.1021/ja058414l; Bram O, 2011, J PHYS CHEM B, V115, P13723, DOI 10.1021/jp207615u; CLOSS GL, 1989, J AM CHEM SOC, V111, P3751, DOI 10.1021/ja00192a044; Consani C, 2013, SCIENCE, V339, P1586, DOI 10.1126/science.1230758; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001; HOCHSTRASSER RM, 1984, P NATL ACAD SCI-BIOL, V81, P4399, DOI 10.1073/pnas.81.14.4399; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032; Zimanyi EN, 2012, PHILOS T R SOC A, V370, P3620, DOI 10.1098/rsta.2011.0204	13	20	20	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1530	1531		10.1126/science.1235761	http://dx.doi.org/10.1126/science.1235761			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539587				2022-12-28	WOS:000316731600028
J	Irannejad, R; Tomshine, JC; Tomshine, JR; Chevalier, M; Mahoney, JP; Steyaert, J; Rasmussen, SGF; Sunahara, RK; El-Samad, H; Huang, B; von Zastrow, M				Irannejad, Roshanak; Tomshine, Jin C.; Tomshine, Jon R.; Chevalier, Michael; Mahoney, Jacob P.; Steyaert, Jan; Rasmussen, Soren G. F.; Sunahara, Roger K.; El-Samad, Hana; Huang, Bo; von Zastrow, Mark			Conformational biosensors reveal GPCR signalling from endosomes	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; CAMP; ENDOCYTOSIS; DESENSITIZATION; ACTIVATION; BINDING; DOMAIN	A long-held tenet of molecular pharmacology is that canonical signal transduction mediated by G-protein-coupled receptor (GPCR) coupling to heterotrimeric G proteins is confined to the plasma membrane. Evidence supporting this traditional view is based on analytical methods that provide limited or no subcellular resolution(1). It has been subsequently proposed that signalling by internalized GPCRs is restricted to G-protein-independent mechanisms such as scaffolding by arrestins(2,3), or GPCR activation elicits a discrete formof persistent G protein signalling(4-9), or that internalized GPCRs can indeed contribute to the acute G-protein-mediated response(10). Evidence supporting these various latter hypotheses is indirect or subject to alternative interpretation, and it remains unknown if endosome-localized GPCRs are even present in an active form. Here we describe the application of conformation-specific single-domain antibodies (nanobodies) to directly probe activation of the beta(2)-adrenoceptor, a prototypical GPCR(11), and its cognate G protein, G(s) (ref. 12), in living mammalian cells. We show that the adrenergic agonist isoprenaline promotes receptor and G protein activation in the plasma membrane as expected, but also in the early endosome membrane, and that internalized receptors contribute to the overall cellular cyclic AMP response within several minutes after agonist application. These findings provide direct support for the hypothesis that canonical GPCR signalling occurs from endosomes as well as the plasma membrane, and suggest a versatile strategy for probing dynamic conformational change in vivo.	[Irannejad, Roshanak; Tomshine, Jin C.; Tomshine, Jon R.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Chevalier, Michael; El-Samad, Hana; Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mahoney, Jacob P.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Steyaert, Jan] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Steyaert, Jan] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	Mark.VonZastrow@ucsf.edu	Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Sunahara, Roger/AAJ-8667-2020	Steyaert, Jan/0000-0002-3825-874X; Tomshine, Jonathan/0000-0001-6633-8678; Rasmussen, Soren/0000-0002-1853-1841	National Institute on Drug Abuse of the US National Institutes of Health [DA010711, DA012864, F32 DA029993]; American Heart Association; National Institute of General Medical Sciences [GM083118, T32 GM007767]; Lundbeck Foundation; FWO-Vlaanderen grants [FWO551, FWO646]; Innoviris-Brussels [BRGEOZ132]; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R01GM068603, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029993, R29DA010711, R01DA010711, P01DA010154, R01DA012864, R37DA010711] Funding Source: NIH RePORTER; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish	National Institute on Drug Abuse of the US National Institutes of Health; American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden); FWO-Vlaanderen grants; Innoviris-Brussels(Innoviris); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden)	We thank B. Kobilka, P. Robinson, A. Kruse, E. Pardon, P. Temkin, M. Puthenveedu, A. Henry, A. Marley and K. Thorn for assistance, advice and discussion. These studies were supported by the National Institute on Drug Abuse of the US National Institutes of Health (DA010711 and DA012864 to M.v.Z. and F32 DA029993 to J.C.T.). R. I. is supported by the American Heart Association. R. K. S. and J.P.M. are supported by the National Institute of General Medical Sciences (GM083118 to R. K. S. and T32 GM007767 to J.P.M.). S. G. F. R. is supported by the Lundbeck Foundation. J.S. is supported by FWO-Vlaanderen grants (FWO551 and FWO646) and Innoviris-Brussels (BRGEOZ132). B. H. is supported by a Packard Fellowship for Science and Engineering.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILMAN AG, 1991, HARVEY LECT, V85, P153; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Luttrell LM, 2002, J CELL SCI, V115, P455; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	41	525	539	7	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					534	+		10.1038/nature12000	http://dx.doi.org/10.1038/nature12000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515162	Green Published, Green Accepted			2022-12-28	WOS:000316682800051
J	Priem, J				Priem, Jason			Beyond the paper	NATURE			English	Editorial Material							CITATION		[Priem, Jason] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Priem, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	jason@impactstory.org						Cronin B, 2001, J INF SCI, V27, P1, DOI 10.1177/016555150102700101; Edelman B, 2009, 09096 HARV BUS SCH N; Esposito J. J., 2008, J ELECT PUBL; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; PRIEM J, 2010, 1 MONDAY; Priem J., 2012, FIGSHARE; Priem J, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00019; Smith JWT, 1999, LEARN PUBL, V12, P79, DOI 10.1087/09531519950145896; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540	10	96	98	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					437	440		10.1038/495437a	http://dx.doi.org/10.1038/495437a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113QN	23538811	Bronze			2022-12-28	WOS:000316682800017
J	Shen, H; Laird, PW				Shen, Hui; Laird, Peter W.			Interplay between the Cancer Genome and Epigenome	CELL			English	Review							METHYLTRANSFERASE GENE EZH2; ISLAND METHYLATOR PHENOTYPE; CHROMATIN REMODELING GENES; DNA METHYLATION; SOMATIC MUTATIONS; CPG ISLAND; PROMOTER HYPERMETHYLATION; MICROSATELLITE INSTABILITY; EPIGENETIC REGULATION; REPRESSIVE CHROMATIN	Cancer arises as a consequence of cumulative disruptions to cellular growth control with Darwinian selection for those heritable changes that provide the greatest clonal advantage. These traits can be acquired and stably maintained by either genetic or epigenetic means. Here, we explore the ways in which alterations in the genome and epigenome influence each other and cooperate to promote oncogenic transformation. Disruption of epigenomic control is pervasive in malignancy and can be classified as an enabling characteristic of cancer cells, akin to genome instability and mutation.	[Shen, Hui; Laird, Peter W.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90089 USA	University of Southern California	Laird, PW (corresponding author), Univ So Calif, USC Epigenome Ctr, Room G511B,1450 Biggy St, Los Angeles, CA 90089 USA.	plaird@usc.edu	Laird, Peter W/G-8683-2012; Shen, Hui/AAO-4387-2020	Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084	NIH [R01-CA170550, R01-CA157918, R01-DA030325, U24 CA143882]; NATIONAL CANCER INSTITUTE [U24CA143882, R01CA170550, R01CA157918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030325] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01-CA170550, R01-CA157918, R01-DA030325, and U24 CA143882 (P.W.L.). We would like to thank Peter Jones, Benjamin Berman, and Timothy Triche, Jr. for helpful discussions.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; BAYLIN SB, 1986, CANCER RES, V46, P2917; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Boyarchuk E, 2011, CURR OPIN CELL BIOL, V23, P266, DOI 10.1016/j.ceb.2011.03.006; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; DIALA ES, 1982, BIOCHEM BIOPH RES CO, V107, P19, DOI 10.1016/0006-291X(82)91663-1; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2000, CANCER RES, V60, P2368; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gessi M, 2013, J NEURO-ONCOL, V112, P67, DOI 10.1007/s11060-012-1040-z; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Hyland EM, 2011, GENE DEV, V25, P1306, DOI 10.1101/gad.2050311; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li J, 2012, PLOS GENET, V8, P201, DOI [10.1371/journal.pgen.1002692, 10.1371/journal.pgen.1002630]; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loughery JEP, 2011, HUM MOL GENET, V20, P3241, DOI 10.1093/hmg/ddr236; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mummert SK, 2005, GENE CHROMOSOME CANC, V43, P155, DOI 10.1002/gcc.20176; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Raddatz G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003146; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sansom OJ, 2003, NAT GENET, V34, P145, DOI 10.1038/ng1155; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Simpkins SB, 1999, HUM MOL GENET, V8, P661, DOI 10.1093/hmg/8.4.661; Smith MJ, 2013, NAT GENET, V45, P295, DOI 10.1038/ng.2552; Sproul D, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R84, 10.1186/gb-2012-13-10-r84]; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 2010, ADV GENET, V70, P309, DOI [10.1016/B978-0-12-380866-0.60011-3, 10.1016/S0065-2660(10)70011-0]; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG RYH, 1982, BIOCHIM BIOPHYS ACTA, V697, P371, DOI 10.1016/0167-4781(82)90101-4; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weissmann S, 2012, LEUKEMIA, V26, P934, DOI 10.1038/leu.2011.326; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Yamazaki J, 2013, EPIGENETICS-US, V8, P92, DOI 10.4161/epi.23243; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	195	583	613	2	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					38	55		10.1016/j.cell.2013.03.008	http://dx.doi.org/10.1016/j.cell.2013.03.008			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540689	Green Accepted, Bronze			2022-12-28	WOS:000316853700005
J	Al Hilfi, TK; Lafta, R; Burnham, G				Al Hilfi, Thamer Kadum; Lafta, Riyadh; Burnham, Gilbert			Health services in Iraq	LANCET			English	Review							SYSTEM; EDUCATION; OUTBREAK; MEDICINE; BAGHDAD	After decades of war, sanctions, and occupation, Iraq's health services are struggling to regain lost momentum. Many skilled health workers have moved to other countries, and young graduates continue to leave. In spite of much rebuilding, health infrastructure is not fully restored. National development plans call for a realignment of the health system with primary health care as the basis. Yet the health-care system continues to be centralised and focused on hospitals. These development plans also call for the introduction of private health care as a major force in the health sector, but much needs to be done before policies to support this change are in place. New initiatives include an active programme to match access to health services with the location and needs of the population.	[Al Hilfi, Thamer Kadum] Al Kindy Coll Med, Dept Community Med, Baghdad, Iraq; [Lafta, Riyadh] Al Munstansiriya Univ, Dept Community Med, Baghdad, Iraq; [Burnham, Gilbert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burnham, G (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	gburnham@jhsph.edu	Al Hilfi, Thamer/HCH-4935-2022	Al Hilfi, Thamer/0000-0002-5840-285X				Abyad A, 2007, FAM MED, V39, P736; AFP, IR HIR IND NURS PLUG; Al-Nasrawi K. K., 2010, Eastern Mediterranean Health Journal, V16, P1128; [Anonymous], 2012, IRAQI BUSINESS  1113; [Anonymous], 2012, IRAQI BUSINESS  1116; [Anonymous], 2011, EMPHNET NEWS     MAR; [Anonymous], 2012, IRAQI BUSINESS  0808; [Anonymous], IR 2012 REP; [Anonymous], 2012, USAID PRIM HLTH CAR; Aziz C, 2003, LANCET, V362, P1288, DOI 10.1016/S0140-6736(03)14618-1; Baylis John, 2007, STRATEGY CONT WORLD; Bolton P, 2013, LANCET, V381, P879, DOI 10.1016/S0140-6736(13)60637-6; Brulliard K, 2007, WASHINGTON POST; Burnham G, 2012, INT J HEALTH PLAN M, V27, pe51, DOI 10.1002/hpm.1091; Burnham G, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-15; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; Central Bank of Iraq, GOV DEBT; Daponte BO, 2000, AM J PUBLIC HEALTH, V90, P546, DOI 10.2105/AJPH.90.4.546; Doocy S, 2011, SOC SCI MED, V72, P273, DOI 10.1016/j.socscimed.2010.10.023; Doocy Shannon, 2010, Am J Disaster Med, V5, P41; Edward A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001066; Fars News Agency, 2012, IR HELP IR BUILD HOS; Garfield R, 2005, INT NURS REV, V52, P180, DOI 10.1111/j.1466-7657.2005.00428.x; Government of Afghanistan Ministry of Health, 2005, ESS PACK HOSP SERV; Government of Afghanistan Ministry of Health, 2003, BAS PACK HLTH SERV; Government of Iraq COSIT KRG MoH UNICEF, 2006, MON SIT CHILDR WOM; Government of Iraq Ministry of Health, 2012, IR PUBL SECT MOD ASS; Government of Iraq Ministry of Health WHO, 2006, CHRON NONC DIS RISK; Government of Iraq. Ministry of Planning, 2010, ENV SURV IR; Hagopian A, 2010, AM J PUBLIC HEALTH, V100, P1081, DOI 10.2105/AJPH.2009.164236; Hansen PM, 2008, INT J QUAL HEALTH C, V20, P375, DOI 10.1093/intqhc/mzn039; Heartland Alliance International, IR COMM MENT HLTH WO; ICRC Iraq, GIV DIS PEOPL CHANG; IDMC, IR RESP STILL CTR RE; Inter-Agency information and Analysis Unit, WHAT IR FACTSH; Iraq Ministry of Health Department of Nursing, 2004, STRAT ACT PLAN DEV N; Juhi B, 2011, NBC NEWS        0816; Kapp C, 2003, LANCET, V361, P1351, DOI 10.1016/S0140-6736(03)13089-9; Khwaif J. M., 2010, Eastern Mediterranean Health Journal, V16, P584; Kruk ME, 2010, SOC SCI MED, V70, P89, DOI 10.1016/j.socscimed.2009.09.042; Levy BS, 2013, LANCET, V381, P949, DOI 10.1016/S0140-6736(13)60254-8; McCrummen Stephanie, 2011, WASHINGTON POST; Middle East Health, 2012, IR REP ROAD REC; Ministry of Health WHO EMRO, 2009, GOV IR WHO JOINT PRO; Morton MJ, 2008, JAMA-J AM MED ASSOC, V300, P727, DOI 10.1001/jama.300.6.727; Raddam KK, 2007, MED J BASRAH U, V25, P51; Republic of Iraq Ministry of Planning, NAT DEV PLAN YEARS 2; Richards LJ, 2000, LANCET, V355, P1093, DOI 10.1016/S0140-6736(00)02049-3; Sadik Sabah, 2011, Ment Health Fam Med, V8, P39; Shabila Nazar P, 2010, Confl Health, V4, P19, DOI 10.1186/1752-1505-4-19; Squires A, 2010, GLOB PUBLIC HEALTH, V5, P561, DOI 10.1080/17441690903473246; Tawfik-Shukor A, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-14; UN Inter-Agency Analysis unit, GOV PROF; UN Interagency Agency Analysis Unit, 2012, WOM IR FACT SHEET; UN Interagency Analysis Unit, 2012, 2012 CHOL IR; UN Interagency Analysis Unit, 2011, POV MEAS IR FIND POV; UN Interagency Information and Analysis Unit, 2010, MISS GOV PROF; UN News Centre, UN NEWS CTR; UN Office for the Coordination of Human Affairs, 2007, IRAQ POP GOV; UNAIDS, 2012, IR GLOB AIDS PROGR R; UNDP, 2013 HUM DEV REP; UNHCR, 2012 UNCHR COUNTR OP; UNICEF, 2012, STAT WORLDS CHILDR; United States Census Bureau, INT DAT BAS; URC-CHS, STRAT IMPR HLTH SERV; US Census Bureau, FERT RAT CUST REG; US Census Bureau, DEM OV IR; USAID Iraq, MAYS HLTH VIS E HLTH; Webster PC, 2011, LANCET, V378, P863, DOI 10.1016/S0140-6736(11)61399-8; WHO, 2005, IR COUNTR COOP STRAT; WHO, GLOB HLTH EXP DAT IR; WHO EMRO, 2012, NAT WORKSH ACC FRAM; WHO EMRO, ASS PREV CONG BIRTH; WHO EMRO, IR PROGR AR TUB; WHO EMRO Regional Health Observatory, COUNTR STAT; WHO Global Health Observatory, DEM SOC STAT; WHO Humanitarian Health Action, MENT HLTH SYST STREN; Williams T, 2010, NY TIMES; Wilson K, 2009, J HEALTH POLIT POLIC, V34, P381, DOI 10.1215/03616878-2009-004; Wood DF, 2003, BMJ-BRIT MED J, V326, P328, DOI 10.1136/bmj.326.7384.328; World Bank, HLTH EXP PER CAP CUR; World Bank, 2013, TUB PREV RAT; World Bank, IR HOUS SOC SURV IHS; World Bank, 2011, CONFR POV IR; World Bank, COUNTR DATA IRAQ; World Food Programme, 2012, CAP DEV REF PUBL DIS	86	77	78	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					939	948		10.1016/S0140-6736(13)60320-7	http://dx.doi.org/10.1016/S0140-6736(13)60320-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499042				2022-12-28	WOS:000316069700029
J	Lee, TI; Young, RA				Lee, Tong Ihn; Young, Richard A.			Transcriptional Regulation and Its Misregulation in Disease	CELL			English	Review							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; ELONGATION COMPLEX SEC; LINK INTELLECTUAL DISABILITY; CHROMATIN-REMODELING COMPLEX; CONGENITAL HEART-DISEASE; THYMIC EPITHELIAL-CELLS; TERT PROMOTER MUTATIONS; OPITZ-KAVEGGIA-SYNDROME; MIXED LINEAGE LEUKEMIA	The gene expression programs that establish and maintain specific cell states in humans are controlled by thousands of transcription factors, cofactors, and chromatin regulators. Misregulation of these gene expression programs can cause a broad range of diseases. Here, we review recent advances in our understanding of transcriptional regulation and discuss how these have provided new insights into transcriptional misregulation in disease.	[Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Stefanadis, Christodoulos/ABH-2232-2020	Young, Richard A/0000-0001-8855-8647; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Our description of the themes highlighted in this review benefited from discussions with Karen Adelman, Jay Bradner, Gerald Crabtree, Rudolf Jaenisch, Ian Krantz, Lee Lawton, David Levens, John Lis, Alex Marson, Matthias Merkenschlager, Alan Mullen, Duncan Odom, David Price, Peter Rahl, Robert Roeder, Ali Shilatifard, Phil Sharp, Alla Sigova, Alexander Stark, Dylan Taatjes, Robert Weinberg, and Leonard Zon. We thank David Orlando for help with data collation and analysis. This work was supported by National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y. and T.I.L.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Berk AJ, 2012, P NATL ACAD SCI USA, V109, P19519, DOI 10.1073/pnas.1217267109; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Demichelis F, 2012, P NATL ACAD SCI USA, V109, P6686, DOI 10.1073/pnas.1117405109; Dikstein R, 2011, TRANSCR-AUSTIN, V2, P201, DOI 10.4161/trns.2.5.17271; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Nguyen D, 2012, NUCLEIC ACIDS RES, V40, P5283, DOI 10.1093/nar/gks191; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gaj P, 2012, J ALZHEIMERS DIS, V32, P157, DOI 10.3233/JAD-2012-120520; Gardner JM, 2009, CURR OPIN IMMUNOL, V21, P582, DOI 10.1016/j.coi.2009.08.007; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Goh YS, 2012, CLIN GENET, V81, P430, DOI 10.1111/j.1399-0004.2011.01821.x; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hashimoto S, 2011, SCIENCE, V333, P1161, DOI 10.1126/science.1206638; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Iida A, 2011, HUM MOL GENET, V20, P3684, DOI 10.1093/hmg/ddr268; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jiang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021563; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Leal A, 2009, NEUROGENETICS, V10, P275, DOI 10.1007/s10048-009-0183-3; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Littlewood TD, 2012, CELL, V151, P11, DOI 10.1016/j.cell.2012.09.006; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mannini L, 2011, MUTAT RES-REV MUTAT, V728, P81, DOI 10.1016/j.mrrev.2011.07.004; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Park KS, 2013, STEM CELLS, V31, P282, DOI 10.1002/stem.1284; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Philibert RA, 2007, AM J MED GENET B, V144B, P743, DOI 10.1002/ajmg.b.30489; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Santen GWE, 2012, EPIGENETICS-US, V7, P1219, DOI 10.4161/epi.22299; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smith ER, 2011, MOL CELL, V44, P954, DOI 10.1016/j.molcel.2011.12.008; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wright JE, 2013, TRENDS GENET, V29, P99, DOI 10.1016/j.tig.2012.10.007; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu HL, 2011, NAT REV CANCER, V11, P199, DOI 10.1038/nrc3018; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Yew PY, 2012, MOL CARCINOGEN, V51, pE74, DOI 10.1002/mc.21857; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao JY, 2012, CIRCULATION, V125, P482, DOI 10.1161/CIRCULATIONAHA.111.050245; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	191	782	797	12	181	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1237	1251		10.1016/j.cell.2013.02.014	http://dx.doi.org/10.1016/j.cell.2013.02.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498934	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000316192500007
J	Savage, N				Savage, Neil			Trick of the light	NATURE			English	Editorial Material																		Bouillard JS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00829; Cecchini MP, 2013, NAT MATER, V12, P165, DOI [10.1038/NMAT3488, 10.1038/nmat3488]; Moreau A, 2012, NATURE, V492, P86, DOI 10.1038/nature11615; Umeton C, 2012, ASIA COMMUN PHOTON; Yang J, 2011, ACS NANO, V5, P6210, DOI 10.1021/nn202144b	5	9	9	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					S8	S9		10.1038/495S8a	http://dx.doi.org/10.1038/495S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486101	Bronze			2022-12-28	WOS:000316652300029
J	Newhouse, JP; Garber, AM				Newhouse, Joseph P.; Garber, Alan M.			Geographic Variation in Medicare Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Garber, Alan M.] Harvard Univ, Off Provost, Cambridge, MA 02138 USA; [Garber, Alan M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University	Newhouse, JP (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022					Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Korea Health Promotion Institute, 2020, 04202000301; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	5	123	123	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1465	1468		10.1056/NEJMp1302981	http://dx.doi.org/10.1056/NEJMp1302981			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23520983	Green Submitted, Green Published			2022-12-28	WOS:000317603300001
J	Kontoyiannis, DP				Kontoyiannis, Dimitrios P.			Preventing Fungal Disease in Chronically Immunosuppressed Outpatients: Time for Action?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dkontoyi@mdanderson.org			MD Anderson Cancer Center [CA016672]; Frances King Black Endowed Professorship for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center; Frances King Black Endowed Professorship for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported in part by the MD Anderson Cancer Center (grant CA016672). Dr. Kontoyiannis is the recipient of the Frances King Black Endowed Professorship for Cancer Research.	Bieri S, 2011, EUR J HAEMATOL, V87, P138, DOI 10.1111/j.1600-0609.2011.01638.x; Centers for Disease Control and Prevention (CDC), HEALTHC ASS INF GUID; Centers for Disease Control and Prevention (CDC), HEALTHC ASS INF BAS; Kontoyiannis DP, 2011, BONE MARROW TRANSPL, V46, P165, DOI 10.1038/bmt.2010.256; Lass-Florl C, 2007, J CLIN MICROBIOL, V45, P2686, DOI 10.1128/JCM.00917-07; Panackal AA, 2010, CLIN INFECT DIS, V50, P1588, DOI 10.1086/652761; Partridge-Hinckley K, 2009, MYCOPATHOLOGIA, V168, P329, DOI 10.1007/s11046-009-9247-z; Raad I, 2002, INFECT CONT HOSP EP, V23, P532, DOI 10.1086/502102; Sipsas NV, 2008, INFECTION, V36, P515, DOI 10.1007/s15010-008-8129-5; Warris A, 2010, J HOSP INFECT, V76, P56, DOI 10.1016/j.jhin.2010.03.014	10	5	5	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					555	+		10.7326/0003-4819-158-7-201304020-00007	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546567				2022-12-28	WOS:000317419400006
J	Garraway, LA; Lander, ES				Garraway, Levi A.; Lander, Eric S.			Lessons from the Cancer Genome	CELL			English	Review							ACUTE MYELOID-LEUKEMIA; ISLAND METHYLATOR PHENOTYPE; LINEAGE-SURVIVAL ONCOGENE; RECURRENT SOMATIC MUTATIONS; CHROMATIN REMODELING GENES; LONG-RANGE INTERACTION; CELL LUNG-CANCER; DNMT3A MUTATIONS; INACTIVATING MUTATIONS; DRIVER MUTATIONS	Systematic studies of the cancer genome have exploded in recent years. These studies have revealed scores of new cancer genes, including many in processes not previously known to be causal targets in cancer. The genes affect cell signaling, chromatin, and epigenomic regulation; RNA splicing; protein homeostasis; metabolism; and lineage maturation. Still, cancer genomics is in its infancy. Much work remains to complete the mutational catalog in primary tumors and across the natural history of cancer, to connect recurrent genomic alterations to altered pathways and acquired cellular vulnerabilities, and to use this information to guide the development and application of therapies.	[Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Garraway, Levi A.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Garraway, Levi A.; Lander, Eric S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lander@broadinstitute.org	wang, edwin/G-5372-2010		U.S. National Human Genome Research Institute; U.S. National Cancer Institute; Slim Initiative for Genomic Medicine; Broad Institute; Department of Defense; Starr Cancer Consortium; Prostate Cancer Foundation; Melanoma Research Alliance; Adelson Medical Research Foundation	U.S. National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Slim Initiative for Genomic Medicine; Broad Institute; Department of Defense(United States Department of Defense); Starr Cancer Consortium; Prostate Cancer Foundation; Melanoma Research Alliance; Adelson Medical Research Foundation	We thank Todd Golub, Matthew Meyerson, and Michael Stratton for reviewing the manuscript and for valuable comments. We thank Gad Getz, Charles Roberts, and Matthew Freedman for helpful discussions. The design of figures was aided by materials from ScienceSlides (http://www.visiscience.com). L.A.G. and E.S.L. are supported by the U.S. National Human Genome Research Institute, the U.S. National Cancer Institute, the Slim Initiative for Genomic Medicine, and the Broad Institute. L.A.G. also receives support from the Department of Defense, the Starr Cancer Consortium, the Prostate Cancer Foundation, the Melanoma Research Alliance, and the Adelson Medical Research Foundation. L.A.G. and E.S.L. are consultants and equity holders in Foundation Medicine, Inc.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beltran H, 2012, EUR UROL; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Cibulskis K, 2013, NAT BIOTECHNOL; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Estey E, 2007, J CLIN ONCOL, V25, P1908, DOI 10.1200/JCO.2006.10.2731; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Hajkova H, 2012, LEUKEMIA RES, V36, P1128, DOI 10.1016/j.leukres.2012.05.012; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hindorff LA, 2011, CARCINOGENESIS, V32, P945, DOI 10.1093/carcin/bgr056; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lindsley RC, 2013, ANNU REV PATHOL-MECH, V8, P21, DOI 10.1146/annurev-pathol-011811-132436; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Miklos GLG, 2005, NAT BIOTECHNOL, V23, P535, DOI 10.1038/nbt0505-535; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Murphy AB, 2012, PROSTATE, V72, P1366, DOI 10.1002/pros.22486; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Pomerantz MM, 2011, CANCER J, V17, P416, DOI 10.1097/PPO.0b013e31823e5387; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg RA, 2010, NATURE, V464, P678, DOI 10.1038/464678a; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whittaker S.R., 2013, CANC DISCOV; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	191	841	874	0	279	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					17	37		10.1016/j.cell.2013.03.002	http://dx.doi.org/10.1016/j.cell.2013.03.002			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540688	Bronze			2022-12-28	WOS:000316853700004
J	Gatsogiannis, C; Lang, AE; Meusch, D; Pfaumann, V; Hofnagel, O; Benz, R; Aktories, K; Raunser, S				Gatsogiannis, Christos; Lang, Alexander E.; Meusch, Dominic; Pfaumann, Vanda; Hofnagel, Oliver; Benz, Roland; Aktories, Klaus; Raunser, Stefan			A syringe-like injection mechanism in Photorhabdus luminescens toxins	NATURE			English	Article							PORE FORMATION; INSECTICIDAL TOXINS; PROTEIN TOXINS; ANTHRAX TOXIN; COMPLEX; BACTERIUM	Photorhabdus luminescens is an insect pathogenic bacterium that is symbiotic with entomopathogenic nematodes(1). On invasion of insect larvae, P. luminescens is released from the nematodes and kills the insect through the action of a variety of virulence factors including large tripartite ABC-type toxin complexes(2) (Tcs). Tcs are typically composed of TcA, TcB and TcC proteins and are biologically active only when complete(3-5). Functioning as ADP-ribosyltransferases, TcC proteins were identified as the actual functional components that induce actin-clustering, defects in phagocytosis and cell death(5-7). However, little is known about the translocation of TcC into the cell by the TcA and TcB components. Here we show that TcA in P. luminescens (TcdA1) forms a transmembrane pore and report its structure in the prepore and pore state determined by cryoelectron microscopy. We find that the TcdA1 prepore assembles as a pentamer forming an alpha-helical, vuvuzela-shaped channel less than 1.5 nanometres in diameter surrounded by a large outer shell. Membrane insertion is triggered not only at low pH as expected, but also at high pH, explaining Tc action directly through the midgut of insects(8). Comparisons with structures of the TcdA1 pore inserted into a membrane and in complex with TcdB2 and TccC3 reveal large conformational changes during membrane insertion, suggesting a novel syringe-like mechanism of protein translocation. Our results demonstrate how ABC-type toxin complexes bridge a membrane to insert their lethal components into the cytoplasm of the host cell. We believe that the proposed mechanism is characteristic of the whole ABC-type toxin family. This explanation of toxin translocation is a step towards understanding the host-pathogen interaction and the complex life cycle of P. luminescens and other pathogens, including human pathogenic bacteria, and serves as a strong foundation for the development of biopesticides.	[Gatsogiannis, Christos; Meusch, Dominic; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Lang, Alexander E.; Pfaumann, Vanda; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxik, D-79104 Freiburg, Germany; [Benz, Roland] Jacobs Univ Bremen, Sch Engn & Sci, D-28759 Bremen, Germany	Max Planck Society; University of Freiburg; Jacobs University	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Aktories, Klaus/CAJ-5682-2022; Raunser, Stefan/AHE-1573-2022; Gatsogiannis, Christos/K-1012-2018	Aktories, Klaus/0000-0002-5397-0436; Gatsogiannis, Christos/0000-0002-4922-4545; Benz, Roland/0000-0002-9510-9265; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [RA 1781/1-1, AK 6/22-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to R. S. Goody for continuous support and for comments on the manuscript. We thank I. Vetter for stimulating discussions. This work was supported by the Deutsche Forschungsgemeinschaft grants RA 1781/1-1 (S. R.) and AK 6/22-1 (K. A.) and by Max Planck Society (S.R.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; DOW JAT, 1984, AM J PHYSIOL, V246, pR633, DOI 10.1152/ajpregu.1984.246.4.R633; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; MILSTEAD JE, 1979, J INVERTEBR PATHOL, V33, P324, DOI 10.1016/0022-2011(79)90033-8; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramon E, 2007, J BIOL CHEM, V282, P14272, DOI 10.1074/jbc.M611091200; Rusu M, 2012, J STRUCT BIOL, V178, P121, DOI 10.1016/j.jsb.2012.03.001; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	25	91	95	2	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					520	523		10.1038/nature11987	http://dx.doi.org/10.1038/nature11987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515159				2022-12-28	WOS:000316682800048
J	Henderson, C; Knapp, M; Fernandez, JL; Beecham, J; Hirani, SP; Cartwright, M; Rixon, L; Beynon, M; Rogers, A; Bower, P; Doll, H; Fitzpatrick, R; Steventon, A; Bardsley, M; Hendy, J; Newman, SP				Henderson, Catherine; Knapp, Martin; Fernandez, Jose-Luis; Beecham, Jennifer; Hirani, Shashivadan P.; Cartwright, Martin; Rixon, Lorna; Beynon, Michelle; Rogers, Anne; Bower, Peter; Doll, Helen; Fitzpatrick, Ray; Steventon, Adam; Bardsley, Martin; Hendy, Jane; Newman, Stanton P.		Whole Syst Demonstrator Evaluation	Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; HOME TELEHEALTH; SHORT-FORM; DISEASE; CARE; MANAGEMENT; TELEMEDICINE; EUROQOL; ANXIETY; STATE	Objective To examine the costs and cost effectiveness of telehealth in addition to standard support and treatment, compared with standard support and treatment. Design Economic evaluation nested in a pragmatic, cluster randomised controlled trial. Setting Community based telehealth intervention in three local authority areas in England. Participants 3230 people with a long term condition (heart failure, chronic obstructive pulmonary disease, or diabetes) were recruited into the Whole Systems Demonstrator telehealth trial between May 2008 and December 2009. Of participants taking part in the Whole Systems Demonstrator telehealth questionnaire study examining acceptability, effectiveness, and cost effectiveness, 845 were randomised to telehealth and 728 to usual care. Interventions Intervention participants received a package of telehealth equipment and monitoring services for 12 months, in addition to the standard health and social care services available in their area. Controls received usual health and social care. Main outcome measure Primary outcome for the cost effectiveness analysis was incremental cost per quality adjusted life year (QALY) gained. Results We undertook net benefit analyses of costs and outcomes for 965 patients (534 receiving telehealth; 431 usual care). The adjusted mean difference in QALY gain between groups at 12 months was 0.012. Total health and social care costs (including direct costs of the intervention) for the three months before 12 month interview were 1390 pound ((sic)1610; $2150) and 1596 pound for the usual care and telehealth groups, respectively. Cost effectiveness acceptability curves were generated to examine decision uncertainty in the analysis surrounding the value of the cost effectiveness threshold. The incremental cost per QALY of telehealth when added to usual care was 92 pound 000. With this amount, the probability of cost effectiveness was low (11% at willingness to pay threshold of 30 pound 000; >50% only if the threshold exceeded about 90 pound 000). In sensitivity analyses, telehealth costs remained slightly (non-significantly) higher than usual care costs, even after assuming that equipment prices fell by 80% or telehealth services operated at maximum capacity. However, the most optimistic scenario (combining reduced equipment prices with maximum operating capacity) eliminated this group difference (cost effectiveness ratio 12 pound 000 per QALY). Conclusions The QALY gain by patients using telehealth in addition to usual care was similar to that by patients receiving usual care only, and total costs associated with the telehealth intervention were higher. Telehealth does not seem to be a cost effective addition to standard support and treatment.	[Henderson, Catherine; Beecham, Jennifer] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Knapp, Martin; Fernandez, Jose-Luis] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England; [Knapp, Martin] Kings Coll London, Personal Social Serv Res Unit, London WC2R 2LS, England; [Hirani, Shashivadan P.; Cartwright, Martin; Rixon, Lorna; Beynon, Michelle; Newman, Stanton P.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Rogers, Anne] Univ Southampton, Southampton, Hants, England; [Bower, Peter] Univ Manchester, Manchester, Lancs, England; [Doll, Helen] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Fitzpatrick, Ray] Univ Oxford, Oxford, England; [Steventon, Adam; Bardsley, Martin] Nuffield Trust, London, England; [Hendy, Jane] Univ Surrey, Guildford GU2 5XH, Surrey, England	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science; University of London; King's College London; City University London; University of Southampton; University of Manchester; University of East Anglia; University of Oxford; University of Surrey	Henderson, C (corresponding author), Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.	C.Henderson@lse.ac.uk	Beecham, Jennifer K/E-7836-2010; Bower, Peter/A-1508-2011; Cartwright, Martin/M-2582-2016; Fernandez, Jose-Luis/D-2451-2010	Beecham, Jennifer K/0000-0001-5147-3383; Bower, Peter/0000-0001-9558-3349; Cartwright, Martin/0000-0002-3404-5659; Fernandez, Jose-Luis/0000-0002-4190-7341; Henderson, Catherine/0000-0003-4340-4702; Hirani, Shashivadan P/0000-0002-1577-8806; Newman, Stanton/0000-0001-6712-6079; Beynon, Michelle/0000-0002-2628-2187; fitzpatrick, Ray/0000-0003-0607-0563; Knapp, Martin/0000-0003-1427-0215; Bardsley, Martin/0000-0002-9853-6019	Policy Research Programme in the Department of Health; Department of Health	Policy Research Programme in the Department of Health; Department of Health	This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Department of Health for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: The study was approved by the Liverpool NHS research ethics committee (reference 08/H1005/4).	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Balk AHMM, 2007, EUR J HEART FAIL, V6, P56, DOI 10.1016/S1567-4215(07)60154-4; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Barlow J, 2007, UNIT COSTS HLTH SOCI, P9; Barlow J, 2007, J TELEMED TELECARE, V13, P172, DOI 10.1258/135763307780908058; Bartholomew DJ, 2008, CHAPMAN HALL CRC STA; Beecham J, 2001, MEASURING MENTAL HLT, V2nd, P200; Bensink M, 2006, J TELEMED TELECARE, V12, P8, DOI 10.1258/135763306779380174; Bergmo Trine S, 2009, Cost Eff Resour Alloc, V7, P18, DOI 10.1186/1478-7547-7-18; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bower P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-184; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Byford S, 2003, NATL I ECON REV, V186, P98, DOI DOI 10.1177/002795010300100114; Care Services Efficiency Delivery Programme of the Department of Health, 2010, TRANSF COMM EQ SERV; Carpenter J. R., 2007, HLTH TECHNOLOGY ASSE; Cartwright Martin, 2013, BMJ, V346, pf653, DOI 10.1136/bmj.f653; Clark CE, 2010, BMJ CLIN RES ED, V341, pc3995; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Coye MJ, 2009, HEALTH AFFAIR, V28, P126, DOI 10.1377/hlthaff.28.1.126; Craig P., 2008, DEV EVALUATING COMPL; Curtis L., 2010, UNIT COSTS HLTH SOCI; Davis JC, 2013, QUAL LIFE RES, V22, P969, DOI 10.1007/s11136-012-0225-4; DEPARTMENT OF EDUCATION AND SKILLS, 2005, BUILD TEL ENGL, P1; Department of Health, 2009, GEN OPHTH SERV INCR; Department of Health, 2008, RED ALC HARM HLTH SE, P1; Department of Health, 2007, WHIT PAP PIL WHOL SY; Department of Health, 2010, NHS REF COSTS 2008 2; Department of Health, 2005, SURV AN REG SPONS MI, P1; Department of Health, 2010, VIS AD SOC CAR CAP C; Department of Health, 2001, EQ NHS TRUSTS CAP AC; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dolan P., 1995, SOCIAL TARIFF EUROQO; Drummond MF, 2015, METHODS EC EVALUATIO; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Glick H., 2007, EC EVALUATION CLIN T; Health and Social Care Information Centre, 2011, PRESCR COST AN ENGL; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Jaana M, 2009, AM J MANAG CARE, V15, P313; Lusignan Simon, 2005, BMC Fam Pract, V6, P13, DOI 10.1186/1471-2296-6-13; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Manca A, 2005, HEALTH ECON, V14, P471, DOI 10.1002/hec.914; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McLean S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007718.pub2; Mistry H., 2011, THESIS BRUNEL U; Mistry H, 2012, J TELEMED TELECARE, V18, P1, DOI 10.1258/jtt.2011.110505; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; NHS Employers, 2009, 12009 AFORC NHS EMPL; Noble M, 2008, ENGLISH INDICES DEPR; Raynes N, 2006, REPORT OLDER PEOPLES; Pare G, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1357; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Polisena J, 2009, DIABETES OBES METAB, V11, P913, DOI 10.1111/j.1463-1326.2009.01057.x; Polisena J, 2010, J TELEMED TELECARE, V16, P120, DOI 10.1258/jtt.2009.090812; Polisena J, 2009, INT J TECHNOL ASSESS, V25, P339, DOI 10.1017/S0266462309990201; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Rogers A, 2006, NATL EVALUATION PILO; Rojas SV, 2008, TELEMED J E-HEALTH, V14, P896, DOI 10.1089/tmj.2008.0009; Rubin DB, 1987, MULTIPLE IMPUTATION; Scarborough P, 2010, CORONARY HEART DIS S; Simpson CR, 2010, BR J GEN PRACT, V60, pe277; StataCorp, 2009, STAT STAT SOFTW REL; Steffens DC, 2002, STROKE, V33, P1636, DOI 10.1161/01.STR.0000018405.59799.D5; Steventon Adam, 2012, BMJ, V344, pe3874, DOI 10.1136/bmj.e3874; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	69	146	147	1	63	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1035	10.1136/bmj.f1035	http://dx.doi.org/10.1136/bmj.f1035			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MQ	23520339	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000316672500001
J	Jaccard, SL; Hayes, CT; Martinez-Garcia, A; Hodell, DA; Anderson, RF; Sigman, DM; Haug, GH				Jaccard, S. L.; Hayes, C. T.; Martinez-Garcia, A.; Hodell, D. A.; Anderson, R. F.; Sigman, D. M.; Haug, G. H.			Two Modes of Change in Southern Ocean Productivity Over the Past Million Years	SCIENCE			English	Article							CARBON-DIOXIDE CONCENTRATION; SEA-ICE; CO2; MARINE; VARIABILITY; SEDIMENT; RECORDS; IMPACT; EXPORT; CYCLE	Export of organic carbon from surface waters of the Antarctic Zone of the Southern Ocean decreased during the last ice age, coinciding with declining atmospheric carbon dioxide (CO2) concentrations, signaling reduced exchange of CO2 between the ocean interior and the atmosphere. In contrast, in the Subantarctic Zone, export production increased into ice ages coinciding with rising dust fluxes, thus suggesting iron fertilization of subantarctic phytoplankton. Here, a new high-resolution productivity record from the Antarctic Zone is compiled with parallel subantarctic data over the past million years. Together, they fit the view that the combination of these two modes of Southern Ocean change determines the temporal structure of the glacial-interglacial atmospheric CO2 record, including during the interval of "lukewarm" interglacials between 450 and 800 thousand years ago.	[Jaccard, S. L.; Martinez-Garcia, A.; Haug, G. H.] Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland; [Hayes, C. T.; Anderson, R. F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Hodell, D. A.] Univ Cambridge, Dept Earth Sci, Godwin Lab Paleoclimate Res, Cambridge CB2 3EQ, England; [Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Hayes, C. T.; Anderson, R. F.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Columbia University; University of Cambridge; Princeton University; Columbia University	Jaccard, SL (corresponding author), Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland.	samuel.jaccard@erdw.ethz.ch	Sigman, Daniel M/A-2649-2008; Jaccard, Samuel/G-3447-2014; Hayes, Christopher T/P-3145-2016; Martínez-García, Alfredo/A-6244-2010	Sigman, Daniel M/0000-0002-7923-1973; Jaccard, Samuel/0000-0002-5793-0896; Hayes, Christopher T/0000-0002-5636-2989; Martínez-García, Alfredo/0000-0002-7206-5079; Anderson, Robert/0000-0002-8472-2494; Hodell, David/0000-0001-8537-1588	Swiss National Science Foundation (SNSF); Deutsche Forschungsgemeinschaft (DFG); U.S. National Science Foundation; Comer Science and Education Foundation; Natural Environment Research Council [NE/H009930/1] Funding Source: researchfish; NERC [NE/H009930/1] Funding Source: UKRI	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Science Foundation(National Science Foundation (NSF)); Comer Science and Education Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Stefer for performing the XRF scanning measurements at the University of Bremen. We also acknowledge the Integrated Ocean Drilling Program for providing the samples used in this study and U. Rohl, A. Wulbers and W. Hale for their support at the Bremen IODP core repository. This research used data acquired at the XRF Core Scanner Laboratory at the MARUM - Center for Marine Environmental Sciences, University of Bremen. We further thank E. D. Galbraith as well as three anonymous reviewers, whose comments improved the manuscript. Financial support for this work was provided by the Swiss National Science Foundation (SNSF), the Deutsche Forschungsgemeinschaft (DFG), the U.S. National Science Foundation, and the Comer Science and Education Foundation.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Brovkin V, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001380; de Boer AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001242; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Hodell D., 2003, P OC DRILL PROGR SCI, V177; Hodell D. A., 1999, P OC DRILL PROGR IN; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Horn MG, 2011, EARTH PLANET SC LETT, V310, P334, DOI 10.1016/j.epsl.2011.08.016; Jaccard SL, 2010, QUATERNARY SCI REV, V29, P206, DOI 10.1016/j.quascirev.2009.10.007; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; Kleiven H. F., 2003, P OC DRILL PROGR SCI, V177; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lang N, 2011, CLIM PAST, V7, P361, DOI 10.5194/cp-7-361-2011; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Lourey MJ, 2001, J GEOPHYS RES-OCEANS, V106, P31463, DOI 10.1029/2000JC000287; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Marinov I, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002958; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Nielsen SHH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001618; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sayles FL, 2001, DEEP-SEA RES PT II, V48, P4323, DOI 10.1016/S0967-0645(01)00091-1; Schneider-Mor A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022543; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Zonneveld KAF, 2010, BIOGEOSCIENCES, V7, P483, DOI 10.5194/bg-7-483-2010	37	165	173	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1419	1423		10.1126/science.1227545	http://dx.doi.org/10.1126/science.1227545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520109	Green Submitted			2022-12-28	WOS:000316740700039
J	Marley, MS				Marley, Mark S.			Probing an Extrasolar Planet	SCIENCE			English	Editorial Material							WATER-ABSORPTION; MU-M; ATMOSPHERE; CARBON; SPECTRUM; MASSES		NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Marley, MS (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA.	mark.s.marley@nasa.gov	Marley, Mark S/I-4704-2013	Marley, Mark/0000-0002-5251-2943				Barman TS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/65; BARSHAY SS, 1978, ICARUS, V33, P593, DOI 10.1016/0019-1035(78)90192-6; Beuzit JL, 2008, PROC SPIE, V7014, DOI 10.1117/12.790120; Currie T, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/128; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Macintosh BA, 2008, PROC SPIE, V7015, DOI 10.1117/12.788083; Miller N, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L29; Redfield S, 2008, ASTROPHYS J LETT, V673, pL87, DOI 10.1086/527475; Swain MR, 2009, ASTROPHYS J, V704, P1616, DOI 10.1088/0004-637X/704/2/1616	15	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1393	1394		10.1126/science.1235078	http://dx.doi.org/10.1126/science.1235078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520101				2022-12-28	WOS:000316740700030
J	Coupland, R				Coupland, Robin			Security of Health Care and Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Comm Red Cross, Geneva, Switzerland		Coupland, R (corresponding author), Int Comm Red Cross, Geneva, Switzerland.							[Anonymous], 2012, EX BOARD 130 SESS GE; Coupland R, 2007, B WORLD HEALTH ORGAN, V85, P181, DOI 10.2471/BLT.06.037135; International Committee of the Red Cross, 2011, HLTH CAR DANG 16 COU; Rubenstein LS, 2010, LANCET, V375, P329, DOI 10.1016/S0140-6736(09)61926-7; WHO, 2012, WHOS RESP ROL HLTH C	5	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1075	1076		10.1056/NEJMp1214182	http://dx.doi.org/10.1056/NEJMp1214182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108TH	23514284	Bronze			2022-12-28	WOS:000316318600013
J	Laurance, WF; Balmford, A				Laurance, William F.; Balmford, Andrew			A global map for road building	NATURE			English	Editorial Material							BRAZILIAN AMAZON		[Laurance, William F.] James Cook Univ, Cairns, Australia; [Balmford, Andrew] Univ Cambridge, Cambridge CB2 1TN, England	James Cook University; University of Cambridge	Laurance, WF (corresponding author), James Cook Univ, Cairns, Australia.	bill.laurance@jcu.edu.au	Laurance, William F/B-2709-2012	Laurance, William F/0000-0003-4430-9408; Balmford, Andrew/0000-0002-0144-3589				[Anonymous], 2002, GREENP PARTN CRIM MA; [Anonymous], 2001, AGR TECHNOLOGIES TRO; Balmford A, 2012, P ROY SOC B-BIOL SCI, V279, P2714, DOI 10.1098/rspb.2012.0515; Boakes EH, 2010, P ROY SOC B-BIOL SCI, V277, P1081, DOI 10.1098/rspb.2009.1771; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Weinhold D, 2008, GLOBAL ENVIRON CHANG, V18, P54, DOI 10.1016/j.gloenvcha.2007.06.004	9	111	115	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					308	309		10.1038/495308a	http://dx.doi.org/10.1038/495308a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EY	23518547				2022-12-28	WOS:000316650500017
J	Schroeder, L; Banaei, N				Schroeder, Lee; Banaei, Niaz			Strongyloides stercoralis Embryonated Ova in the Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schroeder, Lee; Banaei, Niaz] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Schroeder, L (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	niazbanaei@stanford.edu		Banaei, Niaz/0000-0001-8501-3000					0	3	5	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					E15	E15		10.1056/NEJMicm1204579	http://dx.doi.org/10.1056/NEJMicm1204579			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514310				2022-12-28	WOS:000316318600008
J	Gheorghiade, M; Bohm, M; Greene, SJ; Fonarow, GC; Lewis, EF; Zannad, F; Solomon, SD; Baschiera, F; Botha, J; Hua, TA; Gimpelewicz, CR; Jaumont, X; Lesogor, A; Maggioni, AP				Gheorghiade, Mihai; Boehm, Michael; Greene, Stephen J.; Fonarow, Gregg C.; Lewis, Eldrin F.; Zannad, Faiez; Solomon, Scott D.; Baschiera, Fabio; Botha, Jaco; Hua, Tsushung A.; Gimpelewicz, Claudio R.; Jaumont, Xavier; Lesogor, Anastasia; Maggioni, Aldo P.		ASTRONAUT Investigators Coordinato	Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENIN INHIBITOR ALISKIREN; CLINICAL-TRIALS; DOUBLE-BLIND; VASOPRESSIN ANTAGONISM; TASK-FORCE; OUTCOMES; EVEREST; ASSOCIATION; RATIONALE; TOLVAPTAN	Importance Hospitalizations for heart failure (HHF) represent a major health burden, with high rates of early postdischarge rehospitalization and mortality. Objective To investigate whether aliskiren, a direct renin inhibitor, when added to standard therapy, would reduce the rate of cardiovascular (CV) death or HF rehospitalization among HHF patients. Design, Setting, and Participants International, double-blind, placebo-controlled study that randomized hemodynamically stable HHF patients a median 5 days after admission. Eligible patients were 18 years or older with left ventricular ejection fraction (LVEF) 40% or less, elevated natriuretic peptides (brain natriuretic peptide [BNP] >= 400 pg/mL or N-terminal pro-BNP [NT-proBNP] >= 1600 pg/mL), and signs and symptoms of fluid overload. Patients were recruited from 316 sites across North and South America, Europe, and Asia between May 2009 and December 2011. The follow-up period ended in July 2012. Intervention All patients received 150mg(increased to 300 mg as tolerated) of aliskiren or placebo daily, in addition to standard therapy. The study drug was continued after discharge for a median 11.3 months. Main Outcome Measures Cardiovascular death or HF rehospitalization at 6 months and 12 months. Results In total, 1639 patients were randomized, with 1615 patients included in the final efficacy analysis cohort (808 aliskiren, 807 placebo). Mean age was 65 years; mean LVEF, 28%; 41% of patients had diabetes mellitus, mean estimated glomerular filtration rate, 67 mL/min/1.73 m(2). At admission and randomization, median NT-proBNP levels were 4239 pg/mL and 2718 pg/mL, respectively. At randomization, patients were receiving diuretics (95.9%), beta-blockers (82.5%), angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (84.2%), and mineralocorticoid receptor antagonists (57.0%). In total, 24.9% of patients receiving aliskiren (77 CV deaths, 153 HF rehospitalizations) and 26.5% of patients receiving placebo (85 CV deaths, 166 HF rehospitalizations) experienced the primary end point at 6 months (hazard ratio [HR], 0.92; 95% CI, 0.76-1.12; P=.41). At 12 months, the event rates were 35.0% for the aliskiren group (126 CV deaths, 212 HF rehospitalizations) and 37.3% for the placebo group (137 CV deaths, 224 HF rehospitalizations; HR, 0.93; 95% CI, 0.79-1.09; P=.36). The rates of hyperkalemia, hypotension, and renal impairment/renal failure were higher in the aliskiren group compared with placebo. Conclusion and Relevance Among patients hospitalized for HF with reduced LVEF, initiation of aliskiren in addition to standard therapy did not reduce CV death or HF rehospitalization at 6 months or 12 months after discharge. Trial Registration clinicaltrials.gov Identifier: NCT00894387 JAMA. 2013;309(11):1125-1135 Published online March 11, 2013. doi:10.1001/jama.2013.1954 www.jama.com	[Gheorghiade, Mihai; Greene, Stephen J.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Boehm, Michael] Univ Klinikum Saarlandes, Innere Med Klin 3, Homburg, Germany; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Lewis, Eldrin F.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Zannad, Faiez] Hop Jeanne dArc, CHU Nancy, INSERM, Clin Invest Ctr, Dommartin Les Toul, France; [Baschiera, Fabio; Botha, Jaco; Gimpelewicz, Claudio R.; Jaumont, Xavier; Lesogor, Anastasia] Novartis Pharma AG, Basel, Switzerland; [Hua, Tsushung A.] Novartis Pharmaceut, E Hanover, NJ USA; [Maggioni, Aldo P.] Assoc Nazl Med Cardiol Osped, Res Ctr, Florence, Italy	Northwestern University; Feinberg School of Medicine; Universitatsklinikum des Saarlandes; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Novartis; Novartis; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Böhm, Michael/C-3638-2011; Boldueva, Svetlana/AAH-3862-2019; Zadionchenko, Vladimir/A-7445-2016; Hradec, Jaromir/S-2388-2016; Solomon, Scott/I-5789-2013; De Keulenaer, Gilles/D-9321-2017; Fonarow, Gregg C/D-5988-2014; Zannad, Faiez/K-4649-2019; Braun-Dullaeus, Ruediger C/G-1844-2013; Maggioni, Aldo Pietro/AAL-5334-2020	Boldueva, Svetlana/0000-0002-1898-084X; Zadionchenko, Vladimir/0000-0003-2377-5266; Hradec, Jaromir/0000-0001-7597-8239; De Keulenaer, Gilles/0000-0002-4238-4183; Fonarow, Gregg C/0000-0002-3192-8093; Braun-Dullaeus, Ruediger C/0000-0003-3888-6532; Maggioni, Aldo Pietro/0000-0003-2764-6779; Isnard, Richard/0000-0002-3439-8104; URAL, DILEK/0000-0003-0224-1433; GALINIER, Michel/0000-0003-1735-3390; gosse, philippe/0000-0002-5840-7749; Jaramillo, Monica/0000-0003-0100-5682; Kasprzak, Jaroslaw D/0000-0002-5850-8187; Gomez-Bueno, Manuel/0000-0002-9764-7518; jourdain, patrick/0000-0002-5202-6902; Volpe, Massimo/0000-0002-9642-8380	Ahmanson Foundation; Novartis; BG Medicine; Roche Diagnostics; Novartis Pharma; Medtronic; Abbott	Ahmanson Foundation; Novartis(Novartis); BG Medicine; Roche Diagnostics; Novartis Pharma; Medtronic(Medtronic); Abbott(Abbott Laboratories)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gheorghiade reported serving as a consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma, Bayer HealthCare, Cardiorentis, CorThera, Cytokinetics, CytoPherx, DebioPharm, Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Intersection Medical, INC, Johnson and Johnson, Medtronic, Merck, Novartis Pharma, Ono Pharma USA, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, sanofi-aventis, Sigma Tau, Solvay Pharmaceuticals, Sticares InterACT, Takeda Pharmaceuticals, and Trevena Therapeutics. Dr Bohm reported serving as a consultant for AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, sanofi-aventis, Servier, and Medtronic and on speakers' bureaus for AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, AWDDresden, Berlin-Chemie, MSD, Novartis, Pfizer, sanofi-aventis, and Servier. Dr Fonarow reported receiving grant funding from GlaxoSmithKline, the National Institutes of Health, and the Agency for Healthcare Research and Quality; serving on speakers' bureaus for Boston Scientific/Guidant, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, and St Jude Medical; and serving as a consultant for Amgen, Gambro, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Relypsa, Scios, St Jude Medical, Medicines Company, Johnson and Johnson, and Takeda. Dr Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine at UCLA and is also supported by the Ahmanson Foundation. Dr Lewis reported receiving grant funding and other support from Novartis. Dr Zannad reported receiving grant funding from Novartis, BG Medicine, and Roche Diagnostics; serving on speakers' bureaus for Pfizer and AstraZeneca; serving on a board for Boston Scientific; and serving as a consultant for Novartis, Takeda, AstraZeneca, Boehringer-Ingelheim, GEHealthcare, Relypsa, Servier, Boston Scientific, Bayer, Johnson and Johnson, and ResMed. Dr Solomon reported receiving grant funding, consulting fees, and travel support from Novartis. Dr Baschiera reported receiving consulting fees, travel support, stock options, and other funding from Novartis Pharma, where he is an employee. Mr Botha reported receiving consulting fees, travel support, and other funding from Novartis Pharma, where he is an employee. Dr Hua reported receiving travel support and stock options from Novartis Pharma, where he is an employee. Dr Gimpelewicz reported being an employee of Novartis and receiving stock and stock options from Novartis. Dr Jaumont reported receiving consulting fees, travel support, stock options, and other funding from Novartis Pharma, where he is an employee. Dr Lesogor reported receiving consulting fees, travel support, stock options, and other funding from Novartis Pharma, where she is an employee. Dr Maggioni reported serving as a consultant for Bayer, Amgen, Cardiorentis, and Johnson and Johnson; receiving grants from Novartis, Medtronic, and Abbott; and receiving consulting fees and travel support from Novartis Pharma. No other disclosures were reported.	Blair JEA, 2008, J AM COLL CARDIOL, V52, P1640, DOI 10.1016/j.jacc.2008.07.056; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; Fisher NDL, 2008, CIRCULATION, V117, P3199, DOI 10.1161/CIRCULATIONAHA.108.767202; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Gheorghiade M, 2005, AM J CARDIOL, V96, p3L, DOI 10.1016/j.amjcard.2005.09.059; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Gheorghiade M, 2012, HEART FAIL REV, V17, P485, DOI 10.1007/s10741-011-9280-0; Gheorghiade M, 2011, EUR J HEART FAIL, V13, P100, DOI 10.1093/eurjhf/hfq209; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Latini R, 2006, AM J MED, V119; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Sarma S, 2013, EUR J HEART FAIL, V15, P194, DOI 10.1093/eurjhf/hfs153; Schmieder RE, 2009, CIRCULATION, V119, P417, DOI 10.1161/CIRCULATIONAHA.107.750745; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	27	275	289	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1125	1135		10.1001/jama.2013.1954	http://dx.doi.org/10.1001/jama.2013.1954			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23478743	Green Published			2022-12-28	WOS:000316276500026
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE A curious case of childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2013	346								f1705	10.1136/bmj.f1705	http://dx.doi.org/10.1136/bmj.f1705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113LR	23507538				2022-12-28	WOS:000316669700003
J	Larkman, N; Hulson, O; Gilhooly, M				Larkman, Neal; Hulson, Oliver; Gilhooly, Mark			PICTURE QUIZ A man with tingling fingers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUBACUTE COMBINED DEGENERATION; LHERMITTES SIGN; TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; COPPER DEFICIENCY; SPINAL-CORD; MR FINDINGS; MYELOPATHY		[Larkman, Neal] Harrogate Dist Gen Hosp, Harrogate HG2 7SX, England; [Hulson, Oliver] Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England; [Gilhooly, Mark] Airedale NHS Trust, Airedale, England	University of Leeds	Larkman, N (corresponding author), Harrogate Dist Gen Hosp, Harrogate HG2 7SX, England.	neal.larkman@nhs.net						Adachi S, 2000, ANN SURG, V232, P199, DOI 10.1097/00000658-200008000-00008; ALDIN ASN, 1991, J NEUROL NEUROSUR PS, V54, P415, DOI 10.1136/jnnp.54.5.415; BALDWIN RN, 1986, J NEUROL NEUROSUR PS, V49, P840, DOI 10.1136/jnnp.49.7.840; Bhidayasiri R, 2012, CURRENT CLIN NEUROLO, P178; Chong J, 1999, AM J NEURORADIOL, V20, P1412; DALPAN GJ, 1994, NEUROLOGY, V44, P2159; GAUTIERSMITH PC, 1973, J NEUROL NEUROSUR PS, V36, P861, DOI 10.1136/jnnp.36.5.861; Handley A, 2009, AGE AGEING, V38, P260, DOI 10.1093/ageing/afp020; Jacob A, 2008, SEMIN NEUROL, V28, P105, DOI 10.1055/s-2007-1019132; KANCHANDANI R, 1982, J NEUROL NEUROSUR PS, V45, P308, DOI 10.1136/jnnp.45.4.308; KANEKI M, 1994, J NEUROL NEUROSUR PS, V57, P629, DOI 10.1136/jnnp.57.5.629; Khasnis A, 2003, J Postgrad Med, V49, P169; Kumar N, 2006, NEURORADIOLOGY, V48, P78, DOI 10.1007/s00234-005-0016-5; LHERMITTE J, 1924, REV NEUROL PARIS, V2, P36; Long Y, 2010, NEW ENGL J MED, V363, pe29; Marie P., 1917, REV NEUROL PARIS, V24, P336; PENNYPACKER LC, 1992, J AM GERIATR SOC, V40, P1197, DOI 10.1111/j.1532-5415.1992.tb03641.x; Ravina B, 2000, AM J ROENTGENOL, V174, P863, DOI 10.2214/ajr.174.3.1740863; ROOS D, 1974, ACTA NEUROL SCAND, V50, P719; Scott TF, 2011, NEUROLOGY, V77, P2128, DOI 10.1212/WNL.0b013e31823dc535; Seidenwurm DJ, 2008, AM J NEURORADIOL, V29, P1032; Szabo RM, 1999, J HAND SURG-AM, V24A, P704, DOI 10.1053/jhsu.1999.0704; TARTAGLINO LM, 1994, SEMIN ULTRASOUND CT, V15, P158, DOI 10.1016/S0887-2171(05)80071-X; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wu J, 2006, J AM BOARD FAM MED, V19, P191, DOI 10.3122/jabfm.19.2.191	25	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2013	346								f1443	10.1136/bmj.f1443	http://dx.doi.org/10.1136/bmj.f1443			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113LR	23507535				2022-12-28	WOS:000316669700008
J	Xu, W; Sudhof, TC				Xu, Wei; Suedhof, Thomas C.			A Neural Circuit for Memory Specificity and Generalization	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; MIDLINE THALAMUS; SYNAPTIC-TRANSMISSION; INHIBITORY SYNAPSES; PATTERN SEPARATION; NUCLEUS REUNIENS; SPATIAL MEMORY; PLACE CELLS; HIPPOCAMPUS; CONTEXT	Increased fear memory generalization is associated with posttraumatic stress disorder, but the circuit mechanisms that regulate memory specificity remain unclear. Here, we define a neural circuit-composed of the medial prefrontal cortex, the nucleus reuniens (NR), and the hippocampus-that controls fear memory generalization. Inactivation of prefrontal inputs into the NR or direct silencing of NR projections enhanced fear memory generalization, whereas constitutive activation of NR neurons decreased memory generalization. Direct optogenetic activation of phasic and tonic action-potential firing of NR neurons during memory acquisition enhanced or reduced memory generalization, respectively. We propose that the NR determines the specificity and generalization of memory attributes for a particular context by processing information from the medial prefrontal cortex en route to the hippocampus.	[Xu, Wei] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Xu, W (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 265 Campus Dr, Palo Alto, CA 94304 USA.	weixu@stanford.edu; tcs1@stanford.edu		xu, wei/0000-0003-0987-2481	Simons Foundation [177850]; National Institute of Mental Health [P50 MH086403]; National Institute of Neurological Disorders and Stroke [NS077906]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, K99MH099153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following colleagues for providing plasmids and advice: M. Fuccillo and J. Ko (neuroligin-2 knockdown constructs), J. Burre (EGFP-synaptobrevin-2 construct), C. Acuna and R. Tsien (ChIEF-tdTomato), S. Lammel (advice on optogenetics), and K. Diesseroth (WGA-cre plasmid). This study was supported by grants from the Simons Foundation (177850), the National Institute of Mental Health (P50 MH086403), and the National Institute of Neurological Disorders and Stroke (NS077906).	Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dolleman-van der Weel MJ, 2009, BRAIN STRUCT FUNCT, V213, P329, DOI 10.1007/s00429-008-0200-6; DollemanVanderWeel MJ, 1997, J NEUROSCI, V17, P5640; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; FREEMAN FG, 1973, PHYSIOL BEHAV, V11, P273, DOI 10.1016/0031-9384(73)90362-4; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Loureiro M, 2012, J NEUROSCI, V32, P9947, DOI 10.1523/JNEUROSCI.0410-12.2012; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Morales GJ, 2007, P ANN INT IEEE EMBS, P2480, DOI 10.1109/IEMBS.2007.4352831; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; PERKINS CC, 1958, J COMP PHYSIOL PSYCH, V51, P596, DOI 10.1037/h0042550; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Watson JB, 2000, AM PSYCHOL, V55, P313, DOI 10.1037/0003-066X.55.3.313; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Zhang YC, 2012, J NEUROPHYSIOL, V107, P3181, DOI 10.1152/jn.00072.2012; Zhou JL, 1996, LEARN MOTIV, V27, P400, DOI 10.1006/lmot.1996.0023	40	392	406	8	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1290	1295		10.1126/science.1229534	http://dx.doi.org/10.1126/science.1229534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493706	Green Accepted			2022-12-28	WOS:000316053400030
J	Jabre, P; Belpomme, V; Azoulay, E; Jacob, L; Bertrand, L; Lapostolle, F; Tazarourte, K; Bouilleau, G; Pinaud, V; Broche, C; Normand, D; Baubet, T; Ricard-Hibon, A; Istria, J; Beltramini, A; Alheritiere, A; Assez, N; Nace, L; Vivien, B; Turi, L; Launay, S; Desmaizieres, M; Borron, SW; Vicaut, E; Adnet, F				Jabre, Patricia; Belpomme, Vanessa; Azoulay, Elie; Jacob, Line; Bertrand, Lionel; Lapostolle, Frederic; Tazarourte, Karim; Bouilleau, Guillem; Pinaud, Virginie; Broche, Claire; Normand, Domitille; Baubet, Thierry; Ricard-Hibon, Agnes; Istria, Jacques; Beltramini, Alexandra; Alheritiere, Armelle; Assez, Nathalie; Nace, Lionel; Vivien, Benoit; Turi, Laurent; Launay, Stephane; Desmaizieres, Michel; Borron, Stephen W.; Vicaut, Eric; Adnet, Frederic			Family Presence during Cardiopulmonary Resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; WITNESSED RESUSCITATION; INVASIVE PROCEDURES; MEMBERS; GUIDELINES; HEALTH; BEREAVEMENT; DEPRESSION; SYMPTOMS; COUNCIL	BACKGROUND The effect of family presence during cardiopulmonary resuscitation (CPR) on the family members themselves and the medical team remains controversial. METHODS We enrolled 570 relatives of patients who were in cardiac arrest and were given CPR by 15 prehospital emergency medical service units. The units were randomly assigned either to systematically offer the family member the opportunity to observe CPR (intervention group) or to follow standard practice regarding family presence (control group). The primary end point was the proportion of relatives with post-traumatic stress disorder (PTSD)-related symptoms on day 90. Secondary end points included the presence of anxiety and depression symptoms and the effect of family presence on medical efforts at resuscitation, the well-being of the health care team, and the occurrence of medicolegal claims. RESULTS In the intervention group, 211 of 266 relatives (79%) witnessed CPR, as compared with 131 of 304 relatives (43%) in the control group. In the intention-to-treat analysis, the frequency of PTSD-related symptoms was significantly higher in the control group than in the intervention group (adjusted odds ratio, 1.7; 95% confidence interval [CI], 1.2 to 2.5; P = 0.004) and among family members who did not witness CPR than among those who did (adjusted odds ratio, 1.6; 95% CI, 1.1 to 2.5; P = 0.02). Relatives who did not witness CPR had symptoms of anxiety and depression more frequently than those who did witness CPR. Family-witnessed CPR did not affect resuscitation characteristics, patient survival, or the level of emotional stress in the medical team and did not result in medicolegal claims. CONCLUSIONS Family presence during CPR was associated with positive results on psychological variables and did not interfere with medical efforts, increase stress in the health care team, or result in medicolegal conflicts. (Funded by Programme Hospitalier de Recherche Clinique 2008 of the French Ministry of Health; ClinicalTrials.gov number, NCT01009606.)	[Jabre, Patricia; Lapostolle, Frederic; Normand, Domitille; Alheritiere, Armelle; Desmaizieres, Michel; Adnet, Frederic] Hop Avicenne, AP HP, SAMU, F-93000 Bobigny, France; [Baubet, Thierry] Hop Avicenne, AP HP, Serv Psychiat, F-93000 Bobigny, France; [Jabre, Patricia] Univ Paris 05, INSERM, U970, Ctr Rech Cardiovasc Paris, Paris, France; [Jabre, Patricia; Vivien, Benoit] Hop Necker Enfants Malad, AP HP, SAMU Paris, Paris, France; [Azoulay, Elie] Hop St Louis, AP HP, Paris, France; [Broche, Claire] Hop Lariboisiere, AP HP, F-75475 Paris, France; [Vicaut, Eric] Hop Fernand Widal, AP HP, Unite Rech Clin, Paris, France; [Belpomme, Vanessa; Ricard-Hibon, Agnes] Hop Beaujon, AP HP, Clichy, France; [Jacob, Line] Hop Henri Mondor, AP HP, F-94010 Creteil, France; [Bertrand, Lionel] Hop Montauban, Montauban, France; [Tazarourte, Karim] Hop Melun, Melun, France; [Bouilleau, Guillem] Hop Chateauroux, Chateauroux, France; [Pinaud, Virginie] Hop Nantes, Nantes, France; [Istria, Jacques] Hop Toulon, Toulon, France; [Beltramini, Alexandra] Hop Dreux, Dreux, France; [Assez, Nathalie] Hop Lille, Lille, France; [Nace, Lionel] Hop Nancy, Nancy, France; [Turi, Laurent] Hop Comminges Pyrennees, St Gaudens, France; [Launay, Stephane] Hop Pontoise, Pontoise, France; [Borron, Stephen W.] Texas Tech Univ, Hlth Sci Ctr, Dept Emergency Med, El Paso, TX USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; CHU de Nancy; Centre Hospitalier Rene Dubos, Pontoise; Texas Tech University System; Texas Tech University	Adnet, F (corresponding author), Hop Avicenne, F-93000 Bobigny, France.	frederic.adnet@avc.aphp.fr	Tazarourte, karim/GQZ-6054-2022	Baubet, Thierry/0000-0002-4112-1592; tazarourte, karim/0000-0002-3376-1258	Programme Hospitalier de Recherche Clinique of the French Ministry of Health	Programme Hospitalier de Recherche Clinique of the French Ministry of Health	Supported by Programme Hospitalier de Recherche Clinique 2008 of the French Ministry of Health.	Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Boie ET, 1999, ANN EMERG MED, V34, P70, DOI 10.1016/S0196-0644(99)70274-X; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Compton S, 2011, J PALLIAT MED, V14, P715, DOI 10.1089/jpm.2010.0463; Compton S, 2009, ACAD EMERG MED, V16, P226, DOI 10.1111/j.1553-2712.2008.00336.x; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DOYLE CJ, 1987, ANN EMERG MED, V16, P673, DOI 10.1016/S0196-0644(87)80069-0; Dudley NC, 2009, ANN EMERG MED, V53, P777, DOI 10.1016/j.annemergmed.2008.10.002; Fernandez R, 2009, CRIT CARE MED, V37, P1956, DOI 10.1097/CCM.0b013e3181a00818; Fulbrook Paul, 2007, Eur J Cardiovasc Nurs, V6, P255, DOI 10.1016/j.ejcnurse.2007.07.003; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Helmer SD, 2000, J TRAUMA, V48, P1015, DOI 10.1097/00005373-200006000-00004; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lippert FK, 2010, RESUSCITATION, V81, P1445, DOI 10.1016/j.resuscitation.2010.08.013; Lloyd-Jones, 2011, CIRCULATION, V124, pE425, DOI 10.1161/CIR.0b013e3182365a58; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McClenathan BM, 2002, CHEST, V122, P2204, DOI 10.1378/chest.122.6.2204; Meyers T A, 1998, J Emerg Nurs, V24, P400, DOI 10.1016/S0099-1767(98)70005-4; Meyers TA, 2000, AM J NURS, V100, P32, DOI 10.2307/3521954; Mian P, 2007, CRIT CARE NURSE, V27, P52; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; O'Connell KJ, 2007, PEDIATRICS, V120, pE565, DOI 10.1542/peds.2006-2914; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Robinson SM, 1998, LANCET, V352, P614, DOI 10.1016/S0140-6736(97)12179-1; Tsai E, 2002, NEW ENGL J MED, V346, P1019, DOI 10.1056/NEJM200203283461312; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	201	212	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1008	1018		10.1056/NEJMoa1203366	http://dx.doi.org/10.1056/NEJMoa1203366			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484827				2022-12-28	WOS:000315982100007
J	Appleby, J				Appleby, John			The hospital bed: on its way out?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						[Anonymous], 2012, GUARDIAN; *DEP HLTH, 2007, HOSP ORG SPEC MIX MR; Department of Health, 1992, STAT B, V2, P92; Department of Health, 2012, BED AV OCC OV TIM SE; King Edward's Hospital Fund for London, 1967, DES HOSP BEDST; Lawrence G., 2001, LANCET, DOI [10.1016/S0140-6736(01)05957-8, DOI 10.1016/S0140-6736(01)05957-8]; Lawrence G, 2001, THESIS U LONDON; Organisation for Economic Cooperation and Development, OECD HLTH DAT 2012 F	8	16	16	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2013	346								f1563	10.1136/bmj.f1563	http://dx.doi.org/10.1136/bmj.f1563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VM	23482956				2022-12-28	WOS:000316324300013
J	Gao, L; Dong, CX				Gao, Lei; Dong, Changxia			Sub-inner limiting membrane haemorrhages	LANCET			English	Editorial Material									[Gao, Lei; Dong, Changxia] Qingdao Univ, Affiliated Hosp, Yantai Yuhuangding Hosp, Coll Med,Dept Ophthalmol, Yantai 26400, Shandong, Peoples R China	Qingdao University	Gao, L (corresponding author), Qingdao Univ, Affiliated Hosp, Yantai Yuhuangding Hosp, Coll Med,Dept Ophthalmol, Yantai 26400, Shandong, Peoples R China.	gl6365@163.com							0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					535	535		10.1016/S0140-6736(13)60021-5	http://dx.doi.org/10.1016/S0140-6736(13)60021-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23499439				2022-12-28	WOS:000323162400032
J	Lewis, PW; Muller, MM; Koletsky, MS; Cordero, F; Lin, S; Banaszynski, LA; Garcia, BA; Muir, TW; Becher, OJ; Allis, CD				Lewis, Peter W.; Mueller, Manuel M.; Koletsky, Matthew S.; Cordero, Francisco; Lin, Shu; Banaszynski, Laura A.; Garcia, Benjamin A.; Muir, Tom W.; Becher, Oren J.; Allis, C. David			Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma	SCIENCE			English	Article							HISTONE MARKS; BINDING	Sequencing of pediatric gliomas has identified missense mutations Lys27Met (K27M) and Gly34Arg/Val (G34R/V) in genes encoding histone H3.3 (H3F3A) and H3.1 (HIST3H1B). We report that human diffuse intrinsic pontine gliomas (DIPGs) containing the K27M mutation display significantly lower overall amounts of H3 with trimethylated lysine 27 (H3K27me3) and that histone H3K27M transgenes are sufficient to reduce the amounts of H3K27me3 in vitro and in vivo. We find that H3K27M inhibits the enzymatic activity of the Polycomb repressive complex 2 through interaction with the EZH2 subunit. In addition, transgenes containing lysine-to-methionine substitutions at other known methylated lysines (H3K9 and H3K36) are sufficient to cause specific reduction in methylation through inhibition of SET-domain enzymes. We propose that K-to-M substitutions may represent a mechanism to alter epigenetic states in a variety of pathologies.	[Lewis, Peter W.; Koletsky, Matthew S.; Banaszynski, Laura A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Mueller, Manuel M.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Pediat, Durham, NC 27710 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Pathol, Durham, NC 27710 USA; [Lin, Shu; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Rockefeller University; Princeton University; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Muir, Tom/AHD-0860-2022; Becher, Oren/AAI-7495-2020; Mueller, Manuel M/D-5562-2017; Müller, Manuel/F-7399-2014	Muir, Tom/0000-0001-9635-0344; Mueller, Manuel M/0000-0001-6701-0893; Müller, Manuel/0000-0001-6701-0893; Lewis, Peter/0000-0002-9816-7823; Becher, Oren/0000-0003-4016-8492	NIH Innovator grant, Office of the Director, NIH [DP2OD007447]; U.S. Department of Defense; Pediatric Brain Tumor Foundation; Damon Runyon Foundation; Rory David Deutsch Foundation; Cristian Rivera Foundation; NIH [GM040922]; Starr Cancer Consortium [SCC I6-A614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922, R01GM107047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	NIH Innovator grant, Office of the Director, NIH; U.S. Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; Damon Runyon Foundation; Rory David Deutsch Foundation; Cristian Rivera Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.A.G. acknowledges funding from NIH Innovator grant (DP2OD007447), Office of the Director, NIH. O.J. B. is supported by the U.S. Department of Defense; The Pediatric Brain Tumor Foundation; and the Damon Runyon, Rory David Deutsch, and Cristian Rivera Foundations. C. D. A. acknowledges funding from NIH (GM040922) and Starr Cancer Consortium (grant SCC I6-A614). We thank D. Reinberg for reagents, and EMD Millipore for its role in H3K27M antibody generation.	Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	13	804	825	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					857	861		10.1126/science.1232245	http://dx.doi.org/10.1126/science.1232245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23539183	Green Accepted			2022-12-28	WOS:000318997400042
J	Jennings, JH; Sparta, DR; Stamatakis, AM; Ung, RL; Pleil, KE; Kash, TL; Stuber, GD				Jennings, Joshua H.; Sparta, Dennis R.; Stamatakis, Alice M.; Ung, Randall L.; Pleil, Kristen E.; Kash, Thomas L.; Stuber, Garret D.			Distinct extended amygdala circuits for divergent motivational states	NATURE			English	Article							VENTRAL TEGMENTAL AREA; STRIA TERMINALIS; BED NUCLEUS; INDUCED REINSTATEMENT; DOPAMINE NEURONS; GABA NEURONS; REWARD; ACTIVATION; AFFERENTS; BEHAVIOR	The co-morbidity of anxiety and dysfunctional reward processing in illnesses such as addiction(1) and depression(2) suggests that common neural circuitry contributes to these disparate neuropsychiatric symptoms. The extended amygdala, including the bed nucleus of the stria terminalis (BNST), modulates fear and anxiety(3,4), but also projects to the ventral tegmental area (VTA)(5,6), a region implicated in reward and aversion(7-13), thus providing a candidate neural substrate for integrating diverse emotional states. However, the precise functional connectivity between distinct BNST projection neurons and their postsynaptic targets in the VTA, as well as the role of this circuit in controlling motivational states, have not been described. Here we record and manipulate the activity of genetically and neurochemically identified VTA-projecting BNST neurons in freely behaving mice. Collectively, aversive stimuli exposure produced heterogeneous firing patterns in VTA-projecting BNST neurons. By contrast, in vivo optically identified glutamatergic projection neurons displayed a net enhancement of activity to aversive stimuli, whereas the firing rate of identified GABAergic (gamma-aminobutyric acid-containing) projection neurons was suppressed. Channelrhodopsin-2-assisted circuit mapping revealed that both BNST glutamatergic and GABAergic projections preferentially innervate postsynaptic non-dopaminergic VTA neurons, thus providing a mechanistic framework for in vivo circuit perturbations. In vivo photostimulation of BNST glutamatergic projections resulted in aversive and anxiogenic behavioural phenotypes. Conversely, activation of BNST GABAergic projections produced rewarding and anxiolytic phenotypes, which were also recapitulated by direct inhibition of VTA GABAergic neurons. These data demonstrate that functionally opposing BNST to VTA circuits regulate rewarding and aversive motivational states, and may serve as a crucial circuit node for bidirectionally normalizing maladaptive behaviours.	[Jennings, Joshua H.; Sparta, Dennis R.; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Stamatakis, Alice M.; Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Sparta, Dennis R.; Pleil, Kristen E.; Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Pleil, Kristen E.; Kash, Thomas L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kash, Thomas L.; Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Kash, Thomas/G-9625-2013; Stuber, Garret/E-1160-2011; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022	Ung, Randall/0000-0002-5303-3741; Stuber, Garret/0000-0003-1730-4855	Whitehall Foundation; Foundation of Hope; National Institutes of Health [DA029325, DA032750, AA018610, AA007573, NS007431, DA034472, AA021043]; UNC NIAAA alcohol research center [AA011605]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018610, P50AA011605, T32AA007573, F32AA021043, P60AA011605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, F31DA034472, R01DA032750, R21DA029325] Funding Source: NIH RePORTER	Whitehall Foundation; Foundation of Hope; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC NIAAA alcohol research center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Patel, J. Phillips and S. Maciver for assistance; V. Gukassyan and the UNC Neuroscience Center Microscopy Core (P30 NS045892), and members of the Stuber laboratory for discussion. We thank K. Deisseroth for viral constructs and the UNC Vector Core Facility for viral packaging. We thank B. Lowell and L. Vong for providing the Vgat-ires-cre and Vglut2-ires-cre mice. This study was supported by The Whitehall Foundation, The Foundation of Hope, National Institutes of Health grants DA029325 and DA032750 (to G. D. S.), AA018610 and AA007573 (to D. R. S.), NS007431 and DA034472 (to A. M. S.) and AA021043 (to K. P.), and the UNC NIAAA alcohol research center (AA011605).	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Briand LA, 2010, J NEUROSCI, V30, P16149, DOI 10.1523/JNEUROSCI.2827-10.2010; Christianson JP, 2011, BIOL PSYCHIAT, V70, P458, DOI 10.1016/j.biopsych.2011.04.004; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Erb S, 2001, Stress, V4, P289; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FULLER JH, 1976, BRAIN RES, V112, P283, DOI 10.1016/0006-8993(76)90284-5; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Georges F, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0003.2001; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Mahler SV, 2012, J NEUROSCI, V32, P13309, DOI 10.1523/JNEUROSCI.2277-12.2012; Nagy FZ, 2008, J NEUROPHYSIOL, V100, P3429, DOI 10.1152/jn.90936.2008; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poulos AM, 2010, P NATL ACAD SCI USA, V107, P14881, DOI 10.1073/pnas.1005754107; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3	32	443	483	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					224	+		10.1038/nature12041	http://dx.doi.org/10.1038/nature12041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23515155	Green Accepted, Green Submitted			2022-12-28	WOS:000317346300042
J	Xiong, Y; McCormack, M; Li, L; Hall, Q; Xiang, CB; Sheen, J				Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Xiang, Chengbin; Sheen, Jen			Glucose-TOR signalling reprograms the transcriptome and activates meristems	NATURE			English	Article							E2F TARGET GENES; ARABIDOPSIS; ROOT; GROWTH; RAPAMYCIN; PROLIFERATION; EXPRESSION; NUTRIENT; ENERGY; DIFFERENTIATION	Meristems encompass stem/progenitor cells that sustain postembryonic growth of all plant organs. How meristems are activated and sustained by nutrient signalling remains enigmatic in photosynthetic plants. Combining chemical manipulations and chemical genetics at the photoautotrophic transition checkpoint, we reveal that shoot photosynthesis-derived glucose drives target-of-rapamycin (TOR) signalling relays through glycolysis and mitochondrial bioenergetics to control root meristem activation, which is decoupled from direct glucose sensing, growth-hormone signalling and stem-cell maintenance. Surprisingly, glucose-TOR signalling dictates transcriptional reprogramming of remarkable gene sets involved in central and secondary metabolism, cell cycle, transcription, signalling, transport and protein folding. Systems, cellular and genetic analyses uncover TOR phosphorylation of E2Fa transcription factor for an unconventional activation of S-phase genes, and glucose-signalling defects in e2fa root meristems. Our findings establish pivotal roles of glucose-TOR signalling in unprecedented transcriptional networks wiring central metabolism and biosynthesis for energy and biomass production, and integrating localized stem/progenitor-cell proliferation through inter-organ nutrient coordination to control developmental transition and growth.	[Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xiong, Yan; McCormack, Matthew; Li, Lei; Hall, Qi; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Xiang, Chengbin] Univ Sci & Technol China, Sch Life Sci, Hefei 230023, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiong, Y (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	xiong@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Li, Lei/F-9826-2015	Xiong, Yan/0000-0003-0676-8267	MGH Tosteson Postdoctoral Fellowship; Chinese Academy of Sciences [KSCX3-YW-N-007]; NSF; NIH; WJC Special Project RDA-Korea [PJ009106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567, R01GM060493] Funding Source: NIH RePORTER	MGH Tosteson Postdoctoral Fellowship; Chinese Academy of Sciences(Chinese Academy of Sciences); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WJC Special Project RDA-Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Dai and J. Avruch for S6K antibodies and advice, J. L. Celenza for stimulating discussion, M. D. Curtis and Y. J. Niu for the oestradiol-inducible binary vector, L. Li and J. Bush for seeds and plants, B. Muller for TCS::GFP, J. Friml for DR5::GFP, N. S. Gray and D. M. Sabatini for torin1, and J. F. Li, H. Lee and M. Ramon for critical reading of the manuscript. Y. X. is supported by the MGH Tosteson Postdoctoral Fellowship. C. X. is supported by Chinese Academy of Sciences (KSCX3-YW-N-007). The Research is supported by the NSF, NIH and WJC Special Project (PJ009106) RDA-Korea to J.S.	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Jager SM, 2009, PLANT MOL BIOL, V71, P345, DOI 10.1007/s11103-009-9527-5; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Magyar Z, 2012, EMBO J, V31, P1480, DOI 10.1038/emboj.2012.13; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Naouar N, 2009, PLANT J, V57, P184, DOI 10.1111/j.1365-313X.2008.03662.x; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Sanz L, 2011, PLANT CELL, V23, P641, DOI 10.1105/tpc.110.080002; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang ZW, 2010, FEBS LETT, V584, P3573, DOI 10.1016/j.febslet.2010.07.024	42	449	466	15	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					181	+		10.1038/nature12030	http://dx.doi.org/10.1038/nature12030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23542588	Green Submitted, Green Accepted			2022-12-28	WOS:000317346300033
J	Hussain, M; Tangen, CM; Berry, DL; Higano, CS; Crawford, ED; Liu, G; Wilding, G; Prescott, S; Sundaram, SK; Small, EJ; Dawson, NA; Donnelly, BJ; Venner, PM; Vaishampayan, UN; Schellhammer, PF; Quinn, DI; Raghavan, D; Ely, B; Moinpour, CM; Vogelzang, NJ; Thompson, IM				Hussain, Maha; Tangen, Catherine M.; Berry, Donna L.; Higano, Celestia S.; Crawford, E. David; Liu, Glenn; Wilding, George; Prescott, Stephen; Sundaram, Subramanian Kanaga; Small, Eric Jay; Dawson, Nancy Ann; Donnelly, Bryan J.; Venner, Peter M.; Vaishampayan, Ulka N.; Schellhammer, Paul F.; Quinn, David I.; Raghavan, Derek; Ely, Benjamin; Moinpour, Carol M.; Vogelzang, Nicholas J.; Thompson, Ian M., Jr.			Intermittent versus Continuous Androgen Deprivation in Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; CLINICAL-TRIAL; SUPPRESSION; FLUTAMIDE; LEUPROLIDE; CARCINOMA; THERAPY	Background Castration resistance occurs in most patients with metastatic hormone-sensitive prostate cancer who are receiving androgen-deprivation therapy. Replacing androgens before progression of the disease is hypothesized to prolong androgen dependence. Methods Men with newly diagnosed, metastatic, hormone-sensitive prostate cancer, a performance status of 0 to 2, and a prostate-specific antigen (PSA) level of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an antiandrogen agent for 7 months. We then randomly assigned patients in whom the PSA level fell to 4 ng per milliliter or lower to continuous or intermittent androgen deprivation, with patients stratified according to prior or no prior hormonal therapy, performance status, and extent of disease (minimal or extensive). The coprimary objectives were to assess whether intermittent therapy was noninferior to continuous therapy with respect to survival, with a one-sided test with an upper boundary of the hazard ratio of 1.20, and whether quality of life differed between the groups 3 months after randomization. Results A total of 3040 patients were enrolled, of whom 1535 were included in the analysis: 765 randomly assigned to continuous androgen deprivation and 770 assigned to intermittent androgen deprivation. The median follow-up period was 9.8 years. Median survival was 5.8 years in the continuous-therapy group and 5.1 years in the intermittent-therapy group (hazard ratio for death with intermittent therapy, 1.10; 90% confidence interval, 0.99 to 1.23). Intermittent therapy was associated with better erectile function and mental health (P<0.001 and P = 0.003, respectively) at month 3 but not thereafter. There were no significant differences between the groups in the number of treatment-related high-grade adverse events. Conclusions Our findings were statistically inconclusive. In patients with metastatic hormone-sensitive prostate cancer, the confidence interval for survival exceeded the upper boundary for noninferiority, suggesting that we cannot rule out a 20% greater risk of death with intermittent therapy than with continuous therapy, but too few events occurred to rule out significant inferiority of intermittent therapy. Intermittent therapy resulted in small improvements in quality of life. (Funded by the National Cancer Institute and others; ClinicalTrials.govnumber, NCT00002651.)	[Hussain, Maha] Univ Michigan, Ann Arbor, MI 48109 USA; [Tangen, Catherine M.; Ely, Benjamin] SW Oncol Grp, Ctr Stat, Seattle, WA USA; [Higano, Celestia S.] Univ Washington, Seattle, WA 98195 USA; [Berry, Donna L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Crawford, E. David] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; [Liu, Glenn; Wilding, George] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA; [Prescott, Stephen] St James Univ Hosp, Leeds, W Yorkshire, England; [Sundaram, Subramanian Kanaga] Pinderfields Gen Hosp, Mid Yorkshire Hosp, Wakefield, W Yorkshire, England; [Small, Eric Jay] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dawson, Nancy Ann] Georgetown Univ, Hosp Lombardi, Ctr Comprehens Canc, Washington, DC USA; [Donnelly, Bryan J.] Prostate Canc Ctr, Calgary, AB, Canada; [Venner, Peter M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Vaishampayan, Ulka N.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Schellhammer, Paul F.] Urol Virginia, Norfolk, VA USA; [Quinn, David I.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Raghavan, Derek] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA; [Moinpour, Carol M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Vogelzang, Nicholas J.] US Oncol Res, McKesson Specialty Hlth, The Woodlands, TX USA; [Thompson, Ian M., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Vogelzang, Nicholas J.] Comprehens Canc Ctr Nevada, Las Vegas, NV USA	University of Michigan System; University of Michigan; Southwest Oncology Group; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; Saint James's University Hospital; Pinderfields Hospital; University of California System; University of California San Francisco; Georgetown University; Canadian Cancer Society (CCS); University of Alberta; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Southern California; Carolinas HealthCare System; Fred Hutchinson Cancer Center; McKesson Corporation; US Oncology Network; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Comprehensive Cancer Centers of Nevada	Hussain, M (corresponding author), Univ Michigan, Div Hematol Oncol, 1500 E Med Ctr Dr,7314 CC, Ann Arbor, MI 48109 USA.	mahahuss@umich.edu	Quinn, David I/F-4343-2015; Quinn, David/N-3730-2019	Quinn, David I/0000-0002-1411-0417; Quinn, David/0000-0002-1411-0417; Vaishampayan, Ulka/0000-0001-5800-4571	National Cancer Institute; National Cancer Institute [CA32102, CA38926, CA14028, CA55582, CA42777, CA35192, CA46441, CA46282, CA27057, CA128567, CA45807, CA20319, CA58416]; AstraZeneca; Fonds Cancer (FOCA) from Belgium; National Cancer Institute. [CA46113, CA04919, CA76132, CA58861, CA58686, CA68183, CA12644, CA35261, CA35431, CA46368, CA22433, CA63848, CA67575, CA76447, CA67663, CA46136, CA86780, CA35281, CA63844, CA45560, CA37981, CA11083, CA35178, CA95860, CA35176, CA21115, CA31949, CA77202, CCSRI 015469]; NATIONAL CANCER INSTITUTE [U10CA022433, U10CA046282, U10CA035178, U10CA046368, R03CA176132, U10CA035261, U10CA004919, U10CA077202, U10CA063844, U10CA011083, U10CA027057, U10CA032102, U10CA076447, U10CA038926, P30CA014520, U10CA035176, U10CA014028, U10CA058416, U10CA045807, U10CA180835, U10CA020319, U10CA035281, U10CA042777, U10CA035431, U10CA067575, U10CA037981, U10CA067663, U10CA012644, U10CA068183, U10CA021115, U10CA058861, U10CA035192, U10CA086780, U10CA037403, U10CA046113, U10CA063848, U10CA046136, U10CA058686, U10CA045560, U10CA046441, R01CA031949, U10CA095860, U10CA128567] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca(AstraZeneca); Fonds Cancer (FOCA) from Belgium; National Cancer Institute.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others; ClinicalTrials.govnumber, NCT00002651.; Supported in part by PHS Cooperative Agreements awarded by the National Cancer Institute (CA32102, CA38926, CA14028, CA55582, CA42777, CA35192, CA46441, CA46282, CA27057, CA128567, CA45807, CA20319, CA58416, CA46113, CA04919, CA76132, CA58861, CA58686, CA68183, CA12644, CA35261, CA35431, CA46368, CA22433, CA63848, CA67575, CA76447, CA67663, CA46136, CA86780, CA35281, CA63844, CA45560, CA37981, CA11083, CA35178, CA95860, CA35176, CA21115, CA31949, CA77202, and CCSRI 015469) and in part by AstraZeneca. The contribution of EORTC to this study was supported by Fonds Cancer (FOCA) from Belgium.	AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; Bhandari MS, 2005, J CLIN ONCOL, V23, P8212, DOI 10.1200/JCO.2005.03.2557; BRUCHOVSKY N, 1990, CANCER RES, V50, P2275; da Silva FECC, 2009, EUR UROL, V55, P1269, DOI 10.1016/j.eururo.2009.02.016; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Crook JM, 2012, NEW ENGL J MED, V367, P2262; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; de Leval Jean, 2002, Clin Prostate Cancer, V1, P163, DOI 10.3816/CGC.2002.n.018; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; GOLDENBERG SL, 1995, UROLOGY, V45, P839; Gruca D, 2012, INT J UROL, V19, P614, DOI 10.1111/j.1442-2042.2012.03001.x; Higano CS, 1996, UROLOGY, V48, P800, DOI 10.1016/S0090-4295(96)00381-0; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Moinpour C M, 1990, Oncology (Williston Park), V4, P79; Moinpour CM, 1998, J NATL CANCER I, V90, P1537, DOI 10.1093/jnci/90.20.1537; Moinpour CM, 2000, PSYCHO-ONCOL, V9, P340, DOI 10.1002/1099-1611(200007/08)9:4<340::AID-PON466>3.3.CO;2-6; Moinpour CM, 1995, QUALITY LIFE BEHAV M, P79; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pauler DK, 2003, STAT MED, V22, P795, DOI 10.1002/sim.1397; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Salonen AJ, 2012, J UROLOGY, V187, P2074, DOI 10.1016/j.juro.2012.01.122; TRACHTENBERG J, 1987, J UROLOGY, V137, P785, DOI 10.1016/S0022-5347(17)44211-X	26	378	390	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1314	1325		10.1056/NEJMoa1212299	http://dx.doi.org/10.1056/NEJMoa1212299			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550669	Green Accepted			2022-12-28	WOS:000316989900008
J	Son, J; Lyssiotis, CA; Ying, H; Wang, X; Hua, S; Ligorio, M; Perera, RM; Ferrone, CR; Mullarky, E; Ng, SC; Kang, Y; Fleming, JB; Bardeesy, N; Asara, JM; Haigis, MC; DePinho, RA; Cantley, LC; Kimmelman, AC				Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.			Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway	NATURE			English	Article							MASS-SPECTROMETRY; TRANSFORMED-CELLS; ADDICTION; GLUCOSE	Cancer cells have metabolic dependencies that distinguish them from their normal counterparts(1). Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes(2). Indeed, the spectrum of glutamine-dependent tumours and the mechanisms whereby glutamine supports cancer metabolism remain areas of active investigation. Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumour growth. Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into alpha-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1). Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP(+) ratio which can potentially maintain the cellular redox state. Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a reduction in reduced glutathione. Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo. Furthermore, we establish that the reprogramming of glutamine metabolism is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway. The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumours.	[Son, Jaekyoung; Wang, Xiaoxu; Kimmelman, Alec C.] Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Mullarky, Edouard; Ng Shyh-Chang; Cantley, Lewis C.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Mullarky, Edouard; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ligorio, Matteo; Ferrone, Cristina R.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Perera, Rushika M.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ng Shyh-Chang] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Stem Cell Program, Boston, MA 02130 USA; [Ng Shyh-Chang] Dana Farber Canc Inst, Boston, MA 02130 USA; [Kang, Ya'an; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Haigis, Marcia C.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Cantley, LC (corresponding author), Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02215 USA.	lec2014@med.cornell.edu; Alec_Kimmelman@DFCI.harvard.edu	Ying, Haoqiang/AAK-4325-2020; Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014	Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; Shyh-Chang, Ng/0000-0003-3138-9525; DePinho, Ronald/0000-0002-5625-577X	Dana Farber Cancer Institute; National Cancer Institute [R01 CA157490]; Kimmel Scholar Award; AACR-PanCAN Career Development Award; NIH [T32 CA009382-26, P01 CA117969, 5P01CA120964-05]; Dana-Farber/Harvard Cancer Center Support Grant [5P30CA006516-46]; NATIONAL CANCER INSTITUTE [P01CA120964, P01CA117969, T32CA009382, R01CA157490, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	Dana Farber Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR-PanCAN Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Anastasiou for advice and helpful comments on the manuscript; M. Yuan and S. Breitkopf for technical help with mass spectrometry experiments; J. Erickson, R. Cerione and J. Escobedo for the GLS inhibitors. Grant support derives from the Dana Farber Cancer Institute (A. C. K.), National Cancer Institute Grant R01 CA157490 (A. C. K.), Kimmel Scholar Award (A. C. K.), AACR-PanCAN Career Development Award (A. C. K.), NIH grants T32 CA009382-26 (H.Y.) and P01 CA117969 (L. C. C. and R. A. D.). C. A. L. is the Amgen Fellow of the Damon Runyon Cancer Research Foundation (DRG-2056-10). NIH grants 5P01CA120964-05 and Dana-Farber/Harvard Cancer Center Support Grant 5P30CA006516-46 (J.M.A.).	Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	25	1215	1267	20	395	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					101	+		10.1038/nature12040	http://dx.doi.org/10.1038/nature12040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535601	Green Accepted, Green Submitted			2022-12-28	WOS:000316993400033
J	Xing, WM; Busino, L; Hinds, TR; Marionni, ST; Saifee, NH; Bush, MF; Pagano, M; Zheng, N				Xing, Weiman; Busino, Luca; Hinds, Thomas R.; Marionni, Samuel T.; Saifee, Nabiha H.; Bush, Matthew F.; Pagano, Michele; Zheng, Ning			SCFFBXL3 ubiquitin ligase targets cryptochromes at their cofactor pocket	NATURE			English	Article							CIRCADIAN CLOCK; CRYSTAL-STRUCTURE; MAMMALIAN CRY1; PHOTOLYASE; MECHANISM; PHOSPHORYLATION; IDENTIFICATION; COORDINATION; DEGRADATION; OSCILLATION	The cryptochrome (CRY) flavoproteins act as blue-light receptors in plants and insects, but perform light-independent functions at the core of the mammalian circadian clock. To drive clock oscillations, mammalian CRYs associate with the Period proteins (PERs) and together inhibit the transcription of their own genes. The SCFFBXL3 ubiquitin ligase complex controls this negative feedback loop by promoting CRY ubiquitination and degradation. However, the molecular mechanisms of their interactions and the functional role of flavin adenine dinucleotide (FAD) binding in CRYs remain poorly understood. Here we report crystal structures of mammalian CRY2 in its apo, FAD-bound and FBXL3-SKP1-complexed forms. Distinct from other cryptochromes of known structures, mammalian CRY2 binds FAD dynamically with an open cofactor pocket. Notably, the F-box protein FBXL3 captures CRY2 by simultaneously occupying its FAD-binding pocket with a conserved carboxy-terminal tail and burying its PER-binding interface. This novel F-box-protein-substrate bipartite interaction is susceptible to disruption by both FAD and PERs, suggesting a new avenue for pharmacological targeting of the complex and a multifaceted regulatory mechanism of CRY ubiquitination.	[Xing, Weiman; Hinds, Thomas R.; Saifee, Nabiha H.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Xing, Weiman; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Busino, Luca; Pagano, Michele] NYU, Sch Med, Dept Pathol, NYU Canc Inst, New York, NY 10016 USA; [Marionni, Samuel T.; Bush, Matthew F.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; New York University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; New York University	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Bush, Matthew F./Y-2079-2019	Bush, Matthew F./0000-0003-3526-4973; Huq Saifee, Nabiha/0000-0003-1646-9201; pagano, michele/0000-0003-3210-2442; Xing, Weiman/0000-0002-6238-0075	Howard Hughes Medical Institute; National Institutes of Health [R01-CA107134, 5T32-HL007151, R01-GM057587, R37-CA-076584, R21-CA161108]; University of Washington; NATIONAL CANCER INSTITUTE [R21CA161108, R01CA107134, R37CA076584, K99CA166181] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley for help with data collection, and members of the Zheng laboratory for discussion. This work is supported by the Howard Hughes Medical Institute (N. Z. and M. P.), the National Institutes of Health (R01-CA107134 to N. Z., 5T32-HL007151 to L. B., and R01-GM057587, R37-CA-076584 and R21-CA161108 to M. P.), and the University of Washington (S.T.M. and M.F.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2006, CURR BIOL, V16, P730, DOI 10.1016/j.cub.2006.03.026; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	42	156	162	0	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					64	+		10.1038/nature11964	http://dx.doi.org/10.1038/nature11964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23503662	Green Accepted			2022-12-28	WOS:000316993400025
J	Takwoingi, Y; Leeflang, MMG; Deeks, JJ				Takwoingi, Yemisi; Leeflang, Mariska M. G.; Deeks, Jonathan J.			Empirical Evidence of the Importance of Comparative Studies of Diagnostic Test Accuracy	ANNALS OF INTERNAL MEDICINE			English	Article							LYMPH-NODE METASTASES; COMPUTED-TOMOGRAPHY; SYSTEMATIC REVIEWS; ACUTE APPENDICITIS; ESOPHAGEAL CANCER; CERVICAL-CANCER; METAANALYSIS; ECHOCARDIOGRAPHY; ULTRASONOGRAPHY; BIAS	Background: Systematic reviews that "compare" the accuracy of 2 or more tests often include different sets of studies for each test. Purpose: To investigate the availability of direct comparative studies of test accuracy and to assess whether summary estimates of accuracy differ between meta-analyses of noncomparative and comparative studies. Data Sources: Systematic reviews in any language from the Database of Abstracts of Reviews of Effects and the Cochrane Database of Systematic Reviews from 1994 to October 2012. Study Selection: 1 of 2 assessors selected reviews that evaluated at least 2 tests and identified meta-analyses that included both noncomparative studies and comparative studies. Data Extraction: 1 of 3 assessors extracted data about review and study characteristics and test performance. Data Synthesis: 248 reviews compared test accuracy; of the 6915 studies, 2113 (31%) were comparative. Thirty-six reviews (with 52 meta-analyses) had adequate studies to compare results of noncomparative and comparative studies by using a hierarchical summary receiver-operating characteristic meta-regression model for each test comparison. In 10 meta-analyses, noncomparative studies ranked tests in the opposite order of comparative studies. A total of 25 meta-analyses showed more than a 2-fold discrepancy in the relative diagnostic odds ratio between noncomparative and comparative studies. Differences in accuracy estimates between noncomparative and comparative studies were greater than expected by chance (P < 0.001). Limitation: A paucity of comparative studies limited exploration of direction in bias. Conclusion: Evidence derived from noncomparative studies often differs from that derived from comparative studies. Robustly designed studies in which all patients receive all tests or are randomly assigned to receive one or other of the tests should be more routinely undertaken and are preferred for evidence to guide test selection.	[Takwoingi, Yemisi] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Birmingham; University of Amsterdam; Academic Medical Center Amsterdam	Takwoingi, Y (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	y.takwoingi@bham.ac.uk	Leeflang, Mariska/AAF-8199-2019; Deeks, Jon/AAV-5745-2020	Leeflang, Mariska/0000-0001-5960-0471; Deeks, Jon/0000-0002-8850-1971; Takwoingi, Yemisi/0000-0002-5828-9746	National Institute for Health Research (United Kingdom); United Kingdom National Institute for Health Research Award [DRF-2011-04-135]; Netherlands Organization for Scientific Research [916.10.034]; Medical Research Council Midland Hub for Trials Methodology Research [G0800808]; National Institute for Health Research [DRF-2011-04-135] Funding Source: researchfish	National Institute for Health Research (United Kingdom)(National Institute for Health Research (NIHR)); United Kingdom National Institute for Health Research Award; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council Midland Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research (United Kingdom).; Dr. Takwoingi is funded through a United Kingdom National Institute for Health Research Award (DRF-2011-04-135). Dr. Leeflang is supported by the Netherlands Organization for Scientific Research (project 916.10.034). Dr. Deeks is partially supported by the Medical Research Council Midland Hub for Trials Methodology Research (grant number G0800808).	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Al-Khayal KA, 2007, SAUDI MED J, V28, P173; Alldred SK, 2012, COCHRANE DB SYST REV, V6; Balk EM, 2001, ANN EMERG MED, V37, P478, DOI 10.1067/mem.2001.114905; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Choi HJ, 2010, CANCER SCI, V101, P1471, DOI 10.1111/j.1349-7006.2010.01532.x; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Dahabreh IJ, 2012, AHRQ PUBLICATION; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; Deeks J J, 2003, Health Technol Assess, V7, piii; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Elamin MB, 2008, J CLIN ENDOCR METAB, V93, P1553, DOI 10.1210/jc.2008-0139; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Glas AS, 2003, J UROLOGY, V169, P1975, DOI 10.1097/01.ju.0000067461.30468.6d; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Gu P, 2007, J CLIN LAB ANAL, V21, P398, DOI 10.1002/jcla.20208; Gu P, 2009, EUR J RADIOL, V71, P164, DOI 10.1016/j.ejrad.2008.02.019; Heim SW, 2004, CLIN CHEM, V50, P1136, DOI 10.1373/clinchem.2004.031765; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Leeflang M, 2007, CLIN CHEM, V53, P164, DOI 10.1373/clinchem.2006.076398; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; Medical Services Advisory Committee, 2005, GUID ASS DIAGN TECHN; Mirza TA, 2010, EUR J VASC ENDOVASC, V39, P418, DOI 10.1016/j.ejvs.2010.01.001; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Ngamruengphong S, 2010, DIS ESOPHAGUS, V23, P216, DOI 10.1111/j.1442-2050.2009.00989.x; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Noguchi Y, 2005, INT J CARDIOVAS IMAG, V21, P189, DOI 10.1007/s10554-004-5808-x; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Reeves B., 2011, COCHRANE HDB SYSTEMA; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Safdar N, 2005, ANN INTERN MED, V142, P451, DOI 10.7326/0003-4819-142-6-200503150-00011; Scheidler J, 1997, JAMA-J AM MED ASSOC, V278, P1096, DOI 10.1001/jama.278.13.1096; Scherer K, 2005, JAMA-J AM MED ASSOC, V293, P1906, DOI 10.1001/jama.293.15.1906; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Selman TJ, 2005, GYNECOL ONCOL, V99, P206, DOI 10.1016/j.ygyno.2005.05.029; SHEPS SB, 1984, JAMA-J AM MED ASSOC, V252, P2418, DOI 10.1001/jama.252.17.2418; Shiga T, 2006, ARCH INTERN MED, V166, P1350, DOI 10.1001/archinte.166.13.1350; Smith TO, 2011, EUR RADIOL, V21, P863, DOI 10.1007/s00330-010-1956-7; Smith-Bindman R, 2001, JAMA-J AM MED ASSOC, V285, P1044, DOI 10.1001/jama.285.8.1044; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; St John A, 2006, AM J CLIN PATHOL, V126, P428, DOI 10.1309/C69RW1BT7E4QAFPV; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Tian XY, 2012, J CLIN GASTROENTEROL, V46, P285, DOI 10.1097/MCG.0b013e318249c4cd; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; Wardlaw JM, 2006, LANCET, V367, P1503, DOI 10.1016/S0140-6736(06)68650-9; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Xu GZ, 2011, HEAD NECK-J SCI SPEC, V33, P87, DOI 10.1002/hed.21400; Yin ZG, 2010, CLIN ORTHOP RELAT R, V468, P723, DOI 10.1007/s11999-009-1081-6	62	100	104	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					544	+		10.7326/0003-4819-158-7-201304020-00006	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00006			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546566				2022-12-28	WOS:000317419400005
J	Geiss, BJ; Wilusz, J				Geiss, Brian J.; Wilusz, Jeffrey			Ring around the Ro-sie: RNA-Mediated Alterations of PNPase Activity	CELL			English	Editorial Material							IN-VIVO; AUTOANTIGEN; ORTHOLOG; COMPLEX	Chen et al. demonstrate a new way by which noncoding RNAs tailor the function of multicomponent complexes. They show that a noncoding RNA interacts with an exoribonuclease, altering its substrate specificity and enzymatic activity by serving as a ribonucleoprotein scaffold and, perhaps, a gate for entry of the RNA substrate.	[Geiss, Brian J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	brian.geiss@colostate.edu; jeffrey.wilusz@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772	NIAID NIH HHS [U54 AI065357] Funding Source: Medline; NIGMS NIH HHS [R01 GM072481] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072481] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen XG, 2007, GENE DEV, V21, P1328, DOI 10.1101/gad.1548207; Chen XG, 2013, CELL, V153, P166, DOI 10.1016/j.cell.2013.02.037; Delebecque CJ, 2012, NAT PROTOC, V7, P1797, DOI 10.1038/nprot.2012.102; Drazkowska K., 2013, NUCL ACIDS RES; Harjes E, 2012, NUCLEIC ACIDS RES, V40, P9953, DOI 10.1093/nar/gks724; Lebo KJ, 2012, RNA, V18, P1666, DOI 10.1261/rna.033555.112; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Sim S, 2011, WIRES RNA, V2, P686, DOI 10.1002/wrna.85; Wurtmann EJ, 2010, P NATL ACAD SCI USA, V107, P4022, DOI 10.1073/pnas.1000307107	10	0	0	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					12	14		10.1016/j.cell.2013.03.005	http://dx.doi.org/10.1016/j.cell.2013.03.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540686	Green Accepted, Bronze			2022-12-28	WOS:000316853700002
J	Legge, D; Sanders, D				Legge, David; Sanders, David			Commentary: new development goals must focus on social determinants of health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MILLENNIUM DEVELOPMENT GOALS; PROGRESS; POOR		[Legge, David] La Trobe Univ, Melbourne, Vic 3086, Australia; [Sanders, David] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa	La Trobe University; University of the Western Cape	Legge, D (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	dglegge01@gmail.com						[Anonymous], 1999, DEV FREEDOM; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Friel S, 2013, LANCET, V381, P903, DOI 10.1016/S0140-6736(13)60669-8; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Kenny C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1193; Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79; People's Health Movement, HLTH POST 2015 DEV A; United Nations Development Programme, 2011, HUMAN DEV REPORT; World Trade Organisation Ministerial Council, 2001, DOH MIN DECL	9	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1893	10.1136/bmj.f1893	http://dx.doi.org/10.1136/bmj.f1893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538927	Green Submitted			2022-12-28	WOS:000316986200011
J	Vunda, A; Lacroix, LE; Schneider, F; Manzano, S; Gervaix, A				Vunda, Aaron; Lacroix, Laurence E.; Schneider, Franck; Manzano, Sergio; Gervaix, Alain			Reduction of Paraphimosis in Boys	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vunda, Aaron; Lacroix, Laurence E.; Schneider, Franck; Manzano, Sergio; Gervaix, Alain] Univ Hosp Geneva, Geneva, Switzerland	University of Geneva	Vunda, A (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.		Lacroix-Ducardonnoy, Laurence/HDN-9583-2022; Lacroix, Laurence/ABF-5052-2021; Manzano, Sergio/ABG-6281-2020	Lacroix-Ducardonnoy, Laurence/0000-0002-6636-3344; Lacroix, Laurence/0000-0002-6636-3344; Manzano, Sergio/0000-0001-9603-5520				Jones SA, 1996, BRIT J UROL, V78, P803, DOI 10.1046/j.1464-410X.1996.25435.x; Little B, 2005, INT J CLIN PRACT, V59, P591, DOI 10.1111/j.1742-1241.2004.00356.x; Raman SR, 2008, EMERG MED J, V25, DOI 10.1136/emj.2007.054601; Ramdass MJ, 2000, TROP MED INT HEALTH, V5, P906, DOI 10.1046/j.1365-3156.2000.00654.x; Tews M, 2012, PARAPHIMOSIS REDUCTI	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					E16	E16		10.1056/NEJMvcm1105611	http://dx.doi.org/10.1056/NEJMvcm1105611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23534582				2022-12-28	WOS:000316869000011
J	Serisier, DJ; Martin, ML; McGuckin, MA; Lourie, R; Chen, AC; Brain, B; Biga, S; Schlebusch, S; Dash, P; Bowler, SD				Serisier, David J.; Martin, Megan L.; McGuckin, Michael A.; Lourie, Rohan; Chen, Alice C.; Brain, Barbara; Biga, Sally; Schlebusch, Sanmarie; Dash, Peter; Bowler, Simon D.			Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; MACROLIDE ANTIBIOTICS; DOUBLE-BLIND; IN-VITRO; AZITHROMYCIN; VOLUNTEERS; PREVENTION; SURVIVAL; THERAPY; AIRWAY	Importance Macrolide antibiotics such as erythromycin may improve clinical outcomes in non-cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are poorly defined. Objective To evaluate the clinical efficacy and antimicrobial resistance cost of low-dose erythromycin given for 12 months to patients with non-CF bronchiectasis with a history of frequent pulmonary exacerbations. Design, Setting, and Participants Twelve-month, randomized (1: 1), double-blind, placebo-controlled trial of erythromycin in currently nonsmoking, adult patients with non-CF bronchiectasis with a history of 2 or more infective exacerbations in the preceding year. This Australian study was undertaken between October 2008 and December 2011 in a university teaching hospital, with participants also recruited via respiratory physicians at other centers and from public radio advertisements. Interventions Twice-daily erythromycin ethylsuccinate (400mg) or matching placebo. Main Outcome Measures The primary outcome was the annualized mean rate of protocol-defined pulmonary exacerbations (PDPEs) per patient. Secondary outcomes included macrolide resistance in commensal oropharyngeal streptococci and lung function. Results Six-hundred seventy-nine patients were screened, 117 were randomized (58 placebo, 59 erythromycin), and 107 (91.5%) completed the study. Erythromycin significantly reduced PDPEs both overall (mean, 1.29[95% CI, 0.93-1.65] vs 1.97[95% CI, 1.45-2.48] per patient per year; incidence rate ratio [IRR], 0.57 [95% CI, 0.42-0.77]; P=. 003), and in the prespecified subgroup with baseline Pseudomonas aeruginosa airway infection (mean difference, 1.32[95% CI, 0.19-2.46]; P=. 02). Erythromycin reduced 24-hour sputum production (median difference, 4.3 g [interquartile range [IQR], 1 to 7.8], P=. 01) and attenuated lung function decline(mean absolute difference for change in postbronchodilator forced expiratory volume in the first second of expiration, 2.2 percent predicted [95% CI, 0.1% to 4.3%]; P=.04) compared with placebo. Erythromycin increased the proportion of macrolide-resistant oropharyngeal streptococci (median change, 27.7% [IQR, 0.04% to 41.1%] vs 0.04% [IQR, -1.6% to 1.5%]; difference, 25.5% [IQR, 15.0% to 33.7%]; P<.001). Conclusion and Relevance Among patients with non-CF bronchiectasis, the 12-month use of erythromycin compared with placebo resulted in a modest decrease in the rate of pulmonary exacerbations and an increased rate of macrolide resistance. Trial Registration anzctr.org.au Identifier: ACTRN12609000578202 JAMA. 2013; 309(12): 1260-1267 www.jama.com	[Serisier, David J.; Martin, Megan L.; Bowler, Simon D.] Mater Adult Hosp, Dept Resp Med, Brisbane, Qld 4101, Australia; [Brain, Barbara] Mater Hlth Serv, Dept Pharm, Brisbane, Qld, Australia; [Biga, Sally; Schlebusch, Sanmarie] Mater Hlth Serv, Div Microbiol, Brisbane, Qld, Australia; [Lourie, Rohan; Dash, Peter] Mater Hlth Serv, Dept Anat Pathol, Brisbane, Qld, Australia; [Serisier, David J.; Bowler, Simon D.] Univ Queensland, Brisbane, Qld, Australia	Mater Health Services; Mater Health Services; Mater Health Services; University of Queensland	Serisier, DJ (corresponding author), Mater Adult Hosp, Dept Resp Med, Level 9, Brisbane, Qld 4101, Australia.	david.serisier@mater.org.au	McGuckin, Michael/G-2310-2010; Bowler, Simon/AAE-1630-2019	McGuckin, Michael/0000-0002-8375-2675; Lourie, Rohan/0000-0002-0093-911X	Mater Adult Respiratory Research Trust Fund; GlaxoSmithKline; AstraZeneca; Boehringer-Ingelheim; Pharmaxis	Mater Adult Respiratory Research Trust Fund; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); Pharmaxis	This study was internally funded by the Mater Adult Respiratory Research Trust Fund. No pharmaceutical company or other agency (including medical writers) had any role in this study.; All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Serisier reported receiving honoraria for serving on the medical advisory boards of Pharmaxis, Phebra, Boehringer-Ingelheim, and GlaxoSmithKline; speaker's fees for presenting at educational meetings organized by GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, and Pharmaxis; and travel support from Boehringer-Ingelheim to attend a scientific meeting. Dr Bowler reported receiving honoraria for serving on the medical advisory board of Novartis; speaker's fees for presenting at educational meetings organized by AstraZeneca, GlaxoSmithKline, and BoehringerIngelheim; and travel support from GlaxoSmithKline to attend scientific meetings. No other disclosures were reported.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; [Anonymous], EM TABL 400 MG 25; [Anonymous], ZITHR; Barkai G, 2005, EMERG INFECT DIS, V11, P829; Barker AF, 2000, AM J RESP CRIT CARE, V162, P481, DOI 10.1164/ajrccm.162.2.9910086; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Crokaert F, 1998, CLIN DRUG INVEST, V16, P161, DOI 10.2165/00044011-199816020-00009; Dias R, 2004, J ANTIMICROB CHEMOTH, V54, P1035, DOI 10.1093/jac/dkh469; Evans DJ, 2007, COCHRANE DB SYST REV, V13; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Karlowsky JA, 2009, INT J ANTIMICROB AG, V34, P375, DOI 10.1016/j.ijantimicag.2009.05.008; Kastner U, 2001, INFECTION, V29, P251, DOI 10.1007/s15010-001-1072-3; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Matthews JNS, 1996, BRIT MED J, V313, P862; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Serisier DJ, 2011, RESP MED, V105, P946, DOI 10.1016/j.rmed.2011.01.009; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; SWANSON DJ, 1992, AM J MED, V92, P61, DOI 10.1016/0002-9343(92)90016-5; Tsang KW, 2005, THORAX, V60, P239, DOI 10.1136/thx.2002.003236; Tsang KW, 2003, EUR RESPIR J, V21, P401, DOI 10.1183/09031936.03.00050903; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Wilson R, 2012, LANCET, V380, P627, DOI 10.1016/S0140-6736(12)61261-6; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2	32	281	297	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1260	1267		10.1001/jama.2013.2290	http://dx.doi.org/10.1001/jama.2013.2290			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532242	Bronze			2022-12-28	WOS:000316625200026
J	Konopacky, QM; Barman, TS; Macintosh, BA; Marois, C				Konopacky, Quinn M.; Barman, Travis S.; Macintosh, Bruce A.; Marois, Christian			Detection of Carbon Monoxide and Water Absorption Lines in an Exoplanet Atmosphere	SCIENCE			English	Article							MU-M; FIELD SPECTROGRAPH; PLANET FORMATION; LAMBDA-BOOTIS; GIANT PLANETS; T DWARFS; HR; MASSES; COOL; TEMPERATURE	Determining the atmospheric structure and chemical composition of an exoplanet remains a formidable goal. Fortunately, advancements in the study of exoplanets and their atmospheres have come in the form of direct imaging-spatially resolving the planet from its parent star-which enables high-resolution spectroscopy of self-luminous planets in jovian-like orbits. Here, we present a spectrum with numerous, well-resolved molecular lines from both water and carbon monoxide from a massive planet orbiting less than 40 astronomical units from the star HR 8799. These data reveal the planet's chemical composition, atmospheric structure, and surface gravity, confirming that it is indeed a young planet. The spectral lines suggest an atmospheric carbon-to-oxygen ratio that is greater than that of the host star, providing hints about the planet's formation.	[Konopacky, Quinn M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Barman, Travis S.] Lowell Observ, Flagstaff, AZ 86001 USA; [Konopacky, Quinn M.; Macintosh, Bruce A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Marois, Christian] Natl Res Council Canada, Dominion Astrophys Observ, Victoria, BC V9E 2E7, Canada	University of Toronto; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Research Council Canada	Konopacky, QM (corresponding author), Univ Toronto, Dunlap Inst Astron & Astrophys, 50 St George St, Toronto, ON M5S 3H4, Canada.	konopacky@di.utoronto.ca		Konopacky, Quinn/0000-0002-9936-6285; Macintosh, Bruce/0000-0003-1212-7538	U.S. Department of Energy by LLNL [DE-AC52-07NA27344]; NASA; Keck Principal Investigator Data Analysis Fund; NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center; David Dunlap family; University of Toronto; W. M. Keck Foundation	U.S. Department of Energy by LLNL; NASA(National Aeronautics & Space Administration (NASA)); Keck Principal Investigator Data Analysis Fund; NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center; David Dunlap family; University of Toronto(University of Toronto); W. M. Keck Foundation(W.M. Keck Foundation)	We thank A. Conrad, S. Dahm, J. Lyke, H. Tran, H. Hershley, J. McIlroy, J. Rivera, and the entire Keck staff for maximizing our observing efficiency; J. Larkin and S. Wright for their assistance with OSIRIS data reduction; and R. Murray-Clay and K. Oberg for assistance with abundance values. Portions of this work were performed under the auspices of the U.S. Department of Energy by LLNL under contract no. DE-AC52-07NA27344. Support for this work was provided by NASA Origins of the Solar System grants to LLNL and Lowell Observatory and from the Keck Principal Investigator Data Analysis Fund, managed by NExScI on behalf of NASA. Support was also provided by the NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center. Q.M.K. is a Dunlap Fellow at the Dunlap Institute for Astronomy and Astrophysics, University of Toronto. The Dunlap Institute is funded through an endowment established by the David Dunlap family and the University of Toronto. The W. M. Keck Observatory is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Keck Observatory was made possible by the generous financial support of the W. M. Keck Foundation. We also wish to recognize the very important cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. All authors contributed equally to this work.	Asplund M, 2005, ASTR SOC P, V336, P25; Baines EK, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/57; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Barman TS, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L39; Barman TS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/65; Borysov A, 2002, MOL PHYS, V100, P3585, DOI 10.1080/00268970210161430; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Bowler BP, 2010, ASTROPHYS J, V723, P850, DOI 10.1088/0004-637X/723/1/850; Currie T, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/128; Fegley B, 1996, ASTROPHYS J, V472, pL37, DOI 10.1086/310356; Fortney JJ, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L27; Galicher R, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L41; Gray RO, 2002, ASTRON J, V124, P989, DOI 10.1086/341609; Helled R, 2010, ICARUS, V207, P503, DOI 10.1016/j.icarus.2009.11.023; Krabbe A, 2004, P SOC PHOTO-OPT INS, V5492, P1403, DOI 10.1117/12.552592; Larkin J, 2006, NEW ASTRON REV, V50, P362, DOI 10.1016/j.newar.2006.02.005; Madhusudhan N, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/34; Marley MS, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/135; Metchev SA, 2006, ASTROPHYS J, V651, P1166, DOI 10.1086/507836; Oberg KI, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L16; Patience J, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014173; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rafikov RR, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/86; Rothman LS, 2008, J QUANT SPECTROSC RA, V109, P881, DOI 10.1016/j.jqsrt.2008.02.002; Sadakane K, 2006, PUBL ASTRON SOC JPN, V58, P1023, DOI 10.1093/pasj/58.6.1023; Saumon D, 2008, ASTROPHYS J, V689, P1327, DOI 10.1086/592734; Skemer AJ, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/14; Smith MD, 1998, ICARUS, V132, P176, DOI 10.1006/icar.1997.5886; Sudol JJ, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/38; Warmbier R, 2009, ASTRON ASTROPHYS, V495, P655, DOI 10.1051/0004-6361:200810983; Wenger C, 1998, J QUANT SPECTROSC RA, V59, P471, DOI 10.1016/S0022-4073(97)00106-4; Wilson HF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.111101; Wizinowich PL, 2006, PROC SPIE, V6272, pU79, DOI 10.1117/12.672104; Zuckerman B, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/61	38	239	239	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1398	1401		10.1126/science.1232003	http://dx.doi.org/10.1126/science.1232003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23493423	Green Submitted			2022-12-28	WOS:000316740700033
J	Melchor, RN; Buchwaldt, R; Bowring, S				Melchor, Ricardo N.; Buchwaldt, Robert; Bowring, Samuel			A Late Eocene date for Late Triassic bird tracks	NATURE			English	Letter							SANTO-DOMINGO; ARGENTINA; FOOTPRINTS; PRECISION		[Melchor, Ricardo N.] INCITAP, CONICET UNLPam, Santa Rosa 6300, Argentina; [Buchwaldt, Robert; Bowring, Samuel] MIT, Dept Earth Atmosphere & Planet Sci, Cambridge, MA 02139 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Massachusetts Institute of Technology (MIT)	Melchor, RN (corresponding author), INCITAP, CONICET UNLPam, Av Uruguay 151, Santa Rosa 6300, Argentina.	melchor@exactas.unlpam.edu.ar	Melchor, Ricardo Nestor/R-8107-2019					BOWRING JF, 2011, GEOCHEM GEOPHYS SYST, V12; CAMINOS R, 1995, REV ASOC GEOL ARGENT, V50, P262; COUGHLIN TJ, 2001, LINK OROG OBL FAULT; De Valais S, 2008, J VERTEBR PALEONTOL, V28, P145, DOI 10.1671/0272-4634(2008)28[145:IOBFAE]2.0.CO;2; Genise JF, 2009, PALAEOGEOGR PALAEOCL, V272, P143, DOI 10.1016/j.palaeo.2008.08.014; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Mattinson JM, 2005, CHEM GEOL, V220, P47, DOI 10.1016/j.chemgeo.2005.03.011; MCLEAN NM, 2011, GEOCHEM GEOPHYS SYST, V12; Melchor RN, 2006, PALAEOGEOGR PALAEOCL, V239, P253, DOI 10.1016/j.palaeo.2006.01.011; Melchor RN, 2002, NATURE, V417, P936, DOI 10.1038/nature00818; Rioux M, 2012, NAT GEOSCI, V5, P275, DOI [10.1038/ngeo1378, 10.1038/NGEO1378]; Vizan H, 2013, TECTONOPHYSICS, V583, P105, DOI 10.1016/j.tecto.2012.10.026	13	10	12	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					E1	E2		10.1038/nature11931	http://dx.doi.org/10.1038/nature11931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518566				2022-12-28	WOS:000316650500050
J	Boiselle, PM				Boiselle, Phillip M.			Computed Tomography Screening for Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOSE SPIRAL CT; BASE-LINE; COST-EFFECTIVENESS; GENERAL-POPULATION; MORTALITY; TRIAL; PREVALENCE; DESIGN; SCANS; STATISTICS	Importance Low-dose computed tomography (CT) screening was shown to reduce lung cancer-specific mortality in a large randomized trial of a high-risk population. The decision to pursue CT screening for lung cancer is a timely question raised by individuals at risk of lung cancer and by their health care practitioners. Objectives To discuss the evidence for use of chest x-rays and low-dose CT in screening for lung cancer; to describe potential benefits, harms, and uncertainties of CT screening; and to review current guidelines for CT screening. Evidence Review MEDLINE and the Cochrane Library were searched from 1984 to 2012. Additional citations were obtained from lists of references from select research and review articles on this topic. Evidence was graded using the American Hospital Association level of evidence guidelines. Findings Low-dose CT screening has been associated with a 20% reduction in lung cancer mortality in a large randomized controlled trial (National Lung Screening Trial [NLST]) of a high-risk population. Mortality data have not yet been reported for 5 other randomized controlled trials, and the sample sizes were too small to detect a meaningful difference in 2 other completed trials. A major risk of CT screening is a high false-positive rate, with associated risks and costs associated with follow-up CT scans and the potential for more invasive diagnostic procedures. Published guidelines for screening indicate a consensus that screening may be indicated for individuals who meet entry criteria for the NLST, but some guidelines expand their recommendations for screening beyond these criteria. Conclusions and Relevance Individuals at high risk of lung cancer who meet the criteria for CT screening in published guidelines should participate in an informed and shared decision-making process by discussing the potential benefits, harms, and uncertainties of screening with their physicians. JAMA. 2013; 309(11):1163-1170 www.jama.com	[Boiselle, Phillip M.] Harvard Univ, Sch Med, Boston, MA USA; [Boiselle, Phillip M.] Beth Israel Deaconess Med Ctr, Dept Radiol, Ctr Airway Imaging, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Boiselle, PM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave,TCC 4, Boston, MA 02215 USA.	pboisell@bidmc.harvard.edu	Aberle, Denise R./D-5699-2014	Aberle, Denise R./0000-0002-8858-3401				Aberle DR, 2012, J THORAC IMAG, V27, P208, DOI 10.1097/RTI.0b013e318253d74d; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Armato SG, 2002, RADIOLOGY, V225, P685, DOI 10.1148/radiol.2253011376; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Becker NDS, 2008, ONKOLOGIE, V31, P320; BOUCOT KR, 1973, JAMA-J AM MED ASSOC, V224, P1361, DOI 10.1001/jama.224.10.1361; Chirikos TN, 2002, CHEST, V121, P1507, DOI 10.1378/chest.121.5.1507; Croswell JM, 2010, SEMIN ONCOL, V37, P202, DOI 10.1053/j.seminoncol.2010.05.006; Diederich S, 2002, RADIOLOGY, V222, P773, DOI 10.1148/radiol.2223010490; Donnelly EF, 2012, J THORAC IMAG, V27, P224, DOI 10.1097/RTI.0b013e3182568019; EBELING K, 1987, INT J CANCER, V40, P141, DOI 10.1002/ijc.2910400202; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gierada DS, 2008, RADIOLOGY, V246, P265, DOI 10.1148/radiol.2461062097; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Infante M, 2011, J THORAC ONCOL, V6, P327, DOI 10.1097/JTO.0b013e318200f523; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; KUBIK A, 1990, NEOPLASMA, V37, P467; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Li F, 2002, RADIOLOGY, V225, P673, DOI 10.1148/radiol.2253011375; Livingston Edward H, 2012, JAMA, V308, P1599, DOI 10.1001/jama.2012.4090; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Paoletti L, 2012, J THORAC IMAG, V27, P213, DOI 10.1097/RTI.0b013e3182518673; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Schroeder SA, 2012, JAMA-J AM MED ASSOC, V308, P1586, DOI 10.1001/jama.2012.13858; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh S, 2011, RADIOLOGY, V259, P263, DOI 10.1148/radiol.10101254; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; STRAUSS GM, 1995, CHEST, V107, pS270, DOI 10.1378/chest.107.6_Supplement.270S; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; van den Bergh KAM, 2008, CANCER, V113, P396, DOI 10.1002/cncr.23590; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2011, J THORAC IMAG, V26, P4, DOI 10.1097/RTI.0b013e31820badb3; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; White CS, 2011, J THORAC IMAG, V26, P86, DOI 10.1097/RTI.0b013e3182172745; Wisnivesky JP, 2003, CHEST, V124, P614, DOI 10.1378/chest.124.2.614; Wood DE, 2012, J THORAC IMAG, V27, P211, DOI 10.1097/RTI.0b013e318256c22f; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	54	49	54	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1163	1170		10.1001/jama.2012.216988	http://dx.doi.org/10.1001/jama.2012.216988			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512063				2022-12-28	WOS:000316276500030
J	Stremler, R; Hodnett, E; Kenton, L; Lee, K; Weiss, S; Weston, J; Willan, A				Stremler, Robyn; Hodnett, Ellen; Kenton, Laura; Lee, Kathryn; Weiss, Shelly; Weston, Julie; Willan, Andrew			Effect of behavioural-educational intervention on sleep for primiparous women and their infants in early postpartum: multisite randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTNATAL DEPRESSION; PATTERNS; NIGHT; ACTIGRAPHY; PREGNANCY; FRAGMENTATION; PERFORMANCE; COGNITIONS; CHILDREN; INSOMNIA	Objective To evaluate the effectiveness of a behavioural-educational sleep intervention delivered in the early postpartum in improving maternal and infant sleep. Design Randomised controlled trial. Setting Postpartum units of two university affiliated hospitals. Participants 246 primiparous women and their infants randomised while in hospital with an internet based randomisation service to intervention (n=123) or usual care (n=123) groups. Interventions The behavioural-educational sleep intervention included a 45-60 minute meeting with a nurse to discuss sleep information and strategies to promote maternal and infant sleep, a 20 page booklet with the content discussed, and phone contacts at one, two, and four weeks postpartum to reinforce information, provide support, and problem solve. The usual care group received calls at weeks one, two, and four to maintain contact without provision of advice. Main outcome measures Primary outcome was maternal nocturnal (9 pm to 9 am) sleep (minutes) and secondary outcome was longest stretch of infant nocturnal sleep (minutes) measured at six and 12 weeks postpartum by actigraphy. Other outcomes measured at six and 12 weeks were number of maternal and infant night time awakenings by actigraphy, fatigue visual analogue scale, general sleep disturbance scale, and Edinburgh postnatal depression scale. Rates of exclusive breast feeding were measured at 12 weeks postpartum only. Results All women who completed any outcome measures at six or 12 weeks were included in analysis. Sleep outcomes were completed at one or both of six and 12 weeks postpartum for 215 of 246 (87%) women (110/123 intervention and 105/123 usual care). Longitudinal mixed effects model analyses indicated no significant differences between the groups on any of the outcomes. The estimated mean difference in maternal nocturnal sleep between the intervention and usual care groups was 5.97 minutes (95% confidence interval -7.55 to 19.5 minutes, P=0.39). No differences in any outcomes were noted based on the specific nurse delivering the intervention or the number of phone contacts received. Conclusion A behavioural-educational intervention delivered in the early postpartum, in hospital, and in the first weeks at home, was ineffective in improving maternal and infant sleep or other health outcomes in the first months postpartum.	[Stremler, Robyn; Hodnett, Ellen; Kenton, Laura; Weston, Julie] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5T 1P8, Canada; [Stremler, Robyn; Weiss, Shelly; Willan, Andrew] Hosp Sick Children SickKids, Toronto, ON, Canada; [Lee, Kathryn] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Weiss, Shelly] Univ Toronto, Dept Pediat, Toronto, ON M5T 1P8, Canada; [Willan, Andrew] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 1P8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Francisco; University of Toronto; University of Toronto	Stremler, R (corresponding author), Univ Toronto, Lawrence S Bloomberg Fac Nursing, 155 Coll St, Toronto, ON M5T 1P8, Canada.	robyn.stremler@utoronto.ca	杜, 美晨/S-4063-2016	杜, 美晨/0000-0002-1562-1155	Canadian Institutes of Health research [MCT 84658]; Canadian Institutes of Health Research new investigator award; Ontario Ministry of Research and Innovation early researcher award	Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research new investigator award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation early researcher award(Ministry of Research and Innovation, Ontario)	This work was funded by a Canadian Institutes of Health research grant (No MCT 84658). This trial was conducted and data analysed with complete independence of the researchers from the Canadian Institutes of Health Research. RS is recipient of a Canadian Institutes of Health Research new investigator award and an Ontario Ministry of Research and Innovation early researcher award.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bandura A, 1995, SELF EFFICACY CHANGI, DOI DOI 10.1017/CBO9780511527692; Bonnet MH., 2005, SLEEP DEPRIVATION BA, P103; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; CARSKADON MA, 1982, SLEEP, V5, pS73, DOI 10.1093/sleep/5.S2.S73; Coleman Jr J, 2006, SLEEP; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dinges DF, 1997, SLEEP, V20, P267; Dorsey CM, 2004, CLIN THER, V26, P1578, DOI 10.1016/j.clinthera.2004.10.003; Fisher J, 2004, Arch Womens Ment Health, V7, P89, DOI 10.1007/s00737-003-0041-5; Hiscock H, 2001, PEDIATRICS, V107, P1317, DOI 10.1542/peds.107.6.1317; LABBOK M, 1990, STUD FAMILY PLANN, V21, P226, DOI 10.2307/1966617; Lee K A, 1999, J Obstet Gynecol Neonatal Nurs, V28, P183, DOI 10.1111/j.1552-6909.1999.tb01983.x; Lee KA, 2000, OBSTET GYNECOL, V95, P14, DOI 10.1016/S0029-7844(99)00486-X; LEE KA, 1992, SLEEP, V15, P493, DOI 10.1093/sleep/15.6.493; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lee KA, 2011, RES NURS HEALTH, V34, P7, DOI 10.1002/nur.20413; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; McQueen A, 2003, J ADV NURS, V42, P463, DOI 10.1046/j.1365-2648.2003.02645.x; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Nishihara K, 1998, PERCEPT MOTOR SKILL, V87, P1043, DOI 10.2466/pms.1998.87.3.1043; PINILLA T, 1993, PEDIATRICS, V91, P436; Robert C, 2007, SCIENTOMETRICS, V73, P231, DOI 10.1007/s11192-007-1780-2; SADEH A, 1995, INFANT BEHAV DEV, V18, P329, DOI 10.1016/0163-6383(95)90021-7; Sadeh A, 1996, SLEEP, V19, P757, DOI 10.1093/sleep/19.10.757; SADEH A, 1991, PEDIATRICS, V87, P494; Sadeh A, 2007, J FAM PSYCHOL, V21, P74, DOI 10.1037/0893-3200.21.1.74; Signal TL, 2007, AUST NZ J OBSTET GYN, V47, P16, DOI 10.1111/j.1479-828X.2006.00672.x; So K, 2005, PEDIATR RES, V58, P761, DOI 10.1203/01.PDR.0000180568.97221.56; St James-Roberts I, 2001, J PAEDIATR CHILD H, V37, P289, DOI 10.1046/j.1440-1754.2001.00699.x; STEPANSKI E, 1984, SLEEP, V7, P18, DOI 10.1093/sleep/7.1.18; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Stremler R, 2006, SLEEP, V29, P1609, DOI 10.1093/sleep/29.12.1609; Swain AM, 1997, OBSTET GYNECOL, V90, P381, DOI 10.1016/S0029-7844(97)89252-6; Symon BG, 2005, MED J AUSTRALIA, V182, P215, DOI 10.5694/j.1326-5377.2005.tb06669.x; Teti DM, 2012, CHILD DEV, V83, P939, DOI 10.1111/j.1467-8624.2012.01760.x; Tikotzky L, 2009, CHILD DEV, V80, P860, DOI 10.1111/j.1467-8624.2009.01302.x; Touchette E, 2005, ARCH PEDIAT ADOL MED, V159, P242, DOI 10.1001/archpedi.159.3.242; Troy Nancy Wieland, 2003, MCN Am J Matern Child Nurs, V28, P252, DOI 10.1097/00005721-200307000-00009; Tsai SY, 2009, INFANT BEHAV DEV, V32, P340, DOI 10.1016/j.infbeh.2009.02.002; WOLFSON A, 1992, J CONSULT CLIN PSYCH, V60, P41, DOI 10.1037/0022-006X.60.1.41; Wolfson Amy R, 2003, Behav Sleep Med, V1, P54, DOI 10.1207/S15402010BSM0101_6; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	44	64	65	4	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1164	10.1136/bmj.f1164	http://dx.doi.org/10.1136/bmj.f1164			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516146	hybrid, Green Published			2022-12-28	WOS:000316671500001
J	Dell'Angela, M; Anniyev, T; Beye, M; Coffee, R; Fohlisch, A; Gladh, J; Katayama, T; Kaya, S; Krupin, O; LaRue, J; Mogelhoj, A; Nordlund, D; Norskov, JK; Oberg, H; Ogasawara, H; Ostrom, H; Pettersson, LGM; Schlotter, WF; Sellberg, JA; Sorgenfrei, F; Turner, JJ; Wolf, M; Wurth, W; Nilsson, A				Dell'Angela, M.; Anniyev, T.; Beye, M.; Coffee, R.; Foehlisch, A.; Gladh, J.; Katayama, T.; Kaya, S.; Krupin, O.; LaRue, J.; Mogelhoj, A.; Nordlund, D.; Norskov, J. K.; Oberg, H.; Ogasawara, H.; Ostrom, H.; Pettersson, L. G. M.; Schlotter, W. F.; Sellberg, J. A.; Sorgenfrei, F.; Turner, J. J.; Wolf, M.; Wurth, W.; Nilsson, A.			Real-Time Observation of Surface Bond Breaking with an X-ray Laser	SCIENCE			English	Article							EMISSION SPECTROSCOPY; DESORPTION-KINETICS; MOLECULAR-MOTION; METAL-SURFACES; CO; DYNAMICS; ADSORPTION; RU(001)	We used the Linac Coherent Light Source free-electron x-ray laser to probe the electronic structure of CO molecules as their chemisorption state on Ru(0001) changes upon exciting the substrate by using a femtosecond optical laser pulse. We observed electronic structure changes that are consistent with a weakening of the CO interaction with the substrate but without notable desorption. A large fraction of the molecules (30%) was trapped in a transient precursor state that would precede desorption. We calculated the free energy of the molecule as a function of the desorption reaction coordinate using density functional theory, including van der Waals interactions. Two distinct adsorption wells-chemisorbed and precursor state separated by an entropy barrier-explain the anomalously high prefactors often observed in desorption of molecules from metals.	[Dell'Angela, M.; Sorgenfrei, F.; Wurth, W.] Univ Hamburg, D-22761 Hamburg, Germany; [Dell'Angela, M.; Sorgenfrei, F.; Wurth, W.] Ctr Free Electron Laser Sci, D-22761 Hamburg, Germany; [Anniyev, T.; Beye, M.; Katayama, T.; Kaya, S.; LaRue, J.; Sellberg, J. A.; Nilsson, A.] SLAC Natl Accelerator Lab, SIMES, Menlo Pk, CA 94025 USA; [Beye, M.; Foehlisch, A.] Mat & Energie GmbH, Helmholtz Zentrum Berlin, Inst Methods & Instrumentat Synchrotron Radiat Re, D-12489 Berlin, Germany; [Coffee, R.; Krupin, O.; Schlotter, W. F.; Turner, J. J.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Foehlisch, A.] Univ Potsdam, Inst Phys & Astron, D-14476 Golm, Germany; [Gladh, J.; Oberg, H.; Ostrom, H.; Pettersson, L. G. M.; Sellberg, J. A.; Nilsson, A.] Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden; [Krupin, O.] European Xray Free Electron Laser XFEL GmbH, D-22761 Hamburg, Germany; [Mogelhoj, A.; Norskov, J. K.; Nilsson, A.] SLAC Natl Accelerator Lab, Sustainable Energy Catalysis SUNCAT Ctr Interface, Menlo Pk, CA 94025 USA; [Mogelhoj, A.] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design CAMD, DK-2800 Lyngby, Denmark; [Nordlund, D.; Ogasawara, H.; Nilsson, A.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Norskov, J. K.] Stanford Univ, Dept Chem Engn, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 95305 USA; [Wolf, M.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	University of Hamburg; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Potsdam; Stockholm University; European XFEL; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Technical University of Denmark; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Max Planck Society; Fritz Haber Institute of the Max Planck Society	Nilsson, A (corresponding author), SLAC Natl Accelerator Lab, SIMES, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	nilsson@slac.stanford.edu	Nordlund, Dennis/A-8902-2008; Norskov, Jens K/D-2539-2017; Wolf, Martin/Q-3548-2016; Kaya, Sarp/C-4001-2008; Ogasawara, Hirohito/AAC-8754-2020; Beye, Martin/F-1165-2011; Gladh, Jörgen/W-3493-2017; Ogasawara, Hirohito/D-2105-2009; Ogasawara, Hirohito/AGU-4579-2022; Sellberg, Jonas A/C-6506-2009; LaRue, Jerry/N-9047-2017; Pettersson, Lars GM/J-4925-2013; Nilsson, Anders/E-1943-2011	Nordlund, Dennis/0000-0001-9524-6908; Norskov, Jens K/0000-0002-4427-7728; Kaya, Sarp/0000-0002-2591-5843; Beye, Martin/0000-0002-3924-2993; Gladh, Jörgen/0000-0002-5389-5675; Ogasawara, Hirohito/0000-0001-5338-1079; Ogasawara, Hirohito/0000-0001-5338-1079; Sellberg, Jonas A/0000-0003-2793-5052; LaRue, Jerry/0000-0002-8081-5335; Pettersson, Lars GM/0000-0003-1133-9934; Nilsson, Anders/0000-0003-1968-8696; Sorgenfrei, Nomi Lucia Ada Nathalie/0000-0001-9179-8895; Alexander, Fohlisch/0000-0003-4126-8233; Dell'Angela, Martina/0000-0003-1228-2458	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; DOE, Basic Energy Science through the SUNCAT Center for Interface Science and Catalysis; Swedish National Research Council; Danish Center for Scientific Computing; Volkswagen Stiftung; Alexander von Humboldt Foundation; Lundbeck Foundation; LCLS; Stanford University through SIMES; Lawrence Berkeley National Laboratory, University of Hamburg through the BMBF [FSP 301]; Center for Free Electron Laser Science	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); DOE, Basic Energy Science through the SUNCAT Center for Interface Science and Catalysis; Swedish National Research Council; Danish Center for Scientific Computing; Volkswagen Stiftung(Volkswagen); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Lundbeck Foundation(Lundbeckfonden); LCLS; Stanford University through SIMES; Lawrence Berkeley National Laboratory, University of Hamburg through the BMBF; Center for Free Electron Laser Science	This work is supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract DE-AC02-76SF00515; the DOE, Basic Energy Science through the SUNCAT Center for Interface Science and Catalysis; the Swedish National Research Council; the Danish Center for Scientific Computing; the Volkswagen Stiftung; the Alexander von Humboldt Foundation; and the Lundbeck Foundation. The spectrum calculations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the High Performance Computing Center North. Portions of this research were carried out on the SXR Instrument at LCLS, a division of SLAC National Accelerator Laboratory and an Office of Science user facility operated by Stanford University for the DOE. The SXR Instrument is funded by a consortium whose membership includes the LCLS, Stanford University through SIMES, Lawrence Berkeley National Laboratory, University of Hamburg through the BMBF priority program FSP 301, and the Center for Free Electron Laser Science.	Arnolds H, 2010, SURF SCI REP, V65, P45, DOI 10.1016/j.surfrep.2009.12.001; Backus EHG, 2005, SCIENCE, V310, P1790, DOI 10.1126/science.1120693; Bartels L, 2004, SCIENCE, V305, P648, DOI 10.1126/science.1099770; BJORNEHOLM O, 1992, PHYS REV B, V46, P10353, DOI 10.1103/PhysRevB.46.10353; Bonn M, 2000, PHYS REV LETT, V84, P4653, DOI 10.1103/PhysRevLett.84.4653; CASSUTO A, 1981, SURF SCI, V102, P388, DOI 10.1016/0039-6028(81)90036-4; Chorkendorf I., 2003, CONCEPTS MODERN CATA; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; DOREN DJ, 1988, LANGMUIR, V4, P256, DOI 10.1021/la00080a004; DOREN DJ, 1991, J CHEM PHYS, V94, P8428, DOI 10.1063/1.460076; Fohlisch A, 2000, J CHEM PHYS, V112, P1946, DOI 10.1063/1.480773; Fohlisch A, 2004, J CHEM PHYS, V121, P4848, DOI 10.1063/1.1778380; Fournier F, 2004, J CHEM PHYS, V121, P4839, DOI 10.1063/1.1778138; Frischkorn C, 2006, CHEM REV, V106, P4207, DOI 10.1021/cr050161r; HUNT JH, 1987, CHEM PHYS LETT, V133, P189, DOI 10.1016/0009-2614(87)87049-5; Inoue K, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733720; Keller C, 1998, PHYS REV LETT, V80, P1774, DOI 10.1103/PhysRevLett.80.1774; KISLIUK P, 1957, J PHYS CHEM SOLIDS, V3, P95, DOI 10.1016/0022-3697(57)90054-9; Lane IM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.186105; Nilsson A, 2004, SURF SCI REP, V55, P49, DOI 10.1016/j.surfrep.2004.06.002; Nilsson A, 1997, PHYS REV LETT, V78, P2847, DOI 10.1103/PhysRevLett.78.2847; PFNUR H, 1983, J CHEM PHYS, V79, P4613, DOI 10.1063/1.446378; Shen YR, 2003, PRINCIPLES NONLINEAR; Skytt P, 1997, PHYS REV A, V55, P134, DOI 10.1103/PhysRevA.55.134; Taylor JB, 1933, PHYS REV, V44, P0423, DOI 10.1103/PhysRev.44.423; Wellendorff J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235149	26	155	155	2	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1302	1305		10.1126/science.1231711	http://dx.doi.org/10.1126/science.1231711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493709				2022-12-28	WOS:000316053400033
J	Misteli, T				Misteli, Tom			The Cell Biology of Genomes: Bringing the Double Helix to Life	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; ORGANIZATION; CHROMATIN	The recent ability to routinely probe genome function at a global scale has revolutionized our view of genomes. One of the most important realizations from these approaches is that the functional output of genomes is affected by the nuclear environment in which they exist. Integration of sequence information with molecular and cellular features of the genome promises a fuller understanding of genome function.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Due to space limitations, mostly review articles were cited. Work in the author's laboratory is supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research.	Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010	13	50	50	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1209	1212		10.1016/j.cell.2013.02.048	http://dx.doi.org/10.1016/j.cell.2013.02.048			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498929	Green Accepted, Bronze			2022-12-28	WOS:000316192500002
J	Antunes, H; Pereira, A; Cunha, I				Antunes, Henedina; Pereira, Angela; Cunha, Isabel			Chediak-Higashi syndrome: pathognomonic feature	LANCET			English	Editorial Material									[Antunes, Henedina; Pereira, Angela; Cunha, Isabel] Hosp Braga, Dept Paediat, P-4701901 Braga, Portugal; [Antunes, Henedina] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Antunes, Henedina] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Hospital de Braga; Universidade do Minho	Antunes, H (corresponding author), Hosp Braga, Dept Paediat, Sete Fontes,Apartado 2056, P-4701901 Braga, Portugal.	henedinaantunes@gmail.com		Antunes, Henedina/0000-0002-1035-0173					0	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1514	1514		10.1016/S0140-6736(13)60020-3	http://dx.doi.org/10.1016/S0140-6736(13)60020-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	23541537	Green Published			2022-12-28	WOS:000326622500029
J	Treasure, J; Schmidt, U				Treasure, Janet; Schmidt, Ulrike			DBS for treatment-refractory anorexia nervosa	LANCET			English	Editorial Material									[Treasure, Janet; Schmidt, Ulrike] Kings Coll London, Inst Psychiat, Sect Eating Disorders, London SE5 8AF, England	University of London; King's College London	Treasure, J (corresponding author), Kings Coll London, Inst Psychiat, Sect Eating Disorders, London SE5 8AF, England.	janet.treasure@kcl.ac.uk		Treasure, Janet/0000-0003-0871-4596				Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Blomstedt P, 2013, WORLD NEUROSURG, V80, pE245, DOI 10.1016/j.wneu.2012.10.006; Butterfly Foundation, 2012, PAYING PRIC EC SOC I; Guillaume S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023578; Kaye WH, 2011, CURR TOP BEHAV NEURO, V6, P37, DOI 10.1007/7854_2010_85; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Lipsman N, 2013, LANCET; Schmidt U, 2012, BRIT J PSYCHIAT, V201, P392, DOI 10.1192/bjp.bp.112.112078; Stiles-Shields C, 2012, REV RECENT CLIN TRIA, V7, P133, DOI 10.2174/157488712800100242; Treasure J, 2011, BRIT J PSYCHIAT, V199, P5, DOI 10.1192/bjp.bp.110.087585; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; van der Plasse G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033455; Wu HM, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.06.039; Zahodne LB, 2011, J NEUROPSYCH CLIN N, V23, P56, DOI 10.1176/appi.neuropsych.23.1.56	14	11	11	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1338	1339		10.1016/S0140-6736(13)60057-4	http://dx.doi.org/10.1016/S0140-6736(13)60057-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23473848				2022-12-28	WOS:000317894800007
J	Fink, HA; Wilt, TJ; Eidman, KE; Garimella, PS; MacDonald, R; Rutks, IR; Brasure, M; Kane, RL; Ouellette, J; Monga, M				Fink, Howard A.; Wilt, Timothy J.; Eidman, Keith E.; Garimella, Pranav S.; MacDonald, Roderick; Rutks, Indulis R.; Brasure, Michelle; Kane, Robert L.; Ouellette, Jeannine; Monga, Manoj			Medical Management to Prevent Recurrent Nephrolithiasis in Adults: A Systematic Review for an American College of Physicians Clinical Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							CALCIUM-OXALATE UROLITHIASIS; INCIDENT KIDNEY-STONES; LOW-ANIMAL-PROTEIN; ACETOHYDROXAMIC ACID; SHOCKWAVE LITHOTRIPSY; SECONDARY PREVENTION; RANDOMIZED-TRIALS; POTASSIUM CITRATE; DIETARY CALCIUM; ALKALI CITRATE	Background: Optimum management to prevent recurrent kidney stones is uncertain. Purpose: To evaluate the benefits and harms of interventions to prevent recurrent kidney stones. Data Sources: MEDLINE, Cochrane, and other databases through September 2012 and reference lists of systematic reviews and randomized, controlled trials (RCTs). Study Selection: 28 English-language RCTs that studied treatments to prevent recurrent kidney stones and reported stone outcomes. Data Extraction: One reviewer extracted data, a second checked accuracy, and 2 independently rated quality and graded strength of evidence. Data Synthesis: In patients with 1 past calcium stone, low-strength evidence showed that increased fluid intake halved recurrent composite stone risk compared with no treatment (relative risk [RR], 0.45 [95% CI, 0.24 to 0.84]). Low-strength evidence showed that reducing soft-drink consumption decreased recurrent symptomatic stone risk (RR, 0.83 [CI, 0.71 to 0.98]). In patients with multiple past calcium stones, most of whom were receiving increased fluid intake, moderate-strength evidence showed that thiazides (RR, 0.52 [CI, 0.39 to 0.69]), citrates (RR, 0.25 [CI, 0.14 to 0.44]), and allopurinol (RR, 0.59 [CI, 0.42 to 0.84]) each further reduced composite stone recurrence risk compared with placebo or control, although the benefit from allopurinol seemed limited to patients with baseline hyperuricemia or hyperuricosuria. Other baseline biochemistry measures did not allow prediction of treatment efficacy. Low-strength evidence showed that neither citrate nor allopurinol combined with thiazide was superior to thiazide alone. There were few withdrawals among patients with increased fluid intake, many among those with other dietary interventions and more among those who received thiazide and citrate than among control patients. Reporting of adverse events was poor. Limitations: Most trial participants had idiopathic calcium stones. Nearly all studies reported a composite (including asymptomatic) stone recurrence outcome. Conclusion: In patients with 1 past calcium stone, increased fluid intake reduced recurrence risk. In patients with multiple past calcium stones, addition of thiazide, citrate, or allopurinol further reduced risk.	Univ Minnesota, Minneapolis Vet Affairs Med Ctr, Minnesota Evidence Based Practice Ctr, Minneapolis, MN USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Hennepin County Medical Center; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University; Cleveland Clinic Foundation	Fink, HA (corresponding author), Minneapolis Vet Affairs Med Ctr 11 G, 1 Vet Dr, Minneapolis, MN 55417 USA.	howard.fink@va.gov	Garimella, Pranav/D-4256-2013	Garimella, Pranav/0000-0002-6016-4715	Agency for Healthcare Research and Quality; AHRQ [HHSA 290 2007 10064 1]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; By contract HHSA 290 2007 10064 1 from AHRQ to the Minnesota Evidence-based Practice Center.; Dr. Fink: Grant (money to institution): AHRQ; Payment for writing or reviewing the manuscript: American College of Physicians; Travel/accommodations/meeting expenses unrelated to activities listed: USPSTF. Dr. Wilt: Grant (money to author and institution): AHRQ. Dr. Eidman: Grant (money to institution): AHRQ. Dr. Brasure: Grant (money to institution): AHRQ. Dr. Monga: Grant (money to institution): AHRQ; Payment for lectures, including service on speakers bureaus: Mission Pharmacal. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M12-0883.	Ahlstrand C, 1996, PROPHYLACTIC TREATME; Bansal AD, 2009, CLIN J AM SOC NEPHRO, V4, P680, DOI 10.2215/CJN.05181008; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Becker G, 2007, NEPHROLOGY, V12, pS4, DOI 10.1111/j.1440-1797.2006.00722.x; Becker G, 2007, NEPHROLOGY, V12, pS21, DOI 10.1111/j.1440-1797.2007.00774.x; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; BORGHI L, 1993, J CARDIOVASC PHARM, V22, pS78; Boyce CJ, 2010, J UROLOGY, V183, P1017, DOI 10.1016/j.juro.2009.11.047; BROCKS P, 1981, LANCET, V2, P124, DOI 10.1016/S0140-6736(81)90302-0; Burgher A, 2004, J ENDOUROL, V18, P534; Ciacci C, 2008, J UROLOGY, V180, P974, DOI 10.1016/j.juro.2008.05.007; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Dussol B, 2008, NEPHRON CLIN PRACT, V110, pC185, DOI 10.1159/000167271; Escribano J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004754.pub2; ETTINGER B, 1988, J UROLOGY, V139, P679, DOI 10.1016/S0022-5347(17)42599-7; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Fernandez-Rodriguez A, 2006, Actas Urol Esp, V30, P305; Fink HA, 2009, EUR UROL, V56, P72, DOI 10.1016/j.eururo.2009.03.031; GLOWACKI LS, 1992, J UROLOGY, V147, P319, DOI 10.1016/S0022-5347(17)37225-7; GRIFFITH DP, 1988, J UROLOGY, V140, P318, DOI 10.1016/S0022-5347(17)41592-8; GRIFFITH DP, 1991, EUR UROL, V20, P243; Hiatt RA, 1996, AM J EPIDEMIOL, V144, P25, DOI 10.1093/oxfordjournals.aje.a008851; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOFBAUER J, 1994, BRIT J UROL, V73, P362, DOI 10.1111/j.1464-410X.1994.tb07597.x; Inci K, 2007, J UROLOGY, V177, P2189, DOI 10.1016/j.juro.2007.01.154; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kairaitis L, 2007, NEPHROLOGY, V12, pS11, DOI 10.1111/j.1440-1797.2006.00723.x; Kocvara R, 1999, BJU INT, V84, P393; KOHRI K, 1990, UROLOGY, V36, P309, DOI 10.1016/0090-4295(90)80235-F; Kramer HM, 2002, AM J KIDNEY DIS, V40, P37, DOI 10.1053/ajkd.2002.33911; LAERUM E, 1984, SCAND J UROL NEPHROL, V18, P143, DOI 10.3109/00365598409182182; LAERUM E, 1984, ACTA MED SCAND, V215, P383; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; Lojanapiwat B, 2011, INT BRAZ J UROL, V37, P611, DOI 10.1590/S1677-55382011000500007; Mattle D, 2005, UROL RES, V33, P73, DOI 10.1007/s00240-005-0464-8; Miano L, 1985, UROLITHIASIS RELATED, P521; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; MORTENSEN J T, 1986, International Urology and Nephrology, V18, P265, DOI 10.1007/BF02082712; OHKAWA M, 1992, BRIT J UROL, V69, P571, DOI 10.1111/j.1464-410X.1992.tb15624.x; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Pearle MS, 1999, J ENDOUROL, V13, P679, DOI 10.1089/end.1999.13.679; Premgamone Amorn, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P654; Robertson WG, 1985, MULTICENTRE TRIAL EV; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Sarica K, 2006, UROL RES, V34, P184, DOI 10.1007/s00240-006-0040-x; SCHOLZ D, 1982, J UROLOGY, V128, P903, DOI 10.1016/S0022-5347(17)53269-3; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; SHUSTER J, 1992, J CLIN EPIDEMIOL, V45, P911, DOI 10.1016/0895-4356(92)90074-W; SMITH MJV, 1983, P EUR DIAL TRANS, V20, P422; SMITH MJV, 1977, J UROLOGY, V117, P690, DOI 10.1016/S0022-5347(17)58588-2; Soygur T, 2002, J ENDOUROL, V16, P149, DOI 10.1089/089277902753716098; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taylor EN, 2008, KIDNEY INT, V73, P207, DOI 10.1038/sj.ki.5002588; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Taylor EN, 2004, J AM SOC NEPHROL, V15, P3225, DOI 10.1097/01.ASN.0000146012.44570.20; Trochim W., REGRESSION MEAN; URIBARRI J, 1989, ANN INTERN MED, V111, P1006, DOI 10.7326/0003-4819-111-12-1006; Wagner CA, 2010, J NEPHROL, V23, pS165; WILLIAMS JJ, 1984, NEW ENGL J MED, V311, P760, DOI 10.1056/NEJM198409203111203	68	172	179	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					535	+		10.7326/0003-4819-158-7-201304020-00005	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00005			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546565				2022-12-28	WOS:000317419400004
J	Kind, J; Pagie, L; Ortabozkoyun, H; Boyle, S; de Vries, SS; Janssen, H; Amendola, M; Nolen, LD; Bickmore, WA; van Steensel, B				Kind, Jop; Pagie, Ludo; Ortabozkoyun, Havva; Boyle, Shelagh; de Vries, Sandra S.; Janssen, Hans; Amendola, Mario; Nolen, Leisha D.; Bickmore, Wendy A.; van Steensel, Bas			Single-Cell Dynamics of Genome-Nuclear Lamina Interactions	CELL			English	Article							HISTONE H3; CHROMATIN DYNAMICS; EARLY G1; METHYLATION; G9A; HETEROCHROMATIN; MITOSIS; GENES; POSITIONS; DOMAINS	The nuclear lamina (NL) interacts with hundreds of large genomic regions termed lamina associated domains (LADs). The dynamics of these interactions and the relation to epigenetic modifications are poorly understood. We visualized the fate of LADs in single cells using a "molecular contact memory" approach. In each nucleus, only similar to 30% of LADs are positioned at the periphery; these LADs are in intermittent molecular contact with the NL but remain constrained to the periphery. Upon mitosis, LAD positioning is not detectably inherited but instead is stochastically reshuffled. Contact of individual LADs with the NL is linked to transcriptional repression and H3K9 dimethylation in single cells. Furthermore, we identify the H3K9 methyltransferase G9a as a regulator of NL contacts. Collectively, these results highlight principles of the dynamic spatial architecture of chromosomes in relation to gene regulation.	[Kind, Jop; Pagie, Ludo; Ortabozkoyun, Havva; de Vries, Sandra S.; Amendola, Mario; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Janssen, Hans] Netherlands Canc Inst, Electron Microscopy Facil, NL-1066 CX Amsterdam, Netherlands; [Boyle, Shelagh; Nolen, Leisha D.; Bickmore, Wendy A.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Edinburgh	Kind, J (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.kind@nki.nl; b.v.steensel@nki.nl	t, lf/AAJ-4924-2020; amendola, mario/I-1728-2017; Bickmore, Wendy/C-7314-2013	amendola, mario/0000-0002-1188-8856; Bickmore, Wendy/0000-0001-6660-7735	EMBO LTF; NWO-ALW VENI; NWO-ALW VICI; ERC Advanced grant [293662, 249956]; MRC; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish; MRC [MC_PC_U127527202] Funding Source: UKRI	EMBO LTF(European Molecular Biology Organization (EMBO)); NWO-ALW VENI(Netherlands Organization for Scientific Research (NWO)); NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); ERC Advanced grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Wouter Meuleman for help with FISH probe pool design; Federica Morettini for the scoring of FISH images; the NKI Genomics Core Facility for microarray hybridizations and RNA-seq; and the Wolthuis and Neefjes laboratories for reagents. This work was supported by EMBO LTF and NWO-ALW VENI (J.K.), NWO-ALW VICI and ERC Advanced grant 293662 (B.v.S.), and MRC and ERC Advanced grant 249956 (W.A.B.).	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hermann A, 2003, BIOTECHNIQUES, V34, P924, DOI 10.2144/03345bm05; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lionnet T, 2012, EMBO REP, V13, P313, DOI 10.1038/embor.2012.31; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Siwek W, 2012, NUCLEIC ACIDS RES, V40, P7563, DOI 10.1093/nar/gks428; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106	49	434	447	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					178	192		10.1016/j.cell.2013.02.028	http://dx.doi.org/10.1016/j.cell.2013.02.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23523135	Bronze			2022-12-28	WOS:000316853700015
J	Morita, M; Kuba, K; Ichikawa, A; Nakayama, M; Katahira, J; Iwamoto, R; Watanebe, T; Sakabe, S; Daidoji, T; Nakamura, S; Kadowaki, A; Ohto, T; Nakanishi, H; Taguchi, R; Nakaya, T; Murakami, M; Yoneda, Y; Arai, H; Kawaoka, Y; Penninger, JM; Arita, M; Imai, Y				Morita, Masayuki; Kuba, Keiji; Ichikawa, Akihiko; Nakayama, Mizuho; Katahira, Jun; Iwamoto, Ryo; Watanebe, Tokiko; Sakabe, Saori; Daidoji, Tomo; Nakamura, Shota; Kadowaki, Ayumi; Ohto, Takayo; Nakanishi, Hiroki; Taguchi, Ryo; Nakaya, Takaaki; Murakami, Makoto; Yoneda, Yoshihiro; Arai, Hiroyuki; Kawaoka, Yoshihiro; Penninger, Josef M.; Arita, Makoto; Imai, Yumiko			The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza	CELL			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; INFLAMMATION; RESOLUTION; PATHWAYS; REVEALS; MICE; SEQ; EXPRESSION; DEPENDENCE	Influenza A viruses are a major cause of mortality. Given the potential for future lethal pandemics, effective drugs are needed for the treatment of severe influenza such as that caused by H5N1 viruses. Using mediator lipidomics and bioactive lipid screen, we report that the omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediator protectin D1 (PD1) markedly attenuated influenza virus replication via RNA export machinery. Production of PD1 was suppressed during severe influenza and PD1 levels inversely correlated with the pathogenicity of H5N1 viruses. Suppression of PD1 was genetically mapped to 12/15-lipoxygenase activity. Importantly, PD1 treatment improved the survival and pathology of severe influenza in mice, even under conditions where known antiviral drugs fail to protect from death. These results identify the endogenous lipid mediator PD1 as an innate suppressor of influenza virus replication that protects against lethal influenza virus infection.	[Morita, Masayuki; Kuba, Keiji; Ichikawa, Akihiko; Nakayama, Mizuho; Kadowaki, Ayumi; Ohto, Takayo; Imai, Yumiko] Akita Univ, Dept Biol Informat & Expt Therapeut, Grad Sch Med, Akita 0108543, Japan; [Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Biomol Networks Labs, Biomol Dynam Lab, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Nakamura, Shota] Osaka Univ, Dept Infect Metagen, Microbial Dis Res Inst, Osaka 5650871, Japan; [Iwamoto, Ryo; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Dept Hlth Chem, Tokyo 1130033, Japan; [Iwamoto, Ryo] Univ Tokyo, Business Acad Collaborat Lab, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Tokyo 1130033, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Watanebe, Tokiko; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Watanebe, Tokiko; Sakabe, Saori; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Madison, WI 53711 USA; [Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kyoto 6028566, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Tokyo 1568506, Japan; [Penninger, Josef M.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria	Akita University; Osaka University; Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison; Kyoto Prefectural University of Medicine; Tokyo Metropolitan Institute of Medical Science; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Imai, Y (corresponding author), Akita Univ, Dept Biol Informat & Expt Therapeut, Grad Sch Med, Akita 0108543, Japan.	imai@med.akita-u.ac.jp	Penninger, Josef M/I-6860-2013; Imai, Yumiko/GXW-1144-2022; Nakamura, Shota/E-3033-2010	Penninger, Josef M/0000-0002-8194-3777; Nakamura, Shota/0000-0003-2058-5942; Katahira, Jun/0000-0001-5188-0368; Arita, Makoto/0000-0001-9902-0463; Nakanishi, Hiroki/0000-0002-5108-1598	Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS); Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases; Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology; ERATO (Japan Science and Technology Agency); Public Health Service research grants from the National Institute of Allergy and Infectious Diseases; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; IMBA; Advanced ERC grant; European Union; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS); Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases; Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology; ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Public Health Service research grants from the National Institute of Allergy and Infectious Diseases; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IMBA; Advanced ERC grant; European Union(European Commission); Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all members of our laboratories for helpful discussions. We gratefully thank Ms. Michiko Kamio for technical assistance on LC-MS/MS analyses. Y.I. and K.K. are supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS). Y.K. is supported by the "Center of Education and Research for the Advanced Genome-Based Medicine-For Personalized Medicine and the Control of Worldwide Infectious Diseases,'' by a grant-in-aid for Specially Promoted Research and by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, by ERATO (Japan Science and Technology Agency), and by Public Health Service research grants from the National Institute of Allergy and Infectious Diseases. M.A. is supported by a grant-in-aid from the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO), and a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. J.M.P. is supported by IMBA and an Advanced ERC grant by the European Union. H.A. and M.A. are supported in part by the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry.	Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Arya V, 2010, CLIN PHARMACOL THER, V88, P587, DOI 10.1038/clpt.2010.187; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Chanez P, 2002, AM J RESP CELL MOL, V27, P655, DOI 10.1165/rcmb.F253; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Herold A, 2001, RNA, V7, P1768; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Ho DN, 2002, P NATL ACAD SCI USA, V99, P1888, DOI 10.1073/pnas.042698599; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kumar A, 2011, J ANTIMICROB CHEMOTH, V66, P959, DOI 10.1093/jac/dkr090; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodriguez-Navarro S, 2011, CURR OPIN CELL BIOL, V23, P302, DOI 10.1016/j.ceb.2010.12.002; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2003, CHEM IMMUNOL, V83, P115; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Sly PD, 2003, J APPL PHYSIOL, V94, P1460, DOI 10.1152/japplphysiol.00596.2002; Smith JH, 2011, VIRAL IMMUNOL, V24, P131, DOI 10.1089/vim.2010.0085; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10	51	314	324	4	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					112	125		10.1016/j.cell.2013.02.027	http://dx.doi.org/10.1016/j.cell.2013.02.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23477864	Bronze			2022-12-28	WOS:000316853700010
J	Swan, A; Cockerill, M; Sipp, D				Swan, Alma; Cockerill, Matthew; Sipp, Douglas			How to hasten open access	NATURE			English	Editorial Material									[Swan, Alma] Scholarly Publishing & Acad Resources Coalit SPAR, European Advocacy, Apeldoorn, Netherlands; [Cockerill, Matthew] BioMed Cent, London, England; [Sipp, Douglas] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan	RIKEN	Swan, A (corresponding author), Scholarly Publishing & Acad Resources Coalit SPAR, European Advocacy, Apeldoorn, Netherlands.		Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Cockerill, Matthew/0000-0002-3435-1082					0	4	4	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					442	443						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113QN	23538813	Bronze			2022-12-28	WOS:000316682800019
J	Velykoredko, Y; Adam, DN				Velykoredko, Yuliya; Adam, David N.			PICTURE QUIZ Painful blisters on the hand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISTAL DACTYLITIS; ADULT		[Velykoredko, Yuliya] Univ Toronto, Fac Med, Toronto, ON, Canada; [Adam, David N.] St Michaels Hosp, Dept Med, Div Dermatol, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Adam, DN (corresponding author), St Michaels Hosp, Dept Med, Div Dermatol, Toronto, ON M5B 1W8, Canada.	david.adam@utoronto.ca	Adam, David/AFQ-0352-2022					Adams Brian B, 2008, Dermatol Nurs, V20, P39; [Anonymous], 2003, CBC SPORTS; BENSON PM, 1987, J AM ACAD DERMATOL, V17, P310, DOI 10.1016/S0190-9622(87)80333-X; Clarkson M., 2003, TORONTO STAR; Fretzayas A, 2011, PEDIATR DERMATOL, V28, P433, DOI 10.1111/j.1525-1470.2011.01312.x; Lyon M, 2004, J EMERG MED, V26, P421, DOI 10.1016/j.jemermed.2003.08.015; MCCRAY MK, 1981, J AM ACAD DERMATOL, V5, P592, DOI 10.1016/S0190-9622(81)70122-1; Ney AC, 2002, CUTIS, V69, P46; NORCROSS MC, 1993, CUTIS, V51, P353; PARRAS F, 1988, CUTIS, V41, P127; SCHNEIDER JA, 1982, ARCH DERMATOL, V118, P879, DOI 10.1001/archderm.1982.01650230007013; Tlougan BE, 2011, SPORTS MED, V41, P967, DOI 10.2165/11592190-000000000-00000; Wolff K, 2009, FITZPATRICKS COLOUR; Woroszylski A, 1996, PEDIATR DERMATOL, V13, P292, DOI 10.1111/j.1442-200X.1996.tb02869.x	14	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1753	10.1136/bmj.f1753	http://dx.doi.org/10.1136/bmj.f1753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WO	23532869				2022-12-28	WOS:000316984000014
J	Arnoult, L; Su, KFY; Manoel, D; Minervino, C; Magrina, J; Gompel, N; Prud'homme, B				Arnoult, Laurent; Su, Kathy F. Y.; Manoel, Diogo; Minervino, Caroline; Magrina, Justine; Gompel, Nicolas; Prud'homme, Benjamin			Emergence and Diversification of Fly Pigmentation Through Evolution of a Gene Regulatory Module	SCIENCE			English	Article							DROSOPHILA; PATTERNS	The typical pattern of morphological evolution associated with the radiation of a group of related species is the emergence of a novel trait and its subsequent diversification. Yet the genetic mechanisms associated with these two evolutionary steps are poorly characterized. Here, we show that a spot of dark pigment on fly wings emerged from the assembly of a novel gene regulatory module in which a set of pigmentation genes evolved to respond to a common transcriptional regulator determining their spatial distribution. The primitive wing spot pattern subsequently diversified through changes in the expression pattern of this regulator. These results suggest that the genetic changes underlying the emergence and diversification of wing pigmentation patterns are partitioned within genetic networks.	[Arnoult, Laurent; Su, Kathy F. Y.; Manoel, Diogo; Minervino, Caroline; Magrina, Justine; Gompel, Nicolas; Prud'homme, Benjamin] Aix Marseille Univ, CNRS, UMR 7288, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gompel, N (corresponding author), Aix Marseille Univ, CNRS, UMR 7288, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France.	nicolas.gompel@univ-amu.fr; benjamin.prudhomme@univ-amu.fr		Gompel, Nicolas/0000-0003-3358-7963; Manoel, Diogo/0000-0002-0353-1742	French government (Ministere de la Recherche de l'Enseignement Superieur); Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia); GABBA graduate program; Fondation ARC pour la Recherche sur le Cancer; EURYI award; Human Frontier Science Program Career Development Award; Agence Nationale de la Recherche; France-Berkeley Fund; Fondation Schlumberger pour l'Enseignement et la Recherche; CNRS	French government (Ministere de la Recherche de l'Enseignement Superieur); Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); GABBA graduate program; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); EURYI award(European Science Foundation (ESF)); Human Frontier Science Program Career Development Award; Agence Nationale de la Recherche(French National Research Agency (ANR)); France-Berkeley Fund; Fondation Schlumberger pour l'Enseignement et la Recherche(Schlumberger); CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank A. Kopp, S. B. Carroll, J. David, R. Mann, A. Mazo, M. Yamaguchi, and the Vienna Drosophila RNAi Center (VDRC, Vienna), Bloomington (Indiana), National Center of Genetics (Kyoto), and San Diego Drosophila Stock Centers for flies and antibodies; A. Polette and L. Mille for developing a custom quantification program for wing pigmentation; J.-L. Mari for advice on programming; G. Storelli for help with cloning; A. Defaye for qPCR guidance; J.-Y. Sgro for microarray analysis; A. Kopp, F. Leulier, and J. Cande for helpful comments on the manuscript; Flybase for information support; and Le Calendal for logistical support. L.A. and K.F.Y.S. were supported by fellowships from the French government (Ministere de la Recherche de l'Enseignement Superieur), D.M. by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) and the GABBA graduate program, and K.F.Y.S. by the Fondation ARC pour la Recherche sur le Cancer. This work was funded by a EURYI award, a Human Frontier Science Program Career Development Award, the Agence Nationale de la Recherche, the France-Berkeley Fund, the Fondation Schlumberger pour l'Enseignement et la Recherche, and the CNRS. RNAi lines from the VDRC are covered by a Materiels Transfer Agreement. The microarray data set is accessible in the National Center for Biotechnology Information Gene Expression Omnibus database (accession no. GSE43673). Author contributions: B.P. and N.G. conceived the project; all authors designed the experiments; K.F.Y.S. and D.M. performed the RNAi screen; K.F.Y.S., D.M., and L.A. did the antibody stainings; K.F.Y.S., L.A., D.M., C.M., and B.P. cloned the molecular constructs; and D.M. and B.P. ran the biochemistry experiments. L.A. designed and carried out the shRNA experiments in D. biarmipes, did the qPCR analysis, optimized transgenesis, and developed the wing-peeling technique. L.A. and N.G. quantified the effects on pigmentation; K.F.Y.S., L.A., D.M., J.M., N.G., and B.P. made transgenic flies; L.A., N.G., and K.F.Y.S. took the images; all authors analyzed the data; and B.P. and N.G. wrote the paper, with feedback from L.A. and the other authors.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Campbell G, 1998, DEVELOPMENT, V125, P4483; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4	11	98	101	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2013	339	6126					1423	1426		10.1126/science.1233749	http://dx.doi.org/10.1126/science.1233749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520110				2022-12-28	WOS:000316740700040
J	Lewis, P; Al-Muthanna, AN; Patel, P				Lewis, Philip; Al-Muthanna, Ali Nasser; Patel, Preeti		Baroness Nicholson	Effect of armed conflict on health of Marsh Arabs in southern Iraq	LANCET			English	Editorial Material									[Lewis, Philip; Patel, Preeti] Kings Coll London, Dept War Studies, London WC2R 2LS, England; [Al-Muthanna, Ali Nasser] AMAR Int Charitable Fdn, London, England; [Baroness Nicholson] House Lords, London SW1A 0PW, England	University of London; King's College London	Lewis, P (corresponding author), House Lords, London SW1A 0PW, England.			Patel, Preeti/0000-0003-3875-453X				[Anonymous], 2010, MAN CHANG PRES FUT S, P1; Coast E, 2002, IRAQI MARSHLANDS HUM, P19; Ibrahim MH, 2011, MARSH B, V6, P167; Inter-Agency Information and Analysis Unit, 2011, BASR GOV PROF; Inter-Agency Information and Analysis Unit, 2012, WOM IR FACTSH; Inter-Agency Information and Analysis Unit, 2011, MISS GOV PROF; Inter-Agency Information and Analysis Unit, 2011, THI QAR GOV PROF; Inter-Agency Information and Analysis Unit, 2012, LANDM UN ORDN FACTSH; Inter-Agency Information and Analysis Unit, 2009, MARSHL PRES; IOM, 2012, IR SPEC REP WAT SCAR; Iraq Knowledge Network, 2011, FOOD SEC EXP FACTSH; Iraq Knowledge Network, 2011, ESS SERV FACTSH; Newman SD, 2007, ADV NURS SCI, V30, P315, DOI 10.1097/01.ANS.0000300181.71724.c7; Sluglett P, 2002, IRAQI MARSHLANDS HUM, P223; UN Country Team Iraq, 2010, UN DEV ASS FRAM IR 2; *UNEP, 2007, UNEP IR POST CONFL A; United Nations Committee on Economic Social and Cultural Rights, 2000, RIGHT HIGH ATT STAND; United Nations Integrated Water Task Force for Iraq PaPer, 2011, MAN CHANG MARSHL IR; World Health Organization, 2008, SOCIAL DETERMINANTS	19	0	0	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					959	961		10.1016/S0140-6736(13)60282-2	http://dx.doi.org/10.1016/S0140-6736(13)60282-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499044				2022-12-28	WOS:000316069700031
J	MacManus, D; Dean, K; Jones, M; Rona, RJ; Greenberg, N; Hull, L; Fahy, T; Wessely, S; Fear, NT				MacManus, Deirdre; Dean, Kimberlie; Jones, Margaret; Rona, Roberto J.; Greenberg, Neil; Hull, Lisa; Fahy, Tom; Wessely, Simon; Fear, Nicola T.			Violent offending by UK military personnel deployed to Iraq and Afghanistan: a data linkage cohort study	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; COMBAT; WAR; VETERANS; ALCOHOL; TRAUMA; PTSD; AGGRESSION; HOSTILITY	Background Violent off ending by veterans of the Iraq and Afghanistan conflicts is a cause for concern and there is much public debate about the proportion of ex-military personnel in the criminal justice system for violent offences. Although the psychological effects of conflict are well documented, the potential legacy of violent off ending has yet to be ascertained. We describe our use of criminal records to investigate the effect of deployment, combat, and post-deployment mental health problems on violent off ending among military personnel relative to pre-existing risk factors. Methods In this cohort study, we linked data from 13 856 randomly selected, serving and ex-serving UK military personnel with national criminal records stored on the Ministry of Justice Police National Computer database. We describe off ending during the lifetime of the participants and assess the risk factors for violent off ending. Findings 2139 (weighted 17.0%) of 12 359 male UK military personnel had a criminal record for any offence during their lifetime. Violent off enders (1369 [11.0%]) were the most prevalent off ender types; prevalence was highest in men aged 30 years or younger (521 [20.6%] of 2728) and fell with age (164 [4.7%] of 3027 at age >45 years). Deployment was not independently associated with increased risk of violent off ending, but serving in a combat role conferred an additional risk, even after adjustment for confounders (violent off ending in 137 [6.3%] of 2178 men deployed in a combat role vs 140 (2.4%) of 5797 deployed in a non-combat role; adjusted hazard ratio 1.53, 95% CI 1.15-2.03; p=0.003). Increased exposure to traumatic events during deployment also increased risk of violent off ending (violent off ending in 104 [4.1%] of 2753 men with exposure to two to four traumatic events vs 56 [1.6%] of 2944 with zero to one traumatic event, 1.77, 1.21-2.58, p=0.003; and violent off ending in 122 [5.1%] of 2582 men with exposure to five to 16 traumatic events, 1.65, 1.12-2.40, p=0.01; test for trend, p=0.032). Violent off ending was strongly associated with post-deployment alcohol misuse (violent off ending in 120 [9.0%] of 1363 men with alcohol misuse vs 155 [2.3%] of 6768 with no alcohol misuse; 2.16, 1.62-2.90; p<0.0001), post-traumatic stress disorder (violent off ending in 25 [8.6%] of 344 men with post-traumatic stress disorder vs 221 [3.0%] of 7256 with no symptoms of post-traumatic stress disorder; 2.20, 1.36-3.55; p=0.001), and high levels of self-reported aggressive behaviour (violent off ending in 56 [6.7%] of 856 men with an aggression score of six to 16 vs 22 [1.2%] of 1685 with an aggression score of zero; 2.47, 1.37-4.46; p=0.003). Of the post-traumatic stress disorder symptoms, the hyperarousal cluster was most strongly associated with violent off ending (2.01, 1.50-2.70; p<0.0001). Interpretation Alcohol misuse and aggressive behaviour might be appropriate targets for interventions, but any action must be evidence based. Post-traumatic stress disorder, though less prevalent, is also a risk factor for violence, especially hyperarousal symptoms, so if diagnosed it should be appropriately treated and associated risk monitored.	[MacManus, Deirdre; Jones, Margaret; Rona, Roberto J.; Greenberg, Neil; Hull, Lisa; Wessely, Simon; Fear, Nicola T.] Kings Coll London, Weston Educ Ctr, Kings Ctr Mil Hlth Res, London SE5 8AF, England; [MacManus, Deirdre; Dean, Kimberlie; Fahy, Tom] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London SE5 8AF, England; [Dean, Kimberlie] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Greenberg, Neil] Weston Educ Ctr, Acad Ctr Def Mental Hlth, London, England	University of London; King's College London; University of London; King's College London; University of New South Wales Sydney; University of London; King's College London	MacManus, D (corresponding author), Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, PO 23,De Crespigny Pk, London SE5 8AF, England.	deirdre.macmanus@kcl.ac.uk	Wessely, Simon C/A-8713-2008; Fear, Nicola/A-1917-2012	Fear, Nicola/0000-0002-5792-2925; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571; Fahy, Thomas/0000-0003-3019-3547; Jones, Margaret Mary/0000-0002-7450-8195; MacManus, Deirdre/0000-0003-4903-9638; greenberg, neil/0000-0003-4550-2971	Medical Research Council; UK Ministry of Defence; Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre; UK Medical Research Council; MRC [G0901999] Funding Source: UKRI; Medical Research Council [G0901999] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Ministry of Defence; Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding Medical Research Council and the UK Ministry of Defence.; NG is a full-time member of the UK Armed Forces, and is currently seconded to King's College London. NTF and SW are employed by the Academic Centre for Defence Mental Health, based at King's College London, which receives funding from the UK Ministry of Defence. SW is also an honorary civilian consultant adviser in psychiatry to the British Army and a trustee of Combat Stress, a UK charity that provides service and support for veterans with mental health problems. The authors acknowledge financial support from the Department of Health through the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. DM is funded by a Medical Research Council Clinical Research Training Fellowship and undertook this project as part of her PhD studies with the King's Centre for Military Health Research. KD and TF are employed by the Institute of Psychiatry and are forensic psychiatrists who provide supervision and advice about the project; they declare that they have no conflicts of interest.; The UK Medical Research Council and UK Ministry of Defence funded this study.	Alvarey L, 2009, NEW YORK TIMES  0101; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Association of Chief Police Officers, 2012, ACPO CRIM REC OFF AN; Australian Centre for Posttraumatic Mental Health, 2012, SUMM LIT DSM 5 CHANG; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Black DW, 2005, MIL MED, V170, P612, DOI 10.7205/MILMED.170.7.612; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese P., 2004, VALIDATION 90 120 DA; Booth-Kewley S, 2010, AGGRESSIVE BEHAV, V36, P330, DOI 10.1002/ab.20355; Booth-Kewley S, 2010, J NERV MENT DIS, V198, P91, DOI 10.1097/NMD.0b013e3181cc45e9; Brooke C, 2012, MAIL ONLINE LON 0403; Bureau of Justice Statistics, 2004, VET STAT FED PRIS 20; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fontana A, 2005, J NERV MENT DIS, V193, P203, DOI 10.1097/01.nmd.0000154835.92962.e5; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Graham K, 2011, DRUG ALCOHOL REV, V30, P453, DOI 10.1111/j.1465-3362.2011.00340.x; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; House of Commons Defence Select Committee, DUT CAR 3 SESS 2004, V2; Howard League for Penal Reform, 2011, INQ FORM ARM SERV PE; Institute of Medicine, 2010, RETURNING HOME IRAQ; Iversen A, 2005, EUR J PUBLIC HEALTH, V15, P175, DOI 10.1093/eurpub/cki128; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; JOHNSTONE JWC, 1978, SOCIOL SOC RES, V63, P49; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; MacManus D, 2012, SOC PSYCH PSYCH EPID, V47, P1353, DOI 10.1007/s00127-011-0443-z; MacManus D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3898; Maden T., 2007, TREATING VIOLENCE GU; Malvern J., 2012, TIMES LONDON    0313; Miller MW, 2004, J ABNORM PSYCHOL, V113, P636, DOI 10.1037/0021-843X.113.4.636; Ministry of Defence, 2000, MIDT REV NDP8, P5; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Prime J., 2001, CRIMINAL CAREERS THO; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Taft CT, 2007, J TRAUMA STRESS, V20, P135, DOI 10.1002/jts.20197; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Therneau TM, 2000, MODELING SURVIVAL DA; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tsai J, 2013, PSYCHIAT SERV, V64, P36, DOI [10.1176/appi.ps.201200188, 10.1176/appi.ps.001882012]; Turpin J, 1999, ENCY VIOLENCE PEACE, P144; UK Defence Statistics UK Ministry of Defence, DEF AN STAT ADV	45	134	134	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					907	917		10.1016/S0140-6736(13)60354-2	http://dx.doi.org/10.1016/S0140-6736(13)60354-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499041				2022-12-28	WOS:000316069700026
J	Price, BD; D'Andrea, AD				Price, Brendan D.; D'Andrea, Alan D.			Chromatin Remodeling at DNA Double-Strand Breaks	CELL			English	Review							HISTONE H2AX PHOSPHORYLATION; DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; KAP-1 PHOSPHORYLATION; H4-K16 ACETYLATION; REPAIR; NUCLEOSOME; VARIANT; PROTEIN; TIP60	DNA double-strand breaks (DSBs) can arise from multiple sources, including exposure to ionizing radiation. The repair of DSBs involves both posttranslational modification of nucleosomes and concentration of DNA-repair proteins at the site of damage. Consequently, nucleosome packing and chromatin architecture surrounding the DSB may limit the ability of the DNA-damage response to access and repair the break. Here, we review early chromatin-based events that promote the formation of open, relaxed chromatin structures at DSBs and that allow the DNA-repair machinery to access the spatially confined region surrounding the DSB, thereby facilitating mammalian DSB repair.	[Price, Brendan D.; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol,Div Genom Stabil & DNA Repair, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol,Div Genom Stabil & DNA Repair, 450 Brookline Ave, Boston, MA 02215 USA.	alan_dandrea@dfci.harvard.edu			NIH [CA64585, CA93602, RO1-DK43889]; NATIONAL CANCER INSTITUTE [R01CA064585, R01CA093602, R01CA177884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants CA64585 and CA93602 to B.D.P. and grant RO1-DK43889 to A.D.D.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Billon P, 2012, BBA-GENE REGUL MECH, V1819, P290, DOI 10.1016/j.bbagrm.2011.10.004; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1978, BIOCHEMISTRY-US, V17, P2377, DOI 10.1021/bi00605a020; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	100	381	387	0	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1344	1354		10.1016/j.cell.2013.02.011	http://dx.doi.org/10.1016/j.cell.2013.02.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498941	Green Accepted, Bronze			2022-12-28	WOS:000316192500014
J	Schroeder, SA; Frist, W				Schroeder, Steven A.; Frist, William		Natl Commission Phys Payment Refor	Phasing Out Fee-for-Service Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIAN; CARE; TELEMEDICINE		[Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Frist, William] Vanderbilt Univ, Dept Surg, Sch Med, Nashville, TN 37240 USA; [Frist, William] Meharry Med Coll, Nashville, TN 37208 USA	University of California System; University of California San Francisco; Vanderbilt University; Meharry Medical College	Schroeder, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							American Medical Association, 2012, RUC MEMB EFF JUL 1 2; Cummings J, 2007, AM J MED QUAL, V22, P239, DOI 10.1177/1062860607302777; Fortney JC, 2007, J GEN INTERN MED, V22, P1086, DOI 10.1007/s11606-007-0201-9; Ginsburg PB, 2012, HEALTH AFFAIR, V31, P1977, DOI 10.1377/hlthaff.2012.0350; Golden AG, 2010, GERONTOLOGIST, V50, P451, DOI 10.1093/geront/gnq015; Harris G., 2010, NY TIMES, P61; Isaacs SL, 2009, NEW ENGL J MED, V360, P655, DOI 10.1056/NEJMp0808076; Jain Manoj, 2012, WASH POST, pE1; Laugesen MJ, 2012, HEALTH AFFAIR, V31, P965, DOI 10.1377/hlthaff.2011.0557; Laugesen MJ, 2011, HEALTH AFFAIR, V30, P1647, DOI 10.1377/hlthaff.2010.0204	10	110	110	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					2029	2032		10.1056/NEJMsb1302322	http://dx.doi.org/10.1056/NEJMsb1302322			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148TJ	23534546				2022-12-28	WOS:000319270200007
J	Janssen, HLA; Reesink, HW; Lawitz, EJ; Zeuzem, S; Rodriguez-Torres, M; Patel, K; van der Meer, AJ; Patick, AK; Chen, A; Zhou, Y; Persson, R; King, BD; Kauppinen, S; Levin, AA; Hodges, MR				Janssen, Harry L. A.; Reesink, Hendrik W.; Lawitz, Eric J.; Zeuzem, Stefan; Rodriguez-Torres, Maribel; Patel, Keyur; van der Meer, Adriaan J.; Patick, Amy K.; Chen, Alice; Zhou, Yi; Persson, Robert; King, Barney D.; Kauppinen, Sakari; Levin, Arthur A.; Hodges, Michael R.			Treatment of HCV Infection by Targeting MicroRNA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; IN-VIVO; VIRUS-RNA; EXPRESSION; GENOTYPE; METASTASIS; MIR-122; ANTAGONISM	BACKGROUND The stability and propagation of hepatitis C virus (HCV) is dependent on a functional interaction between the HCV genome and liver-expressed microRNA-122 (miR-122). Miravirsen is a locked nucleic acid-modified DNA phosphorothioate antisense oligonucleotide that sequesters mature miR-122 in a highly stable heteroduplex, thereby inhibiting its function. METHODS In this phase 2a study at seven international sites, we evaluated the safety and efficacy of miravirsen in 36 patients with chronic HCV genotype 1 infection. The patients were randomly assigned to receive five weekly subcutaneous injections of miravirsen at doses of 3 mg, 5 mg, or 7 mg per kilogram of body weight or placebo over a 29-day period. They were followed until 18 weeks after randomization. RESULTS Miravirsen resulted in a dose-dependent reduction in HCV RNA levels that endured beyond the end of active therapy. In the miravirsen groups, the mean maximum reduction in HCV RNA level (log(10) IU per milliliter) from baseline was 1.2 (P = 0.01) for patients receiving 3 mg per kilogram, 2.9 (P = 0.003) for those receiving 5 mg per kilogram, and 3.0 (P = 0.002) for those receiving 7 mg per kilogram, as compared with a reduction of 0.4 in the placebo group. During 14 weeks of follow-up after treatment, HCV RNA was not detected in one patient in the 5-mg group and in four patients in the 7-mg group. We observed no dose-limiting adverse events and no escape mutations in the miR-122 binding sites of the HCV genome. CONCLUSIONS The use of miravirsen in patients with chronic HCV genotype 1 infection showed prolonged dose-dependent reductions in HCV RNA levels without evidence of viral resistance. (Funded by Santaris Pharma; ClinicalTrials.gov number, NCT01200420.)	[Janssen, Harry L. A.; van der Meer, Adriaan J.] Erasmus MC Univ Hosp, Rotterdam, Netherlands; [Reesink, Hendrik W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Janssen, Harry L. A.] Univ Hlth Network, Toronto Western & Gen Hosp, Toronto, ON M5T 2S8, Canada; [Lawitz, Eric J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Zeuzem, Stefan] JW Goethe Univ Hosp, Frankfurt, Germany; [Rodriguez-Torres, Maribel] Fdn Invest, San Juan, PR USA; [Patel, Keyur; Zhou, Yi] Duke Univ, Durham, NC USA; [Patick, Amy K.; Chen, Alice; Persson, Robert; King, Barney D.; Kauppinen, Sakari; Levin, Arthur A.; Hodges, Michael R.] Santaris Pharma, San Diego, CA USA	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Texas System; University of Texas Health San Antonio; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Duke University	Janssen, HLA (corresponding author), Univ Hlth Network, Div Gastroenterol, Francis Family Liver Clin, 399 Bathurst St,6B Fell Pavil,Room 164, Toronto, ON M5T 2S8, Canada.	harry.janssen@uhn.ca	Zeuzem, Stefan/AAE-7435-2019		Santaris Pharma	Santaris Pharma	Supported by Santaris Pharma.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Crooke ST, 2008, ANTISENSE DRUG TECHN, P365; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Garchow BG, 2011, EMBO MOL MED, V3, P605, DOI 10.1002/emmm.201100171; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hildebrandt-Eriksen ES, 2009, HEPATOLOGY S, V50, p228A; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; World Health Organization, IN VACC RES	33	1583	1652	3	210	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1685	1694		10.1056/NEJMoa1209026	http://dx.doi.org/10.1056/NEJMoa1209026			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23534542				2022-12-28	WOS:000318214400002
J	Canzio, D; Liao, MF; Naber, N; Pate, E; Larson, A; Wu, SP; Marina, DB; Garcia, JF; Madhani, HD; Cooke, R; Schuck, P; Cheng, YF; Narlikar, GJ				Canzio, Daniele; Liao, Maofu; Naber, Nariman; Pate, Edward; Larson, Adam; Wu, Shenping; Marina, Diana B.; Garcia, Jennifer F.; Madhani, Hiten D.; Cooke, Roger; Schuck, Peter; Cheng, Yifan; Narlikar, Geeta J.			A conformational switch in HP1 releases auto-inhibition to drive heterochromatin assembly	NATURE			English	Article							HISTONE H3; SHADOW DOMAIN; SELF-ASSOCIATION; FAMILY PROTEINS; LYSINE 9; CHROMODOMAIN; METHYLATION; PARTICLE; BINDING; VISUALIZATION	A hallmark of histone H3 lysine 9 (H3K9)-methylated heterochromatin, conserved from the fission yeast Schizosaccharomyces pombe to humans, is its ability to spread to adjacent genomic regions(1-6). Central to heterochromatin spread is heterochromatin protein 1 (HP1), which recognizes H3K9-methylated chromatin, oligomerizes and forms a versatile platform that participates in diverse nuclear functions, ranging from gene silencing to chromosome segregation(1-6). How HP1 proteins assemble on methylated nucleosomal templates and how the HP1-nucleosome complex achieves functional versatility remain poorly understood. Here we show that binding of the key S. pombe HP1 protein, Swi6, to methylated nucleosomes drives a switch from an auto-inhibited state to a spreading-competent state. In the auto-inhibited state, a histonemimic sequence in one Swi6 monomer blocks methyl-mark recognition by the chromodomain of another monomer. Auto-inhibition is relieved by recognition of two template features, the H3K9 methyl mark and nucleosomal DNA. Cryo-electron-microscopy-based reconstruction of the Swi6-nucleosome complex provides the overall architecture of the spreading-competent state in which two unbound chromodomain sticky ends appear exposed. Disruption of the switch between the auto-inhibited and spreading-competent states disrupts heterochromatin assembly and gene silencing in vivo. These findings are reminiscent of other conditionally activated polymerization processes, such as actin nucleation, and open up a new class of regulatory mechanisms that operate on chromatin in vivo.	[Canzio, Daniele; Liao, Maofu; Naber, Nariman; Larson, Adam; Wu, Shenping; Marina, Diana B.; Garcia, Jennifer F.; Madhani, Hiten D.; Cooke, Roger; Cheng, Yifan; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Canzio, Daniele] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Pate, Edward] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Larson, Adam; Marina, Diana B.; Garcia, Jennifer F.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Schuck, Peter] Nat Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington State University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	geeta.narlikar@ucsf.edu	Schuck, Peter/AAA-6888-2020; Garcia, Jennifer/HDN-4569-2022; Liao, Maofu/AAD-7333-2021	Schuck, Peter/0000-0002-8859-6966; Liao, Maofu/0000-0002-3481-450X; Garcia, Jennifer/0000-0002-0620-0594; Cheng, Yifan/0000-0001-9535-0369; Madhani, Hiten/0000-0001-7400-6657	Hillblom foundation; American Cancer Society; Leukemia and Lymphoma Society; National Institutes of Health (NIH) [R01GM071801, AR053720]; UCSF Program for Breakthrough Biomedical Research; NIBIB, NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053720, R01AR062279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	Hillblom foundation; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; NIBIB, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Tretyakova for preparation of histone proteins and J. Leonard for sample preparation for cryo-electron microscopy of nucleosome alone. We thank W. Lim, M. Simon, K. Armache, J. Zalatan, L. Racki and members of the Narlikar laboratory for discussions. D.C. would like to thank I. Ortiz Torres and K. M. Kuchenbecker for scientific discussions and members of the Schuck laboratory for advice on AUC approaches. This work was supported by a grant from the Hillblom foundation to D.C., by grants from the American Cancer Society and Leukemia and Lymphoma Society to G.J.N., National Institutes of Health (NIH) grant R01GM071801 to H.D.M. and by a New Technology Award to Y.C. from the UCSF Program for Breakthrough Biomedical Research. P.S. was supported by the Intramural Research Program of the NIBIB, NIH. N.N. and E.P. were supported by the NIH grant AR053720.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Keller C, 2012, MOL CELL; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Li XM, 2010, J STRUCT BIOL, V172, P407, DOI 10.1016/j.jsb.2010.06.010; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purcell TJ, 2011, J MOL BIOL, V407, P79, DOI 10.1016/j.jmb.2010.11.053; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Simon M.D., 2010, CURR PROTOCOLS MOL B, VChapter 21, pUNIT 21.18.1, DOI [10.1002/0471142727.mb2118s90, DOI 10.1002/0471142727.MB2118S90]; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Yamada T, 1999, J BIOCHEM, V125, P832, DOI 10.1093/oxfordjournals.jbchem.a022356; Zhao T, 2000, J BIOL CHEM, V275, P28332	40	96	97	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					377	+		10.1038/nature12032	http://dx.doi.org/10.1038/nature12032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23485968	Green Accepted			2022-12-28	WOS:000317599200041
J	Thompson, RC; Allam, AH; Lombardi, GP; Wann, LS; Sutherland, ML; Sutherland, JD; Soliman, MA; Frohlich, B; Mininberg, DT; Monge, JM; Vallodolid, CM; Cox, SL; Abd el-Maksoud, G; Badr, I; Miyamoto, MI; el-Din, AEN; Narula, J; Finch, CE; Thomas, GS				Thompson, Randall C.; Allam, Adel H.; Lombardi, Guido P.; Wann, L. Samuel; Sutherland, M. Linda; Sutherland, James D.; Soliman, Muhammad Al-Tohamy; Frohlich, Bruno; Mininberg, David T.; Monge, Janet M.; Vallodolid, Clide M.; Cox, Samantha L.; Abd el-maksoud, Gomaa; Badr, Ibrahim; Miyamoto, Michael I.; el-Din, Abd el-Halim Nur; Narula, Jagat; Finch, Caleb E.; Thomas, Gregory S.			Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations	LANCET			English	Article							EGYPTIAN MUMMIES; LESIONS	Background Atherosclerosis is thought to be a disease of modern human beings and related to contemporary lifestyles. However, its prevalence before the modern era is unknown. We aimed to evaluate preindustrial populations for atherosclerosis. Methods We obtained whole body CT scans of 137 mummies from four different geographical regions or populations spanning more than 4000 years. Individuals from ancient Egypt, ancient Peru, the Ancestral Puebloans of southwest America, and the Unangan of the Aleutian Islands were imaged. Atherosclerosis was regarded as definite if a calcified plaque was seen in the wall of an artery and probable if calcifications were seen along the expected course of an artery. Findings Probable or definite atherosclerosis was noted in 47 (34%) of 137 mummies and in all four geographical populations: 29 (38%) of 76 ancient Egyptians, 13 (25%) of 51 ancient Peruvians, two (40%) of five Ancestral Puebloans, and three (60%) of five Unangan hunter gatherers (p=NS). Atherosclerosis was present in the aorta in 28 (20%) mummies, iliac or femoral arteries in 25 (18%), popliteal or tibial arteries in 25 (18%), carotid arteries in 17 (12%), and coronary arteries in six (4%). Of the five vascular beds examined, atherosclerosis was present in one to two beds in 34 (25%) mummies, in three to four beds in 11 (8%), and in all five vascular beds in two (1%). Age at time of death was positively correlated with atherosclerosis (mean age at death was 43 [SD 10] years for mummies with atherosclerosis vs 32 [15] years for those without; p<0.0001) and with the number of arterial beds involved (mean age was 32 [SD 15] years for mummies with no atherosclerosis, 42 [10] years for those with atherosclerosis in one or two beds, and 44 [8] years for those with atherosclerosis in three to five beds; p<0.0001). Interpretation Atherosclerosis was common in four preindustrial populations including preagricultural hunter-gatherers. Although commonly assumed to be a modern disease, the presence of atherosclerosis in premodern human beings raises the possibility of a more basic predisposition to the disease.	[Thompson, Randall C.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Thompson, Randall C.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Allam, Adel H.] Azhar Med Sch, Cairo, Egypt; [Lombardi, Guido P.] Catedra Pedro Weiss, Lab Paleopatol, Lima, Peru; [Lombardi, Guido P.] Univ Peruana Cayetano Heredia, Lima, Peru; [Wann, L. Samuel] Columbia St Marys Healthcare, Milwaukee, WI USA; [Sutherland, M. Linda] Newport Diagnost Ctr, Newport Beach, CA USA; [Sutherland, James D.] South Coast Radiol Med Grp, Laguna Hills, CA USA; [Soliman, Muhammad Al-Tohamy] Natl Res Ctr, Giza, Egypt; [Frohlich, Bruno] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Mininberg, David T.] Metropolitan Museum Art, New York, NY 10028 USA; [Mininberg, David T.] Weill Cornell Med Coll, New York, NY USA; [Monge, Janet M.; Cox, Samantha L.] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Vallodolid, Clide M.] Museo Sitio Puruchuco Arturo Jimenez Borja, Lima, Peru; [Cox, Samantha L.] Univ Cambridge, Cambridge, England; [Abd el-maksoud, Gomaa; el-Din, Abd el-Halim Nur] Cairo Univ, Cairo, Egypt; [Badr, Ibrahim] Inst Restorat, Alexandria, Egypt; [Miyamoto, Michael I.] Mission Internal Med Grp, Mission Viejo, CA USA; [el-Din, Abd el-Halim Nur] Univ Sci & Technol, 6th October City, Egypt; [Narula, Jagat] Mt Sinai, New York, NY USA; [Finch, Caleb E.] Univ So Calif, Los Angeles, CA USA; [Thomas, Gregory S.] Long Beach Mem Med Ctr, Long Beach, CA USA; [Thomas, Gregory S.] Univ Calif Irvine, Irvine, CA USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Egyptian Knowledge Bank (EKB); Al Azhar University; Universidad Peruana Cayetano Heredia; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Smithsonian Institution; Smithsonian National Museum of Natural History; Metropolitan Museum of Art; Cornell University; University of Pennsylvania; University of Cambridge; Egyptian Knowledge Bank (EKB); Cairo University; University of Southern California; University of California System; University of California Irvine	Thompson, RC (corresponding author), St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA.	rthompson@saint-lukes.org	Finch, Caleb/AAA-7250-2022; Al-Tohamy, Muhammad/B-4273-2016	Al-Tohamy, Muhammad/0000-0001-9368-2570; Thomas, Gregory S./0000-0002-9705-304X; Abdel-Maksoud, Gomaa/0000-0002-7964-5746; Lombardi, Guido/0000-0002-3402-0339; Miyamoto, Michael/0000-0002-8204-2815	National Endowment for the Humanities [HJ-50069-12]; Paleocardiology Foundation; Siemens; National Bank of Egypt; St Luke's Hospital Foundation of Kansas City; National Endowment for the Humanities	National Endowment for the Humanities; Paleocardiology Foundation; Siemens(Siemens AG); National Bank of Egypt; St Luke's Hospital Foundation of Kansas City; National Endowment for the Humanities	National Endowment for the Humanities, Paleocardiology Foundation, The National Bank of Egypt, Siemens, and St Luke's Hospital Foundation of Kansas City.; Funding for the study was supplied by the National Endowment for the Humanities (#HJ-50069-12), the Paleocardiology Foundation, Siemens, the National Bank of Egypt, and the St Luke's Hospital Foundation of Kansas City. The study also would not have been possible without the generosity of numerous museum and medical personnel who aided in the CT scanning or provided essential CT images or anthropological data. We thank the Metropolitan Museum of Art for generously providing us with full access to the data that they had gathered for their 1997 study.<SUP>10</SUP> We also thank Kevin F Kennedy of the Saint Luke's Mid America Heart Institute for statistical analysis, John N Makaryus and Amgad N Makaryus of the North Shore LIJ Health System for providing the CT data for mummies 71-76, Jon Kardatzke of the Museum of World Treasures, Wichita, KS, for access to the CT data for mummies 68 and 69, Sallam Lotfy Mohamed of Alfascan, Cairo, Egypt, for his expert postprocessing CT assistance, Hany Abd el-Rahman Amer of the National Research Center, Giza, Egypt, for his skilled assistance in the imaging of mummies 1-44, Yrma Soledad Quispe Zapana of the Instituto Nacional de Ciencias Neurologicas, Lima, Peru for making possible the CT scanning of mummies 79-113 and 123-127 and Janet Oshiro, for her anthropological research in Peru.	Allam AH, 2011, JACC-CARDIOVASC IMAG, V4, P315, DOI 10.1016/j.jcmg.2011.02.002; Allam AH, 2009, JAMA-J AM MED ASSOC, V302, P2091, DOI 10.1001/jama.2009.1641; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Allison MA, 2009, AM J CARDIOL, V104, P812, DOI 10.1016/j.amjcard.2009.05.004; Antunez de Mayolo S, 1981, NUTR ANTIGUO PERU, P127; Buikstra J. E., 1994, ARKANSAS ARCHEO LOGI, V44; Czermack J, 1852, S B AKAD WISS WIEN, V9, P27; Dall WH, 1878, REMAINS LATER PREHIS; Darby WJ, 1957, FOOD GIFT OSIRIS, V1; David AR, 2010, LANCET, V375, P718, DOI 10.1016/S0140-6736(10)60294-2; Downum C, 2012, HISATSINOM ANCIENT P; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2007, BIOL HUMAN LONGEVITY; Hrdlicka A., 1945, ALEUTIAN COMMANDER I; Jonsdottir B, 2002, COPENHEGEN PUBLICATI, V20, P155; Laughlin William S., 1980, ALEUTS SURVIVORS BER; Long AR., 1931, ARCH PATHOL, V12, P92; Mininberg DT, 2001, NEUROSURGERY, V49, P192; Missala I, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/480784; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; O'Keefe JH, 2004, MAYO CLIN PROC, V79, P101, DOI 10.4065/79.1.101; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ruffer MA, 1911, J PATHOL BACTERIOL, V15, P453, DOI 10.1002/path.1700150403; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; WALKER RA, 1985, AM J PHYS ANTHROPOL, V68, P67, DOI 10.1002/ajpa.1330680107; World Health Organization, TOP 10 CAUS DEATH FA; ZIMMERMAN MR, 1993, TEX HEART I J, V20, P252; ZIMMERMAN MR, 1981, ARCH PATHOL LAB MED, V105, P638; Zimmerman MR, 1971, B NY ACAD MED, V47, P108	30	220	232	1	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1211	1222		10.1016/S0140-6736(13)60598-X	http://dx.doi.org/10.1016/S0140-6736(13)60598-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23489753				2022-12-28	WOS:000317350100031
J	Sedghizadeh, PP				Sedghizadeh, Parish P.			Bulimia Nervosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ So Calif, Los Angeles, CA 90089 USA	University of Southern California	Sedghizadeh, PP (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	sedghiza@usc.edu	Sedghizadeh, Parish/AAI-8453-2020	Sedghizadeh, Parish/0000-0003-4190-0497					0	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1238	1238		10.1056/NEJMicm1207495	http://dx.doi.org/10.1056/NEJMicm1207495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23534563				2022-12-28	WOS:000316869000012
J	Wain-Hobson, S				Wain-Hobson, Simon			H5N1 viral-engineering dangers will not go away	NATURE			English	Editorial Material									Fdn Vaccine Res, Washington, DC 20005 USA		Wain-Hobson, S (corresponding author), Fdn Vaccine Res, Washington, DC 20005 USA.	simon.wain-hobson@pasteur.fr							0	11	12	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					411	411		10.1038/495411a	http://dx.doi.org/10.1038/495411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113QN	23538789	Bronze			2022-12-28	WOS:000316682800006
J	Corrigan, P; Smith, R				Corrigan, Paul; Smith, Richard			Innovate or die	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FITNESS-RELATED ACTIVITIES; HEALTH-PROMOTION PROGRAM; PARTICIPATION; EDUCATION; DISEASE; COSTS; CARE		[Corrigan, Paul; Smith, Richard] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England	Imperial College London	Smith, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England.	richardswsmith@yahoo.co.uk						[Anonymous], HLTH WELLN INN 2013; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Centers for Medicare & Medicaid Services, 2011, CHRON COND MED BEN; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Foliaki S, 2009, INT J TUBERC LUNG D, V13, P142; George Institute, CHIN RUR HLTH IN; Gibson PG, 1996, COCHRANE DB SYST REV, V2; Hajat C, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-18; Lambert EV, 2009, PREV CHRONIC DIS, V6; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Organization WH, 2016, GLOBAL STATUS REPORT; Patel D, 2011, AM J HEALTH PROMOT, V25, P341, DOI 10.4278/ajhp.100603-QUAN-172; Patel DN, 2010, AM J HEALTH PROMOT, V24, P199, DOI 10.4278/090217-QUAN-68R2.1; Smith R.W., 2012, DEFG0207ER64404; Syed SB, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-17; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	18	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f1699	10.1136/bmj.f1699	http://dx.doi.org/10.1136/bmj.f1699			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WT	23535258				2022-12-28	WOS:000316984500004
J	Hunt, ML				Hunt, Melany L.			Robotic Walking in the Real World	SCIENCE			English	Editorial Material							LOCOMOTION; MISSION		CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology	Hunt, ML (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	hunt@caltech.edu						Arvidson RE, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003633; Bekker M, 1960, OFF THE ROAD LOCOMOT; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Farley CT, 1997, J EXP BIOL, V200, P2177; Gabrielli G., 1950, MECH ENG ASME, V72, P775; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; MoreaS F, 1988, NASA C PUBLICATIONS, V3166, P619; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; Wong JY., 2001, THEORY GROUND VEHICL; Yong J., 2005, INGENIA, V22, P46	12	9	10	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1389	1390		10.1126/science.1235276	http://dx.doi.org/10.1126/science.1235276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520098				2022-12-28	WOS:000316740700027
J	Nuttall, I; Dye, C				Nuttall, Isabelle; Dye, Christopher			The SARS Wake-Up Call	SCIENCE			English	Editorial Material									[Nuttall, Isabelle; Dye, Christopher] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Nuttall, I (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	nuttalli@who.int; dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				Fischer J, 2011, INT HLTH REG 2005 SU; Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Martin R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-532; WHO, 2012, M STAT PART BIOL TOX; Wilson K, 2008, CAN MED ASSOC J, V179, P44, DOI 10.1503/cmaj.080516; World Health Organization, 2005, IMPL INT HLTH REG; [World Health Organization Global Alert and Response (GAR)], 2013, GLOB AL RESP GAR UPD; World Health Organization (WHO), 2011, PAND INFL PREP FRAM; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	10	19	19	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1287	1288		10.1126/science.1236434	http://dx.doi.org/10.1126/science.1236434			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GC	23493705				2022-12-28	WOS:000316053400028
J	Brody, H				Brody, Herb			GOLD	NATURE			English	Editorial Material																			0	6	6	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S1	S1		10.1038/495S1a	http://dx.doi.org/10.1038/495S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486094	Bronze			2022-12-28	WOS:000316652300025
J	Raj, VS; Mou, HH; Smits, SL; Dekkers, DHW; Muller, MA; Dijkman, R; Muth, D; Demmers, JAA; Zaki, A; Fouchier, RAM; Thiel, V; Drosten, C; Rottier, PJM; Osterhaus, ADME; Bosch, BJ; Haagmans, BL				Raj, V. Stalin; Mou, Huihui; Smits, Saskia L.; Dekkers, Dick H. W.; Mueller, Marcel A.; Dijkman, Ronald; Muth, Doreen; Demmers, Jeroen A. A.; Zaki, Ali; Fouchier, Ron A. M.; Thiel, Volker; Drosten, Christian; Rottier, Peter J. M.; Osterhaus, Albert D. M. E.; Bosch, Berend Jan; Haagmans, Bart L.			Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC	NATURE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; SARS CORONAVIRUS; AMINOPEPTIDASE-N; PATHOGENESIS; MECHANISMS; RESERVOIRS; BATS	Most human coronaviruses cause mild upper respiratory tract disease but may be associated with more severe pulmonary disease in immunocompromised individuals'. However, SARS coronavirus caused severe lower respiratory disease with nearly 10% mortality and evidence of systemic spread(2). Recently, another coronavirus (human coronavirus-Erasmus Medical Center (hCoV-EMC)) was identified in patients with severe and sometimes lethal lower respiratory tract infection(3,4). Viral genome analysis revealed close relatedness to coronaviruses found in bats'. Here we identify dipeptidyl peptidase 4 (DPP4; also known as CD26) as a functional receptor for hCoV-EMC. DPP4 specifically co-purified with the receptor-binding Si domain of the hCoV-EMC spike protein from lysates of susceptible Huh-7 cells. Antibodies directed against DPP4 inhibited hCoV-EMC infection of primary human bronchial epithelial cells and Huh-7 cells. Expression of human and bat (Pipistrellus pipistrellus) DPP4 in non-susceptible COS-7 cells enabled infection by hCoV-EMC. The use of the evolutionarily conserved DPP4 protein from different species as a functional receptor provides clues about the host range potential of hCoV-EMC. In addition, it will contribute critically to our understanding of the pathogenesis and epidemiology of this emerging human coronavirus, and may facilitate the development of intervention strategies.	[Raj, V. Stalin; Smits, Saskia L.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Haagmans, Bart L.] Erasmus MC, Dept Virosci, NL-3000 CA Rotterdam, Netherlands; [Mou, Huihui; Rottier, Peter J. M.; Bosch, Berend Jan] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3508 TD Utrecht, Netherlands; [Smits, Saskia L.] Viroclin Biosci BV, NL-3029 AK Rotterdam, Netherlands; [Dekkers, Dick H. W.; Demmers, Jeroen A. A.] Erasmus MC, Prote Dept, NL-3000 CA Rotterdam, Netherlands; [Mueller, Marcel A.; Muth, Doreen; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, D-53105 Bonn, Germany; [Dijkman, Ronald; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Zaki, Ali] Dr Soliman Fakeeh Hosp, Virol Lab, Jeddah, Saudi Arabia; [Thiel, Volker] Univ Zurich, Vetsuisse Fac, CH-8057 Zurich, Switzerland	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Erasmus University Rotterdam; Erasmus MC; University of Bonn; Kantonsspital St. Gallen; University of Zurich	Bosch, BJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3508 TD Utrecht, Netherlands.	b.j.bosch@uu.nl; b.haagmans@erasmusmc.nl	Thiel, Volker/AAI-2391-2019; Smits, Saskia/A-2953-2014; Haagmans, Bart/E-9791-2015; Fouchier, Ron A/A-1911-2014; Bosch, Berend/ABD-8740-2021; Demmers, Jeroen AA/F-4046-2016; Müller, Marcel A./O-2425-2019; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Fouchier, Ron A/0000-0001-8095-2869; Demmers, Jeroen AA/0000-0002-8757-9611; Müller, Marcel A./0000-0003-2242-5117; Raj, Victor Stalin/0000-0003-2250-8481; Osterhaus, Albert/0000-0002-6074-1172; Dijkman, Ronald/0000-0003-0320-2743; Thiel, Volker/0000-0002-5783-0887	European Union FP7 [223498]; ANTIGONE [278976]; Swiss National Science Foundation [31003A_132898]; 3R Research Foundation Switzerland [128-11]; German Research Foundation (DFG) [DR 772/3-1, KAl241/18-1]; German Ministry of Education and Research (BMBF SARS II)	European Union FP7(European Commission); ANTIGONE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 3R Research Foundation Switzerland; German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF SARS II)(Federal Ministry of Education & Research (BMBF))	We thank E. Snijder for peoviding the anti-SARS-CoV NSP4 antibody, and E. Kindler, H. Jonsdottir, R. Rodriguez, T. Bestebroer, S. Pas, G. Arron, M. van Velzen and W. Ouwendijk for techn ical assistance. This work was supported by a fellowship from China Scholarship Council to H.M. The study was financed by the European Union FP7 project EMPERIE (contract number 223498), ANTIGONE (contract number 278976), the Swiss National Science Foundation (31003A_132898) and the 3R Research Foundation Switzerland (Project 128-11). C.D. was supported by the German Research Foundation (DFG grant DR 772/3-1, KAl241/18-1) and the German Ministry of Education and Research (BMBF SARS II).	Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; World Health Organization, 2013, INT SURV REC HUM INF; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	23	1317	1414	3	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					251	254		10.1038/nature12005	http://dx.doi.org/10.1038/nature12005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486063	Green Published, Bronze			2022-12-28	WOS:000316652300054
J	Wandke, C; Kutay, U				Wandke, Cornelia; Kutay, Ulrike			Enclosing Chromatin: Reassembly of the Nucleus after Open Mitosis	CELL			English	Review							TO-TUBULE TRANSFORMATION; ENDOPLASMIC-RETICULUM; ENVELOPE FORMATION; MAMMALIAN-CELLS; COMPLEX; POM121; REORGANIZATION; KINASE	During mitosis in vertebrate cells, the nuclear envelope undergoes extensive structural reorganization, starting with the retraction of nuclear membranes into the ER at mitotic onset and ending with the re-enclosure of chromatin by ER-derived membranes during mitotic exit. Here, we review our current understanding of postmitotic nuclear assembly.	[Wandke, Cornelia; Kutay, Ulrike] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kutay, U (corresponding author), ETH, Dept Biol, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch			SNSF; ERC	SNSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission)	We apologize for the few citations owing to space limitations, and we thank Drs. M. Mayr and A. Rothballer for critical reading and the SNSF and ERC for funding.	Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Fichtman B, 2010, MOL BIOL CELL, V21, P4197, DOI 10.1091/mbc.E10-04-0309; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Shaulov L, 2011, J CELL SCI, V124, P3822, DOI 10.1242/jcs.086660; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6	17	50	50	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1222	1225		10.1016/j.cell.2013.02.046	http://dx.doi.org/10.1016/j.cell.2013.02.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498932	Bronze			2022-12-28	WOS:000316192500005
J	Wang, PY; Ma, WZ; Park, JY; Celi, FS; Arena, R; Choi, JW; Ali, QA; Tripodi, DJ; Zhuang, J; Lago, CU; Strong, LC; Talagala, SL; Balaban, RS; Kang, JG; Hwang, PM				Wang, Ping-yuan; Ma, Wenzhe; Park, Joon-Young; Celi, Francesco S.; Arena, Ross; Choi, Jeong W.; Ali, Qais A.; Tripodi, Dotti J.; Zhuang, Jie; Lago, Cory U.; Strong, Louise C.; Talagala, S. Lalith; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.			Increased Oxidative Metabolism in the Li-Fraumeni Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL METABOLISM; MUSCLE; CANCER; APOPTOSIS; EXERCISE	There is growing evidence that alterations in metabolism may contribute to tumorigenesis. Here, we report on members of families with the Li-Fraumeni syndrome who carry germline mutations in TP53, the gene encoding the tumor-suppressor protein p53. As compared with family members who are not carriers and with healthy volunteers, family members with these mutations have increased oxidative phosphorylation of skeletal muscle. Basic experimental studies of tissue samples from patients with the Li-Fraumeni syndrome and a mouse model of the syndrome support this in vivo finding of increased mitochondrial function. These results suggest that p53 regulates bioenergetic homeostasis in humans. (Funded by the National Heart, Lung, and Blood Institute and the National Institutes of Health; ClinicalTrials.govnumber, NCT00406445.)	[Wang, Ping-yuan; Ma, Wenzhe; Choi, Jeong W.; Ali, Qais A.; Tripodi, Dotti J.; Zhuang, Jie; Lago, Cory U.; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Celi, Francesco S.] NIDDKD, NIH, Bethesda, MD 20892 USA; [Talagala, S. Lalith] NINDS, NIH, Bethesda, MD 20892 USA; [Park, Joon-Young] Temple Univ, Philadelphia, PA 19122 USA; [Arena, Ross] Univ New Mexico, Albuquerque, NM 87131 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of New Mexico; University of Texas System; UTMD Anderson Cancer Center	Hwang, PM (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10CRC 5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.	hwangp@nhlbi.nih.gov	Arena, Ross/AAY-7646-2020; Arena, Ross/A-3141-2008	Arena, Ross/0000-0002-6675-1996; Park, Joon-Young/0000-0002-7705-7086	Division of Intramural Research, National Heart, Lung, and Blood Institute; National Institutes of Health Bench-to-Bedside Award; National Heart, Lung, and Blood Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [U24CA078142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004601, ZIAHL006051, ZIGHL006020, ZIAHL005101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075001] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Bench-to-Bedside Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute and by a National Institutes of Health Bench-to-Bedside Award (to Drs. Hwang and Strong).; Funded by the National Heart, Lung, and Blood Institute and the National Institutes of Health.	Argov Z, 2000, MUSCLE NERVE, V23, P1316, DOI 10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lago CU, 2011, ANTIOXID REDOX SIGN, V15, P1739, DOI 10.1089/ars.2010.3650; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Macedo GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047010; MALKIN D, 1993, SCIENCE, V259, P878, DOI 10.1126/science.8438145; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nakagawa Y, 2005, MED SCI SPORT EXER, V37, P937, DOI 10.1249/01.mss.0000166946.94871.9b; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SCHNEIDER K, 2010, GENEREVIEWS; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	26	86	87	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1027	1032		10.1056/NEJMoa1214091	http://dx.doi.org/10.1056/NEJMoa1214091			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484829	Green Accepted			2022-12-28	WOS:000315982100009
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Early nutrition and adult outcomes: pieces of the puzzle	LANCET			English	Editorial Material							CHILD UNDERNUTRITION; METHYLATION; DISEASE		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Adair LS, 2013, LANCET; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black R., 2013, LANCET; Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708; Lakshmi S, 2012, PEDIATR OBES, V7, P347, DOI 10.1111/j.2047-6310.2012.00063.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Save the Children, 2012, NUTR 1 1000 DAYS STA; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	14	40	41	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					486	487		10.1016/S0140-6736(13)60716-3	http://dx.doi.org/10.1016/S0140-6736(13)60716-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23541369				2022-12-28	WOS:000323162400007
J	Bredenoord, AJ; Pandolfino, JE; Smout, AJPM				Bredenoord, Albert J.; Pandolfino, John E.; Smout, Andre J. P. M.			Gastro-oesophageal reflux disease	LANCET			English	Article							LOWER ESOPHAGEAL SPHINCTER; PUMP INHIBITOR THERAPY; SYMPTOM ASSOCIATION ANALYSIS; GASTRIC-ACID; DOUBLE-BLIND; PERISTALTIC DYSFUNCTION; ESOMEPRAZOLE TREATMENT; OMEPRAZOLE THERAPY; POSITION STATEMENT; BARRETT-ESOPHAGUS	Gastro-oesophageal reflux disease is one of the most common disorders of the gastrointestinal tract. Over past decades, considerable shifts in thinking about the disease have taken place. At a time when radiology was the only diagnostic test available, reflux disease was regarded as synonymous with hiatus hernia. After the advent of the flexible endoscope, reflux disease was, for a period, equated to oesophagitis. The introduction of oesophageal pH monitoring made us believe that reflux disease could be defined by an abnormally high proportion of time with oesophageal pH less than 4. Moreover, the successive arrival of histamine-2-receptor antagonists and proton-pump inhibitors changed our idea of treatment for the disease, with swings from and towards surgery, endoscopic techniques, and alternative pharmaceutical options.	[Bredenoord, Albert J.; Smout, Andre J. P. M.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DD Amsterdam, Netherlands; [Pandolfino, John E.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	University of Amsterdam; Academic Medical Center Amsterdam; Northwestern University; Feinberg School of Medicine	Smout, AJPM (corresponding author), Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DD Amsterdam, Netherlands.	a.j.smout@amc.uva.nl		Bredenoord, Albert/0000-0001-5918-2062	Shire/Movetis; Endostim; Given Imaging; XenoPort; Reckitt Benckiser; MMS international	Shire/Movetis; Endostim; Given Imaging; XenoPort; Reckitt Benckiser; MMS international	AJB has received research funding from Shire/Movetis and Endostim and payment for development of educational presentations from MMS International. JEP has participated in educational programmes organised and sponsored by Given Imaging, has acted as a consultant for Given Imaging and Sandhill Scientific, and has received research grants from Given Imaging. AJPMS has received consultation fees from XenoPort and Reckitt Benckiser and sponsorship for an educational meeting from Shire/Movetis, MMS international, and Given Imaging.	Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701; Barak N, 2002, Obes Rev, V3, P9, DOI 10.1046/j.1467-789X.2002.00049.x; Bardhan KD, 1999, BRIT MED J, V318, P502, DOI 10.1136/bmj.318.7182.502; Barlow WJ, 2005, GASTROENTEROLOGY, V128, P771, DOI 10.1053/j.gastro.2004.08.014; Beaumont H, 2010, GUT, V59, P441, DOI 10.1136/gut.2009.178061; Boeckxstaens GE, 2010, GASTROENTEROLOGY, V139, P409, DOI 10.1053/j.gastro.2010.04.051; Bonavina L, 2010, ANN SURG, V252, P857, DOI 10.1097/SLA.0b013e3181fd879b; Bredenoord AJ, 2006, AM J GASTROENTEROL, V101, P453, DOI 10.1111/j.1572-0241.2006.00427.x; Bredenoord AJ, 2006, GUT, V55, P313, DOI 10.1136/gut.2005.074690; Bredenoord AJ, 2005, GUT, V54, P1810, DOI 10.1136/gut.2005.072629; Bredenoord AJ, 2008, EUR J GASTROEN HEPAT, V20, P217, DOI 10.1097/MEG.0b013e3282f1cc39; Bredenoord AJ, 2007, AM J GASTROENTEROL, V102, P187, DOI 10.1111/j.1572-0241.2006.00966.x; Bredenoord AJ, 2012, AM J GASTROENTEROL, V107, P8, DOI 10.1038/ajg.2011.286; Broeders JAJL, 2010, BRIT J SURG, V97, P1318, DOI 10.1002/bjs.7174; Broekaert D, 2006, ALIMENT PHARM THER, V23, P365, DOI 10.1111/j.1365-2036.2006.02772.x; Broeren MAC, 2009, ANN INTERN MED, V151, P755, DOI 10.7326/0003-4819-151-10-200911170-00016; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Egan JV, 2006, GASTROINTEST ENDOSC, V63, P755, DOI 10.1016/j.gie.2006.02.031; Eherer AJ, 2012, AM J GASTROENTEROL, V107, P372, DOI 10.1038/ajg.2011.420; El-Serag H, 2010, ALIMENT PHARM THER, V32, P720, DOI 10.1111/j.1365-2036.2010.04406.x; El-Serag H, 2009, ALIMENT PHARM THER, V29, P470, DOI 10.1111/j.1365-2036.2008.03901.x; Fackler WK, 2002, GASTROENTEROLOGY, V122, P625, DOI 10.1053/gast.2002.31876; Fass R, 2009, GUT, V58, P295, DOI 10.1136/gut.2007.145581; Fass R, 2000, ALIMENT PHARM THER, V14, P1595, DOI 10.1046/j.1365-2036.2000.00882.x; Fibbe C, 2001, GASTROENTEROLOGY, V121, P5, DOI 10.1053/gast.2001.25486; Fletcher J, 2001, GASTROENTEROLOGY, V121, P775, DOI 10.1053/gast.2001.27997; Galmiche JP, 2006, GASTROENTEROLOGY, V130, P1459, DOI 10.1053/j.gastro.2005.08.060; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; GILLEN P, 1987, BRIT J SURG, V74, P774, DOI 10.1002/bjs.1800740906; Gorelick AB, 1998, AM J PHYSIOL-GASTR L, V275, pG460, DOI 10.1152/ajpgi.1998.275.3.G460; GOYAL RK, 1976, GASTROENTEROLOGY, V71, P62; GRANDE L, 1992, DIGEST DIS SCI, V37, P583, DOI 10.1007/BF01307583; Guarino MPL, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01514.x; Hemmink GJM, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01327.x; Hemmink GJM, 2008, AM J GASTROENTEROL, V103, P2446, DOI 10.1111/j.1572-0241.2008.02033.x; Hill LD, 1996, GASTROINTEST ENDOSC, V44, P541, DOI 10.1016/S0016-5107(96)70006-8; HIRSCHOWITZ BI, 1991, GASTROENTEROLOGY, V101, P1149, DOI 10.1016/0016-5085(91)90062-P; Ikramuddin S, 2008, DIGEST DIS SCI, V53, P2318, DOI 10.1007/s10620-008-0415-7; ISMAIL-BEIGI F, 1970, Gastroenterology, V58, P163; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Johnsson F, 2003, SCAND J GASTROENTERO, V38, P354, DOI 10.1080/0036552031002139; Jones MP, 2001, AM J GASTROENTEROL, V96, P1711, DOI 10.1016/S0002-9270(01)02489-3; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kahrilas PJ, 1999, GUT, V44, P476, DOI 10.1136/gut.44.4.476; KAHRILAS PJ, 1986, GASTROENTEROLOGY, V91, P897, DOI 10.1016/0016-5085(86)90692-X; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V94, P73, DOI 10.1016/0016-5085(88)90612-9; KARVELIS KC, 1987, RADIOLOGY, V162, P97, DOI 10.1148/radiology.162.1.3786789; Kessing BF, 2011, CLIN GASTROENTEROL H, V9, P1020, DOI 10.1016/j.cgh.2011.04.022; Khan M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003244.pub2; Kinoshita Y, 2012, AM J GASTROENTEROL, V107, P522, DOI 10.1038/ajg.2012.19; KLINKENBERGKNOL EC, 1990, ALIMENT PHARM THERAP, V4, P485; Knowles CH, 2008, GUT, V57, P674, DOI 10.1136/gut.2007.127886; Koufman JA, 2002, OTOLARYNG HEAD NECK, V127, P32, DOI 10.1067/mhn.2002.125760; Kwiatek MA, 2011, ALIMENT PHARM THER, V34, P59, DOI 10.1111/j.1365-2036.2011.04678.x; Leite LP, 1996, AM J GASTROENTEROL, V91, P1527; Lidums I, 2000, GASTROENTEROLOGY, V118, P7, DOI 10.1016/S0016-5085(00)70408-2; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Mainie I, 2006, BRIT J SURG, V93, P1483, DOI 10.1002/bjs.5493; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARCUARD SP, 1994, ANN INTERN MED, V120, P211, DOI 10.7326/0003-4819-120-3-199402010-00006; Miner P, 2003, AM J GASTROENTEROL, V98, P2616, DOI 10.1016/j.amjgastroenterol.2003.09.053; MITTAL RK, 1995, GASTROENTEROLOGY, V109, P601, DOI 10.1016/0016-5085(95)90351-8; MITTAL RK, 1988, J CLIN INVEST, V81, P1182, DOI 10.1172/JCI113433; MITTAL RK, 1990, GASTROENTEROLOGY, V99, P1265, DOI 10.1016/0016-5085(90)91148-Y; MITTAL RK, 1989, AM J PHYSIOL, V256, pG139, DOI 10.1152/ajpgi.1989.256.1.G139; Niebisch S, 2012, J AM COLL SURGEONS, V215, P61, DOI 10.1016/j.jamcollsurg.2012.03.022; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; NISSEN R, 1956, Schweiz Med Wochenschr, V86, P590; Orr WC, 2009, ALIMENT PHARM THER, V31, P47, DOI 10.1111/j.1365-2036.2009.04124.x; Ours TM, 2003, AM J GASTROENTEROL, V98, P545, DOI 10.1016/S0002-9270(02)06026-4; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Pandolfino JE, 2003, AM J GASTROENTEROL, V98, P740, DOI 10.1016/S0002-9270(03)00062-5; Pandolfino JE, 2005, GASTROENTEROLOGY, V128, P209, DOI 10.1053/j.gastro.2004.11.008; Pandolfino JE, 2003, GASTROENTEROLOGY, V125, P1018, DOI 10.1016/S0016-5085(03)01210-1; Pandolfino JE, 2007, AM J GASTROENTEROL, V102, P2633, DOI 10.1111/j.1572-0241.2007.01488.x; Pandolfino JE, 2007, AM J GASTROENTEROL, V102, P1056, DOI 10.1111/j.1572-0241.2007.01138.x; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Penagini R, 2010, BEST PRACT RES CL GA, V24, P831, DOI 10.1016/j.bpg.2010.09.003; Qadeer MA, 2005, LARYNGOSCOPE, V115, P1947, DOI 10.1097/01.mlg.0000176547.90094.ac; Ramage JI, 2005, AM J GASTROENTEROL, V100, P2419, DOI 10.1111/j.1572-0241.2005.00331.x; Reimer C, 2009, GASTROENTEROLOGY, V137, P80, DOI 10.1053/j.gastro.2009.03.058; Rodriguez L, 2012, NEUROGASTROENT MOTIL, V24, P446, DOI 10.1111/j.1365-2982.2012.01878.x; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Scheffer RCH, 2005, GASTROENTEROLOGY, V129, P1900, DOI 10.1053/j.gastro.2005.09.018; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Singh M, 2013, OBESITY, V21, P284, DOI 10.1002/oby.20279; SINGH P, 1992, GUT, V33, P1590, DOI 10.1136/gut.33.12.1590; SLOAN S, 1991, GASTROENTEROLOGY, V100, P596, DOI 10.1016/0016-5085(91)80003-R; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Stacher G, 2000, GUT, V47, P661, DOI 10.1136/gut.47.5.661; Tan GW, 2011, ANZ J SURG, V81, P246, DOI 10.1111/j.1445-2197.2010.05481.x; Thomas T, 2011, ENDOSCOPY, V43, P386, DOI 10.1055/s-0030-1256331; TIMMER R, 1993, AM J GASTROENTEROL, V88, P837; Tobey NA, 1996, GASTROENTEROLOGY, V111, P1200, DOI 10.1053/gast.1996.v111.pm8898633; TRIMBLE KC, 1995, GUT, V37, P7, DOI 10.1136/gut.37.1.7; Tytgat GN, 2008, ALIMENT PHARM THER, V27, P249, DOI 10.1111/j.1365-2036.2007.03565.x; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Van Soest EM, 2006, ALIMENT PHARM THERAP, V24, P377, DOI 10.1111/j.1365-2036.2006.02982.x; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; Veugelers PJ, 2006, DIS ESOPHAGUS, V19, P321, DOI 10.1111/j.1442-2050.2006.00602.x; VIGNERI S, 1995, NEW ENGL J MED, V333, P1106, DOI 10.1056/NEJM199510263331703; Watson AHR, 2005, GUIDELINES DIAGNOSIS; Weijenborg PW, 2012, NEUROGASTROENT MOTIL, V24, P747; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zerbib F, 2006, AM J GASTROENTEROL, V101, P1956, DOI 10.1111/j.1572-0241.2006.00711.x	109	81	90	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1933	1942		10.1016/S0140-6736(12)62171-0	http://dx.doi.org/10.1016/S0140-6736(12)62171-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23477993				2022-12-28	WOS:000320319500034
J	Osnas, JLD; Lichstein, JW; Reich, PB; Pacala, SW				Osnas, Jeanne L. D.; Lichstein, Jeremy W.; Reich, Peter B.; Pacala, Stephen W.			Global Leaf Trait Relationships: Mass, Area, and the Leaf Economics Spectrum	SCIENCE			English	Article							NITROGEN; CANOPY; INVESTMENT; IRRADIANCE; WORLDWIDE; LIGHT; MODEL	The leaf economics spectrum (LES) describes multivariate correlations that constrain leaf traits of plant species primarily to a single axis of variation if data are normalized by leaf mass. We show that these traits are approximately distributed proportional to leaf area instead of mass, as expected for a light-and carbon dioxide-collecting organ. Much of the structure in the mass-normalized LES results from normalizing area-proportional traits by mass. Mass normalization induces strong correlations among area-proportional traits because of large variation among species in leaf mass per area (LMA). The high LMA variance likely reflects its functional relationship with leaf life span. A LES that is independent of mass-or area-normalization and LMA reveals physiological relationships that are inconsistent with those in global vegetation models designed to address climate change.	[Osnas, Jeanne L. D.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08542 USA; [Osnas, Jeanne L. D.; Lichstein, Jeremy W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia	Princeton University; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University	Osnas, JLD (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, 106 Guyot Hall, Princeton, NJ 08542 USA.	jldosnas@gmail.com	Lichstein, Jeremy/GMW-6555-2022	Reich, Peter/0000-0003-4424-662X	NSF [DEB 0620652]	NSF(National Science Foundation (NSF))	The GLOPNET data set is archived in the online supplementary materials in (2) (DOI: 10.1038/nature02403) and is available at www.nature.com/nature/journal/v428/n6985/suppinfo/nature02403.html. J.L.D.O. and S. W. P. articulated the problem and analyses; J.L.D.O., J.W.L., and S. W. P. performed analyses; and J.L.D.O., S. W. P., J.W.L., and P. B. R. interpreted results and wrote the manuscript. P. B. R. thanks the NSF Long Term Ecological Research program (grant DEB 0620652) for support. No competing interests exist between the authors' funding sources and this research.	Aranda I, 2004, ACTA OECOL, V25, P187, DOI 10.1016/j.actao.2004.01.003; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falster DS, 2012, NEW PHYTOL, V193, P409, DOI 10.1111/j.1469-8137.2011.03940.x; FIELD C, 1983, OECOLOGIA, V56, P348, DOI 10.1007/BF00379711; Field C., 1986, EC PLANT FORM FUNCTI, P22; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Koike T, 2001, TREE PHYSIOL, V21, P951, DOI 10.1093/treephys/21.12-13.951; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Thornton PE, 2007, J CLIMATE, V20, P3902, DOI 10.1175/JCLI4222.1; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; ZAEHLE S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI DOI 10.1029/2009GB003521	18	263	309	25	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					741	744		10.1126/science.1231574	http://dx.doi.org/10.1126/science.1231574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23539179				2022-12-28	WOS:000318619000038
J	Bonnet, J; Yin, P; Ortiz, ME; Subsoontorn, P; Endy, D				Bonnet, Jerome; Yin, Peter; Ortiz, Monica E.; Subsoontorn, Pakpoom; Endy, Drew			Amplifying Genetic Logic Gates	SCIENCE			English	Article							RECOMBINATION DIRECTIONALITY; CELLS; CIRCUITS; SYSTEMS; DESIGN; PARTS	Organisms must process information encoded via developmental and environmental signals to survive and reproduce. Researchers have also engineered synthetic genetic logic to realize simpler, independent control of biological processes. We developed a three-terminal device architecture, termed the transcriptor, that uses bacteriophage serine integrases to control the flow of RNA polymerase along DNA. Integrase-mediated inversion or deletion of DNA encoding transcription terminators or a promoter modulates transcription rates. We realized permanent amplifying AND, NAND, OR, XOR, NOR, and XNOR gates actuated across common control signal ranges and sequential logic supporting autonomous cell-cell communication of DNA encoding distinct logic-gate states. The single-layer digital logic architecture developed here enables engineering of amplifying logic gates to control transcription rates within and across diverse organisms.	[Bonnet, Jerome; Yin, Peter; Ortiz, Monica E.; Subsoontorn, Pakpoom; Endy, Drew] Dept Bioengn, Stanford, CA 94305 USA		Endy, D (corresponding author), Dept Bioengn, Y2E2-269B,473 Via Ortega, Stanford, CA 94305 USA.	endy@stanford.edu	Bonnet, Jerome/D-3041-2014; Bonnet, Jerome/AAT-5600-2020	Bonnet, Jerome/0000-0002-8420-9359; Bonnet, Jerome/0000-0002-8420-9359; Endy, Drew/0000-0001-6952-8098	NSF Synthetic Biology Engineering Research Center; Stanford Center for Longevity; Stanford Bio-X; Townshend/Lamarre Family Foundation; Siebel Foundation	NSF Synthetic Biology Engineering Research Center; Stanford Center for Longevity; Stanford Bio-X; Townshend/Lamarre Family Foundation; Siebel Foundation	We thank M. Juul, T. Knight, S. Kushner, C. Smolke, B. Townshend, the Endy and Smolke labs, and the Stanford Shared FACS Facility. Funding was provided by the NSF Synthetic Biology Engineering Research Center, Stanford Center for Longevity, Stanford Bio-X, the Townshend/Lamarre Family Foundation, and the Siebel Foundation. DNA sequences are available in GenBank (accession nos. KC529324 to KC529332). DNA constructs will be made available via Addgene.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; BARDEEN J, 1948, PHYS REV, V74, P230, DOI 10.1103/PhysRev.74.230; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brown WRA, 2011, METHODS, V53, P372, DOI 10.1016/j.ymeth.2010.12.031; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Ortiz ME, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-16; Pasotti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039407; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Siuti P, 2013, NAT BIOTECHNOL; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Varadarajan PA, 2009, IEEE T NANOBIOSCI, V8, P281, DOI 10.1109/TNB.2009.2028687; Wadey C., 2005, ADVENTURES SYNTHETIC; Wang BJ, 2012, TRENDS MICROBIOL, V20, P376, DOI 10.1016/j.tim.2012.05.001; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	25	319	330	17	371	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					599	603		10.1126/science.1232758	http://dx.doi.org/10.1126/science.1232758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23539178				2022-12-28	WOS:000318268900045
J	Butler, J; Fonarow, GC; Gheorghiade, M				Butler, Javed; Fonarow, Gregg C.; Gheorghiade, Mihai			Strategies and Opportunities for Drug Development in Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA	Emory University; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Gheorghiade M, 2014, HEART FAIL REV, V19, P135, DOI 10.1007/s10741-012-9361-8; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P2349, DOI 10.1016/j.jacc.2009.01.075	3	38	38	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1593	1594		10.1001/jama.2013.1063	http://dx.doi.org/10.1001/jama.2013.1063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23538438				2022-12-28	WOS:000317599500020
J	Rechel, B; Mladovsky, P; Ingleby, D; Mackenbach, JP; McKee, M				Rechel, Bernd; Mladovsky, Philipa; Ingleby, David; Mackenbach, Johan P.; McKee, Martin			Migration and health in an increasingly diverse Europe	LANCET			English	Article							MIGRANT HEALTH; CARDIOVASCULAR-DISEASES; ETHNIC-MINORITY; RISK-FACTORS; CANCER-RISK; MORTALITY; CARE; OBESITY; NETHERLANDS; POPULATIONS	The share of migrants in European populations is substantial and growing, despite a slowdown in immigration after the global economic crisis. This paper describes key aspects of migration and health in Europe, including the scale of international migration, available data for migrant health, barriers to accessing health services, ways of improving health service provision to migrants, and migrant health policies that have been adopted across Europe. Improvement of migrant health and provision of access for migrants to appropriate health services is not without challenges, but knowledge about what steps need to be taken to achieve these aims is increasing.	[Rechel, Bernd; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Rechel, Bernd; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Mladovsky, Philipa] Univ London London Sch Econ & Polit Sci, European Observ Hlth Syst & Policies, London WC2A 2AE, England; [Ingleby, David] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; University of London; London School Economics & Political Science; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	bernd.rechel@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mladovsky, Philipa/AAN-2264-2020; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Mladovsky, Philipa/0000-0001-7761-6928; Rechel, Bernd/0000-0001-8020-3956	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This work has been supported by the European Observatory on Health Systems and Policies. We thank our partner organisations, the International Organization for Migration and the European Public Health Association Section on Migrant and Ethnic Minority Health, and all contributors to the study on which this paper is based.	Agudelo-Suarez A. A., 2011, Migration and health in the European Union, P155; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Alderliesten ME, 2008, EUR J OBSTET GYN R B, V138, P164, DOI 10.1016/j.ejogrb.2007.08.022; Ambrosini M, 2007, EMPLOYMENT AND WORKI; [Anonymous], 2011, MIGRATION HLTH EUROP; [Anonymous], 2010, BBC; [Anonymous], 2000, OFF J EUR COMMUNITIE; Arnold M, 2010, EUR J CANCER, V46, P2647, DOI 10.1016/j.ejca.2010.07.050; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Bernd Rechel., 2011, MIGRATION HLTH EUROP, P169; Bhopal RS, 2012, EUR J PUBLIC HEALTH, V22, P353, DOI 10.1093/eurpub/ckr062; Bjorngren-Cuadra C., 2010, COUNTRY REPORT SPAIN; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Boulogne R, 2012, SOC SCI MED, V74, P1213, DOI 10.1016/j.socscimed.2012.01.002; Bruyneel L., 2010, SUMMARY REPORT OF TH; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cattacin S, POLICIES ON HEALTH C; Commission on Social Determinants of Health, 2008, FINAL REPORT OF THE; Council of the European Union, 2010, COUNCIL CONCLUSIONS; David Matthias, 2006, Archives of Gynecology and Obstetrics, V274, P271, DOI 10.1007/s00404-006-0182-7; Davies A. A., 2010, Eurohealth, V16, P10; Davies AA, 2009, MIGRATION A SOCIAL D; Deboosere P., 2005, POPULATION, V60, P655, DOI [DOI 10.3917/POPE.505.0655, 10.3917/pope.505.0655]; ECDC, 2010, TUBERCULOSIS SURVEIL; EUR-Lex, 2003, OFFICIAL J EUROPEA L, VL31, P18; EuroHIV, 2007, END YEAR REPORT 2006; Fajnzylber P, 2008, REMITTANCES AND DEVE; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Fortier JP, 2004, SETTING THE AGENDA F; Garcia-Ramirez M, 2009, INT J MIGR HEALTH SO, V5, P2, DOI 10.1108/17479894200900001; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Gorst Isabel, 2011, FINANCIAL TIMES; Gushulak B., 2010, REPORT GLOBAL CONSUL, P28; Gushulak B., 2010, POVERTY SOCIAL EXCLU, P257; Harding S, 2009, EUR J CANCER, V45, P2168, DOI 10.1016/j.ejca.2009.02.029; Ingleby D., 2011, Migration and health in the European Union, P227; Ingleby D, 2009, EUROPEAN RESEARCH ON; Ingleby D., 2005, SOCIAL INTEGRATION M, P89; Ingleby David, 2012, Psychosocial Intervention, V21, P331, DOI 10.5093/in2012a29; Ingleby D, 2006, INT J MIGR HEALTH SO, V2, P4, DOI 10.1108/17479894200600023; International Organization for Migration, 2010, WORLD MIGRATION REPO; Iontsev V, 2012, ROLE OF INTERNATIONA; Juhasz J, 2010, POSSIBILITIES AND LI; Karl-Trummer U., 2010, Eurohealth, V16, P13; Koller D, 2009, GESUNDHEITSWESEN, V71, P10, DOI 10.1055/s-0028-1082310; Kovacheva V, 2009, THE SIZE OF THE IRRE; Kraler A, 2010, STATISTICS ON MIGRAT; Kraler A, 2010, QUANTITATIVE DATA IN; Kunst A. E., 2011, Migration and health in the European Union, P101; Labree LJW, 2011, OBES REV, V12, pe535, DOI 10.1111/j.1467-789X.2010.00839.x; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Madrigal L, 2011, HUM BIOL, V83, P71, DOI 10.3378/027.083.0105; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McKay L, 2003, MIGRATION AND HEALTH; McKee M, 2004, ACCESSING HEALTH CAR; McKee M, 2011, MIGRATION AND HEALTH, P139; Messina A., 2011, MIGRATION HLTH EUROP, P37; Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008; Mladovsky P., 2011, Migration and health in the European Union, P185; Mladovsky P, 2007, RESEARCH NOTE MIGRAT; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; Mladovsky P, 2009, HEALTH POLICY, V93, P55, DOI 10.1016/j.healthpol.2009.05.015; Netto G, 2010, HEALTH PROMOT INT, V25, P248, DOI 10.1093/heapro/daq012; Nielsen SS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-210; Norredam M., 2011, Migration and health in the European Union, P67; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; Pace P., 2011, Migration and health in the European Union, P55; Padilla B, MATERNAL AND CHILD H; Padilla B, 2009, HLTH MIGRATION EUROP, P8; Pajares M., 2008, INMIGRACION Y MERCAD; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; Peiro M. J., 2010, Eurohealth, V16, P1; Rafnsson SB, 2008, PUBLIC HEALTH, V122, P532, DOI 10.1016/j.puhe.2008.02.001; Rafnsson SB, 2009, EUR J PUBLIC HEALTH, V19, P484, DOI 10.1093/eurpub/ckp073; Rechel B, 2012, HEALTH POLICY, V105, P10, DOI 10.1016/j.healthpol.2012.01.003; Regidor E, 2009, MED CLIN-BARCELONA, V132, P621, DOI 10.1016/j.medcli.2008.06.025; Reime B, 2012, ACTA OBSTET GYN SCAN, V91, P824, DOI 10.1111/j.1600-0412.2012.01390.x; Schenker M, 2008, OCCUP ENVIRON MED, V65, P717, DOI 10.1136/oem.2008.040907; Schenker MB, 2010, AM J IND MED, V53, P329, DOI 10.1002/ajim.20834; Schulpen TWJ, 2001, ARCH DIS CHILD, V84, P222, DOI 10.1136/adc.84.3.222; Schwenken H., 2005, DOMESTIC SLAVERY VER; Simon P., 2007, STUDY REPORT; Singh M, 2011, ANTHROPOL ANZ, V68, P239, DOI 10.1127/0003-5548/2011/0132; Spallek J, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-6; Spallek J, 2009, CANCER EPIDEMIOL, V33, P413, DOI 10.1016/j.canep.2009.10.006; Spijkerboer TP, 2012, SOC SCI RES NET; Stirbu I, 2006, INT J CANCER, V119, P2665, DOI 10.1002/ijc.22200; Thorne C, 2010, LANCET INFECT DIS, V10, P479, DOI 10.1016/S1473-3099(10)70118-3; Traynor I., 2011, GUARDIAN; Tsolova S, 2005, THE CONTRIBUTION OF; Tverdova YV, 2011, HUM RIGHTS REV, V12, P329, DOI 10.1007/s12142-010-0188-1; Uiters E, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-76; Ujcic-Voortman JK, 2012, OBES REV, V13, P2, DOI 10.1111/j.1467-789X.2011.00932.x; UN, 2009, TRENDS IN INTERNATIO; UN Off. High Comm. Hum. Rights, 1966, INT COVENANT EC SOCI; United Nations Department of Economic and Social Affairs, 1998, RECOMMENDATIONS ON S; Vandenheede H, 2012, EUR J EPIDEMIOL, V27, P109, DOI 10.1007/s10654-011-9638-6; Vasileva K., 2011, EUROSTAT STAT FOCUS, V34, P1; Visser O, 2007, EUR J CANCER, V43, P901, DOI 10.1016/j.ejca.2006.12.010; Watson R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3895; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, THE TALLINN CHARTER; World Bank, 2011, MIGRATION AND REMITT; World Health Organization (WHO), 1946, WHO CONSTITUTION; Wormann T., 2011, Migration and health in the European Union, P121; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	109	526	528	7	141	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1235	1245		10.1016/S0140-6736(12)62086-8	http://dx.doi.org/10.1016/S0140-6736(12)62086-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WU	23541058				2022-12-28	WOS:000317350100034
J	Gornall, J				Gornall, Jonathan			Doctors and the alcohol industry: an unhealthy mix?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2012, REDUCING HARMFUL USE; Bounds A., 2013, FINANCIAL TIMES; Craig T, 2013, BREWERS GUARDIA 0213; Dingle AE, 1980, COMPAIGN PROHIBITION; Institute of Alcohol Studies, WE AR FUND; Jernigan D, 2013, STATEMENT INT PUBLIC; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; Mellows P, 2009, PUBLICAN        0202, P18; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1659; Rush James, 2013, DAILY MAIL; World Health Organization, 2010, GLOB STRAT RED HARMF	11	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f1889	10.1136/bmj.f1889	http://dx.doi.org/10.1136/bmj.f1889			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SA	23550047				2022-12-28	WOS:000317337200008
J	Shetty, P				Shetty, Priya			Martin McKee: champion of public health in Europe Profile	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1089	1089		10.1016/S0140-6736(13)60748-5	http://dx.doi.org/10.1016/S0140-6736(13)60748-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23540843				2022-12-28	WOS:000317348900014
J	Branch, TA; Hively, DJ; Hilborn, R				Branch, Trevor A.; Hively, Daniel J.; Hilborn, Ray			Is the ocean food provision index biased?	NATURE			English	Letter							FISHERIES; FISH		[Branch, Trevor A.; Hively, Daniel J.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Branch, TA (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	tbranch@uw.edu	Hilborn, Ray W/D-6332-2013					Arnason R., 2008, SUNKEN BILLIONS EC J; Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Carruthers TR, 2012, FISH RES, V119, P66, DOI 10.1016/j.fishres.2011.12.011; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Daan N, 2011, ICES J MAR SCI, V68, P1375, DOI 10.1093/icesjms/fsr069; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Froese R, 2010, FISH FISH, V11, P194, DOI 10.1111/j.1467-2979.2009.00349.x; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Pauly D., 2011, FOCUSING ONES MICROS; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sumaila UR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040542; Thorson JT, 2012, CAN J FISH AQUAT SCI, V69, P1556, DOI 10.1139/F2012-077; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	16	13	13	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					E5	E6		10.1038/nature11974	http://dx.doi.org/10.1038/nature11974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538835				2022-12-28	WOS:000316682800001
J	Caron, JB; Morris, SC; Cameron, CB				Caron, Jean-Bernard; Morris, Simon Conway; Cameron, Christopher B.			Tubicolous enteropneusts from the Cambrian period	NATURE			English	Article							DEUTEROSTOME PHYLOGENY; HEMICHORDATA; EVOLUTION; COMMUNITY; ORIGINS; ORGAN	Hemichordates are a marine group that, apart from one mono-specific pelagic larval form, are represented by the vermiform enteropneusts and minute colonial tube-dwelling pterobranchs. Together with echinoderms, they comprise the clade Ambulacraria(1). Despite their restricted diversity, hemichordates provide important insights into early deuterostome evolution, notably because of their pharyngeal gill slits(2). Hemichordate phylogeny has long remained problematic(3,4), not least because the nature of any transitional form that might serve to link the anatomically disparate enteropneusts and pterobranchs is conjectural. Hence, inter-relationships have also remained controversial. For example, pterobranchs have sometimes been compared to ancestral echinoderms(1). Molecular data identify enteropneusts as paraphyletic, and harrimaniids(5-8) as the sister group of pterobranchs. Recent molecular phylogenies suggest that enteropneusts are probably basal within hemichordates, contrary to previous views(9), but otherwise provide little guidance as to the nature of the primitive hemichordate(7,8). In addition, the hemichordate fossil record is almost entirely restricted to peridermal skeletons of pterobranchs, notably graptolites(10,11). Owing to their low preservational potentials, fossil enteropneusts are exceedingly rare(12-15), and throw no light on either hemichordate phylogeny or the proposed harrimaniid-pterobranch transition. Here we describe an enteropneust, Spartobranchus tenuis (Walcott, 1911), from the Middle Cambrian-period (Series 3, Stage 5) Burgess Shale. It is remarkably similar to the extant harrimaniids, but differs from all known enteropneusts in that it is associated with a fibrous tube that is sometimes branched. Wesuggest that this is the precursor of the pterobranch periderm, and supports the hypothesis that pterobranchs are miniaturized and derived from an enteropneust-like worm(5,6). It also shows that the periderm was acquired before size reduction and acquisition of feeding tentacles, and that coloniality emerged through aggregation of individuals, perhaps similar to the Cambrian rhabdopleurid Fasciculitubus(11). The presence of both suggests that hemichordates originated at the onset of the Cambrian explosion.	[Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Cameron, Christopher B.] Univ Montreal, Dept Sci Biol, Montreal, PQ H2V 2S9, Canada	Royal Ontario Museum; University of Cambridge; Universite de Montreal	Caron, JB (corresponding author), Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada.	jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Natural Sciences and Engineering Research Council; St John's College, University of Cambridge, UK; Royal Ontario Museum Burgess Shale project [41]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); St John's College, University of Cambridge, UK; Royal Ontario Museum Burgess Shale project	We thank C. Lowe for constructive comments, D. Erwin and M. Florence for access to the Smithsonian Institution collections, Parks Canada for collection and research permits, P. Fenton and V. Brown for assistance, R. Gaines for donation of specimens from Utah, and M. Collins (ARTofFACT) for reconstructions. J.-B.C. and C.B.C. are supported by Natural Sciences and Engineering Research Council Discovery Grants, and S. C. M. is supported by St John's College, University of Cambridge, UK. This is Royal Ontario Museum Burgess Shale project number 41.	Alessandrello Anna, 2004, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V32, P1; Arduini P., 1981, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V122, P104; Bardack David, 1997, P89; Bechly G., 1999, FOSSILS SOLNHOFEN, P76; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Conway Morris S., 1977, SPEC PAP PALAEONTOL, V20, P1; Gonzalez P, 2009, BIOL J LINN SOC, V98, P898, DOI 10.1111/j.1095-8312.2009.01332.x; Hyman L. H., 1959, INVERTEBRATES, V5, P72; Kazmierczak J., 1969, Acta Palaeontologica Polonica, V14, P299; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Mitchell CE, 2013, LETHAIA, V46, P34, DOI 10.1111/j.1502-3931.2012.00319.x; MORRIS SC, 1979, ANNU REV ECOL SYST, V10, P327, DOI 10.1146/annurev.es.10.110179.001551; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Rickards Barrie, 2006, National Museum of Wales Geological Series, V25, P5; RICKARDS RB, 1984, ALCHERINGA, V8, P101, DOI 10.1080/03115518408618936; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Stach T, 2011, ACTA ZOOL-STOCKHOLM, V92, P150, DOI 10.1111/j.1463-6395.2010.00462.x; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Twitchett RJ, 1996, J PALEONTOL, V70, P126; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376; Wetzei W., 1972, Schriften des Naturwissenschaftichen Vereins fuer Schleswig-Holstein, V42, P104; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529	28	58	58	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					503	506		10.1038/nature12017	http://dx.doi.org/10.1038/nature12017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23485974				2022-12-28	WOS:000316682800044
J	Deneux-Tharaux, C; Sentilhes, L; Maillard, F; Closset, E; Vardon, D; Lepercq, J; Goffinet, F				Deneux-Tharaux, Catherine; Sentilhes, Loic; Maillard, Francoise; Closset, Emmanuel; Vardon, Delphine; Lepercq, Jacques; Goffinet, Francois			Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MATERNAL MORBIDITY; UMBILICAL-CORD; DELIVERY; PLACENTA; INTERVENTION; POLICIES	Objective To assess the impact of controlled cord traction on the incidence of postpartum haemorrhage and other characteristics of the third stage of labour in a high resource setting. Design Randomised controlled trial. Setting Five university hospital maternity units in France. Participants Women aged 18 or more with a singleton fetus at 35 or more weeks' gestation and planned vaginal delivery. Interventions Women were randomly assigned to management of the third stage of labour by controlled cord traction or standard placenta expulsion (awaiting spontaneous placental separation before facilitating expulsion). Women in both arms received prophylactic oxytocin just after birth. Main outcome measure Incidence of postpartum haemorrhage >= 500 mL as measured in a collector bag. Results The incidence of postpartum haemorrhage did not differ between the controlled cord traction arm (9.8%, 196/2005) and standard placenta expulsion arm (10.3%, 206/2008): relative risk 0.95 (95% confidence interval 0.79 to 1.15). The need for manual removal of the placenta was significantly less frequent in the controlled cord traction arm (4.2%, 85/2033) compared with the standard placenta expulsion arm (6.1%, 123/2024): relative risk 0.69, 0.53 to 0.90); as was third stage of labour of more than 15 minutes (4.5%, 91/2030 and 14.3%, 289/2020, respectively): relative risk 0.31, 0.25 to 0.39. Women in the controlled cord traction arm reported a significantly lower intensity of pain and discomfort during the third stage than those in the standard placenta expulsion arm. No uterine inversion occurred in either arm. Conclusions In a high resource setting, the use of controlled cord traction for the management of placenta expulsion had no significant effect on the incidence of postpartum haemorrhage and other markers of postpartum blood loss. Evidence to recommend routine controlled cord traction for the management of placenta expulsion to prevent postpartum haemorrhage is therefore lacking.	[Deneux-Tharaux, Catherine; Maillard, Francoise] Univ Paris 06, INSERM, U953, Paris, France; [Sentilhes, Loic] Univ Hosp, Dept Obstet & Gynaecol, Angers, France; [Closset, Emmanuel] Jeanne de Flandre Univ Hosp, Dept Obstet & Gynaecol, Lille, France; [Vardon, Delphine] Univ Hosp, Dept Obstet & Gynaecol, Caen, France; [Lepercq, Jacques] St Vincent de Paul Cochin Univ Hosp, Assistance Publ Hop Paris, Dept Obstet & Gynaecol, Paris, France; [Goffinet, Francois] Cochin Univ Hosp, Assistance Publ Hop Paris, Port Royal Matern Unit, Dept Obstet & Gynaecol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Lille - ISITE; CHU Lille; CHU de Caen NORMANDIE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Deneux-Tharaux, C (corresponding author), INSERM, U953, F-75014 Paris, France.	catherine.deneux-tharaux@inserm.fr	; deneux-tharaux, catherine/R-1111-2016	GOFFINET, Francois/0000-0001-9643-0299; deneux-tharaux, catherine/0000-0002-6561-3321	Bettencourt Foundation (Coups d'elan pour la Recherche francaise); French Ministry of Health [P081206]	Bettencourt Foundation (Coups d'elan pour la Recherche francaise); French Ministry of Health	The full trial protocol can be accessed at www.u953.idf.inserm.fr/page.asp?page=5211. We thank the independent data monitoring committee chaired by JM Treluyer from the Unite de Recherche Clinique Paris Centre; the women who participated in the trial; the staff from the participating maternity units for including women, and the members of the TRACOR Study Group (see supplementary file). Inserm Unit 953 has received a grant from the Bettencourt Foundation (Coups d'elan pour la Recherche francaise) in support of its research activities.; The TRACOR trial was funded by the French Ministry of Health under its clinical research hospital programme (contract No P081206). The Ministry of Health had no role in the design and conduct of the study, the collection, management, analysis, or interpretation of the data, and the preparation, review, and approval of the manuscript or in the decision to submit for publication.	Althabe F, 2006, INT J GYNECOL OBSTET, V94, pS126, DOI 10.1016/S0020-7292(06)60006-4; Andersson O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7157; Begley C M, 1990, Midwifery, V6, P3, DOI 10.1016/S0266-6138(05)80091-9; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; BONHAM D G, 1963, Br Med J, V2, P1620; Brace V, 2004, BJOG-INT J OBSTET GY, V111, P481, DOI 10.1111/j.1471-0528.2004.00101.x; Cheung WMC, 2011, J OBSTET GYNAECOL, V31, P37, DOI 10.3109/01443615.2010.531301; Chongsomchai C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004904.pub2; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Cotter AM, 2010, COCHRANE DB SYST REV; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Deneux-Tharaux C, 2009, BJOG-INT J OBSTET GY, V116, P119, DOI 10.1111/j.1471-0528.2008.01996.x; Goffinet F, 2005, Gynecol Obstet Fertil, V33, P268, DOI 10.1016/j.gyobfe.2005.03.016; Goffinet F, 2003, TRAITE OBSTETRIQUE, P941; Gulmezoglu AM, 2012, LANCET, V379, P1721, DOI 10.1016/S0140-6736(12)60206-2; Hutton EK, 2007, JAMA-J AM MED ASSOC, V297, P1241, DOI 10.1001/jama.297.11.1241; KEMP J, 1971, MED J AUSTRALIA, V1, P899, DOI 10.5694/j.1326-5377.1971.tb87932.x; Khan GQ, 1997, AM J OBSTET GYNECOL, V177, P770, DOI 10.1016/S0002-9378(97)70266-7; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lalonde A, 2006, INT J GYNECOL OBSTET, V94, P243, DOI 10.1016/j.ijgo.2006.04.016; Leduc D, 2009, J OBSTET GYNAECOL CA, V31, P980, DOI 10.1016/S1701-2163(16)34329-8; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; Royal College of Obstetricians and Gynecologists, 2009, GREEN TOP GUID 52 PR; Weeks AD, 2008, BEST PRACT RES CL OB, V22, P1103, DOI 10.1016/j.bpobgyn.2008.07.005; Winter C, 2007, BJOG-INT J OBSTET GY, V114, P845, DOI 10.1111/j.1471-0528.2007.01377.x; World Health Organization, 2007, REC PREV POSTP HAEM; World Health Organization (WHO), 2007, WHO REC PREV POSTP H; Zhang WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c293; Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	33	43	44	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1541	10.1136/bmj.f1541	http://dx.doi.org/10.1136/bmj.f1541			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117XI	23538918	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000316986200002
J	Kozauer, N; Katz, R				Kozauer, Nicholas; Katz, Russell			Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT		[Kozauer, Nicholas; Katz, Russell] US FDA, Div Neurol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Kozauer, N (corresponding author), US FDA, Div Neurol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Center for Drug Evaluation and Research, 2013, GUID IND ALZH DIS DE; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6	5	140	144	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1169	1171		10.1056/NEJMp1302513	http://dx.doi.org/10.1056/NEJMp1302513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23484795				2022-12-28	WOS:000316869000001
J	Lam, C; Vleugels, RA				Lam, Christina; Vleugels, Ruth Ann			Epidermolysis Bullosa Acquisita	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lam, Christina] Boston Univ, Sch Med, Boston, MA 02118 USA; [Vleugels, Ruth Ann] Brigham & Womens Hosp, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital	Lam, C (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	cslam@bu.edu		Lam, Christina/0000-0002-4761-5163					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					E17	E17		10.1056/NEJMicm1204895	http://dx.doi.org/10.1056/NEJMicm1204895			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23534583				2022-12-28	WOS:000316869000013
J	Swedberg, K; Young, JB; Anand, IS; Cheng, SF; Desai, AS; Diaz, R; Maggioni, AP; McMurray, JJV; O'Connor, C; Pfeffer, MA; Solomon, SD; Sun, Y; Tendera, M; van Veldhuisen, DJ				Swedberg, Karl; Young, James B.; Anand, Inder S.; Cheng, Sunfa; Desai, Akshay S.; Diaz, Rafael; Maggioni, Aldo P.; McMurray, John J. V.; O'Connor, Christopher; Pfeffer, Marc A.; Solomon, Scott D.; Sun, Yan; Tendera, Michal; van Veldhuisen, Dirk J.		RED-HF Comm Investigators	Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CITY CARDIOMYOPATHY QUESTIONNAIRE; CHRONIC KIDNEY-DISEASE; DOUBLE-BLIND; CONTROLLED-TRIAL; MORBIDITY; MORTALITY; REDUCTION; EPOETIN	BACKGROUND Patients with systolic heart failure and anemia have worse symptoms, functional capacity, and outcomes than those without anemia. We evaluated the effects of darbepoetin alfa on clinical outcomes in patients with systolic heart failure and anemia. METHODS In this randomized, double-blind trial, we assigned 2278 patients with systolic heart failure and mild-to-moderate anemia (hemoglobin level, 9.0 to 12.0 g per deciliter) to receive either darbepoetin alfa (to achieve a hemoglobin target of 13 g per deciliter) or placebo. The primary outcome was a composite of death from any cause or hospitalization for worsening heart failure. RESULTS The primary outcome occurred in 576 of 1136 patients (50.7%) in the darbepoetin alfa group and 565 of 1142 patients (49.5%) in the placebo group (hazard ratio in the darbepoetin alfa group, 1.01; 95% confidence interval, 0.90 to 1.13; P = 0.87). There was no significant between-group difference in any of the secondary outcomes. The neutral effect of darbepoetin alfa was consistent across all prespecified subgroups. Fatal or nonfatal stroke occurred in 42 patients (3.7%) in the darbepoetin alfa group and 31 patients (2.7%) in the placebo group (P = 0.23). Thromboembolic adverse events were reported in 153 patients (13.5%) in the darbepoetin alfa group and 114 patients (10.0%) in the placebo group (P = 0.01). Cancer-related adverse events were similar in the two study groups. CONCLUSIONS Treatment with darbepoetin alfa did not improve clinical outcomes in patients with systolic heart failure and mild-to-moderate anemia. Our findings do not support the use of darbepoetin alfa in these patients. (Funded by Amgen; RED-HF ClinicalTrials.gov number, NCT00358215.)	[Swedberg, Karl] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Young, James B.] Cleveland Clin, Dept Med, Endocrinol & Metab Inst, Cleveland, OH USA; [Anand, Inder S.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Anand, Inder S.] VA Med Ctr, Minneapolis, MN USA; [Cheng, Sunfa; Sun, Yan] Amgen Inc, Thousand Oaks, CA USA; [Desai, Akshay S.; Pfeffer, Marc A.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Maggioni, Aldo P.] Italian Assoc Hosp Cardiologists Res Ctr, Florence, Italy; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [O'Connor, Christopher] Duke Univ, Med Ctr, Durham, NC USA; [Tendera, Michal] Med Univ Silesia, Div Cardiol, Katowice, Poland; [van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Gothenburg; Cleveland Clinic Foundation; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Amgen; Harvard University; Brigham & Women's Hospital; University of Glasgow; Duke University; Medical University Silesia; University of Groningen	Swedberg, K (corresponding author), Sahlgrens Univ Hosp, Dept Med, S-41645 Gothenburg, Sweden.	karl.swedberg@gu.se	Ponikowski, Piotr/O-6454-2015; Maggioni, Aldo Pietro/AAL-5334-2020; Pascual-Figal, Domingo/B-3794-2008; Marchev, Sotir/AAH-6529-2020; Trochu, Jean-Noel/D-6378-2015; Senni, Michele/J-9380-2018; mcmurray, John/B-2467-2013; Hradec, Jaromir/S-2388-2016; Zadionchenko, Vladimir/A-7445-2016; Tendera, Michal/AAA-1875-2022; Linhart, Ales/O-2375-2017; Swedberg, Karl/B-2475-2008; Desai, Akshay/ABE-7250-2020; van Veldhuisen, Dirk Jan/E-8967-2014; De Keulenaer, Gilles/D-9321-2017; Solomon, Scott/I-5789-2013; Mareev, Vyacheslav Yurievich/Q-1375-2017; Froissart, Marc/L-7493-2014	Ponikowski, Piotr/0000-0002-3391-7064; Maggioni, Aldo Pietro/0000-0003-2764-6779; Pascual-Figal, Domingo/0000-0002-4993-9540; Marchev, Sotir/0000-0001-9250-510X; Senni, Michele/0000-0001-5502-7882; mcmurray, John/0000-0002-6317-3975; Hradec, Jaromir/0000-0001-7597-8239; Zadionchenko, Vladimir/0000-0003-2377-5266; Linhart, Ales/0000-0002-3372-7850; De Keulenaer, Gilles/0000-0002-4238-4183; Tendera, Michal/0000-0002-0812-6113; GALINIER, Michel/0000-0003-1735-3390; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Lupon, Josep/0000-0002-5601-9611; Isnard, Richard/0000-0002-3439-8104; Anand, Inder/0000-0003-1308-4963; Bozkurt, Biykem/0000-0002-6362-0253; Witte, Klaus/0000-0002-7146-7105; Froissart, Marc/0000-0002-4010-3173; Kober, Lars/0000-0002-6635-1466; de Groote, Pascal/0000-0002-6211-0147; Lupon, Josep/0000-0002-3981-3020	Amgen	Amgen(Amgen)	Supported by Amgen.	Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; Anand Inder S, 2010, Heart Fail Clin, V6, P279, DOI 10.1016/j.hfc.2010.03.002; Anand IS, 2005, CIRCULATION, V112, P1121, DOI 10.1161/CIRCULATIONAHA.104.512988; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Cleland JGE, 2005, J CARDIOVASC PHARM, V46, P155, DOI 10.1097/01.fjc.0000167013.77092.c4; Ghali JK, 2008, CIRCULATION, V117, P526, DOI 10.1161/CIRCULATIONAHA.107.698514; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Klapholz M, 2009, EUR J HEART FAIL, V11, P1071, DOI 10.1093/eurjhf/hfp130; Komajda M, 2006, EUR HEART J, V27, P1440, DOI 10.1093/eurheartj/ehl012; Maggioni AP, 2005, J CARD FAIL, V11, P91, DOI 10.1016/j.cardfail.2004.05.004; McMurray JJV, 2013, EUR J HEART FAIL, V15, P334, DOI 10.1093/eurjhf/hfs204; McMurray JJV, 2010, EUR J HEART FAIL, V12, P765, DOI 10.1093/eurjhf/hfq067; Ngo K, 2010, COCHRANE DB SYST REV, V1; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; O'Meara Eileen, 2004, Curr Heart Fail Rep, V1, P176, DOI 10.1007/s11897-004-0006-7; Pettersen KI, 2005, EUR J HEART FAIL, V7, P235, DOI 10.1016/j.ejheart.2004.05.012; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Ponikowski P, 2007, J AM COLL CARDIOL, V49, P753, DOI 10.1016/j.jacc.2006.11.024; Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; van Veldhuisen DJ, 2007, EUR HEART J, V28, P2208, DOI 10.1093/eurheartj/ehm328; Westenbrink BD, 2010, EUR J HEART FAIL, V12, P676, DOI 10.1093/eurjhf/hfq061	23	338	349	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1210	1219		10.1056/NEJMoa1214865	http://dx.doi.org/10.1056/NEJMoa1214865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23473338	Green Published			2022-12-28	WOS:000316869000008
J	Watson, E; MacNeil, LT; Arda, HE; Zhu, LJ; Walhout, AJM				Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Zhu, Lihua Julie; Walhout, Albertha J. M.			Integration of Metabolic and Gene Regulatory Networks Modulates the C. elegans Dietary Response	CELL			English	Article							NUCLEAR HORMONE-RECEPTORS; ONE-HYBRID ASSAYS; EXPRESSION; DISEASES	Expression profiles are tailored according to dietary input. However, the networks that control dietary responses remain largely uncharacterized. Here, we combine forward and reverse genetic screens to delineate a network of 184 genes that affect the C. elegans dietary response to Comamonas DA1877 bacteria. We find that perturbation of a mitochondrial network composed of enzymes involved in amino acid metabolism and the TCA cycle affects the dietary response. In humans, mutations in the corresponding genes cause inborn diseases of amino acid metabolism, most of which are treated by dietary intervention. We identify several transcription factors (TFs) that mediate the changes in gene expression upon metabolic network perturbations. Altogether, our findings unveil a transcriptional response system that is poised to sense dietary cues and metabolic imbalances, illustrating extensive communication between metabolic networks in the mitochondria and gene regulatory networks in the nucleus.	[Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Watson, Emma; MacNeil, Lesley T.; Arda, H. Efsun; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590; Walhout, Marian/0000-0001-5587-3608	National Institutes of Health (NIH) grant [DK068429]; CIHR postdoctoral fellowship; AHA Founders Affiliate Predoctoral Fellowship [11PRE6590003]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); AHA Founders Affiliate Predoctoral Fellowship; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Walhout laboratory, Amy Walker, and Victor Ambros for discussions and critical reading of the manuscript. We thank Jean Francois Rual and Marc Vidal (CCSB at the Dana-Farber Cancer Institute) for a copy of the ORFeome RNAi library and L. Safak Yilmaz for help with the creation of Figure 3. This work was supported by the National Institutes of Health (NIH) grant DK068429 to A.J.M.W. L.T.M. was supported by a CIHR postdoctoral fellowship. E.W. was supported by an AHA Founders Affiliate Predoctoral Fellowship (11PRE6590003). Some nematode strains used in this work were provided by the CGC, which is funded by the NIH National Center for Research Resources (NCRR).	Acosta P.B, 2010, NUTR MANAGEMENT PATI; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Carsten LD, 2005, MOL ECOL, V14, P3203, DOI 10.1111/j.1365-294X.2005.02654.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Du D, 2010, MOL BIOL REP, V37, P1867, DOI 10.1007/s11033-009-9622-3; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Saudubray JM, 2006, J INHERIT METAB DIS, V29, P261, DOI 10.1007/s10545-006-0358-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Weisfeld-Adams JD, 2010, MOL GENET METAB, V99, P116, DOI 10.1016/j.ymgme.2009.09.008; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	37	81	86	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					253	266		10.1016/j.cell.2013.02.050	http://dx.doi.org/10.1016/j.cell.2013.02.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540702	Bronze, Green Accepted			2022-12-28	WOS:000316853700021
J	Wallace, WHB; Thompson, L; Anderson, RA				Wallace, W. H. B.; Thompson, L.; Anderson, R. A.		Guideline Dev Grp	GUIDELINES Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wallace, W. H. B.] Royal Hosp Sick Children, Dept Haematol & Oncol, Edinburgh EH9 1LF, Midlothian, Scotland; [Thompson, L.] Healthcare Improvement Scotland, Scottish Intercoll Guidelines Network, Edinburgh EH12 9EB, Midlothian, Scotland; [Anderson, R. A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol & Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net		wallace, william, hamish/0000-0001-8080-5674	MRC [G1002033, G1100357, G1002118] Funding Source: UKRI; Medical Research Council [G1100357, G1002118, G1002033] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], LONG TERM FOLL SURV; Cancer Research UK, CHILH CANC STAT; Children's Oncology Group, 2008, KEEP YOUR HEART HLTH; National Cancer Survivorship Initiative, RISK STRAT PATHW CAR; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Scottish Intercollegiate Guidelines Network, 2004, LONG TERM FOLL SURV; Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547	7	65	66	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2013	346								f1190	10.1136/bmj.f1190	http://dx.doi.org/10.1136/bmj.f1190			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WT	23535255				2022-12-28	WOS:000316984500001
J	Toroyan, T; Peden, M; Iaych, K; Krug, E				Toroyan, Tami; Peden, Margie; Iaych, Kacem; Krug, Etienne			More action needed to protect vulnerable road users	LANCET			English	Editorial Material									[Toroyan, Tami; Peden, Margie; Iaych, Kacem; Krug, Etienne] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Toroyan, T (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	toroyant@who.int		Mary, Margaret/0000-0003-0872-9851				Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, DISEASE AND INJURY R; WHO, 2009, GLOBAL STATUS REPORT	4	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					977	979		10.1016/S0140-6736(13)60606-6	http://dx.doi.org/10.1016/S0140-6736(13)60606-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23499438				2022-12-28	WOS:000316936800009
J	Burkle, F; Garfield, R				Burkle, Frederick, Jr.; Garfield, Richard			Civilian mortality after the 2003 invasion of Iraq	LANCET			English	Editorial Material									[Burkle, Frederick, Jr.] Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Garfield, Richard] Columbia Univ, Sch Nursing, New York, NY USA; [Garfield, Richard] Columbia Univ, Sch Publ Hlth, New York, NY USA	Harvard University; Columbia University; Columbia University	Burkle, F (corresponding author), Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Carpenter D, 2013, PREHOSP DISASTER MED; Galbraith Peter, 2006, END IRAQ AM INCOMPET; Garfield R., 1999, MORTALITY MORBIDITY; Henderson Schuyler W, 2009, Confl Health, V3, P9, DOI 10.1186/1752-1505-3-9; Iraq Body Count Project 2003-12, 2012, IRAQ BODY COUNT PROJ; Mitchell D, 2009, FOREIGN POLICY ANAL, V5, P265, DOI 10.1111/j.1743-8594.2009.00093.x; Opinion Research Business. Independent polling agency London, 2008, OPINION RES BUSIESS; Political Videos, 2006, POLITICAL VIDEOS TRA; Republic of Iraq Council of Ministers Planning Commission Fund Central Statistical Organisation and UNICEF (Iraq), 2001, MULT IND CLUST SURV; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Siegler A, 2008, PREHOSP DISASTER MED, V23, P369, DOI 10.1017/S1049023X00006026; Woodward B., 2006, STATE DENIAL; Wright DP, 2003, LEADING NEW CAMPAIGN	15	25	25	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					877	879		10.1016/S0140-6736(12)62196-5	http://dx.doi.org/10.1016/S0140-6736(12)62196-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499026				2022-12-28	WOS:000316069700004
J	Linnen, CR; Poh, YP; Peterson, BK; Barrett, RDH; Larson, JG; Jensen, JD; Hoekstra, HE				Linnen, Catherine R.; Poh, Yu-Ping; Peterson, Brant K.; Barrett, Rowan D. H.; Larson, Joanna G.; Jensen, Jeffrey D.; Hoekstra, Hopi E.			Adaptive Evolution of Multiple Traits Through Multiple Mutations at a Single Gene	SCIENCE			English	Article							AGOUTI; ADAPTATION; MICE; SELECTION	The identification of precise mutations is required for a complete understanding of the underlying molecular and evolutionary mechanisms driving adaptive phenotypic change. Using plasticine models in the field, we show that the light coat color of deer mice that recently colonized the light-colored soil of the Nebraska Sand Hills provides a strong selective advantage against visually hunting predators. Color variation in an admixed population suggests that this light Sand Hills phenotype is composed of multiple traits. We identified distinct regions within the Agouti locus associated with each color trait and found that only haplotypes associated with light trait values have evidence of selection. Thus, local adaptation is the result of independent selection on many mutations within a single locus, each with a specific effect on an adaptive phenotype, thereby minimizing pleiotropic consequences.	[Linnen, Catherine R.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Poh, Yu-Ping; Peterson, Brant K.; Barrett, Rowan D. H.; Larson, Joanna G.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Peterson, Brant K.; Hoekstra, Hopi E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Poh, Yu-Ping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Poh, Yu-Ping; Jensen, Jeffrey D.] SIB, Lausanne, Switzerland	University of Kentucky; Harvard University; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Linnen, CR (corresponding author), Univ Kentucky, Dept Biol, 200A Thomas Hunt Morgan Bldg, Lexington, KY 40506 USA.	catherine.linnen@uky.edu; hoekstra@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Jensen, Jeffrey/0000-0002-4786-8064; Larson, Joanna/0000-0002-1401-7837; Peterson, Brant/0000-0002-0433-3035; Barrett, Rowan/0000-0003-3044-2531	NIH; Jane Coffins Child Postdoctoral Fellowship; Swiss National Science Foundation; European Research Council; Defense Advanced Research Projects Agency; Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship; Foundational Questions in Evolutionary Biology Postdoctoral Fellowship; MCZ Museum of Comparative Zoology (MCZ); Harvard University; National Science Foundation [DEB-0749958]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffins Child Postdoctoral Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundational Questions in Evolutionary Biology Postdoctoral Fellowship; MCZ Museum of Comparative Zoology (MCZ); Harvard University; National Science Foundation(National Science Foundation (NSF))	We thank K. Duryea and G. Goncalves for laboratory assistance; J. Chupasko, E. Kay, E. Kingsley, M. Manceau, and J. Weber for field assistance; J. Demboski and the Denver Museum of Nature and Science for logistical support; and J. Chupasko for curation assistance. C. R. L. was supported by a Ruth Kirschstein National Research Service Award from NIH; B. K. P. by a Jane Coffins Child Postdoctoral Fellowship; J. D. J. and Y-P.P. by grants from the Swiss National Science Foundation, the European Research Council, and Defense Advanced Research Projects Agency; R. D. H. B. by a Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship and a Foundational Questions in Evolutionary Biology Postdoctoral Fellowship. Laboratory and fieldwork was funded by Putnam Expedition Grants from the MCZ Museum of Comparative Zoology (MCZ), the Swiss National Science Foundation, Harvard University, and the National Science Foundation (DEB-0749958 to H. E. H.). P. maniculatus were collected under the Nebraska Game and Parks Commission Scientific and Educational Permit 901, and voucher specimens were deposited in the MCZ's Mammal Department. Sequence data were deposited in the NCBI Short Read Archive (accession no. SRP017939).	[Anonymous], 1861, ORIGIN SPECIES MEANS; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; Dice L. R., 1941, Contributions from the Laboratory of Vertebrate Genetics University of Michigan, Vno. 15, P1; Dice Lee R., 1947, CONIR LAB VERTEBRATE BIOL UNIV MICHIGAN, V34, P1; Domingues VS, 2012, EVOLUTION, V66, P3209, DOI 10.1111/j.1558-5646.2012.01669.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Loope D.B., 2000, GREAT PLAINS RES, V10, P5; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Prasad KVSK, 2012, SCIENCE, V337, P1081, DOI 10.1126/science.1221636; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667	24	210	213	0	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1312	1316		10.1126/science.1233213	http://dx.doi.org/10.1126/science.1233213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493712	Green Accepted			2022-12-28	WOS:000316053400036
J	Zayats, AV				Zayats, Anatoly V.			A glint of the future	NATURE			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Zayats, AV (corresponding author), Kings Coll London, London, England.	a.zayats@kcl.ac.uk						Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Stockman MI, 2011, OPT EXPRESS, V19, P22029, DOI 10.1364/OE.19.022029; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001	4	4	4	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S7	S7		10.1038/495S7a	http://dx.doi.org/10.1038/495S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486100				2022-12-28	WOS:000316652300028
J	Burnaevskiy, N; Fox, TG; Plymire, DA; Ertelt, JM; Weigele, BA; Selyunin, AS; Way, SS; Patrie, SM; Alto, NM				Burnaevskiy, Nikolay; Fox, Thomas G.; Plymire, Daniel A.; Ertelt, James M.; Weigele, Bethany A.; Selyunin, Andrey S.; Way, Sing Sing; Patrie, Steven M.; Alto, Neal M.			Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ	NATURE			English	Article							PROTEIN; EFFECTOR; COMPLEX; GTPASE; IDENTIFICATION; INACTIVATION; AUTOPHAGY; SEQUENCE; GLYCINE; FAMILY	Protein N-myristoylation is a 14-carbon fatty-acid modification that is conserved across eukaryotic species and occurs on nearly 1% of the cellular proteome(1,2). The ability of the myristoyl group to facilitate dynamic protein-protein and protein-membrane interactions (known as the myristoyl switch) makes it an essential feature of many signal transduction systems(3). Thus pathogenic strategies that facilitate protein demyristoylation would markedly alter the signalling landscape of infected host cells. Here we describe an irreversible mechanism of protein demyristoylation catalysed by invasion plasmid antigen J (IpaJ), a previously uncharacterized Shigella flexneri type III effector protein with cysteine protease activity. A yeast genetic screen for IpaJ substrates identified ADP-ribosylation factor (ARF)1p and ARF2p, small molecular mass GTPases that regulate cargo transport through the Golgi apparatus(4). Mass spectrometry showed that IpaJ cleaved the peptide bond between N-myristoylated glycine-2 and asparagine-3 of human ARF1, thereby providing a new mechanism for host secretory inhibition by a bacterial pathogen(5,6). We further demonstrate that IpaJ cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. Taken together, these findings show a previously unrecognized pathogenic mechanism for the site-specific elimination of N-myristoyl protein modification.	[Burnaevskiy, Nikolay; Weigele, Bethany A.; Selyunin, Andrey S.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Fox, Thomas G.] Indiana Univ Sch Med, Sect Pediat Infect Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Plymire, Daniel A.; Patrie, Steven M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ertelt, James M.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu		Way, Sing Sing/0000-0001-8948-1952; Fox, Thomas/0000-0002-3418-3832	Cancer Prevention and Research Institute of Texas [RP120613]; Howard Hughes Medical Institute; National Institutes of Health (NIAID) [5T32AI007520, RO1AI083359]; Burroughs Wellcome Fund; National Institutes of Health (NIGMS) [R01GM100486]; Welch Foundation [I-1704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359, R01AI100934, T32AI007520, R01AI087830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100486] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues at University of Texas Southwestern Medical Center, specifically K. Orth, Y. M. Chook and J. Seeman, for discussions in preparing this manuscript. We are particularly indebted to L. Kinch, N. Grishin, D. Mitchel, X. Guo, D. Trudgian and S. Perelman for their contributions. We acknowledge the services of the University of Texas Southwestern Medical Center proteomics core, supported by a Cancer Prevention and Research Institute of Texas grant RP120613. A. S. S. was supported by the Howard Hughes Medical Institute International Student Research fellowship. B. A. W. was supported by a National Institutes of Health training grant (NIAID; 5T32AI007520) and S. S. W. by the Burroughs Wellcome Fund. This work was supported by grants from the National Institutes of Health (NIAID; RO1AI083359 and NIGMS; R01GM100486), the Welch Foundation (I-1704) and the Burroughs Wellcome Fund to N.M.A.	Alto NM, 2008, METHOD ENZYMOL, V439, P131, DOI 10.1016/S0076-6879(07)00410-7; Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Buysse JM, 1997, MICROB PATHOGENESIS, V23, P357, DOI 10.1006/mpat.1997.0164; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Liu MQ, 2002, PLASMID, V48, P59, DOI 10.1016/S0147-619X(02)00008-2; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Roth MJ, 2011, ANAL CHEM, V83, P9586, DOI 10.1021/ac202339x; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998	36	103	106	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					106	+		10.1038/nature12004	http://dx.doi.org/10.1038/nature12004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535599	Green Accepted			2022-12-28	WOS:000316993400034
J	Pirnot, MT; Rankic, DA; Martin, DBC; MacMillan, DWC				Pirnot, Michael T.; Rankic, Danica A.; Martin, David B. C.; MacMillan, David W. C.			Photoredox Activation for the Direct beta-Arylation of Ketones and Aldehydes	SCIENCE			English	Article							COORDINATION-COMPOUNDS; FUNCTIONALIZATION; 1,4-ADDITION	The direct beta-activation of saturated aldehydes and ketones has long been an elusive transformation. We found that photoredox catalysis in combination with organocatalysis can lead to the transient generation of 5 pi-electron beta-enaminyl radicals from ketones and aldehydes that rapidly couple with cyano-substituted aryl rings at the carbonyl beta-position. This mode of activation is suitable for a broad range of carbonyl beta-functionalization reactions and is amenable to enantioselective catalysis.	[Pirnot, Michael T.; Rankic, Danica A.; Martin, David B. C.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Martin, David/0000-0002-8084-8225	National Institute of General Medical Sciences [R01 GM103558-01]; Merck; Amgen; Abbott; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213, R01GM103558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Amgen(Amgen); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institute of General Medical Sciences grant R01 GM103558-01 and gifts from Merck, Amgen, Abbott, and Bristol-Myers Squibb.	Ano Y, 2011, J AM CHEM SOC, V133, P12984, DOI 10.1021/ja206002m; Dixon IM, 2000, CHEM SOC REV, V29, P385, DOI 10.1039/b000704h; Evans D. A., 2006, ASYMMETRIC SYNTHESIS; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Gus'kova T.A., 2010, GAUSSIAN 09 REVISION; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Itooka R, 2003, J ORG CHEM, V68, P6000, DOI 10.1021/jo0207067; KAWANISI M, 1968, TETRAHEDRON, V24, P6557, DOI 10.1016/S0040-4020(01)96868-1; Leskinen MV, 2012, J AM CHEM SOC, V134, P5750, DOI 10.1021/ja300684r; Lopez F, 2004, J AM CHEM SOC, V126, P12784, DOI 10.1021/ja046632t; Mangion D, 2002, ACCOUNTS CHEM RES, V35, P297, DOI 10.1021/ar010108z; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Narayanam J.M.R., 2011, J AM CHEM SOC COLLEC, V76, P859; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Paras NA, 2002, J AM CHEM SOC, V124, P7894, DOI 10.1021/ja025981p; Renaud V. P., 1990, ANGEW CHEM, V102, P416; Renaudat A, 2010, ANGEW CHEM INT EDIT, V49, P7261, DOI 10.1002/anie.201003544; Wasa M, 2009, J AM CHEM SOC, V131, P9886, DOI 10.1021/ja903573p; Zhang SL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1214	21	389	388	9	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1593	1596		10.1126/science.1232993	http://dx.doi.org/10.1126/science.1232993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539600	Green Accepted			2022-12-28	WOS:000316731600045
J	Kakar, K; Zhang, HT; Scheres, B; Dhonukshe, P				Kakar, Klementina; Zhang, Hongtao; Scheres, Ben; Dhonukshe, Pankaj			RETRACTED: CLASP-mediated cortical microtubule organization guides PIN polarization axis (Retracted article. See vol. 508, 2014)	NATURE			English	Article; Retracted Publication							AUXIN-EFFLUX; PLANT DEVELOPMENT; ARABIDOPSIS ROOT; PLASMA-MEMBRANE; CELL-DIVISION; ENDOCYTOSIS; PROTEINS; LOCALIZATION; CYTOKINESIS; TRANSPORT	Recent evidence indicates a correlation between orientation of the plant cortical microtubule cytoskeleton and localization of polar cargoes(1). However, the molecules and mechanisms that create this correlation have remained unknown. Here we show that, in Arabidopsis thaliana, the microtubule orientation regulators CLASP(2,3) and MAP65 (refs 3, 4) control the abundance of polarity regulator PINOID kinase(5,6) at the plasma membrane. By localized upregulation of clathrin-dependent endocytosis(7) at cortical microtubule- and clathrin-rich domains orthogonal to the axis of polarity, PINOID accelerates the removal of auxin transporter PIN proteins(8-10) from those sites. This mechanism links directional microtubule organization to the polar localization of auxin transporter PIN proteins, and clarifies how microtubule-enriched cell sides are kept distinct from polar delivery domains. Our results identify the molecular machinery that connects microtubule organization to the regulation of the axis of PIN polarization.	[Kakar, Klementina; Zhang, Hongtao; Scheres, Ben; Dhonukshe, Pankaj] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Zhang, Hongtao] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Zhang, Hongtao] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Zhang, Hongtao; Scheres, Ben] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Scheres, Ben] Wageningen Univ Res, NL-6708 PB Wageningen, Netherlands; [Dhonukshe, Pankaj] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Dhonukshe, Pankaj] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium	Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research; Flanders Institute for Biotechnology (VIB); Ghent University	Dhonukshe, P (corresponding author), Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands.	pankaj.dhonukshe@psb.ugent.be		Scheres, Ben/0000-0001-5400-9578	Utrecht University; Netherlands Organisation for Scientific Research VIDI; European Research Council; European Research Council Advanced Investigator grant; Netherlands Organisation for Scientific Research Spinoza; Netherlands Proteomics Centre	Utrecht University; Netherlands Organisation for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); European Research Council Advanced Investigator grant(European Research Council (ERC)); Netherlands Organisation for Scientific Research Spinoza; Netherlands Proteomics Centre	We thank M. Estelle, G. Wasteneys, K. Hayashi, C. Luschnig, I. Hwang, M. Sasabe and M. Heisler for sharing published material. We thank F. Kindt and R. Leito for photography and image processing, and the Akhmanova laboratory for the western blotting facility. This work was supported by the Utrecht University's Starting Independent Investigator, the Netherlands Organisation for Scientific Research VIDI and European Research Council Starting Investigator grants to P. D., and the European Research Council Advanced Investigator grant, the Netherlands Organisation for Scientific Research Spinoza and Netherlands Proteomics Centre grants to B. S. K. K. was recruited from grants of P. D., and H.Z. was supported by grants of B.S.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dhonukshe P, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-11; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Karahara I, 2009, PLANT J, V57, P819, DOI 10.1111/j.1365-313X.2008.03725.x; Kim YW, 2001, PLANT PHYSIOL, V127, P1243, DOI 10.1104/pp.010450; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Sasabe M, 2011, PLANT SIGNAL BEHAV, V6, P743, DOI 10.4161/psb.6.5.15146; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003	34	21	25	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					529	+		10.1038/nature11980	http://dx.doi.org/10.1038/nature11980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515161				2022-12-28	WOS:000316682800050
J	Klein, F; Diskin, R; Scheid, JF; Gaebler, C; Mouquet, H; Georgiev, IS; Pancera, M; Zhou, TQ; Incesu, RB; Fu, BZ; Gnanapragasam, PNP; Oliveira, TY; Seaman, MS; Kwong, PD; Bjorkman, PJ; Nussenzweig, MC				Klein, Florian; Diskin, Ron; Scheid, Johannes F.; Gaebler, Christian; Mouquet, Hugo; Georgiev, Ivelin S.; Pancera, Marie; Zhou, Tongqing; Incesu, Reha-Baris; Fu, Brooks Zhongzheng; Gnanapragasam, Priyanthi N. P.; Oliveira, Thiago Y.; Seaman, Michael S.; Kwong, Peter D.; Bjorkman, Pamela J.; Nussenzweig, Michel C.			Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; 3-DIMENSIONAL STRUCTURE; ANTIGEN; EPITOPE; BREADTH; COMPLEX; DOMAIN; GLYCOPROTEIN; COMBINATION	Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.	[Klein, Florian; Scheid, Johannes F.; Gaebler, Christian; Mouquet, Hugo; Incesu, Reha-Baris; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Diskin, Ron; Fu, Brooks Zhongzheng; Gnanapragasam, Priyanthi N. P.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Diskin, Ron] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Gaebler, Christian] Tech Univ Dresden, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Georgiev, Ivelin S.; Pancera, Marie; Zhou, Tongqing; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Incesu, Reha-Baris] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany; [Oliveira, Thiago Y.] Univ Sao Paulo, Dept Genet, Med Sch Ribeirao Preto, Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Oliveira, Thiago Y.] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Weizmann Institute of Science; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade de Sao Paulo; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Gaebler, Christian/GWZ-2628-2022; Zhou, Tongqing/A-6880-2010; Oliveira, Thiago Y/ABF-5186-2020; Mouquet, Hugo/M-2750-2014; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019	Gaebler, Christian/0000-0001-7295-8128; Zhou, Tongqing/0000-0002-3935-4637; Oliveira, Thiago Y/0000-0002-2654-0879; Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; 	German Research Foundation (DFG) [KL 2389/1-1]; Stavros Niarchos Foundation; Robert Mapplethorpe Foundation; German National Academic Foundation; Vaccine Research Center, NIAID, NIH; Bill and Melinda Gates Foundation [1032144, 38660, OPP1033115]; CHAVI-ID Award [UM1AI100663]; NIH grant [AI081677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, ZICAI005112, P01AI081677, ZIAAI005022, UM1AI100663] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Stavros Niarchos Foundation; Robert Mapplethorpe Foundation; German National Academic Foundation; Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CHAVI-ID Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Louise Scharf for her help on generating structural images and Kai-Hui Yao for technical assistance. We thank Paola Marchovecchio and Han Gan for preparation of 3BNC60<SUP>P61A</SUP> as well as the members of the Nussenzweig and Bjorkman laboratory for helpful discussions. We also thank R. Wyatt for the YU2-gp140 plasmid; Davide Corti and Antonio Lanzavecchia for the HJ16 plasmids, and Francine McCutchan, Beatrice Hahn, David Montefiori, Michael Thomson, Ronald Swanstrom, Lynn Morris, Jerome Kim, Linqi Zhang, Dennis Ellenberger, and Carolyn Williamson for contributing HIV-1 envelope plasmids used in neutralization assays. F.K. was supported by the German Research Foundation (DFG, KL 2389/1-1), the Stavros Niarchos Foundation and the Robert Mapplethorpe Foundation. C.G. and R.-B.I. were supported by The German National Academic Foundation. I.G., M.P., T.Z., and P.D.K. were supported by intramural funding to the Vaccine Research Center, NIAID, NIH. M.S.S., P.J.B., and M.C.N. were supported by the Bill and Melinda Gates Foundation (M.S.S., Comprehensive Antibody Vaccine Immune Monitoring Consortium grant 1032144; P.J.B. and M.C.N., Collaboration for AIDS Vaccine Discovery grants 38660 [P.J.B.] and OPP1033115 [M.C.N.]). M.C.N is supported by the CHAVI-ID Award UM1AI100663 and The NIH grant AI081677. M.C.N. and P.J.B. are HHMI investigators.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; GORNY MK, 1993, J IMMUNOL, V150, P635; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Jolly C J, 1996, Semin Immunol, V8, P159, DOI 10.1006/smim.1996.0020; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	62	356	375	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					126	138		10.1016/j.cell.2013.03.018	http://dx.doi.org/10.1016/j.cell.2013.03.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540694	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000316853700011
J	Kettl, P				Kettl, Paul			The NRA Let Me Down	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Philadelphia VA Med Ctr, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Kettl, P (corresponding author), Philadelphia VA Med Ctr, Philadelphia, PA USA.	paul.kettl@va.gov						Hoyert DL, 2012, NATL VITAL STAT REP, V61, P2013; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1239	1240		10.1001/jama.2013.1302	http://dx.doi.org/10.1001/jama.2013.1302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532239				2022-12-28	WOS:000316625200023
J	Husereau, D; Drummond, M; Petrou, S; Carswell, C; Moher, D; Greenberg, D; Augustovski, F; Briggs, AH; Mauskopf, J; Loder, E				Husereau, Don; Drummond, Michael; Petrou, Stavros; Carswell, Chris; Moher, David; Greenberg, Dan; Augustovski, Federico; Briggs, Andrew H.; Mauskopf, Josephine; Loder, Elizabeth		CHEERS Task Force	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY; TRIALS; DESIGN; RECOMMENDATIONS; GUIDELINES; CONDUCT	Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance. The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication. The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website (www.ispor.org/TaskForces/EconomicPubGuidelines.asp). We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years.	[Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Husereau, Don] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Husereau, Don] Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria; [Drummond, Michael] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Petrou, Stavros] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Carswell, Chris] Adis Int, Pharmacoecon, Auckland, New Zealand; [Moher, David] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Hlth Syst Management, Beer Sheva, Israel; [Greenberg, Dan] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA USA; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Briggs, Andrew H.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Mauskopf, Josephine] RTI Hlth Solut, Res Triangle Pk, NC USA; [Loder, Elizabeth] Faulkner Hosp, Div Headache & Pain, Boston, MA USA	University of Ottawa; University of York - UK; University of Warwick; Adis International; University of Ottawa; Ottawa Hospital Research Institute; Ben Gurion University; Tufts Medical Center; University of Buenos Aires; University of Glasgow; Research Triangle Institute	Husereau, D (corresponding author), 879 Winnington Ave, Ottawa, ON K2B 5C4, Canada.	donh@donhusereau.com	Moher, David/I-3408-2019; Husereau, Don/AAJ-7722-2021; Carswell, Chris/AAU-3160-2021; Petrou, Stavros/ABD-8323-2021	Moher, David/0000-0003-2434-4206; Husereau, Don/0000-0002-4416-6876; Petrou, Stavros/0000-0003-3121-6050; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Greenberg, Dan/0000-0002-6759-3985; Carswell, Christopher/0000-0003-0828-0548	International Society for Pharmacoeconomics and Outcomes Research	International Society for Pharmacoeconomics and Outcomes Research	All CHEERS Task Force members are volunteers. Support for this initiative was provided by the International Society for Pharmacoeconomics and Outcomes Research.	Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 1998, PHARMACOECONOMICS, V14, P1, DOI 10.2165/00019053-199814010-00001; Drummond MF, 2015, METHODS EC EVALUATIO; Drummond MF, 2008, INT J TECHNOL ASSESS, V24, P244, DOI 10.1017/S0266462308080343; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; McGhan WF, 2009, VALUE HEALTH, V12, P1086, DOI 10.1111/j.1524-4733.2009.00605.x; Moher D, 2009, REPORTING GUIDELINES; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Rosen AB, 2005, MED DECIS MAKING, V25, P424, DOI 10.1177/0272989X05278932; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021	24	484	484	2	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2013	346								f1049	10.1136/bmj.f1049	http://dx.doi.org/10.1136/bmj.f1049			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117VT	23529982	Green Accepted, hybrid			2022-12-28	WOS:000316981900001
J	Sharwood, LN; Elkington, J; Meuleners, L; Ivers, R; Boufous, S; Stevenson, M				Sharwood, Lisa N.; Elkington, Jane; Meuleners, Lynn; Ivers, Rebecca; Boufous, Soufiane; Stevenson, Mark			Use of caffeinated substances and risk of crashes in long distance drivers of commercial vehicles: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SLEEPINESS	Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers. Design Case-control study. Setting New South Wales (NSW) and Western Australia (WA), Australia. Participants 530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months. Main outcome measure The likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules. Results Forty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine ("speed"); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Conclusions Caffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.	[Sharwood, Lisa N.; Elkington, Jane; Boufous, Soufiane] George Inst Global Hlth, Camperdown, NSW 2050, Australia; [Ivers, Rebecca] George Inst Global Hlth, Injury Div, Camperdown, NSW 2050, Australia; [Meuleners, Lynn] Curtin Monash Accid Res Ctr, Perth, WA 6845, Australia; [Boufous, Soufiane] Univ New S Wales, Sydney, NSW 2052, Australia; [Stevenson, Mark] Monash Univ, Accid Res Ctr, Monash Injury Res Inst, Clayton, Vic 3800, Australia	George Institute for Global Health; University of Sydney; George Institute for Global Health; University of Sydney; University of New South Wales Sydney; Monash University	Sharwood, LN (corresponding author), 98 Bunnerong Rd, Pagewood, NSW 2035, Australia.	lsharwood@george.org.au	stevenson, mark/AAE-9706-2019; Sharwood, Lisa N/I-5157-2019	stevenson, mark/0000-0003-3166-5876; Sharwood, Lisa N/0000-0001-8977-6144; Ivers, Rebecca/0000-0003-3448-662X; Boufous, Soufiane/0000-0002-5686-1729	Australian Research Council; Australian Government Department of Infrastructure, Transport, Regional Development and Local Government; DiagnoseIT; National Transport Commission; Queensland Transport; Roads and Traffic Authority of New South Wales and Main Roads in Western Australia; NHMRC	Australian Research Council(Australian Research Council); Australian Government Department of Infrastructure, Transport, Regional Development and Local Government(Australian Government); DiagnoseIT; National Transport Commission; Queensland Transport; Roads and Traffic Authority of New South Wales and Main Roads in Western Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the Australian Research Council, the Australian Government Department of Infrastructure, Transport, Regional Development and Local Government, DiagnoseIT, the National Transport Commission, Queensland Transport, the Roads and Traffic Authority of New South Wales and Main Roads in Western Australia. LNS is supported by Australian postgraduate awards industry grant (Australian Research Council). MS and RI are supported by NHMRC fellowships.	Addicott MA, 2009, PSYCHOPHARMACOLOGY, V203, P571, DOI 10.1007/s00213-008-1403-5; Australian demographic statistics, 2011, AUSTR DEM STAT; Brice C, 2001, HUM PSYCHOPHARM CLIN, V16, P523, DOI 10.1002/hup.327; Canberra National Information and Referral Service. National health survey, 2009, NAT HLTH SURV SUMM R, P1; Carrier J, 2009, SLEEP MED, V10, P1016, DOI 10.1016/j.sleep.2009.01.001; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; De Valck E, 2001, J SLEEP RES, V10, P203, DOI 10.1046/j.1365-2869.2001.00260.x; Department of Health and Ageing, 2011, AUSTR ALC GUID; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FREWER LJ, 1991, HUM PSYCHOPHARM CLIN, V6, P119, DOI 10.1002/hup.470060206; Hall J, 1995, INT COUNC ALC DRUGS; Heatherley SV, 2011, NUTR NEUROSCI, V14, P89, DOI 10.1179/147683011X13019262348785; Horne JA, 2001, AMINO ACIDS, V20, P83, DOI 10.1007/s007260170068; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones I, 1987, EFFECT DRIVER HOURS; Ker K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008508; Mabbott NA, 1999, TRANSPORT RES F-TRAF, V2, P115, DOI DOI 10.1016/S1369-8478(99)00012-1; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; McCartt AT, 2000, ACCIDENT ANAL PREV, V32, P493, DOI 10.1016/S0001-4575(99)00067-6; Mets MAJ, 2012, PSYCHOPHARMACOLOGY, V222, P337, DOI 10.1007/s00213-012-2647-7; Mets MAJ, 2011, PSYCHOPHARMACOLOGY, V214, P737, DOI 10.1007/s00213-010-2078-2; Philip P, 2006, ANN INTERN MED, V144, P785, DOI 10.7326/0003-4819-144-11-200606060-00004; Schweitzer PK, 2006, SLEEP, V29, P39, DOI 10.1093/sleep/29.1.39; Sharwood LN, 2011, J AUSTRALAS COLL ROA, V22, P24; Spiller G, 1984, METHYLXANTHINE BEVER; Stevenson M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-162; Williamson A, 2007, AM J EPIDEMIOL, V166, P1320, DOI 10.1093/aje/kwm205	30	31	31	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f1140	10.1136/bmj.f1140	http://dx.doi.org/10.1136/bmj.f1140			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113LX	23511947	Green Submitted, hybrid			2022-12-28	WOS:000316670500001
J	Bali, E; Audetat, A; Keppler, H				Bali, Eniko; Audetat, Andreas; Keppler, Hans			Water and hydrogen are immiscible in Earth's mantle	NATURE			English	Article							OXIDATION-STATE; FLUID INCLUSIONS; CARBON; SOLUBILITY; QUARTZ; GASES	In the deep, chemically reducing parts of Earth's mantle(1), hydrous fluids contain significant amounts of molecular hydrogen (H-2). Thermodynamic models of fluids in Earth's mantle so far have always assumed that molecular hydrogen and water are completely miscible. Here we show experimental evidence that water and hydrogen can coexist as two separate, immiscible phases. Immiscibility between water and hydrogen may be the cause of the formation of enigmatic, ultra-reducing domains in the mantle that contain moissanite (SiC) and other phases indicative of extremely reducing conditions(2,3). Moreover, the immiscibility between water and hydrogen may provide a mechanism for the rapid oxidation of Earth's upper mantle immediately following core formation(4).	[Bali, Eniko; Audetat, Andreas; Keppler, Hans] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Bali, Eniko] Univ Gottingen, Geowissensch Zentrum, D-37077 Gottingen, Germany	University of Bayreuth; University of Gottingen	Bali, E (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	enikoe.bali@geo.uni-goettingen.de	Bali, Eniko/E-7231-2011	Bali, Eniko/0000-0001-7289-6393; Audetat, Andreas/0000-0002-6176-4122				Andersen T, 2001, LITHOS, V55, P301, DOI 10.1016/S0024-4937(00)00049-9; Audetat A, 2010, EUR J MINERAL, V22, P23, DOI 10.1127/0935-1221/2010/0022-1982; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Gaillard F, 2011, NATURE, V478, P229, DOI 10.1038/nature10460; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Jaupart C, 1999, LITHOS, V48, P93, DOI 10.1016/S0024-4937(99)00023-7; Kawamoto T, 2006, REV MINERAL GEOCHEM, V62, P273, DOI 10.2138/rmg.2006.62.12; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; Mareschal JC, 2006, GEOPHYS MONOGR SER, V164, P61, DOI 10.1029/164GM06; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; MATHEZ EA, 1995, GEOCHIM COSMOCHIM AC, V59, P781, DOI 10.1016/0016-7037(95)00002-H; Morizet Y, 2010, CHEM GEOL, V279, P1, DOI 10.1016/j.chemgeo.2010.09.011; Rudnick R. L., 1999, GEOCHEMICAL SOC SPEC, V6, P3; Rupke LH, 2004, EARTH PLANET SC LETT, V223, P17, DOI 10.1016/j.epsl.2004.04.018; SEWARD TM, 1981, BER BUNSEN PHYS CHEM, V85, P2, DOI 10.1002/bbpc.19810850103; Shiryaev AA, 2011, LITHOS, V122, P152, DOI 10.1016/j.lithos.2010.12.011; Sillitoe RH, 1997, AUST J EARTH SCI, V44, P373, DOI 10.1080/08120099708728318; STERNER SM, 1984, GEOCHIM COSMOCHIM AC, V48, P2659, DOI 10.1016/0016-7037(84)90314-4; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; Trumbull RB, 2009, LITHOS, V113, P612, DOI 10.1016/j.lithos.2009.06.033; Ulmer GC, 1998, NEUES JB MINER ABH, V172, P279; WALTHER JV, 1983, AM MINERAL, V68, P731; Williams HM, 2012, EARTH PLANET SC LETT, V321, P54, DOI 10.1016/j.epsl.2011.12.030; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337	30	56	60	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					220	222		10.1038/nature11908	http://dx.doi.org/10.1038/nature11908			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486061				2022-12-28	WOS:000316652300047
J	Gwynne, P				Gwynne, Peter			There's gold in them there bugs	NATURE			English	Editorial Material																		Fairbrother L, 2012, CHEM GEOL, V320, P17, DOI 10.1016/j.chemgeo.2012.05.025; Johnston CW, 2013, NAT CHEM BIOL, V9, P241, DOI [10.1038/NCHEMBIO.1179, 10.1038/nchembio.1179]; Lengke M, 2006, GEOCHIM COSMOCHIM AC, V70, P3646, DOI 10.1016/j.gca.2006.04.018; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106	4	18	18	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S12	S13		10.1038/495S12a	http://dx.doi.org/10.1038/495S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486096	Bronze			2022-12-28	WOS:000316652300031
J	Ma, D; Gulani, V; Seiberlich, N; Liu, KC; Sunshine, JL; Duerk, JL; Griswold, MA				Ma, Dan; Gulani, Vikas; Seiberlich, Nicole; Liu, Kecheng; Sunshine, Jeffrey L.; Duerk, Jeffrey L.; Griswold, Mark A.			Magnetic resonance fingerprinting	NATURE			English	Article							STATE FREE PRECESSION; SIGNAL RECOVERY; SPIRAL TRAJECTORIES; SENSING MRI; TIME; T-2; BRAIN; QUANTIFICATION; TRUEFISP; T2	Magnetic resonance is an exceptionally, powerful and versatile measurement technique. The basic structure of a magnetic resonance experiment has remained largely unchanged for almost 50 years, being mainly restricted to the qualitative probing of only a limited set of the properties that can in principle be accessed by this technique. Here we introduce an approach to data acquisition, post-processing and visualization which we term 'magnetic resonance fingerprinting' (MRF) - that permits the simultaneous non-invasive quantification of multiple important properties of a material or tissue. MRF thus provides an alternative way to quantitatively detect and analyse complex changes that can represent physical alterations of a substance or early indicators of disease. MRF can also be used to identify the presence of a specific target material or tissue, which will increase the sensitivity, specificity and speed of a magnetic resonance study, and potentially lead to new diagnostic testing methodologies. When-paired with an appropriate pattern-recognition algorithm, MRF inherently suppresses measurement errors and can thus improve measurement accuracy.	[Ma, Dan; Gulani, Vikas; Seiberlich, Nicole; Duerk, Jeffrey L.; Griswold, Mark A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Gulani, Vikas; Sunshine, Jeffrey L.; Duerk, Jeffrey L.; Griswold, Mark A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Gulani, Vikas; Sunshine, Jeffrey L.; Duerk, Jeffrey L.; Griswold, Mark A.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Liu, Kecheng] Siemens Healthcare USA, Malvern, PA 19355 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Siemens AG	Griswold, MA (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mark.griswold@case.edu		Duerk, Jeffrey/0000-0002-3272-8085; Griswold, Mark/0000-0002-3011-6747; Ma, Dan/0000-0003-1664-9579; Seiberlich, Nicole/0000-0002-8356-5407	NIH [R01HL094557]; Siemens Healthcare; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siemens Healthcare(Siemens AG); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study was provided by NIH R01HL094557 and Siemens Healthcare. We also thank H. Saybasili and G. Lee for technical assistance during the implementation of these concepts; M. Lustig and W. Grissom for discussions. regarding this work; and A. Exner, S. Brady-Kalnay, E. Karathanasis, E. Lavik and H. Salz for their assistance in preparing the manuscript.	Barger AV, 2002, MAGN RESON MED, V48, P297, DOI 10.1002/mrm.10212; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; Bilgic B, 2011, MAGN RESON MED, V66, P1601, DOI 10.1002/mrm.22956; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chartrand R, 2008, INT CONF ACOUST SPEE, P3869, DOI 10.1109/ICASSP.2008.4518498; CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; Cukur T, 2009, MAGN RESON MED, V62, P193, DOI 10.1002/mrm.21990; Davenport M.A., 2006, 0610 TREE RIC U; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deshpande VS, 2003, MAGNET RESON MED, V49, P151, DOI 10.1002/mrm.10337; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Ehses P, 2013, MAGN RESON MED, V69, P71, DOI 10.1002/mrm.24225; Ernst R.R., 1970, J MAGN RESON, V3, P10; Fessler JA, 2003, IEEE T SIGNAL PROCES, V51, P560, DOI 10.1109/TSP.2002.807005; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haacke E.M., 1999, MAGNETIC RESONANCE I, P669; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Haldar JP, 2011, IEEE T MED IMAGING, V30, P893, DOI 10.1109/TMI.2010.2085084; Hargreaves BA, 2004, MAGN RESON MED, V51, P81, DOI 10.1002/mrm.10666; Heidemann RM, 2006, MAGN RESON MED, V56, P317, DOI 10.1002/mrm.20951; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Lee JH, 2003, MAGN RESON MED, V50, P1276, DOI 10.1002/mrm.10644; Lee KJ, 2012, MAGN RESON MED, V68, P220, DOI 10.1002/mrm.23221; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Marseille GJ, 1996, J MAGN RESON SER B, V111, P70, DOI 10.1006/jmrb.1996.0061; Nayak KS, 2007, MAGN RESON MED, V58, P931, DOI 10.1002/mrm.21296; Needell D, 2009, APPL COMPUT HARMON A, V26, P301, DOI 10.1016/j.acha.2008.07.002; Perlin K., 1985, Computer Graphics, V19, P287, DOI 10.1145/325165.325247; Pitkanen A, 1996, NEUROLOGY, V46, P1724, DOI 10.1212/WNL.46.6.1724; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rife M.J., 2007, P 15 SCI M INT SOC M, P1879; Scheffler K, 1996, MAGNET RESON MED, V35, P569, DOI 10.1002/mrm.1910350417; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Schmitt P, 2006, MAGN RESON MED, V55, P177, DOI 10.1002/mrm.20738; Schmitt P, 2004, MAGN RESON MED, V51, P661, DOI 10.1002/mrm.20058; Seiberlich N, 2011, MAGN RESON MED, V65, P492, DOI 10.1002/mrm.22618; Smith DS, 2012, IEEE T MED IMAGING, V31, P504, DOI 10.1109/TMI.2011.2172216; Stoecker T., 2011, P 19 SCI M INT SOC M, P381; Tropp JA, 2007, IEEE T INFORM THEORY, V53, P4655, DOI 10.1109/TIT.2007.909108; Tsai CM, 2000, MAGNET RESON MED, V43, P452, DOI 10.1002/(SICI)1522-2594(200003)43:3<452::AID-MRM18>3.0.CO;2-B; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; WILLIAMSON P, 1992, AM J PSYCHIAT, V149, P549	52	828	923	17	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					187	192		10.1038/nature11971	http://dx.doi.org/10.1038/nature11971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486058	Green Accepted, Green Submitted			2022-12-28	WOS:000316652300041
J	Weaver, K				Weaver, Keith			Scientists are snobs	NATURE			English	Editorial Material									Univ S Dakota, Sanford Sch Med, Vermillion, SD 57049 USA	University of South Dakota	Weaver, K (corresponding author), Univ S Dakota, Sanford Sch Med, Vermillion, SD 57049 USA.	keith.weaver@usd.edu						Weaver KE, 2012, RNA BIOL, V9, P1498, DOI 10.4161/rna.22311	1	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					167	168		10.1038/495167a	http://dx.doi.org/10.1038/495167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486042				2022-12-28	WOS:000316652300016
J	Markel, H				Markel, Howard			Happy Birthday, Dr Snow	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA.	howard@umich.edu						JOHNSON STEVEN, 2006, GHOST MAP STORY LOND; Markel Howard, 2004, GERMS TRAVEL 6 MAJOR; Rosenberg Charles E, 1987, CHOLERA YEARS US 183; SNOW J, 1965, SNOW CHOLERA BEING R; Thomas KB, 1973, DICT SCI BIOGRAPHY, V12, P502; WHO, 2012, UN WAT GLOB AN ASS S; Wohl Anthony, 1983, ENDANGERED LIVES PUB	7	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					995	996		10.1001/jama.2013.1304	http://dx.doi.org/10.1001/jama.2013.1304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483173				2022-12-28	WOS:000315938700027
J	Adair, LS; Fall, CHD; Osmond, C; Stein, AD; Martorell, R; Ramirez-Zea, M; Sachdev, HS; Dahly, DL; Bas, I; Norris, SA; Micklesfield, L; Hallal, P; Victora, CG				Adair, Linda S.; Fall, Caroline H. D.; Osmond, Clive; Stein, Aryeh D.; Martorell, Reynaldo; Ramirez-Zea, Manuel; Sachdev, Harshpal Singh; Dahly, Darren L.; Bas, Isabelita; Norris, Shane A.; Micklesfield, Lisa; Hallal, Pedro; Victora, Cesar G.		COHORTS Grp	Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies	LANCET			English	Article							BODY-MASS INDEX; CATCH-UP GROWTH; EARLY-CHILDHOOD; BLOOD-PRESSURE; PROFILE; NUTRITION; SIZE; PATTERNS; UNDERNUTRITION; METABOLISM	Background Fast weight gain and linear growth in children in low-income and middle-income countries are associated with enhanced survival and improved cognitive development, but might increase risk of obesity and related adult cardiometabolic diseases. We investigated how linear growth and relative weight gain during infancy and childhood are related to health and human capital outcomes in young adults. Methods We used data from five prospective birth cohort studies from Brazil, Guatemala, India, the Philippines, and South Africa. We investigated body-mass index, systolic and diastolic blood pressure, plasma glucose concentration, height, years of attained schooling, and related categorical indicators of adverse outcomes in young adults. With linear and logistic regression models, we assessed how these outcomes relate to birthweight and to statistically independent measures representing linear growth and weight gain independent of linear growth (relative weight gain) in three age periods: 0-2 years, 2 years to mid-childhood, and mid-childhood to adulthood. Findings We obtained data for 8362 participants who had at least one adult outcome of interest. A higher birthweight was consistently associated with an adult body-mass index of greater than 25 kg/m(2) (odds ratio 1.28, 95% CI 1.21-1.35) and a reduced likelihood of short adult stature (0.49, 0.44-0.54) and of not completing secondary school (0.82, 0.78-0.87). Faster linear growth was strongly associated with a reduced risk of short adult stature (age 2 years: 0.23, 0.20-0.52; mid-childhood: 0.39, 0.36-0.43) and of not completing secondary school (age 2 years: 0.74, 0.67-0.78; mid-childhood: 0.87, 0.83-0.92), but did raise the likelihood of overweight (age 2 years: 1.24, 1.17-1.31; mid-childhood: 1.12, 1.06-1.18) and elevated blood pressure (age 2 years: 1.12, 1.06-1.19; mid-childhood: 1.07, 1.01-1.13). Faster relative weight gain was associated with an increased risk of adult overweight (age 2 years: 1.51, 1.43-1.60; mid-childhood: 1.76, 1.69-1.91) and elevated blood pressure (age 2 years: 1.07, 1.01-1.13; mid-childhood: 1.22, 1.15-1.30). Linear growth and relative weight gain were not associated with dysglycaemia, but a higher birthweight was associated with decreased risk of the disorder (0.89, 0.81-0.98). Interpretation Interventions in countries of low and middle income to increase birthweight and linear growth during the first 2 years of life are likely to result in substantial gains in height and schooling and give some protection from adult chronic disease risk factors, with few adverse trade-offs.	[Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27516 USA; [Fall, Caroline H. D.; Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Stein, Aryeh D.; Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, Unit Nutr & Chron Dis, Guatemala City, Guatemala; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Dahly, Darren L.] Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Bas, Isabelita] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines; [Norris, Shane A.; Micklesfield, Lisa] Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC,Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Hallal, Pedro; Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	University of North Carolina; University of North Carolina Chapel Hill; University of Southampton; Emory University; Rollins School Public Health; Institute of Nutrition of Central America & Panama (INCAP); Sitaram Bhartia Institute of Science & Research; University of Leeds; University of San Carlos; University of Witwatersrand; Universidade Federal de Pelotas	Adair, LS (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.	linda_adair@unc.edu	Victora, Cesar Gomes/Y-2455-2019; Martorell, Reynaldo/I-2539-2012; Horta, Bernardo/A-7604-2008; Hallal, Pedro C/A-3249-2011; Norris, Shane/C-4664-2014; Victora, Cesar G/D-4476-2013; Micklesfield, Lisa/AAR-8262-2021	Victora, Cesar Gomes/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; Hallal, Pedro C/0000-0003-1470-6461; Norris, Shane/0000-0001-7124-3788; Victora, Cesar G/0000-0002-2465-2180; Micklesfield, Lisa/0000-0002-4994-0779; Dahly, Darren/0000-0003-0110-324X; Stein, Aryeh/0000-0003-1138-6458; Osmond, Clive/0000-0002-9054-4655; Sachdev, Harshpal Singh/0000-0002-4956-9391; Addo, O.Yaw/0000-0003-1269-759X; Fall, Caroline/0000-0003-4402-5552	Wellcome Trust; Bill & Melinda Gates Foundation; MRC [G1001333, MC_UP_A620_1016, G0902101, MC_UU_12011/4, MC_UU_12011/3] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; Medical Research Council [G0902101, MC_UU_12011/3, MC_UU_12011/4, G1001333, MC_UP_A620_1016] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust and Bill & Melinda Gates Foundation.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Carba DB, 2009, ECON HUM BIOL, V7, P7, DOI 10.1016/j.ehb.2009.01.010; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jones A, 2012, HYPERTENSION, V59, P919, DOI 10.1161/HYPERTENSIONAHA.111.187716; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Kumar Gautam, 2004, Prehosp Emerg Care, V8, P378, DOI 10.1016/j.prehos.2004.06.010; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c; Petersen JR, 2008, CLIN CHIM ACTA, V396, P10, DOI 10.1016/j.cca.2008.06.010; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Thomas D, 2002, B WORLD HEALTH ORGAN, V80, P106; Tu Yu-Kang, 2006, Epidemiol Perspect Innov, V3, P9, DOI 10.1186/1742-5573-3-9; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; W.H. Organization, 1999, DEFINITION DIAGNOSIS; World Health Organization/United Nations Children's Fund, 2012, COUNTD 2015 BUILD FU	39	489	500	7	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					525	534		10.1016/S0140-6736(13)60103-8	http://dx.doi.org/10.1016/S0140-6736(13)60103-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23541370	Green Published			2022-12-28	WOS:000323162400031
J	Steer, PJ				Steer, Philip J.			Is vitamin D supplementation in pregnancy advisable?	LANCET			English	Editorial Material							25-HYDROXYVITAMIN D		[Steer, Philip J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Canc, London, England; [Steer, Philip J.] Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England	Imperial College London; Imperial College London	Steer, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Canc, London, England.	p.steer@imperial.ac.uk						Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Committee on Obstetric Practice, 2011, OP NUMB 495 VIT D SC; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Department of Health, 2012, VIT D ADV SUPPL RISK; Godel JC, 2007, POSITION STATEMENT V; Institute of Medicine, 2010, DIETARY REFERENCE IN; Macdonald HM, 2013, CALCIFIED TISSUE INT, V92, P163, DOI 10.1007/s00223-012-9634-1; Makgoba M, 2011, DIABETES CARE, V34, P1091, DOI 10.2337/dc10-2264; National Institute for Health and Clinical Excellence, 2010, ANT CAR; National Institutes of Health, 25 HYDR VIT D TEST; Savvidou MD, 2012, BRIT J NUTR, V108, P1972, DOI 10.1017/S0007114512000207; Sayers A, 2009, J CLIN ENDOCR METAB, V94, P765, DOI 10.1210/jc.2008-2146; Sharma S, 2009, BJOG-INT J OBSTET GY, V116, P1678, DOI 10.1111/j.1471-0528.2009.02285.x; Thorp JM, 2012, BJOG-INT J OBSTET GY, V119, P1617, DOI 10.1111/j.1471-0528.2012.03495.x; Tobias JH, 2013, LANCET; Ward LM, 2007, CAN MED ASSOC J, V177, P161, DOI 10.1503/cmaj.061377; Yu CKH, 2011, FETAL DIAGN THER, V30, P94, DOI 10.1159/000324340	17	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2143	2145		10.1016/S0140-6736(13)60098-7	http://dx.doi.org/10.1016/S0140-6736(13)60098-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23518315				2022-12-28	WOS:000320925600009
J	Blackburn, TJ; Olsen, PE; Bowring, SA; McLean, NM; Kent, DV; Puffer, J; McHone, G; Rasbury, ET; Et-Touhami, M				Blackburn, Terrence J.; Olsen, Paul E.; Bowring, Samuel A.; McLean, Noah M.; Kent, Dennis V.; Puffer, John; McHone, Greg; Rasbury, E. Troy; Et-Touhami, Mohammed			Zircon U-Pb Geochronology Links the End-Triassic Extinction with the Central Atlantic Magmatic Province	SCIENCE			English	Article							MASS-EXTINCTION; FLOOD BASALTS; SYNCHRONY; ERUPTIONS; ADJACENT; JERSEY; EVENT	The end-Triassic extinction is characterized by major tosses in both terrestrial and marine diversity, setting the stage for dinosaurs to dominate Earth for the next 136 million years. Despite the approximate coincidence between this extinction and flood basalt volcanism, existing geochronotogic dates have insufficient resolution to confirm eruptive rates required to induce major climate perturbations. Here, we present new zircon uranium-lead (U-Pb) geochronotogic constraints on the age and duration of flood basalt volcanism within the Central Atlantic Magmatic Province. This chronology demonstrates synchroneity between the earliest volcanism and extinction, tests and corroborates the existing astrochronologic time scale, and shows that the release of magma and associated atmospheric flux occurred in four pulses over about 600,000 years, indicating expansive volcanism even as the biologic recovery was under way.	[Blackburn, Terrence J.; Bowring, Samuel A.; McLean, Noah M.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Olsen, Paul E.; Kent, Dennis V.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Kent, Dennis V.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08554 USA; [Puffer, John] Rutgers State Univ, Newark Coll Arts & Sci, Dept Earth & Environm Sci, Newark, NJ 07102 USA; [Rasbury, E. Troy] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Et-Touhami, Mohammed] Univ Mohammed Premier Oujda, Dept Sci Terre, Oujda 60000, Morocco	Massachusetts Institute of Technology (MIT); Columbia University; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Mohammed First University of Oujda	Blackburn, TJ (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	tblackburn@ciw.edu	Et-Touhami, Mohammed/AAX-2737-2020	McLean, Noah/0000-0003-0388-1862; Blackburn, Terrence/0000-0003-0029-0709; Rasbury, Troy/0000-0003-0591-4461; Olsen, Paul/0000-0002-5852-6326; Kent, Dennis/0000-0002-7677-2993	U.S. National Science Foundation [EAR-0446880, EAR-0931839, EAR 0753496, EAR 0345664]; Bahamas Petroleum Company	U.S. National Science Foundation(National Science Foundation (NSF)); Bahamas Petroleum Company	We express our gratitude to S. Burgess, N. Youbi, B. Schoene, J. Ramezani, D. Condon, and two anonymous reviewers. We acknowledge that this work owes much to the collective effort of the EARTHTIME community. We also thank Vulcan Materials and Carolina Sunrock LLC for quarry access, G. Fisher of the Alcatel-Lucent EH&S-Americas for Preakness Basalt cores, B. Smith for the Rossville and York Haven diabase samples, and J. Smoot and N. Ratcliff for access to cores and thin sections. We acknowledge support from the U.S. National Science Foundation (grants EAR-0446880 and EAR-0931839 to S.A.B., EAR 0753496 to P.E.O. and D.V.K., and EAR 0345664 to E.T.R.). P.E.O. received support from the Bahamas Petroleum Company. Data presented in this paper are fully documented in the supplementary materials. U-Pb zircon data are deposited at the Geochron database (www.geochron.org) with SESAR IGSNs SAB000002-SAB00000A, available at www.geochron.org/dataset/html/5QlSoX9SCtJbNfOZbNeXtuwSK.	Bartolini A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003807; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BERGER A, 1992, SCIENCE, V255, P560, DOI 10.1126/science.255.5044.560; Cirilli S, 2009, EARTH PLANET SC LETT, V286, P514, DOI 10.1016/j.epsl.2009.07.021; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Deenen MHL, 2011, CAN J EARTH SCI, V48, P1282, DOI 10.1139/E11-015; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; El Hachimi H., 2012, THESIS CADI AYYAD U; GOTTFRIE.D, 1968, GEOCHIM COSMOCHIM AC, V32, P925, DOI 10.1016/0016-7037(68)90059-8; Gottfried D., 1991, 91322C USGS; Gottfried D., 1991, 91322E USGS; Gottfried D., 1991, 91322F USGS; Greene SE, 2012, GEOLOGY, V40, P1043, DOI 10.1130/G33205.1; Grossman J. N., 1991, 91322J USGS; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hinnov LA, 2007, STRATIGRAPHY, V4, P239; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Jourdan F, 2009, LITHOS, V110, P167, DOI 10.1016/j.lithos.2008.12.011; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; Kent DV, 2005, SCIENCE, V307, P240, DOI 10.1126/science.1105826; LEMARCHAND F, 1987, GEOCHIM COSMOCHIM AC, V51, P1071, DOI 10.1016/0016-7037(87)90201-8; Marzoli A, 2004, GEOLOGY, V32, P973, DOI 10.1130/G20652.1; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McHone G., 2003, VOLATILE EMISSIONS C, V136, P14; MORTON N, 2008, INT SUBCOMMISSION JU, V35, P74; Olsen PE, 2003, GEOPH MONOG SERIES, V136, P7; Olsen PE, 2002, GEOL SOC AM SPEC PAP, V356, P505; Olsen PE, 1996, PALAEOGEOGR PALAEOCL, V122, P1, DOI 10.1016/0031-0182(95)00171-9; Puffer JH, 2009, J GEOL, V117, P139, DOI 10.1086/595663; Rampino MR, 2011, SCIENCE, V334, DOI 10.1126/science.1208653; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Todo R. P., 1992, SPEC PAP GEOL SOC AM, V268, P233; VANHOUTEN FB, 1962, AM J SCI, V260, P561, DOI 10.2475/ajs.260.8.561; von Hillebrandt A., 2009, GEOLOGIE PALONTOLOGI, V253, P163; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107	40	336	346	11	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					941	945		10.1126/science.1234204	http://dx.doi.org/10.1126/science.1234204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23519213	Green Submitted			2022-12-28	WOS:000319344100037
J	Jardine, J; Julien, JP; Menis, S; Ota, T; Kalyuzhniy, O; McGuire, A; Sok, D; Huang, PS; MacPherson, S; Jones, M; Nieusma, T; Mathison, J; Baker, D; Ward, AB; Burton, DR; Stamatatos, L; Nemazee, D; Wilson, IA; Schief, WR				Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Ota, Takayuki; Kalyuzhniy, Oleksandr; McGuire, Andrew; Sok, Devin; Huang, Po-Ssu; MacPherson, Skye; Jones, Meaghan; Nieusma, Travis; Mathison, John; Baker, David; Ward, Andrew B.; Burton, Dennis R.; Stamatatos, Leonidas; Nemazee, David; Wilson, Ian A.; Schief, William R.			Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors	SCIENCE			English	Article							STRUCTURAL BASIS; ANTIBODIES; POTENT; BROAD; NEUTRALIZATION; VIRUSES; ENV	Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 have been isolated from HIV-1-infected individuals; however, such bNAbs have not been induced by vaccination. Wild-type gp120 proteins lack detectable affinity for predicted germline precursors of VRC01-class bNAbs, making them poor immunogens to prime a VRC01-class response. We employed computation-guided, in vitro screening to engineer a germline-targeting gp120 outer domain immunogen that binds to multiple VRC01-class bNAbs and germline precursors, and elucidated germline binding crystallographically. When multimerized on nanoparticles, this immunogen (eOD-GT6) activates germline and mature VRC01-class B cells. Thus, eOD-GT6 nanoparticles have promise as a vaccine prime. In principle, germline-targeting strategies could be applied to other epitopes and pathogens.	[Jardine, Joseph; Menis, Sergey; Ota, Takayuki; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Jones, Meaghan; Mathison, John; Burton, Dennis R.; Nemazee, David; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Jones, Meaghan; Nieusma, Travis; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Jardine, Joseph; Julien, Jean-Philippe; Menis, Sergey; Kalyuzhniy, Oleksandr; Sok, Devin; MacPherson, Skye; Nieusma, Travis; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Jardine, Joseph; Menis, Sergey; Kalyuzhniy, Oleksandr; Huang, Po-Ssu; MacPherson, Skye; Jones, Meaghan; Baker, David; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Julien, Jean-Philippe; Nieusma, Travis; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [McGuire, Andrew; Stamatatos, Leonidas] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02129 USA; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle; Scripps Research Institute; Center for Infectious Disease Research; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Scripps Research Institute	Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	schief@scripps.edu	Schief, William/ABF-3645-2020; Baker, David/K-8941-2012; Ota, Takayuki/Q-5528-2017; Cheng, Yushao/E-6256-2011; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Schief, William/0000-0002-1120-0150; Baker, David/0000-0001-7896-6217; Ota, Takayuki/0000-0001-6249-0664; Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; McGuire, Andrew/0000-0003-1841-6859; Spencer, Skye/0000-0001-9570-9634; Julien, Jean-Philippe/0000-0001-7602-3995; Huang, Possu/0000-0002-7948-2895; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	IAVI Neutralizing Antibody Center, CHAVI-ID [UM1 AI100663]; NIH [AI84817, AI081625, AI33292]; NIH National Research Service Award [T32CA080416]; Canadian Institutes of Health Research; Creative and Novel Ideas in HIV Research grant [P30 AI027767-24]; NIH Interdisciplinary Training Program in Immunology [5T32AI007606-10]; Ragon Institute; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences (NIGMS); DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606, R01AI081625, UM1AI100663, R56AI084817, R37AI033292, P01AI094419, R01AI033292, R01AI073148, P30AI027767, R01AI084817] Funding Source: NIH RePORTER	IAVI Neutralizing Antibody Center, CHAVI-ID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Creative and Novel Ideas in HIV Research grant; NIH Interdisciplinary Training Program in Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Mascola and X. Wu for providing sequences of mature PGV19 and PGV20; R. Wyatt for providing the YU2 gp140 trimer; C. Sundling and G. Karlsson Hedestam for the sequence of the Rhe1 VH gene; A. Bradley, R. L. Stanfield, and D. C. Diwanji for technical assistance and insightful discussions; and M. Azoitei, R. Jacak, and D. Kulp for comments on the manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. Coordinates and structure factors for GL-VRC01 Fab, eOD-GT6, and GL-VRC01+eODGT6 structures have been deposited with the PDB under accession codes 4JPI, 4JPJ, and 4JPK, respectively. The International AIDS Vaccine Initiative (IAVI) has filed a patent relating to immunogens in this manuscript: PCT Application PCT/US12/60062, titled "Engineered Outer Domain (EOD) of HIV GP120 and Mutants Thereof," with inventors W. R. S., J. J., S. M., and P.-S.H. Materials and information will be provided under a material transfer agreement. This work was supported by IAVI Neutralizing Antibody Center, CHAVI-ID (UM1 AI100663); NIH grants AI84817 (I. A. W.), AI081625 (L. S.), and AI33292 (D. R. B.); NIH National Research Service Award Training Grant fellowship T32CA080416 (J. J.); Canadian Institutes of Health Research fellowship (J.-P.J.); Creative and Novel Ideas in HIV Research grant P30 AI027767-24 (T.O.); NIH Interdisciplinary Training Program in Immunology 5T32AI007606-10 (D. S.); and the Ragon Institute. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Use of the Advanced Photon Source was supported by the DOE, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). This is manuscript 23050 from The Scripps Research Institute.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Knight KL, 1997, CURR OPIN IMMUNOL, V9, P228, DOI 10.1016/S0952-7915(97)80140-9; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Ota T, 2012, J IMMUNOL, V189, P4816, DOI 10.4049/jimmunol.1202165; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	29	501	531	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					711	716		10.1126/science.1234150	http://dx.doi.org/10.1126/science.1234150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23539181	Green Accepted			2022-12-28	WOS:000318619000030
J	Fairchild, AL				Fairchild, Amy L.			Half Empty or Half Full? New York's Soda Rule in Historical Perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUBLIC-HEALTH		Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				Bayer R, 2004, BIOETHICS, V18, P473, DOI 10.1111/j.1467-8519.2004.00412.x; Fairchild AL, 2010, AM J PUBLIC HEALTH, V100, P54, DOI 10.2105/AJPH.2009.163956; Fee Elizabeth, 1987, DIS DISCOVERY HIST J; Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020	4	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1765	1767		10.1056/NEJMp1303698	http://dx.doi.org/10.1056/NEJMp1303698			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23550599	Bronze			2022-12-28	WOS:000318540000003
J	Bhatt, DL; Stone, GW; Mahaffey, KW; Gibson, CM; Steg, PG; Hamm, CW; Price, MJ; Leonardi, S; Gallup, D; Bramucci, E; Radke, PW; Widimsky, P; Tousek, F; Tauth, J; Spriggs, D; McLaurin, BT; Angiolillo, DJ; Genereux, P; Liu, TP; Prats, J; Todd, M; Skerjanec, S; White, HD; Harrington, RA				Bhatt, Deepak L.; Stone, Gregg W.; Mahaffey, Kenneth W.; Gibson, C. Michael; Steg, P. Gabriel; Hamm, Christian W.; Price, Matthew J.; Leonardi, Sergio; Gallup, Dianne; Bramucci, Ezio; Radke, Peter W.; Widimsky, Petr; Tousek, Frantisek; Tauth, Jeffrey; Spriggs, Douglas; McLaurin, Brent T.; Angiolillo, Dominick J.; Genereux, Philippe; Liu, Tiepu; Prats, Jayne; Todd, Meredith; Skerjanec, Simona; White, Harvey D.; Harrington, Robert A.		CHAMPION PHOENIX Investigators	Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACHIEVE OPTIMAL MANAGEMENT; ANTIPLATELET THERAPY; CLOPIDOGREL PRETREATMENT; CARDIOVASCULAR EVENTS; STANDARD THERAPY; PRASUGREL; METAANALYSIS; TICAGRELOR; STRATEGIES	BACKGROUND The intensity of antiplatelet therapy during percutaneous coronary intervention (PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a potent intravenous adenosine diphosphate (ADP)-receptor antagonist that acts rapidly and has quickly reversible effects. METHODS In a double-blind, placebo-controlled trial, we randomly assigned 11,145 patients who were undergoing either urgent or elective PCI and were receiving guideline-recommended therapy to receive a bolus and infusion of cangrelor or to receive a loading dose of 600 mg or 300 mg of clopidogrel. The primary efficacy end point was a composite of death, myocardial infarction, ischemia-driven revascularization, or stent thrombosis at 48 hours after randomization; the key secondary end point was stent thrombosis at 48 hours. The primary safety end point was severe bleeding at 48 hours. RESULTS The rate of the primary efficacy end point was 4.7% in the cangrelor group and 5.9% in the clopidogrel group (adjusted odds ratio with cangrelor, 0.78; 95% confidence interval [CI], 0.66 to 0.93; P = 0.005). The rate of the primary safety end point was 0.16% in the cangrelor group and 0.11% in the clopidogrel group (odds ratio, 1.50; 95% CI, 0.53 to 4.22; P = 0.44). Stent thrombosis developed in 0.8% of the patients in the cangrelor group and in 1.4% in the clopidogrel group (odds ratio, 0.62; 95% CI, 0.43 to 0.90; P = 0.01). The rates of adverse events related to the study treatment were low in both groups, though transient dyspnea occurred significantly more frequently with cangrelor than with clopidogrel (1.2% vs. 0.3%). The benefit from cangrelor with respect to the primary end point was consistent across multiple prespecified subgroups. CONCLUSIONS Cangrelor significantly reduced the rate of ischemic events, including stent thrombosis, during PCI, with no significant increase in severe bleeding. (Funded by the Medicines Company; CHAMPION PHOENIX ClinicalTrials.gov number, NCT01156571.)	[Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Mahaffey, Kenneth W.; Gallup, Dianne] Duke Clin Res Inst, Durham, NC USA; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; [Steg, P. Gabriel] Univ Paris Diderot, INSERM, U698, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Hamm, Christian W.] Kerckhoff Heart & Thorax Ctr, Bad Nauheim, Germany; [Price, Matthew J.] Scripps Clin, La Jolla, CA 92037 USA; [Price, Matthew J.] Scripps Translat Sci Inst, La Jolla, CA USA; [Leonardi, Sergio; Bramucci, Ezio] Fdn IRCCS Policlin S Matteo, Pavia, Italy; [Radke, Peter W.] Univ Klinikum Schleswig Holstein, D-23538 Lubeck, Germany; [Widimsky, Petr] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic; [Tousek, Frantisek] Nemocnice Ceske Budejovice, Ceske Budejovice, Czech Republic; [Tauth, Jeffrey] Natl Pk Med Ctr, Hot Springs, AR USA; [Spriggs, Douglas] Clearwater Cardiovasc & Intervent Consultants, Clearwater, FL USA; [McLaurin, Brent T.] AnMed Hlth, Anderson, SC USA; [Angiolillo, Dominick J.] Univ Florida, Coll Med, Jacksonville, FL USA; [Liu, Tiepu; Prats, Jayne; Todd, Meredith; Skerjanec, Simona] Med Co, Parsippany, NJ USA; [White, Harvey D.] Green Lane Cardiovasc Serv, Auckland, New Zealand; [Harrington, Robert A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Columbia University; Cardiovascular Research Foundation (CRF); Duke University; Harvard University; Beth Israel Deaconess Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Kerckhoff Clinic; Scripps Research Institute; Scripps Research Institute; IRCCS Fondazione San Matteo; University of Kiel; Schleswig Holstein University Hospital; University Hospital Vinohrady; Hospital Ceske Budejovice; State University System of Florida; University of Florida; Stanford University	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	De+Servi, Stefano/AAT-2631-2021; Vasilieva, Elena/B-2137-2016; STEG, Philippe Gabriel/Z-1567-2019; Widimsky, Petr/P-8088-2016; Poerner, Tudor C/L-1755-2016; Gibson, C. Michael/AAE-8212-2019; Kočka, Viktor/K-7552-2017; Hamm, Christian W./I-3155-2017; Leonardi, Sergio/AAK-1490-2020; Price, Matthew/AAJ-7679-2020; Leonardi, Sergio/K-4334-2018; Verheugt, F.W.A./H-8105-2014	Vasilieva, Elena/0000-0003-4111-0874; Widimsky, Petr/0000-0001-5686-7752; Poerner, Tudor C/0000-0001-9303-6165; Kočka, Viktor/0000-0002-2806-0545; Hamm, Christian W./0000-0001-6763-4161; Leonardi, Sergio/0000-0002-4800-6132; Price, Matthew/0000-0002-7892-2430; Leonardi, Sergio/0000-0002-4800-6132; Brilakis, Emmanouil/0000-0001-9416-9701; Kasprzak, Jaroslaw D/0000-0002-5850-8187; Van de Werf, Frans/0000-0001-9479-7767; STEG, Philippe Gabriel/0000-0001-6896-2941	Medicines Company; CHAMPION PHOENIX	Medicines Company; CHAMPION PHOENIX	Funded by the Medicines Company; CHAMPION PHOENIX ClinicalTrials.govnumber, NCT01156571.)	Agrawal K, 2013, NAT REV CARDIOL; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Angiolillo DJ, 2012, J THROMB THROMBOLYS, V34, P44, DOI 10.1007/s11239-012-0737-3; Angiolillo DJ, 2012, JAMA-J AM MED ASSOC, V307, P265, DOI 10.1001/jama.2011.2002; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bhatt DL, 2005, JAMA-J AM MED ASSOC, V293, P2935, DOI 10.1001/jama.293.23.2935; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Bhatt DL, 2007, EUR J CLIN PHARMACOL, V357, P2078; Bonello L, 2011, J AM COLL CARDIOL, V58, P467, DOI 10.1016/j.jacc.2011.04.017; Brener SJ, 2013, JACC-CARDIOVASC INTE, V6, P36, DOI 10.1016/j.jcin.2012.08.018; De Bruyne B, 2012, NEW ENGL J MED, V367, P1768; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Desai NR, 2010, JACC-CARDIOVASC INTE, V3, P571, DOI 10.1016/j.jcin.2010.04.008; Frelinger III AL, 2013, J AM COLL CARDIOL; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Kastrati A, 2009, NEW ENGL J MED, V361, P2382, DOI 10.1056/NEJMe0910677; Leonardi S, 2012, AM HEART J, V163, P768, DOI 10.1016/j.ahj.2012.02.018; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Mehta SR, 2010, NEW ENGL J MED, V363, P1585; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P2174, DOI 10.1001/jama.2011.711; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; White HD, 2012, AM HEART J, V163, P182, DOI 10.1016/j.ahj.2011.11.001; Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yousuf O, 2011, NAT REV CARDIOL, V8, P547, DOI 10.1038/nrcardio.2011.96	33	552	581	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1303	1313		10.1056/NEJMoa1300815	http://dx.doi.org/10.1056/NEJMoa1300815			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23473369	Bronze			2022-12-28	WOS:000316989900007
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			Health in Europe-successes, failures, and new challenges	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.							Gauck J, 2012, COMMUNICATION; Greer SL, 2013, LANCET; Karanikolos M, 2013, LANCET; Mackenbach JP, 2013, LANCET; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Murray C. J. L., 2013, LANCET; Rechel B, 2013, LANCET; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; Wolfe I, 2013, LANCET; World Health Organization, 2013, EUR HLTH REP 2012 CH	10	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1073	1074		10.1016/S0140-6736(13)60603-0	http://dx.doi.org/10.1016/S0140-6736(13)60603-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541050				2022-12-28	WOS:000317348900004
J	Clemmensen, KE; Bahr, A; Ovaskainen, O; Dahlberg, A; Ekblad, A; Wallander, H; Stenlid, J; Finlay, RD; Wardle, DA; Lindahl, BD				Clemmensen, K. E.; Bahr, A.; Ovaskainen, O.; Dahlberg, A.; Ekblad, A.; Wallander, H.; Stenlid, J.; Finlay, R. D.; Wardle, D. A.; Lindahl, B. D.			Roots and Associated Fungi Drive Long-Term Carbon Sequestration in Boreal Forest	SCIENCE			English	Article							LITTER DECOMPOSITION; ISOTOPE PATTERNS; NITROGEN UPTAKE; N-15 ABUNDANCE; ISLAND AREA; SOIL; ECTOMYCORRHIZAL; RATES; ERGOSTEROL; PROFILES	Boreal forest soils function as a terrestrial net sink in the global carbon cycle. The prevailing dogma has focused on aboveground plant litter as a principal source of soil organic matter. Using C-14 bomb-carbon modeling, we show that 50 to 70% of stored carbon in a chronosequence of boreal forested islands derives from roots and root-associated microorganisms. Fungal biomarkers indicate impaired degradation and preservation of fungal residues in late successional forests. Furthermore, 454 pyrosequencing of molecular barcodes, in conjunction with stable isotope analyses, highlights root-associated fungi as important regulators of ecosystem carbon dynamics. Our results suggest an alternative mechanism for the accumulation of organic matter in boreal forests during succession in the long-term absence of disturbance.	[Clemmensen, K. E.; Dahlberg, A.; Stenlid, J.; Finlay, R. D.; Lindahl, B. D.] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, SE-75007 Uppsala, Sweden; [Bahr, A.; Wallander, H.] Lund Univ, Microbial Ecol Grp, Dept Biol, SE-22100 Lund, Sweden; [Ovaskainen, O.] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Dahlberg, A.] Swedish Univ Agr Sci, Swedish Species Informat Ctr, SE-75007 Uppsala, Sweden; [Ekblad, A.] Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Wardle, D. A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Lund University; University of Helsinki; Swedish University of Agricultural Sciences; Orebro University; Swedish University of Agricultural Sciences	Clemmensen, KE (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Box 7026, SE-75007 Uppsala, Sweden.	karina.clemmensen@slu.se	Lindahl, Björn D./AAH-4538-2019; Stenlid, Jan/K-5909-2019; Ekblad, Alf/AAG-2632-2019; Ovaskainen, Otso/AGN-4838-2022; Wardle, David A./F-6031-2011; Finlay, Roger D/B-4731-2009; Finlay, Roger/Q-7796-2019; Clemmensen, Karina Engelbrecht/C-9555-2014; Ovaskainen, Otso/D-9119-2012	Ovaskainen, Otso/0000-0001-9750-4421; Wardle, David A./0000-0002-0476-7335; Finlay, Roger D/0000-0002-3652-2930; Finlay, Roger/0000-0002-3652-2930; Clemmensen, Karina Engelbrecht/0000-0002-9627-6428; Ovaskainen, Otso/0000-0001-9750-4421; Wallander, Hakan/0000-0002-9220-4590; Stenlid, Jan/0000-0002-5344-2094	7th European Community Framework Program; Lammska Stiftelsen; research center LUCCI at Lund University; FORMAS [2007-1365, 2011-1747]; Wallenberg Scholar award; European Research Council [205905]; KoN; Swedish University of Agricultural Sciences	7th European Community Framework Program(European Commission); Lammska Stiftelsen; research center LUCCI at Lund University; FORMAS(Swedish Research Council Formas); Wallenberg Scholar award; European Research Council(European Research Council (ERC)European Commission); KoN; Swedish University of Agricultural Sciences	The molecular data are archived at the Sequence Read Archive under accession number SRP016090 (www.ncbi.nlm.nih.gov/sra). This research was supported by the 7th European Community Framework Program (a Marie Curie Intra-European Fellowship to K. E. C.), Lammska Stiftelsen, the research center LUCCI at Lund University, FORMAS grants (2007-1365 and 2011-1747 to B. D. L.), a Wallenberg Scholar award to D. A. W., the European Research Council (grant 205905 to O.O.), and KoN grants to R. D. F. and J.S. by the Swedish University of Agricultural Sciences. We gratefully acknowledge M. Brandstrom-Durling for development of the SCATA bioinformatics pipeline, T. Nasholm for help with the chitin analyses, G. Nyakatura at LGC Genomics for assistance with sequencing, and G. Possnert at the Tandem Laboratory for help with <SUP>14</SUP>C dating.	Alberton O, 2007, PLANT SOIL, V296, P159, DOI 10.1007/s11104-007-9306-5; BONAN GB, 1989, ANNU REV ECOL SYST, V20, P1, DOI 10.1146/annurev.es.20.110189.000245; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Brovkin V, 2012, BIOGEOSCIENCES, V9, P565, DOI 10.5194/bg-9-565-2012; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dijkstra FA, 2007, ECOL LETT, V10, P1046, DOI 10.1111/j.1461-0248.2007.01095.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Ekblad A, 1998, NEW PHYTOL, V138, P143, DOI 10.1046/j.1469-8137.1998.00891.x; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2007, GLOBAL CHANGE BIOL, V13, P1786, DOI 10.1111/j.1365-2486.2007.01383.x; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hobbie EA, 2009, BIOGEOCHEMISTRY, V95, P355, DOI 10.1007/s10533-009-9328-6; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; Hogberg P, 2011, NEW PHYTOL, V189, P515, DOI 10.1111/j.1469-8137.2010.03485.x; Hyodo F, 2009, RAPID COMMUN MASS SP, V23, P1892, DOI 10.1002/rcm.4095; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Phillips RP, 2012, ECOL LETT, V15, P1042, DOI 10.1111/j.1461-0248.2012.01827.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Taylor AFS, 2003, NEW PHYTOL, V159, P757, DOI 10.1046/j.1469-8137.2003.00838.x; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Yuan JP, 2008, APPL MICROBIOL BIOT, V80, P459, DOI 10.1007/s00253-008-1589-9	33	865	929	82	1536	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1615	1618		10.1126/science.1231923	http://dx.doi.org/10.1126/science.1231923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539604				2022-12-28	WOS:000316731600051
J	Hailer, F; Kutschera, VE; Hallstrom, BM; Fain, SR; Leonard, JA; Arnason, U; Janke, A				Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Fain, Steven R.; Leonard, Jennifer A.; Arnason, Ulfur; Janke, Axel			Response to Comment on "Nuclear Genomic Sequences Reveal that Polar Bears Are an Old and Distinct Bear Lineage"	SCIENCE			English	Editorial Material							EFFECTIVE POPULATION-SIZE; GENE TREES; BAYESIAN-INFERENCE; SPECIES TREES; ORIGIN	Nakagome et al. reanalyzed some of our data and assert that we cannot refute the mitochondrial DNA-based scenario for polar bear evolution. Their single-locus test statistic is strongly affected by introgression and incomplete lineage sorting, whereas our multilocus approaches are better suited to recover the true species relationships. Indeed, our sister-lineage model receives high support in a Bayesian model comparison.	[Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Janke, Axel] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Hallstroem, Bjoern M.] Sch Biotechnol, Sci Life Lab, S-10450 Stockholm, Sweden; [Fain, Steven R.] Natl Fish & Wildlife Forens Lab, Ashland, OR 97520 USA; [Leonard, Jennifer A.] Estn Biol Donana EBD CSIC, Conservat & Evolutionary Genet Grp, Seville 41092, Spain; [Arnason, Ulfur] Lund Univ Hosp, S-22100 Lund, Sweden; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60438 Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Lund University; Skane University Hospital; Goethe University Frankfurt	Hailer, F (corresponding author), Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany.	frashai@gmx.net; ajanke@senckenberg.de	Janke, Axel/M-2135-2013; Kutschera, Verena E./H-8706-2013; Hailer, Frank/Y-3595-2019; Hailer, Frank/C-9114-2012; Leonard, Jennifer/A-7894-2010	Janke, Axel/0000-0002-9394-1904; Kutschera, Verena E./0000-0002-8930-534X; Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Leonard, Jennifer/0000-0003-0291-7819				Cronin MA, 2009, J HERED, V100, P681, DOI 10.1093/jhered/esp061; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Tallmon DA, 2004, J WILDLIFE MANAGE, V68, P960, DOI 10.2193/0022-541X(2004)068[0960:GMOSBB]2.0.CO;2	15	9	9	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127								10.1126/science.1228066	http://dx.doi.org/10.1126/science.1228066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539581				2022-12-28	WOS:000316731600022
J	Shridharani, SM; Mohan, R				Shridharani, Sachin M.; Mohan, Raja			A 51-Year-Old Man With HIV and Cervicodorsal Lipodystrophy (Buffalo Hump)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGICAL-MANAGEMENT; PROTEASE INHIBITORS; LIPOSUCTION		Johns Hopkins Univ, Dept Plast Surg, Baltimore, MD USA; [Shridharani, Sachin M.] Johns Hopkins Univ Hosp, Outpatient Ctr, Dept Plast Surg, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Shridharani, SM (corresponding author), Johns Hopkins Univ Hosp, Outpatient Ctr, Dept Plast Surg, 601 N Caroline St,McElderry 8161, Baltimore, MD 21287 USA.	sachin_shridharani@hotmail.com	Shridharani, Sachin/AAH-2846-2019					Davison SP, 2007, PLAST RECONSTR SURG, V120, P1843, DOI 10.1097/01.prs.0000267341.14550.a7; DEWEESE J, 2003, 10 C RETR OPP INF CR; Haeck PC, 2009, PLAST RECONSTR SURG, V124, p28S, DOI 10.1097/PRS.0b013e3181b52fcd; Hengel RL, 1997, LANCET, V350, P1596, DOI 10.1016/S0140-6736(05)64011-1; Hultman CS, 2007, ANN PLAS SURG, V58, P255, DOI 10.1097/01.sap.0000248128.33465.83; Mallon PWG, 2005, JAIDS-J ACQ IMM DEF, V38, P156, DOI 10.1097/01.qai.0000147527.64863.1a; Nelson L, 2008, J PLAST RECONSTR AES, V61, P366, DOI 10.1016/j.bjps.2007.10.031; Roth VR, 1998, CLIN INFECT DIS, V27, P65, DOI 10.1086/514639; Sharma D, 2009, J PLAST RECONSTR AES, V62, P946, DOI 10.1016/j.bjps.2007.10.086; Sivakumar T, 2011, HIV MED, V12, P453, DOI 10.1111/j.1468-1293.2010.00906.x	10	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1289	1290		10.1001/jama.2013.2552	http://dx.doi.org/10.1001/jama.2013.2552			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532244				2022-12-28	WOS:000316625200029
J	Starren, J; Williams, MS; Bottinger, EP				Starren, Justin; Williams, Marc S.; Bottinger, Erwin P.			Crossing the Omic Chasm A Time for Omic Ancillary Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Starren, Justin] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Hlth & Biomed Informat, Chicago, IL 60611 USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA; [Bottinger, Erwin P.] Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, New York, NY USA	Northwestern University; Feinberg School of Medicine; Geisinger Health System; Icahn School of Medicine at Mount Sinai	Starren, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Hlth & Biomed Informat, 750 N Lake Shore Dr,11th Floor, Chicago, IL 60611 USA.	justin.starren@northwestern.edu		Williams, Marc/0000-0001-6165-8701	NHGRI NIH HHS [U01 HG006378, U01HG006385, U01HG006378, U01HG006828, U01HG006389, U01 HG006830, U01HG006375, U01 HG006385, U01 HG006388, U01 HG006375, U01HG006380, U01HG006379, U01 HG006389, U01 HG006828, U01HG006830, U01HG006382, U01 HG006379, U01 HG006382, U01HG006388, U01 HG006380] Funding Source: Medline; NIAID NIH HHS [R37 AI024717] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U01HG006382, U01HG006389, U01HG006380, U01HG006385, U01HG006379, U01HG006388, U01HG006830, U01HG006375, U01HG006828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Health Level 7 International (HL7) Clinical Genomics Committee, CLIN GEN; Institute of Medicine Roundtable on Translating Genomic-Based Research for Health, 2012, INT LARG SCAL GEN IN; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111	7	52	52	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1237	1238		10.1001/jama.2013.1579	http://dx.doi.org/10.1001/jama.2013.1579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23494000	Green Accepted			2022-12-28	WOS:000316625200022
J	Sawyer, DB				Sawyer, Douglas B.			Anthracyclines and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOXORUBICIN		Vanderbilt Univ, Med Ctr, Nashville, TN 37240 USA	Vanderbilt University	Sawyer, DB (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37240 USA.							Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; UNVERFERTH BJ, 1983, CANCER, V52, P215, DOI 10.1002/1097-0142(19830715)52:2<215::AID-CNCR2820520206>3.0.CO;2-F; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	3	98	101	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1154	1156		10.1056/NEJMcibr1214975	http://dx.doi.org/10.1056/NEJMcibr1214975			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514294				2022-12-28	WOS:000316318600011
J	Wise, J				Wise, Jacqui			Boldt: the great pretender	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CRITICALLY-ILL PATIENTS; HYDROXYETHYL STARCH; RESUSCITATION; METAANALYSIS; ALBUMIN; THERAPY					jacquiyoung1@gmail.com						[Anonymous], COCHRANE DATABASE SY; [Anonymous], 2011, EDITORS CHIEF STATEM; Antonelli M, 2013, JAMA-J AM MED ASSOC, V309, P7234; Boldt J, 2009, ANESTH ANALG, V109, P1752, DOI 10.1213/ANE.0b013e3181b5a24b; Dyer C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1492; European Commission, PROP REG EUR PARL CO; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; KLiLu, PRESS C 20 NOV 2010; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	11	49	55	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2013	346								f1738	10.1136/bmj.f1738	http://dx.doi.org/10.1136/bmj.f1738			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113LX	23512099				2022-12-28	WOS:000316670500035
J	Zheng, XT; Zhou, ZH; Wang, XL; Zhang, FC; Zhang, XM; Wang, Y; Wei, GJ; Wang, S; Xu, X				Zheng, Xiaoting; Zhou, Zhonghe; Wang, Xiaoli; Zhang, Fucheng; Zhang, Xiaomei; Wang, Yan; Wei, Guangjin; Wang, Shuo; Xu, Xing			Hind Wings in Basal Birds and the Evolution of Leg Feathers	SCIENCE			English	Article							INTEGUMENTARY STRUCTURES; 4-WINGED DINOSAURS; LONG FEATHERS; ORIGIN; CHINA; PALEONTOLOGY; THEROPOD; SCALES; FLIGHT	Recent discoveries of large leg feathers in some theropods have implications for our understanding of the evolution of integumentary features on the avialan leg, and particularly of their relevance for the origin of avialan flight. Here we report 11 basal avialan specimens that will greatly improve our knowledge of leg integumentary features among early birds. In particular, they provide solid evidence for the existence of enlarged leg feathers on a variety of basal birds, suggest that extensively scaled feet might have appeared secondarily at an early stage in ornithuromorph evolution, and demonstrate a distal-to-proximal reduction pattern for leg feathers in avialan evolution.	[Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan; Wei, Guangjin; Xu, Xing] Linyi Univ, Inst Geol & Palaeontol, Linyi 276005, Shandong, Peoples R China; [Zheng, Xiaoting; Zhang, Xiaomei] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Zhou, Zhonghe; Zhang, Fucheng; Wang, Shuo; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Wang, Shuo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zheng, XT (corresponding author), Linyi Univ, Inst Geol & Palaeontol, Shuangling Rd, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com	Wang, Shuo/AAX-8516-2020; Xiaoli, Wang/H-1079-2014	Wang, Shuo/0000-0002-4076-0202; 	National Natural Sciences Foundation of China (NNSFC) [41172016, 41120124002, 41125008]; National Basic Research Program of China [2012CB821900]; Chinese Academy of Sciences [KZCX2-EW-105]	National Natural Sciences Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Support for this research was provided by the National Natural Sciences Foundation of China (NNSFC grant nos. 41172016, 41120124002, and 41125008), the National Basic Research Program of China (grant no. 2012CB821900), and the Chinese Academy of Sciences (grant no. KZCX2-EW-105). We thank K. Padian and C. Sullivan for critical comments; C.-M. Chuong and T. Stidham for discussions; R. Li and H. Zang for illustrations; X. Ding for preparation of some of the specimens; and O. Rauhut, M. Koebl-Ebert, and M. Roeper for access to Archaeopteryx specimens.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Beebee C. W., 1915, Zoologica New York, V2; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Hall J., 2012, J VERTEBR PALEONTOL, V32, p105B; Harris MP, 2004, DEV DYNAM, V231, P22, DOI 10.1002/dvdy.20096; Hou L.-H., 2003, FOSSIL BIRDS CHINA; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; KELSO LEON, 1936, AUK, V53, P51; Koehl MAR, 2011, INTEGR COMP BIOL, V51, P1002, DOI 10.1093/icb/icr112; Logan M, 2003, DEVELOPMENT, V130, P6401, DOI 10.1242/dev.00956; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Lucas A., 1972, AVIAN ANATOMY INTEGU; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 2003, BIOSCIENCE, V53, P450; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Prum RO, 2003, NATURE, V421, P323, DOI 10.1038/421323a; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X., 2002, DEINONYCHOSAURIAN FO; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2005, NATURE, V438, pE4, DOI 10.1038/nature04356; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	37	75	84	2	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1309	1312		10.1126/science.1228753	http://dx.doi.org/10.1126/science.1228753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493711				2022-12-28	WOS:000316053400035
J	Yokobayashi, S; Liang, CY; Kohler, H; Nestorov, P; Liu, ZC; Vidal, M; van Lohuizen, M; Roloff, TC; Peters, AHFM				Yokobayashi, Shihori; Liang, Ching-Yeu; Kohler, Hubertus; Nestorov, Peter; Liu, Zichuan; Vidal, Miguel; van Lohuizen, Maarten; Roloff, Tim C.; Peters, Antoine H. F. M.			PRC1 coordinates timing of sexual differentiation of female primordial germ cells	NATURE			English	Article							RETINOIC ACID; HOX GENES; MICE; MEIOSIS; FATE; MECHANISMS; EXPRESSION	In mammals, sex differentiation of primordial germ cells (PGCs) is determined by extrinsic cues from the environment(1). In mouse female PGCs, expression of stimulated by retinoic acid gene 8 (Stra8) and meiosis are induced in response to retinoic acid provided from the mesonephroi(2-5). Given the widespread role of retinoic add signalling during development(6,7), the molecular mechanisms that enable PGCs to express Stra8 and enter meiosis in a timely manner are unknown(2,8). Here we identify gene-dosage-dependent roles in PGC development for Ring1 and Rnf2, two central components of the Polycomb repressive complex 1 (PRC1)(9,10). Both paralogues are essential for PGC development between days 10.5 and 11.5 of gestation. Rnf2 is subsequently required in female PGCs to maintain high levels of Oct4 (also known as Pou5f1) and Nanog expression(11), and to prevent premature induction of meiotic gene expression and entry into meiotic prophase. Chemical inhibition of retinoic acid signalling partially suppresses precocious Oct4 downregulation and Stra8 activation in Rnf2-deficient female PGCs. Chromatin immunoprecipitation analyses show that Stra8 is a direct target of PRC1 and PRC2 in PGCs. These data demonstrate the importance of PRC1 gene dosage in PGC development and in coordinating the timing of sex differentiation of female PGCs by antagonizing extrinsic retinoic add signalling.	[Yokobayashi, Shihori; Liang, Ching-Yeu; Kohler, Hubertus; Nestorov, Peter; Liu, Zichuan; Roloff, Tim C.; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Liang, Ching-Yeu; Nestorov, Peter; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Vidal, Miguel] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [van Lohuizen, Maarten] Netherlands Canc Inst NKI, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [van Lohuizen, Maarten] Netherlands Canc Inst NKI, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Friedrich Miescher Institute for Biomedical Research; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Netherlands Cancer Institute; Netherlands Cancer Institute	Peters, AHFM (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland.	antoine.peters@fmi.ch	Peters, Antoine/ABA-6283-2020; Vidal, Miguel/M-8861-2016	Peters, Antoine/0000-0002-0311-1887; Vidal, Miguel/0000-0003-4374-6761; Liang, Ching-Yeu/0000-0002-9027-1853	Human Frontier Science Program long-term fellowship; Japan Society for the Promotion of Science postdoctoral fellowship; Novartis Research Foundation; Swiss National Science Foundation [31003A_125386, NRP 63]; SystemsX.ch; Japanese Swiss Science and Technology Cooperation Program; European Network of Excellence; EMBO Young Investigator program	Human Frontier Science Program long-term fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; Japanese Swiss Science and Technology Cooperation Program; European Network of Excellence(European Commission); EMBO Young Investigator program(European Molecular Biology Organization (EMBO))	We thank A. Nagy and H. Scholer for the Tnap-cre and Oct4(APE)GFP mice, respectively, and M. Griswold for the Stra8 antibody. We are grateful to L. Gelman (microscopy and imaging), L Burger, M. Stadler (bioinformatics), E Cabuy, S. Thiry, K.Jacobeit (functional genomics) nd the FMI animal facilityfor assistance. We thank members of the Peters laboratory, particularly M. Tardat, S. Erkek and M. Gill, for experimental support and discussions. S.Y. is a recipient of a Human Frontier Science Program long-term fellowship and a Japan Society for the Promotion of Science postdoctoral fellowship. Research in the Peters laboratory is supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_125386 and NRP 63-Stem Cells and Regenerative Medicine), SystemsX.ch (Cell plasticity), the Japanese Swiss Science and Technology Cooperation Program, the European Network of Excellence 'The Epigenome' and the EMBO Young Investigator program.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Hogarth CA, 2011, BIOL REPROD, V84, P957, DOI 10.1095/biolreprod.110.088575; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	27	79	80	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					236	240		10.1038/nature11918	http://dx.doi.org/10.1038/nature11918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486062	Green Accepted			2022-12-28	WOS:000316652300051
J	Khullar, D; Schroeder, SA; Maa, J				Khullar, Dhruv; Schroeder, Steven A.; Maa, John			Helping Smokers Quit Around the Time of Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTOPERATIVE COMPLICATIONS; SMOKING-CESSATION; INTERVENTION		[Khullar, Dhruv] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, Smoking Cessat Leadership Ctr, San Francisco, CA 94131 USA; [Maa, John] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94131 USA	Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maa, J (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave,C 341, San Francisco, CA 94131 USA.	john.maa@ucsfmedctr.org						Baumgardner JR, 2012, NEW ENGL J MED, V367, P2068, DOI 10.1056/NEJMp1210319; Chow CK, 2011, ARCH INTERN MED, V171, P989, DOI 10.1001/archinternmed.2011.88; Khullar D, 2012, J AM COLL SURGEONS, V215, P418, DOI 10.1016/j.jamcollsurg.2012.05.023; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Myers K, 2011, ARCH INTERN MED, V171, P983, DOI 10.1001/archinternmed.2011.97; Rigotti NA, 2012, JAMA-J AM MED ASSOC, V308, P1573, DOI 10.1001/jama.2012.13043; *US DEP HHS, 2008, TREAT TOB US DEP 200; Vaughan-Sarrazin M, 2011, SURGERY, V149, P474, DOI 10.1016/j.surg.2010.12.004; Warner DO, 2009, ANESTHESIOLOGY, V110, P1223, DOI 10.1097/ALN.0b013e3181a5d03e	10	8	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					993	994		10.1001/jama.2013.1702	http://dx.doi.org/10.1001/jama.2013.1702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483172				2022-12-28	WOS:000315938700026
J	Johnson, S				Johnson, Sonia			Can we reverse the rising tide of compulsory admissions?	LANCET			English	Editorial Material							HEALTH-CARE		UCL, Mental Hlth Sci Unit, London W1W 7EY, England	University of London; University College London	Johnson, S (corresponding author), UCL, Mental Hlth Sci Unit, London W1W 7EY, England.	s.johnson@ucl.ac.uk	Johnson, Sonia/ABF-1457-2020; Johnson, Sonia/A-5220-2008	Johnson, Sonia/0000-0002-2219-1384; Johnson, Sonia/0000-0002-2219-1384				Burns T, 2013, LANCET; Crawford V, 2003, DRUG-EDUC PREV POLIC, V10, pS1, DOI 10.1080/0968763031000072990; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Jones J, 2010, J PSYCHIATR MENT HLT, V17, P124, DOI 10.1111/j.1365-2850.2009.01482.x; Keown P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3736; Khurmi S, 2010, ADV PSYCHIAT TREAT, V16, P263; Kisely S. R., 2011, COCHRANE DB SYST REV, V2; Rowe R, 2006, EUR J PUBLIC HEALTH, V16, P4, DOI 10.1093/eurpub/ckl004; Rugkasa J, 2009, PSYCHIATRY, V8, P493, DOI DOI 10.1016/J.MPPSY.2009.09.009; Tew J, 2012, BRIT J SOC WORK, V42, P443, DOI 10.1093/bjsw/bcr076; The Schizophrenia Commission, 2012, THE ABANDONED ILLNES; Thornicroft G, 2013, LANCET; Wierdsma Andre I, 2009, Int J Integr Care, V9, pe90	14	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1603	1604		10.1016/S0140-6736(13)60442-0	http://dx.doi.org/10.1016/S0140-6736(13)60442-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23537604	Green Submitted			2022-12-28	WOS:000319112400006
J	Smith, R; McCready, T; Yusuf, S				Smith, Richard; McCready, Tara; Yusuf, Salim			Combination Therapy to Prevent Cardiovascular Disease Slow Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Smith, Richard] UnitedHlth Chron Dis Initiat, London, England; [McCready, Tara; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [McCready, Tara; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				American Heart Association, 2012, PEOPLE MORE LIKELY T; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Diaz R, 2012, EUROPEAN SOCIETY OF; Dudl RJ, 2009, AM J MANAG CARE, V15, pE88; Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; The Global Summit on Combination Polypharmacy for Cardiovascular Disease, 2012, THE GLOBAL SUMMIT ON; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	8	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1595	1596		10.1001/jama.2013.3180	http://dx.doi.org/10.1001/jama.2013.3180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23529576				2022-12-28	WOS:000317599500021
J	Chen, XG; Taylor, DW; Fowler, CC; Galan, JE; Wang, HW; Wolin, SL				Chen, Xinguo; Taylor, David W.; Fowler, Casey C.; Galan, Jorge E.; Wang, Hong-Wei; Wolin, Sandra L.			An RNA Degradation Machine Sculpted by Ro Autoantigen and Noncoding RNA	CELL			English	Article							5S RIBOSOMAL-RNA; Y-RNAS; POLYNUCLEOTIDE PHOSPHORYLASE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; BINDING; RIBONUCLEOPROTEIN; RECOGNITION; ORTHOLOG; PROTEIN	Many bacteria contain an ortholog of the Ro autoantigen, a ring-shaped protein that binds noncoding RNAs (ncRNAs) called Y RNAs. In the only studied bacterium, Deinococcus radiodurans, the Ro ortholog Rsr functions in heat-stress-induced ribosomal RNA (rRNA) maturation and starvation-induced rRNA decay. However, the mechanism by which this conserved protein and its associated ncRNAs act has been obscure. We report that Rsr and the exoribonuclease polynucleotide phosphorylase (PNPase) form an RNA degradation machine that is scaffolded by Y RNA. Single-particle electron microscopy, followed by docking of atomic models into the reconstruction, suggests that Rsr channels single-stranded RNA into the PNPase cavity. Biochemical assays reveal that Rsr and Y RNA adapt PNPase for effective degradation of structured RNAs. A Ro ortholog and ncRNA also associate with PNPase in Salmonella Typhimurium. Our studies identify another ribonucleoprotein machine and demonstrate that ncRNA, by tethering a protein cofactor, can alter the substrate specificity of an enzyme.	[Chen, Xinguo; Galan, Jorge E.; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Taylor, David W.; Wang, Hong-Wei; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Fowler, Casey C.; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Wolin, SL (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	sandra.wolin@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399; Taylor, David/0000-0002-6198-1194; Fowler, Casey/0000-0001-6494-5650	Smith Family Awards Program for Excellence in Biomedical Research; NIH [R01 AI079022, R01 GM073863]; Molecular Biophysics training grant [5 T32 GM008283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073863, T32GM008283] Funding Source: NIH RePORTER	Smith Family Awards Program for Excellence in Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X.C. identified the Rsr/Y RNA/PNPase RNP, reconstituted it in E. coli, and performed all biochemical experiments. D.W.T. performed the single-particle electron microscopy and three-dimensional reconstruction. C.C.F. prepared S. Typhimurium strains and extracts. All authors contributed to planning experiments and analyzing data. We thank J. Button for assistance in preparing S. Typhimurium strains; A. Carpousis, N. Kucera, A. Ramesh, J. Sacchettini, S. Sim, and E. Wurtmann for reagents; H. Zheng and K. Reinisch for assistance with baculovirus; G. Lander, M. Cianfrocco, and P. Grob for electron microscopy assistance; E. Conti for advice; and S. Baserga, E. De La Cruz, A. Horwich, J. Steitz, E. Ullu, and Y. Zuo for comments on the manuscript. We thank the Yale Center for Cellular and Molecular Imaging and E. Nogales for use of the EM facility at UC-Berkeley. D.W.T is an NSF Graduate Research Fellow. This work was supported by the Smith Family Awards Program for Excellence in Biomedical Research (to H.W.), NIH grants R01 AI079022 (to J.E.G.) and R01 GM073863 (to S.L.W.), and Molecular Biophysics training grant 5 T32 GM008283 (to D.W.T.).	Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bouffard P, 2000, RNA, V6, P66, DOI 10.1017/S1355838200990277; Chen XG, 2000, GENE DEV, V14, P777; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Chen XG, 2007, GENE DEV, V21, P1328, DOI 10.1101/gad.1548207; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Evguenieva-Hackenberg E, 2010, ADV EXP MED BIOL, V702, P29; Evguenieva-Hackenberg E, 2008, BIOCHEMISTRY-US, V47, P13158, DOI 10.1021/bi8012214; Fabini G, 2001, J BIOL CHEM, V276, P20711, DOI 10.1074/jbc.M101360200; Fouraux MA, 2002, J MOL BIOL, V320, P475, DOI 10.1016/S0022-2836(02)00518-1; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Gorna MW, 2012, Q REV BIOPHYS, V45, P105, DOI 10.1017/S003358351100014X; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Labbe JC, 1999, GENETICS, V151, P143; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Ramesh A, 2007, J BIOL CHEM, V282, P14960, DOI 10.1074/jbc.M611163200; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shi H, 1996, RNA, V2, P769; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Teunissen SWM, 2000, NUCLEIC ACIDS RES, V28, P610, DOI 10.1093/nar/28.2.610; Wurtmann EJ, 2010, P NATL ACAD SCI USA, V107, P4022, DOI 10.1073/pnas.1000307107; Yoshioka C, 2007, J STRUCT BIOL, V159, P335, DOI 10.1016/j.jsb.2007.03.005	37	68	69	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					166	177		10.1016/j.cell.2013.02.037	http://dx.doi.org/10.1016/j.cell.2013.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540697	Green Accepted, Bronze			2022-12-28	WOS:000316853700014
J	Epstein, AJ; Srinivas, SK; Nicholson, S; Herrin, J; Asch, DA				Epstein, Andrew J.; Srinivas, Sindhu K.; Nicholson, Sean; Herrin, Jeph; Asch, David A.			Association between physicians' experience after training and maternal obstetrical outcomes: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEARNING-CURVE; MORTALITY; SURGEONS; CARE	Objective To assess the association between obstetricians' years of experience after training and the maternal complications of their patients during their first 40 years of post-residency practice. Design Retrospective cohort analysis. Setting Obstetrical discharges from acute care hospitals in Florida and New York between academic years 1992 and 2009. Population 6 704 311 deliveries performed by 5175 obstetricians. Main outcome measure Three composite measures of maternal complication rates per physician year from vaginal and cesarean births separately and combined, adjusted for secular trends. Results Obstetricians' maternal complication rates declined during the first three decades after completion of residency. The improvement was largest in the first decade and diminished thereafter. For all deliveries, the change was -0.21 (95% confidence interval -0.23 to -0.19) percentage points per year in the first decade, -0.11 (-0.13 to -0.09) percentage points per year in the second decade, and -0.05 (-0.08 to -0.01) percentage points in the third decade (P<0.001 for second to first decade comparison; P=0.001 for third to second decade comparison). The patterns were comparable for cesarean deliveries and vaginal deliveries and across several sensitivity checks. Conclusions Among obstetricians practicing in Florida and New York, those with more years of experience had fewer maternal complications. This association persisted over the first three decades of practice but diminished in magnitude.	[Epstein, Andrew J.; Asch, David A.] Philadelphia Vet Affairs Med Ctr, Dept Vet Affairs, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; [Epstein, Andrew J.; Asch, David A.] Univ Penn, Div Gen Internal Med, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Epstein, Andrew J.; Srinivas, Sindhu K.; Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Srinivas, Sindhu K.] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nicholson, Sean] Cornell Univ, Dept Policy Anal & Management, Coll Human Ecol, Ithaca, NY 14853 USA; [Herrin, Jeph] Yale Univ, Sect Cardiovasc Med, Dept Med, Sch Med, New Haven, CT 06510 USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL 60606 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Yale University	Epstein, AJ (corresponding author), Philadelphia Vet Affairs Med Ctr, Dept Vet Affairs, Ctr Hlth Equity Res & Promot, 3900 Woodland Ave, Philadelphia, PA 19104 USA.	eandrew@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X; Epstein, Andrew/0000-0001-5078-6564				Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bridgewater B, 2004, BMJ-BRIT MED J, V329, P421, DOI 10.1136/bmj.38173.577697.55; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Epstein AJ, 2010, J HEALTH ECON, V29, P718, DOI 10.1016/j.jhealeco.2010.06.002; Gawande A. A., 2011, PERSONAL BEST; Gregory KD, 2002, HEALTH SERV RES, V37, P1387, DOI 10.1111/1475-6773.10762; Hopper AN, 2007, POSTGRAD MED J, V83, P777, DOI 10.1136/pgmj.2007.057190; Huesch MD, 2009, HEALTH SERV RES, V44, P1960, DOI 10.1111/j.1475-6773.2009.01018.x; Huesch MD, 2009, HEALTH ECON, V18, P855, DOI 10.1002/hec.1412; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Pisano GP, 2001, MANAGE SCI, V47, P752, DOI 10.1287/mnsc.47.6.752.9811; Rathore SS, 2005, JAMA-J AM MED ASSOC, V293, P1383, DOI 10.1001/jama.293.11.1383; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Srinivas SK, 2010, MED CARE, V48, P487, DOI 10.1097/MLR.0b013e3181d68840; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Waljee JF, 2006, ANN SURG, V244, P353, DOI 10.1097/01.sla.0000234803.11991.6d; Waljee Jennifer F, 2007, Adv Surg, V41, P189, DOI 10.1016/j.yasu.2007.05.012	17	17	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1596	10.1136/bmj.f1596	http://dx.doi.org/10.1136/bmj.f1596			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117XI	23538919	Green Published, hybrid			2022-12-28	WOS:000316986200003
J	Olma, MH; Dikic, I				Olma, Michael H.; Dikic, Ivan			Cullins Getting Undressed by the Protein Exchange Factor Cand1	CELL			English	Editorial Material							UBIQUITIN LIGASES; COMPLEX	Cullin-RING ubiquitin ligase complexes (CRLs) rely on a vast array of adaptor proteins to recognize their substrates. Pierce et al. and related papers from Zemla et al. and Wu et al. in Nature Communications show that Cand1 promotes exchange of adaptor proteins to regulate the CRL repertoire.	[Olma, Michael H.; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Olma, Michael H.; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Wu S., 2013, NAT COMMUN; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628	10	3	4	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					14	16		10.1016/j.cell.2013.03.014	http://dx.doi.org/10.1016/j.cell.2013.03.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540687	Bronze			2022-12-28	WOS:000316853700003
J	Ekstrom, G; Stark, CP				Ekstroem, Goeran; Stark, Colin P.			Simple Scaling of Catastrophic Landslide Dynamics	SCIENCE			English	Article							MOUNT ST-HELENS; STROMBOLI VOLCANO; SEISMIC SIGNALS; SINGLE-FORCE; WAVES; EARTHQUAKES; ERUPTION; COLLAPSE; TSUNAMI	Catastrophic landslides involve the acceleration and deceleration of millions of tons of rock and debris in response to the forces of gravity and dissipation. Their unpredictability and frequent location in remote areas have made observations of their dynamics rare. Through real-time detection and inverse modeling of teleseismic data, we show that landslide dynamics are primarily determined by the length scale of the source mass. When combined with geometric constraints from satellite imagery, the seismically determined landslide force histories yield estimates of landslide duration, momenta, potential energy loss, mass, and runout trajectory. Measurements of these dynamical properties for 29 teleseismogenic landslides are consistent with a simple acceleration model in which height drop and rupture depth scale with the length of the failing slope.	[Ekstroem, Goeran; Stark, Colin P.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Ekstrom, G (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	ekstrom@ldeo.columbia.edu	Ekstrom, Goran/C-9771-2012	Ekstrom, Goran/0000-0001-6410-275X	NSF [EAR-0824694, EAR-1150072, EAR-1227083]; Directorate For Geosciences [1227083] Funding Source: National Science Foundation; Division Of Earth Sciences [0824694] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful to C.-W. Lin, R.-J. Rau, S.-P. Lee, Hongey Chen, S.-H. Liu, and Y.-C. Tsang for help with analysis of landslides triggered by Typhoon Morakot; to E. Choi and M. Reitz for discussions on landslide mechanics; and to D. Petley for help and information on several of the landslide events reported here. Data are available in the supplementary materials. This research was supported by NSF Awards EAR-0824694, EAR-1150072, and EAR-1227083.	Brodsky EE, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018; Crosta GB, 2004, GEOMORPHOLOGY, V60, P127, DOI 10.1016/j.geomorph.2003.07.015; Downes G., 2002, LANDSLIDES, P649; Eberhardt E, 2004, INT J ROCK MECH MIN, V41, P69, DOI 10.1016/S1365-1609(03)00076-5; Ekstrom G, 2003, SCIENCE, V302, P622, DOI 10.1126/science.1088057; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Ekstrom G, 2006, B SEISMOL SOC AM, V96, P1201, DOI 10.1785/0120050175; Favreau P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043512; FUKAO Y, 1995, GEOPHYS J INT, V122, P243, DOI 10.1111/j.1365-246X.1995.tb03551.x; HASEGAWA HS, 1987, B SEISMOL SOC AM, V77, P1984; KANAMORI H, 1984, J GEOPHYS RES, V89, P1856, DOI 10.1029/JB089iB03p01856; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; Kotlyakov V. M., 2003, MAT GLYATSIOL ISSLED, V95, P221; La Rocca M, 2004, B SEISMOL SOC AM, V94, P1850, DOI 10.1785/012003238; Lin CH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044685; Moretti L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052511; Nettles M, 2010, ANNU REV EARTH PL SC, V38, P467, DOI 10.1146/annurev-earth-040809-152414; OKAL EA, 1990, J PHYS EARTH, V38, P445, DOI 10.4294/jpe1952.38.445; PARISEAU WG, 1980, ENG GEOL, V16, P111, DOI 10.1016/0013-7952(80)90011-3; PEART M, 1991, Q J ENG GEOL, V24, P399, DOI 10.1144/GSL.QJEG.1991.024.04.07; Petley David, 2011, International Water Power and Dam Construction, V63, P27; Pino NA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018385; Shang YJ, 2003, GEOMORPHOLOGY, V54, P225, DOI 10.1016/S0169-555X(02)00358-6; Shuler A, 2009, J VOLCANOL GEOTH RES, V181, P219, DOI 10.1016/j.jvolgeores.2009.01.011; TAKEI Y, 1994, GEOPHYS J INT, V118, P20, DOI 10.1111/j.1365-246X.1994.tb04672.x; Ward SN, 2006, GEOPHYS J INT, V167, P991, DOI 10.1111/j.1365-246X.2006.03118.x; WEICHERT D, 1994, B SEISMOL SOC AM, V84, P1523; Yamada M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052174	28	149	155	7	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1416	1419		10.1126/science.1232887	http://dx.doi.org/10.1126/science.1232887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520108	Green Submitted			2022-12-28	WOS:000316740700038
J	Carroll, JD; Saver, JL; Thaler, DE; Smalling, RW; Berry, S; MacDonald, LA; Marks, DS; Tirschwell, DL				Carroll, John D.; Saver, Jeffrey L.; Thaler, David E.; Smalling, Richard W.; Berry, Scott; MacDonald, Lee A.; Marks, David S.; Tirschwell, David L.		RESPECT Investigators	Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSIENT ISCHEMIC ATTACK; THROMBUS FORMATION; PREVENTION; DEVICES; EVENTS	Background Whether closure of a patent foramen ovale is effective in the prevention of recurrent ischemic stroke in patients who have had a cryptogenic stroke is unknown. We conducted a trial to evaluate whether closure is superior to medical therapy alone in preventing recurrent ischemic stroke or early death in patients 18 to 60 years of age. Methods In this prospective, multicenter, randomized, event-driven trial, we randomly assigned patients, in a 1:1 ratio, to medical therapy alone or closure of the patent foramen ovale. The primary results of the trial were analyzed when the target of 25 primary end-point events had been observed and adjudicated. Results We enrolled 980 patients mean age, 45.9 years) at 69 sites. The medical-therapy group received one or more antiplatelet medications 74.8%) or warfarin 25.2%). Treatment exposure between the two groups was unequal 1375 patient-years in the closure group vs. 1184 patient-years in the medical-therapy group, P=0.009) owing to a higher dropout rate in the medical-therapy group. In the intention-to-treat cohort, 9 patients in the closure group and 16 in the medical-therapy group had a recurrence of stroke hazard ratio with closure, 0.49; 95% confidence interval [CI], 0.22 to 1.11; P=0.08). The between-group difference in the rate of recurrent stroke was significant in the prespecified per-protocol cohort 6 events in the closure group vs. 14 events in the medical-therapy group; hazard ratio, 0.37; 95% CI, 0.14 to 0.96; P=0.03) and in the as-treated cohort 5 events vs. 16 events; hazard ratio, 0.27; 95% CI, 0.10 to 0.75; P=0.007). Serious adverse events occurred in 23.0% of the patients in the closure group and in 21.6% in the medical-therapy group P=0.65). Procedure-related or device-related serious adverse events occurred in 21 of 499 patients in the closure group 4.2%), but the rate of atrial fibrillation or device thrombus was not increased. Conclusions In the primary intention-to-treat analysis, there was no significant benefit associated with closure of a patent foramen ovale in adults who had had a cryptogenic ischemic stroke. However, closure was superior to medical therapy alone in the prespecified per-protocol and as-treated analyses, with a low rate of associated risks. Funded by St. Jude Medical; RESPECT ClinicalTrials.gov number, NCT00465270.)	[Carroll, John D.] Univ Colorado Denver, Univ Colorado Hosp, Aurora, CO 80045 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, Los Angeles, CA USA; [Thaler, David E.] Tufts Univ, Tufts Med Ctr, Boston, MA 02111 USA; [Smalling, Richard W.] Univ Texas Houston, Mem Hermann Heart & Vasc Inst, Houston, TX USA; [Berry, Scott] Berry Consultants, Austin, TX USA; [MacDonald, Lee A.] South Denver Cardiol, Swedish Med Ctr, Littleton, CO USA; [Marks, David S.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Tirschwell, David L.] Univ Washington, Seattle, WA 98195 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Hospital; University of California System; University of California Los Angeles; Tufts Medical Center; Tufts University; University of Texas System; University of Texas Health Science Center Houston; Medical College of Wisconsin; University of Washington; University of Washington Seattle	Carroll, JD (corresponding author), Univ Colorado Denver, Anschutz Med Campus,Leprino Bldg,12401 East 17th, Aurora, CO 80045 USA.	john.carroll@ucdenver.edu	Dias, Bryan/G-3290-2011; Meurer, William J/A-7547-2010; Spence, J. David/K-6396-2013; Hill, Michael D/C-9073-2012; Buck, Brian H/B-8482-2009	Meurer, William J/0000-0002-1158-5302; Spence, J. David/0000-0001-7478-1098; Hill, Michael D/0000-0002-6269-1543; Buck, Brian H/0000-0002-7984-6062; Saver, Jeffrey/0000-0001-9141-2251; Tirschwell, David/0000-0002-8059-2901; Moscucci, Mauro/0000-0002-9123-4472	St. Jude Medical	St. Jude Medical(St. Jude Medical)	Supported by St. Jude Medical.	Agarwal S, 2012, JACC-CARDIOVASC INTE, V5, P777, DOI 10.1016/j.jcin.2012.02.021; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Amin Z, 2008, CATHETER CARDIO INTE, V72, P74, DOI 10.1002/ccd.21582; Anzai H, 2004, AM J CARDIOL, V93, P426, DOI 10.1016/j.amjcard.2003.10.036; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; International Conference on Harmonization, 1998, GUID IND E9 STAT PRI; Karanjia PN, 1997, NEUROLOGY, V48, P346, DOI 10.1212/WNL.48.2.346; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Kramer P, 2007, CATHETER CARDIO INTE, V69, P1, DOI 10.1002/ccd.20724; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Silvestry FE, 2009, J AM SOC ECHOCARDIOG, V22, P213, DOI 10.1016/j.echo.2008.12.013; Staubach S, 2009, CATHETER CARDIO INTE, V74, P889, DOI 10.1002/ccd.22172; Thaler DE, 2012, STROKE, V43, P3147, DOI 10.1161/STROKEAHA.112.659599; Toole JF, 1996, AM J EPIDEMIOL, V144, P849; WEBSTER MWI, 1988, LANCET, V2, P11	19	607	637	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1092	1100		10.1056/NEJMoa1301440	http://dx.doi.org/10.1056/NEJMoa1301440			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514286				2022-12-28	WOS:000316318600002
J	Naif, S; Key, K; Constable, S; Evans, RL				Naif, S.; Key, K.; Constable, S.; Evans, R. L.			Melt-rich channel observed at the lithosphere-asthenosphere boundary	NATURE			English	Article							WATER; DYNAMICS; ORIGIN	The lithosphere-asthenosphere boundary (LAB) separates rigid oceanic plates from the underlying warm ductile asthenosphere. Although a viscosity decrease beneath this boundary is essential for plate tectonics, a consensus on its origin remains elusive. Seismic studies identify a prominent velocity discontinuity at depths thought to coincide with the LAB but disagree on its cause(1-5), generally invoking either partial melting(6) or a mantle dehydration boundary(7) as explanations. Here we use sea-floor magnetotelluric data to image the electrical conductivity of the LAB beneath the edge of the Cocos plate at the Middle America trench offshore of Nicaragua. Underneath the resistive oceanic lithosphere, the magnetotelluric data reveal a high-conductivity layer confined to depths of 45 to 70 kilometres. Because partial melts are stable at these depths in a warm damp mantle(8), we interpret the conductor to be a partially molten layer capped by an impermeable frozen lid that is the base of the lithosphere. A conductivity anisotropy parallel to plate motion indicates that this melt has been sheared into flow-aligned tube-like structures(9). We infer that the LAB beneath young plates consists of a thin, partially molten, channel of low viscosity that acts to decouple the overlying brittle lithosphere from the deeper convecting mantle. Because this boundary layer has the potential to behave as a lubricant to plate motion, its proximity to the trench may have implications for subduction dynamics.	[Naif, S.; Key, K.; Constable, S.] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Evans, R. L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution	Naif, S (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	snaif@ucsd.edu	Key, Kerry/AAH-6949-2021; Key, Kerry W/B-1092-2008; Constable, Steven C/B-8959-2008	Key, Kerry/0000-0003-1169-6683; Constable, Steven/0000-0001-6324-3470; Naif, Samer/0000-0003-3579-5379; Evans, Robert/0000-0001-5585-0684	National Science Foundation [OCE-08411141, OCE-0840894]; Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography; Directorate For Geosciences [0840894] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain (M. Stein) and crew of R/V Melville and the governments of Nicaragua and Costa Rica for permission to work in their exclusive economic zones. The following are thanked for their participation in the research cruise: C. Armerding, C. Berger, E. Carruthers, B. Cohen, J. Elsenbeck, T. Matsuno, D. Myer, A. Orange, J. Perez, K. Shadle, J. Souders, K. Weitemeyer, B. Wheelock and S. Zipper; J. Lemire and A. Jacobs are thanked for their efforts with cruise planning, mobilization and demobilization. We thank B. Wheelock and D. Hasterok for discussions. This work was supported by the National Science Foundation (grants OCE-08411141 and OCE-0840894) and the Seafloor Electromagnetic Methods Consortium at Scripps Institution of Oceanography.	Anderson D.L., 1970, PHYS EARTH PLANET IN, V3, P41, DOI DOI 10.1016/0031-9201(70)90042-7; Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; Bagley B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005692; Ballmer MD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031636; Caricchi L, 2011, EARTH PLANET SC LETT, V302, P81, DOI 10.1016/j.epsl.2010.11.041; COX CS, 1986, NATURE, V320, P52, DOI 10.1038/320052a0; DEGROOTHEDLIN C, 1990, GEOPHYSICS, V55, P1613, DOI 10.1190/1.1442813; Egbert GD, 1997, GEOPHYS J INT, V130, P475, DOI 10.1111/j.1365-246X.1997.tb05663.x; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hoink T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003698; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Katz RF, 2008, J PETROL, V49, P2099, DOI 10.1093/petrology/egn058; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Key K, 2012, EARTH PLANET SC LETT, V351, P45, DOI 10.1016/j.epsl.2012.07.020; Key K, 2011, GEOPHYS J INT, V186, P137, DOI 10.1111/j.1365-246X.2011.05025.x; Kohlstedt DL, 2009, ANNU REV EARTH PL SC, V37, P561, DOI 10.1146/annurev.earth.031208.100104; Matsuno T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003101; Mierdel K, 2007, SCIENCE, V315, P364, DOI 10.1126/science.1135422; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; Poe BT, 2010, PHYS EARTH PLANET IN, V181, P103, DOI 10.1016/j.pepi.2010.05.003; Rychert CA, 2009, SCIENCE, V324, P495, DOI 10.1126/science.1169754; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Takei Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005850; Zhu WL, 2011, SCIENCE, V332, P88, DOI 10.1126/science.1202221	30	170	184	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					356	359		10.1038/nature11939	http://dx.doi.org/10.1038/nature11939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518564				2022-12-28	WOS:000316650500040
J	Sedgwick, P				Sedgwick, Philip			Limits of agreement (Bland-Altman method)	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Altman DG, 1983, J R STAT SOC D-STAT, V32, P307, DOI DOI 10.2307/2987937; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6727; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5407; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8010	5	51	52	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2013	346								f1630	10.1136/bmj.f1630	http://dx.doi.org/10.1136/bmj.f1630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VT	23502707				2022-12-28	WOS:000316325000002
J	Detsky, AS; Berwick, DM				Detsky, Allan S.; Berwick, Donald M.			Teaching Physicians to Care Amid Chaos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUTY HOURS		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Berwick, Donald M.] Harvard Univ, Sch Med, Boston, MA USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Harvard Medical School; Institute for Healthcare Improvement	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Arora VM, 2012, JAMA-J AM MED ASSOC, V308, P2195, DOI 10.1001/jama.2012.14584; Cimino JJ, 2013, JAMA-J AM MED ASSOC, V309, P991, DOI 10.1001/jama.2013.890; Hirschtick RE, 2012, JAMA-J AM MED ASSOC, V308, P463, DOI 10.1001/jama.2012.8331; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Lucas BP, 2012, JAMA-J AM MED ASSOC, V308, P2199, DOI 10.1001/jama.2012.36522; Rafelson WM, 2012, JAMA-J AM MED ASSOC, V308, P579, DOI 10.1001/jama.2012.8727; Rosenbaum L, 2012, NEW ENGL J MED, V367, P2044, DOI 10.1056/NEJMsr1210160; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946	8	25	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					987	988		10.1001/jama.2013.620	http://dx.doi.org/10.1001/jama.2013.620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483169				2022-12-28	WOS:000315938700023
J	Lawlor, DA; Wills, AK; Fraser, A; Sayers, A; Fraser, WD; Tobias, JH				Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail; Sayers, Adrian; Fraser, William D.; Tobias, Jonathan H.			Association of maternal vitamin D status during pregnancy with bone-mineral content in off spring: a prospective cohort study	LANCET			English	Article							D DEFICIENCY; CHILDHOOD; BODY; MASS; PREVENTION	Background Maternal vitamin D status in pregnancy is a suggested determinant of bone-mineral content (BMC) in off spring, but has been assessed in small studies. We investigated this association in a large prospective study. Methods Eligible participants were mother-and-singleton-off spring pairs who had participated in the Avon Longitudinal Study of Parents and Children, and in which the mother had recorded measurements of 25(OH) D concentration in pregnancy and the off spring had undergone dual-energy x-ray absorptiometry at age 9-10 years. 25(OH) D concentrations in pregnancy were assessed per 10.0 nmol/L and classified as sufficient (more than 50.00 nmol/L), insufficient (49.99-27.50 nmol/L), or deficient (lower than 27.50 nmol/L). Associations between maternal serum 25(OH) D concentrations and off spring total body less head (TBLH) and spinal BMC were assessed by trimester. Results 3960 mother-and-off spring pairs, mainly of white European origin, were assessed (TBLH BMC n=3960, spinal BMC n=3196). Mean off spring age was 9.9 years. 2644 (67%) mothers had sufficient, 1096 (28%) insufficient, and 220 (6%) deficient 25(OH) D concentrations in pregnancy, but TBLH and spinal BMC did not differ between off spring of mothers in the lower two groups versus sufficient 25(OH) D concentration. No associations with off spring BMC were found for any trimester, including the third trimester, which is thought to be most relevant (TBLH BMC confounder-adjusted mean difference -0.03 g per 10.0 nmol/L, 95% CI -1.71 to 1.65; spinal BMC 0.04 g per 10.0 nmol/L, 95% CI -0.12 to 0.21). Conclusions We found no relevant association between maternal vitamin D status in pregnancy and off spring BMC in late childhood.	[Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Lawlor, Debbie A.; Wills, Andrew K.; Fraser, Abigail; Sayers, Adrian] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Fraser, William D.] Univ Bristol, Sch Clin Sci, Bristol BS8 2BN, Avon, England; [Tobias, Jonathan H.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Bristol; University of Bristol; University of Bristol; University of East Anglia	Lawlor, DA (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Oakfield House, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk	Wills, Andrew/AAO-5279-2020; Tobias, Jon/E-2832-2014; Sayers, Adrian/AAU-8134-2020	Tobias, Jon/0000-0002-7475-3932; Sayers, Adrian/0000-0001-7452-5043; Fraser, Abigail/0000-0002-7741-9470; Lawlor, Debbie A/0000-0002-6793-2262; Wills, Andrew/0000-0002-9751-4707	UK Medical Research Council; Wellcome Trust; University of Bristol; Medical Research Council [G0701594, G0701603, G0600705] Funding Source: researchfish; MRC [G0600705, G0701594, G0701603] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council, Wellcome Trust, and University of Bristol.	Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Dawodu A, 2007, ARCH DIS CHILD, V92, P737, DOI 10.1136/adc.2007.122689; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gartner LM, 2003, PEDIATRICS, V111, P908, DOI 10.1542/peds.111.4.908; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Lapillonne A, 1997, ACTA PAEDIATR, V86, P196, DOI 10.1111/j.1651-2227.1997.tb08868.x; Macdonald-Wallis C, 2010, AM J CLIN NUTR, V92, P872, DOI 10.3945/ajcn.2010.29501; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Sayers A, 2012, OSTEOPOROSIS INT, V23, P2117, DOI 10.1007/s00198-011-1813-9; Sayers A, 2009, J CLIN ENDOCR METAB, V94, P765, DOI 10.1210/jc.2008-2146; Thomas SDC, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000236; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Viljakainen HT, 2011, OSTEOPOROSIS INT, V22, P883, DOI 10.1007/s00198-010-1499-4; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; Weaver CM, 2007, J BONE MINER RES, V22, pV45, DOI 10.1359/JBMR.07S201; Weiler H, 2005, CAN MED ASSOC J, V172, P757, DOI 10.1503/cmaj.1040508; Yu CKH, 2011, FETAL DIAGN THER, V30, P94, DOI 10.1159/000324340	20	110	111	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2176	2183		10.1016/S0140-6736(12)62203-X	http://dx.doi.org/10.1016/S0140-6736(12)62203-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23518316	Green Published, Bronze			2022-12-28	WOS:000320925600034
J	Chapman, S; Alpers, P				Chapman, Simon; Alpers, Philip			Gun-Related Deaths: How Australia Stepped Off "The American Path"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chapman, Simon; Alpers, Philip] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, A27, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					Alpers Philip, 2013, REDUCING GUN VIOLENC, V205; Baker J, 2007, BRIT J CRIMINOL, V47, P455, DOI 10.1093/bjc/azl084; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chapman S., 1998, OUR DEAD BODIES PORT; Chapman S, 2008, HEALTH POLICY, V88, P152, DOI 10.1016/j.healthpol.2008.04.013; Commonwealth of Australia, 1996, RES SPEC FIR M; Hemenway D, 2009, J PUBLIC HEALTH POL, V30, P260, DOI 10.1057/jphp.2009.26; Leigh A, 2010, AM LAW ECON REV, V12, P509, DOI 10.1093/aler/ahq013; Neill C, 2007, 555 EPS AUSTR NAT U; Rossetti A., 2013, GUNS AUSTR FACTS FIG	10	8	8	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					770	+		10.7326/0003-4819-158-10-201305210-00624	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00624			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	154HY	23478752				2022-12-28	WOS:000319666200019
J	Cleland, J; Shah, IH				Cleland, John; Shah, Iqbal H.			The contraceptive revolution: focused efforts are still needed	LANCET			English	Editorial Material							UNMET NEED; DEVELOPING-COUNTRIES		[Cleland, John] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Shah, Iqbal H.] Susan Thompson Buffett Fdn, Omaha, NE USA	University of London; London School of Hygiene & Tropical Medicine	Cleland, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, Keppel St, London WC1E 7HT, England.	john.cleland@lshtm.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				Ali M., 2012, CAUSES CONSEQUENCES; BONGAARTS J, 1995, STUD FAMILY PLANN, V26, P57, DOI 10.2307/2137932; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Feyisetan B, 2000, INT FAM PLAN PERSPEC, V26, P100, DOI 10.2307/2648298; FishelJoy D, 2012, DHS ANAL STUDIES, V25; Menozzi C, 2013, LANCET; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2012, BANGL DEM HLTH SURV; Rutstein S. O., 2011, DHS COMP REPORTS, V28; United Nations Population Division, 2012, WORLD CONTR US 2011; United Nations Population Division, WORLD POP PROSP 2010; USAID, 2012, 3 SUCC SUBS AFR FAM; WESTOFF CF, 1978, FAM PLANN PERSPECT, V10, P173, DOI 10.2307/2134309; [No title captured]	15	15	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1604	1606		10.1016/S0140-6736(13)60588-7	http://dx.doi.org/10.1016/S0140-6736(13)60588-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23489752				2022-12-28	WOS:000319112400007
J	Gabay, C; Emery, P; van Vollenhoven, R; Dikranian, A; Alten, R; Pavelka, K; Klearman, M; Musselman, D; Agarwal, S; Green, J; Kavanaugh, A				Gabay, Cem; Emery, Paul; van Vollenhoven, Ronald; Dikranian, Ara; Alten, Rieke; Pavelka, Karel; Klearman, Micki; Musselman, David; Agarwal, Sunil; Green, Jennifer; Kavanaugh, Arthur		ADACTA Study Investigators	Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; INTERLEUKIN-6 RECEPTOR INHIBITION; DISEASE-ACTIVITY; INADEQUATE RESPONSE; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; METHOTREXATE; IL-6; COHORT; VALIDATION	Background Roughly a third of patients with rheumatoid arthritis treated with biological treatments receive them as monotherapy. Tocilizumab-an inhibitor of interleukin 6 receptor signalling-has been studied as monotherapy in several clinical trials. We assessed the efficacy and safety of tocilizumab monotherapy compared with adalimumab monotherapy for patients with rheumatoid arthritis. Methods We did this randomised, double-blind, parallel-group, phase 4 superiority study in 76 centres in 15 countries in North and South America, Australasia, and Europe. We enrolled patients who were aged at least 18 years, had severe rheumatoid arthritis for 6 months or more, and were intolerant to methotrexate or were inappropriate for continued methotrexate treatment. Patients were randomly assigned (1: 1; block size of four) to receive tocilizumab 8 mg per kg bodyweight intravenously every 4 weeks plus placebo subcutaneously every 2 weeks or adalimumab 40 mg subcutaneously every 2 weeks plus placebo intravenously every 4 weeks for 24 weeks. Investigators, patients, and sponsor personnel were masked to assignment. The primary endpoint was change in disease activity score using 28 joints (DAS28) from baseline to week 24. This trial is registered with ClinicalTrials.gov, number NCT01119859. Findings We screened 452 patients and enrolled 326 patients. The intention-to-treat population contained 325 patients (163 assigned to tocilizumab, 162 assigned to adalimumab). Week 24 mean change from baseline in DAS28 was significantly greater in the tocilizumab group (-3.3) than in the adalimumab group (-1.8) patients (difference -1.5, 95% CI -1.8 to -1.1; p<0.0001). 16 of 162 (10%) patients in the adalimumab group versus 19 of 162 (12%) in the tocilizumab group had serious adverse events. More patients in the tocilizumab group than in the adalimumab group had increased LDL-cholesterol, increased alanine aminotransferase concentrations, and reduced platelet and neutrophil counts. Interpretation Tocilizumab monotherapy was superior to adalimumab monotherapy for reduction of signs and symptoms of rheumatoid arthritis in patients for whom methotrexate was deemed inappropriate. The adverse event profiles of tocilizumab and adalimumab were consistent with previous findings.	[Gabay, Cem] Univ Hosp Geneva, Geneva, Switzerland; [Emery, Paul] Univ Leeds, Leeds, W Yorkshire, England; [van Vollenhoven, Ronald] Karolinska Inst, Stockholm, Sweden; [Dikranian, Ara] San Diego Arthrit Med Clin, San Diego, CA USA; [Alten, Rieke] Univ Berlin, Berlin, Germany; [Pavelka, Karel] Res Inst Rheumat Dis, Prague, Czech Republic; [Klearman, Micki; Musselman, David; Agarwal, Sunil] Genentech Inc, San Francisco, CA 94080 USA; [Kavanaugh, Arthur] Univ Calif San Diego, San Diego, CA 92103 USA	University of Geneva; University of Leeds; Karolinska Institutet; Roche Holding; Genentech; University of California System; University of California San Diego	Kavanaugh, A (corresponding author), UCSD Thornton Hosp, La Jolla, CA 92037 USA.	akavanaugh@ucsd.edu	van Vollenhoven, Ronald/ABE-1244-2021; Sanmarti, Raimon/M-4434-2017; Alten, Rieke/M-1045-2019; emery, paul/B-3560-2013; Pavelka, Karel/E-6578-2017; Blanco, Francisco J./C-3192-2014	Sanmarti, Raimon/0000-0002-8864-3806; Pavelka, Karel/0000-0003-1952-8422; Blanco, Francisco J./0000-0001-9821-7635; Specker, Christof/0000-0003-2504-3229	Roche; Merck Sharp Dohme; Abbott; Pfizer; UCB; Bristol-Myers Squibb; Novartis; GlaxoSmithKline; Genentech; Amgen; Janssen; Teva; Human Genome Sciences; AstraZeneca; Astellas; AB Science; Ardea; Celgene; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish	Roche(Roche Holding); Merck Sharp Dohme(Merck & Company); Abbott(Abbott Laboratories); Pfizer(Pfizer); UCB(UCB Pharma SA); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Genentech(Roche HoldingGenentech); Amgen(Amgen); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Teva(Teva Pharmaceutical Industries); Human Genome Sciences(GlaxoSmithKline); AstraZeneca(AstraZeneca); Astellas(Astellas Pharmaceuticals); AB Science; Ardea; Celgene(Bristol-Myers SquibbCelgene Corporation); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	CG has received research grants from Roche, Merck Sharp & Dohme, and Abbott; been a consultant for Merck Sharp & Dohme, and MerckSerono; sat on advisory boards for Roche, Merck Sharp & Dohme, Pfizer, Abbott, Bristol-Myers Squibb, and UCB; and received honoraria as a speaker for Roche, Merck Sharp & Dohme, Abbott, Bristol-Myers Squibb, and UCB. PE has received fees for expert advice and research grants paid to his institution from Pfizer, UCB, Merck Sharp & Dohme, Abbott, Bristol-Myers Squibb, Roche, and Novartis. RvV has received research grants paid to his institution from Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Roche, and UCB, has been a consultant for Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Roche, and UCB, for which he received honoraria, and has sat on advisory boards for Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Roche, and UCB, for which he received honoraria. AD has received a research grant, paid to his institution, from Genentech, has sat on advisory boards for Genentech, Abbott, UCB, and Pfizer, and has taken part in speakers bureaus for Genentech, Bristol-Myers Squibb, Abbott, and UCB. RA has received research grants paid to him and his institution, has been a consultant, has sat on an advisory board, has taken part in a speakers bureau, and has received honoraria, all from Roche. KP has taken part in a speakers bureau and has been a consultant for Roche. MK, DM, and SA are employees of Genentech-a member of the Roche Group-and own stock in Roche. JG is an employee of Roche and owns shares in Roche. AK has received research grants, paid to his institution (from Roche, Abbott, Amgen, Bristol-Myers Squibb, Pfizer, UCB, Janssen, Teva, Human Genome Sciences, AstraZeneca, Astellas, AB Science, Ardea, Celgene) and has been a consultant for Roche, Abbott, UCB, and Celgene.	[Anonymous], 2010, HUM 40 MG SOL INJ SU; [Anonymous], 2011, ROACTEMRA TOC SUMM P; Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Cannon GW, 2011, ARTHRIT CARE RES, V63, P1680, DOI 10.1002/acr.20629; Cella D, 2005, J RHEUMATOL, V32, P811; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; de Thurah A, 2010, RHEUMATOL INT, V30, P1441, DOI 10.1007/s00296-009-1160-8; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, JAMA-J AM MED ASSOC, V2815, P2486; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; FRIES JF, 1982, J RHEUMATOL, V9, P789; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1243, DOI 10.1136/annrheumdis-2011-200975; Goudie CT, 2012, ARTHRITIS RHEUM-US, V64, pS560; Grijalva CG, 2010, ARTHRIT CARE RES, V62, P730, DOI 10.1002/acr.20087; Heiberg MS, 2008, ARTHRIT RHEUM-ARTHR, V59, P234, DOI 10.1002/art.23333; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Lee SJ, 2009, J RHEUMATOL, V36, P1611, DOI 10.3899/jrheum.080889; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; Mariette X, 2011, RHEUMATOLOGY, V50, P222, DOI 10.1093/rheumatology/keq368; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Nishimoto N., 2008, V181, P151; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Soliman MM, 2011, ANN RHEUM DIS, V70, P583, DOI 10.1136/ard.2010.139774; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; VanRiel PLCM, 1996, BRIT J RHEUMATOL, V35, P4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinblatt ME, 2011, ARTHRITIS RHEUM-US, V63, pS162; Yazici Y, 2008, BULL HOSP JT DIS, V66, P77	39	446	468	3	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1541	1550		10.1016/S0140-6736(13)60250-0	http://dx.doi.org/10.1016/S0140-6736(13)60250-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23515142				2022-12-28	WOS:000318609600029
J	Gibb, DM				Gibb, Diana M.		ARROW Trial Team	Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial	LANCET			English	Article							INFECTED CHILDREN; PHARMACOKINETICS; ADULTS; NEVIRAPINE; RIFAMPICIN; LOPINAVIR; UGANDA	Background No trials have investigated routine laboratory monitoring for children with HIV, nor four-drug induction strategies to increase durability of first-line antiretroviral therapy (ART). Methods In this open-label parallel-group trial, Ugandan and Zimbabwean children or adolescents with HIV, aged 3 months to 17 years and eligible for ART, were randomly assigned in a factorial design. Randomisation was to either clinically driven monitoring or routine laboratory and clinical monitoring for toxicity (haematology and biochemistry) and efficacy (CD4 cell counts; non-inferiority monitoring randomisation); and simultaneously to standard three-drug or to four-drug induction first-line ART, in three groups: three-drug treatment (non-nucleoside reverse transcriptase inhibitor [NNRTI], lamivudine, abacavir; group A) versus four-drug induction (NNRTI, lamivudine, abacavir, zidovudine; groups B and C), decreasing after week 36 to three-drug NNRTI, lamivudine, plus abacavir (group B) or lamivudine, abacavir, plus zidovudine (group C; superiority ART-strategy randomisation). For patients assigned to routine laboratory monitoring, results were returned every 12 weeks to clinicians; for clinically driven monitoring, toxicity results were only returned for requested clinical reasons or if grade 4. Children switched to second-line ART for WHO stage 3 or 4 events or (routine laboratory monitoring only) age-dependent WHO CD4 criteria. Randomisation used computer-generated sequentially numbered tables incorporated securely within the database. Primary efficacy endpoints were new WHO stage 4 events or death for monitoring and change in CD4 percentage at 72 and 144 weeks for ART-strategy randomisations; the co-primary toxicity endpoint was grade 3 or 4 adverse events. Analysis was by intention to treat. This trial is registered, ISRCTN24791884. Findings 1206 children were randomly assigned to clinically driven (n=606) versus routine laboratory monitoring (n=600), and groups A (n=397), B (n=404), and C (n=405). 47 (8%) children on clinically driven monitoring versus 39 (7%) on routine laboratory monitoring had a new WHO stage 4 event or died (hazard ratio [HR] 1.13, 95% CI 0.73-1.73, p=0.59; non-inferiority criterion met). However, in years 2-5, rates were higher in children on clinically driven monitoring (1.3 vs 0.4 per 100 child-years, difference 0.99, 0.37-1.60, p=0.002). One or more grade 3 or 4 adverse events occurred in 283 (47%) children on clinically driven versus 282 (47%) on routine laboratory monitoring (HR 0.98, 0.83-1.16, p=0.83). Mean CD4 percentage change did not differ between ART groups at week 72 (16.5% [SD 8.6] vs 17.1% [8.5] vs 17.3% [8.0], p=0.33) or week 144 (p=0.69), but four-drug groups (B, C) were superior to three-drug group A at week 36 (12.4% [7.2] vs 14.1% [7.1] vs 14.6% [7.3], p<0.0001). Excess grade 3 or 4 events in groups B (one or more events reported by 157 [40%] children in A, 190 [47%] in B; HR [B: A] 1.32, 1.07-1.63) and C (218 [54%] children in C; HR [C: A] 1.58, 1.29-1.94; global p=0.0001) were driven by asymptomatic neutropenia in zidovudine-containing groups (B, C; 86 group A, 133 group B, 184 group C), but resulted in drug substitutions in only zero versus two versus four children, respectively. Interpretation NNRTI plus NRTI-based three-drug or four-drug ART can be given across childhood without routine toxicity monitoring; CD4 monitoring provided clinical benefit after the first year on ART, but event rates were very low and long-term survival high, suggesting ART rollout should take priority. CD4 benefits from four-drug induction were not durable, but three-NRTI long-term maintenance was immunologically and clinically similar to NNRTI-based ART and could be valuable during tuberculosis co-treatment.	[Gibb, Diana M.] MRC Clin Trials Unit, London WC2B 6NH, England	Medical Research Council Clinical Trials Unit	Gibb, DM (corresponding author), MRC Clin Trials Unit, London WC2B 6NH, England.	dmg@ctu.mrc.ac.uk		Musiime, Victor/0000-0001-7472-9054; Kasirye, Phillip/0000-0001-6620-483X	UK Medical Research Council; UK Department for International Development; ViiV Healthcare; GlaxoSmithKline; MRC [MC_U950097146, MC_EX_G0300400] Funding Source: UKRI; Medical Research Council [MC_U950097146, MC_EX_G0300400] Funding Source: researchfish; National Institute for Health Research [CL-2009-13-005] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; ViiV Healthcare; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Medical Research Council, the UK Department for International Development; drugs donated and viral load assays funded by ViiV Healthcare and GlaxoSmithKline.	Abongomera G, 2012, 19 INT AIDS C WASH D; Aboulker JP, 2002, LANCET, V359, P733; [Anonymous], 1994, CLIN SAF DAT MAN DEF; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Gilks CF, PLOS ONE IN PRESS; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Green H, 2007, AIDS, V21, P947, DOI 10.1097/QAD.0b013e3280e087e7; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2011 C; Jourdain G, 2011, 18 C RETR OPP INF BO; Judd A, 2011, AIDS, V25, P2279, DOI 10.1097/QAD.0b013e32834d614c; Kasirye P, 2012, CLIN PHARMACOL THER, V91, P272, DOI 10.1038/clpt.2011.225; Lara AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033672; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga V, 2010, CLIN INFECT DIS, V51, P1081, DOI 10.1086/656628; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Musiime V, 2013, AIDS RES HUM RETROV, V29, P449, DOI 10.1089/aid.2012.0283; Musiime V, 2010, ANTIVIR THER, V15, P1115, DOI 10.3851/IMP1695; Nahirya-Ntege P, 2011, PEDIATR INFECT DIS J, V30, P535, DOI 10.1097/INF.0b013e3182076864; National Institutes of Health Division of AIDS, 2004, DIV AIDS TABL GRAD S; Oudijk JM, 2012, AIDS, V26, P1523, DOI 10.1097/QAD.0b013e3283550e20; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Ssali F, 2006, ANTIVIR THER, V11, P741; UNAIDS, 2012, WORLD AIDS DAY REP 2; van Rossum AMC, 2002, LANCET INFECT DIS, V2, P93, DOI 10.1016/S1473-3099(02)00183-4; Violari A, HIV11 C GLASG UK NOV; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; WADE AM, 1994, STAT MED, V13, P2359, DOI 10.1002/sim.4780132207; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; WHO, 2010, ANN E PRESCR INF WEI; World Health Organisation, 2006, ANT THER HIV INF INF	39	84	84	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1391	1403		10.1016/S0140-6736(12)62198-9	http://dx.doi.org/10.1016/S0140-6736(12)62198-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23473847	Green Published			2022-12-28	WOS:000317894800036
J	Jamel, S; Malde, S; Ali, IM; Masood, S				Jamel, S.; Malde, S.; Ali, I. M.; Masood, S.			Vasectomy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jamel, S.; Malde, S.; Masood, S.] Medway NHS Fdn Trust, Dept Urol, Gillingham ME7 5NY, Kent, England; [Ali, I. M.] Halfway Surg, Chatham ME4 4QR, Kent, England		Malde, S (corresponding author), Medway NHS Fdn Trust, Dept Urol, Gillingham ME7 5NY, Kent, England.	sachmalde@gmail.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f1674	10.1136/bmj.f1674	http://dx.doi.org/10.1136/bmj.f1674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SA	23550045				2022-12-28	WOS:000317337200006
J	Geng, Y; Sarkis, J; Ulgiati, S; Zhang, P				Geng, Yong; Sarkis, Joseph; Ulgiati, Sergio; Zhang, Pan			Measuring China's Circular Economy	SCIENCE			English	Editorial Material							EMERGY SYNTHESIS		[Geng, Yong] Chinese Acad Sci, Key Lab Pollut Ecol & Environm Engn, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China; [Sarkis, Joseph] Clark Univ, Worcester, MA 01610 USA; [Sarkis, Joseph] Dalian Univ Technol, Dalian 116024, Liaoning, Peoples R China; [Ulgiati, Sergio] Parthenope Univ Napoli, I-80133 Naples, Italy; [Zhang, Pan] China Business Execut Acad, Dalian 116024, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Clark University; Dalian University of Technology; Parthenope University Naples	Geng, Y (corresponding author), Chinese Acad Sci, Key Lab Pollut Ecol & Environm Engn, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China.	gengyong@iae.ac.cn	Sarkis, Joseph/F-4508-2014; Geng, Yong/B-6310-2018; Ulgiati, Sergio/ABE-9420-2020	Sarkis, Joseph/0000-0003-0143-804X; Geng, Yong/0000-0002-2284-1375; Ulgiati, Sergio/0000-0001-6159-4947				[Anonymous], INTEGRATED ENV ASSES; Brown MT, 2011, ECOL MODEL, V223, P4, DOI 10.1016/j.ecolmodel.2011.05.019; Brown MT, 2012, ECOL INDIC, V15, P227, DOI 10.1016/j.ecolind.2011.09.021; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Ellen MacArthur Foundation, 2012, CIRC EC; Garcia M., GDP SOCIAL ENV SUSTA; Geng Y, 2012, ENVIRON SCI TECHNOL, V46, P7067, DOI 10.1021/es3022446; Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005; Geng Y, 2012, ENVIRON SCI TECHNOL, V46, P107, DOI 10.1021/es204293x; Geng Y, 2010, SCI TOTAL ENVIRON, V408, P5273, DOI 10.1016/j.scitotenv.2010.07.081; Hashimoto S, 2010, RESOUR CONSERV RECY, V54, P704, DOI 10.1016/j.resconrec.2009.11.013; Huang SL, 2006, RESOUR CONSERV RECY, V48, P166, DOI 10.1016/j.resconrec.2006.01.005; Odum H. T., 1996, ENV ACCOUNTING EMERG; ODUM HT, 1988, SCIENCE, V242, P1132, DOI 10.1126/science.242.4882.1132; Raugei M, 2011, ECOL MODEL, V222, P3821, DOI 10.1016/j.ecolmodel.2011.10.012; Rugani B, 2012, ENVIRON SCI TECHNOL, V46, P4701, DOI 10.1021/es203440n; Van Berkel R, 2009, J ENVIRON MANAGE, V90, P1544, DOI 10.1016/j.jenvman.2008.11.010	17	283	289	12	411	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1526	1527		10.1126/science.1227059	http://dx.doi.org/10.1126/science.1227059			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114HL	23539584				2022-12-28	WOS:000316731600025
J	Zhang, QH; Zhang, BC; Lockwood, M; Hu, HQ; Moen, J; Ruohoniemi, JM; Thomas, EG; Zhang, SR; Yang, HG; Liu, RY; McWilliams, KA; Baker, JBH				Zhang, Qing-He; Zhang, Bei-Chen; Lockwood, Michael; Hu, Hong-Qiao; Moen, Joran; Ruohoniemi, J. Michael; Thomas, Evan G.; Zhang, Shun-Rong; Yang, Hui-Gen; Liu, Rui-Yuan; McWilliams, Kathryn A.; Baker, Joseph B. H.			Direct Observations of the Evolution of Polar Cap Ionization Patches	SCIENCE			English	Article							F-REGION PATCHES; SUBSTORM CYCLES; PLASMA-DENSITY; RECONNECTION; CONVECTION; IONOSPHERE; BOUNDARY; PULSES; MOTION	Patches of ionization are common in the polar ionosphere, where their motion and associated density gradients give variable disturbances to high-frequency (HF) radio communications, over-the-horizon radar location errors, and disruption and errors to satellite navigation and communication. Their formation and evolution are poorly understood, particularly under disturbed space weather conditions. We report direct observations of the full evolution of patches during a geomagnetic storm, including formation, polar cap entry, transpolar evolution, polar cap exit, and sunward return flow. Our observations show that modulation of nightside reconnection in the substorm cycle of the magnetosphere helps form the gaps between patches where steady convection would give a "tongue" of ionization (TOI).	[Zhang, Qing-He; Zhang, Bei-Chen; Hu, Hong-Qiao; Yang, Hui-Gen; Liu, Rui-Yuan] State Ocean Adm Peoples Republ China, Key Lab Polar Sci, Polar Res Inst China, Shanghai, Peoples R China; [Lockwood, Michael; McWilliams, Kathryn A.] Univ Reading, Dept Meteorol, Earley Gate RG6 6BB, England; [Moen, Joran] Univ Oslo, Dept Phys, Oslo, Norway; [Ruohoniemi, J. Michael; Thomas, Evan G.; Baker, Joseph B. H.] Virginia Tech, Bradley Dept Elect & Comp Engn, Blacksburg, VA USA; [Zhang, Shun-Rong] MIT, Haystack Observ, Westford, MA 01886 USA; [McWilliams, Kathryn A.] Univ Saskatchewan, Inst Space & Atmospher Studies, Saskatoon, SK S7N 0W0, Canada	Polar Research Institute of China; University of Reading; University of Oslo; Virginia Polytechnic Institute & State University; Massachusetts Institute of Technology (MIT); University of Saskatchewan	Zhang, QH (corresponding author), State Ocean Adm Peoples Republ China, Key Lab Polar Sci, Polar Res Inst China, Shanghai, Peoples R China.	zhangqinghe@pric.gov.cn	Zhang, Shun-Rong/G-7593-2015; Zhang, Qing-He/G-4572-2014; Lockwood, Mike/G-1030-2011; Thomas, Evan G/B-3921-2017	Zhang, Shun-Rong/0000-0002-1946-3166; Zhang, Qing-He/0000-0003-2429-4050; Lockwood, Mike/0000-0002-7397-2172; Thomas, Evan G/0000-0001-8036-8793; Baker, Joseph/0000-0001-6255-3039; Zhang, Beichen/0000-0002-0927-9568	National Basic Research Program [2012CB825603]; National Natural Science Foundation [41274149, 41104091, 41031064, 40890164]; Ocean Public Welfare Scientific Research Project, State Oceanic Administration [201005017]; Research Council of Norway; NSF [AGS-0946900, AGS-0838219]; Virginia Space Grant Consortium; Directorate For Geosciences [1242204] Funding Source: National Science Foundation; STFC [PP/E007929/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E007929/1] Funding Source: researchfish	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ocean Public Welfare Scientific Research Project, State Oceanic Administration; Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF)); Virginia Space Grant Consortium; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work in China was supported by the National Basic Research Program (grant 2012CB825603), the National Natural Science Foundation (grants 41274149, 41104091, 41031064, and 40890164), and the Ocean Public Welfare Scientific Research Project, State Oceanic Administration (201005017). The Norwegian contribution was supported by the Research Council of Norway. SuperDARN is a collection of radars funded by national scientific funding agencies in Australia, Canada, China, France, Japan, South Africa, the United Kingdom, and the United States. The Virginia Tech authors acknowledge the support of NSF awards AGS-0946900 and AGS-0838219 and a graduate research fellowship from the Virginia Space Grant Consortium. The GPS TEC acquisition effort is led by A. J. Coster at MIT Haystack Observatory. The GPS TEC and SuperDARN data are available on the public database http://sd-software.ece.vt.edu/tiki/tiki-index.php?page=DaViT TEC. We also thank the NASA OMNIWeb for making available the solar wind/IMF data (http://omniweb.gsfc.nasa.gov/html/sc_merge_data1.html) and World Data Center C1, Kyoto, for the AE indices (http://wdc.kugi.kyoto-u.ac.jp/wdc/Sec3.html).	Bust GS, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2005JA011597; Carlson HC, 2012, RADIO SCI, V47, DOI 10.1029/2011RS004946; Coster A., 2003, GPS WORLD, V14; COWLEY SWH, 1992, ANN GEOPHYS, V10, P103; Crowley G, 2000, J GEOPHYS RES-SPACE, V105, P5215, DOI 10.1029/1999JA900357; Crowley G., 1996, REV RADIO SCI 1992 1, P619; Foster JC, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010928; Hosokawa K, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA014020; LOCKWOOD M, 1992, GEOPHYS RES LETT, V19, P1731, DOI 10.1029/92GL01993; Lockwood M, 2005, ANN GEOPHYS-GERMANY, V23, P3513, DOI 10.5194/angeo-23-3513-2005; Lockwood M, 2005, ANN GEOPHYS-GERMANY, V23, P3495, DOI 10.5194/angeo-23-3495-2005; Lockwood M, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2003JA010307; Lockwood M, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013697; Moen J, 2008, ANN GEOPHYS-GERMANY, V26, P2427, DOI 10.5194/angeo-26-2427-2008; Moen J, 2006, ANN GEOPHYS-GERMANY, V24, P2363, DOI 10.5194/angeo-24-2363-2006; Morley SK, 2006, ANN GEOPHYS-GERMANY, V24, P961, DOI 10.5194/angeo-24-961-2006; Oksavik K, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015817; RODGER AS, 1994, J GEOPHYS RES-SPACE, V99, P6425, DOI 10.1029/93JA01501; Ruohoniemi JM, 1998, J GEOPHYS RES-SPACE, V103, P20797, DOI 10.1029/98JA01288; SOJKA JJ, 1993, GEOPHYS RES LETT, V20, P1783, DOI 10.1029/93GL01347; Stolle C, 2006, ANN GEOPHYS-GERMANY, V24, P107, DOI 10.5194/angeo-24-107-2006; Thomas EG, 2013, J GEOPHYS RES-SPACE, V118, P1180, DOI 10.1002/jgra.50116; Valladares CE, 1999, ANN GEOPHYS-ATM HYDR, V17, P1020, DOI 10.1007/s00585-999-1020-6; Wood AG, 2009, ANN GEOPHYS-GERMANY, V27, P3923, DOI 10.5194/angeo-27-3923-2009; Zhang QH, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016287	25	100	109	8	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1597	1600		10.1126/science.1231487	http://dx.doi.org/10.1126/science.1231487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539601				2022-12-28	WOS:000316731600046
J	Shukla, R; Upton, KR; Munoz-Lopez, M; Gerhardt, DJ; Fisher, ME; Nguyen, T; Brennan, PM; Baillie, JK; Collino, A; Ghisletti, S; Sinha, S; Iannelli, F; Radaelli, E; Dos Santos, A; Rapoud, D; Guettier, C; Samuel, D; Natoli, G; Carninci, P; Ciccarelli, FD; Garcia-Perez, JL; Faivre, J; Faulkner, GJ				Shukla, Ruchi; Upton, Kyle R.; Munoz-Lopez, Martin; Gerhardt, Daniel J.; Fisher, Malcolm E.; Thu Nguyen; Brennan, Paul M.; Baillie, J. Kenneth; Collino, Agnese; Ghisletti, Serena; Sinha, Shruti; Iannelli, Fabio; Radaelli, Enrico; Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Natoli, Gioacchino; Carninci, Piero; Ciccarelli, Francesca D.; Luis Garcia-Perez, Jose; Faivre, Jamila; Faulkner, Geoffrey J.			Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma	CELL			English	Article							HEPATITIS-B-VIRUS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; SOMATIC RETROTRANSPOSITION; LINE-1 RETROTRANSPOSITION; L1 RETROTRANSPOSITION; IDENTIFICATION; GENE; TRANSCRIPTION; LANDSCAPE	LINE-1 (L1) retrotransposons are mobile genetic elements comprising similar to 17% of the human genome. New L1 insertions can profoundly alter gene function and cause disease, though their significance in cancer remains unclear. Here, we applied enhanced retrotransposon capture sequencing (RC-seq) to 19 hepatocellular carcinoma (HCC) genomes and elucidated two archetypal L1-mediated mechanisms enabling tumorigenesis. In the first example, 4/19 (21.1%) donors presented germline retrotransposition events in the tumor suppressor mutated in colorectal cancers (MCC). MCC expression was ablated in each case, enabling oncogenic beta-catenin/Wnt signaling. In the second example, suppression of tumorigenicity 18 (ST18) was activated by a tumor-specific L1 insertion. Experimental assays confirmed that the L1 interrupted a negative feedback loop by blocking ST18 repression of its enhancer. ST18 was also frequently amplified in HCC nodules from Mdr2(-/-) mice, supporting its assignment as a candidate liver oncogene. These proof-of-principle results substantiate L1-mediated retrotransposition as an important etiological factor in HCC.	[Shukla, Ruchi; Fisher, Malcolm E.; Baillie, J. Kenneth; Faulkner, Geoffrey J.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Shukla, Ruchi; Fisher, Malcolm E.; Baillie, J. Kenneth; Faulkner, Geoffrey J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Upton, Kyle R.; Gerhardt, Daniel J.; Thu Nguyen; Faulkner, Geoffrey J.] Mater Med Res Inst, Canc Biol Program, South Brisbane, Qld 4101, Australia; [Munoz-Lopez, Martin; Luis Garcia-Perez, Jose] Pfizer Univ Granada, Dept Human DNA Variabil, Granada 18007, Spain; [Munoz-Lopez, Martin; Luis Garcia-Perez, Jose] Andalusian Govt Ctr Genom & Oncol GENYO, Granada 18007, Spain; [Brennan, Paul M.] Univ Edinburgh, Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Collino, Agnese; Ghisletti, Serena; Sinha, Shruti; Iannelli, Fabio; Natoli, Gioacchino; Ciccarelli, Francesca D.] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Radaelli, Enrico] Univ Milan, DIVET, Sch Vet Med, I-20133 Milan, Italy; [Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Faivre, Jamila] INSERM, U785, Ctr Hepatobiliaire, F-94800 Villejuif, France; [Dos Santos, Alexandre; Rapoud, Delphine; Guettier, Catherine; Samuel, Didier; Faivre, Jamila] Univ Paris 11, Fac Med, F-94800 Villejuif, France; [Carninci, Piero] RIKEN, Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Faulkner, Geoffrey J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Mater Research; Pfizer; University of Granada; University of Edinburgh; IRCCS European Institute of Oncology (IEO); University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; RIKEN; University of Queensland	Faulkner, GJ (corresponding author), Univ Edinburgh, Div Genet & Genom, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	faulknergj@gmail.com	Shukla, Ruchi/AAD-7610-2020; Dos Santos, Alexandre/S-1933-2018; Baillie, John Kenneth/F-3124-2011; Fisher, Malcolm Edgar/GQH-8954-2022; Natoli, gioacchino/J-2100-2018; Upton, Kyle R./M-4772-2014; Natoli, gioacchino/ABB-8679-2020; Carninci, Piero/K-1568-2014; Faulkner, Geoffrey J/M-3168-2014; Ghisletti, Serena/AAO-6437-2021; Baillie, Kenneth/AEK-6650-2022; Ciccarelli, Francesca/D-5380-2014	Baillie, John Kenneth/0000-0001-5258-793X; Fisher, Malcolm Edgar/0000-0003-1074-8103; Upton, Kyle R./0000-0003-1101-8081; Carninci, Piero/0000-0001-7202-7243; Faulkner, Geoffrey J/0000-0001-5769-4494; Baillie, Kenneth/0000-0001-5258-793X; Ciccarelli, Francesca/0000-0002-9325-0900; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Natoli, Gioacchino/0000-0003-0711-2411; Munoz-Lopez, Martin/0000-0002-2137-6539; Ghisletti, Serena/0000-0002-7087-5553; Brennan, Paul/0000-0002-7347-830X; Iannelli, Fabio/0000-0002-2777-1417	European Union's Seventh Framework Programme (FP7) underpinning the MODHEP consortium [259743]; Wellcome Trust Clinical Fellowships through the Edinburgh Clinical Academic Track (ECAT) [090385/Z/09/Z, 090386/Z/09/Z]; Howard Hughes Medical Institute [IECS-55007420]; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer [ARC 4866]; Institut National du Cancer (INCa PAIR-CHC); New Investigator Award from the British BBSRC [BB/H005935/1]; C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC [575585];  [FP7-PEOPLE-2007-4-3-IRG];  [CICE-FEDER-P09-CTS-4980];  [PeS-FEDER-PI-002];  [FIS-FEDER-PI11/01489]; BBSRC [BB/I024801/1, BB/H005935/1, BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000, BB/I024801/1, BB/H005935/1] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	European Union's Seventh Framework Programme (FP7) underpinning the MODHEP consortium; Wellcome Trust Clinical Fellowships through the Edinburgh Clinical Academic Track (ECAT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (INCa PAIR-CHC)(Institut National du Cancer (INCA) France); New Investigator Award from the British BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Professor Haig Kazazian, Professor Bert Vogelstein, Dr. Bruno Amati, and Dr. Alister Funnell for helpful discussion. We thank Professor Daniel Azoulay, Professor Denis Castaing, Professor Rene Adam and Dr. Eric Vibert (Centre Hepatobiliaire, Villejuif), and the Tissue Biobank Group (AP-HP and Universite Paris-Sud) for providing HCC specimens. We thank Dr. Christine Beck and Professor John Moran for providing the genomic coordinates of a recently published full-length L1 insertion cohort (Beck et al., 2010). Research performed in the laboratories of D.S., G.N., P.C., F.D.C., J.F., and G.J.F. was funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 259743 underpinning the MODHEP consortium. J.K.B. and P.M.B. were supported by Wellcome Trust Clinical Fellowships (090385/Z/09/Z and 090386/Z/09/Z, respectively) through the Edinburgh Clinical Academic Track (ECAT). J.L.G.P was supported by FP7-PEOPLE-2007-4-3-IRG, CICE-FEDER-P09-CTS-4980, PeS-FEDER-PI-002, FIS-FEDER-PI11/01489, and the Howard Hughes Medical Institute (IECS-55007420). J.F. acknowledges the support of the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer (ARC 4866), and the Institut National du Cancer (INCa 2009-PAIR-CHC). G.J.F. acknowledges the support of a New Investigator Award from the British BBSRC (BB/H005935/1) and a C.J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585).	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FORNACE AJ, 1986, NUCLEIC ACIDS RES, V14, P5793, DOI 10.1093/nar/14.14.5793; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Senda T, 1999, J HISTOCHEM CYTOCHEM, V47, P1149, DOI 10.1177/002215549904700907; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Steinbach D, 2006, CLIN CANCER RES, V12, P2434, DOI 10.1158/1078-0432.CCR-05-2552; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tateishi R, 2012, NAT REV GASTRO HEPAT, V9, P69, DOI 10.1038/nrgastro.2011.255; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366	59	262	268	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					101	111		10.1016/j.cell.2013.02.032	http://dx.doi.org/10.1016/j.cell.2013.02.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540693	Green Published, hybrid			2022-12-28	WOS:000316853700009
J	Schembri, S; Williamson, PA; Short, PM; Singanayagam, A; Akram, A; Taylor, J; Singanayagam, A; Hill, AT; Chalmers, JD				Schembri, Stuart; Williamson, Peter A.; Short, Philip M.; Singanayagam, Aran; Akram, Ahsan; Taylor, Joanne; Singanayagam, Anika; Hill, Adam T.; Chalmers, James D.			Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; SHORT-TERM CLARITHROMYCIN; CORONARY-HEART-DISEASE; ANTIBIOTIC-THERAPY; RANDOMIZED-TRIAL; RISK; EXACERBATIONS; MORTALITY; AZITHROMYCIN	Objective To study the association of clarithromycin with cardiovascular events in the setting of acute exacerbations of chronic obstructive pulmonary disease and community acquired pneumonia. Design Analysis of two prospectively collected datasets. Setting Chronic obstructive pulmonary disease dataset including patients admitted to one of 12 hospitals around the United Kingdom between 2009 and 2011; Edinburgh pneumonia study cohort including patients admitted to NHS Lothian Hospitals between 2005 and 2009. Population 1343 patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease and 1631 patients admitted with community acquired pneumonia. Main outcome measures Hazard ratios for cardiovascular events at one year (defined as hospital admissions with acute coronary syndrome, decompensated cardiac failure, serious arrhythmia, or sudden cardiac death) and admissions for acute coronary syndrome (acute ST elevation myocardial infarction, non-ST elevation myocardial infarction, and unstable angina). Secondary outcomes were all cause and cardiovascular mortality at one year. Results 268 cardiovascular events occurred in the acute exacerbations of chronic obstructive pulmonary disease cohort and 171 in the community acquired pneumonia cohort over one year. After multivariable adjustment, clarithromycin use in acute exacerbations of chronic obstructive pulmonary disease was associated with an increased risk of cardiovascular events and acute coronary syndrome-hazard ratios 1.50 (95% confidence interval 1.13 to 1.97) and 1.67 (1.04 to 2.68). After multivariable adjustment, clarithromycin use in community acquired pneumonia was associated with increased risk of cardiovascular events (hazard ratio 1.68, 1.18 to 2.38) but not acute coronary syndrome (1.65, 0.97 to 2.80). The association between clarithromycin use and cardiovascular events persisted after matching for the propensity to receive clarithromycin. A significant association was found between clarithromycin use and cardiovascular mortality (adjusted hazard ratio 1.52, 1.02 to 2.26) but not all cause mortality (1.16, 0.90 to 1.51) in acute exacerbations of chronic obstructive pulmonary disease. No association was found between clarithromycin use in community acquired pneumonia and all cause mortality or cardiovascular mortality. Longer durations of clarithromycin use were associated with more cardiovascular events. Use of beta lactam antibiotics or doxycycline was not associated with increased cardiovascular events in patients with acute exacerbations of chronic obstructive pulmonary disease, suggesting an effect specific to clarithromycin. Conclusions The use of clarithromycin in the setting of acute exacerbations of chronic obstructive pulmonary disease or community acquired pneumonia may be associated with increased cardiovascular events. These findings require confirmation in other datasets.	[Schembri, Stuart; Short, Philip M.; Chalmers, James D.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Williamson, Peter A.] Perth Royal Infirm, Perth PH1 1NX, Scotland; [Short, Philip M.; Chalmers, James D.] Univ Dundee, Dundee, Scotland; [Singanayagam, Aran] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Akram, Ahsan; Taylor, Joanne; Hill, Adam T.] Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland; [Singanayagam, Anika] Chase Farm & Barnet Hosp NHS Trust, London E1 1BB, England; [Hill, Adam T.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Dundee; University of Dundee; Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Chalmers, JD (corresponding author), Ninewells Hosp, Dundee DD1 9SY, Scotland.	jameschalmers1@nhs.net	; Taylor, Joanne K/F-4747-2011	Singanayagam, Aran/0000-0001-9849-0033; Chalmers, James/0000-0001-5514-7868; Singanayagam, Anika/0000-0002-2572-0173; Akram, Ahsan/0000-0003-4605-1682; Taylor, Joanne K/0000-0001-9882-0119				Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bril F, 2010, CURR DRUG SAF, V5, P85, DOI 10.2174/157488610789869184; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chalmers JD, 2011, J ANTIMICROB CHEMOTH, V66, P416, DOI 10.1093/jac/dkq426; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Gluud C, 2008, CARDIOLOGY, V111, P280, DOI 10.1159/000128994; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Levesque L, 2010, BMJ-BRIT MED J, V340, pb508; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; National Respiratory Training Centre, 2002, IMP RESP COND GUID P; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Shorr AF, 2011, CHEST, V140, P1177, DOI 10.1378/chest.10-3035; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; White AJ, 2003, THORAX, V58, P73, DOI 10.1136/thorax.58.1.73; Winkel P, 2011, CARDIOLOGY, V118, P63, DOI 10.1159/000324533	31	83	90	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1235	10.1136/bmj.f1235	http://dx.doi.org/10.1136/bmj.f1235			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MQ	23525864	hybrid, Green Submitted			2022-12-28	WOS:000316672500002
J	Bennett, CL; Djulbegovic, B; Norris, LB; Armitage, JO				Bennett, Charles L.; Djulbegovic, Benjamin; Norris, LeAnn B.; Armitage, James O.			Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; NON-HODGKIN-LYMPHOMA; CELL LUNG-CANCER; BREAST-CANCER; MYELODYSPLASTIC SYNDROME; CLINICAL-TRIALS; GROWTH-FACTORS; SOLID TUMORS; DOSE-DENSE	A 55-year-old, previously healthy woman received a diagnosis of diffuse large-B-cell lymphoma after the evaluation of an enlarged left axillary lymph node obtained on biopsy. She had been asymptomatic except for the presence of enlarged axillary lymph nodes, which she had found while bathing. She was referred to an oncologist, who performed a staging evaluation. A complete blood count and test results for liver and renal function and serum lactate dehydrogenase were normal. Positron-emission tomography and computed tomography (PET-CT) identified enlarged lymph nodes with abnormal uptake in the left axilla, mediastinum, and retroperitoneum. Results on bone marrow biopsy were normal. The patient's oncologist recommends treatment with six cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab (CHOP-R) at 21-day intervals. Is the administration of prophylactic granulocyte colony-stimulating factor (G-CSF) with the first cycle of chemotherapy indicated?	[Bennett, Charles L.; Norris, LeAnn B.] Univ S Carolina, South Carolina Coll Pharm, South Carolina Ctr Econ Excellence Medicat Safety, Columbia, SC 29208 USA; [Bennett, Charles L.; Norris, LeAnn B.] Univ S Carolina, South Carolina Coll Pharm, Southern Network Adverse React SONAR, Columbia, SC 29208 USA; [Bennett, Charles L.; Norris, LeAnn B.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Bennett, Charles L.; Norris, LeAnn B.] William Jennings Bryan Dorn Vet Affairs Med Ctr, Columbia, SC USA; [Djulbegovic, Benjamin] Univ S Florida, Morsani Coll Med, Ctr Evidence Based Med & Hlth Outcome Res, Clin & Translat Sci Inst,Dept Med, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Armitage, James O.] Univ Nebraska, Omaha Sch Med, Omaha, NE 68182 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Nebraska System	Bennett, CL (corresponding author), South Carolina Coll Pharm, 715 Sumter St, Columbia, SC 29208 USA.	bennettc@sccp.sc.edu	Djulbegovic, Benjamin/I-3661-2012; Norris, LeAnn B./H-8313-2019	Djulbegovic, Benjamin/0000-0003-0671-1447; Norris, LeAnn B./0000-0001-7656-1259	NCI [1R01CA 102713-01, 1R01CA165609-01A1, 1R01HL71650-01]; National Heart, Lung, and Blood Institute [1R01HL71650-01]; South Carolina Centers of Economic Excellence; Center for Medication Safety initiative; Doris Levkoff Meddin Medication Safety Education Program, South Carolina College of Pharmacy, the University of South Carolina; NATIONAL CANCER INSTITUTE [R01CA102713, R01CA165609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071650] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); South Carolina Centers of Economic Excellence; Center for Medication Safety initiative; Doris Levkoff Meddin Medication Safety Education Program, South Carolina College of Pharmacy, the University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by grants from the NCI (1R01CA 102713-01, 1R01CA165609-01A1, and 1R01HL71650-01, to Dr. Bennett; and 1R01CA165609-01A1, to Dr. Norris), grants from the National Heart, Lung, and Blood Institute (1R01HL71650-01, to Dr. Djulbegovic), the South Carolina Centers of Economic Excellence, the Center for Medication Safety initiative, and the Doris Levkoff Meddin Medication Safety Education Program, South Carolina College of Pharmacy, the University of South Carolina.	Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; [Anonymous], 2011, NEUL PEGF; [Anonymous], 2012, NEUP FILGR; Bacher U, 2007, BRIT J HAEMATOL, V137, P78, DOI 10.1111/j.1365-2141.2007.06529.x; BENNETT CL, 1995, J CLIN ONCOL, V13, P2457, DOI 10.1200/JCO.1995.13.9.2457; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Bohlius J., 2008, COCHRANE DB SYST REV, V4; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Burris HA, 2010, J ONCOL PRACT, V6, P133, DOI 10.1200/JOP.091094; Caggiano V, 2005, CANCER-AM CANCER SOC, V103, P1916, DOI 10.1002/cncr.20983; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clark OAC, 2005, J CLIN ONCOL, V23, P4198, DOI 10.1200/JCO.2005.05.645; Confer DL, 2007, BRIT J HAEMATOL, V137, P77, DOI 10.1111/j.1365-2141.2007.06524.x; Cooper KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-404; Crawford J, 2002, DRUGS, V62, P89, DOI 10.2165/00003495-200262001-00007; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Cullen M, 2005, NEW ENGL J MED, V353, P988, DOI 10.1056/NEJMoa050078; Donadieu J, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-26; Engert A, 2009, ONKOLOGIE, V32, P599, DOI 10.1159/000232580; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gafter-Gvili A, 2006, ANN INTERN MED, V144, P704, DOI 10.7326/0003-4819-144-9-200605020-00027; GULATI SC, 1992, ANN INTERN MED, V116, P177, DOI 10.7326/0003-4819-116-3-177; Hadji P, 2012, INT J CLIN PHARM TH, V50, P281, DOI 10.5414/CP201633; Hershman D, 2007, JNCI-J NATL CANCER I, V99, P196, DOI 10.1093/jnci/djk028; Holig K, 2009, BLOOD, V114, P3757, DOI 10.1182/blood-2009-04-218651; Jelkmann W, 2010, AM J HEMATOL, V85, P771, DOI 10.1002/ajh.21805; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; Lokich JJ, 2006, AM J CLIN ONCOL-CANC, V29, P361, DOI 10.1097/01.coc.0000217816.16236.22; Lyman GH, 2012, CRIT REV ONCOL HEMAT, V81, P296, DOI 10.1016/j.critrevonc.2011.04.010; Lyman GH, 2010, J CLIN ONCOL, V28, P2914, DOI 10.1200/JCO.2009.25.8723; National Comprehensive Cancer Network, MYEL GROWTH FACT V10; NEMUNAITIS J, 1991, NEW ENGL J MED, V324, P1773, DOI 10.1056/NEJM199106203242504; Potosky AL, 2011, JNCI-J NATL CANCER I, V103, P979, DOI 10.1093/jnci/djr152; Ramsey SD, 2010, AM J MANAG CARE, V16, P678; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; Ringden O, 2004, J CLIN ONCOL, V22, P416, DOI 10.1200/JCO.2004.06.102; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Smith RE, 2003, J CLIN ONCOL, V21, P1195, DOI 10.1200/JCO.2003.03.114; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sung L, 2007, ANN INTERN MED, V147, P400, DOI 10.7326/0003-4819-147-6-200709180-00010; Veerappan R, 2007, BONE MARROW TRANSPL, V40, P361, DOI 10.1038/sj.bmt.1705736; Vogel CL, 2005, J CLIN ONCOL, V23, P1178, DOI 10.1200/JCO.2005.09.102; Waters GE, J ONCOL PRA IN PRESS; Zwick C, 2011, ANN ONCOL, V22, P1872, DOI 10.1093/annonc/mdq674	45	114	123	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1131	1139		10.1056/NEJMct1210890	http://dx.doi.org/10.1056/NEJMct1210890			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514290	Green Accepted			2022-12-28	WOS:000316318600006
J	Clark, T; Berger, U; Mansmann, U				Clark, Timothy; Berger, Ursula; Mansmann, Ulrich			Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOMES	Objectives To assess the completeness of reporting of sample size determinations in unpublished research protocols and to develop guidance for research ethics committees and for statisticians advising these committees. Design Review of original research protocols. Study selection Unpublished research protocols for phase IIb, III, and IV randomised clinical trials of investigational medicinal products submitted to research ethics committees in the United Kingdom during 1 January to 31 December 2009. Main outcome measures Completeness of reporting of the sample size determination, including the justification of design assumptions, and disagreement between reported and recalculated sample size. Results 446 study protocols were reviewed. Of these, 190 (43%) justified the treatment effect and 213 (48%) justified the population variability or survival experience. Only 55 (12%) discussed the clinical importance of the treatment effect sought. Few protocols provided a reasoned explanation as to why the design assumptions were plausible for the planned study. Sensitivity analyses investigating how the sample size changed under different design assumptions were lacking; six (1%) protocols included a re-estimation of the sample size in the study design. Overall, 188 (42%) protocols reported all of the information to accurately recalculate the sample size; the assumed withdrawal or dropout rate was not given in 177 (40%) studies. Only 134 of the 446 (30%) sample size calculations could be accurately reproduced. Study size tended to be over-estimated rather than under-estimated. Studies with non-commercial sponsors justified the design assumptions used in the calculation more often than studies with commercial sponsors but less often reported all the components needed to reproduce the sample size calculation. Sample sizes for studies with non-commercial sponsors were less often reproduced. Conclusions Most research protocols did not contain sufficient information to allow the sample size to be reproduced or the plausibility of the design assumptions to be assessed. Greater transparency in the reporting of the determination of the sample size and more focus on study design during the ethical review process would allow deficiencies to be resolved early, before the trial begins. Guidance for research ethics committees and statisticians advising these committees is needed.	[Clark, Timothy; Berger, Ursula; Mansmann, Ulrich] Univ Munich, Fac Med, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany	University of Munich	Mansmann, U (corresponding author), Univ Munich, Fac Med, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany.	mansmann@ibe.med.uni-muenchen.de	Berger, Ursula/ABI-7872-2020		National Research Ethics Service	National Research Ethics Service	We thank the National Research Ethics Service for its support; IBE research assistants Mathias Heibeck and Linda Hayanga for their contribution to this project; and Michael Campbell, Sir Iain Chalmers, Douglas Altman, Gary Collins, and Hugh Davies for their comments on this work.	ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bacchetti P, 2005, AM J EPIDEMIOL, V161, P105, DOI 10.1093/aje/kwi014; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Chalmers I, 2002, BRIT MED J, V324, P483; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Chow S. C., 2003, SAMPLE SIZE CALCULAT; Djulbegovic B, 2011, J CLIN EPIDEMIOL, V64, P583, DOI 10.1016/j.jclinepi.2010.09.007; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Food and Drug Administration, 2010, GUID IND AD IN PRESS; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; ICH, 1998, ICH HARM TRIP GUID S; Julious S A, 1999, J Biopharm Stat, V9, P241, DOI 10.1081/BIP-100101174; Julious SA, 2004, PHARM STAT, V3, P261, DOI 10.1002/pst.139; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Julious SA, 2009, SAMPLE SIZES CLIN TR; Julious SA, 2012, PHARM STAT, V11, P177, DOI 10.1002/pst.515; Kieser M, 1996, BIOMETRICAL J, V38, P941, DOI 10.1002/bimj.4710380806; Kieser M, 2003, STAT MED, V22, P3571, DOI 10.1002/sim.1585; MacHin D, 2008, SAMPLE SIZE TABLES C, V3rd; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Norman G, 2012, BMJ-BRIT MED J, V345, pe5278; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Senn SJ., 2007, STAT ISSUES DRUG DEV, P198; Victor N., 1999, MEDIZINRECHT, V9, P408; Williamson P, 2000, J R STAT SOC A STAT, V163, P5, DOI 10.1111/1467-985X.00152; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	33	42	43	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2013	346								f1135	10.1136/bmj.f1135	http://dx.doi.org/10.1136/bmj.f1135			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MJ	23518273	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000316671800001
J	Davis, J; Banks, I; Wrigley, D; Peedell, C; Pollock, A; McPherson, K; McKee, M; Irving, WL; Crome, P; Greenhalgh, T; Holland, W; Evans, D; Maryon-Davis, A; Smyth, A; Fleming, P; Coleman, M; Sharp, DJ; Whincup, P; Logan, S; Cook, D; Moore, R; Rawaf, S; McEewen, J; West, R; Yudkin, JS; Clarke, A; Finer, N; Domizio, P; Bambra, C; Jones, A; Feder, G; Scott-Samuel, A; Irvine, L; Fitchett, M; Boomla, K; Folb, J; Paul, A; McCoy, D; Tallis, R; Burgess-Allen, J; Edwards, M; Tomlinson, J; Colvin, D; Gore, J; Kirsten, L; Mitchel, S; Lau, A; Sayer, M; Clark, L; Silverman, R; Marmot, S; Rainbow, D; Carter, L; Mann, N; Fielding, R; Logan, J; Tebboth, L; Arnold, N; Stobbart, K; Finer, S; Edwards, M; Davies, D; Buttivant, H; Kraemer, S; Newell, J; Griffiths, A; FitzGerald, R; MacGibbon, R; Lee, A; Hobson, E; Jenner, D; Jacobson, B; Timmis, A; Salim, A; Evans-Jones, J; Caan, W; Awsare, N; Pride, N; Suckling, R; Bratty, C; Hawkins, D; Currie, J; Camilleri-Ferrante, C; Fluxman, J; Anson, J; Etherington, R; Lawrence, D; Fell, H; Clarke, E; Ormerod, O; Ireland, M; Duncan, JAT; Chandy, R; Mindell, J; Mullen, P; Bennett-Richards, P; Hamlets, T; Murphy, DE; Martin, P; Lowes, S; Fleming, P; Grunewald, R; Reeve, J; Schweiger, M; Coates, J; Chamberlain, MA; Lewis, G; Young, J; Scott, B; Gibbs, J; Landers, A; Deveson, P; Leigh, M; Nixon, J; Bareford, D; Lockwood, K; Ehrhardt, P; Bell, D; Wortley, P; Tomlinson, L; Ford, S; Lewis, D; Bell, D; Tomson, M; Tulloch, A; Dickinson, J; Holt, K; Klonin, H; Goodger, BV; Puntis, J; Gould, DA; Livingstone, A; Lefevre, D; Singh, LG; Hall, P; Darling, J; Hamlyn, AN; Patel, A; Fisher, B; Highton, C; Venning, H; Singer, R; Sikorski, J; Paintin, D; Feehally, J; Savage, W; McAdam, K; Holt, VJ; Gill, A; Waterston, T; De Souza, R; Hopkinson, N; Beadsworth, M; Franks, A; Daley, H; Cullinan, P; Basarab, A; Folb, J; Gurling, H; Zinkin, P; Buhrs, E; West, A; Marlowe, G; Main, J; Applebee, J; Koperski, M; Jones, P; Macfarlane, A; Beer, N; Mason, R; Deanery, M; Eisner, M; Timms, P; Jones, C; Wesby, B; Lyttelton, L; Morrison, R; Bossano, D; Walker, J; Davies, G; Godfrey, P; Wolfe, I; Nsutebu, E; Stevenson, N; Cheeroth, S; Miller, J; Johnson, G; Hall, A; Bostock, D; Sharvill, J; Kent, D; Macpherson, J; Lewis, D; Ma, R; Middleton, J; Jeffreys, A; Cole, J; Boswell, JP; Bury, B; Kinmonth, AL; Young, G; Maclennan, I; Munday, P				Davis, Jacky; Banks, Ian; Wrigley, David; Peedell, Clive; Pollock, Alyson; McPherson, Klim; McKee, Martin; Irving, William L.; Crome, Peter; Greenhalgh, Trisha; Holland, Walter; Evans, David; Maryon-Davis, Alan; Smyth, Alan; Fleming, Peter; Coleman, Michel; Sharp, Deborah J.; Whincup, Peter; Logan, Stuart; Cook, Derek; Moore, Robert; Rawaf, Salman; McEewen, J.; West, Robert; Yudkin, John S.; Clarke, Aileen; Finer, Nick; Domizio, Paola; Bambra, Clare; Jones, Anna; Feder, Gene; Scott-Samuel, Alex; Irvine, Louise; Fitchett, Mike; Boomla, Kambiz; Folb, Jonathan; Paul, Ashish; McCoy, David; Tallis, Ray; Burgess-Allen, Jilla; Edwards, Mark; Tomlinson, Jonathon; Colvin, Deborah; Gore, Jonathan; Kirsten, London; Mitchel, Sarah; Lau, Alice; Sayer, Mel; Clark, Leon; Silverman, Ruth; Marmot, Saul; Rainbow, Daniel; Carter, Lucy; Mann, Nick; Fielding, Richard; Logan, Jane; Tebboth, Louise; Arnold, Natasha; Stobbart, Kate; Finer, Sarah; Edwards, Martin; Davies, David; Buttivant, Helen; Kraemer, Sebastian; Newell, Jo; Griffiths, Alun; FitzGerald, Richard; MacGibbon, Robert; Lee, Alan; Hobson, Esther; Jenner, David; Jacobson, Bobbie; Timmis, Alison; Salim, Asad; Evans-Jones, John; Caan, Woody; Awsare, Ninaad; Pride, Neil; Suckling, Ruth; Bratty, Catherine; Hawkins, David; Currie, Jonny; Camilleri-Ferrante, Corinne; Fluxman, Jonathan; Anson, James; Etherington, Robert; Lawrence, David; Fell, Henry; Clarke, Edward; Ormerod, Oliver; Ireland, Maggie; Duncan, John A. T.; Chandy, Rajiv; Mindell, Jennifer; Mullen, Paul; Bennett-Richards, Phillip; Hamlets, Tower; Murphy, Derbyshire E.; Martin, P.; Lowes, Simon; Fleming, Peter; Grunewald, Richard; Reeve, Joanne; Schweiger, Martin; Coates, Jonathan; Chamberlain, M. A.; Lewis, Geoffrey; Young, Jane; Scott, Brian; Gibbs, John; Landers, Aileen; Deveson, Pete; Leigh, Martha; Nixon, Jonathan; Bareford, David; Lockwood, Kate; Ehrhardt, Peter; Bell, David; Wortley, Pam; Tomlinson, Laurie; Ford, Steven; Lewis, David; Bell, David; Tomson, Mike; Tulloch, Alex; Dickinson, Jane; Holt, Kim; Klonin, Hilary; Goodger, Bradford V.; Puntis, John; Gould, Derek A.; Livingstone, Anna; Lefevre, Dianne; Singh, Liverpool G.; Hall, Peter; Darling, Jonathan; Hamlyn, Adrian N.; Patel, Anita; Fisher, Brian; Highton, Clare; Venning, Helen; Singer, Ron; Sikorski, Jim; Paintin, David; Feehally, John; Savage, Wendy; McAdam, Kathy; Holt, Victoria J.; Gill, Alison; Waterston, Tony; De Souza, Richard; Hopkinson, Nicholas; Beadsworth, Mike; Franks, Andrea; Daley, Helen; Cullinan, Paul; Basarab, Adriana; Folb, Jonathan; Gurling, Hugh; Zinkin, Pam; Buhrs, Ernst; West, Andrew; Marlowe, Gary; Main, John; Applebee, Jackie; Koperski, M.; Jones, Phil; Macfarlane, Alison; Beer, Naomi; Mason, Rebecca; Deanery, Mersey; Eisner, Maggie; Timms, Philip; Jones, Coral; Wesby, Barbara; Lyttelton, Laura; Morrison, Richard; Bossano, David; Walker, Jonathan; Davies, Gerry; Godfrey, Peter; Wolfe, Ingrid; Nsutebu, Emmanuel; Stevenson, Nicola; Cheeroth, Sheila; Miller, Jo; Johnson, Guy; Hall, Alyson; Bostock, David; Sharvill, John; Kent, Deal; Macpherson, Jamie; Lewis, David; Ma, Richard; Middleton, John; Jeffreys, Anne; Cole, Jim; Boswell, John P.; Bury, Bob; Kinmonth, Ann-Louise; Young, Gail; Maclennan, Iain; Munday, Pat			Act now against new NHS competition regulations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davis, Jacky] Whittington Hosp, London, England; [Wrigley, David] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Pollock, Alyson] Univ London, London WC1E 7HU, England; [McPherson, Klim] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX1 2JD, England; [McKee, Martin] London Sch Hyg & Trop Med, London, England; [Irving, William L.] Univ Nottingham, Nottingham NG7 2RD, England; [Irving, William L.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Crome, Peter] Keele Univ, Inst Social Sci, Keele, Staffs, England; [Crome, Peter] Keele Univ, Sch Med, Keele, Staffs, England; [Crome, Peter] UCL, Dept Primary Care & Populat Hlth, London WC1E 6BT, England; [Greenhalgh, Trisha] Barts & London Queen Marys Sch Med & Dent, Policy & Innovat Unit, Ctr Primary Care & Publ Hlth, Blizard Inst, London, England; [Holland, Walter] London Sch Econ & Polit Sci, London, England; [Evans, David] Univ W England, Ctr Hlth & Clin Res, Bristol BS16 1QY, Avon, England; [Evans, David] Univ W England, Dept Hlth & Appl Social Sci, Bristol BS16 1QY, Avon, England; [Maryon-Davis, Alan] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London, England; [Maryon-Davis, Alan] Univ Nottingham, Nottingham NG7 2RD, England; [Fleming, Peter] Univ Hosp Bristol, Brisbane, Qld, Australia; [Sharp, Deborah J.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis epidemiol, London, England; [Whincup, Peter] Univ London, London WC1E 7HU, England; [Cook, Derek] Univ Liverpool, Sch Sociol & Social Policy, Liverpool L69 3BX, Merseyside, England; [Rawaf, Salman] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Rawaf, Salman] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [West, Robert] UCL, Canc Res UK, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Yudkin, John S.] UCL, London WC1E 6BT, England; [Clarke, Aileen] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Finer, Nick] UCL Inst Cardiovasc Sci, Natl Ctr Cardiovasc Prevent & Outcomes, London, England; [Bambra, Clare] Univ Durham, Wolfson Res Inst Hlth, Durham DH1 3HP, England; [Bambra, Clare] Univ Durham, Dept Geog, Durham DH1 3HP, England; [Jones, Anna] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Feder, Gene] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol BS8 1TH, Avon, England; [Irvine, Louise] Isl Hlth, London, England; [Fitchett, Mike] Chrisp St Hlth Ctr, London, England; [Folb, Jonathan; Paul, Ashish; McCoy, David; Tallis, Ray; Burgess-Allen, Jilla; Edwards, Mark] Univ Southampton, Southampton SO9 5NH, Hants, England; [Carter, Lucy; Mann, Nick] Well St Surg, London, England; [Fielding, Richard] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Arnold, Natasha] Homerton Hosp, London, England; [Kraemer, Sebastian] Whittington Hosp, Dept Paediat, London, England; [Lee, Alan] Cty Durham & Darlington Fdn Trust, Durham, England; [Timmis, Alison; Salim, Asad] Countess Chester Hosp NHS Fdn Trust, Chester, Cheshire, England; [Evans-Jones, John] Countess Chester Hosp NHS Fdn Trust, Integrated Contracept & Sexual Hlth Serv, Chester, Cheshire, England; [Caan, Woody] Royal Soc Publ Hlth, Cambridge, England; [Awsare, Ninaad] Wirral Univ Teaching Hosp NHS Fdn Trust, Wirral, Merseyside, England; [Pride, Neil] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Currie, Jonny] Jonny Currie Univ Hosp, Bristol, Avon, England; [Anson, James] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Etherington, Robert] Countess Chester Hosp, Chester, Cheshire, England; [Lawrence, David] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Clarke, Edward] Julian Ormerod Great Western Hosp, Swindon, Wilts, England; [Ormerod, Oliver] John Radcliffe Hosp, Oxford, England; [Chandy, Rajiv] UCL, Hlth & Social Surveys Res Grp, Res Dept Epidemiol & Publ Hlth, London, England; [Fleming, Peter] Univ Hosp Bristol, Bristol, Avon, England; [Landers, Aileen] Kingston Hosp NHS Trust, Kingston Upon Thames, Surrey, England; [Leigh, Martha] Wapping Hlth Ctr, London, England; [Bell, David] Tavistock & Potman NHS Fdn Trust, London, England; [Tomlinson, Laurie] Addenbrookes Hosp, Cambridge, England; [Lewis, David] Vauxhall Primary Heath Care, Liverpool, Merseyside, England; [Tomson, Mike] Kings Coll Hosp London, Dept Clin Gerontol, London, England; [Tulloch, Alex] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London, England; [Puntis, John] Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Gould, Derek A.] Royal Liverpool NHS Trust, Liverpool, Merseyside, England; [Darling, Jonathan] Leeds Inst Med Educ, Acad Unit Paediat & Obstet & Gynaecol, Leeds, W Yorkshire, England; [Patel, Anita] Univ Durham, Ctr Publ Policy & Hlth, Sch Med Pharm & Hlth, Durham DH1 3HP, England; [Sikorski, Jim] Countess Chester Fdn NHS Trust, Chester, Cheshire, England; [Sikorski, Jim] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Feehally, John] Univ Hosp Leicester, Leicester, Leics, England; [Feehally, John] Univ Leicester, Leicester LE1 7RH, Leics, England; [Holt, Victoria J.] Homerton Univ Hosp, London, England; [Daley, Helen] Child Hlth Serv, Fareham, England; [Cullinan, Paul] Imperial Coll NHLI, London, England; [Basarab, Adriana] Univ Hosp Southampton NHS Fdn Trust, Dept Infect, Southampton, Hants, England; [Gurling, Hugh] UCL, Mental Hlth Sci Unit, London WC1E 6BT, England; [Jones, Phil] St Bartholomews Hosp, London, England; [Macfarlane, Alison] City Univ London, Alison Macfarlane Sch Hlth Sci, London, England; [Deanery, Mersey] Cardiff Univ, Wales Heart Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Timms, Philip] Kings Coll London, London, England; [Timms, Philip] South London & Maudsley NHS Fdn Trust, David Knight Barnabas Med Ctr, London, England; [Walker, Jonathan] Royal Liverpool Univ, Liverpool, Merseyside, England; [Walker, Jonathan] Broadgreen Hosp NHS Trust, Liverpool, Merseyside, England; [Godfrey, Peter] London Sch Hyg & Trop Med, London, England; [Nsutebu, Emmanuel] Royal Liverpool Hosp, Liverpool, Merseyside, England; [Stevenson, Nicola] Wirral Hosp, Wirral, Merseyside, England; [Cheeroth, Sheila] Gill St Hlth Ctr, London, England; [Johnson, Guy] East London Fdn NHS Trust, London, England; [Bostock, David] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Kinmonth, Ann-Louise] Univ Cambridge, Cambridge CB2 1TN, England; [Kinmonth, Ann-Louise] London Sch Hyg & Trop Med, London, England; [Kinmonth, Ann-Louise] Univ Cambridge, Cambridge, England	University of London; University College London; James Cook University Hospital; University of London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; Nottingham University Hospital NHS Trust; Keele University; Keele University; University of London; University College London; University of London; Queen Mary University London; University of London; London School Economics & Political Science; University of West England; University of West England; University of London; King's College London; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine; University of London; University of Liverpool; Imperial College London; University of Glasgow; Cancer Research UK; University of London; University College London; University of London; University College London; University of Warwick; University of London; University College London; Durham University; Durham University; University of Brighton; University of Sussex; University of Bristol; University of Southampton; University of Hong Kong; University of London; University College London; Imperial College London; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of London; University College London; University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Leeds General Infirmary; University of Leeds; Durham University; Imperial College London; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University of London; Queen Mary University London; Imperial College London; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; City University London; Cardiff University; University of London; King's College London; South London & Maudsley NHS Trust; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Davis, J (corresponding author), Whittington Hosp, London, England.	drjcdavis@hotmail.com	Fleming, Peter/O-3231-2019; Mindell, Jennifer S/G-2241-2011; Greenhalgh, Trisha/B-1825-2015; Yudkin, John S/C-1988-2008; McKee, Marc D/E-2187-2011; Ma, Richard/Z-6047-2019; Coleman, Michel/AAA-9543-2020; Darling, Jonathan C/A-6288-2012; Clarke, Aileen/I-5679-2012; Silverman, Ruth/GYE-3363-2022; Finer, Nicholas/B-9981-2009; McKee, Martin/E-6673-2018; Bambra, Clare/C-1392-2010	Fleming, Peter/0000-0003-2521-5764; Mindell, Jennifer S/0000-0002-7604-6131; Greenhalgh, Trisha/0000-0003-2369-8088; McKee, Marc D/0000-0001-8349-965X; Ma, Richard/0000-0001-6877-2785; Coleman, Michel/0000-0001-8940-3807; Darling, Jonathan C/0000-0001-7176-5957; Clarke, Aileen/0000-0001-8299-3146; Finer, Nicholas/0000-0003-2468-6804; Whincup, Peter/0000-0002-5589-4107; McCartney, Margaret/0000-0002-7238-6358; Feder, Gene/0000-0002-7890-3926; Michael, Benedict/0000-0002-8693-8926; young, john/0000-0003-4085-9306; Rawaf, Salman/0000-0001-7191-2355; Logan, Stuart/0000-0002-9279-261X; McKee, Martin/0000-0002-0121-9683; Finer, Sarah/0000-0002-2684-4653; pollock, allyson/0000-0002-7388-3110; Smyth, Alan/0000-0001-5494-5438; Irving, William/0000-0002-7268-3168; Ormerod, Julian/0000-0003-1612-8992; Bambra, Clare/0000-0002-1294-6851	MRC [G0902037, G0800441] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Cancer Research UK [11700] Funding Source: Medline; Medical Research Council [G0800441, G0902037, G0100222, G8802774, G19/35] Funding Source: Medline; Department of Health [DRF-2010-03-97] Funding Source: Medline; Cancer Research UK [16148] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10031] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))			0	6	6	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1819	10.1136/bmj.f1819	http://dx.doi.org/10.1136/bmj.f1819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516260	Green Submitted			2022-12-28	WOS:000316671500010
J	Spence, D				Spence, Des			Bad medicine: co-codamol	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						ACMD Advisory Council on the Misuse of Drugs, 2013, ACMD CONS TRAM; All-Party Parliamentary Drugs Misuse Group, 2007, INQ PHYS DEP ADD PRE; Centers for Disease Control and Prevention, 2012, POL IMP PRESCR PAINK; NHS National Treatment Agency for Substance Misuse, ADD MED INV CONF COM; PAGB Proprietary Association of Great Britain, 2012, OTC MED ADD; The NHS Information Centre, PRESCR COST AN ENGL	6	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1821	10.1136/bmj.f1821	http://dx.doi.org/10.1136/bmj.f1821			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113MG	23516162				2022-12-28	WOS:000316671500015
J	Merkenschlager, M; Odom, DT				Merkenschlager, Matthias; Odom, Duncan T.			CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets	CELL			English	Review							DNA-BINDING PROTEIN; RNA-POLYMERASE-II; ENHANCER-BLOCKING ACTIVITY; HIGH-RESOLUTION MAP; DE-LANGE-SYNDROME; C-MYC; TRANSPOSABLE ELEMENTS; HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; CONTROL REGION	Current epigenomics approaches have facilitated the genome-wide identification of regulatory elements based on chromatin features and transcriptional regulator binding and have begun to map long-range interactions between regulatory elements and their targets. Here, we focus on the emerging roles of CTCF and the cohesin in coordinating long-range interactions between regulatory elements. We discuss how species-specific transposable elements may influence such interactions by remodeling the CTCF binding repertoire and suggest that cohesin's association with enhancers, promoters, and sites defined by CTCF binding has the potential to form developmentally regulated networks of long-range interactions that reflect and promote cell-type-specific transcriptional programs.	[Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England	Imperial College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Merkenschlager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk; duncan.odom@cruk.cam.ac.uk		Merkenschlager, Matthias/0000-0003-2889-3288; Odom, Duncan/0000-0001-6201-5599	Medical Research Council, UK; Wellcome Trust; Cancer Research UK; European Research Council; EMBO Young Investigators Programme; MRC [MC_U120027516] Funding Source: UKRI; Cancer Research UK [15603] Funding Source: researchfish; Medical Research Council [MC_U120027516] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigators Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Vlad Seitan and other lab members for suggestions and Anthony Lewis (MRC Clinical Sciences Centre) and Michelle Ward (University of Cambridge) for help with graphics, and we apologize to our colleagues whose work could not be cited due to space constraints. This work was supported by the Medical Research Council, UK (M.M.), the Wellcome Trust (M.M.), Cancer Research UK (D.T.O.), European Research Council (D.T.O.), and EMBO Young Investigators Programme (D.T.O.).	BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Beygo J, 2013, HUM MOL GENET, V22, P544, DOI 10.1093/hmg/dds465; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Brockdorff N, 2011, DEVELOPMENT, V138, P5057, DOI 10.1242/dev.065276; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen HS, 2012, J VIROL, V86, P9454, DOI 10.1128/JVI.00787-12; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dostie J, 2012, CURR OPIN GENET DEV, V22, P125, DOI 10.1016/j.gde.2011.12.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Giles KE, 2010, COLD SH Q B, V75, P79, DOI 10.1101/sqb.2010.75.006; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Holdorf MM, 2011, VIROLOGY, V415, P1, DOI 10.1016/j.virol.2011.04.004; Hughes DJ, 2012, J VIROL, V86, P1034, DOI 10.1128/JVI.05923-11; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kang H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002140; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lopez-Flores I, 2010, GENOME DYN, V7, P1; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Lusk RW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000829; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rollins RA, 1999, GENETICS, V152, P577; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Seitan VC, 2012, TRENDS IMMUNOL, V33, P153, DOI 10.1016/j.it.2012.02.004; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Shrimali S, 2012, NUCLEIC ACIDS RES, V40, P7753, DOI 10.1093/nar/gks556; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Siomi H, 2011, CELL, V145, P1005, DOI 10.1016/j.cell.2011.06.009; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Spencer RJ, 2011, GENETICS, V189, P441, DOI 10.1534/genetics.111.132662; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stevens HC, 2012, VIRUS GENES, V45, P265, DOI 10.1007/s11262-012-0769-y; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tempera I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001048; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhong XP, 1999, J IMMUNOL, V163, P295	139	263	272	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1285	1297		10.1016/j.cell.2013.02.029	http://dx.doi.org/10.1016/j.cell.2013.02.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498937	Bronze			2022-12-28	WOS:000316192500010
J	Pope, BD; Aparicio, OM; Gilbert, DM				Pope, Benjamin D.; Aparicio, Oscar M.; Gilbert, David M.			SnapShot: Replication Timing	CELL			English	Editorial Material							CHROMOSOME-REPLICATION; KINASES; REVEALS		[Pope, Benjamin D.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Aparicio, Oscar M.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	State University System of Florida; Florida State University; University of Southern California	Pope, BD (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.		Pope, Ben/Y-4326-2019	Pope, Ben/0000-0003-1847-9163; Aparicio, Oscar/0000-0002-5591-0277	NCI NIH HHS [F31 CA165863] Funding Source: Medline; NIGMS NIH HHS [P01 GM085354] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F31CA165863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, R01GM065494] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Maya-Mendoza A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000900; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Rhind N., 2013, DNA REPLICATION HUMA; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042	10	15	15	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1390	1390	1390.e1	10.1016/j.cell.2013.02.038	http://dx.doi.org/10.1016/j.cell.2013.02.038			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498945	Bronze			2022-12-28	WOS:000316192500018
J	Grossman, D				Grossman, Daniel			Moving Oral Contraceptives Over the Counter as a Strategy to Reduce Unintended Pregnancy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTRAINDICATIONS		Ibis Reprod Hlth, Oakland, CA 94612 USA		Grossman, D (corresponding author), Ibis Reprod Hlth, 1330 Broadway, Oakland, CA 94612 USA.	DGrossman@ibisreproductivehealth.org						Committee on Gynecologic Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1527, DOI 10.1097/01.AOG.0000423818.85283.bd; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Grindlay K, 2012, CONTRACEPTION; Grossman D, 2012, CONTRACEPTION, V86, P293, DOI 10.1016/j.contraception.2012.05.033; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Hopkins K, 2012, CONTRACEPTION, V86, P376, DOI 10.1016/j.contraception.2012.03.003; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Potter JE, 2011, OBSTET GYNECOL, V117, P551, DOI 10.1097/AOG.0b013e31820afc46; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; White K, 2012, CONTRACEPTION, V86, P199, DOI 10.1016/j.contraception.2012.01.008	10	5	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					839	+		10.7326/0003-4819-158-11-201306040-00629	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23529386				2022-12-28	WOS:000320379800007
J	Bressan, M; Liu, G; Mikawa, T				Bressan, Michael; Liu, Gary; Mikawa, Takashi			Early Mesodermal Cues Assign Avian Cardiac Pacemaker Fate Potential in a Tertiary Heart Field	SCIENCE			English	Article							CELLS	Cardiac pacemaker cells autonomously generate electrical impulses that initiate and maintain the rhythmic contraction of the heart. Although the majority of heart cells are thought to originate from the primary and secondary heart fields, we found that chick pacemaker cells arise from a discrete region of mesoderm outside of these fields. Shortly after gastrulation, canonical Wnts promote the recruitment of mesodermal cells within this region into the pacemaker lineage. These findings suggest that cardiac pacemaker cells are physically segregated and molecularly programmed in a tertiary heart field prior to the onset of cardiac morphogenesis.	[Bressan, Michael; Liu, Gary; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	takashi.mikawa@ucsf.edu			NIH [R01HL093566, R01HL112268, T32HL007544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007544, R01HL093566, R01HL112268, R37HL078921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Kornberg, D. Stainier, S. Coughlin, and R. Shaw for their comments, and Mikawa lab members for their suggestions. All data reported in this paper can be found in the main text or supplementary materials. Supported by NIH grants R01HL093566 and R01HL112268 (T. M.) and T32HL007544 (M.B.).	Abu-Issa R, 2008, DEV BIOL, V319, P223, DOI 10.1016/j.ydbio.2008.04.014; Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hoff EC, 1939, AM HEART J, V17, P470, DOI 10.1016/S0002-8703(39)90597-1; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Keith A, 1907, J ANAT PHYSIOL, V41, P172; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Manisastry SM, 2006, DEV DYNAM, V235, P2160, DOI 10.1002/dvdy.20878; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; VANMIEROP LH, 1967, AM J PHYSIOL, V212, P407, DOI 10.1152/ajplegacy.1967.212.2.407; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5	25	100	100	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					744	748		10.1126/science.1232877	http://dx.doi.org/10.1126/science.1232877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23519212	Green Accepted			2022-12-28	WOS:000318619000039
J	Garner, P; Taylor-Robinson, D; Sachdev, HS				Garner, Paul; Taylor-Robinson, David; Sachdev, Harshpal Singh			DEVTA: results from the biggest clinical trial ever	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS		[Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Taylor-Robinson, David] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; Sitaram Bhartia Institute of Science & Research	Garner, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	pgarner@liv.ac.uk	Garner, Paul/Y-8385-2019; Garner, Paul/HII-5856-2022	Garner, Paul/0000-0002-0607-6941; Sachdev, Harshpal Singh/0000-0002-4956-9391	Medical Research Council [G0802448] Funding Source: Medline; MRC [G0802448] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AWASTHI S, 6 MONTHLY VITAMIN A; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Godlee F, 2013, BMJ-BRIT MED J, V346, pf159; Hawkes N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8558; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Karlan D, 2012, STANFORD SOCIAL INNO; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peto R, 2013, LANCET; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; United Nations Children's Fund (UNICEF), 2007, VIT A SUPPL DEC PROG; World Health Organization (WHO), 2012, DEW COMB HLTH NUTR I; Yngve A, 2008, PUBLIC HEALTH NUTR, V11, P655, DOI 10.1017/S1368980008002796; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	17	14	14	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1439	1441		10.1016/S0140-6736(13)60600-5	http://dx.doi.org/10.1016/S0140-6736(13)60600-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23498851				2022-12-28	WOS:000318607300012
J	Johansen, JP				Johansen, Joshua P.			NEUROSCIENCE Anxiety is the sum of its parts	NATURE			English	Editorial Material							STRIA TERMINALIS; BED NUCLEUS; FEAR; CIRCUITS; AREA		RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Johansen, JP (corresponding author), RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan.	jjohans@brain.riken.jp	Johansen, Joshua/N-8010-2015	Johansen, Joshua/0000-0003-4240-1550				Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Poulos AM, 2010, P NATL ACAD SCI USA, V107, P14881, DOI 10.1073/pnas.1005754107; Sullivan GM, 2004, NEUROSCIENCE, V128, P7, DOI 10.1016/j.neuroscience.2004.06.015; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820	12	14	15	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					174	175		10.1038/nature12087	http://dx.doi.org/10.1038/nature12087			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23515160				2022-12-28	WOS:000317346300029
J	Chen, CC; Zhu, C; White, ER; Chiu, CY; Scott, MC; Regan, BC; Marks, LD; Huang, Y; Miao, JW				Chen, Chien-Chun; Zhu, Chun; White, Edward R.; Chiu, Chin-Yi; Scott, M. C.; Regan, B. C.; Marks, Laurence D.; Huang, Yu; Miao, Jianwei			Three-dimensional imaging of dislocations in a nanoparticle at atomic resolution	NATURE			English	Article							ELECTRON-MICROSCOPY; PHASE-CONTRAST; TOMOGRAPHY; ENHANCEMENT; DEFECTS; GOLD	Dislocations and their interactions strongly influence many material properties, ranging from the strength of metals and alloys to the efficiency of light-emitting diodes and laser diodes(1-4). Several experimental methods can be used to visualize dislocations. Transmission electron microscopy (TEM) has long been used to image dislocations in materials(5-9), and high-resolution electron microscopy can reveal dislocation core structures in high detail(10), particularly in annular dark-field mode(11). A TEM image, however, represents a two-dimensional projection of a three-dimensional (3D) object (although stereo TEM provides limited information about 3D dislocations(4)). X-ray topography can image dislocations in three dimensions, but with reduced resolution(12). Using weak-beam dark-field TEM13 and scanning TEM14, electron tomography has been used to image 3D dislocations at a resolution of about five nanometres (refs 15, 16). Atom probe tomography can offer higher-resolution 3D characterization of dislocations, but requires needle-shaped samples and can detect only about 60 per cent of the atoms in a sample(17). Here we report 3D imaging of dislocations in materials at atomic resolution by electron tomography. By applying 3D Fourier filtering together with equal-slope tomographic reconstruction, we observe nearly all the atoms in a multiply twinned platinum nanoparticle. We observed atomic steps at 3D twin boundaries and imaged the 3D core structure of edge and screw dislocations at atomic resolution. These dislocations and the atomic steps at the twin boundaries, which appear to be stress-relief mechanisms, are not visible in conventional two-dimensional projections. The ability to image 3D disordered structures such as dislocations at atomic resolution is expected to find applications in materials science, nanoscience, solid-state physics and chemistry.	[Chen, Chien-Chun; Zhu, Chun; White, Edward R.; Scott, M. C.; Regan, B. C.; Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Chen, Chien-Chun; Zhu, Chun; White, Edward R.; Chiu, Chin-Yi; Scott, M. C.; Regan, B. C.; Huang, Yu; Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Chiu, Chin-Yi; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Marks, Laurence D.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Marks, Laurence/B-7527-2009; Huang, Yu/AAZ-9747-2020	Huang, Yu/0000-0003-1793-0741; Regan, B. C./0000-0003-3923-2688	UC Discovery/TomoSoft Technologies [IT107-10166]; NSF MRSEC at the Materials Research Center of Northwestern University [DMR-1121262]; Division Of Materials Research [1121262] Funding Source: National Science Foundation	UC Discovery/TomoSoft Technologies(University of California System); NSF MRSEC at the Materials Research Center of Northwestern University; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank B. S. Dunn for commenting on our manuscript and L. Ruan for discussions. The tomographic tilt series were acquired at the Electron Imaging Center for NanoMachines of California NanoSystems Institute. This work was supported by UC Discovery/TomoSoft Technologies (IT107-10166). L. D. M. acknowledges support by the NSF MRSEC (DMR-1121262) at the Materials Research Center of Northwestern University.	Averbuch A, 2008, SIAM J SCI COMPUT, V30, P785, DOI 10.1137/060650301; Bacon D.J., 2011, INTRO DISLOCATIONS; BAILEY DH, 1991, SIAM REV, V33, P389, DOI 10.1137/1033097; Balk TJ, 2001, PHILOS MAG A, V81, P1507, DOI 10.1080/01418610108214360; Bar Sadan M, 2008, NANO LETT, V8, P891, DOI 10.1021/nl073149i; Barnard JS, 2006, SCIENCE, V313, P319, DOI 10.1126/science.1125783; BOLLMANN W, 1956, PHYS REV, V103, P1588, DOI 10.1103/PhysRev.103.1588; Brown R. G., 1996, INTRO RANDOM SIGNALS, V3rd; CHISHOLM MF, 1991, NATURE, V351, P47, DOI 10.1038/351047a0; Chiu CY, 2011, NAT CHEM, V3, P393, DOI [10.1038/nchem.1025, 10.1038/NCHEM.1025]; COCKAYNE DJ, 1969, PHILOS MAG, V20, P1265, DOI 10.1080/14786436908228210; Fahimian BP, 2010, PHYS MED BIOL, V55, P5383, DOI 10.1088/0031-9155/55/18/008; Hawkes P. W., 1980, COMPUTER PROCESSING; Hirsch P, 2006, PHILOS MAG, V86, P4519, DOI 10.1080/14786430600768634; HIRSCH PB, 1956, PHILOS MAG, V1, P677, DOI 10.1080/14786435608244003; HOWIE A, 1984, PHILOS MAG A, V49, P95, DOI 10.1080/01418618408233432; HOWIE A, 1966, PHILOS MAG, V14, P223, DOI 10.1080/14786436608219008; HOWIE A, 1962, PROC R SOC LON SER-A, V267, P206, DOI 10.1098/rspa.1962.0093; HUA GC, 1994, APPL PHYS LETT, V65, P1331, DOI 10.1063/1.112042; Johnson CL, 2008, NAT MATER, V7, P120, DOI 10.1038/nmat2083; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Kirkland E.J., 2010, ADV COMPUTING ELECT, V2nd; Lee E, 2008, J STRUCT BIOL, V164, P221, DOI 10.1016/j.jsb.2008.07.011; Ludwig W, 2001, J APPL CRYSTALLOGR, V34, P602, DOI 10.1107/S002188980101086X; Marks LD, 1996, ULTRAMICROSCOPY, V62, P43, DOI 10.1016/0304-3991(95)00085-2; MENTER JW, 1956, PROC R SOC LON SER-A, V236, P119, DOI 10.1098/rspa.1956.0117; Miao JW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052103; Midgley P.A., 2011, SCANNING TRANSMISSIO, P353; MOBUS G, 1993, ULTRAMICROSCOPY, V49, P46, DOI 10.1016/0304-3991(93)90212-G; Nakamura S, 1998, SCIENCE, V281, P956, DOI 10.1126/science.281.5379.956; Pennycook S. J., 2011, SCANNING TRANSMISSIO; Saxton W. O., 1978, COMPUTER TECHNIQUES; Smith W. F., 2005, FDN MAT SCI ENG; SPENCE JCH, 2003, EXPT HIGH RESOLUTION; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Xin HL, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3442496; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	38	252	256	43	744	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					74	+		10.1038/nature12009	http://dx.doi.org/10.1038/nature12009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535594				2022-12-28	WOS:000316993400027
J	Nijman, RG; Vergouwe, Y; Thompson, M; van Veen, M; van Meurs, AHJ; van der Lei, J; Steyerberg, EW; Moll, HA; Oostenbrink, R				Nijman, Ruud G.; Vergouwe, Yvonne; Thompson, Matthew; van Veen, Mirjam; van Meurs, Alfred H. J.; van der Lei, Johan; Steyerberg, Ewout W.; Moll, Henriette A.; Oostenbrink, Rianne			Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; IDENTIFYING CHILDREN; OCCULT PNEUMONIA; MENINGOCOCCAL DISEASE; HOSPITAL EMERGENCY; TRACT-INFECTION; APPARENT SOURCE; PRIMARY-CARE; FEVER; INFANTS	Objective To derive, cross validate, and externally validate a clinical prediction model that assesses the risks of different serious bacterial infections in children with fever at the emergency department. Design Prospective observational diagnostic study. Setting Three paediatric emergency care units: two in the Netherlands and one in the United Kingdom. Participants Children with fever, aged 1 month to 15 years, at three paediatric emergency care units: Rotterdam (n=1750) and the Hague (n=967), the Netherlands, and Coventry (n=487), United Kingdom. A prediction model was constructed using multivariable polytomous logistic regression analysis and included the predefined predictor variables age, duration of fever, tachycardia, temperature, tachypnoea, ill appearance, chest wall retractions, prolonged capillary refill time (> 3 seconds), oxygen saturation < 94%, and C reactive protein. Main outcome measures Pneumonia, other serious bacterial infections (SBIs, including septicaemia/meningitis, urinary tract infections, and others), and no SBIs. Results Oxygen saturation < 94% and presence of tachypnoea were important predictors of pneumonia. A raised C reactive protein level predicted the presence of both pneumonia and other SBIs, whereas chest wall retractions and oxygen saturation < 94% were useful to rule out the presence of other SBIs. Discriminative ability (C statistic) to predict pneumonia was 0.81 (95% confidence interval 0.73 to 0.88); for other SBIs this was even better: 0.86 (0.79 to 0.92). Risk thresholds of 10% or more were useful to identify children with serious bacterial infections; risk thresholds less than 2.5% were useful to rule out the presence of serious bacterial infections. External validation showed good discrimination for the prediction of pneumonia (0.81, 0.69 to 0.93); discriminative ability for the prediction of other SBIs was lower (0.69, 0.53 to 0.86). Conclusion A validated prediction model, including clinical signs, symptoms, and C reactive protein level, was useful for estimating the likelihood of pneumonia and other SBIs in children with fever, such as septicaemia/meningitis and urinary tract infections.	[Nijman, Ruud G.; van Veen, Mirjam; Moll, Henriette A.; Oostenbrink, Rianne] Erasmus MC Sophia Childrens Hosp, Dept Gen Paediat, NL-3015 GJ Rotterdam, Netherlands; [Vergouwe, Yvonne; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Thompson, Matthew] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [van Meurs, Alfred H. J.] Haga Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands; [van der Lei, Johan] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Haga Hospital; Erasmus University Rotterdam; Erasmus MC	Oostenbrink, R (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Gen Paediat, NL-3015 GJ Rotterdam, Netherlands.	r.oostenbrink@erasmusmc.nl	Steyerberg, Ewout W/C-1509-2018	Steyerberg, Ewout W/0000-0002-7787-0122; Nijman, Ruud Gerard/0000-0001-9671-8161	ZonMW; Dutch organisation for health research and development; Erasmus MC Doelmatigheid; Europe Container Terminals; European Society of Paediatric Infectious Diseases; National Institute for Health Research	ZonMW(Netherlands Organization for Health Research and Development); Dutch organisation for health research and development(Netherlands Organization for Health Research and Development); Erasmus MC Doelmatigheid; Europe Container Terminals; European Society of Paediatric Infectious Diseases; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RGN is supported by ZonMW, a Dutch organisation for health research and development, and Erasmus MC Doelmatigheid; RO is supported by an unrestricted grant from Europe Container Terminals and a fellowship grant from the European Society of Paediatric Infectious Diseases in 2010; this report is independent research arising from MT's career development fellowship supported by the National Institute for Health Research and the views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the Institute for Health Research, or Department of Health; no other relationships or activities that could have influenced the submitted work.	Almond SC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1878; Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; Bleeker SE, 2001, ACTA PAEDIATR, V90, P1226, DOI 10.1080/080352501317130236; Bressan S, 2012, PEDIATR INFECT DIS J, V31, P1239, DOI 10.1097/INF.0b013e318266a9aa; Bressan S, 2012, ACTA PAEDIATR, V101, P271, DOI 10.1111/j.1651-2227.2011.02478.x; Carrol ED, 2002, ARCH DIS CHILD, V86, P282, DOI 10.1136/adc.86.4.282; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Curtis S, 2010, PEDIATRICS, V126, P952, DOI 10.1542/peds.2010-0277; DahlerEriksen BS, 1997, CLIN CHEM, V43, P2064; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Galetto-Lacour A, 2003, PEDIATRICS, V112, P1054, DOI 10.1542/peds.112.5.1054; Galetto-Lacour A, 2010, ARCH DIS CHILD, V95, P968, DOI 10.1136/adc.2009.176800; Gomez B, 2012, PEDIATRICS, V130, P815, DOI 10.1542/peds.2011-3575; Haddon RA, 1999, MED J AUSTRALIA, V170, P475, DOI 10.5694/j.1326-5377.1999.tb127847.x; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; Hsiao AL, 2005, CURR OPIN PEDIATR, V17, P56, DOI 10.1097/01.mop.0000151781.13635.70; Huppler AR, 2010, PEDIATRICS, V125, P228, DOI 10.1542/peds.2009-1070; JOFFE A, 1983, AM J DIS CHILD, V137, P1153, DOI 10.1001/archpedi.1983.02140380013005; Kuppermann N, 1998, ANN EMERG MED, V31, P679, DOI 10.1016/S0196-0644(98)70225-2; Lacour AG, 2008, PEDIATR INFECT DIS J, V27, P654, DOI 10.1097/INF.0b013e318168d2b4; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Leroy S, 2006, ARCH DIS CHILD, V91, P241, DOI 10.1136/adc.2004.068205; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Mahabee-Gittens EM, 2005, CLIN PEDIATR, V44, P427, DOI 10.1177/000992280504400508; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; Mintegi S, 2010, PEDIATR EMERG CARE, V26, P470, DOI 10.1097/PEC.0b013e3181e582e4; Mintegi S, 2009, EUR J EMERG MED, V16, P199, DOI 10.1097/MEJ.0b013e32831cefc9; Murphy CG, 2007, ACAD EMERG MED, V14, P243, DOI 10.1197/j.aem.2006.08.022; NELSON DS, 1992, PEDIATRICS, V90, P5; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Nijman RG, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4224; OFFRINGA M, 1992, DEV MED CHILD NEUROL, V34, P15; Oostenbrink R, 2001, ACTA PAEDIATR, V90, P611, DOI 10.1080/080352501750258649; Oostenbrink R, 2012, ARCH DIS CHILD, V97, P667, DOI 10.1136/archdischild-2011-300667; Pulliam PN, 2001, PEDIATRICS, V108, P1275, DOI 10.1542/peds.108.6.1275; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Roukema J, 2006, PEDIATRICS, V117, P15, DOI 10.1542/peds.2004-2741; Roukema J, 2008, J AM MED INFORM ASSN, V15, P107, DOI 10.1197/jamia.M2164; Rudensky B, 2008, PEDIATR EMERG CARE, V24, P745, DOI 10.1097/PEC.0b013e31818c2679; Rutman MS, 2009, PEDIATR EMERG CARE, V25, P1, DOI 10.1097/PEC.0b013e318191dab2; Sanders S, 2008, J PEDIATR, V153, P570, DOI 10.1016/j.jpeds.2008.04.023; Shah S, 2010, PEDIATR EMERG CARE, V26, P615, DOI 10.1097/PEC.0b013e3181ef04a3; Slater M, 1999, EMERG MED CLIN N AM, V17, P97, DOI 10.1016/S0733-8627(05)70049-3; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Steyerberg EW, 2009, CLIN PREDICITON MODE; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; TAYLOR JA, 1995, ARCH PEDIAT ADOL MED, V149, P283, DOI 10.1001/archpedi.1995.02170150063011; Team RDC, 2006, R LANG ENV STAT COMP; TEELE DW, 1975, J PEDIATR-US, V87, P227, DOI 10.1016/S0022-3476(75)80584-1; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Trautner BW, 2006, PEDIATRICS, V118, P34, DOI 10.1542/peds.2005-2823; Turner N., 2006, ADV PAEDIAT LIFE SUP; Van Calster B, 2012, EUR J EPIDEMIOL, V27, P761, DOI 10.1007/s10654-012-9733-3; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; van Veen M, 2011, ARCH DIS CHILD, V96, P513, DOI 10.1136/adc.2010.199018; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; WASKERWITZ S, 1981, J PEDIATR-US, V99, P231, DOI 10.1016/S0022-3476(81)80458-1; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218; World Health 0rganization, 1995, MAN AC RESP INF CHIL; Yo CH, 2012, ANN EMERG MED, V60, P591, DOI 10.1016/j.annemergmed.2012.05.027	73	98	100	3	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f1706	10.1136/bmj.f1706	http://dx.doi.org/10.1136/bmj.f1706			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SA	23550046	Green Published, hybrid			2022-12-28	WOS:000317337200001
J	Ricciardi, W				Ricciardi, Walter			Health in Europe-policies for progress	LANCET			English	Editorial Material									Univ Cattolica Sacro Cuore, Fac Med & Surg, Dept Publ Hlth, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ricciardi, W (corresponding author), Univ Cattolica Sacro Cuore, Fac Med & Surg, Dept Publ Hlth, I-00168 Rome, Italy.	wricciardi@rm.unicatt.it	Ricciardi, Walter/K-3342-2018; Ricciardi, Walter/AAB-2056-2019	Ricciardi, Walter/0000-0002-5655-688X				Greer SL, 2013, LANCET; Guest C, 2013, OXFORD HDB PUBLIC HL; Jakab Z, 2012, LANCET, V380, P951, DOI 10.1016/S0140-6736(12)61481-0; Karanikolos M, 2013, LANCET; Mackenbach JP, 2013, LANCET; Mackenbach JP., 2013, SUCCESSES FAILURES H; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McCarthy M, 2012, EUR J PUBLIC HEALTH, V22, P455, DOI 10.1093/eurpub/cks082; Rechel B, 2013, LANCET; WHO, 2012, HLTH 2020 EUR POL FR; Wolfe I, 2013, LANCET; World Health Organisation, 2012, EUR ACT PLAN STRENGT; World Health Organization, EUR HLTH ALL DAT; World Health Organization, 2013, EUR HLTH REP 2012 CH	14	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1075	1076		10.1016/S0140-6736(13)60356-6	http://dx.doi.org/10.1016/S0140-6736(13)60356-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23541051				2022-12-28	WOS:000317348900005
J	Marimuthu, A; Zhang, JW; Linic, S				Marimuthu, Andiappan; Zhang, Jianwen; Linic, Suljo			Tuning Selectivity in Propylene Epoxidation by Plasmon Mediated Photo-Switching of Cu Oxidation State	SCIENCE			English	Article							ELECTRON-TRANSFER; METAL; PHOTOCHEMISTRY; NANOPARTICLES; NANOSTRUCTURES; CU(111); ALKENE; ATOMS	Oxidation of functioning copper has restricted its applicability as a catalyst for commercially important epoxidation of propylene to form propylene oxide. Here, we report that steady-state selectivity in propylene epoxidation on copper (Cu) nanoparticles increases sharply when the catalyst is illuminated with visible light. The selectivity increase is accompanied by light-induced reduction of the surface Cu atoms, which is brought about by photoexcitation of the localized surface plasmon resonance (LSPR) of Cu. We discuss multiple mechanisms by which Cu LSPR weakens the Cu-O bonds, reducing Cu2O.	[Marimuthu, Andiappan; Zhang, Jianwen; Linic, Suljo] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Linic, S (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linic@umich.edu		Linic, Suljo/0000-0003-2153-6755	U.S. Department of Energy, Office of Basic Energy Science, Division of Chemical Sciences [FG-02-05ER15686]; National Science Foundation [CBET-0966700, CBET-1132777, CHE-1111770]; DuPont corporation; Camille Dreyfus Teacher-Scholar Award from the Camille & Henry Dreyfus Foundation	U.S. Department of Energy, Office of Basic Energy Science, Division of Chemical Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); DuPont corporation; Camille Dreyfus Teacher-Scholar Award from the Camille & Henry Dreyfus Foundation	We gratefully acknowledge support from the U.S. Department of Energy, Office of Basic Energy Science, Division of Chemical Sciences (FG-02-05ER15686) and National Science Foundation (CBET-0966700, CBET-1132777 and CHE-1111770). S. L. acknowledges the DuPont Young Professor grant by the DuPont corporation and the Camille Dreyfus Teacher-Scholar Award from the Camille & Henry Dreyfus Foundation. We also acknowledge H. Xin for discussions and insight. We declare no competing financial interests.	Awazu K, 2008, J AM CHEM SOC, V130, P1676, DOI 10.1021/ja076503n; Brus L, 2008, ACCOUNTS CHEM RES, V41, P1742, DOI 10.1021/ar800121r; Chan GH, 2007, NANO LETT, V7, P1947, DOI 10.1021/nl070648a; Christopher P, 2012, NAT MATER, V11, P1044, DOI [10.1038/nmat3454, 10.1038/NMAT3454]; Christopher P, 2011, NAT CHEM, V3, P467, DOI [10.1038/NCHEM.1032, 10.1038/nchem.1032]; Christopher P, 2010, J PHYS CHEM C, V114, P9173, DOI 10.1021/jp101633u; Cowell JJ, 2000, J AM CHEM SOC, V122, P2381, DOI 10.1021/ja994125j; Cropley RL, 2005, J AM CHEM SOC, V127, P6069, DOI 10.1021/ja042758e; Cushing SK, 2012, J AM CHEM SOC, V134, P15033, DOI 10.1021/ja305603t; Furube A, 2007, J AM CHEM SOC, V129, P14852, DOI 10.1021/ja076134v; Hara M, 1998, CHEM COMMUN, P357, DOI 10.1039/a707440i; HOVEL H, 1993, PHYS REV B, V48, P18178, DOI 10.1103/PhysRevB.48.18178; Ingram DB, 2011, ACS CATAL, V1, P1441, DOI 10.1021/cs200320h; Ingram DB, 2011, J AM CHEM SOC, V133, P5202, DOI 10.1021/ja200086g; Kreibig U, 2008, APPL PHYS B-LASERS O, V93, P79, DOI 10.1007/s00340-008-3213-1; Kreibig U., 1995, OPTICAL PROPERTIES M, P1, DOI [10.1007/978-3-662-09109-8_1, DOI 10.1007/978-3-662-09109-8_1]; Lambert RM, 2005, J MOL CATAL A-CHEM, V228, P27, DOI 10.1016/j.molcata.2004.09.077; Larsson EM, 2009, SCIENCE, V326, P1091, DOI 10.1126/science.1176593; Linic S, 2011, NAT MATER, V10, P911, DOI [10.1038/NMAT3151, 10.1038/nmat3151]; Michaels AM, 2000, J PHYS CHEM B, V104, P11965, DOI 10.1021/jp0025476; Monnier JR, 2001, J CATAL, V203, P253, DOI 10.1006/jcat.2001.3336; Novo C, 2008, NAT NANOTECHNOL, V3, P598, DOI 10.1038/nnano.2008.246; PERSSON BNJ, 1993, SURF SCI, V281, P153, DOI 10.1016/0039-6028(93)90865-H; Rice KP, 2011, J PHYS CHEM C, V115, P1793, DOI 10.1021/jp110483z; Santra AK, 2000, CATAL LETT, V67, P87, DOI 10.1023/A:1019053118841; Seo D, 2012, J AM CHEM SOC, V134, P1221, DOI 10.1021/ja2093663; Tian Y, 2004, CHEM COMMUN, P1810, DOI 10.1039/b405061d; Torres D, 2007, ANGEW CHEM INT EDIT, V46, P2055, DOI 10.1002/anie.200603803; Watanabe K, 2006, CHEM REV, V106, P4301, DOI 10.1021/cr050167g	29	449	462	39	907	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1590	1593		10.1126/science.1231631	http://dx.doi.org/10.1126/science.1231631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539599				2022-12-28	WOS:000316731600044
J	Vogelstein, B; Papadopoulos, N; Velculescu, VE; Zhou, SB; Diaz, LA; Kinzler, KW				Vogelstein, Bert; Papadopoulos, Nickolas; Velculescu, Victor E.; Zhou, Shibin; Diaz, Luis A., Jr.; Kinzler, Kenneth W.			Cancer Genome Landscapes	SCIENCE			English	Review							TERT PROMOTER MUTATIONS; REMODELING GENE ARID1A; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; COLORECTAL ADENOMAS; FREQUENT MUTATION; PATHWAY MUTATIONS; COLON-CANCER; EVOLUTION; BREAST	Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer. For most cancer types, this landscape consists of a small number of "mountains" (genes altered in a high percentage of tumors) and a much larger number of "hills" (genes altered infrequently). To date, these studies have revealed similar to 140 genes that, when altered by intragenic mutations, can promote or "drive" tumorigenesis. A typical tumor contains two to eight of these "driver gene" mutations; the remaining mutations are passengers that confer no selective growth advantage. Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance. A better understanding of these pathways is one of the most pressing needs in basic cancer research. Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.	[Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr, Baltimore, MD 21287 USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Kinzler, KW (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr, Baltimore, MD 21287 USA.	kinzlke@jhmi.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914	Virginia and D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; NIH [CA 43460, CA 47345, CA 62924, CA 121113]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA121113, R01CA043460, R01CA057345, P50CA062924, R37CA043460] Funding Source: NIH RePORTER	Virginia and D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Nowak and I. Bozic for critical reading of the manuscript, S. Gabelli for assisting with the production of Fig. 8, and A. Dixon, V. Ferranta, and E. Cook for artwork. This work was supported by The Virginia and D.K. Ludwig Fund for Cancer Research; The Lustgarten Foundation for Pancreatic Cancer Research; and NIH grants CA 43460, CA 47345, CA 62924, and CA 121113. All authors are Founding Scientific Advisors of Personal Genome Diagnostics (PGDx), a company focused on the identification of genetic alterations in human cancer for diagnostic and therapeutic purposes. All authors are also members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. All authors own stock in PGDx and Inostics. The terms of these arrangements are being managed by Johns Hopkins University, in accordance with their conflict-of-interest policies.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Baish JW, 2011, P NATL ACAD SCI USA, V108, P1799, DOI 10.1073/pnas.1018154108; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Beal MA, 2012, MUTAT RES-REV MUTAT, V750, P96, DOI 10.1016/j.mrrev.2011.11.002; Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bienstock RJ, 2012, CURR PHARM DESIGN, V18, P1240; Bottcher R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks393; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brock DW, 2010, ONCOLOGIST, V15, P36, DOI 10.1634/theoncologist.2010-S1-36; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2013, CANCER CHEMOTH PHARM, V71, P265, DOI 10.1007/s00280-012-2005-9; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Dunn BK, 2011, RECENT RESULTS CANC, V188, P21, DOI 10.1007/978-3-642-10858-7_3; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forster M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks836; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Gryfe R, 2001, SURGERY, V130, P17, DOI 10.1067/msy.2001.112738; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoglund M, 2002, CANCER GENET CYTOGEN, V135, P103, DOI 10.1016/S0165-4608(01)00645-8; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irshad S, 2011, EXPERT REV ANTICANC, V11, P1243, DOI [10.1586/era.11.52, 10.1586/ERA.11.52]; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kerbel R S, 1990, Adv Cancer Res, V55, P87, DOI 10.1016/S0065-230X(08)60469-8; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kirkwood JM, 2012, CA-CANCER J CLIN, V62, P309, DOI 10.3322/caac.20132; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laurenti E, 2012, ANN NY ACAD SCI, V1266, P68, DOI 10.1111/j.1749-6632.2012.06577.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lopes LC, 2010, REV SAUDE PUBL, V44, P620, DOI 10.1590/S0034-89102010000400005; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pear WS, 2004, CURR OPIN HEMATOL, V11, P426, DOI 10.1097/01.moh.0000143965.90813.70; Pelizzola M, 2011, FEBS LETT, V585, P1994, DOI 10.1016/j.febslet.2010.10.061; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHIBATA D, 1993, J NATL CANCER I, V85, P1058, DOI 10.1093/jnci/85.13.1058; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Sottoriva A, 2013, CANCER RES, V73, P41, DOI 10.1158/0008-5472.CAN-12-2273; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yen H, 2000, SCIENCE, V289, P1890; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	152	4875	5083	48	1025	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1546	1558		10.1126/science.1235122	http://dx.doi.org/10.1126/science.1235122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539594	Green Accepted			2022-12-28	WOS:000316731600036
J	Cheng, L; Huang, Z; Zhou, WC; Wu, QL; Donnola, S; Liu, JK; Fang, XG; Sloan, AE; Mao, YB; Lathia, JD; Min, W; McLendon, RE; Rich, JN; Bao, SD				Cheng, Lin; Huang, Zhi; Zhou, Wenchao; Wu, Qiulian; Donnola, Shannon; Liu, James K.; Fang, Xiaoguang; Sloan, Andrew E.; Mao, Yubin; Lathia, Justin D.; Min, Wang; McLendon, Roger E.; Rich, Jeremy N.; Bao, Shideng			Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth	CELL			English	Article							ADHESION MOLECULE-1 PROMOTER; MESENCHYMAL DIFFERENTIATION; PROGENITOR CELLS; EXPRESSION; BRAIN; ANGIOGENESIS; ABNORMALITIES; LINEAGE; CLONING; CANCER	Glioblastomas (GBMs) are highly vascular and lethal brain tumors that display cellular hierarchies containing self-renewing tumorigenic glioma stem cells (GSCs). Because GSCs often reside in perivascular niches and may undergo mesenchymal differentiation, we interrogated GSC potential to generate vascular pericytes. Here, we show that GSCs give rise to pericytes to support vessel function and tumor growth. In vivo cell lineage tracing with constitutive and lineage-specific fluorescent reporters demonstrated that GSCs generate the majority of vascular pericytes. Selective elimination of GSC-derived pericytes disrupts the neovasculature and potently inhibits tumor growth. Analysis of human GBM specimens showed that most pericytes are derived from neoplastic cells. GSCs are recruited toward endothelial cells via the SDF-1/CXCR4 axis and are induced to become pericytes predominantly by transforming growth factor beta. Thus, GSCs contribute to vascular pericytes that may actively remodel perivascular niches. Therapeutic targeting of GSC-derived pericytes may effectively block tumor progression and improve antiangiogenic therapy.	[Cheng, Lin; Huang, Zhi; Zhou, Wenchao; Wu, Qiulian; Donnola, Shannon; Fang, Xiaoguang; Lathia, Justin D.; Rich, Jeremy N.; Bao, Shideng] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Liu, James K.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44195 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Brain Tumor & Neurooncol Ctr, Univ Hosp, Cleveland, OH 44106 USA; [Mao, Yubin] Xiamen Univ, Dept Pathol, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Min, Wang] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Xiamen University; Yale University; Duke University	Bao, SD (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA.	baos@ccf.org	Lathia, Justin/AHB-8296-2022; Sloan, Andrew/AAE-9842-2020; Zhou, Wenchao/ABE-9015-2020; Fang, Xiaoguang/N-2313-2014; Rich, Jeremy/AAM-1445-2021	Liu, James/0000-0002-1907-7150	Cleveland Clinic Foundation; National Institutes of Health [NS070315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070315] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Brain Tumor and Neuro-Oncology Centers at Cleveland Clinic, University Hospitals, and Duke Medical Center for providing GBM specimens. We also thank Dr. Dolores Hambardzumyan for providing the genetically engineered mouse GBMs. We are grateful to Cathy Shemo at the Flow Cytometry Core and Judith Drazba at the Imaging Core for their help. This work was supported by the Cleveland Clinic Foundation and National Institutes of Health R01 grant NS070315 (to S.B.).	Almendro N, 1996, J IMMUNOL, V157, P5411; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Keogh MC, 1999, GENE THER, V6, P616, DOI 10.1038/sj.gt.3300866; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Komatani H, 2009, INT J ONCOL, V34, P665, DOI 10.3892/ijo_00000192; Kulla A, 2003, ACTA NEUROPATHOL, V105, P328, DOI 10.1007/s00401-003-0681-6; LI ZL, 1991, J BIOL CHEM, V266, P6562; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Morishita R, 2007, J NEUROCHEM, V101, P1031, DOI 10.1111/j.1471-4159.2006.04405.x; NAKANO Y, 1991, GENE, V99, P285; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rius C, 1998, BLOOD, V92, P4677; Rodriguez FJ, 2012, ONCOTARGET, V3, P98; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	46	560	584	9	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					139	152		10.1016/j.cell.2013.02.021	http://dx.doi.org/10.1016/j.cell.2013.02.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540695	Green Accepted, Bronze			2022-12-28	WOS:000316853700012
J	Grigoropoulos, NF; Petter, R; Van't Veer, MB; Scott, MA; Follows, GA				Grigoropoulos, Nicholas F.; Petter, Roger; Van't Veer, Mars B.; Scott, Mike A.; Follows, George A.			Leukaemia update. Part 1: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELOID-LEUKEMIA; TRIAL; MULTICENTER; DELETION; CHILDREN; CANCER		[Grigoropoulos, Nicholas F.] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Petter, Roger] Linton Hlth Ctr, Cambridge, England; [Van't Veer, Mars B.; Scott, Mike A.; Follows, George A.] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge	Follows, GA (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge CB2 0QQ, England.	george.follows@addenbrookes.nhs.uk						Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Cancer Research UK, LEUK INC STAT; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Else M, 2012, LEUKEMIA LYMPHOMA, V53, P1289, DOI 10.3109/10428194.2011.649479; Geisler C, 1999, JNCI-J NATL CANCER I, V91, P861; Grove CS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2119; Hann I, 2000, LEUKEMIA, V14, P356, DOI 10.1038/sj.leu.2401704; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Mitchell C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2285; National Institute for Health and Clinical Excellence, 2012, DAS HIGH DOS IM NIL; National Institute for Health and Clinical Excellence, 2011, BEND 1 LIN TREATM CH; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Oscier D, 2012, BRIT J HAEMATOL, V159, P541, DOI 10.1111/bjh.12067; Pettitt AR, 2012, J CLIN ONCOL, V30, P1647, DOI 10.1200/JCO.2011.35.9695; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Sanz MA, 2008, BLOOD, V112, P3130, DOI 10.1182/blood-2008-05-159632; Sive JI, 2012, BRIT J HAEMATOL, V157, P463, DOI 10.1111/j.1365-2141.2012.09095.x; Swerdlow SH, 2008, WHO CLASSIFICATION T	18	9	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2013	346								f1660	10.1136/bmj.f1660	http://dx.doi.org/10.1136/bmj.f1660			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117XI	23538920				2022-12-28	WOS:000316986200004
J	Hanada, T; Weitzer, S; Mair, B; Bernreuther, C; Wainger, BJ; Ichida, J; Hanada, R; Orthofer, M; Cronin, SJ; Komnenovic, V; Minis, A; Sato, F; Mimata, H; Yoshimura, A; Tamir, I; Rainer, J; Kofler, R; Yaron, A; Eggan, KC; Woolf, CJ; Glatzel, M; Herbst, R; Martinez, J; Penninger, JM				Hanada, Toshikatsu; Weitzer, Stefan; Mair, Barbara; Bernreuther, Christian; Wainger, Brian J.; Ichida, Justin; Hanada, Reiko; Orthofer, Michael; Cronin, Shane J.; Komnenovic, Vukoslav; Minis, Adi; Sato, Fuminori; Mimata, Hiromitsu; Yoshimura, Akihiko; Tamir, Ido; Rainer, Johannes; Kofler, Reinhard; Yaron, Avraham; Eggan, Kevin C.; Woolf, Clifford J.; Glatzel, Markus; Herbst, Ruth; Martinez, Javier; Penninger, Josef M.			CLP1 links tRNA metabolism to progressive motor-neuron loss	NATURE			English	Article							3-END FORMATION; PHOSPHORYLATION; ENDONUCLEASE; STRESS; ENZYME; MOUSE; HCLP1; SITE; IA	CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive. Here we generated kinase-dead Clp1 (Clp1(K/K)) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1(K/K) mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.	[Hanada, Toshikatsu; Weitzer, Stefan; Mair, Barbara; Hanada, Reiko; Orthofer, Michael; Komnenovic, Vukoslav; Martinez, Javier; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Wainger, Brian J.; Cronin, Shane J.; Woolf, Clifford J.] Boston Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Cronin, Shane J.; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Department Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ichida, Justin; Eggan, Kevin C.] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Minis, Adi; Yaron, Avraham] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Sato, Fuminori; Mimata, Hiromitsu] Oita Univ, Dept Urol, Fac Med, Oita 8795593, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tamir, Ido] Campus Sci Support Facil GmbH, A-1030 Vienna, Austria; [Rainer, Johannes; Kofler, Reinhard] Med Univ Innsbruck, Div Mol Pathophysiol, Bioctr, A-6020 Innsbruck, Austria; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Herbst, Ruth] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Weizmann Institute of Science; Oita University; Keio University; Medical University of Innsbruck; Harvard University; Harvard Medical School; Medical University of Vienna	Martinez, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; josef.penninger@imba.oeaw.ac.at	Glatzel, Markus/G-3356-2011; Penninger, Josef M/I-6860-2013; Minis, Adi/AAJ-6098-2020; Glatzel, Markus/V-8844-2019; Yoshimura, Akihiko/K-5515-2013; Woolf, Clifford/A-9784-2010; Sato, Fuminori/O-4449-2015; Wainger, Brian/L-7553-2017; Eggan, Kevin/P-7119-2018	Glatzel, Markus/0000-0002-7720-8817; Penninger, Josef M/0000-0002-8194-3777; Minis, Adi/0000-0001-8532-313X; Glatzel, Markus/0000-0002-7720-8817; Rainer, Johannes/0000-0002-6977-7147; Martinez, Javier/0000-0001-9152-7323; Herbst, Ruth/0000-0002-7764-5363; Mair, Barbara/0000-0001-6982-2529	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Austrian Ministry of Sciences; Austrian Academy of Sciences; AustroMouse network of Genome Research in Austria (GEN-AU); Apoptosis systems biology applied to cancer and AIDS (ApoSys); European Research Council Advanced Grant from the European Union; IMBA; GEN-AU (AustroMouse); Japan Society for the Promotion of Science; Astellas Foundation; National Institutes of Health (NIH) [K99NS077435-01A1]; German Research Foundation (DFG) [FG885, GRK 1459]; Landesexzellenzinitiative Hamburg (Neurodapt); Austrian Science Fund [P19223, P21667]; NIH [NS038253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS077435, R01NS038253, K99NS077435] Funding Source: NIH RePORTER	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Austrian Ministry of Sciences; Austrian Academy of Sciences; AustroMouse network of Genome Research in Austria (GEN-AU); Apoptosis systems biology applied to cancer and AIDS (ApoSys); European Research Council Advanced Grant from the European Union; IMBA; GEN-AU (AustroMouse); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation(Astellas Pharmaceuticals); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Landesexzellenzinitiative Hamburg (Neurodapt); Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Meixner, M. Foong, T. Nakashima, H. C. Theussl, J. R. Wojciechowski, A. Bichl, the mouse pathology unit of the Universitatsklinikum Hamburg-Eppendorf, and G. P. Resch for discussions and technical support. We also thank T. Buerckstuemmer for providing the pRV-NTAP vector. J. M. P. is supported by grants from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), the Austrian Ministry of Sciences, the Austrian Academy of Sciences, AustroMouse network of Genome Research in Austria (GEN-AU), Apoptosis systems biology applied to cancer and AIDS (ApoSys) and a European Research Council Advanced Grant from the European Union. J. M., S. W. and B. M. are supported by IMBA and GEN-AU (AustroMouse). T. H. is supported by the Japan Society for the Promotion of Science and the Astellas Foundation. J. K. I. was supported by National Institutes of Health (NIH) grant K99NS077435-01A1. M. G. is supported by grants from the German Research Foundation (DFG) (FG885 and GRK 1459), the Landesexzellenzinitiative Hamburg (Neurodapt). R. H. was supported by the Austrian Science Fund (P19223, P21667). C. J. W. is supported by the NIH (NS038253).	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Ghazy MA, 2012, NUCLEIC ACIDS RES, V40, P1214, DOI 10.1093/nar/gkr801; Haddad R, 2012, NUCLEIC ACIDS RES, V40, P1226, DOI 10.1093/nar/gkr800; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Herbst R, 2009, NEUROMUSCULAR DISORD, V19, P366, DOI 10.1016/j.nmd.2009.02.011; Holbein S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029139; Hurto RL, 2011, ADV EXP MED BIOL, V722, P137, DOI 10.1007/978-1-4614-0332-6_9; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sanchez-Carbente MR, 2005, CELL DEATH DIFFER, V12, P279, DOI 10.1038/sj.cdd.4401560; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	27	151	160	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					474	480		10.1038/nature11923	http://dx.doi.org/10.1038/nature11923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23474986	Green Accepted			2022-12-28	WOS:000316682800038
J	Shaikh, F; Brzezinski, J; Alexander, S; Arzola, C; Carvalho, JCA; Beyene, J; Sung, L				Shaikh, Furqan; Brzezinski, Jack; Alexander, Sarah; Arzola, Cristian; Carvalho, Jose C. A.; Beyene, Joseph; Sung, Lillian			Ultrasound imaging for lumbar punctures and epidural catheterisations: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; REGIONAL ANESTHESIA; CEREBROSPINAL-FLUID; CHILDREN; LANDMARKS; LOCALIZATION; EFFICACY; BLASTS; TRIAL; PART	Objective To determine whether ultrasound imaging can reduce the risk of failed lumbar punctures or epidural catheterisations, when compared with standard palpation methods, and whether ultrasound imaging can reduce traumatic procedures, insertion attempts, and needle redirections. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Ovid Medline, Embase, and Cochrane Central Register of Controlled Trials up to May 2012, without restriction by language or publication status. Review methods Randomised trials that compared ultrasound imaging with standard methods (no imaging) in the performance of a lumbar puncture or epidural catheterisation were identified. Results 14 studies with a total of 1334 patients were included (674 patients assigned to the ultrasound group, 660 to the control group). Five studies evaluated lumbar punctures and nine evaluated epidural catheterisations. Six of 624 procedures conducted in the ultrasound group failed; 44 of 610 procedures in the control group failed. Ultrasound imaging reduced the risk of failed procedures (risk ratio 0.21 (95% confidence interval 0.10 to 0.43), P<0.001). Risk reduction was similar when subgroup analysis was performed for lumbar punctures (risk ratio 0.19 (0.07 to 0.56), P=0.002) or epidural catheterisations (0.23 (0.09 to 0.60), P=0.003). Ultrasound imaging also significantly reduced the risk of traumatic procedures (risk ratio 0.27 (0.11 to 0.67), P=0.005), the number of insertion attempts (mean difference -0.44 (-0.64 to -0.24), P<0.001), and the number of needle redirections (mean difference -1.00 (-1.24 to -0.75), P<0.001). Conclusions Ultrasound imaging can reduce the risk of failed or traumatic lumbar punctures and epidural catheterisations, as well as the number of needle insertions and redirections. Ultrasound may be a useful adjunct for these procedures.	[Shaikh, Furqan; Brzezinski, Jack; Alexander, Sarah; Sung, Lillian] Hosp Sick Children, Div Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Shaikh, Furqan; Brzezinski, Jack; Alexander, Sarah; Arzola, Cristian; Carvalho, Jose C. A.; Sung, Lillian] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Arzola, Cristian; Carvalho, Jose C. A.] Mt Sinai Hosp, Dept Anaesthesia & Pain Management, Toronto, ON M5G 1X5, Canada; [Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University	Shaikh, F (corresponding author), Hosp Sick Children, Div Haematol & Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	furqan.shaikh@sickkids.ca			Pediatric Oncology Group of Ontario research unit; Canadian Institutes of Health Research; Pediatric Oncology Group of Ontario	Pediatric Oncology Group of Ontario research unit; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pediatric Oncology Group of Ontario	FS is supported by a research fellowship from the Pediatric Oncology Group of Ontario research unit. LS is supported by a New Investigator Award from the Canadian Institutes of Health Research. The funders had no role in the design, execution, and writing up of the study. All researchers were independent from funders.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the Pediatric Oncology Group of Ontario and the Canadian Institutes of Health Research for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Arzola C, 2007, ANESTH ANALG, V104, P1188, DOI 10.1213/01.ane.0000250912.66057.41; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Burger B, 2003, J CLIN ONCOL, V21, P184, DOI 10.1200/JCO.2003.04.096; Carvalho Jose Carlos Almeida, 2008, Anesthesiol Clin, V26, P145, DOI 10.1016/j.anclin.2007.11.007; Chin KJ, 2011, ANESTHESIOLOGY, V115, P94, DOI 10.1097/ALN.0b013e31821a8ad4; Cook TM, 2009, BRIT J ANAESTH, V102, P179, DOI 10.1093/bja/aen360; 조용철, 2009, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V20, P304; Eskey CJ, 2001, AM J NEURORADIOL, V22, P571; Fogel ST, 2011, REGION ANESTH PAIN M, V36, P508; Gajjar A, 2000, BLOOD, V96, P3381; Gnaho A, 2011, EUR J PAIN S, V5, P102; Gogalniceanu P, 2010, J SURG EDUC, V67, P152, DOI 10.1016/j.jsurg.2010.02.008; Grau T, 2004, EUR J ANAESTH, V21, P25, DOI 10.1017/S026502150400105X; Grau T, 2003, ANAESTHESIST, V52, P68, DOI 10.1007/s00101-002-0393-7; Grau T, 2002, J CLIN ANESTH, V14, P169, DOI 10.1016/S0952-8180(01)00378-6; Grau T, 2001, ACTA ANAESTH SCAND, V45, P766, DOI 10.1034/j.1399-6576.2001.045006766.x; Grau T, 2001, REGION ANESTH PAIN M, V26, P64, DOI 10.1053/rapm.2001.19633; Heasley DC, 2005, AM J NEURORADIOL, V26, P820; Hind D, 2003, BMJ-BRIT MED J, V327, P361, DOI 10.1136/bmj.327.7411.361; Hoppmann Richard, 2006, J S C Med Assoc, V102, P330; 이원석, 2008, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V19, P562; Kawaguchi R, 2011, EUR J ANAESTH, V28, P137, DOI 10.1097/EJA.0b013e3283423457; Kumar A, 2009, BEST PRACT RES-CLIN, V23, P299, DOI 10.1016/j.bpa.2009.02.006; Liu SS, 2009, REGION ANESTH PAIN M, V34, P47, DOI 10.1097/AAP.0b013e3181933ec3; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mazor SS, 2003, PEDIATRICS, V111, P525; Miksys N, 2010, AM J ROENTGENOL, V194, P1315, DOI 10.2214/AJR.09.3634; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; National Institute for Health and Clinical Excellence, 2008, GUID ULTR GUID CATH; Nomura JT, 2007, J ULTRAS MED, V26, P1341, DOI 10.7863/jum.2007.26.10.1341; Perlas A, 2010, REGION ANESTH PAIN M, V35, pS43, DOI 10.1097/AAP.0b013e3181d2462e; Pisupati D, 2004, ANN EMERG MED, V44, pS83, DOI 10.1016/j.annemergmed.2004.07.272; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Rao S, 2008, J ULTRAS MED, V27, P745, DOI 10.7863/jum.2008.27.5.745; Seeberger MD, 1996, ANESTH ANALG, V82, P302, DOI 10.1097/00000539-199602000-00015; Shah KH, 2003, ACAD EMERG MED, V10, P151, DOI 10.1111/j.1553-2712.2003.tb00033.x; Sidhu M, 2009, PEDIATR RADIOL, V39, P1135, DOI 10.1007/s00247-009-1392-5; Stiffler KA, 2007, AM J EMERG MED, V25, P331, DOI 10.1016/j.ajem.2006.07.010; Straus SE, 2006, JAMA-J AM MED ASSOC, V296, P2012, DOI 10.1001/jama.296.16.2012; te Loo DMWM, 2006, J CLIN ONCOL, V24, P2332, DOI 10.1200/JCO.2005.03.9727; Tran D, 2010, CAN J ANAESTH, V57, P313, DOI 10.1007/s12630-009-9252-1; Tsui BCH, 2010, ANESTHESIOLOGY, V112, P719, DOI 10.1097/ALN.0b013e3181c5e03a; Vallejo MC, 2010, INT J OBSTET ANESTH, V19, P373, DOI 10.1016/j.ijoa.2010.04.002; Willschke H, 2006, BRIT J ANAESTH, V97, P200, DOI 10.1093/bja/ael121; Yu SD, 2009, AM J NEURORADIOL, V30, P512, DOI 10.3174/ajnr.A1420	46	139	143	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1720	10.1136/bmj.f1720	http://dx.doi.org/10.1136/bmj.f1720			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WO	23532866	hybrid			2022-12-28	WOS:000316984000010
J	Hoggatt, J; Mohammad, KS; Singh, P; Hoggatt, AF; Chitteti, BR; Speth, JM; Hu, PR; Poteat, BA; Stilger, KN; Ferraro, F; Silberstein, L; Wong, FK; Farag, SS; Czader, M; Milne, GL; Breyer, RM; Serezani, CH; Scadden, DT; Guise, TA; Srour, EF; Pelus, LM				Hoggatt, Jonathan; Mohammad, Khalid S.; Singh, Pratibha; Hoggatt, Amber F.; Chitteti, Brahmananda R.; Speth, Jennifer M.; Hu, Peirong; Poteat, Bradley A.; Stilger, Kayla N.; Ferraro, Francesca; Silberstein, Lev; Wong, Frankie K.; Farag, Sherif S.; Czader, Magdalena; Milne, Ginger L.; Breyer, Richard M.; Serezani, Carlos H.; Scadden, David T.; Guise, Theresa A.; Srour, Edward F.; Pelus, Louis M.			Differential stem- and progenitor-cell trafficking by prostaglandin E-2	NATURE			English	Article							BONE-MARROW NICHE; HEMATOPOIETIC STEM; RECEPTOR; MICROENVIRONMENT; OSTEOPONTIN; IMPACT; SIZE	To maintain lifelong production of blood cells, haematopoietic stem cells (HSCs) are tightly regulated by inherent programs and extrinsic regulatory signals received from their microenvironmental niche. Long-term repopulating HSCs reside in several, perhaps overlapping, niches that produce regulatory molecules and signals necessary for homeostasis and for increased output after stress or injury(1-5). Despite considerable advances in the specific cellular or molecular mechanisms governing HSC-niche interactions, little is known about the regulatory function in the intact mammalian haematopoietic niche. Recently, we and others described a positive regulatory role for prostaglandin E-2 (PGE(2)) on HSC function ex vivo(6,7). Here we show that inhibition of endogenous PGE(2) by nonsteroidal anti-inflammatory drug (NSAID) treatment in mice results in modest HSC egress from the bone marrow. Surprisingly, this was independent of the SDF-1-CXCR4 axis implicated in stem-cell migration. Stem and progenitor cells were found to have differing mechanisms of egress, with HSC transit to the periphery dependent on niche attenuation and reduction in the retentive molecule osteopontin. Haematopoietic grafts mobilized with NSAIDs had superior repopulating ability and long-term engraftment. Treatment of non-human primates and healthy human volunteers confirmed NSAID-mediated egress in other species. PGE(2) receptor knockout mice demonstrated that progenitor expansion and stem/progenitor egress resulted from reduced E-prostanoid 4 (EP4) receptor signalling. These results not only uncover unique regulatory roles for EP4 signalling in HSC retention in the niche, but also define a rapidly translatable strategy to enhance transplantation therapeutically.	[Hoggatt, Jonathan; Mohammad, Khalid S.; Singh, Pratibha; Hoggatt, Amber F.; Speth, Jennifer M.; Hu, Peirong; Stilger, Kayla N.; Czader, Magdalena; Serezani, Carlos H.; Guise, Theresa A.; Srour, Edward F.; Pelus, Louis M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hoggatt, Jonathan; Ferraro, Francesca; Silberstein, Lev; Wong, Frankie K.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Harvard Med Sch, Ctr Regenerat Med,Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hoggatt, Amber F.] Univ Illinois, Biol Resources Lab, Chicago, IL 60612 USA; [Chitteti, Brahmananda R.; Poteat, Bradley A.; Farag, Sherif S.; Srour, Edward F.] Indiana Univ Sch Med, Div Hematol & Oncol, Indianapolis, IN 46202 USA; [Milne, Ginger L.] Vanderbilt Univ, Div Clin Pharmacol, Eicosanoid Core Lab, Nashville, TN 37232 USA; [Breyer, Richard M.] Vanderbilt Univ, Div Nephrol & Hypertens, Nashville, TN 37232 USA	Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University Bloomington; Vanderbilt University; Vanderbilt University	Pelus, LM (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	lpelus@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Singh, Pratibha/AAI-9796-2020; Milne, Ginger/D-7648-2014; Mohammad, Khalid/AFE-4205-2022; serezani, C. Henrique/H-1675-2013	Milne, Ginger/0000-0003-3890-151X; Speth, Jennifer/0000-0002-7724-6995; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health (NIH) [HL096305, CA143057, CA069158, HL100402, DK37097]; NIH [DK07519, HL07910, HL087735]; Center of Excellence in Hematology [P01 DK090948]; NATIONAL CANCER INSTITUTE [U01CA143057, P30CA082709, R29CA069158, R01CA069158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U01HL100402, R01HL096305, T32HL087735, T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948, T32DK007519, R01DK037097] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health (NIH) grants HL096305 (L.M.P.), CA143057, CA069158 (T.A.G., K.S.M.), HL100402 (D.T.S.) and DK37097 (R.M.B.). J.H. was supported by NIH training grants DK07519, HL07910 and HL087735. Flow cytometry was performed in the Flow Cytometry Resource Facility of the Indiana University Simon Cancer Center (NCI P30 CA082709). Additional core support was provided by a Center of Excellence in Hematology grant P01 DK090948. The authors would like to thank H. E. Broxmeyer and B. Saez for critically reading the manuscript.	Ahmed Mansoor, 2005, Expert Opin Drug Metab Toxicol, V1, P739, DOI 10.1517/17425255.1.4.739; Bethel Monique, 2011, Curr Osteoporos Rep, V9, P96, DOI 10.1007/s11914-011-0048-1; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Guan Y, 2007, J CLIN INVEST, V117, P2496, DOI 10.1172/JCI29838; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mundy GR, 2001, SEMIN ONCOL, V28, P35, DOI 10.1053/sonc.2001.24158; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rinder HM, 2002, J CLIN PHARMACOL, V42, P881, DOI 10.1177/009127002401102795; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	26	106	109	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					365	369		10.1038/nature11929	http://dx.doi.org/10.1038/nature11929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485965	Green Submitted, Green Accepted			2022-12-28	WOS:000316650500042
J	Vieira, JD; Marrone, DP; Chapman, SC; De Breuck, C; Hezaveh, YD; Weiss, A; Aguirre, JE; Aird, KA; Aravena, M; Ashby, MLN; Bayliss, M; Benson, BA; Biggs, AD; Bleem, LE; Bock, JJ; Bothwell, M; Bradford, CM; Brodwin, M; Carlstrom, JE; Chang, CL; Crawford, TM; Crites, AT; de Haan, T; Dobbs, MA; Fomalont, EB; Fassnacht, CD; George, EM; Gladders, MD; Gonzalez, AH; Greve, TR; Gullberg, B; Halverson, NW; High, FW; Holder, GP; Holzapfel, WL; Hoover, S; Hrubes, JD; Hunter, TR; Keisler, R; Lee, AT; Leitch, EM; Lueker, M; Luong-Van, D; Malkan, M; McIntyre, V; McMahon, JJ; Mehl, J; Menten, KM; Meyer, SS; Mocanu, LM; Murphy, EJ; Natoli, T; Padin, S; Plagge, T; Reichardt, CL; Rest, A; Ruel, J; Ruhl, JE; Sharon, K; Schaffer, KK; Shaw, L; Shirokoff, E; Spilker, JS; Stalder, B; Staniszewski, Z; Stark, AA; Story, K; Vanderlinde, K; Welikala, N; Williamson, R				Vieira, J. D.; Marrone, D. P.; Chapman, S. C.; De Breuck, C.; Hezaveh, Y. D.; Weiss, A.; Aguirre, J. E.; Aird, K. A.; Aravena, M.; Ashby, M. L. N.; Bayliss, M.; Benson, B. A.; Biggs, A. D.; Bleem, L. E.; Bock, J. J.; Bothwell, M.; Bradford, C. M.; Brodwin, M.; Carlstrom, J. E.; Chang, C. L.; Crawford, T. M.; Crites, A. T.; de Haan, T.; Dobbs, M. A.; Fomalont, E. B.; Fassnacht, C. D.; George, E. M.; Gladders, M. D.; Gonzalez, A. H.; Greve, T. R.; Gullberg, B.; Halverson, N. W.; High, F. W.; Holder, G. P.; Holzapfel, W. L.; Hoover, S.; Hrubes, J. D.; Hunter, T. R.; Keisler, R.; Lee, A. T.; Leitch, E. M.; Lueker, M.; Luong-Van, D.; Malkan, M.; McIntyre, V.; McMahon, J. J.; Mehl, J.; Menten, K. M.; Meyer, S. S.; Mocanu, L. M.; Murphy, E. J.; Natoli, T.; Padin, S.; Plagge, T.; Reichardt, C. L.; Rest, A.; Ruel, J.; Ruhl, J. E.; Sharon, K.; Schaffer, K. K.; Shaw, L.; Shirokoff, E.; Spilker, J. S.; Stalder, B.; Staniszewski, Z.; Stark, A. A.; Story, K.; Vanderlinde, K.; Welikala, N.; Williamson, R.			Dusty starburst galaxies in the early Universe as revealed by gravitational lensing	NATURE			English	Article							SOUTH-POLE TELESCOPE; SUBMILLIMETER GALAXY; MOLECULAR GAS; DEEP-FIELD; REDSHIFT; COUNTS; MODEL	In the past decade, our understanding of galaxy evolution has been revolutionized by the discovery that luminous, dusty starburst galaxies were 1,000 times more abundant in the early Universe than at present(1,2). It has, however, been difficult to measure the complete redshift distribution of these objects, especially at the highest redshifts (z>4). Here we report a redshift survey at a wavelength of three millimetres, targeting carbon monoxide line emission from the star-forming molecular gas in the direction of extraordinarily bright millimetre-wave-selected sources. High-resolution imaging demonstrates that these sources are strongly gravitationally lensed by foreground galaxies. We detect spectral lines in 23 out of 26 sources and multiple lines in 12 of those 23 sources, from which we obtain robust, unambiguous redshifts. At least 10 of the sources are found to lie at z > 4, indicating that the fraction of dusty starburst galaxies at high redshifts is greater than previously thought. Models of lens geometries in the sample indicate that the background objects are ultra-luminous infrared galaxies, powered by extreme bursts of star formation.	[Vieira, J. D.; Bock, J. J.; Lueker, M.; Padin, S.; Shirokoff, E.; Staniszewski, Z.] CALTECH, Pasadena, CA 91125 USA; [Marrone, D. P.; Bothwell, M.; Spilker, J. S.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Chapman, S. C.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada; [Chapman, S. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [De Breuck, C.; Aravena, M.; Biggs, A. D.; Gullberg, B.] European So Observ, D-85748 Garching, Germany; [Hezaveh, Y. D.; de Haan, T.; Dobbs, M. A.; Holder, G. P.; Shaw, L.; Vanderlinde, K.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Weiss, A.; Menten, K. M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Aguirre, J. E.] Univ Penn, Philadelphia, PA 19104 USA; [Aird, K. A.; Hrubes, J. D.; Luong-Van, D.] Univ Chicago, Chicago, IL 60637 USA; [Ashby, M. L. N.; Stalder, B.; Stark, A. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Bayliss, M.; Ruel, J.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Benson, B. A.; Bleem, L. E.; Carlstrom, J. E.; Chang, C. L.; Crawford, T. M.; Crites, A. T.; Gladders, M. D.; High, F. W.; Hoover, S.; Keisler, R.; Leitch, E. M.; McMahon, J. J.; Mehl, J.; Meyer, S. S.; Mocanu, L. M.; Natoli, T.; Padin, S.; Plagge, T.; Sharon, K.; Schaffer, K. K.; Story, K.; Williamson, R.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Benson, B. A.; Carlstrom, J. E.; Chang, C. L.; Hoover, S.; McMahon, J. J.; Meyer, S. S.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Bleem, L. E.; Carlstrom, J. E.; Keisler, R.; Meyer, S. S.; Natoli, T.; Story, K.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Bock, J. J.; Bradford, C. M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Brodwin, M.] Univ Missouri, Dept Phys & Astron, Kansas City, MO 64110 USA; [Carlstrom, J. E.; Crawford, T. M.; Crites, A. T.; Gladders, M. D.; High, F. W.; Leitch, E. M.; Mehl, J.; Meyer, S. S.; Mocanu, L. M.; Padin, S.; Plagge, T.; Sharon, K.; Williamson, R.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Carlstrom, J. E.; Chang, C. L.] Argonne Natl Lab, Argonne, IL 60439 USA; [Fomalont, E. B.; Hunter, T. R.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Fassnacht, C. D.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [George, E. M.; Holzapfel, W. L.; Lee, A. T.; Reichardt, C. L.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Gonzalez, A. H.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Greve, T. R.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Halverson, N. W.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Halverson, N. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Lee, A. T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Phys, Berkeley, CA 94720 USA; [Malkan, M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [McIntyre, V.] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [McMahon, J. J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Murphy, E. J.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Rest, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Ruhl, J. E.; Staniszewski, Z.] Case Western Reserve Univ, Dept Phys, Ctr Educ & Res Cosmol & Astrophys, Cleveland, OH 44106 USA; [Sharon, K.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Schaffer, K. K.] Sch Art Inst Chicago, Liberal Arts Dept, Chicago, IL 60603 USA; [Shaw, L.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Welikala, N.] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Welikala, N.] CNRS, F-91405 Orsay, France	California Institute of Technology; University of Arizona; Dalhousie University; University of Cambridge; European Southern Observatory; McGill University; Max Planck Society; University of Pennsylvania; University of Chicago; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University; University of Chicago; University of Chicago; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Missouri System; University of Missouri Kansas City; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; National Radio Astronomy Observatory (NRAO); University of California System; University of California Davis; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of London; University College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Michigan System; University of Michigan; Carnegie Institution for Science; Space Telescope Science Institute; Case Western Reserve University; University of Michigan System; University of Michigan; School of the Art Institute of Chicago; Yale University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Vieira, JD (corresponding author), CALTECH, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	vieira@caltech.edu	Williamson, Ross/H-1734-2015; Rest, Armin/ABE-6469-2020; Ruhl, John/HHS-2212-2022; Holzapfel, William L/I-4836-2015; Murphy, Eric/AAE-8450-2021; George, Elizabeth/AAR-7371-2021	Williamson, Ross/0000-0002-6945-2975; Ruhl, John/0000-0001-5875-4751; George, Elizabeth/0000-0001-7874-0445; Bayliss, Matthew/0000-0003-1074-4807; Hunter, Todd/0000-0001-6492-0090; Gullberg, Bitten/0000-0002-4671-3036; Bleem, Lindsey/0000-0001-7665-5079; Fassnacht, Christopher/0000-0002-4030-5461; De Breuck, Carlos/0000-0002-6637-3315; CRAWFORD, THOMAS/0000-0001-9000-5013; Biggs, Andrew/0000-0002-1117-9961; Marrone, Daniel/0000-0002-2367-1080; Greve, Thomas R./0000-0002-2554-1837; Chang, Clarence/0000-0002-6311-0448; Stark, Antony/0000-0002-2718-9996; Aird, Kenneth/0000-0003-1441-9518; Benson, Bradford/0000-0002-5108-6823; Dobbs, Matt/0000-0001-7166-6422; Reichardt, Christian/0000-0003-2226-9169	National Science Foundation; Kavli Foundation; Gordon and Betty Moore Foundation; NASA from the Space Telescope Science Institute; NSERC; CRC; ClfAR; STFC [ST/I005544/1, ST/J000647/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J000647/1, ST/I005544/1, ST/H00243X/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1009012] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Kavli Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA from the Space Telescope Science Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); ClfAR; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The SPT is supported by the National Science Foundation, the Kavli Foundation and the Gordon and Betty Moore Foundation. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. Partial support for this work was provided by NASA from the Space Telescope Science Institute. This work is based in part on observations made with Herschel, a European Space Agency Cornerstone Mission with significant participation by NASA. Work at McGill University is supported by NSERC, the CRC programme and ClfAR.	Banerji M, 2011, MON NOT R ASTRON SOC, V418, P1071, DOI 10.1111/j.1365-2966.2011.19558.x; Baugh CM, 2005, MON NOT R ASTRON SOC, V356, P1191, DOI 10.1111/j.1365-2966.2004.08553.x; Benson AJ, 2012, NEW ASTRON, V17, P175, DOI 10.1016/j.newast.2011.07.004; BLAIN AW, 1993, MON NOT R ASTRON SOC, V264, P509, DOI 10.1093/mnras/264.2.509; Blain AW, 1996, MON NOT R ASTRON SOC, V283, P1340, DOI 10.1093/mnras/283.4.1340; Bock DCJ, 1998, ASTRON J, V116, P1886, DOI 10.1086/300563; Capak P, 2008, ASTROPHYS J LETT, V681, pL53, DOI 10.1086/590555; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Combes F, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118750; Coppin KEK, 2009, MON NOT R ASTRON SOC, V395, P1905, DOI 10.1111/j.1365-2966.2009.14700.x; Cox P, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/63; Daddi E, 2009, ASTROPHYS J LETT, V695, pL176, DOI 10.1088/0004-637X/695/2/L176; Daddi E, 2009, ASTROPHYS J, V694, P1517, DOI 10.1088/0004-637X/694/2/1517; Greve TR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/101; Hezaveh Y. D., ASTROPHYS J UNPUB; Hezaveh YD, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/52; Ivison RJ, 2002, MON NOT R ASTRON SOC, V337, P1, DOI 10.1046/j.1365-8711.2002.05900.x; Moshir M., 1992, IRAS FAINT SOURCE SU; Negrello M, 2007, MON NOT R ASTRON SOC, V377, P1557, DOI 10.1111/j.1365-2966.2007.11708.x; Riechers DA, 2010, ASTROPHYS J LETT, V720, pL131, DOI 10.1088/2041-8205/720/2/L131; Smolcic V., 2012, MILLIMETER IMAGING S; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Vieira JD, 2010, ASTROPHYS J, V719, P763, DOI 10.1088/0004-637X/719/1/763; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Weiss A., ASTROPHYS J IN PRESS	27	230	230	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					344	347		10.1038/nature12001	http://dx.doi.org/10.1038/nature12001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485967	Green Submitted			2022-12-28	WOS:000316650500037
J	Rutten-Jacobs, LCA; Arntz, RM; Maaijwee, NAM; Schoonderwaldt, HC; Dorresteijn, LD; van Dijk, EJ; de Leeuw, FE				Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; Dorresteijn, Lucille D.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik			Long-term Mortality After Stroke Among Adults Aged 18 to 50 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC-STROKE; YOUNG-ADULTS; CEREBRAL INFARCTION; PROGNOSIS; CLASSIFICATION; PREDICTORS; RATIONALE; COMMUNITY; REGISTRY; EVENTS	Importance Long-term data on mortality after first-ever stroke in adults aged 18 through 50 years are scarce and usually restricted to ischemic stroke. Moreover, expected mortality not related to first-ever stroke is not taken in account. Objectives To investigate long-term mortality and cause of death after acute stroke in adults aged 18 through 50 years and to compare this with nationwide age-and sex-matched mortality rates. Design, Setting, and Participants The Follow-Up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation (FUTURE) study, a prospective cohort study of prognosis after transient ischemic attack (TIA), ischemic stroke, or hemorrhagic stroke in adults aged 18 through 50 years admitted to Radboud University Nijmegen Medical Centre, the Netherlands, between January 1, 1980, and November 1, 2010. The survival status of 959 consecutive patients with a first-ever TIA (n=262), ischemic stroke (n=606), or intracerebral hemorrhage (n=91) was assessed as of November 1, 2012. Mean follow-up duration was 11.1 (SD, 8.7) years (median, 8.3 [interquartile range, 4.0-17.4]). Observed mortality was compared with the expected mortality, derived from mortality rates in the general population with similar age, sex, and calendar-year characteristics. Main Outcome Measures Cumulative 20-year mortality among 30-day survivors of stroke. Results At the end of follow-up, 192 patients (20.0%) had died. For each stroke type, observed 20-year mortality among 30-day survivors exceeded expected mortality in the general population. [GRAPHICS] For ischemic stroke, cumulative 20-year mortality among 30-day survivors was higher in men than in women (33.7% [95% CI, 26.1%-41.3%] vs 19.8% [95% CI, 13.8%-25.9%]). The standardized mortality ratio was 4.3 (95% CI, 3.2-5.6) for women and 3.6 (95% CI, 2.8-4.6) for men. For all etiologic subtypes of ischemic stroke, observed mortality exceeded expected mortality. Conclusions and Relevance Among adults aged 18 through 50 years, 20-year mortality following acute stroke was relatively high compared with expected mortality. These findings may warrant further research evaluating secondary prevention strategies in these patients. JAMA. 2013;309(11):1136-1144 www.jama.com	[Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Dorresteijn, Lucille D.] Med Spectrum Twente, Dept Neurol, Nijmegen, Netherlands	Radboud University Nijmegen; Medical Spectrum Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.deleeuw@neuro.umcn.nl	de Leeuw, Frank-Erik/E-4795-2012; Rutten-Jacobs, Loes/C-7746-2013; de Leeuw, H.F./L-4479-2015; van Dijk, Ewoud J/J-7951-2012	Rutten-Jacobs, Loes/0000-0003-3223-885X; Rutten-Jacobs, Loes/0000-0001-6275-0462	Dutch Epilepsy Fund [2010-18]; Netherlands Organization for Scientific Research [016.126.351]	Dutch Epilepsy Fund; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Epilepsy Fund (grant 2010-18) and by a Vidi innovational grant from the Netherlands Organization for Scientific Research (grant 016.126.351).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; Breslow NE, 1987, STATISTICAL METHODS, P1; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Greisenegger S, 2011, J NEUROL, V258, P1105, DOI 10.1007/s00415-010-5893-9; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; KAPPELLE LJ, 1994, STROKE, V25, P1360, DOI 10.1161/01.STR.25.7.1360; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Marini C, 2001, STROKE, V32, P52, DOI 10.1161/01.STR.32.1.52; Naess H, 2004, ACTA NEUROL SCAND, V110, P107, DOI 10.1111/j.1600-0404.2004.00273.x; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Statistics Netherlands, STATLINE DAT; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varona JF, 2004, J NEUROL, V251, P1507, DOI 10.1007/s00415-004-0583-0; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waje-Andreassen U, 2007, ACTA NEUROL SCAND, V116, P150, DOI 10.1111/j.1600-0404.2007.00822.x; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; World Health Organization, 2018, INT CLASSIFICATION D; World Health Organization (WHO), 2009, CARD DIS	28	144	148	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1136	1144		10.1001/jama.2013.842	http://dx.doi.org/10.1001/jama.2013.842			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512060	Bronze			2022-12-28	WOS:000316276500027
J	Toll, E				Toll, Elizabeth			278.00 Obesity, Not Otherwise Specified	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toll, Elizabeth] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA; [Toll, Elizabeth] Brown Univ, Dept Internal Med, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University	Toll, E (corresponding author), Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA.	etoll@lifespan.org							0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1123	1124		10.1001/jama.2013.1241	http://dx.doi.org/10.1001/jama.2013.1241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512059				2022-12-28	WOS:000316276500025
J	Forbes, D; Bryant, RA				Forbes, David; Bryant, Richard A.			When the violence of war comes home	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; IRAQ; AFGHANISTAN; SYMPTOMS; ALCOHOL; TRAUMA		[Forbes, David] Univ Melbourne, Dept Psychiat, Australian Ctr Posttraumat Mental Hlth, East Melbourne, Vic 3002, Australia; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Melbourne; University of New South Wales Sydney	Forbes, D (corresponding author), Univ Melbourne, Dept Psychiat, Australian Ctr Posttraumat Mental Hlth, East Melbourne, Vic 3002, Australia.	dforbes@unimelb.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; Forbes, David/0000-0001-9145-1605				Chung H, 2008, PSYCHOL MED, V38, P563, DOI 10.1017/S0033291707002589; Forbes D, 2012, J CLIN PSYCHIAT, V73, P372, DOI 10.4088/JCP.10m06640; Gilbert F, 2015, J PERS DISORD, V29, P100, DOI 10.1521/pedi_2013_27_077; Graham K, 2011, DRUG ALCOHOL REV, V30, P453, DOI 10.1111/j.1465-3362.2011.00340.x; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Leeies M, 2010, DEPRESS ANXIETY, V27, P731, DOI 10.1002/da.20677; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; MacManus D, 2013, LANCET, V381, P907, DOI 10.1016/S0140-6736(13)60354-2; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434	9	9	9	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					883	884		10.1016/S0140-6736(13)60635-2	http://dx.doi.org/10.1016/S0140-6736(13)60635-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499029				2022-12-28	WOS:000316069700007
J	Antonucci, R				Antonucci, Robert			Quasars still defy explanation	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Antonucci, R (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	skiantonucci0@gmail.com						ALLOIN D, 1986, ASTROPHYS J, V308, P23, DOI 10.1086/164475; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Antonucci R., 2013, ASTRON ASTROPHYS T, V27, P557; BEGELMAN MC, 1984, REV MOD PHYS, V56, P255, DOI 10.1103/RevModPhys.56.255; Blaes O., 2007, ASP C SERIES, V373, P75; Dexter J, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/1/L24; Kishimoto M, 2008, NATURE, V454, P492, DOI 10.1038/nature07114; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; OKE JB, 1963, NATURE, V197, P1040, DOI 10.1038/1971040b0; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; ULRICH MH, 1984, MON NOT R ASTRON SOC, V209, P479, DOI 10.1093/mnras/209.3.479; Zoghbi A, 2012, MON NOT R ASTRON SOC, V422, P129, DOI 10.1111/j.1365-2966.2012.20587.x; Zoghbi A., 2013, PREPRINT	13	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					165	167		10.1038/495165a	http://dx.doi.org/10.1038/495165a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486041	Bronze			2022-12-28	WOS:000316652300015
J	Li, J; D'Angiolella, V; Seeley, ES; Kim, S; Kobayashi, T; Fu, WX; Campos, EI; Pagano, M; Dynlacht, BD				Li, Ji; D'Angiolella, Vincenzo; Seeley, E. Scott; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Campos, Eric I.; Pagano, Michele; Dynlacht, Brian David			USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110	NATURE			English	Article							LINDAU TUMOR-SUPPRESSOR; CHROMOSOMAL INSTABILITY; DRUG TARGETS; CELLS; ABNORMALITIES; DEGRADATION; CARCINOMA	Centrosome duplication is critical for cell division, and genome instability can result if duplication is not restricted to a single round per cell cycle. Centrosome duplication is controlled in part by CP110, a centriolar protein that positively regulates centriole duplication while restricting centriole elongation and ciliogenesis. Maintenance of normal CP110 levels is essential, as excessive CP110 drives centrosome over-duplication and suppresses ciliogenesis, whereas its depletion inhibits centriole amplification and leads to highly elongated centrioles and aberrant assembly of cilia in growing cells(1,2). CP110 levels are tightly controlled, partly through ubiquitination by the ubiquitin ligase complex SCFcyclin (F) during G2 and M phases of the cell cycle(3). Here, using human cells, we report a new mechanism for the regulation of centrosome duplication that requires USP33, a deubiquitinating enzyme that is able to regulate CP110 levels. USP33 interacts with CP110 and localizes to centrioles primarily in S and G2/M phases, the periods during which centrioles duplicate and elongate. USP33 potently and specifically deubiquitinates CP110, but not other cyclin-F substrates. USP33 activity antagonizes SCFcyclin F-mediated ubiquitination and promotes the generation of supernumerary centriolar foci, whereas ablation of USP33 destabilizes CP110 and thereby inhibits centrosome amplification and mitotic defects. To our knowledge, we have identified the first centriolar deubiquitinatimg enzyme whose expression regulates centrosome homeostasis by countering cyclin-F-mediated destruction of a key substrate. Our results point towards potential therapeutic strategies for inhibiting tumorigenesis associated with centrosome amplification.	[Li, Ji; D'Angiolella, Vincenzo; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Pagano, Michele; Dynlacht, Brian David] NYU, Sch Med, Smilow Res Ctr, Dept Pathol, New York, NY 10016 USA; [Li, Ji; D'Angiolella, Vincenzo; Kim, Sehyun; Kobayashi, Tetsuo; Fu, Wenxiang; Pagano, Michele; Dynlacht, Brian David] NYU, Sch Med, Smilow Res Ctr, Inst Canc, New York, NY 10016 USA; [Seeley, E. Scott] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Campos, Eric I.] NYU, Sch Med, Smilow Res Ctr, Dept Biochem, New York, NY 10016 USA; [Pagano, Michele] NYU, Sch Med, Smilow Res Ctr, Dept Pathol,Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; University of California System; University of California San Francisco; New York University; Howard Hughes Medical Institute; New York University	Dynlacht, BD (corresponding author), NYU, Sch Med, Smilow Res Ctr, Dept Pathol, 522 1st Ave, New York, NY 10016 USA.	Brian.Dynlacht@nyumc.org	Li, Ji/J-6026-2014	pagano, michele/0000-0003-3210-2442; Campos, Eric I./0000-0001-8152-3994	National Institutes of Health [5R01HD069647-02]; March of Dimes [FY11-432]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069647] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Hajdu, G. Miller, L. Chiriboga, H. Court, C. Zambirinis, E. Bekes, L Taylor, S. Krauter, M. Philips and D. Bar-Sagi for help with staining and analysis of pancreatic cancer samples. We thank F. Liang, Y. Deng, C. Petzold and K. Dancel for help with correlative electron microscopy. We thank J. Jastrab and S. Vijayakumar for initial experiments pertaining to the USP20-CP110 interaction. We thank J. Pollack for providing pancreatic cell lines. We thank G. Wu, S. Shenoy, R. Baer and T. Huang for providing plasmids. We thank members of the Dynlacht laboratory and T. Huang for advice. B.D.D. was supported by National Institutes of Health grant 5R01HD069647-02 and March of Dimes grant FY11-432. M.P. is an Investigator with the Howard Hughes Medical Institute.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Li J, 2012, EMBO REP, V13, P547, DOI 10.1038/embor.2012.40; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Sato N, 1999, CLIN CANCER RES, V5, P963; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Shono M, 2001, LAB INVEST, V81, P945, DOI 10.1038/labinvest.3780306; Sippl W, 2011, FUTURE ONCOL, V7, P619, DOI [10.2217/FON.11.39, 10.2217/fon.11.39]; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Thorne C, 2011, TRAFFIC, V12, P1563, DOI 10.1111/j.1600-0854.2011.01261.x	20	95	102	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					255	259		10.1038/nature11941	http://dx.doi.org/10.1038/nature11941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486064	Green Accepted			2022-12-28	WOS:000316652300055
J	Kowdley, KV; Lawitz, E; Crespo, I; Hassanein, T; Davis, MN; DeMicco, M; Bernstein, DE; Afdhal, N; Vierling, JM; Gordon, SC; Anderson, JK; Hyland, RH; Dvory-Sobol, H; An, D; Hindes, RG; Albanis, E; Symonds, WT; Berrey, MM; Nelson, DR; Jacobson, IM				Kowdley, Kris V.; Lawitz, Eric; Crespo, Israel; Hassanein, Tarek; Davis, Mitchell N.; DeMicco, Michael; Bernstein, David E.; Afdhal, Nezam; Vierling, John M.; Gordon, Stuart C.; Anderson, Jane K.; Hyland, Robert H.; Dvory-Sobol, Hadas; An, Di; Hindes, Robert G.; Albanis, Efsevia; Symonds, William T.; Berrey, M. Michelle; Nelson, David R.; Jacobson, Ira M.			Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial	LANCET			English	Article							TRIPLE THERAPY; ADVERSE EVENTS; TELAPREVIR; BOCEPREVIR; LIFE	ackground The uridine nucleotide analogue sofosbuvir is a selective inhibitor of hepatitis C virus (HCV) NS5B polymerase. We assessed the safety and efficacy of sofosbuvir in combination with pegylated interferon alfa-2a (peginterferon) and ribavirin in non-cirrhotic treatment-naive, patients with HCV. Methods For this open-label, randomised phase 2 trial, we recruited patients from 42 centres in the USA and Puerto Rico between March 23, 2011, and Sept 21, 2011. Patients were eligible for inclusion if they had chronic HCV infection (genotypes 1, 4, 5, or 6), were aged 18 years or older, and had not previously received treatment for HCV infection. Using a computer-generated randomisation sequence, we randomly assigned patients with HCV genotype-1 to one of three cohorts (A, B, and C; in a 1: 2: 3 ratio), with randomisation stratified by IL28B (CC vs non-CC allele) and HCV RNA (<800 000 IU/mL vs >= 800 000 IU/mL). Patients received sofosbuvir 400 mg plus peginterferon and ribavirin for 12 weeks (cohort A) or for 24 weeks (cohort B), or 12 weeks of sofosbuvir plus peginterferon and ribavirin followed by 12 weeks of either sofosbuvir monotherapy or sofosbuvir plus ribavirin (cohort C). We enrolled patients with all other eligible genotypes in cohort B. The primary efficacy endpoint was sustained virological response at post-treatment week 24 (SVR24) by intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT01329978. Results We enrolled 316 patients with HCV genotype-1: 52 to cohort A, 109 to cohort B, and 155 to cohort C. We assigned 11 patients with HCV genotype-4 and five patients with genotype-6 to cohort B (we detected no patients with genotype 5). In patients with HCV genotype-1, SVR24 was achieved by 46 patients (89%, 95% CI 77-96) in cohort A, 97 patients (89%, 82-94) in cohort B, and by 135 (87%, 81-92) in cohort C. We detected no difference in the proportion of patients achieving SVR24 in cohort A compared with cohort B (p=0.94), or in cohort C (p=0.78). Nine (82%) of 11 patients with genotype-4 and all five with genotype-6 achieved SVR24. Seven patients, all with genotype-1 infection, relapsed after completion of assigned treatment. The most common adverse events that led to the discontinuation of any study drug-anaemia and neutropenia-were associated with peginterferon and ribavirin treatment. Three (6%) patients in cohort A, 18 (14%) patients in cohort B, and three (2%) patients in cohort C discontinued treatment because of an adverse event. Interpretation Our findings suggest that sofosbuvir is well tolerated and that there is no additional benefit of extending treatment beyond 12 weeks, but these finding will have to be substantiated in phase 3 trials. These results lend support to the further assessment of a 12 week sofosbuvir regimen in a broader population of patients with chronic HCV genotype-1 infection, including those with cirrhosi	[Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Lawitz, Eric] Alamo Med Res, San Antonio, TX USA; [Crespo, Israel] Adv Res Inst, Trinity, FL USA; [Hassanein, Tarek] Southern Calif Liver Ctr, Coronado, CA USA; [Davis, Mitchell N.] South Florida Ctr Gastroenterol, Digest CARE, Wellington, FL USA; [DeMicco, Michael] Adv Clin Res Inst, Anaheim, CA USA; [Bernstein, David E.] N Shore Univ Hosp, Manhasset, NY USA; [Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Vierling, John M.] Baylor Coll Med, Houston, TX 77030 USA; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Anderson, Jane K.; Hyland, Robert H.; Dvory-Sobol, Hadas; An, Di; Symonds, William T.] Gilead Sci Inc, Foster City, CA 94404 USA; [Hindes, Robert G.] Gilead Sci, Southbury, CT USA; [Albanis, Efsevia] Mt Sinai Med Ctr, New York, NY 10029 USA; [Berrey, M. Michelle] Chimerix Inc, Durham, NC USA; [Nelson, David R.] Univ Florida, Gainesville, FL USA; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA	Virginia Mason Medical Center; Northwell Health; North Shore University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Baylor College of Medicine; Henry Ford Health System; Henry Ford Hospital; Gilead Sciences; Gilead Sciences; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida; Cornell University	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, Inst Digest Dis, 1100 9th Ave, Seattle, WA 98101 USA.	kris.kowdley@vmmc.org	Kowdley, Kris/AAF-5202-2019	Davis, Mitchell/0000-0002-0526-5564; Afdhal, Nezam/0000-0002-7342-6593	Abbot; Beckman; Boehringer Ingelheim; Bristol-Myers Squibb; Conatus; Gilead; Ikaria; Intercept; Janssen; Merck; Mochida; Vertex; Achillion; Anadys; Biolex; GlaxoSmithKline; GlobeImmune; Idenix; Idera; Inhibitex; Medarex; Medtronic; Novartis; Pharmasset; Roche; Schering-Plough; Santaris; Scynexis; ViroChem; ZymoGenetics; Abbott Pharmaceuticals; Gilead Sciences; Janssen Pharmaceuticals; Ikaria Pharmaceuticals; Takeda Pharmaceuticals; Mochida Pharmaceuticals; Sundise Pharmaceuticals; Roche Pharmaceuticals; Eisai Pharmaceuticals; Vertex Pharmaceuticals; Abbott; Abbott and Merck; Echosens; Quest; Schering Plough/Merck; Bristol-Myers-Squibb; Excalenz; Hyperion; Ocera; Pfizer; Sundise; Genentech; Schering-Plough/Merck; Enanta; Kadmon; Presidio	Abbot; Beckman; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Conatus; Gilead(Gilead Sciences); Ikaria; Intercept; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Mochida; Vertex(Vertex Pharmaceuticals); Achillion; Anadys; Biolex; GlaxoSmithKline(GlaxoSmithKline); GlobeImmune; Idenix; Idera; Inhibitex; Medarex; Medtronic(Medtronic); Novartis(Novartis); Pharmasset; Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Santaris; Scynexis; ViroChem; ZymoGenetics; Abbott Pharmaceuticals(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Ikaria Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Mochida Pharmaceuticals; Sundise Pharmaceuticals; Roche Pharmaceuticals(Roche Holding); Eisai Pharmaceuticals(Eisai Co Ltd); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Abbott(Abbott Laboratories); Abbott and Merck; Echosens; Quest; Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Bristol-Myers-Squibb(Bristol-Myers Squibb); Excalenz; Hyperion; Ocera; Pfizer(Pfizer); Sundise; Genentech(Roche HoldingGenentech); Schering-Plough/Merck(Merck & CompanySchering Plough Corporation); Enanta; Kadmon; Presidio	KVK has received research support and grants from Abbot, Beckman, Boehringer Ingelheim, Bristol-Myers Squibb, Conatus, Gilead, Ikaria, Intercept, Janssen, Merck, Mochida, and Vertex; has served as a consultant to Novartis; and has served on advisory boards for Abbott, Gilead, Merck, and Vertex. EL has received research support and grants from Abbott, Achillion, Anadys, Biolex, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, GlobeImmune, Idenix, Idera, Inhibitex, Intercept, Janssen, Medarex, Medtronic, Merck, Novartis, Pharmasset, Roche, Schering-Plough, Santaris, Scynexis, Vertex, ViroChem, and ZymoGenetics; was on speakers' bureaus for Gilead, Merck, and Vertex; and has served on advisory boards for Abbott, Achillion, Anadys, Biolex, Biotica, GlobeImmune, Inhibitex, Merck, Novartis, Pharmasset, Tibotec, Theravance, and Vertex. TH has received research grants from Bristol-Myers Squibb, Abbott Pharmaceuticals, Gilead Sciences, Janssen Pharmaceuticals, Ikaria Pharmaceuticals, Takeda Pharmaceuticals, Mochida Pharmaceuticals, Sundise Pharmaceuticals, Roche Pharmaceuticals, Eisai Pharmaceuticals, Vertex Pharmaceuticals; and has received honoraria as a speaker for Gilead. MND has received research support and grants from Abbott and Merck; is on speakers' bureaus for Genentech, Merck, and Vertex; and has served as a consultant or adviser to Gilead and Vertex. DEB has received honoraria for serving on speakers' bureau from Gilead. NA has received research support and grants from Abbott, Echosens, Gilead, GlaxoSmithKline, Quest, Pharmasset, Schering Plough/Merck, and Vertex; and has served on advisory boards for Boehringer Ingelheim, Echosens, Gilead, GlaxoSmithKline, Ligand, Medgenics, Novartis, Springbank, and Vertex. JMV has received research support and grants from Abbott, Bristol-Myers-Squibb, Conatus, Excalenz, Gilead, GlobeImmune, Hyperion, Idenix, Ikaria, Intercept, Merck, Mochida, Novartis, Ocera, Pfizer, Pharmasset, Roche, Sundise, Vertex, and Zymogenetics; and has served on advisory boards for Abbott, Bristol-Myers Squibb, Excalenz, Gilead, GlobeImmune, HepaLife, HepQuant, Herbalife, Hyperion, Immuron, Janssen, Novartis, Ocera, Roche, Schering Plough, Salix, Sundise, Vertex, and Zymogenetics. SCG has served as a consultant to Abbott, Bristol-Myers Squibb, CVS-Caremark, Gilead, Merck, and Vertex. JKA, RGH, EA, and MMB were employees of Pharmasset at the time this study was done. RHH, HDS, DA, and WTS are employees and stockholders of Gilead Sciences. DRN has received research support and has served as a consultant and adviser to Gilead. IMJ has received research support and grants from Abbott, Achillion, Anadys, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead, Janssen, Novartis, Pfizer, Schering-Plough/Merck, and Vertex; was on the speakers' bureau for Bristol-Myers Squibb, Genentech, Gilead, Schering-Plough/Merck, and Vertex; and has received consultancy fees from Abbott, Achillion, Boehringer Ingelheim, Bristol-Myers Squibb, Enanta, Genentech, Gilead, GlaxoSmithKline, Idenix, Janssen, Kadmon, Novartis, Presidio, Schering-Plough/Merck, and Vertex. IC and MD declare that they have no conflicts of interest.	Bichoupan K, 2012, HEPATOLOGY, V56, p1044A; Bichoupan K, 2012, HEPATOLOGY, V56, p1010A; Chen EY, 2012, HEPATOLOGY, V56, p259A; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gao X, 2012, EXPERT REV PHARM OUT, V12, P335, DOI [10.1586/ERP.12.10, 10.1586/erp.12.10]; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hezode C, 2012, LIVER INT, V32, P32, DOI 10.1111/j.1478-3231.2011.02707.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lawitz E, 2013, LANCET INFECT DIS; Mousa O, 2012, HEPATOLOGY, V56, p661A; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Schering Corporation, 2011, VICTR BOC CAPS US PR; Vertex Pharmaceuticals Inc, 2012, INC TEL CAPS US PRES; Wyles David L, 2012, Top Antivir Med, V20, P139	15	219	228	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2100	2107		10.1016/S0140-6736(13)60247-0	http://dx.doi.org/10.1016/S0140-6736(13)60247-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23499440				2022-12-28	WOS:000320924800032
J	Karanikolos, M; Mladovsky, P; Cylus, J; Thomson, S; Basu, S; Stuckler, D; Mackenbach, JP; McKee, M				Karanikolos, Marina; Mladovsky, Philipa; Cylus, Jonathan; Thomson, Sarah; Basu, Sanjay; Stuckler, David; Mackenbach, Johan P.; McKee, Martin			Financial crisis, austerity, and health in Europe	LANCET			English	Article							ECONOMIC-CRISIS; PUBLIC-HEALTH; MENTAL-HEALTH; MORTALITY; UNEMPLOYMENT; CARE; IMPACT; CUTS; POLICY; TIMES	The financial crisis in Europe has posed major threats and opportunities to health. We trace the origins of the economic crisis in Europe and the responses of governments, examine the effect on health systems, and review the effects of previous economic downturns on health to predict the likely consequences for the present. We then compare our predictions with available evidence for the effects of the crisis on health. Whereas immediate rises in suicides and falls in road traffic deaths were anticipated, other consequences, such as HIV outbreaks, were not, and are better understood as products of state retrenchment. Greece, Spain, and Portugal adopted strict fiscal austerity; their economies continue to recede and strain on their health-care systems is growing. Suicides and outbreaks of infectious diseases are becoming more common in these countries, and budget cuts have restricted access to health care. By contrast, Iceland rejected austerity through a popular vote, and the financial crisis seems to have had few or no discernible effects on health. Although there are many potentially confounding differences between countries, our analysis suggests that, although recessions pose risks to health, the interaction of fiscal austerity with economic shocks and weak social protection is what ultimately seems to escalate health and social crises in Europe. Policy decisions about how to respond to economic crises have pronounced and unintended effects on public health, yet public health voices have remained largely silent during the economic crisis.	[Karanikolos, Marina; Cylus, Jonathan; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Mladovsky, Philipa; Cylus, Jonathan; Thomson, Sarah] Univ London London Sch Econ & Polit Sci, European Observ Hlth Syst & Policies, London WC2A 2AE, England; [Basu, Sanjay] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England; [Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; University of London; London School Economics & Political Science; Stanford University; University of Cambridge; Erasmus University Rotterdam; Erasmus MC	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mladovsky, Philipa/AAN-2264-2020; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; SOULIOTIS, KYRIAKOS/0000-0003-1624-9444; Stuckler, David/0000-0002-1288-8401; Karanikolos, Marina/0000-0002-3824-8226; Mladovsky, Philipa/0000-0001-7761-6928; Cylus, Jonathan/0000-0001-8269-1578; McKee, Martin/0000-0002-0121-9683	EU-FP7 DEMETRIQ project grant	EU-FP7 DEMETRIQ project grant	DS is supported by an EU-FP7 DEMETRIQ project grant.	Ahmad S, 2008, PUBLIC HEALTH, V122, P3, DOI 10.1016/j.puhe.2007.02.020; Andrews E, RESCUES HOMEOWNERS D; Augusto GF, 2012, LANCET, V379, P400, DOI 10.1016/S0140-6736(12)60174-3; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Barros P. P., 2012, Eurohealth, V18, P33; Barros PP, 2012, HEALTH POLICY, V106, P17, DOI 10.1016/j.healthpol.2012.04.008; Bor J, 2013, ALCOHOL ALCOHOLISM, V48, P343, DOI 10.1093/alcalc/agt002; British Broadcasting Corporation, UK ROAD DEATHS RIS P; Carassava A, EUROCRISIS WHY GREEC; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Catalano R, 2005, INT J EPIDEMIOL, V34, P1212, DOI 10.1093/ije/dyi145; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Creed PA, 1998, MED J AUSTRALIA, V168, P177, DOI 10.5694/j.1326-5377.1998.tb126775.x; Cylus J, 2012, HEALTH SERV RES, V47, P2204, DOI 10.1111/j.1475-6773.2012.01428.x; Davies SC., 2012, STATE PUBLICS HLTH 2; de Lago M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d242; Economou A, 2008, J ECON STUD, V35, P368, DOI 10.1108/01443580810903536; Economou C., 2012, SOCIAL THEORY, V2, P33; Economou M, 2011, LANCET, V378, P1459, DOI 10.1016/S0140-6736(11)61638-3; European Centre for Disease Prevention and Control, RISK ASS HIV GREEC; European Commission, 2012, OCC PAP; European Commission, EUR STAT DAT 2012; European Public Health Alliance, OP LETT EUR COUNC EU; Fahy N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1712; Financial Crisis Inquiry Commission, 2011, FIN CRIS INQ REP; Fishback PV, 2007, REV ECON STAT, V89, P1, DOI 10.1162/rest.89.1.1; Rada AG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3196; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Gene-Badia J, 2012, HEALTH POLICY, V106, P23, DOI 10.1016/j.healthpol.2012.02.001; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Glader P., GREEKS VEXED GROWING; Gudmundsdottir DG, 2013, SOC INDIC RES, V110, P1083, DOI 10.1007/s11205-011-9973-8; Guojonsdottir GR, 2012, EMERG MED J, V29, P694, DOI 10.1136/emermed-2011-200518; Hadjimatheou C., GREEK PARENTS TOO PO; HAMMARSTROM A, 1994, SOC SCI MED, V38, P699, DOI 10.1016/0277-9536(94)90460-X; Houston M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d982; IMF (Int. Monet. Fund), 2021, REP; International Monetary Fund, 2012, WORLD EC OUTLOOK; JANTTI M, 2000, MORTALITY CRISIS TRA, P351; JOYCE T, 1993, J HUM RESOUR, V28, P185, DOI 10.2307/146093; JUNANKAR PN, 1991, OXFORD ECON PAP, V43, P305, DOI 10.1093/oxfordjournals.oep.a042001; Karamanoli E, 2012, LANCET, V379, P302, DOI 10.1016/S0140-6736(12)60129-9; Karamanoli E, 2011, LANCET, V378, P303, DOI 10.1016/S0140-6736(11)61152-5; Kentikelenis A, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr190; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Lai T, 2011, ALCOHOL ALCOHOLISM, V46, P200, DOI 10.1093/alcalc/agr001; Lhachimi SK, 2012, PREV MED, V55, P237, DOI 10.1016/j.ypmed.2012.06.006; Lowen M., M NEW HOMELESS GREEC; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Madianos M, 2011, SOC PSYCH PSYCH EPID, V46, P943, DOI 10.1007/s00127-010-0265-4; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6; Mazick A, 2012, EUROSURVEILLANCE, V17, P6; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Mladovsky P, 2012, POLICY SUMMARY 5 HLT; MORRIS JK, 1994, BMJ-BRIT MED J, V308, P1135, DOI 10.1136/bmj.308.6937.1135; MOSER KA, 1986, LANCET, V1, P365; Muiznieks N., 2012, REPORT COMMISSIONER; Newhouse JP; Insurance Experiment Group, 1993, FREE ALL LESS RAND H; Obstfeld M., 2009, CEPR DISCUSSION PAPE; Organisation for Economic Co-operation and Development, STAT DAT; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Quieroz M., WINTER CRISIS KILLIN; Rabinovich L., 2009, AFFORDABILITY ALCOHO; Rajmil L., DESTRUCTION LESS DEV; Rauch B, 2011, GER ECON REV, V12, P243, DOI 10.1111/j.1468-0475.2011.00542.x; Reichert AR., 2011, CAUSAL IMPACT FEAR U; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Sachs J., 1994, UNDERSTANDING SHOCK; Schuring M, 2007, J EPIDEMIOL COMMUN H, V61, P597, DOI 10.1136/jech.2006.047456; STERN J, 1983, POP STUD-J DEMOG, V37, P61, DOI 10.2307/2174380; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Stuckler David, 2009, Ulster Med J, V78, P142; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suhrcke M, 2009, RECESSION HLTH EUROE; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Theodossiou I, 1998, J HEALTH ECON, V17, P85, DOI 10.1016/S0167-6296(97)00018-0; Thomas S, 2012, LANCET, V380, P1056, DOI 10.1016/S0140-6736(12)61599-2; Townsend J, 1996, BRIT MED BULL, V52, P132, DOI 10.1093/oxfordjournals.bmb.a011521; Ungvary G., 1999, CENT EUR J OCCUP ENV, V5, P91; Vuori J, 2005, J OCCUP ORGAN PSYCH, V78, P43, DOI 10.1348/096317904X23790; Wade R, 2009, CAMB J ECON, V33, P539, DOI 10.1093/cje/bep032; WAGSTAFF A, 1992, J HEALTH ECON, V11, P361, DOI 10.1016/0167-6296(92)90012-P; Wahlbeck K, 2012, WORLD PSYCHIATRY, V11, P139; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Waters H, 2003, HEALTH POLICY PLANN, V18, P172, DOI 10.1093/heapol/czg022; Wedel J., 2001, COLLISION COLLUSION; Westerlund H, 2001, SOC SCI MED, V52, P405, DOI 10.1016/S0277-9536(00)00145-3; WHO, 2012, DET MORT DAT; WHO Regional Office for Europe, 2011, INT REP OMPL TALL CH; WHO Regional Office for Europe, 2012, ENV HLTH IN EUR ASS; Yur'yev A, 2012, INT J SOC WELF, V21, P26, DOI 10.1111/j.1468-2397.2010.00777.x; Zarocostas J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d200; Zavras D, 2013, EUR J PUBLIC HEALTH, V23, P206, DOI 10.1093/eurpub/cks143	104	864	888	14	481	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1323	1331		10.1016/S0140-6736(13)60102-6	http://dx.doi.org/10.1016/S0140-6736(13)60102-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23541059				2022-12-28	WOS:000317351000035
J	Lee, P				Lee, Pyng			Primary spontaneous pneumothorax: to pleurodese or not?	LANCET			English	Editorial Material							COMPUTED-TOMOGRAPHY; TALC PLEURODESIS; THORACOSCOPY; MANAGEMENT; RECURRENCE; SURGERY		[Lee, Pyng] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lee, Pyng] Natl Univ Singapore Hosp, Div Resp & Crit Care Med, Singapore 119228, Singapore	National University of Singapore; National University of Singapore	Lee, P (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore.	pynglee@hotmail.com						Barker A, 2007, LANCET, V370, P329, DOI 10.1016/S0140-6736(07)61163-5; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; Baumann MH, 1997, CHEST, V112, P789, DOI 10.1378/chest.112.3.789; BENSE L, 1993, CHEST, V103, P433, DOI 10.1378/chest.103.2.433; BOUTIN C, 1995, CLIN CHEST MED, V16, P497; Chen J-S, 2013, LANCET; Horio H, 1998, SURG ENDOSC-ULTRAS, V12, P1155, DOI 10.1007/s004649900805; Huang TW, 2007, CHEST, V132, P1146, DOI 10.1378/chest.06-2772; KENNEDY L, 1994, CHEST, V106, P1215, DOI 10.1378/chest.106.4.1215; LESUR O, 1990, CHEST, V98, P341, DOI 10.1378/chest.98.2.341; Loubani M, 2000, RESP MED, V94, P888, DOI 10.1053/rmed.2000.0862; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Melton LJ, 1987, AM REV RESPIR DIS, V29, P1379; Noppen M, 2006, AM J RESP CRIT CARE, V174, P26, DOI 10.1164/rccm.200602-259OC; Noppen M, 2002, AM J RESP CRIT CARE, V165, P1240, DOI 10.1164/rccm.200111-078OC; Sadikot RT, 1997, THORAX, V52, P805, DOI 10.1136/thx.52.9.805; SENAC JP, 1985, ANN RADIOL, V28, P586; Tschopp JM, 1997, THORAX, V52, P329, DOI 10.1136/thx.52.4.329; VANDERSCHUEREN RGJRA, 1990, LUNG, V168, P1122, DOI 10.1007/BF02718252; WARNER BW, 1991, AM J SURG, V162, P39, DOI 10.1016/0002-9610(91)90199-N	20	7	10	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1252	1254		10.1016/S0140-6736(13)60285-8	http://dx.doi.org/10.1016/S0140-6736(13)60285-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23489755				2022-12-28	WOS:000317351000006
J	Kullgren, JT; Troxel, AB; Loewenstein, G; Asch, DA; Norton, LA; Wesby, L; Tao, YY; Zhu, JS; Volpp, KG				Kullgren, Jeffrey T.; Troxel, Andrea B.; Loewenstein, George; Asch, David A.; Norton, Laurie A.; Wesby, Lisa; Tao, Yuanyuan; Zhu, Jingsan; Volpp, Kevin G.			Individual- Versus Group-Based Financial Incentives for Weight Loss A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							EATING QUESTIONNAIRE-R18; FOOD PROVISION; OBESITY; PREDICTORS; OVERWEIGHT; ATTRITION; REGRET; LIFE; REIMBURSEMENT; INTERVENTIONS	Background: Data on the effectiveness of employer-sponsored financial incentives for employee weight loss are limited. Objective: To test the effectiveness of 2 financial incentive designs for promoting weight loss among obese employees. Design: Randomized, controlled trial. (ClinicalTrials.gov: NCT01208350) Setting: Children's Hospital of Philadelphia. Participants: 105 employees with a body mass index between 30 and 40 kg/m(2). Intervention: 24 weeks of monthly weigh-ins (control group; n = 35); individual incentive, designed as $100 per person per month for meeting or exceeding weight-loss goals (n = 35); and group incentive, designed as $500 per month split among participants within groups of 5 who met or exceeded weight-loss goals (n = 35). Measurements: Weight loss after 24 weeks (primary outcome) and 36 weeks and changes in behavioral mediators of weight loss (secondary outcomes). Results: Group-incentive participants lost more weight than control participants (mean between-group difference, 4.4 kg [95% CI, 2.0 to 6.7 kg]; P < 0.001) and individual-incentive participants (mean between-group difference, 3.2 kg [CI, 0.9 to 5.5 kg]; P = 0.008). Twelve weeks after incentives ended and after adjustment for 3-group comparisons, group-incentive participants maintained greater weight loss than control group participants (mean between-group difference, 2.9 kg [CI, 0.5 to 5.3 kg]; P = 0.016) but not greater than individual-incentive participants (mean between-group difference, 2.7 kg [CI, 0.4 to 5.0 kg]; P = 0.024). Limitation: Single employer and short follow-up. Conclusion: A group-based financial incentive was more effective than an individual incentive and monthly weigh-ins at promoting weight loss among obese employees at 24 weeks.	Univ Michigan, Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; Univ Penn, Perelman Sch Med,Ctr Hlth Incent & Behav Econ, Leonard Davis Inst Hlth Econ, Penn CMU Roybal Ctr Behav Econ & Hlth, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Carnegie Mellon University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Carnegie Mellon University	Kullgren, JT (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, POB 130170, Ann Arbor, MI 48113 USA.	jkullgre@med.umich.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Troxel, Andrea/0000-0002-1393-3075; Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599	National Institute on Aging [RC2103282621]; Department of Veterans Affairs; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036592, P30AG034546] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging.; By grant RC2103282621 (National Institute on Aging). Support was also provided by the Department of Veterans Affairs and the Robert Wood Johnson Foundation.	Angle S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-41; [Anonymous], 1995, J Am Diet Assoc, V95, P96; Asch DA, 2012, NEW ENGL J MED, V367, P1, DOI 10.1056/NEJMp1203869; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Butsch WS, 2007, OBESITY, V15, P2733, DOI 10.1038/oby.2007.325; Cai LM, 2010, MED CARE, V48, P510, DOI 10.1097/MLR.0b013e3181dbdb20; Claxton G, 2009, HEALTH AFFAIR, V28, pW1002, DOI 10.1377/hlthaff.28.6.w1002; Connolly T, 2006, J BEHAV DECIS MAKING, V19, P139, DOI 10.1002/bdm.510; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis MJ, 1999, ANN BEHAV MED, V21, P339, DOI 10.1007/BF02895967; de Lauzon B, 2004, J NUTR, V134, P2372; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Department of Labor Department of Treasury Department of Health and Human Services, 2006, FED REGISTER, V71, P75014; Finkelstein E, 2005, AM J HEALTH PROMOT, V20, P45, DOI 10.4278/0890-1171-20.1.45; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Finkelstein EA, 2007, J OCCUP ENVIRON MED, V49, P981, DOI 10.1097/JOM.0b013e31813c6dcb; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FORSTER JL, 1985, J OCCUP ENVIRON MED, V27, P804, DOI 10.1097/00043764-198511000-00011; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x; Hoelzl E, 2005, ORGAN BEHAV HUM DEC, V98, P15, DOI 10.1016/j.obhdp.2005.04.004; Honas JJ, 2003, OBES RES, V11, P888, DOI 10.1038/oby.2003.122; Hubbert KA, 2003, INT J OBESITY, V27, P1423, DOI 10.1038/sj.ijo.0802403; Jeffery RW, 2012, PREV MED, V55, pS61, DOI 10.1016/j.ypmed.2011.12.024; JEFFERY RW, 1993, J CONSULT CLIN PSYCH, V61, P1038, DOI 10.1037/0022-006X.61.6.1038; JEFFERY RW, 1995, J CONSULT CLIN PSYCH, V63, P793, DOI 10.1037/0022-006X.63.5.793; John LK, 2011, J GEN INTERN MED, V26, P621, DOI 10.1007/s11606-010-1628-y; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lahiri S, 2012, J OCCUP ENVIRON MED, V54, P371, DOI 10.1097/JOM.0b013e318247a394; Little R.J.A., 2002, STAT ANAL MISSING DA; Madison KM, 2011, J LAW MED ETHICS, V39, P450, DOI 10.1111/j.1748-720X.2011.00614.x; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Morgan PJ, 2011, PREV MED, V52, P317, DOI 10.1016/j.ypmed.2011.01.031; National Heart Lung and Blood Institute, 2005, AIM HLTH WEIGHT; National Institute of Diabetes and Digestive and Kidney Diseases, 2005, TALK PAT WEIGHT LOSS; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Relton C, 2011, J PUBLIC HEALTH-UK, V33, P536, DOI 10.1093/pubmed/fdr030; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; SEIDMAN LS, 1984, J OCCUP ENVIRON MED, V26, P725, DOI 10.1097/00043764-198410000-00010; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Teixeira PJ, 2004, INT J OBESITY, V28, P1124, DOI 10.1038/sj.ijo.0802727; Towers Watson, 2011, HLTH CAR CHANG AH; Towers Watson National Business Group on Health, 2011, ROAD AH SHAP HLTH CA; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Zeelenberg M, 2004, ORGAN BEHAV HUM DEC, V93, P155, DOI 10.1016/j.obhdp.2003.10.001	52	130	130	0	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					505	+		10.7326/0003-4819-158-7-201304020-00002	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00002			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	123VM	23546562	Green Accepted			2022-12-28	WOS:000317419400001
J	Hsieh, J; Schneider, JW				Hsieh, Jenny; Schneider, Jay W.			Neural Stem Cells, Excited	SCIENCE			English	Editorial Material							SMALL MOLECULES; ADULT; NEUROGENESIS; DIFFERENTIATION; FATE; GABA		[Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu; jay.schneider@utsouthwestern.edu						Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644	16	13	13	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1534	1535		10.1126/science.1237576	http://dx.doi.org/10.1126/science.1237576			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539589				2022-12-28	WOS:000316731600031
J	Gutmann, A				Gutmann, Amy			Safeguarding Children - Pediatric Research on Medical Countermeasures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gutmann, Amy] Presidential Commiss Study Bioeth Issues, Washington, DC USA; [Gutmann, Amy] Univ Penn, Off President, Philadelphia, PA 19104 USA; [Gutmann, Amy] Univ Penn, Dept Polit Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Gutmann, A (corresponding author), Presidential Commiss Study Bioeth Issues, Washington, DC USA.							National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1977, RES INV CHILDR; Presidential Commission for the Study of Bioethical Issues (PCSBI), 2013, SAF CHILDR PED MED C; White R, 2012, BIOETHICS FORUM 0522	3	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1171	1173		10.1056/NEJMp1302093	http://dx.doi.org/10.1056/NEJMp1302093			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23506617				2022-12-28	WOS:000316869000002
J	Lamas, GA; Goertz, C; Boineau, R; Mark, DB; Rozema, T; Nahin, RL; Lindblad, L; Lewis, EF; Drisko, J; Lee, KL				Lamas, Gervasio A.; Goertz, Christine; Boineau, Robin; Mark, Daniel B.; Rozema, Theodore; Nahin, Richard L.; Lindblad, Lauren; Lewis, Eldrin F.; Drisko, Jeanne; Lee, Kerry L.		TACT Investigators	Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction The TACT Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; INTERMITTENT CLAUDICATION; ENDOTHELIAL FUNCTION; DOUBLE-BLIND; VITAMIN-C; THERAPY; PREVENTION; MORTALITY; HEALTH	Importance Chelation therapy with disodium EDTA has been used for more than 50 years to treat atherosclerosis without proof of efficacy. Objective To determine if an EDTA-based chelation regimen reduces cardiovascular events. Design, Setting, and Participants Double-blind, placebo-controlled, 2 x 2 factorial randomized trial enrolling 1708 patients aged 50 years or older who had experienced a myocardial infarction (MI) at least 6 weeks prior and had serum creatinine levels of 2.0 mg/dL or less. Participants were recruited at 134 US and Canadian sites. Enrollment began in September 2003 and follow-up took place until October 2011 (median, 55 months). Two hundred eighty-nine patients (17% of total; n=115 in the EDTA group and n=174 in the placebo group) withdrew consent during the trial. Interventions Patients were randomized to receive 40 infusions of a 500-mL chelation solution (3 g of disodium EDTA, 7 g of ascorbate, B vitamins, electrolytes, procaine, and heparin) (n=839) vs placebo (n=869) and an oral vitamin-mineral regimen vs an oral placebo. Infusions were administered weekly for 30 weeks, followed by 10 infusions 2 to 8 weeks apart. Fifteen percent discontinued infusions (n=38 [16%] in the chelation group and n=41 [15%] in the placebo group) because of adverse events. Main Outcome Measures The prespecified primary end point was a composite of total mortality, recurrent MI, stroke, coronary revascularization, or hospitalization for angina. This report describes the intention-to-treat comparison of EDTA chelation vs placebo. To account for multiple interim analyses, the significance threshold required at the final analysis was P=.036. Results Qualifying previous MIs occurred a median of 4.6 years before enrollment. Median age was 65 years, 18% were female, 9% were nonwhite, and 31% were diabetic. The primary end point occurred in 222 (26%) of the chelation group and 261 (30%) of the placebo group (hazard ratio [HR], 0.82 [95% CI, 0.69-0.99]; P=. 035). There was no effect on total mortality (chelation: 87 deaths [10%]; placebo, 93 deaths [11%]; HR, 0.93 [95% CI, 0.70-1.25]; P=. 64), but the study was not powered for this comparison. The effect of EDTA chelation on the components of the primary end point other than death was of similar magnitude as its overall effect (MI: chelation, 6%; placebo, 8%; HR, 0.77 [95% CI, 0.54-1.11]; stroke: chelation, 1.2%; placebo, 1.5%; HR, 0.77 [95% CI, 0.34-1.76]; coronary revascularization: chelation, 15%; placebo, 18%; HR, 0.81 [95% CI, 0.64-1.02]; hospitalization for angina: chelation, 1.6%; placebo, 2.1%; HR, 0.72 [95% CI, 0.35-1.47]). Sensitivity analyses examining the effect of patient dropout and treatment adherence did not alter the results. Conclusions and Relevance Among stable patients with a history of MI, use of an intravenous chelation regimen with disodium EDTA, compared with placebo, modestly reduced the risk of adverse cardiovascular outcomes, many of which were revascularization procedures. These results provide evidence to guide further research but are not sufficient to support the routine use of chelation therapy for treatment of patients who have had an MI.	[Lamas, Gervasio A.] Columbia Univ, Div Cardiol, Mt Sinai Med Ctr, Miami Beach, FL 33140 USA; [Goertz, Christine] Palmer Ctr Chiropract Res, Davenport, IA USA; [Boineau, Robin] NHLBI, Bethesda, MD 20892 USA; [Nahin, Richard L.] Natl Ctr Complementary & Alternat Med, Bethesda, MD USA; [Mark, Daniel B.; Lindblad, Lauren; Lee, Kerry L.] Duke Clin Res Inst, Durham, NC USA; [Rozema, Theodore] Biogenesis Med Ctr, Landrum, SC USA; [Lewis, Eldrin F.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lewis, Eldrin F.] Harvard Univ, Sch Med, Boston, MA USA; [Drisko, Jeanne] Univ Kansas, Med Ctr, Kansas City, MO USA	Columbia University; Mount Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Kansas	Lamas, GA (corresponding author), Columbia Univ, Div Cardiol, Mt Sinai Med Ctr, 4300 Alton Rd, Miami Beach, FL 33140 USA.	gervasio.lamas@msmc.com	Boineau, Robin/AAR-4452-2021	Nahin, Richard/0000-0002-3682-4816; Mark, Daniel/0000-0001-6340-8087	NCCAM [U01AT001156]; NHLBI [U01HL092607]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT001156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL092607] Funding Source: NIH RePORTER	NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The NCCAM (grant U01AT001156) and the NHLBI (grant U01HL092607) provided sole support for this study.	Agarwal S, 2011, ANGIOLOGY, V62, P422, DOI 10.1177/0003319710395562; American Heart Association, 2000, QUEST ANSW CHEL THER; Anderson TJ, 2003, J AM COLL CARDIOL, V41, P420, DOI 10.1016/S0735-1097(02)02770-5; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P204; Barnes Patricia M, 2008, Natl Health Stat Report, P1; BESSMAN SAMUEL P., 1952, MED ANN DIST COLUMBIA, V21, P312; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Casdorph HR., 1983, J HOLIST MED, V5, P3; Casdorph HR, 1981, J HOLIST MED, V3, P53; CLARKE NE, 1956, AM J MED SCI, V232, P654, DOI 10.1097/00000441-195612000-00006; CLARKE NE, 1955, AM J MED SCI, V229, P142, DOI 10.1097/00000441-195502000-00004; COX DR, 1972, J R STAT SOC B, V34, P187; Cranton EM, 2001, TXB EDTA CHELATION T, V2, P503; GRIER MT, 1993, ANN PHARMACOTHER, V27, P1504, DOI 10.1177/106002809302701217; GULDAGER B, 1992, J INTERN MED, V231, P261, DOI 10.1111/j.1365-2796.1992.tb00533.x; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KITCHELL JR, 1963, AM J CARDIOL, V11, P501, DOI 10.1016/0002-9149(63)90011-0; Knudtson ML, 2002, JAMA-J AM MED ASSOC, V287, P481, DOI 10.1001/jama.287.4.481; LAMAR CP, 1966, J AM GERIATR SOC, V14, P272, DOI 10.1111/j.1532-5415.1966.tb05318.x; Lamas GA, 2012, AM HEART J, V163, P7, DOI 10.1016/j.ahj.2011.10.002; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levine GN, 1996, CIRCULATION, V93, P1107, DOI 10.1161/01.CIR.93.6.1107; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OLSZEWER E, 1988, MED HYPOTHESES, V27, P41, DOI 10.1016/0306-9877(88)90082-5; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Plantinga Y, 2007, AM J HYPERTENS, V20, P392, DOI 10.1016/j.amjhyper.2006.09.021; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011; Rudolph C.J., 1991, J ADV MED, V4, P39; Rudolph CJ, 1991, J ADV MED, V4, P157; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; US Food and Drug Administration, PUBL HLTH ADV ED DIS; VANRIJ AM, 1994, CIRCULATION, V90, P1194, DOI 10.1161/01.CIR.90.3.1194; Weisskopf MG, 2009, CIRCULATION, V120, P1056, DOI 10.1161/CIRCULATIONAHA.108.827121; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Yusuf S, 2001, NEW ENGL J MED, V345, P494; [No title captured]	38	144	146	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1241	1250		10.1001/jama.2013.2107	http://dx.doi.org/10.1001/jama.2013.2107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532240	Green Accepted, Bronze			2022-12-28	WOS:000316625200024
J	Fracchia, MS; El Saleeby, CM; Murali, MR; Sagar, P; Mino-Kenudson, M				Fracchia, Mary Shannon; El Saleeby, Chadi M.; Murali, Mandakolathur R.; Sagar, Pallavi; Mino-Kenudson, Mari			Case 9-2013: A 9-Year-Old Boy with Fever, Cough, Respiratory Distress, and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERSENSITIVITY; EPIDEMIOLOGY; EVOLUTION; DISEASE		[Fracchia, Mary Shannon; El Saleeby, Chadi M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Murali, Mandakolathur R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sagar, Pallavi] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fracchia, Mary Shannon; El Saleeby, Chadi M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Murali, Mandakolathur R.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Sagar, Pallavi] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fracchia, MS (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.				Department of Continuing Education, Harvard Medical School	Department of Continuing Education, Harvard Medical School	This case was discussed at the postgraduate course, Primary Care Pediatrics; course directors: Ronni L. Goldsmith, M. D., Peter T. Greenspan, M. D., Ronald E. Kleinman, M. D., Janice A. Lowe, M. D., and John Patrick T. Co, M. D., M. P. H., sponsored by the Department of Continuing Education, Harvard Medical School.	Abdelsamed HA, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-15; Ampofo K, 2011, PEDIATR INFECT DIS J, V30, P1100, DOI 10.1097/INF.0b013e318232ee3e; Aquino-Galvez A, 2008, EXP MOL PATHOL, V84, P173, DOI 10.1016/j.yexmp.2008.01.002; Bogaert P, 2009, AM J PATHOL, V174, P3, DOI 10.2353/ajpath.2009.071151; Fenoglio CM, 2007, EUR RESPIR J, V29, P706, DOI 10.1183/09031936.00001006; Gell PGH, 1968, CLIN ASPECTS IMMUNOL, VSecond, P580; Greenberg D, 2006, LANCET INFECT DIS, V6, P529, DOI 10.1016/S1473-3099(06)70553-9; Hariri LP, 2012, HUM PATHOL, V43, P660, DOI 10.1016/j.humpath.2011.06.001; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Margileth AM, 1998, CLIN INFECT DIS, V27, P353, DOI 10.1086/514671; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Monto AS, 2002, AM J MED, V112, p4S; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661; Schaaf BM, 2001, AM J RESP CRIT CARE, V163, P379, DOI 10.1164/ajrccm.163.2.2002062; Schuyler M, 1997, CHEST, V111, P534, DOI 10.1378/chest.111.3.534; Sinico RA, 2009, BEST PRACT RES CL RH, V23, P355, DOI 10.1016/j.berh.2009.02.004; Sundar KM, 2003, CHEST, V123, P1673, DOI 10.1378/chest.123.5.1673; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005	19	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1141	1150		10.1056/NEJMcpc1208144	http://dx.doi.org/10.1056/NEJMcpc1208144			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514292				2022-12-28	WOS:000316318600009
J	Friboulet, L; Olaussen, KA; Pignon, JP; Shepherd, FA; Tsao, MS; Graziano, S; Kratzke, R; Douillard, JY; Seymour, L; Pirker, R; Filipits, M; Andre, F; Solary, E; Ponsonnailles, F; Robin, A; Stoclin, A; Dorvault, N; Commo, F; Adam, J; Vanhecke, E; Saulnier, P; Thomale, J; Le Chevalier, T; Dunant, A; Rousseau, V; Le Teuff, G; Brambilla, E; Soria, JC				Friboulet, Luc; Olaussen, Ken Andre; Pignon, Jean-Pierre; Shepherd, Frances A.; Tsao, Ming-Sound; Graziano, Stephen; Kratzke, Robert; Douillard, Jean-Yves; Seymour, Lesley; Pirker, Robert; Filipits, Martin; Andre, Fabrice; Solary, Eric; Ponsonnailles, Florence; Robin, Angelique; Stoclin, Annabelle; Dorvault, Nicolas; Commo, Frederic; Adam, Julien; Vanhecke, Elsa; Saulnier, Patrick; Thomale, Juergen; Le Chevalier, Thierry; Dunant, Ariane; Rousseau, Vanessa; Le Teuff, Gwenael; Brambilla, Elisabeth; Soria, Jean-Charles			ERCC1 Isoform Expression and DNA Repair in Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							III BETA-TUBULIN; MESSENGER-RNA EXPRESSION; COMPLEMENTATION GROUP 1; MONOCLONAL-ANTIBODIES; SURVIVAL; CHEMOTHERAPY; VALIDATION; TRIAL; RRM1	Background The excision repair cross-complementation group 1 (ERCC1) protein is a potential prognostic biomarker of the efficacy of cisplatin-based chemotherapy in non-small-cell lung cancer (NSCLC). Although several ongoing trials are evaluating the level of expression of ERCC1, no consensus has been reached regarding a method for evaluation. Methods We used the 8F1 antibody to measure the level of expression of ERCC1 protein by means of immunohistochemical analysis in a validation set of samples obtained from 494 patients in two independent phase 3 trials (the National Cancer Institute of Canada Clinical Trials Group JBR. 10 and the Cancer and Leukemia Group B 9633 trial from the Lung Adjuvant Cisplatin Evaluation Biology project). We compared the results of repeated staining of the entire original set of samples obtained from 589 patients in the International Adjuvant Lung Cancer Trial Biology study, which had led to the initial correlation between the absence of ERCC1 expression and platinum response, with our previous results in the same tumors. We mapped the epitope recognized by 16 commercially available ERCC1 antibodies and investigated the capacity of the different ERCC1 isoforms to repair platinum-induced DNA damage. Results We were unable to validate the predictive effect of immunostaining for ERCC1 protein. The discordance in the results of staining for ERCC1 suggested a change in the performance of the 8F1 antibody since 2006. We found that none of the 16 antibodies could distinguish among the four ERCC1 protein isoforms, whereas only one isoform produced a protein that had full capacities for nucleotide excision repair and cisplatin resistance. Conclusions Immunohistochemical analysis with the use of currently available ERCC1 antibodies did not specifically detect the unique functional ERCC1 isoform. As a result, its usefulness in guiding therapeutic decision making is limited. (Funded by Eli Lilly and others.)	[Friboulet, Luc; Olaussen, Ken Andre; Andre, Fabrice; Ponsonnailles, Florence; Robin, Angelique; Stoclin, Annabelle; Dorvault, Nicolas; Commo, Frederic; Adam, Julien; Vanhecke, Elsa; Soria, Jean-Charles] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France; [Friboulet, Luc; Olaussen, Ken Andre; Ponsonnailles, Florence; Robin, Angelique; Stoclin, Annabelle; Dorvault, Nicolas; Commo, Frederic; Adam, Julien; Vanhecke, Elsa; Soria, Jean-Charles] Inst Gustave Roussy, Dept Hosp Univ Thorax Innovat, F-94805 Villejuif, France; [Andre, Fabrice; Le Chevalier, Thierry; Soria, Jean-Charles] Inst Gustave Roussy, Dept Canc Med, F-94805 Villejuif, France; [Pignon, Jean-Pierre; Dunant, Ariane; Rousseau, Vanessa; Le Teuff, Gwenael] Inst Gustave Roussy, Biostat & Epidemiol Unit, F-94805 Villejuif, France; [Solary, Eric] Inst Gustave Roussy, INSERM, UMR1009, F-94805 Villejuif, France; [Saulnier, Patrick] Inst Gustave Roussy, Translat Res Unit, F-94805 Villejuif, France; [Friboulet, Luc; Olaussen, Ken Andre; Andre, Fabrice; Solary, Eric; Ponsonnailles, Florence; Robin, Angelique; Stoclin, Annabelle; Dorvault, Nicolas; Commo, Frederic; Adam, Julien; Vanhecke, Elsa; Le Chevalier, Thierry; Soria, Jean-Charles] Univ Paris 11, Le Kremlin Bicetre, France; [Douillard, Jean-Yves] Inst Canc Ouest Rene Gauducheau, Nantes, France; [Brambilla, Elisabeth] Univ Grenoble 1, CHU Grenoble, Hop Albert Michallon, Inst Albert Bonniot,Dept Pathol,INSERM,U823, Grenoble, France; [Shepherd, Frances A.] Univ Hlth Network, Princess Margaret Hosp, Dept Med, Toronto, ON, Canada; [Tsao, Ming-Sound] Univ Hlth Network, Princess Margaret Hosp, Dept Pathol, Toronto, ON, Canada; [Graziano, Stephen] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Kratzke, Robert] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Seymour, Lesley] Canada Clin Trials Grp, NCI, Kingston, ON, Canada; [Pirker, Robert; Filipits, Martin] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Thomale, Juergen] Univ Duisburg Essen Med Sch, Inst Cell Biol, Essen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Queens University - Canada; Medical University of Vienna; University of Duisburg Essen	Soria, JC (corresponding author), Inst Gustave Roussy, INSERM, U981, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	soria@igr.fr	Soria, Jean-Charles/F-3619-2014; friboulet, luc/N-7276-2015; Brambilla, Elisabeth MP/L-8796-2013; Tsao, Ming-Sound/M-3503-2017; ANDRE, Fabrice/AAL-2683-2020; Tsao, Ming Sound/AFQ-7332-2022	friboulet, luc/0000-0002-1129-4978; ANDRE, Fabrice/0000-0001-5795-8357; Tsao, Ming Sound/0000-0002-9160-5405; PIGNON, Jean-Pierre/0000-0003-2047-1582; Filipits, Martin/0000-0003-2847-4534; Olaussen, Ken/0000-0002-3115-8914; Solary, Eric/0000-0002-8629-1341	Eli Lilly; Institut National du Cancer Programme National d'Excellence Specialise and Programme Hospitalier de Recherche Clinique; La Ligue Nationale contre le Cancer; Sanofi-Aventis; European Union [HEALTH-F2-2010-258677-CURELUNG]; Roche; NATIONAL CANCER INSTITUTE [R01CA165958] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); Institut National du Cancer Programme National d'Excellence Specialise and Programme Hospitalier de Recherche Clinique; La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Sanofi-Aventis(Sanofi-Aventis); European Union(European Commission); Roche(Roche Holding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by an unrestricted grant from Eli Lilly and by grants from Institut National du Cancer Programme National d'Excellence Specialise and Programme Hospitalier de Recherche Clinique (to the International Adjuvant Lung Cancer Trial Biology); by La Ligue Nationale contre le Cancer and an unrestricted grant from Sanofi-Aventis (to the Lung Adjuvant Cisplatin Evaluation Biology project); by a contract (FP7-2007-13) from the European Union Seventh Framework Program under a grant agreement (HEALTH-F2-2010-258677-CURELUNG); and by a translational research fellowship from Roche (to Dr. Friboulet).	Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Bepler G, 2011, AM J PATHOL, V178, P69, DOI 10.1016/j.ajpath.2010.11.029; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Bhagwat NR, 2009, CANCER RES, V69, P6831, DOI 10.1158/0008-5472.CAN-09-1237; Booton R, 2007, J THORAC ONCOL, V2, P902, DOI 10.1097/JTO.0b013e318155a637; Chen SF, 2010, LUNG CANCER, V70, P63, DOI 10.1016/j.lungcan.2010.05.010; Choi CM, 2012, ANN ONCOL, V23, P2088, DOI 10.1093/annonc/mdr606; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; DABHOLKAR M, 1995, ONCOL REP, V2, P209; Friboulet L, 2011, CLIN CANCER RES, V17, P5562, DOI 10.1158/1078-0432.CCR-11-0790; Hede K, 2008, J NATL CANCER I, V100, P836, DOI 10.1093/jnci/djn200; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee KH, 2008, LUNG CANCER, V60, P401, DOI 10.1016/j.lungcan.2007.10.014; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Ma DH, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-88; Niedernhofer LJ, 2007, NEW ENGL J MED, V356, P2538; Okuda K, 2008, LUNG CANCER, V62, P105, DOI 10.1016/j.lungcan.2008.02.021; Olaussen KA, 2007, NEW ENGL J MED, V357, P1559, DOI 10.1056/NEJMc072007; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olaussen KA, 2010, CANCER RES, V70, P3851, DOI 10.1158/0008-5472.CAN-09-4352; Ota S, 2009, LUNG CANCER, V64, P98, DOI 10.1016/j.lungcan.2008.07.014; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Postel-Vinay S, 2012, NAT REV CLIN ONCOL, V9, P144, DOI 10.1038/nrclinonc.2012.3; Reiman T, 2012, ANN ONCOL, V23, P86, DOI 10.1093/annonc/mdr033; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Roth JA, 2011, CLIN LUNG CANCER, V12, P393, DOI 10.1016/j.cllc.2011.04.005; Seyhan EC, 2011, ANN THORAC CARDIOVAS, V17, P110, DOI 10.5761/atcs.oa.09.01526; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Sun YH, 2009, CANCER INVEST, V27, P891, DOI 10.3109/07357900902744536; Tseden-Ish M, 2012, RESPIROLOGY, V17, P127, DOI 10.1111/j.1440-1843.2011.02060.x; Vilmar AC, 2010, ANN ONCOL, V21, P1817, DOI 10.1093/annonc/mdq053; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Zhang SC, 2010, INT J BIOL MARKER, V25, P141, DOI 10.1177/172460081002500304; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	39	284	300	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1101	1110		10.1056/NEJMoa1214271	http://dx.doi.org/10.1056/NEJMoa1214271			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108TH	23514287	Green Accepted			2022-12-28	WOS:000316318600003
J	Levy, C; Zoltowski, BD; Jones, AR; Vaidya, AT; Top, D; Widom, J; Young, MW; Scrutton, NS; Crane, BR; Leys, D				Levy, Colin; Zoltowski, Brian D.; Jones, Alex R.; Vaidya, Anand T.; Top, Deniz; Widom, Joanne; Young, Michael W.; Scrutton, Nigel S.; Crane, Brian R.; Leys, David			Updated structure of Drosophila cryptochrome	NATURE			English	Letter									[Levy, Colin; Jones, Alex R.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Zoltowski, Brian D.; Vaidya, Anand T.; Widom, Joanne; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Top, Deniz; Young, Michael W.] Rockefeller Univ, Lab Genet, New York, NY 10065 USA	University of Manchester; Cornell University; Rockefeller University	Levy, C (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	bc69@cornell.edu	Jones, Alex/AFQ-8212-2022; , 机智的马小跳和机智的羊不愁/ABC-5169-2020	Vaidya, Anand/0000-0002-5812-5266; Jones, Alex/0000-0001-6021-7824; Levy, Colin/0000-0002-9724-310X; Top, Deniz/0000-0002-1042-8460	EPSRC [EP/J020192/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM079679] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079679, R37 GM054339] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afonine P. V., 2005, CCP4 NEWSLETT; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	2	69	71	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					E3	E4		10.1038/nature11995	http://dx.doi.org/10.1038/nature11995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518567	Green Accepted			2022-12-28	WOS:000316650500051
J	McCartney, M				McCartney, Margaret			How do we know whether medical apps work?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams S., 2013, DAILY TELEGRAPH; [Anonymous], COMM US PULS OX SPOR; Food and Drug Administration, 2011, GUID IND FO IN PRESS; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1501; Instant Heart Rate by Azumio, INST HEART RAT; MHRA, FREQ ASK QUEST OTH D; NHS Choices, HLTH APPS LIB; Sharpe R, 2012, LACKING REGULATION M; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382	10	34	35	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2013	346								f1811	10.1136/bmj.f1811	http://dx.doi.org/10.1136/bmj.f1811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MG	23516158				2022-12-28	WOS:000316671500012
J	Dietrich, A; Cristiano, A; Serra, M; Garcia-Monaco, R; de Santibanes, M				Dietrich, Agustin; Cristiano, Agustin; Serra, Marcelo; Garcia-Monaco, Ricardo; de Santibanes, Martin			Haemoperitoneum with hereditary haemorrhagic telangiectasia	LANCET			English	Editorial Material							LIVER INVOLVEMENT		[Dietrich, Agustin] Hosp Italiano Buenos Aires, Dept Gen Surg, RA-1181 Buenos Aires, DF, Argentina; [Cristiano, Agustin; de Santibanes, Martin] Hosp Italiano Buenos Aires, Dept Hepatobiliary Pancreat Surg, RA-1181 Buenos Aires, DF, Argentina; [Cristiano, Agustin; de Santibanes, Martin] Hosp Italiano Buenos Aires, Liver Transplant Unit, RA-1181 Buenos Aires, DF, Argentina; [Serra, Marcelo] Hosp Italiano Buenos Aires, Dept Internal Med, RA-1181 Buenos Aires, DF, Argentina; [Garcia-Monaco, Ricardo] Hosp Italiano Buenos Aires, Dept Radiol, RA-1181 Buenos Aires, DF, Argentina	Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	de Santibanes, M (corresponding author), Hosp Italiano Buenos Aires, Peron 4190, RA-1181 Buenos Aires, DF, Argentina.	martin.desantibanes@hospitalitaliano.org.ar		Garcia Monaco, Ricardo/0000-0003-3201-4426				Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18; Buonamico P, 2008, J HEPATOL, V48, P811, DOI 10.1016/j.jhep.2007.12.022; Garcia-Tsao G, 2007, J HEPATOL, V46, P499, DOI 10.1016/j.jhep.2006.12.008; Khalid SK, 2008, SEMIN LIVER DIS, V28, P247, DOI 10.1055/s-0028-1085093; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 16	2013	381	9870					962	962		10.1016/S0140-6736(12)62172-2	http://dx.doi.org/10.1016/S0140-6736(12)62172-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105LB	23499045				2022-12-28	WOS:000316069700032
J	Faber, J; Saggurthi, P				Faber, Jantien; Saggurthi, Prem			Physical rehabilitation services in Iraq	LANCET			English	Editorial Material									[Faber, Jantien; Saggurthi, Prem] Int Comm Red Cross, CH-1202 Geneva, Switzerland		Faber, J (corresponding author), Int Comm Red Cross, CH-1202 Geneva, Switzerland.	jfaber@icrc.org						Al-Hamadani ASI, 2011, FACTORS IMPEDING PUB; [Anonymous], 2005, GUID TRAIN PERS DEV; Naji L., 2012, FINANCIAL TIMES 0808	3	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					881	883		10.1016/S0140-6736(13)60323-2	http://dx.doi.org/10.1016/S0140-6736(13)60323-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499028				2022-12-28	WOS:000316069700006
J	Lever, MA; Rouxel, O; Alt, JC; Shimizu, N; Ono, SH; Coggon, RM; Shanks, WC; Lapham, L; Elvert, M; Prieto-Mollar, X; Hinrichs, KU; Inagaki, F; Teske, A				Lever, Mark A.; Rouxel, Olivier; Alt, Jeffrey C.; Shimizu, Nobumichi; Ono, Shuhei; Coggon, Rosalind M.; Shanks, Wayne C., III; Lapham, Laura; Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe; Inagaki, Fumio; Teske, Andreas			Evidence for Microbial Carbon and Sulfur Cycling in Deeply Buried Ridge Flank Basalt	SCIENCE			English	Article							DE-FUCA RIDGE; OCEAN CRUST; SUBSEAFLOOR SEDIMENTS; SULFIDE OXIDATION; SULFATE REDUCTION; DIVERSITY; FLUIDS; DISPROPORTIONATION; FRACTIONATION; COMMUNITY	Sediment-covered basalt on the flanks of mid-ocean ridges constitutes most of Earth's oceanic crust, but the composition and metabolic function of its microbial ecosystem are largely unknown. By drilling into 3.5-million-year-old subseafloor basalt, we demonstrated the presence of methane-and sulfur-cycling microbes on the eastern flank of the Juan de Fuca Ridge. Depth horizons with functional genes indicative of methane-cycling and sulfate-reducing microorganisms are enriched in solid-phase sulfur and total organic carbon, host delta C-13- and delta S-34-isotopic values with a biological imprint, and show clear signs of microbial activity when incubated in the laboratory. Downcore changes in carbon and sulfur cycling show discrete geochemical intervals with chemoautotrophic delta C-13 signatures locally attenuated by heterotrophic metabolism.	[Lever, Mark A.; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Lever, Mark A.; Lapham, Laura] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Rouxel, Olivier; Shimizu, Nobumichi] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Rouxel, Olivier] IFREMER, Ctr Brest, F-29280 Plouzane, France; [Alt, Jeffrey C.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Coggon, Rosalind M.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Shanks, Wayne C., III] US Geol Survey, Denver, CO 80225 USA; [Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe] Univ Bremen, Dept Geosci, Organ Geochem Grp, D-28334 Bremen, Germany; [Elvert, Marcus; Prieto-Mollar, Xavier; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Geomicrobiol Grp, Nanko Ku, Kochi 7838502, Japan	University of North Carolina; University of North Carolina Chapel Hill; Aarhus University; Woods Hole Oceanographic Institution; Ifremer; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Imperial College London; United States Department of the Interior; United States Geological Survey; University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Lever, MA (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA.	mark.lever@biology.au.dk; teske@email.unc.edu	Hinrichs, Kai-Uwe/C-7675-2009; Lapham, Laura Lee/AAD-7655-2022; Teske, Andreas/AAQ-9577-2021; Rouxel, Olivier J/F-3954-2014; Lapham, Laura L/A-4035-2011; Coggon, Rosalind/M-8816-2017; Facility, NENIMF/B-8811-2015; Inagaki, Fumio/AAI-1156-2019; Lever, Mark A/C-2134-2011	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Lapham, Laura Lee/0000-0002-7045-1785; Rouxel, Olivier J/0000-0002-1431-222X; Coggon, Rosalind/0000-0002-9228-9707; Inagaki, Fumio/0000-0003-2887-6525; Lever, Mark A/0000-0002-2046-8028; Elvert, Marcus/0000-0003-3863-0975	IODP Expedition 301 Scientists; Schlanger Ocean Drilling Fellowship; University of North Carolina Dissertation Completion Fellowship; Marie-Curie Intra-European Fellowship [255135]; Danish National Research Foundation; Max Planck Society; Europole Mer; European Research Council Advanced Grant DARCLIFE; NASA Astrobiology Institute Subsurface Biospheres; Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program); National Science Foundation [NSF-OCE 0622949, OCE 1129631, OCE-0753126, NSF-ODP 0727175]; National Science Foundation (NSF-STC for Dark Energy Biosphere Investigations)	IODP Expedition 301 Scientists; Schlanger Ocean Drilling Fellowship; University of North Carolina Dissertation Completion Fellowship; Marie-Curie Intra-European Fellowship(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Max Planck Society(Max Planck SocietyFoundation CELLEX); Europole Mer; European Research Council Advanced Grant DARCLIFE; NASA Astrobiology Institute Subsurface Biospheres; Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); National Science Foundation (NSF-STC for Dark Energy Biosphere Investigations)(National Science Foundation (NSF))	We thank B. Jorgensen, M. Sogin, and the IODP Expedition 301 Scientists for advice and support in this project. Funding was obtained from a Schlanger Ocean Drilling Fellowship, a University of North Carolina Dissertation Completion Fellowship, a Marie-Curie Intra-European Fellowship (255135) (all to M. A. L.); the Danish National Research Foundation and the Max Planck Society (both to B. Jorgensen); Europole Mer (to O.R.); the European Research Council Advanced Grant DARCLIFE (to K.-U.H.); the NASA Astrobiology Institute Subsurface Biospheres (to A. T.); the Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers (NEXT Program) (to F. I.); and the National Science Foundation (NSF-OCE 0622949 and OCE 1129631 to J.C.A.; OCE-0753126 to S.O. and O.R.; and NSF-ODP 0727175 and NSF-STC for Dark Energy Biosphere Investigations to A. T.). We thank three anonymous reviewers for very helpful comments. The geochemical data are available in the supplementary tables. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. The functional gene sequence data are available from the GenBank database (accession numbers GU182109 to GU182110 and JX465656 to JX465658).	Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Edwards KJ, 2003, GEOCHIM COSMOCHIM AC, V67, P2843, DOI 10.1016/S0016-7037(03)00089-9; Fisher A. T., 2005, P IODP, P1; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lever MA, 2010, GEOMICROBIOL J, V27, P183, DOI 10.1080/01490450903456681; Lin HT, 2012, GEOCHIM COSMOCHIM AC, V85, P213, DOI 10.1016/j.gca.2012.02.017; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Mason OU, 2009, ISME J, V3, P231, DOI 10.1038/ismej.2008.92; McCarthy MD, 2011, NAT GEOSCI, V4, P32, DOI 10.1038/NGEO1015; McCollom TM, 2007, CHEM REV, V107, P382, DOI 10.1021/cr0503660; Ono SH, 2012, GEOCHIM COSMOCHIM AC, V87, P323, DOI 10.1016/j.gca.2012.04.016; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Rouxel O, 2008, EARTH PLANET SC LETT, V268, P110, DOI 10.1016/j.epsl.2008.01.010; Rudnicki MD, 2001, GEOCHIM COSMOCHIM AC, V65, P777, DOI 10.1016/S0016-7037(00)00579-2; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schippers A, 2002, GEOCHIM COSMOCHIM AC, V66, P85, DOI 10.1016/S0016-7037(01)00745-1; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; Wagner M., 1998, APPL ENVIRON MICROB, V75, P7086; Walker BD, 2008, MAR CHEM, V108, P123, DOI 10.1016/j.marchem.2007.11.002; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Wheat CG, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003057; WHITMAN WB, 2006, PROKARYOTES, V3, P165; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467; Zhang GS, 2008, ENVIRON MICROBIOL, V10, P1850, DOI 10.1111/j.1462-2920.2008.01606.x	30	150	156	8	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1305	1308		10.1126/science.1229240	http://dx.doi.org/10.1126/science.1229240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493710	Green Submitted, Green Published			2022-12-28	WOS:000316053400034
J	Natalio, F; Corrales, TP; Panthofer, M; Schollmeyer, D; Lieberwirth, I; Muller, WEG; Kappl, M; Butt, HJ; Tremel, W				Natalio, Filipe; Corrales, Tomas P.; Panthoefer, Martin; Schollmeyer, Dieter; Lieberwirth, Ingo; Mueller, Werner E. G.; Kappl, Michael; Butt, Hans-Juergen; Tremel, Wolfgang			Flexible Minerals: Self-Assembled Calcite Spicules with Extreme Bending Strength	SCIENCE			English	Article							URCHIN LARVAL SPICULE; ECHINODERM CALCITE; SPONGE SPICULES; CRYSTAL TEXTURE; CARBONATE; PROTEINS; GROWTH; BIOMINERALIZATION; COMPOSITE; BIOSILICA	Silicatein-alpha is responsible for the biomineralization of silicates in sponges. We used silicatein-alpha to guide the self-assembly of calcite "spicules" similar to the spicules of the calcareous sponge Sycon sp. The self-assembled spicules, 10 to 300 micrometers (mu m) in length and 5 to 10 mu m in diameter, are composed of aligned calcite nanocrystals. The spicules are initially amorphous but transform into calcite within months, exhibiting unusual growth along [100]. They scatter x-rays like twinned calcite crystals. Whereas natural spicules evidence brittle failure, the synthetic spicules show an elastic response, which greatly enhances bending strength. This remarkable feature is linked to a high protein content. With nano-thermogravimetric analysis, we measured the organic content of a single spicule to be 10 to 16%. In addition, the spicules exhibit waveguiding properties even when they are bent.	[Natalio, Filipe; Panthoefer, Martin; Tremel, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Anorgan Chem & Analyt Chem, D-55099 Mainz, Germany; [Natalio, Filipe] Univ Halle Wittenberg, Inst Chem Anorgan Chem, D-06120 Halle, Germany; [Corrales, Tomas P.; Lieberwirth, Ingo; Kappl, Michael; Butt, Hans-Juergen] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Schollmeyer, Dieter] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany; [Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med, Inst Physiol Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; Martin Luther University Halle Wittenberg; Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Tremel, W (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anorgan Chem & Analyt Chem, Duesbergweg 10-14, D-55099 Mainz, Germany.	tremel@uni-mainz.de	Lieberwirth, Ingo/Q-5862-2017; Tremel, Wolfgang/D-8125-2011; Kappl, Michael/A-5697-2009; Butt, Hans-Jürgen/C-4811-2011; Natalio, Filipe/D-4417-2011; Tremel, Wolfgang/AAT-1137-2021; Corrales, Tomas/F-1717-2016; Corrales, Tomas/I-1969-2013; Müller, W. E. G./AAR-8651-2020	Tremel, Wolfgang/0000-0002-4536-994X; Butt, Hans-Jürgen/0000-0001-5391-2618; Müller, W. E. G./0000-0002-8223-3689; Panthofer, Martin/0000-0001-6888-5552; Natalio, Filipe/0000-0002-4166-6947; Corrales, Tomas P./0000-0003-0197-9735	Deutsche Forschungsgemeinschaft [SPP 1420]; Deutscher Akademischer Austauschdienst scholarship; Center for Complex Matter;  [SFB 625]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst scholarship; Center for Complex Matter; 	This work was partially supported by the Deutsche Forschungsgemeinschaft within the SPP 1420. T. P. C. was supported by a Deutscher Akademischer Austauschdienst scholarship. We acknowledge the use of the facilities of the EM Center in Mainz (EZMZ) supported by the Center for Complex Matter and the SFB 625. We are grateful to R. Jung-Pothmann for performing single-crystal x-ray measurements and J. Ally for insightful discussions. The authors declare that they have no competing financial interests.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; AIZENBERG J, 1995, FASEB J, V9, P262, DOI 10.1096/fasebj.9.2.7781928; AIZENBERG J, 1995, CHEM-EUR J, V1, P414, DOI 10.1002/chem.19950010705; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; Carey P. R., 1982, BIOCH APPL RAMAN RES; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0; EMLET RB, 1982, BIOL BULL, V163, P264, DOI 10.2307/1541265; Gilbert P.U.P.A., 2011, P199, DOI 10.1007/978-3-642-21230-7_7; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Johnson M, 2010, ACTA BIOMATER, V6, P2181, DOI 10.1016/j.actbio.2009.12.006; Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d; LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; ONEILL PL, 1981, SCIENCE, V213, P646, DOI 10.1126/science.213.4508.646; Pipich V, 2008, J AM CHEM SOC, V130, P6879, DOI 10.1021/ja801798h; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Rieger J, 1997, TENSIDE SURFACT DET, V34, P430; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251	29	96	96	1	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1298	1302		10.1126/science.1216260	http://dx.doi.org/10.1126/science.1216260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493708				2022-12-28	WOS:000316053400032
J	Schreiber, KH; Kennedy, BK				Schreiber, Katherine H.; Kennedy, Brian K.			When Lamins Go Bad: Nuclear Structure and Disease	CELL			English	Review							HUTCHINSON-GILFORD-PROGERIA; A-TYPE LAMINS; SIGNAL-REGULATED KINASE; DILATED CARDIOMYOPATHY; FARNESYLTRANSFERASE INHIBITOR; MUSCULAR-DYSTROPHY; LMNA-MUTATIONS; MOUSE MODEL; RETINOBLASTOMA PROTEIN; RESTRICTIVE DERMOPATHY	Mutations in nuclear lamins or other proteins of the nuclear envelope are the root cause of a group of phenotypically diverse genetic disorders known as laminopathies, which have symptoms that range from muscular dystrophy to neuropathy to premature aging syndromes. Although precise disease mechanisms remain unclear, there has been substantial progress in our understanding of not only laminopathies, but also the biological roles of nuclear structure. Nuclear envelope dysfunction is associated with altered nuclear activity, impaired structural dynamics, and aberrant cell signaling. Building on these findings, small molecules are being discovered that may become effective therapeutic agents.	[Schreiber, Katherine H.; Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA; [Kennedy, Brian K.] Guangdong Med Coll, Aging Res Inst, Dongguan 523808, Guangdong, Peoples R China	Buck Institute for Research on Aging; Guangdong Medical University	Kennedy, BK (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	bkennedy@buckinstitute.org		Kennedy, Brian/0000-0002-5754-1874	National Institute of Aging [R01 AG024287]; Ruth L. Kirschstein NRSA Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING [R01AG024287] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ruth L. Kirschstein NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to apologize to those scientists whose studies were not referenced due to space limitations and also acknowledge the editorial contributions of Juniper Pennypacker. Lamin-related research in the lab of B.K.K. is supported by a grant from the National Institute of Aging (R01 AG024287). K.H.S. is supported by a Ruth L. Kirschstein NRSA Postdoctoral Fellowship. B.K.K. is an Ellison Medical Foundation Senior Scholar in Aging.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Benson EK, 2010, J CELL SCI, V123, P2605, DOI 10.1242/jcs.067306; Best S, 2003, BRIT J HAEMATOL, V123, P542, DOI 10.1046/j.1365-2141.2003.04621.x; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BROERS JLV, 1993, AM J PATHOL, V143, P211; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Caux F, 2003, J CLIN ENDOCR METAB, V88, P1006, DOI 10.1210/jc.2002-021506; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Chen S.C., 2012, EXP CELL RES; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Davies BSJ, 2011, NUCLEUS-PHILA, V2, P4, DOI [10.4161/nucl.2.1.13723, 10.1093/hmg/ddq158]; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Decker ML, 2009, MECH AGEING DEV, V130, P377, DOI 10.1016/j.mad.2009.03.001; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Frock RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042918; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Hegele RA, 2006, AM J HUM GENET, V79, P383, DOI 10.1086/505885; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; HENNEKES H, 1994, J CELL SCI, V107, P1019; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; KAUFMANN SH, 1992, CANCER RES, V52, P2847; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; Kudlow BA, 2008, MOL BIOL CELL, V19, P5238, DOI 10.1091/mbc.E08-05-0492; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee R, 2010, HUM MOL GENET, V19, P1603, DOI 10.1093/hmg/ddq036; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mendez-Lopez I, 2012, CHROMOSOMA, V121, P153, DOI 10.1007/s00412-012-0360-2; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2012, HUM MOL GENET, V21, P4325, DOI 10.1093/hmg/dds265; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Parnaik VK, 2011, J BIOSCIENCES, V36, P471, DOI 10.1007/s12038-011-9085-2; Piercy RJ, 2007, NEUROMUSCULAR DISORD, V17, P297, DOI 10.1016/j.nmd.2007.01.003; Puckelwartz Megan, 2011, Handb Clin Neurol, V101, P155, DOI 10.1016/B978-0-08-045031-5.00012-8; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531; Renou L, 2008, J MED GENET, V45, P666, DOI 10.1136/jmg.2008.060020; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shalev SA, 2007, AM J MED GENET A, V143A, P1821, DOI 10.1002/ajmg.a.31803; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sun LP, 2010, CHINESE MED J-PEKING, V123, P1058, DOI 10.3760/cma.j.issn.0366-6999.2010.08.015; Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; van Engelen BGM, 2005, NEUROLOGY, V64, P374, DOI 10.1212/01.WNL.0000149763.15180.00; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vaughan OA, 2001, J CELL SCI, V114, P2577; Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172; Viteri G, 2010, MECH AGEING DEV, V131, P2, DOI 10.1016/j.mad.2009.11.006; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wu W, 2010, BBA-MOL BASIS DIS, V1802, P632, DOI 10.1016/j.bbadis.2010.04.001; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003; Yang SH, 2011, HUM MOL GENET, V20, P436, DOI 10.1093/hmg/ddq490; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238	102	253	263	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1365	1375		10.1016/j.cell.2013.02.015	http://dx.doi.org/10.1016/j.cell.2013.02.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498943	Green Accepted, Bronze			2022-12-28	WOS:000316192500016
J	Nordstrom, A; Edin, BB; Lindstrom, S; Nordstrom, P				Nordstrom, Anna; Edin, Benoni B.; Lindstroem, Sara; Nordstrom, Peter			Cognitive function and other risk factors for mild traumatic brain injury in young men: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLLABORATING-CENTER; TWINS DISCORDANT; TASK-FORCE; INTELLIGENCE; VALIDATION	Objective To investigate cognitive function and other risk factors for mild traumatic brain injury in young men. Design Nationwide prospective cohort study. Setting Sweden. Participants 305 885 men conscripted for military service from 1989 to 1994. Main outcome measure mild traumatic brain injuries in relation to cognitive function and other potential risk factors assessed at conscription and follow-up. Results Men with one mild traumatic brain injury within two years before (n=1988) or after cognitive testing (n=2214) had about 5.5% lower overall cognitive function scores than did men with no mild traumatic brain injury during follow up (P<0.001 for both). Moreover, men with at least two mild traumatic brain injuries after cognitive testing (n=795) had 15% lower overall cognitive function scores compared with those with no such injury (P<0.001). Independent strong risk factors (P<1x10(-10)) for at least one mild traumatic brain injury after cognitive testing (n=12 494 events) included low overall cognitive function, a previous mild traumatic brain injury, hospital admission for intoxications, and low education and socioeconomic status. In a sub-cohort of twin pairs in which one twin had a mild traumatic brain injury before cognitive testing (n=63), both twins had lower logical performance and technical performance compared with men in the total cohort with no mild traumatic brain injury (P<0.05 for all). Conclusion Low cognitive function, intoxications, and factors related to low socioeconomic status were strong independent risk factors for mild traumatic brain injuries in men. The low cognitive function in twin pairs discordant for mild traumatic brain injury suggests a genetic component to the low cognitive function associated with such injuries. The study included only men, so inferences to women should be made with caution.	[Nordstrom, Anna; Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden; [Edin, Benoni B.] Umea Univ, Physiol Sect, Dept Integrat Med Biol, SE-90187 Umea, Sweden; [Lindstroem, Sara] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Umea University; Umea University; Harvard University; Harvard T.H. Chan School of Public Health	Nordstrom, A (corresponding author), Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden.	anna.nordstrom@idrott.umu.se	Edin, Benoni/D-1057-2009; Edin, Benoni B/AAI-3964-2020; Nordström, Anna/F-2238-2010; Nordström, Anna/O-2504-2018	Edin, Benoni/0000-0001-9010-5612; Edin, Benoni B/0000-0001-9010-5612; Nordström, Anna/0000-0003-3534-456X; Nordström, Anna/0000-0003-3534-456X; Nordstrom, Peter/0000-0003-2924-508X	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Research Council. The researchers conducted this study totally independently of the funding body.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Ashman TA, 2006, MT SINAI J MED, V73, P999; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brinch CN, 2012, P NATL ACAD SCI USA, V109, P425, DOI 10.1073/pnas.1106077109; CARLSTEDT B, 1993, SCAND J PSYCHOL, V34, P353, DOI 10.1111/j.1467-9450.1993.tb01131.x; Carlstedt B, 2005, SCAND J PSYCHOL, V46, P31, DOI 10.1111/j.1467-9450.2005.00432.x; Carlstedt B, 2000, COGNITIVE ABILITIES; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL, V02-158; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	28	33	33	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2013	346								f723	10.1136/bmj.f723	http://dx.doi.org/10.1136/bmj.f723			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VQ	23482939	Green Submitted, hybrid			2022-12-28	WOS:000316324700012
J	Barde, I; Rauwel, B; Marin-Florez, RM; Corsinotti, A; Laurenti, E; Verp, S; Offner, S; Marquis, J; Kapopoulou, A; Vanicek, J; Trono, D				Barde, Isabelle; Rauwel, Benjamin; Marin-Florez, Ray Marcel; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Vanicek, Jiri; Trono, Didier			A KRAB/KAP1-miRNA Cascade Regulates Erythropoiesis Through Stage-Specific Control of Mitophagy	SCIENCE			English	Article							CONTRIBUTES; EXPRESSION; GENE; CELL; REPRESSION; PROTEIN-1; SEQUENCE	During hematopoiesis, lineage- and stage-specific transcription factors work in concert with chromatin modifiers to direct the differentiation of all blood cells. We explored the role of KRAB-containing zinc finger proteins (KRAB-ZFPs) and their cofactor KAP1 in this process. In mice, hematopoietic-restricted deletion of Kap1 resulted in severe hypoproliferative anemia. Kap1-deleted erythroblasts failed to induce mitophagy-associated genes and retained mitochondria. This was due to persistent expression of microRNAs (miRNAs) targeting mitophagy transcripts, itself secondary to a lack of repression by stage-specific KRAB-ZFPs. The KRAB/KAP1-miRNA regulatory cascade is evolutionarily conserved, as it also controls mitophagy during human erythropoiesis. Thus, a multilayered transcription regulatory system is present, in which protein- and RNA-based repressors are superimposed in combinatorial fashion to govern the timely triggering of an important differentiation event.	[Barde, Isabelle; Rauwel, Benjamin; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Barde, Isabelle; Rauwel, Benjamin; Corsinotti, Andrea; Laurenti, Elisa; Verp, Sonia; Offner, Sandra; Marquis, Julien; Kapopoulou, Adamandia; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, CH-1015 Lausanne, Switzerland; [Marin-Florez, Ray Marcel; Vanicek, Jiri] Ecole Polytech Fed Lausanne, Sch Basic Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Marin, Ray/C-5515-2013; Vanicek, Jiri/I-6479-2013	Marin, Ray/0000-0002-5648-0731; Vanicek, Jiri/0000-0002-2080-4378; Laurenti, Elisa/0000-0002-9917-9092	Swiss National Science Foundation; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank the staff of our core facilities for technical expertise, and P. Turelli, B. Yazdanpanah, and F. Marzetta (EPFL), P. Malik (Cincinnati Children's Hospital), and G. Ferrari (San Raffaele Telethon Institute for Gene Therapy, Milano) for the kind gift of reagents. Supported by grants from the Swiss National Science Foundation and the European Research Council (D.T.). The cDNA and miRNA microarray and ChIP-seq data are deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession number GSE44061. D.T. and I.B. are inventors on a patent application submitted by EPFL for the control of mitophagy.	BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Bojkowska K, 2012, HEPATOLOGY, V56, P1279, DOI 10.1002/hep.25767; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Lawrie CH, 2010, BRIT J HAEMATOL, V150, P144, DOI 10.1111/j.1365-2141.2009.07978.x; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Marin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032208; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	27	79	87	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					350	353		10.1126/science.1232398	http://dx.doi.org/10.1126/science.1232398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23493425	Green Accepted			2022-12-28	WOS:000317657500055
J	Jacobs, AK; Normand, SLT; Massaro, JM; Cutlip, DE; Carrozza, JP; Marks, AD; Murphy, N; Romm, IK; Biondolillo, M; Mauri, L				Jacobs, Alice K.; Normand, Sharon-Lise T.; Massaro, Joseph M.; Cutlip, Donald E.; Carrozza, Joseph P., Jr.; Marks, Anthony D.; Murphy, Nancy; Romm, Iyah K.; Biondolillo, Madeleine; Mauri, Laura		MASS COMM Investigators	Nonemergency PCI at Hospitals with or without On-Site Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; SURGICAL BACKUP; OUTCOMES; ANGIOPLASTY; TRIALS	BACKGROUND Emergency surgery has become a rare event after percutaneous coronary intervention (PCI). Whether having cardiac-surgery services available on-site is essential for ensuring the best possible outcomes during and after PCI remains uncertain. METHODS We enrolled patients with indications for nonemergency PCI who presented at hospitals in Massachusetts without on-site cardiac surgery and randomly assigned these patients, in a 3: 1 ratio, to undergo PCI at that hospital or at a partner hospital that had cardiac surgery services available. A total of 10 hospitals without on-site cardiac surgery and 7 with on-site cardiac surgery participated. The coprimary end points were the rates of major adverse cardiac events - a composite of death, myocardial infarction, repeat revascularization, or stroke - at 30 days (safety end point) and at 12 months (effectiveness end point). The primary end points were analyzed according to the intention-to-treat principle and were tested with the use of multiplicative noninferiority margins of 1.5 (for safety) and 1.3 (for effectiveness). RESULTS A total of 3691 patients were randomly assigned to undergo PCI at a hospital without on-site cardiac surgery (2774 patients) or at a hospital with on-site cardiac surgery (917 patients). The rates of major adverse cardiac events were 9.5% in hospitals without on-site cardiac surgery and 9.4% in hospitals with on-site cardiac surgery at 30 days (relative risk, 1.00; 95% one-sided upper confidence limit, 1.22; P<0.001 for noninferiority) and 17.3% and 17.8%, respectively, at 12 months (relative risk, 0.98; 95% one-sided upper confidence limit, 1.13; P<0.001 for noninferiority). The rates of death, myocardial infarction, repeat revascularization, and stroke (the components of the primary end point) did not differ significantly between the groups at either time point. CONCLUSIONS Nonemergency PCI procedures performed at hospitals in Massachusetts without on-site surgical services were noninferior to procedures performed at hospitals with on-site surgical services with respect to the 30-day and 1-year rates of clinical events. (Funded by the participating hospitals without on-site cardiac surgery; MASS COM ClinicalTrials.gov number, NCT01116882.)	[Jacobs, Alice K.] Boston Univ, Sch Med, Dept Med, Boston Med Ctr, Boston, MA 02118 USA; [Normand, Sharon-Lise T.; Cutlip, Donald E.; Mauri, Laura] Harvard Univ, Sch Med, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Massaro, Joseph M.] Boston Univ, Boston, MA 02215 USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Carrozza, Joseph P., Jr.] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Boston, MA 02111 USA; [Murphy, Nancy; Romm, Iyah K.; Biondolillo, Madeleine] Massachusetts Dept Publ Hlth, Boston, MA USA; [Mauri, Laura] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Marks, Anthony D.] South Shore Hosp, Ctr Cardiovasc, Weymouth, MA USA	Boston Medical Center; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Beth Israel Deaconess Medical Center; St. Elizabeth's Medical Center; Tufts University; Massachusetts Department of Public Health; Harvard University; Brigham & Women's Hospital	Jacobs, AK (corresponding author), Boston Med Ctr, Cardiol Sect, 88 E Newton St, Boston, MA 02118 USA.	alice.jacobs@bmc.org	mauri, laura/GPS-4868-2022	Jacobs, Alice/0000-0002-2428-2458; Massaro, Joseph/0000-0002-2682-4812; Normand, Sharon-Lise/0000-0001-7027-4769				Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P3212; Aversano T, 2012, NEW ENGL J MED, V366, P1650; Aversano T, 2012, NEW ENGL J MED, V366, P1792, DOI 10.1056/NEJMoa1114540; Bashore TM, 2012, J AM COLL CARDIOL, V59, P2221, DOI 10.1016/j.jacc.2012.02.010; COWLEY MJ, 1984, AM J CARDIOL, V53, pC22, DOI 10.1016/0002-9149(84)90740-9; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dehmer GJ, 2007, CATHETER CARDIOVASC, V69, P931; Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Frutkin AD, 2008, AM J CARDIOL, V101, P53, DOI 10.1016/j.amjcard.2007.07.047; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Hannan EL, 2009, CIRC-CARDIOVASC INTE, V2, P519, DOI 10.1161/CIRCINTERVENTIONS.109.894048; Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038; Levine, 2012, CIRCULATION, V125, pE412, DOI 10.1161/CIR.0b013e31824da922; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Massachusetts Registry of Vital Records and Statistics, VIT REC DAT; Mauri L, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.018; Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026; National Research Council Panel on Handling Missing Data in Clinical Trials, 2010, PREV TREATM MISS DAT; Pride YB, 2009, JACC-CARDIOVASC INTE, V2, P944, DOI 10.1016/j.jcin.2009.07.008; Pride YB, 2009, CIRC-CARDIOVASC QUAL, V2, P574, DOI 10.1161/CIRCOUTCOMES.108.841296; Shahian DM, 2012, NEW ENGL J MED, V366, P1814, DOI 10.1056/NEJMra1109616; Singh M, 2011, JAMA-J AM MED ASSOC, V306, P2487, DOI 10.1001/jama.2011.1790; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001	27	47	48	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1498	1508		10.1056/NEJMoa1300610	http://dx.doi.org/10.1056/NEJMoa1300610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23477625	Bronze			2022-12-28	WOS:000317603300007
J	Rechel, B; Grundy, E; Robine, JM; Cylus, J; Mackenbach, JP; Knai, C; McKee, M				Rechel, Bernd; Grundy, Emily; Robine, Jean-Marie; Cylus, Jonathan; Mackenbach, Johan P.; Knai, Cecile; McKee, Martin			Ageing in the European Union	LANCET			English	Article							LIFE-COURSE APPROACH; HEALTH-CARE; OLDER-PEOPLE; LAST YEAR; ELDERLY POPULATION; HEART-DISEASE; EXPECTANCY; COSTS; TRENDS; AGE	The ageing of European populations presents health, long-term care, and welfare systems with new challenges. Although reports of ageing as a fundamental threat to the welfare state seem exaggerated, societies have to embrace various policy options to improve the robustness of health, long-term care, and welfare systems in Europe and to help people to stay healthy and active in old age. These policy options include prevention and health promotion, better selfcare, increased coordination of care, improved management of hospital admissions and discharges, improved systems of long-term care, and new work and pension arrangements. Ageing of the health workforce is another challenge, and policies will need to be pursued that meet the particular needs of older workers (ie, those aged 50 years or older) while recruiting young practitioners.	[Rechel, Bernd; Cylus, Jonathan; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Rechel, Bernd; Knai, Cecile; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Grundy, Emily] Univ Cambridge, Cambridge, England; [Robine, Jean-Marie] French Natl Inst Hlth & Med Res INSERM, Paris, France; [Cylus, Jonathan] Univ London London Sch Econ & Polit Sci, European Observ Hlth Syst & Policies, London WC2A 2AE, England; [Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); European Observatory on Health Systems & Policies; University of London; London School Economics & Political Science; Erasmus University Rotterdam; Erasmus MC	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	bernd.rechel@lshtm.ac.uk	Grundy, Emily/AAC-3260-2019; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Robine, Jean-Marie/F-5439-2011	Grundy, Emily/0000-0002-9633-1116; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Robine, Jean-Marie/0000-0002-4111-6195; Rechel, Bernd/0000-0001-8020-3956; Cylus, Jonathan/0000-0001-8269-1578; Knai, Cecile/0000-0001-6663-7379	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	This work has been supported by the European Observatory on Health Systems and Policies.	Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; [Anonymous], 2007, TRENDS SEVERE DISABI; [Anonymous], 2006, SECURING GOOD CARE O; Attias-Donfut C., 2003, MYTH GENERATIONAL CO, P22; Beard JR, 2010, PUBLIC HEALTH REV, V32, P427, DOI 10.1007/BF03391610; Bech M, 2011, EUR J HEALTH ECON, V12, P469, DOI 10.1007/s10198-010-0260-4; Borsch-Supan A, 2005, HLTH AGEING RETIREME, P133; Breyer F, 2006, HEALTH POLICY, V75, P178, DOI 10.1016/j.healthpol.2005.03.011; Bronnum-Hansen H, 2005, EUR J PUBLIC HEALTH, V15, P20, DOI 10.1093/eurpub/cki106; Byberg L, 2009, BMJ-BRIT MED J, V338, P688; Calfo S, 2009, LAST YEAR LIFE STUDY; Casey B., 2003, POLICIES AGEING SOC; Chen KM, 2009, INT J NURS STUD, V46, P154, DOI 10.1016/j.ijnurstu.2008.09.005; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Coyte PC, 2008, CAN SITTINGS USED PR; Dale B, 2012, SCAND J CARING SCI, V26, P113, DOI 10.1111/j.1471-6712.2011.00917.x; Daviglus ML, 2005, ARCH INTERN MED, V165, P1028, DOI 10.1001/archinte.165.9.1028; Dormont B., 2009, DEPENSES SANTE AUGME; Doyle Y., 2009, BMJ-BRIT MED J, V339, P892; Doyle YG, 2012, EUR J PUBLIC HEALTH, V22, P71, DOI 10.1093/eurpub/ckq132; Dubois C-A, 2006, HUMAN RESOURCES HLTH, P15; European Commission, 2008, LONG TERM CAR EUR UN; European Commission, 2013, EUR DAT; European Commission, 2008, GREEN PAP EUR WORKF; European Commission, 2006, COMM COMM DEM FUT EU; European Commission, 2009, 2009 AG REP EC BUDG; Eurostat, 2011, ACT AG SOL GEN STAT; Fahy N, 2011, BMJ-BRIT MED J, V342, P3815; Figueras J., 2008, HLTH SYSTEMS HLTH WE; Forster A., 2009, COCHRANE DB SYST REV, V1; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Freedman VA, 2006, GERONTOLOGIST, V46, P124, DOI 10.1093/geront/46.1.124; Fries JF, 2005, AM J PREV MED, V29, P164, DOI 10.1016/j.amepre.2005.07.004; FRIES JF, 1983, MILBANK FUND Q, V61, P397, DOI 10.2307/3349864; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; Gandjour A, 2005, J HEALTH ECON, V24, P715, DOI 10.1016/j.jhealeco.2004.11.009; Gandjour A., 2008, HEALTH ECON, V18, P355; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Glei DA, 2010, INT DIFFERENCES MORT, P17; Glymour M, 2012, BMJ-BRIT MED J, V345, P10; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Hakkinen U, 2008, HEALTH ECON POLICY L, V3, P165, DOI 10.1017/S174413310800443X; Hartman M, 2008, HEALTH AFFAIR, V27, pW1, DOI 10.1377/hlthaff.27.1.w1; Hillman K, 1999, MED J AUSTRALIA, V170, P325, DOI 10.5694/j.1326-5377.1999.tb127789.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164; Jagger C, 2011, GERONTOLOGIST, V51, P250; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jagger C, 2011, INT HANDB POPUL, V2, P551, DOI 10.1007/978-90-481-9996-9_26; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Kendrick S, 2006, EUR J POPUL, V22, P281, DOI 10.1007/s10680-006-9002-9; King AC, 2010, PUBLIC HEALTH REV, V32, P401, DOI 10.1007/BF03391609; Kohler H-P, 2003, ENCY POPULATION, P405; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kuh D, 2012, PUBLIC HEALTH, V126, P193, DOI 10.1016/j.puhe.2012.01.025; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lievre A, 2007, J NUTR HEALTH AGING, V11, P508; Mackenbach JP, 2011, EUR J EPIDEMIOL, V26, P903, DOI 10.1007/s10654-011-9633-y; Majer IM, 2011, OBESITY, V19, P1451, DOI 10.1038/oby.2011.46; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; MANTON KG, 1988, J GERONTOL, V43, pS153, DOI 10.1093/geronj/43.5.S153; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Matthews RJ, 2006, SOC SCI MED, V62, P2489, DOI 10.1016/j.socscimed.2005.11.019; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; MOON L, 2003, STROKE CARE OECD COU; Mura T, 2010, EUR J NEUROL, V17, P252, DOI 10.1111/j.1468-1331.2009.02783.x; Nolte E, 2008, CARING PEOPLE CHRONI; Nusselder WJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-487; Oliveira Martins J, 2006, PROJECTING OECD HLTH; Oliveira Martins J, 2005, IMPACTS AGEING DEMAN; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Organisation for Economic Co-operation and Development, 2008, LOOM CRIS HLT WORKF; Organisation for Economic Co-operation and Development, 2011, PENS GLANC; Organisation for Economic Co-operation and Development, 2010, LAB FORC STAT OECD M; Oxley H., 2009, POLICIES HLTH AGEING; Parker M, 2005, J GERONTOL A-BIOL, V60, P933; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; PRESTON SH, 1989, DEMOGRAPHY, V26, P691, DOI 10.2307/2061266; Rathmann W, 2005, GESUNDHEITSWESEN, V67, pS110, DOI 10.1055/s-2005-858227; Rechel B., 2009, INVESTING HOSP FUTUR; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rechel B, 2013, LANCET; Ritsatakis A., 2008, DEMYSTIFYING MYTHS A; Robine JM, 2009, QUAL AGEING OLDER AD, V10, P5, DOI 10.1108/14717794200900012; ROBINE JM, 1992, B WORLD HEALTH ORGAN, V70, P791; Saltman RB, 1997, EUROPEAN HLTH CARE R; Schelleman H, 2004, J HUM HYPERTENS, V18, P317, DOI 10.1038/sj.jhh.1001672; Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sihvonen AP, 1998, SOC SCI MED, V47, P303, DOI 10.1016/S0277-9536(98)00020-3; Steinberg BA, 2008, AM HEART J, V156, P719, DOI 10.1016/j.ahj.2008.05.020; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Suhrcke M, 2006, BRIT MED J, V333, P1017, DOI 10.1136/bmj.38951.614144.68; The Economist, 2009, HEALTHC STRAT AG SOC; Trippel M, 2011, TRULY IMPOSSIBLE EQU; UN, REPL MIGR IS SOL DEC; van Baal PH, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-51; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van Gool CH, 2011, INT J EPIDEMIOL, V40, P1056, DOI 10.1093/ije/dyr009; Vass M, 2007, Z GERONTOL GERIATR, V40, P209, DOI 10.1007/s00391-007-0470-2; Vickerstaff S., 2011, WORK HLTH WELLBEING; Werblow A, 2007, HEALTH ECON, V16, P1109, DOI 10.1002/hec.1213; Winblad K, 2001, J CLIN EPIDEMIOL, V54, P1019; Wiskow C., 2010, CREATE ATTRACTIVE SU	109	370	373	12	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1312	1322		10.1016/S0140-6736(12)62087-X	http://dx.doi.org/10.1016/S0140-6736(12)62087-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23541057				2022-12-28	WOS:000317351000034
J	Keestra, AM; Winter, MG; Auburger, JJ; Frassle, SP; Xavier, MN; Winter, SE; Kim, A; Poon, V; Ravesloot, MM; Waldenmaier, JFT; Tsolis, RM; Eigenheer, RA; Baumler, AJ				Keestra, A. Marijke; Winter, Maria G.; Auburger, Josef J.; Fraessle, Simon P.; Xavier, Mariana N.; Winter, Sebastian E.; Kim, Anita; Poon, Victor; Ravesloot, Marietta M.; Waldenmaier, Julian F. T.; Tsolis, Renee M.; Eigenheer, Richard A.; Bauemler, Andreas J.			Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1	NATURE			English	Article							NF-KAPPA-B; SEROVAR TYPHIMURIUM COLITIS; SALMONELLA-TYPHIMURIUM; CHEMOKINE EXPRESSION; NUCLEAR RESPONSES; SIGNALING PATHWAY; EPITHELIAL-CELLS; HOST-CELLS; ACTIVATION; MODEL	Our innate immune system distinguishes microbes from self by detecting conserved pathogen-associated molecular patterns(1). However, these are produced by all microbes, regardless of their pathogenic potential. To distinguish virulent microbes from those with lower disease-causing potential the innate immune system detects conserved pathogen-induced processes(2), such as the presence of microbial products in the host cytosol, by mechanisms that are not fully resolved. Here we show that NOD1 senses cytosolic microbial products by monitoring the activation state of small Rho GTPases. Activation of RAC1 and CDC42 by bacterial delivery or ectopic expression of SopE, a virulence factor of the enteric pathogen Salmonella, triggered the NOD1 signalling pathway, with consequent RIP2 (also known as RIPK2)-mediated induction of NF-kappa B-dependent inflammatory responses. Similarly, activation of the NOD1 signalling pathway by peptidoglycan required RAC1 activity. Furthermore, constitutively active forms of RAC1, CDC42 and RHOA activated the NOD1 signalling pathway. Our data identify the activation of small Rho GTPases as a pathogen-induced process sensed through the NOD1 signalling pathway.	[Keestra, A. Marijke; Winter, Maria G.; Auburger, Josef J.; Fraessle, Simon P.; Xavier, Mariana N.; Winter, Sebastian E.; Kim, Anita; Poon, Victor; Ravesloot, Marietta M.; Waldenmaier, Julian F. T.; Tsolis, Renee M.; Bauemler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Eigenheer, Richard A.] Univ Calif Davis, UC Davis Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Winter, Sebastian E/A-4118-2009; Byndloss, Mariana Xavier/ABD-5506-2021; Baumler, Andreas J/H-2301-2011; Keestra-Gounder, A. Marijke/H-4394-2012; Byndloss, Mariana X/D-9890-2014	Winter, Sebastian E/0000-0003-1532-9178; Byndloss, Mariana Xavier/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Keestra-Gounder, A. Marijke/0000-0002-2231-652X; Byndloss, Mariana X/0000-0002-2122-4156; Tsolis, Renee/0000-0001-9131-6657	Public Health Service Grants [AI044170, AI076246]; American Heart Association [12SDG12220022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076246, R01AI044170] Funding Source: NIH RePORTER	Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S.-P. Nuccio for providing PCR primers for the construction of the bacterial strains. This work was supported by Public Health Service Grants AI044170 and AI076246. A. M. K. is supported by the American Heart Association Grant 12SDG12220022.	Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Figueiredo JF, 2009, MICROBES INFECT, V11, P302, DOI 10.1016/j.micinf.2008.12.005; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hobbie S, 1997, J IMMUNOL, V159, P5550; Inohara N, 2000, J BIOL CHEM, V275, P27823; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAWES M, 1995, J BACTERIOL, V177, P1383, DOI 10.1128/jb.177.5.1383-1387.1995; Le Bourhis L, 2009, INFECT IMMUN, V77, P4480, DOI 10.1128/IAI.00519-09; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Muller AJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000795; Sambrook J., 2002, MOL CLONING LAB MANU; Schlumberger MC, 2003, J BIOL CHEM, V278, P27149, DOI 10.1074/jbc.M302475200; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wong KW, 2008, J BIOL CHEM, V283, P35954, DOI 10.1074/jbc.M804717200; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	33	169	178	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					233	+		10.1038/nature12025	http://dx.doi.org/10.1038/nature12025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23542589	Green Submitted, Green Accepted			2022-12-28	WOS:000317346300044
J	Smith, RDL; Prevot, MS; Fagan, RD; Zhang, ZP; Sedach, PA; Siu, MKJ; Trudel, S; Berlinguette, CP				Smith, Rodney D. L.; Prevot, Mathieu S.; Fagan, Randal D.; Zhang, Zhipan; Sedach, Pavel A.; Siu, Man Kit Jack; Trudel, Simon; Berlinguette, Curtis P.			Photochemical Route for Accessing Amorphous Metal Oxide Materials for Water Oxidation Catalysis	SCIENCE			English	Article							OXYGEN-EVOLVING CATALYST; THERMAL-DECOMPOSITION; COBALT-PHOSPHATE; THIN-FILMS; EVOLUTION; CO3O4; HEMATITE	Large-scale electrolysis of water for hydrogen generation requires better catalysts to lower the kinetic barriers associated with the oxygen evolution reaction (OER). Although most OER catalysts are based on crystalline mixed-metal oxides, high activities can also be achieved with amorphous phases. Methods for producing amorphous materials, however, are not typically amenable to mixed-metal compositions. We demonstrate that a low-temperature process, photochemical metal-organic deposition, can produce amorphous (mixed) metal oxide films for OER catalysis. The films contain a homogeneous distribution of metals with compositions that can be accurately controlled. The catalytic properties of amorphous iron oxide prepared with this technique are superior to those of hematite, whereas the catalytic properties of a-Fe100-y-zCoyNizOx are comparable to those of noble metal oxide catalysts currently used in commercial electrolyzers.	[Trudel, Simon] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; Univ Calgary, Ctr Adv Solar Mat, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Trudel, S (corresponding author), Univ Calgary, Dept Chem, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	trudels@ucalgary.ca; cberling@ucalgary.ca	Prévot, Mathieu S/E-1473-2014; Trudel, Simon/B-5367-2008; Smith, Rodney/K-6870-2016	Prévot, Mathieu S/0000-0003-4367-5502; Trudel, Simon/0000-0001-5757-2219; Smith, Rodney/0000-0003-1209-9653	Natural Sciences and Engineering Research Council of Canada; Mitacs; FireWater Fuel Corp.; Canada Research Chairs; Alfred P. Sloan Foundation; University of Calgary; Canadian Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mitacs; FireWater Fuel Corp.; Canada Research Chairs(Canada Research ChairsCGIAR); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of Calgary; Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Natural Sciences and Engineering Research Council of Canada, Mitacs, and FireWater Fuel Corp. for financial support. C. P. B. also thanks Canada Research Chairs and the Alfred P. Sloan Foundation for support. This research used facilities funded by the University of Calgary and the Canadian Foundation for Innovation. We thank R. Marr for running XRD experiments. S. T. and C. P. B. proposed the concept, designed the experiments, and supervised the project. R. D. L. S. and M. S. P. carried out electrochemical, structural, and optical characterization. Z.Z., P. A. S., and M.K.J.S. conducted preliminary experiments. R. D. F. carried out microscopy experiments. The authors declare competing financial interests: intellectual property pertaining to the technology described in this Report is protected by patent application PCT/CA2012/050609.	Avey AA, 1996, J AM CHEM SOC, V118, P237, DOI 10.1021/ja952937j; Blakemore JD, 2011, CHEM SCI, V2, P94, DOI 10.1039/c0sc00418a; BOCKRIS JO, 1983, J PHYS CHEM-US, V87, P2960, DOI 10.1021/j100238a048; Cook TR, 2010, CHEM REV, V110, P6474, DOI 10.1021/cr100246c; Dinca M, 2010, P NATL ACAD SCI USA, V107, P10337, DOI 10.1073/pnas.1001859107; Esswein AJ, 2011, ENERG ENVIRON SCI, V4, P499, DOI 10.1039/c0ee00518e; GALIZZIOLI D, 1974, J APPL ELECTROCHEM, V4, P57, DOI 10.1007/BF00615906; Gu F, 2007, J CRYST GROWTH, V304, P369, DOI 10.1016/j.jcrysgro.2007.03.040; Hamdani M, 2010, INT J ELECTROCHEM SC, V5, P556; HORKANS J, 1977, J ELECTROCHEM SOC, V124, P1202, DOI 10.1149/1.2133528; IWAKURA C, 1981, ELECTROCHIM ACTA, V26, P1319, DOI 10.1016/0013-4686(81)85116-X; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Klahr B, 2012, J AM CHEM SOC, V134, P16693, DOI 10.1021/ja306427f; Marshall AT, 2010, ELECTROCHIM ACTA, V55, P1978, DOI 10.1016/j.electacta.2009.11.018; MARUSAK LA, 1980, J PHYS CHEM SOLIDS, V41, P981, DOI 10.1016/0022-3697(80)90105-5; NEWMAN R, 1959, PHYS REV, V114, P1507, DOI 10.1103/PhysRev.114.1507; Ouattara L, 2009, J APPL ELECTROCHEM, V39, P1361, DOI 10.1007/s10800-009-9809-2; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Surendranath Y, 2010, J AM CHEM SOC, V132, P16501, DOI 10.1021/ja106102b; Thota S, 2009, MATER SCI ENG B-ADV, V164, P30, DOI 10.1016/j.mseb.2009.06.002; Trudel S, 2006, J PHOTOPOLYM SCI TEC, V19, P467, DOI 10.2494/photopolymer.19.467; Trudel S, 2011, J SOLID STATE CHEM, V184, P1025, DOI 10.1016/j.jssc.2011.03.015; Tsuji E, 2011, ELECTROCHIM ACTA, V56, P2009, DOI 10.1016/j.electacta.2010.11.062; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Zaharieva I, 2012, ENERG ENVIRON SCI, V5, P7081, DOI 10.1039/c2ee21191b; Zhong DK, 2011, J AM CHEM SOC, V133, P18370, DOI 10.1021/ja207348x; Zhong DK, 2010, J AM CHEM SOC, V132, P4202, DOI 10.1021/ja908730h	27	1139	1153	47	1943	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					60	63		10.1126/science.1233638	http://dx.doi.org/10.1126/science.1233638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23539180				2022-12-28	WOS:000317061100043
J	Pryor, EE; Horanyi, PS; Clark, KM; Fedoriw, N; Connelly, SM; Koszelak-Rosenblum, M; Zhu, GY; Malkowski, MG; Wiener, MC; Dumont, ME				Pryor, Edward E., Jr.; Horanyi, Peter S.; Clark, Kathleen M.; Fedoriw, Nadia; Connelly, Sara M.; Koszelak-Rosenblum, Mary; Zhu, Guangyu; Malkowski, Michael G.; Wiener, Michael C.; Dumont, Mark E.			Structure of the Integral Membrane Protein CAAX Protease Ste24p	SCIENCE			English	Article							A-FACTOR; SACCHAROMYCES-CEREVISIAE; INHIBITORS BLOCK; THERMOLYSIN; PROTEOLYSIS; MECHANISM; ZMPSTE24; FAMILY; STEP; RAS	Posttranslational lipidation provides critical modulation of the functions of some proteins. Isoprenoids (i.e., farnesyl or geranylgeranyl groups) are attached to cysteine residues in proteins containing C-terminal CAAX sequence motifs (where A is an aliphatic residue and X is any residue). Isoprenylation is followed by cleavage of the AAX amino acid residues and, in some cases, by additional proteolytic cuts. We determined the crystal structure of the CAAX protease Ste24p, a zinc metalloprotease catalyzing two proteolytic steps in the maturation of yeast mating pheromone a-factor. The Ste24p core structure is a ring of seven transmembrane helices enclosing a voluminous cavity containing the active site and substrate-binding groove. The cavity is accessible to the external milieu by means of gaps between splayed transmembrane helices. We hypothesize that cleavage proceeds by means of a processive mechanism of substrate insertion, translocation, and ejection.	[Pryor, Edward E., Jr.; Horanyi, Peter S.; Wiener, Michael C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Clark, Kathleen M.; Fedoriw, Nadia; Connelly, Sara M.; Wiener, Michael C.; Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Koszelak-Rosenblum, Mary; Zhu, Guangyu; Malkowski, Michael G.] Hauptman Woodward Inst, Buffalo, NY 14203 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Virginia; University of Rochester; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester	Wiener, MC (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.	mwiener@virginia.edu; mark_dumont@urmc.rochester.edu	Zhu, Guangyu/F-6279-2011	Zhu, Guangyu/0000-0003-4228-135X; Pryor, Edward/0000-0001-8328-9126; Malkowski, Michael/0000-0002-1203-7463	Protein Structure Initiative: Biology grant [U54 GM094611]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	Protein Structure Initiative: Biology grant; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Author contributions (authorship of relevant supplementary materials: Materials and Methods sections denoted by *): target selection and yeast homology screening (M.E.D.*); cloning (S. M. C); expression, solubilization, purification, and functional characterization with accompanying fig. S3 (K.M.C.*, N.F.*, M.E.D.*); preliminary crystallization and diffraction screening (M.K.-R., G.Z., M.G.M.*); SmSte24p crystallization (E.E.P.*), SmSte24p crystallography (E.E.P.*, P.S.H.*, M. C. W.). M. C. W. conceptualized and wrote the main paper, with the following exceptions: introduction (M. E. D.), figures and captions (E. E. P, P. S. H., M. C. W.). All authors critically read the manuscript before submission. In particular, M. E. D. contributed substantially to the editing, revision, and improvement of the manuscript. This work was supported by Protein Structure Initiative: Biology grant U54 GM094611 (NIH) for membrane protein structural genomics. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. We thank P. Loll, R. Nakamoto, and J. Zimmer for useful discussion. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession number 4IL3. Vectors and clones are available from the NIH Protein Structure Initiative Materials Repository, under a Materials Transfer Agreement. The authors declare no competing financial interests.	Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Golde Todd E, 2003, Sci STKE, V2003, pRE4, DOI 10.1126/stke.2003.172.re4; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Huyer G, 2006, EUKARYOT CELL, V5, P1560, DOI 10.1128/EC.00161-06; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P41, DOI 10.1038/newbio238041a0; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999	34	64	65	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1600	+		10.1126/science.1232048	http://dx.doi.org/10.1126/science.1232048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539602	Green Accepted			2022-12-28	WOS:000316731600047
J	Holmes, DL; Lancaster, AK; Lindquist, S; Halfmann, R				Holmes, Daniel L.; Lancaster, Alex K.; Lindquist, Susan; Halfmann, Randal			Heritable Remodeling of Yeast Multicellularity by an Environmentally Responsive Prion	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDOHYPHAL GROWTH; DRUG-RESISTANCE; GENE-EXPRESSION; TRANSCRIPTION; EVOLUTION; PROTEIN; HSP104; PSI+; FLOCCULATION	Prion proteins undergo self-sustaining conformational conversions that heritably alter their activities. Many of these proteins operate at pivotal positions in determining how genotype is translated into phenotype. But the breadth of prion influences on biology and their evolutionary significance are just beginning to be explored. We report that a prion formed by the Mot3 transcription factor, [MOT3(+)], governs the acquisition of facultative multicellularity in the budding yeast Saccharomyces cerevisiae. The traits governed by [MOT3(+)] involved both gains and losses of Mot3 regulatory activity. [MOT3(+)]-dependent expression of FLO11, a major determinant of cell-cell adhesion, produced diverse lineage-specific multicellular phenotypes in response to nutrient deprivation. The prions themselves were induced by ethanol and eliminated by hypoxia-conditions that occur sequentially in the natural respiro-fermentative cycles of yeast populations. These data demonstrate that prions can act as environmentally responsive molecular determinants of multicellularity and contribute to the natural morphological diversity of budding yeast.	[Holmes, Daniel L.; Halfmann, Randal] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Halfmann, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	randal.halfmann@utsouthwestern.edu	Lancaster, Alexander K/K-2855-2013	Lancaster, Alexander K/0000-0002-0002-9263; Holmes, Daniel/0000-0002-0489-4043; Halfmann, Randal/0000-0002-6592-1471	NIH Director's Early Independence Award Program [DP5-OD009152-01]; Sara and Frank McKnight Fellowship; G. Harold and Leila Y. Mathers Foundation; HHMI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	NIH Director's Early Independence Award Program; Sara and Frank McKnight Fellowship; G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by the NIH Director's Early Independence Award Program, grant number DP5-OD009152-01 (to R.H.) and by the Sara and Frank McKnight Fellowship (R.H.). S.L. is a Howard Hughes Medical Institute (HHMI) investigator. This work was supported by grants from the G. Harold and Leila Y. Mathers Foundation and HHMI (to S.L.). We thank Cintia Hongay for fruitful early discussions about Mot3, Oliver King for assistance with the prion prediction algorithm, and Sunil Laxman and members of the S.L. lab for critical reading of the manuscript. We thank Gerry Fink and Fred Winston for yeast strains Sigma 1278b and FY2609, respectively, and Mikko Taipale for unpublished plasmids.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barrales RR, 2012, GENETICS, V191, P791, DOI 10.1534/genetics.112.140301; Bauer F. F., 2000, South African Journal of Enology and Viticulture, V21, P27; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Casalone E, 2005, RES MICROBIOL, V156, P191, DOI 10.1016/j.resmic.2004.09.008; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INGLEDEW WM, 1987, AM J ENOL VITICULT, V38, P246; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Koschwanez JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001122; Kryndushkin DS, 2011, GENETICS, V188, P339, DOI 10.1534/genetics.111.127779; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Kuthan M, 2003, MOL MICROBIOL, V47, P745, DOI 10.1046/j.1365-2958.2003.03332.x; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu HP, 1996, GENETICS, V144, P967; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; OUGH CS, 1974, AM J ENOL VITICULT, V25, P7; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Ratcliff WC, 2012, P NATL ACAD SCI USA, V109, P1595, DOI 10.1073/pnas.1115323109; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sertil O, 2003, NUCLEIC ACIDS RES, V31, P5831, DOI 10.1093/nar/gkg792; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Turkel S, 1999, FOLIA MICROBIOL, V44, P372, DOI 10.1007/BF02903707; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vachova L, 2011, J CELL BIOL, V194, P679, DOI 10.1083/jcb.201103129; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WRIGHT RM, 1993, CURR GENET, V23, P388, DOI 10.1007/BF00312623; Zupan J, 2010, YEAST, V27, P217, DOI 10.1002/yea.1746	72	127	131	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					153	165		10.1016/j.cell.2013.02.026	http://dx.doi.org/10.1016/j.cell.2013.02.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540696	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000316853700013
J	Zuckerman, B; Margolis, PA; Mate, KS				Zuckerman, Barry; Margolis, Peter A.; Mate, Kedar S.			Health Services Innovation The Time Is Now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMS		[Zuckerman, Barry] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA; [Margolis, Peter A.] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH USA; [Mate, Kedar S.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Mate, Kedar S.] Weill Cornell Med Coll, Inst Healthcare Improvement, New York, NY USA	Boston Medical Center; Boston University; Cincinnati Children's Hospital Medical Center; Cornell University; Cornell University	Zuckerman, B (corresponding author), 771 Albany St,Dowling 3rd Floor, Boston, MA 02118 USA.	barry.zuckerman@bmc.org		Mate, Kedar/0000-0001-7579-6697; Zuckerman, Barry/0000-0002-0044-2592	NIDDK NIH HHS [R01DK085719] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085719] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergman DA, 2011, ACAD PEDIATR, V11, P360, DOI 10.1016/j.acap.2011.06.004; Brook RH, 2013, J GEN INTERN MED, V28, P172, DOI 10.1007/s11606-012-2242-y; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Esserman LJ, 2011, JAMA-J AM MED ASSOC, V306, P2608, DOI 10.1001/jama.2011.1837; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Shojania KG, 2009, JAMA-J AM MED ASSOC, V301, P766, DOI 10.1001/jama.2009.140	7	25	25	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1113	1114		10.1001/jama.2013.2007	http://dx.doi.org/10.1001/jama.2013.2007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512055				2022-12-28	WOS:000316276500020
J	Weintraub, K				Weintraub, Karen			The new gold standard	NATURE			English	Editorial Material							PHOTOTHERMAL THERAPY; DELIVERY; SIRNA											Gad SC, 2012, INT J TOXICOL, V31, P584, DOI 10.1177/1091581812465969; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w; Jun YW, 2009, P NATL ACAD SCI USA, V106, P17735, DOI 10.1073/pnas.0907367106; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Zhang K, 2012, J AM CHEM SOC, V134, P16488, DOI 10.1021/ja306854d; Zheng D, 2012, P NATL ACAD SCI USA, V109, P11975, DOI 10.1073/pnas.1118425109	8	62	100	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					S14	S16		10.1038/495S14a	http://dx.doi.org/10.1038/495S14a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486097	Bronze			2022-12-28	WOS:000316652300032
J	Lee, Y; Rubio, MC; Alassimone, J; Geldner, N				Lee, Yuree; Rubio, Maria C.; Alassimone, Julien; Geldner, Niko			A Mechanism for Localized Lignin Deposition in the Endodermis	CELL			English	Article							CELL-WALL; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; EXTRACELLULAR-MATRIX; CROSS-LINKING; ARABIDOPSIS; ROS; EXPRESSION; PROTEIN; GROWTH	The precise localization of extracellular matrix and cell wall components is of critical importance for multicellular organisms. Lignin is a major cell wall modification that often forms intricate subcellular patterns that are central to cellular function. Yet the mechanisms of lignin polymerization and the subcellular precision of its formation remain enigmatic. Here, we show that the Casparian strip, a lignin-based, paracellular diffusion barrier in plants, forms as a precise, median ring by the concerted action of a specific, localized NADPH oxidase, brought into proximity of localized peroxidases through the action of Casparian strip domain proteins (CASPs). Our findings in Arabidopsis provide a simple mechanistic model of how plant cells regulate lignin formation with subcellular precision. We speculate that scaffolding of NADPH oxidases to the downstream targets of the reactive oxygen species (ROS) that they produce might be a widespread mechanism to ensure specificity and subcellular precision of ROS action within the extracellular matrix.	[Lee, Yuree; Rubio, Maria C.; Alassimone, Julien; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, UNIL Sorge, CH-1015 Lausanne, Switzerland; [Rubio, Maria C.] CSIC, Dept Nutr Vegetal, Estn Expt Aula Dei, Zaragoza 50080, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Geldner, N (corresponding author), Univ Lausanne, Dept Plant Mol Biol, UNIL Sorge, Biophore Bldg, CH-1015 Lausanne, Switzerland.	niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019; Rubio, Maria Carmen/L-6350-2014; Rubio-Gámez, M Carmen/U-8822-2019	Rubio, Maria Carmen/0000-0002-9378-7775; Rubio-Gámez, M Carmen/0000-0002-1874-5129; Alassimone, Julien/0000-0002-8118-2605; Lee, Yuree/0000-0002-4663-6974; Geldner, Niko/0000-0002-2300-9644	European Research Council; Swiss National Science Foundation; European Molecular Biology Organization long-term fellowship	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO))	We wish to thank M.A. Torres for providing mutant lines and P.N. Benfey for providing microarray data for analysis. We thank E.M.N. Dohmann, E.E. Farmer, S. Naseer, D.E. Salt, and J.E.M. Vermeer for critically reading the manuscript. This work was funded by a European Research Council Young Investigator grant and grants from the Swiss National Science Foundation to N.G. and a European Molecular Biology Organization long-term fellowship to Y.L. Electron microscopy and confocal microscopy were done using expertise and equipment of the Electron Microscopy Facility (EMF) and the Cellular Imaging Facility (CIF) at the University of Lausanne.	Alassimone J, 2010, P NATL ACAD SCI USA, V107, P5214, DOI 10.1073/pnas.0910772107; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Barcelo AR, 1998, PLANTA, V207, P207, DOI 10.1007/s004250050474; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Fagerstedt KV, 2010, J INTEGR PLANT BIOL, V52, P186, DOI 10.1111/j.1744-7909.2010.00928.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jiang CF, 2012, EMBO J, V31, P4359, DOI 10.1038/emboj.2012.273; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; Karlsson M, 2005, J EXP BOT, V56, P2085, DOI 10.1093/jxb/eri207; Karpinska B, 2001, PLANT PHYSIOL, V126, P1668, DOI 10.1104/pp.126.4.1668; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Martiniere A, 2011, PLANT J, V66, P354, DOI 10.1111/j.1365-313X.2011.04497.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Moller IM, 2010, TRENDS PLANT SCI, V15, P370, DOI 10.1016/j.tplants.2010.04.008; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Oda Y, 2012, CURR OPIN PLANT BIOL, V15, P38, DOI 10.1016/j.pbi.2011.10.005; Pesquet E, 2010, CURR BIOL, V20, P744, DOI 10.1016/j.cub.2010.02.057; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Vanholme R, 2010, TRENDS BIOTECHNOL, V28, P543, DOI 10.1016/j.tibtech.2010.07.008	42	317	328	3	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					402	412		10.1016/j.cell.2013.02.045	http://dx.doi.org/10.1016/j.cell.2013.02.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23541512	Bronze, Green Submitted			2022-12-28	WOS:000317349700018
J	Antonyuk, SV; Han, C; Eady, RR; Hasnain, SS				Antonyuk, Svetlana V.; Han, Cong; Eady, Robert R.; Hasnain, S. Samar			Structures of protein-protein complexes involved in electron transfer	NATURE			English	Article							ATOMIC-RESOLUTION STRUCTURES; COPPER NITRITE REDUCTASE; ACTIVE-SITE; BINDING	Electron transfer reactions are essential for life because they underpin oxidative phosphorylation and photosynthesis, processes leading to the generation of ATP, and are involved in many reactions of intermediary metabolism(1). Key to these roles is the formation of transient inter-protein electron transfer complexes. The structural basis for the control of specificity between partner proteins is lacking because these weak transient complexes have remained largely intractable for crystallographic studies(2,3). Inter-protein electron transfer processes are central to all of the key steps of denitrification, an alternative form of respiration in which bacteria reduce nitrate or nitrite to N-2 through the gaseous intermediates nitric oxide (NO) and nitrous oxide (N2O) when oxygen concentrations are limiting. The one-electron reduction of nitrite to NO, a precursor to N2O, is performed by either a haem-or copper-containing nitrite reductase (CuNiR) where they receive an electron from redox partner proteins a cupredoxin or a c-type cytochrome(4,5). Here we report the structures of the newly characterized three-domain haem-c-Cu nitrite reductase from Ralstonia pickettii (RpNiR) at 1.01 angstrom resolution and its M92A and P93A mutants. Very high resolution provides the first view of the atomic detail of the interface between the core trimeric cupredoxin structure of CuNiR and the tethered cytochrome c domain that allows the enzyme to function as an effective self-electron transfer system where the donor and acceptor proteins are fused together by genomic acquisition for functional advantage. Comparison of RpNiR with the binary complex of a CuNiR with a donor protein, AxNiR-cytc551 (ref. 6), and mutagenesis studies provide direct evidence for the importance of a hydrogen-bonded water at the interface in electron transfer. The structure also provides an explanation for the preferential binding of nitrite to the reduced copper ion at the active site in RpNiR, in contrast to other CuNiRs where reductive inactivation occurs, preventing substrate binding.	[Antonyuk, Svetlana V.; Han, Cong; Eady, Robert R.; Hasnain, S. Samar] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZX, Merseyside, England	University of Liverpool	Hasnain, SS (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZX, Merseyside, England.	antonyuk@liverpool.ac.uk; s.s.hasnain@liverpool.ac.uk	Antonyuk, Svetlana/W-5159-2019; Antonyuk, Svetlana V/B-6002-2013	Antonyuk, Svetlana/0000-0002-2779-9946; 	Biotechnology and Biological Sciences Research Council, UK [BB/G005869/1]; Wellcome Trust [097826/Z/11/Z]; BBSRC [BB/G005869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G005869/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (grant number BB/G005869/1 (to S. S. H. & R. R. E.)). S. V. A. acknowledges the support from the Wellcome Trust (grant number 097826/Z/11/Z). We thank the staff and management of SOLEIL and Diamond for the provision of crystallographic facilities at their synchrotron centres. We thank the members of the molecular biophysics groups, particularly R. Strange and G. Wright, for their help.	Antonyuk SV, 2005, P NATL ACAD SCI USA, V102, P12041, DOI 10.1073/pnas.0504207102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Boulanger MJ, 2000, J BIOL CHEM, V275, P23957, DOI 10.1074/jbc.M001859200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de la Lande A, 2010, P NATL ACAD SCI USA, V107, P11799, DOI 10.1073/pnas.0914457107; Eady R. R., 2004, COMPR COORD CHEM 2, V8, P759; Ellis MJ, 2007, J BIOL INORG CHEM, V12, P1119, DOI 10.1007/s00775-007-0282-2; Ellis MJ, 2003, J MOL BIOL, V328, P429, DOI 10.1016/S0022-2836(03)00308-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; Han C, 2012, BIOCHEM J, V444, P219, DOI 10.1042/BJ20111623; Hough MA, 2008, BIOCHEMISTRY-US, V47, P13547, DOI 10.1021/bi801369y; JENG MF, 1994, NAT STRUCT BIOL, V1, P234, DOI 10.1038/nsb0494-234; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Merkle AC, 2012, DALTON T, V41, P3355, DOI 10.1039/c1dt11049g; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nojiri M, 2007, P NATL ACAD SCI USA, V104, P4315, DOI 10.1073/pnas.0609195104; Nojiri M, 2009, NATURE, V462, P117, DOI 10.1038/nature08507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Strange RW, 1999, J MOL BIOL, V287, P1001, DOI 10.1006/jmbi.1999.2648; STRANGE RW, 1995, NAT STRUCT BIOL, V2, P287, DOI 10.1038/nsb0495-287; Tocheva EI, 2004, SCIENCE, V304, P867, DOI 10.1126/science.1095109; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wijma HJ, 2007, J AM CHEM SOC, V129, P8557, DOI 10.1021/ja071274q; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; Yamaguchi K, 2004, BIOCHEMISTRY-US, V43, P14180, DOI 10.1021/bi0492657; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	31	55	56	1	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					123	127		10.1038/nature11996	http://dx.doi.org/10.1038/nature11996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535590	Green Accepted			2022-12-28	WOS:000316993400038
J	Marmot, M				Marmot, Michael			The art of medicine Europe: good, bad, and beautiful	LANCET			English	Editorial Material									[Marmot, Michael] UCL, UCL Inst Hlth Equ, London WC1E 7HB, England; [Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London; University of London; University College London	Marmot, M (corresponding author), UCL, UCL Inst Hlth Equ, London WC1E 7HB, England.		Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G1000616] Funding Source: researchfish; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G0100222, G0902037, G19/35] Funding Source: Medline; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G1000616, G0902037] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Applebaum Anne, 2012, IRON CURTAIN CRUSHIN, P358; Commission on Social Determinants of Health, 2008, CLOSING THE GAP IN A; Menand Louis, 2012, NEW YORKER	3	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1090	1091		10.1016/S0140-6736(13)60749-7	http://dx.doi.org/10.1016/S0140-6736(13)60749-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23547298				2022-12-28	WOS:000317348900015
J	Recupero, DR				Recupero, Diego Reforgiato			Toward a Green Internet	SCIENCE			English	Editorial Material									Univ Catania, Dept Elect Elect & Comp Engn, I-95125 Catania, Italy	University of Catania	Recupero, DR (corresponding author), Univ Catania, Dept Elect Elect & Comp Engn, I-95125 Catania, Italy.	diegoref@dieei.unict.it		Reforgiato Recupero, Diego/0000-0001-8646-6183				Belady C., 2007, ELECT COOL, V13, P1; Bianco C, 2007, INT TELECOM ENERGY, P737, DOI 10.1109/INTLEC.2007.4448879; Bianzino AP, 2012, COMPUT NETW, V56, P3219, DOI 10.1016/j.comnet.2012.06.011; Bolla R, 2011, IEEE COMMUN SURV TUT, V13, P223, DOI 10.1109/SURV.2011.071410.00073; Govindan S, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P341, DOI 10.1145/2024723.2000105; Lombardo A., 2012, C SUST INT ICT SUST, P1; Nedevschi S, 2008, P 5 USENIX S NETW SY, P323; Panarello C., 2012, GLOBECOM, P3086; Vasan A., 2010, HIGH PERF COMP ARCH, P1, DOI DOI 10.1109/HPCA.2010.5463056	9	5	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1533	1534		10.1126/science.1235623	http://dx.doi.org/10.1126/science.1235623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539588				2022-12-28	WOS:000316731600030
J	Lurie, N; Manolio, T; Patterson, AP; Collins, F; Frieden, T				Lurie, Nicole; Manolio, Teri; Patterson, Amy P.; Collins, Francis; Frieden, Thomas			Research as a Part of Public Health Emergency Response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lurie, Nicole] Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA; [Manolio, Teri; Patterson, Amy P.; Collins, Francis] NIH, Bethesda, MD 20892 USA; [Frieden, Thomas] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Lurie, N (corresponding author), Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA.			Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 2011, PROGR ROADM IMM ACT; [Anonymous], 2012, 3318 SECR INT; National Biodefense Science Board, 2011, CALL ACT INCL SCI IN; National Institutes of Health, COMM BAS PART RES	4	136	137	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1251	1255		10.1056/NEJMsb1209510	http://dx.doi.org/10.1056/NEJMsb1209510			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23534565	Bronze			2022-12-28	WOS:000316869000017
J	Satoh, T; Kidoya, H; Naito, H; Yamamoto, M; Takemura, N; Nakagawa, K; Yoshioka, Y; Morii, E; Takakura, N; Takeuchi, O; Akira, S				Satoh, Takashi; Kidoya, Hiroyasu; Naito, Hisamichi; Yamamoto, Masahiro; Takemura, Naoki; Nakagawa, Katsuhiro; Yoshioka, Yoshichika; Morii, Eiichi; Takakura, Nobuyuki; Takeuchi, Osamu; Akira, Shizuo			Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages	NATURE			English	Article							TRIBBLES HOMOLOG; ALTERNATIVE ACTIVATION; MYELOID LEUKEMOGENESIS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATION; OBESITY; POLARIZATION; ASSOCIATION	Macrophages consist of at least two subgroups, M1 and M2 (refs 1-3). Whereas M1 macrophages are proinflammatory and have a central role in host defence against bacterial and viral infections(4,5), M2 macrophages are associated with responses to anti-inflammatory reactions, helminth infection, tissue remodelling, fibrosis and tumour progression(6). Trib1 is an adaptor protein involved in protein degradation by interacting with COP1 ubiquitin ligase(7). Genome-wide association studies in humans have implicated TRIB1 in lipid metabolism(8-10). Here we show that Trib1 is critical for the differentiation of F4/80(+)MR(+) tissue-resident macrophages-that share characteristics with M2 macrophages (which we term M2-like macrophages)-and eosinophils but not for the differentiation of M1 myeloid cells. Trib1 deficiency results in a severe reduction of M2-like macrophages in various organs, including bone marrow, spleen, lung and adipose tissues. Aberrant expression of C/EBP alpha in Trib1-deficient bone marrow cells is responsible for the defects in macrophage differentiation. Unexpectedly, mice lacking Trib1 in haematopoietic cells show diminished adipose tissue mass accompanied by evidence of increased lipolysis, even when fed a normal diet. Supplementation of M2-like macrophages rescues the pathophysiology, indicating that a lack of these macrophages is the cause of lipolysis. In response to a high-fat diet, mice lacking Trib1 in haematopoietic cells develop hypertriglyceridaemia and insulin resistance, together with increased proinflammatory cytokine gene induction. Collectively, these results demonstrate that Trib1 is critical for adipose tissue maintenance and suppression of metabolic disorders by controlling the differentiation of tissue-resident M2-like macrophages.	[Satoh, Takashi; Takemura, Naoki; Nakagawa, Katsuhiro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Lab Host Def, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Satoh, Takashi; Takemura, Naoki; Nakagawa, Katsuhiro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kidoya, Hiroyasu; Naito, Hisamichi; Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro] Osaka Univ, Lab Immunoparasitol, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro] Osaka Univ, Dept Immunoparasitol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yoshioka, Yoshichika] Osaka Univ, Lab Biofunct Imaging, WPI Immunol Frontier Res Ctr WPI IFReC, Suita, Osaka 5650871, Japan; [Morii, Eiichi] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu] Kyoto Univ, Lab Infect & Prevent, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Kyoto University	Akira, S (corresponding author), Osaka Univ, Lab Host Def, WPI Immunol Frontier Res Ctr WPI IFReC, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019	Takeuchi, Osamu/0000-0002-1260-6232; Naito, Hisamichi/0000-0002-0750-1743	Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Grants-in-Aid for Scientific Research [22689016] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Shimomura and Y. Miyata for providing us with the key protocols for the metabolic experiments; T. Kitamura for providing the PlatE cells; M. Higa, H. Tanaka, N. Miyamoto, K. Miura, D. Ori, T. Uehata and K. Kuniyoshi for assistance with the experiments; and T. Kawai, S. Uematsu, T. Saitoh and Y. Kumagai for discussions. We also thank E. Kamada and M. Kageyama for secretarial assistance, and N. Umano, Y. Matsumoto and M. Kumagai for technical assistance. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare in Japan, the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Aung LHH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-230; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hong S, 2011, J LEUKOCYTE BIOL, V90, P643, DOI 10.1189/jlb.0111043; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264	30	217	226	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					524	+		10.1038/nature11930	http://dx.doi.org/10.1038/nature11930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23515163				2022-12-28	WOS:000316682800049
J	Yin, XB; Ye, ZL; Rho, J; Wang, Y; Zhang, X				Yin, Xiaobo; Ye, Ziliang; Rho, Junsuk; Wang, Yuan; Zhang, Xiang			Photonic Spin Hall Effect at Metasurfaces	SCIENCE			English	Article							LIGHT; BIREFRINGENCE; INDEX; PHASE	The spin Hall effect (SHE) of light is very weak because of the extremely small photon momentum and spin-orbit interaction. Here, we report a strong photonic SHE resulting in a measured large splitting of polarized light at metasurfaces. The rapidly varying phase discontinuities along a metasurface, breaking the axial symmetry of the system, enable the direct observation of large transverse motion of circularly polarized light, even at normal incidence. The strong spin-orbit interaction deviates the polarized light from the trajectory prescribed by the ordinary Fermat principle. Such a strong and broadband photonic SHE may provide a route for exploiting the spin and orbit angular momentum of light for information processing and communication.	[Yin, Xiaobo; Ye, Ziliang; Rho, Junsuk; Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, Natl Sci Fdn, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Natl Sci Fdn, Nanoscale Sci & Engn Ctr, 3112 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Wang, Yuan/F-7211-2011; Ye, Ziliang/A-2104-2011; Rho, Junsuk/AAN-7917-2020; Zhang, Xiang/F-6905-2011; Ye, Ziliang/AGU-2783-2022; Yin, Xiaobo/A-4142-2011	Wang, Yuan/0000-0001-7892-2812; Rho, Junsuk/0000-0002-2179-2890; Ye, Ziliang/0000-0001-8314-6977; Zhang, Xiang/0000-0002-3272-894X	U.S. Department of Energy, Office of Basic Energy Sciences through the Materials Sciences Division of LBNL [DE-AC02-05CH11231]; Samsung Scholarship Foundation, Republic of Korea	U.S. Department of Energy, Office of Basic Energy Sciences through the Materials Sciences Division of LBNL; Samsung Scholarship Foundation, Republic of Korea	This research is supported by the U.S. Department of Energy, Office of Basic Energy Sciences under contract no. DE-AC02-05CH11231 through the Materials Sciences Division of LBNL. J.R. acknowledges a fellowship from the Samsung Scholarship Foundation, Republic of Korea. We thank S. Dhuey and S. Cabrini of the Molecular Foundry at LBNL for their help on electron beam lithography over large areas.	Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Bernevig BA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076602; BERRY MV, 1987, NATURE, V326, P277, DOI 10.1038/326277a0; Bliokh KY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.030404; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Bliokh KY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073903; CHIAO RY, 1986, PHYS REV LETT, V57, P933, DOI 10.1103/PhysRevLett.57.933; DEBEAUREGARD OC, 1977, PHYS REV D, V15, P3553; Falcone F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.197401; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Genevet P, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673334; Gorodetski Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.013901; Gorodetski Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043903; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Jungwirth T, 2012, NAT MATER, V11, P382, DOI [10.1038/NMAT3279, 10.1038/nmat3279]; Kats MA, 2012, P NATL ACAD SCI USA, V109, P12364, DOI 10.1073/pnas.1210686109; LIBERMAN VS, 1994, PHYS REV E, V49, P2389, DOI 10.1103/PhysRevE.49.2389; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036609; Sun SL, 2012, NAT MATER, V11, P426, DOI [10.1038/nmat3292, 10.1038/NMAT3292]; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhao Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205428	29	853	885	33	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1405	1407		10.1126/science.1231758	http://dx.doi.org/10.1126/science.1231758			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520105				2022-12-28	WOS:000316740700035
J	Lane, R				Lane, Richard			Thamer Kadum Al Hilfi : looking ahead to a healthier Iraq Profile	LANCET			English	Biographical-Item													Al Hilfi, Thamer/HCH-4935-2022	Al Hilfi, Thamer/0000-0002-5840-285X				ALHILFI TK, PUBLICATION LIST, P24516	1	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 16	2013	381	9870					897	897		10.1016/S0140-6736(13)60661-3	http://dx.doi.org/10.1016/S0140-6736(13)60661-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499031	Bronze			2022-12-28	WOS:000316069700013
J	Parson, EA; Keith, DW				Parson, Edward A.; Keith, David W.			End the Deadlock on Governance of Geoengineering Research	SCIENCE			English	Editorial Material									[Parson, Edward A.] UCLA Sch Law, Emmett Ctr Climate Change & Law, Los Angeles, CA 90095 USA; [Keith, David W.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Parson, EA (corresponding author), UCLA Sch Law, Emmett Ctr Climate Change & Law, Los Angeles, CA 90095 USA.	parson@law.ucla.edu						Asilomar Scientific Organizing Committee, 2010, C REP; Biello D, 2012, SCI AM; Bipartisan Policy Center Task Force on Climate Remediation Research, 2011, GEOENG NAT STRAT PLA; Hamilton Clive, 2011, GUARDIAN; Keith DW, 2010, NATURE, V463, P426, DOI 10.1038/463426a; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; Levitt S. D., 2011, SUPERFREAKONOMICS; Lukacs M, 2012, GUARDIAN; NATIONAL RESEARCH COUNCIL, 2010, AM CLIM CHOIC PAN AD, P377; Oxford Geoengineering Programme, 2009, OXF PRINC GEOENG RES; Parson E., 2013, THEORET INQ LAW, V14, P311; Robock A, 2008, B ATOM SCI, V64, P14, DOI 10.1080/00963402.2008.11461140; Solar Radiation Management Governance Initiative, 2011, SOL RAD MAN GOV RES; Wood L., 2002, UCRLJC148012 LAWR LI	15	82	85	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1278	1279		10.1126/science.1232527	http://dx.doi.org/10.1126/science.1232527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GC	23493699				2022-12-28	WOS:000316053400021
J	Roehr, B				Roehr, Bob			Grappling with concussion: discovery, policy, and practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2013	346								f1693	10.1136/bmj.f1693	http://dx.doi.org/10.1136/bmj.f1693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VT	23502708				2022-12-28	WOS:000316325000003
J	Cooper, L; Ford, K; Miller, E				Cooper, Lillian; Ford, Kathryn; Miller, Elizabeth			Preparing a Jehovah's Witness for major elective surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENT BLOOD MANAGEMENT; RECOMBINANT-HUMAN-ERYTHROPOIETIN; ANEMIA; TRANSFUSION		[Cooper, Lillian] Royal London Hosp, London E1 1BB, England; [Ford, Kathryn] Kings Coll Hosp London, London SE5 9RS, England; [Miller, Elizabeth] Milton Keynes Dist Gen Hosp, Milton Keynes, Bucks, England	Barts Health NHS Trust; Royal London Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Ford, K (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	kathryneford@gmail.com						ATABEK U, 1995, AM SURGEON, V61, P74; Barosi G, 1998, BRIT J CANCER, V78, P781, DOI 10.1038/bjc.1998.579; BMA/Royal Pharmaceutical Society, 2012, BNF; BUSUTTIL D, 1995, BRIT MED J, V311, P1115, DOI 10.1136/bmj.311.7013.1115; Department of Health, BETT BLOOD TRANSF PR; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; Kiran RP, 2004, ARCH SURG-CHICAGO, P13939; OERTLI D, 1994, BRIT J SURG, V81, P856, DOI 10.1002/bjs.1800810621; Pattakos G, 2012, ARCH INTERN MED, V172, P1154, DOI 10.1001/archinternmed.2012.2449; Putney LJ, 2007, CRIT CARE NURS Q, V30, P263, DOI 10.1097/01.CNQ.0000278927.44691.8c; Shander A, 2012, BRIT J ANAESTH, V109, P55, DOI 10.1093/bja/aes139; Shander A, 2012, MT SINAI J MED, V79, P56, DOI 10.1002/msj.21290; Spahn DR, 2012, BRIT J ANAESTH, V108, P889, DOI 10.1093/bja/aes166; Tartter PI, 1998, AM J SURG, V176, P462, DOI 10.1016/S0002-9610(98)00245-1; Wooding N, 1999, BRIT MED J, V318, P873, DOI 10.1136/bmj.318.7187.873a	15	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2013	346								f1588	10.1136/bmj.f1588	http://dx.doi.org/10.1136/bmj.f1588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VS	23493825				2022-12-28	WOS:000316324900002
J	Owens, B				Owens, Brian			Extreme prospects	NATURE			English	Editorial Material																			0	32	35	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S4	S6		10.1038/495S4a	http://dx.doi.org/10.1038/495S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486099	Bronze			2022-12-28	WOS:000316652300027
J	Martin, RM; Patel, R; Kramer, MS; Guthrie, L; Vilchuck, K; Bogdanovich, N; Sergeichick, N; Gusina, N; Foo, Y; Palmer, T; Rifas-Shiman, SL; Gillman, MW; Smith, GD; Oken, E				Martin, Richard M.; Patel, Rita; Kramer, Michael S.; Guthrie, Lauren; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina; Foo, Ying; Palmer, Tom; Rifas-Shiman, Sheryl L.; Gillman, Matthew W.; Smith, George Davey; Oken, Emily			Effects of Promoting Longer-term and Exclusive Breastfeeding on Adiposity and Insulin-like Growth Factor-I at Age 11.5 Years A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FILTER-PAPER; IGF-I; BLOOD-PRESSURE; OBESITY; OVERWEIGHT; RISK; LIFE; HEALTH; ASSOCIATION	Importance Evidence that longer-term and exclusive breastfeeding reduces child obesity risk is based on observational studies that are prone to confounding. Objective To investigate effects of an intervention to promote increased duration and exclusivity of breastfeeding on child adiposity and circulating insulin-like growth factor (IGF)-I, which regulates growth. Design, Setting, and Participants Cluster-randomized controlled trial in 31 Be-larusian maternity hospitals and their affiliated clinics, randomized into 1 of 2 groups: breastfeeding promotion intervention (n=16) or usual practices (n=15). Participants were 17 046 breastfeeding mother-infant pairs enrolled in 1996 and 1997, of whom 13 879 (81.4%) were followed up between January 2008 and December 2010 at a median age of 11.5 years. Intervention Breastfeeding promotion intervention modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative (World Health Organization/United Nations Children's Fund). Main Outcome Measures Body mass index (BMI), fat and fat-free mass indices (FMI and FFMI), percent body fat, waist circumference, triceps and subscapular skinfold thicknesses, overweight and obesity, and whole-blood IGF-I. Primary analysis was based on modified intention-to-treat (without imputation), accounting for clustering within hospitals and clinics. Results The experimental intervention substantially increased breastfeeding duration and exclusivity when compared with the control (43% vs 6% exclusively breast-fed at 3 months and 7.9% vs 0.6% at 6 months). Cluster-adjusted mean differences in outcomes at 11.5 years of age between experimental vs control groups were: 0.19 (95% CI, -0.09 to 0.46) for BMI; 0.12 (-0.03 to 0.28) for FMI; 0.04 (-0.11 to 0.18) for FFMI; 0.47% (-0.11% to 1.05%) for percent body fat; 0.30 cm (-1.41 to 2.01) for waist circumference; -0.07 mm (-1.71 to 1.57) for triceps and -0.02 mm (-0.79 to 0.75) for subscapular skinfold thicknesses; and -0.02 standard deviations (-0.12 to 0.08) for IGF-I. The cluster-adjusted odds ratio for overweight/obesity (BMI >= 85th vs <85th percentile) was 1.18 (95% CI, 1.01 to 1.39) and for obesity (BMI >= 95th vs <85th percentile) was 1.17 (95% CI, 0.97 to 1.41). Conclusions and Relevance Among healthy term infants in Belarus, an intervention that succeeded in improving the duration and exclusivity of breastfeeding did not prevent overweight or obesity, nor did it affect IGF-I levels at age 11.5 years. Breastfeeding has many advantages but population strategies to increase the duration and exclusivity of breastfeeding are unlikely to curb the obesity epidemic.	[Martin, Richard M.; Patel, Rita; Foo, Ying; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Martin, Richard M.; Palmer, Tom; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Med Res Council Ctr Causal Anal Translat Epidemio, Bristol BS8 2PS, Avon, England; [Kramer, Michael S.] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Guthrie, Lauren; Rifas-Shiman, Sheryl L.; Gillman, Matthew W.; Oken, Emily] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Guthrie, Lauren; Rifas-Shiman, Sheryl L.; Gillman, Matthew W.; Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS	University of Bristol; University of Bristol; McGill University; McGill University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.	richard.martin@bristol.ac.uk	Davey Smith, George/A-7407-2013; Palmer, Tom Michael/X-6807-2019	Davey Smith, George/0000-0002-1407-8314; Palmer, Tom Michael/0000-0003-4655-4511; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Martin, Richard/0000-0002-7992-7719; s, hema/0000-0002-3440-9475	Canadian Institutes of Health Research; National Institutes of Health (NIH); European Union; Early Nutrition Programming Long-term Efficacy and Safety Trials [FOOD-DT-2005-007036]; Canadian Institutes of Health Research [MOP-53155]; NIH [R01 HD050758]; US National Institute of Child Health and Development [K24 HD069408]; Medical Research Council [G0600705]; University of Bristol; MRC [G0600705] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069408, R01HD050758] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Early Nutrition Programming Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Child Health and Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Martin reports presenting an invited talk for the Nestle Nutrition Institute. Dr Kramer reports receipt of an institutional grant from the Canadian Institutes of Health Research and receipt of unrelated meeting expenses from Nestle Nutrition Institute. Dr Foo reports receipt of a consulting fee support for travel to meetings from the University of Bristol. Ms Guthrie and Drs Gillman and Oken report receipt of an institutional grant from the National Institutes of Health (NIH). Dr Oken reports presenting an invited talk for Nestle Nutrition Institute and also receipt of travel reimbursement.; This study was supported by grants from: the European Union, Early Nutrition Programming Long-term Efficacy and Safety Trials (FOOD-DT-2005-007036); Canadian Institutes of Health Research (MOP-53155); and NIH (R01 HD050758). Dr Oken was supported by US National Institute of Child Health and Development (K24 HD069408). Drs Martin, Palmer, and Davey Smith work within the CAiTE Centre, which is supported by the Medical Research Council (G0600705) and the University of Bristol.	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Chivers P, 2010, INT J OBESITY, V34, P1169, DOI 10.1038/ijo.2010.61; Diamandi A, 1998, J CLIN ENDOCR METAB, V83, P2296, DOI 10.1210/jc.83.7.2296; Gillman MW, 2006, EPIDEMIOLOGY, V17, P112, DOI 10.1097/01.ede.0000181629.59452.95; Goran MI, 1998, PEDIATRICS, V101, P505; Guthrie LB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-29; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hoppe C, 2004, AM J CLIN NUTR, V79, P494; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jones JS, 2001, HORM RES, V55, P80, DOI 10.1159/000063481; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2011, AM J EPIDEMIOL, V173, P978, DOI 10.1093/aje/kwq495; Kramer MS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2900; Kramer MS, 2002, PEDIATRICS, V110, P343, DOI 10.1542/peds.110.2.343; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kwok MK, 2010, INT J EPIDEMIOL, V39, P297, DOI 10.1093/ije/dyp274; Larnkjaer A, 2009, GROWTH HORM IGF RES, V19, P82, DOI 10.1016/j.ghir.2008.06.003; Martin RM, 2005, CLIN ENDOCRINOL, V62, P728, DOI 10.1111/j.1365-2265.2005.02287.x; Martin RM, 2002, ARCH DIS CHILD-FETAL, V87, P193; Martin RM, 2012, PLOS ONE, V7; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Michels KB, 2007, INT J OBESITY, V31, P1078, DOI 10.1038/sj.ijo.0803622; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; National Committee for Clinical Laboratory Standards (NCCLS), 1997, BLOOD COLL FILT PAP; Nelson MC, 2005, EPIDEMIOLOGY, V16, P247, DOI 10.1097/01.ede.0000152900.81355.00; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2012, PREVALENCE OBESITY U; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Parsons TJ, 2003, ARCH DIS CHILD, V88, P793, DOI 10.1136/adc.88.9.793; Rowlands MA, 2012, CANCER RES, V72, P503, DOI 10.1158/0008-5472.CAN-11-1601; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schutt BS, 2003, GROWTH HORM IGF RES, V13, P75, DOI 10.1016/S1096-6374(03)00004-2; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Ukoumunne OC, 1999, BRIT MED J, V319, P376, DOI 10.1136/bmj.319.7206.376; Victora CG, 2003, BMJ-BRIT MED J, V327, P901, DOI 10.1136/bmj.327.7420.901; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; WARNICK GR, 1994, ARCH PATHOL LAB MED, V118, P1110; WHO/UNICEF, 1989, PROT PROM SUPP BREAS	44	123	126	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1005	1013		10.1001/jama.2013.167	http://dx.doi.org/10.1001/jama.2013.167			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483175	Green Accepted			2022-12-28	WOS:000315938700029
J	Tanaka, Y; Hipolito, CJ; Maturana, AD; Ito, K; Kuroda, T; Higuchi, T; Katoh, T; Kato, HE; Hattori, M; Kumazaki, K; Tsukazaki, T; Ishitani, R; Suga, H; Nureki, O				Tanaka, Yoshiki; Hipolito, Christopher J.; Maturana, Andres D.; Ito, Koichi; Kuroda, Teruo; Higuchi, Takashi; Katoh, Takayuki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Suga, Hiroaki; Nureki, Osamu			Structural basis for the drug extrusion mechanism by a MATE multidrug transporter	NATURE			English	Article							IN-VITRO SELECTION; VIBRIO-PARAHAEMOLYTICUS; STAPHYLOCOCCUS-AUREUS; EFFLUX PROTEIN; NORM; RESISTANCE; FAMILY; ANTIPORTER; METFORMIN; HOMOLOG	Multidrug and toxic compound extrusion(MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electro-chemical gradient of H+ or Na+ across the membrane(1,2). MATE transporters confer multidrug resistance to bacterial pathogens(3-6) and cancer cells(7), thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine(8,9). Here we present the crystal structures of the H+-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 angstrom resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.	[Tanaka, Yoshiki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Tanaka, Yoshiki; Kato, Hideaki E.; Hattori, Motoyuki; Kumazaki, Kaoru; Tsukazaki, Tomoya; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Hipolito, Christopher J.; Higuchi, Takashi; Katoh, Takayuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ito, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Kuroda, Teruo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Appl Microbiol, Okayama 7008530, Japan; [Hattori, Motoyuki; Tsukazaki, Tomoya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; University of Tokyo; Nagoya University; University of Tokyo; Okayama University; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), RIKEN Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hsuga@chem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	KURODA, Teruo/B-2028-2011; NUREKI, OSAMU/G-4960-2014; Hattori, Motoyuki/B-6069-2014; Kato, Hideaki/AAQ-4323-2020; Tsukazaki, Tomoya/N-2299-2019	Kato, Hideaki/0000-0002-1941-5535; Tsukazaki, Tomoya/0000-0002-6386-723X; Hattori, Motoyuki/0000-0002-5327-5337; Ito, Koichi/0000-0002-2042-405X; Tanaka, Yoshiki/0000-0001-6960-5276; Katoh, Takayuki/0000-0001-6550-6203	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency; MEXT [24227004, 22687007, P11344]; JSPS [21000005]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to the beam-line staff at BL32XU of SPring-8 for assistance in data collection (proposals 2011B1062, 2012A1087 and 2012B1161), and the RIKEN BioResource Center (Ibaraki, Japan) for providing the P. furiosus genomic DNA. We are also grateful to N. Dohmae and Y. Sugita (RIKEN Advanced Science Institute, Japan) for discussions. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)' to O.N.; by the Core Research for Evolutional Science and Technology Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency to O.N.; and by a Grant-in-Aid for Scientific Research (S) (24227004) and a Grant-in-Aid for Young Scientists (A) (22687007) from MEXT to O.N. and R. I., respectively. This work was also supported by a JSPS Grant-in-Aid for the Specially Promoted Research (21000005) and MEXT Platform for Drug Discovery, Informatics, and Structural Life Science to H. S., and a Grant-in-Aid for JSPS post-doctoral fellows to C.J.H. (P11344).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Hayashi Y, 2012, ACS CHEM BIOL, V7, P607, DOI 10.1021/cb200388k; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; KOGA H, 1980, J MED CHEM, V23, P1358, DOI 10.1021/jm00186a014; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Kusuhara H, 2011, CLIN PHARMACOL THER, V89, P837, DOI 10.1038/clpt.2011.36; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tsuda M, 2007, AM J PHYSIOL-RENAL, V292, pF593, DOI 10.1152/ajprenal.00312.2006; TSUJIMOTO K, 1988, BIOCHEM BIOPH RES CO, V155, P123, DOI 10.1016/S0006-291X(88)81058-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wasaznik A, 2009, POSTEP HIG MED DOSW, V63, P123; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Xu HL, 2008, J APPL CRYSTALLOGR, V41, P644, DOI 10.1107/S0021889808007966; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	194	197	0	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					247	+		10.1038/nature12014	http://dx.doi.org/10.1038/nature12014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535598				2022-12-28	WOS:000317346300047
J	Wolfe, I; Thompson, M; Gill, P; Tamburlini, G; Blair, M; van den Bruel, A; Ehrich, J; Pettoello-Mantovani, M; Janson, S; Karanikolos, M; McKee, M				Wolfe, Ingrid; Thompson, Matthew; Gill, Peter; Tamburlini, Giorgio; Blair, Mitch; van den Bruel, Ann; Ehrich, Jochen; Pettoello-Mantovani, Massimo; Janson, Staffan; Karanikolos, Marina; McKee, Martin			Health services for children in western Europe	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; HOSPITAL ADMISSIONS; OUTPATIENT MANAGEMENT; GENERAL-PRACTITIONERS; CHILDHOOD; ASTHMA; QUALITY; NURSE; ACCIDENT	Western European health systems are not keeping pace with changes in child health needs. Non-communicable diseases are increasingly common causes of childhood illness and death. Countries are responding to changing needs by adapting child health services in different ways and useful insights can be gained through comparison, especially because some have better outcomes, or have made more progress, than others. Although overall child health has improved throughout Europe, wide inequities remain. Health services and social and cultural determinants contribute to differences in health outcomes. Improvement of child health and reduction of suffering are achievable goals. Development of systems more responsive to evolving child health needs is likely to necessitate reconfiguring of health services as part of a whole-systems approach to improvement of health. Chronic care services and first-contact care systems are important aspects. The Swedish and Dutch experiences of development of integrated systems emphasise the importance of supportive policies backed by adequate funding. France, the UK, Italy, and Germany off er further insights into chronic care services in different health systems. First-contact care models and the outcomes they deliver are highly variable. Comparisons between systems are challenging. Important issues emerging include the organisation of first-contact models, professional training, arrangements for provision of out-of-hours services, and task-sharing between doctors and nurses. Flexible first-contact models in which child health professionals work closely together could off er a way to balance the need to provide expertise with ready access. Strategies to improve child health and health services in Europe necessitate a whole-systems approach in three interdependent systems-practice (chronic care models, first-contact care, competency standards for child health professionals), plans (child health indicator sets, reliable systems for capture and analysis of data, scale-up of child health research, anticipation of future child health needs), and policy (translation of high-level goals into actionable policies, open and transparent accountability structures, political commitment to delivery of improvements in child health and equity throughout Europe).	[Wolfe, Ingrid; Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Karanikolos, Marina; McKee, Martin] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1H 9SH, England; [Thompson, Matthew; Gill, Peter; van den Bruel, Ann] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Tamburlini, Giorgio] Ctr Salute Bambino, Trieste, Italy; [Blair, Mitch] Univ London Imperial Coll Sci Technol & Med, Div Paediat, London, England; [Ehrich, Jochen] Hannover Med Sch, D-30623 Hannover, Germany; [Pettoello-Mantovani, Massimo] Univ Foggia, Sch Med, Foggia, Italy; [Janson, Staffan] Karlstad Univ, Ctr Publ Hlth Res, Karlstad, Sweden	University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Imperial College London; Hannover Medical School; University of Foggia; Karlstad University	Wolfe, I (corresponding author), Univ London London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.	ingrid.wolfe@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Van den Bruel, Ann/AAC-2442-2020; Mckee, Martin/E-6673-2018; MANTOVANI, Massimo PETTOELLO/AAC-1990-2019; Gill, Peter J./A-6021-2012	McKee, Marc D/0000-0001-8349-965X; Van den Bruel, Ann/0000-0001-9012-2009; Mckee, Martin/0000-0002-0121-9683; MANTOVANI, Massimo PETTOELLO/0000-0002-0688-1131; Gill, Peter J./0000-0002-6253-1312; Karanikolos, Marina/0000-0002-3824-8226; Wolfe, Ingrid/0000-0002-4717-7634; Blair, Mitch/0000-0001-7442-0188	European Observatory on Health Systems and Policies; National Institute for Health Research; National Institute for Health Research [CDF-2011-04-052, CL-2009-13-007] Funding Source: researchfish	European Observatory on Health Systems and Policies; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the European Observatory on Health Systems and Policies. This report is independent research arising from a Career Development Fellowship supported by the National Institute for Health Research. The views expressed are those of the authors and not necessarily those of the UK National Health Service, National Institute for Health Research, or Department of Health. We thank Bjorn Wettergren and David Stuckler.	Ahgren Bengt, 2003, Int J Integr Care, V3, pe01; Anderson HR, 2008, INT J EPIDEMIOL, V37, P573, DOI 10.1093/ije/dyn039; Arah OA, 2006, INT J QUAL HEALTH C, V18, P5, DOI 10.1093/intqhc/mzl024; Armour-Marshall J, 2012, EUR J PUBLIC HEALTH, V22, P61, DOI 10.1093/eurpub/ckr004; Beal AC, 2004, PEDIATRICS, V113, P199; British Medical Association, 2011, QUALITY AND OUTCOMES; Caminal J, 2004, EUR J PUBLIC HEALTH, V14, P246, DOI 10.1093/eurpub/14.3.246; Cattaneo A, 2012, CHILD HEALTH IN THE; Children and Young People's Health Outcomes Forum, CHILDREN AND YOUNG P; Christensen MB, 1998, BMJ-BRIT MED J, V316, P1502, DOI 10.1136/bmj.316.7143.1502; Council of Europe, GUIDELINES OF THE CO; DALE J, 1995, BRIT MED J, V311, P427, DOI 10.1136/bmj.311.7002.427; Department of Health, NHS OUTCOMES FRAMEWO; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; European Academy of Teachers in General Practice, 2011, SPECIALIST TRAINING; European Commission, EUROSTAT DATABASE; European Union Agency for Fundamental Rights, 2010, DEVELOPING INDICATOR; Feltbower RG, 2004, BRIT J CANCER, V90, P1882, DOI 10.1038/sj.bjc.6601733; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Fuhrman C, 2011, J ASTHMA, V48, P565, DOI 10.3109/02770903.2011.580031; Gill PJ, 2013, ARCH DIS CHILD, V98, P328, DOI 10.1136/archdischild-2012-302383; Gill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023051; Hajioff S, 2000, J EPIDEMIOL COMMUN H, V54, P864, DOI 10.1136/jech.54.11.864; Hartling L, 2012, PEDIATRICS, V129, pS112, DOI 10.1542/peds.2012-0055C; Heath I, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6814; Hodgkin R, 2007, IMPLEMENTATION HANDB; Independent Expert Review Group, 2012, EVERY WOMAN EVERY CH; Institute for Health Metrics and Evaluation, GLOBAL BURDEN OF DIS; Jones J., 2006, PARENTS VIEWS ABOUT; Kamps AWA, 2004, EUR RESPIR J, V23, P304, DOI 10.1183/09031936.03.00052203; Kamps AWA, 2003, THORAX, V58, P968, DOI 10.1136/thorax.58.11.968; Karanikolos M, 2013, LANCET; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kuethe M, 2011, PRIM CARE RESP J, V20, P84, DOI 10.4104/pcrj.2011.00003; Lee A, 2000, SOC SCI MED, V51, P1075, DOI 10.1016/S0277-9536(00)00039-3; Mackenbach JP, 2013, LANCET; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; Marchetti F, 2005, ARCH PEDIAT ADOL MED, V159, P679, DOI 10.1001/archpedi.159.7.679; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Melville C, 2002, MED EDUC, V36, P449, DOI 10.1046/j.1365-2923.2002.01199.x; Modi N, 2013, LANCET, V381, P73, DOI 10.1016/S0140-6736(12)61818-2; Moll van Charante Eric Peter, 2006, BMC Fam Pract, V7, P74; Moore E, 2006, BRIT J DERMATOL, V155, P1242, DOI 10.1111/j.1365-2133.2006.07534.x; Murphy AW, 1996, BRIT MED J, V312, P1135; Nolte E, 2004, DOES HEALTH CARE SAV; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; Parekh N, 2011, CENT EUR J PUBL HEAL, V19, P139, DOI 10.21101/cejph.a3661; Pearson G., 2008, WHY CHILDREN DIE A P; Pearson GA, 2011, ARCH DIS CHILD, V96, P927, DOI 10.1136/adc.2009.177071; Piovani D, 2012, EUR J CLIN PHARMACOL, V68, P997, DOI 10.1007/s00228-011-1204-3; Pritchard-Jones K, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.210; Reindal L, 2006, J ASTHMA, V43, P801, DOI 10.1080/02770900601034320; Rigby MJ, 2003, EUR J PUBLIC HEALTH, V13, P38, DOI 10.1093/eurpub/13.suppl_1.38; Rothman Russell L, 2009, Pediatrics, V124 Suppl 3, pS315, DOI 10.1542/peds.2009-1163H; Royal College of General Practitioners, 2012, PREPARING THE FUTURE; Royal College of General Practitioners, 2010, RCGP CHILD HEALTH ST; Royal College of Paediatrics and Child Health, 2012, BRINGING NETWORKS TO; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; Schuttelaar MLA, 2010, BRIT J DERMATOL, V162, P162, DOI 10.1111/j.1365-2133.2009.09502.x; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stephenson T, 2010, ARCH DIS CHILD, V95, P767, DOI 10.1136/adc.2010.184788; Strassburg Hans Michael, 2011, KINDER JUGENDLICHE B, P91; Szczepanski R, 2010, KINDER UND JUGENDARZ, V41, P361; Tamburlini G, 2011, MEDICO E BAMBINO, V8, P505; Tamburlini G, 2012, MEDICO E BAMBINO, V31, P178; UNICEF Innocenti Research Centre, 2012, INNOCENTI REPORT CAR; United Nations, 1989, CONVENTION ON THE RI; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van der Linden BA, 2001, THE BIRTH OF INTEGRA; van Uden CJT, 2006, FAM MED, V38, P565; Westert G. P., 2006, MORBIDITY PERFORMANC; WHO, WHO MORTALITY DATABA; WHO, WHO EUROPEAN MORTALI; WHO, EUROPEAN HEALTH FOR; Wolfe I., 2013, SUCCESSES AND FAILUR; Wolfe I, 2011, BMJ-BRIT MED J, V342, P1277; World Health Organization, 2008, FINAL REPORT OF THE	77	165	167	1	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1224	1234		10.1016/S0140-6736(12)62085-6	http://dx.doi.org/10.1016/S0140-6736(12)62085-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WU	23541056				2022-12-28	WOS:000317350100033
J	Pickrell, WO; Hirst, C; Brunt, H; Pearson, OR				Pickrell, William Owen; Hirst, Claire; Brunt, Huw; Pearson, Owen R.			Peripheral neuropathy-lead astray?	LANCET			English	Editorial Material							DIPLEGIA		[Pickrell, William Owen] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Hirst, Claire; Pearson, Owen R.] Morriston Hosp, Dept Neurol, Swansea, W Glam, Wales; [Brunt, Huw] Publ Hlth Wales, Cardiff, S Glam, Wales	Swansea University; Morriston Hospital	Pickrell, WO (corresponding author), Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales.	w.o.pickrell@swansea.ac.uk	Pickrell, William Owen/F-7110-2014	Pickrell, William Owen/0000-0003-4396-5657; Brunt, Huw/0000-0002-3976-672X				Binnie C., 2002, BASIC WATER TREATMEN; Finsterer J, 2010, SOUTH MED J, V103, P9, DOI 10.1097/SMJ.0b013e3181c3892e; Gorson KC, 2011, NEUROLOGIST, V17, P24, DOI 10.1097/NRL.0b013e31820038cd; Hughes RAC, 2011, OXFORD TXB MED; Katz JS, 1999, NEUROLOGY, V53, P1071, DOI 10.1212/WNL.53.5.1071	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1156	1156		10.1016/S0140-6736(12)62169-2	http://dx.doi.org/10.1016/S0140-6736(12)62169-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23540854				2022-12-28	WOS:000317348900034
J	Zhang, JS; Chang, CZ; Tang, PZ; Zhang, ZC; Feng, X; Li, K; Wang, LL; Chen, X; Liu, CX; Duan, WH; He, K; Xue, QK; Ma, XC; Wang, YY				Zhang, Jinsong; Chang, Cui-Zu; Tang, Peizhe; Zhang, Zuocheng; Feng, Xiao; Li, Kang; Wang, Li-li; Chen, Xi; Liu, Chaoxing; Duan, Wenhui; He, Ke; Xue, Qi-Kun; Ma, Xucun; Wang, Yayu			Topology-Driven Magnetic Quantum Phase Transition in Topological Insulators	SCIENCE			English	Article							SINGLE DIRAC CONE; SURFACE; FERMIONS	The breaking of time reversal symmetry in topological insulators may create previously unknown quantum effects. We observed a magnetic quantum phase transition in Cr-doped Bi-2(SexTe1-x)(3) topological insulator films grown by means of molecular beam epitaxy. Across the critical point, a topological quantum phase transition is revealed through both angle-resolved photoemission measurements and density functional theory calculations. We present strong evidence that the bulk band topology is the fundamental driving force for the magnetic quantum phase transition. The tunable topological and magnetic properties in this system are well suited for realizing the exotic topological quantum phenomena in magnetic topological insulators.	[Zhang, Jinsong; Chang, Cui-Zu; Tang, Peizhe; Zhang, Zuocheng; Chen, Xi; Duan, Wenhui; Xue, Qi-Kun; Wang, Yayu] Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China; [Chang, Cui-Zu; Feng, Xiao; Li, Kang; Wang, Li-li; He, Ke; Xue, Qi-Kun; Ma, Xucun] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Liu, Chaoxing] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	He, K (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	kehe@aphy.iphy.ac.cn; yayuwang@tsinghua.edu.cn	Tang, Peizhe/N-7685-2019; HE, KE/G-7538-2011; Duan, Wenhui/H-4992-2011; Wang, Lili/C-4156-2014; Chang, Cui-Zu/P-3049-2014; Tang, Peizhe/P-4289-2014; Feng, Xiao/W-4051-2017; HE, KE/A-9078-2013; Feng, Xiao/AAJ-3617-2020	Tang, Peizhe/0000-0002-6345-5809; Duan, Wenhui/0000-0001-9685-2547; Wang, Lili/0000-0001-6035-1660; Tang, Peizhe/0000-0002-6345-5809; Feng, Xiao/0000-0001-7982-0455; He, Ke/0000-0001-6787-3453; Zhang, Jinsong/0000-0002-3601-4995	Natural Science Foundation; Ministry of Science and Technology of China; Chinese Academy of Sciences; EPSRC [EP/G069115/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G069115/1] Funding Source: researchfish	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank X. Dai, Z. Fang, and S. C. Zhang for helpful discussions. We thank Y. G. Zhao, P. S. Li, X. L. Dong, and Y. Wu for assistance with superconducting quantum interference device measurements. This work is supported by the Natural Science Foundation and Ministry of Science and Technology of China and the Chinese Academy of Sciences.	Beidenkopf H, 2011, NAT PHYS, V7, P939, DOI [10.1038/nphys2108, 10.1038/NPHYS2108]; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Garate I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146802; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; He HT, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166805; Hor YS, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195203; Jin H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.134408; Liu MH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.036805; Liu Q, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156603; MacDonald A, 2004, PHYS WORLD, V17, P18; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Nomura K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166802; Okada Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.206805; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Qi XL, 2009, SCIENCE, V323, P1184, DOI 10.1126/science.1167747; Rosenberg G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195119; Sato T, 2011, NAT PHYS, V7, P840, DOI [10.1038/nphys2058, 10.1038/NPHYS2058]; Sinova J, 2004, INT J MOD PHYS B, V18, P1083, DOI 10.1142/S0217979204024677; Tse WK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057401; Wray LA, 2011, NAT PHYS, V7, P32, DOI 10.1038/NPHYS1838; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Xu SY, 2011, SCIENCE, V332, P560, DOI 10.1126/science.1201607; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang YB, 2010, NAT PHYS, V6, P74, DOI 10.1038/nphys1502	27	175	179	7	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1582	1586		10.1126/science.1230905	http://dx.doi.org/10.1126/science.1230905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23539598				2022-12-28	WOS:000316731600042
J	Elmegreen, BG; Rubio, M; Hunter, DA; Verdugo, C; Brinks, E; Schruba, A				Elmegreen, Bruce G.; Rubio, Monica; Hunter, Deidre A.; Verdugo, Celia; Brinks, Elias; Schruba, Andreas			Carbon monoxide in clouds at low metallicity in the dwarf irregular galaxy WLM	NATURE			English	Article							STAR-FORMATION; DUST PROPERTIES; GAS; CO; EMISSION; MASS; ABUNDANCES; DYNAMICS; EXCESS; DISK	Carbon monoxide (CO) is the primary tracer for interstellar clouds where stars form, but it has never been detected in galaxies in which the oxygen abundance relative to hydrogen is less than 20 per cent of that of the Sun, even though such 'low-metallicity' galaxies often form stars. This raises the question of whether stars can form in dense gas without molecules, cooling to the required near-zero temperatures by atomic transitions and dust radiation rather than by molecular line emission(1); and it highlights uncertainties about star formation in the early Universe, when the metallicity was generally low. Here we report the detection of CO in two regions of a local dwarf irregular galaxy, WLM, where the metallicity is 13 per cent of the solar value(2,3). We use new submillimetre observations and archival far-infrared observations to estimate the cloud masses, which are both slightly greater than 100,000 solar masses. The clouds have produced stars at a rate per molecule equal to 10 per cent of that in the local Orion nebula cloud. The CO fraction of the molecular gas is also low, about 3 per cent of the Milky Way value. These results suggest that in small galaxies both star-forming cores and CO molecules become increasingly rare in molecular hydrogen clouds as the metallicity decreases.	[Elmegreen, Bruce G.] TJ Watson Res Ctr, IBM Res Div, Yorktown Hts, NY 10598 USA; [Rubio, Monica; Verdugo, Celia] Univ Chile, Dept Astron, Santiago, Chile; [Hunter, Deidre A.] Lowell Observ, Flagstaff, AZ 86001 USA; [Brinks, Elias] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Schruba, Andreas] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA	International Business Machines (IBM); Universidad de Chile; University of Hertfordshire; California Institute of Technology	Elmegreen, BG (corresponding author), TJ Watson Res Ctr, IBM Res Div, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	bge@us.ibm.com	Rubio, Monica/J-3384-2016	Brinks, Elias/0000-0002-7758-9699	US National Science Foundation [AST-0707563, AST-0707426]; CONICYT (FONDECYT) [1080335]; Chilean Center for Astrophysics FONDAP [15010003]; Deutsche Forschungsgemeinschaft [1177]; Science and Technology Facilities Council [ST/J001333/1] Funding Source: researchfish; STFC [ST/J001333/1] Funding Source: UKRI	US National Science Foundation(National Science Foundation (NSF)); CONICYT (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean Center for Astrophysics FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was funded in part by the US National Science Foundation through grants AST-0707563 and AST-0707426 to D. A. H. and B. G. E. M. R. and C. V. wish to acknowledge support from CONICYT (FONDECYT grant no. 1080335). M. R. was also supported by the Chilean Center for Astrophysics FONDAP grant no. 15010003. A. S. was supported by the Deutsche Forschungsgemeinschaft Priority Program 1177. We are grateful to M. Albrecht for help with the LABOCA data reduction and to L. Hill for making Fig. 1a. The National Radio Astronomy Observatory is a facility of the US National Science Foundation operated under cooperative agreement by Associated Universities, Inc.	Abergel A, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116483; Ade PAR, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116473; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bigiel F, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L13; Chomiuk L, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/197; Coupeaud A, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201116945; Dale DA, 2009, ASTROPHYS J, V703, P517, DOI 10.1088/0004-637X/703/1/517; Draine BT, 2007, ASTROPHYS J, V663, P866, DOI 10.1086/518306; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; DUFOUR RJ, 1984, IAU SYMP, P353; Engelbracht CW, 2008, ASTROPHYS J, V678, P804, DOI 10.1086/529513; Galametz M, 2012, MON NOT R ASTRON SOC, V425, P763, DOI 10.1111/j.1365-2966.2012.21667.x; Galametz M, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201014904; Hunter DA, 2010, ASTRON J, V139, P447, DOI 10.1088/0004-6256/139/2/447; Krumholz MR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/9; Lada CJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/190; Leaman R, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/33; Lee H, 2005, ASTROPHYS J, V620, P223, DOI 10.1086/427019; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Leroy AK, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/12; Mannucci F, 2009, MON NOT R ASTRON SOC, V398, P1915, DOI 10.1111/j.1365-2966.2009.15185.x; McMillan PJ, 2011, MON NOT R ASTRON SOC, V414, P2446, DOI 10.1111/j.1365-2966.2011.18564.x; Nikolic S, 2007, ASTRON ASTROPHYS, V471, P561, DOI 10.1051/0004-6361:20067034; Schruba A, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/6/138; Siringo G, 2009, ASTRON ASTROPHYS, V497, P945, DOI 10.1051/0004-6361/200811454; Taylor CL, 1998, ASTRON J, V116, P2746, DOI 10.1086/300655; Taylor CL, 2001, ASTRON ASTROPHYS, V366, P811, DOI 10.1051/0004-6361:20000337; Vassilev V, 2008, ASTRON ASTROPHYS, V490, P1157, DOI 10.1051/0004-6361:200810459; Verdugo C., 2012, THESIS U CHILE; Zhang HX, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/47	30	42	42	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					487	489		10.1038/nature11933	http://dx.doi.org/10.1038/nature11933			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538829	Green Submitted			2022-12-28	WOS:000316682800040
J	Zemach, A; Kim, MY; Hsieh, PH; Coleman-Derr, D; Eshed-Williams, L; Thao, K; Harmer, SL; Zilberman, D				Zemach, Assaf; Kim, M. Yvonne; Hsieh, Ping-Hung; Coleman-Derr, Devin; Eshed-Williams, Leor; Thao, Ka; Harmer, Stacey L.; Zilberman, Daniel			The Arabidopsis Nucleosome Remodeler DDM1 Allows DNA Methyltransferases to Access H1-Containing Heterochromatin	CELL			English	Article							HISTONE H1; TRANSPOSABLE ELEMENTS; CYTOSINE METHYLATION; GENE-EXPRESSION; RNA; MAINTENANCE; RETROTRANSPOSITION; DEMETHYLATION; DYNAMICS; PATTERNS	Nucleosome remodelers of the DDM1/Lsh family are required for DNA methylation of transposable elements, but the reason for this is unknown. How DDM1 interacts with other methylation pathways, such as small-RNA-directed DNA methylation (RdDM), which is thought to mediate plant asymmetric methylation through DRM enzymes, is also unclear. Here, we show that most asymmetric methylation is facilitated by DDM1 and mediated by the methyltransferase CMT2 separately from RdDM. We find that heterochromatic sequences preferentially require DDM1 for DNA methylation and that this preference depends on linker histone H1. RdDM is instead inhibited by heterochromatin and absolutely requires the nucleosome remodeler DRD1. Together, DDM1 and RdDM mediate nearly all transposon methylation and collaborate to repress transposition and regulate the methylation and expression of genes. Our results indicate that DDM1 provides DNA methyltransferases access to H1-containing heterochromatin to allow stable silencing of transposable elements in cooperation with the RdDM pathway.	[Zemach, Assaf; Kim, M. Yvonne; Hsieh, Ping-Hung; Coleman-Derr, Devin; Eshed-Williams, Leor; Thao, Ka; Harmer, Stacey L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	danielz@berkeley.edu	Zhu, Anyu/J-8298-2012	Zilberman, Daniel/0000-0002-0123-8649; Zemach, Assaf/0000-0003-3282-4445; Harmer, Stacey/0000-0001-6813-6682; Eshed Williams, Leor/0000-0002-2766-2608	Jane Coffin Childs Memorial Fund for Medical Research; Taiwan Ministry of Education Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069418] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Taiwan Ministry of Education Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Toshiro Nishimura for computational support, Minyong Chung for Illumina sequencing, and Robert Fischer for critical reading of the manuscript. A.Z. was supported by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. P-H.H. is supported by a Taiwan Ministry of Education Scholarship. D.Z. is a Young Investigator of the Arnold and Mabel Beckman Foundation.	Ahmed I, 2011, NUCLEIC ACIDS RES, V39, P6919, DOI 10.1093/nar/gkr324; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Blevins T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005932; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Iyer VR, 2012, TRENDS CELL BIOL, V22, P250, DOI 10.1016/j.tcb.2012.02.004; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Probst AV, 2004, PLANT CELL, V16, P1021, DOI 10.1105/tpc.018754; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Raghuram N, 2009, BIOCHEM CELL BIOL, V87, P189, DOI 10.1139/O08-127; Rea M, 2012, PLANT J, V71, P776, DOI 10.1111/j.1365-313X.2012.05028.x; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; You WH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-51; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	49	630	647	8	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					193	205		10.1016/j.cell.2013.02.033	http://dx.doi.org/10.1016/j.cell.2013.02.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540698	Green Accepted, Bronze			2022-12-28	WOS:000316853700016
J	Chapman, ALN				Chapman, Ann L. N.			Outpatient parenteral antimicrobial therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFECTIOUS-DISEASE CONSULTATION; ANTIBIOTIC-THERAPY; JOINT INFECTIONS; MANAGEMENT; ENDOCARDITIS; EXPERIENCE; DIAGNOSIS; OPAT; UK; GUIDELINES		Sheffield Teaching Hosp NHS Foundat Trust, Dept Infect & Trop Med, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Chapman, ALN (corresponding author), Sheffield Teaching Hosp NHS Foundat Trust, Dept Infect & Trop Med, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England.	ann.chapman@sth.nhs.uk						Amodeo MR, 2009, J INFECTION, V59, P387, DOI 10.1016/j.jinf.2009.09.009; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Barr DA, 2012, EUR J CLIN MICROBIOL, V31, P2611, DOI 10.1007/s10096-012-1604-z; Barr DA, 2012, INT J ANTIMICROB AG, V39, P407, DOI 10.1016/j.ijantimicag.2012.01.016; Bazaz R, 2010, J ANTIMICROB CHEMOTH, V65, P1510, DOI 10.1093/jac/dkq152; Chapman ALN, 2012, J ANTIMICROB CHEMOTH, V67, P1053, DOI 10.1093/jac/dks003; Chapman ALN, 2009, J ANTIMICROB CHEMOTH, V64, P1316, DOI 10.1093/jac/dkp343; Chary A, 2006, CLIN INFECT DIS, V43, P1290, DOI 10.1086/508456; Corwin P, 2005, BRIT MED J, V330, P129, DOI 10.1136/bmj.38309.447975.EB; CREST, 2005, GUID MAN CELL AD; Department of Health, 2011, ANT STEW START SMART; Duncan CJA, 2012, INT J CLIN PHARM-NET, V34, P410, DOI 10.1007/s11096-012-9637-z; Esposito S, 2007, J CHEMOTHERAPY, V19, P417, DOI 10.1179/joc.2007.19.4.417; Gilchrist M, 2008, J ANTIMICROB CHEMOTH, V62, P177, DOI 10.1093/jac/dkn152; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Heintz BH, 2011, ANN PHARMACOTHER, V45, P1329, DOI 10.1345/aph.1Q240; Howden BP, 2002, MED J AUSTRALIA, V176, P440, DOI 10.5694/j.1326-5377.2002.tb04450.x; Ingram PR, 2008, RESPIROLOGY, V13, P893, DOI 10.1111/j.1440-1843.2008.01370.x; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis346, 10.1093/cid/cis460]; Mackintosh CL, 2011, J ANTIMICROB CHEMOTH, V66, P408, DOI 10.1093/jac/dkq445; Marwick C, 2011, J ANTIMICROB CHEMOTH, V66, P387, DOI 10.1093/jac/dkq362; Matthews PC, 2008, J ANTIMICROB CHEMOTH, V61, P226; Montalto M, 1998, MED J AUSTRALIA, V168, P277, DOI 10.5694/j.1326-5377.1998.tb140161.x; Nathwani D, 2000, CLIN MICROBIOL INFEC, V6, P464, DOI 10.1046/j.1469-0691.2000.00113.x; Partridge DG, 2012, POSTGRAD MED J, V88, P377, DOI 10.1136/postgradmedj-2011-130355; Phoenix G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4955; Royal College of Nursing, 2010, STAND INF THER; RUCKER RW, 1974, PEDIATRICS, V54, P358; Seaton RA, 2005, J ANTIMICROB CHEMOTH, V55, P764, DOI 10.1093/jac/dki092; Sharma R, 2005, AM J MED SCI, V330, P60, DOI 10.1097/00000441-200508000-00002; Shrestha NK, 2012, J HOSP MED, V7, P365, DOI 10.1002/jhm.1902; Teuffel O, 2011, ANN ONCOL, V22, P2358, DOI 10.1093/annonc/mdq745; Tice AD, 1999, CLIN INFECT DIS, V29, P1394, DOI 10.1086/313503; Tice AD, 2004, CLIN INFECT DIS, V38, P1651, DOI 10.1086/420939	35	26	26	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1585	10.1136/bmj.f1585	http://dx.doi.org/10.1136/bmj.f1585			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117WO	23532865				2022-12-28	WOS:000316984000008
J	Rasmussen, J				Rasmussen, Jill			Would doctors routinely asking older patients about their memory improve dementia outcomes? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Clin Commissioning Grp, E Surrey CR3 5QX, Caterham, England		Rasmussen, J (corresponding author), Clin Commissioning Grp, E Surrey CR3 5QX, Caterham, England.	jill.Rasmussen@virgin.net						All Party Parliamentary Group on Dementia, 2012, UNL DIAGN; Alzheimer's Society, DEM 2012 NAT CHALL; Ballard C, 2006, J QUAL RES DEMENTIA, V2, P14; Ballard C, 2013, HELPING YOU ASSESS C; Burns A, 2009, BMJ, V338, P405; De Mendonca Lima CA, 2012, COMPANION PRIMARY CA, P571; Department of Health, 2009, CLIN HLTH EC CAS EAR; Department of Health, 2012, PRIM MIN CHALL DEM D; Department of Health, 2009, LIVING WELL DEMENTIA; Greaves N., 2011, J CARE SERVICES MANA, V5, P49, DOI DOI 10.1179/175016811X12883685967016; NHS Public Health Resource Unit, 2009, APPR SCREEN ALZH DIS; NICE, 2011, NICE SCIE GUID SUPP; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2	13	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1780	10.1136/bmj.f1780	http://dx.doi.org/10.1136/bmj.f1780			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WO	23532870				2022-12-28	WOS:000316984000015
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN The ethical gift box: suggestions for improving the ethical conduct of doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						[Anonymous], 2013, BMA NEWS        0119, P4; Dyer C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8686; Osler W, AEQUANIMITAS OTHER A; Osler W., 1899, ALBANY MED ANN, V20, P307; Penfield W, 1949, CMAJ, V61, P69	5	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2013	346								f1915	10.1136/bmj.f1915	http://dx.doi.org/10.1136/bmj.f1915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117VT	23529984				2022-12-28	WOS:000316981900003
J	Petley, DN				Petley, David N.			Characterizing Giant Landslides	SCIENCE			English	Editorial Material							AVALANCHE; MOBILITY		Univ Durham, Dept Geog, Durham DH1 3LE, England	Durham University	Petley, DN (corresponding author), Univ Durham, Dept Geog, Durham DH1 3LE, England.	d.n.petley@durham.ac.uk						Crosta GB, 2009, GEOMORPHOLOGY, V103, P1, DOI 10.1016/j.geomorph.2008.04.007; Dammeier F, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002037; Ekstrom G, 2013, SCIENCE, V339, P1416, DOI 10.1126/science.1232887; Feng Z, 2011, NAT HAZARD EARTH SYS, V11, P1559, DOI 10.5194/nhess-11-1559-2011; Heim A., 1882, GESELL Z, V34, P74; Huggel C, 2005, NAT HAZARD EARTH SYS, V5, P173, DOI 10.5194/nhess-5-173-2005; Kao H, 2012, LANDSLIDES, V9, P557, DOI 10.1007/s10346-012-0322-z; Korup O, 2007, EARTH PLANET SC LETT, V261, P578, DOI 10.1016/j.epsl.2007.07.025; Legros F, 2002, ENG GEOL, V63, P301, DOI 10.1016/S0013-7952(01)00090-4; Schneider D, 2011, EARTH SURF PROC LAND, V36, P1948, DOI 10.1002/esp.2218; Stead D., 2012, LANDSLIDES	11	17	20	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1395	1396		10.1126/science.1236165	http://dx.doi.org/10.1126/science.1236165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520102				2022-12-28	WOS:000316740700031
J	Noble, DJ; Casalino, LP				Noble, Douglas J.; Casalino, Lawrence P.			Can Accountable Care Organizations Improve Population Health? Should They Try?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Noble, Douglas J.; Casalino, Lawrence P.] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA	Cornell University	Noble, DJ (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 E 67th St, New York, NY 10065 USA.	djn2004@med.cornell.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				Gourevitch Marc N, 2012, Am J Public Health, V102 Suppl 3, pS322, DOI 10.2105/AJPH.2011.300642; Institute of Medicine of the National Academies, 2011, FOR THE PUBLICS HEAL; Magnan S, 2012, ACHIEVING ACCOUNTABI; Stiefel M, 2012, INSTITUTE FOR HEALTH; Stine NW, 2013, JAMA-J AM MED ASSOC, V309, P449, DOI 10.1001/jama.2012.154302; UCLA Public Health, 2012, UCLA PUBLIC HEALTH 3	6	46	46	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1119	1120		10.1001/jama.2013.592	http://dx.doi.org/10.1001/jama.2013.592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FF	23512057				2022-12-28	WOS:000316276500023
J	Bolton, P				Bolton, Paul			Mental health in Iraq: issues and challenges	LANCET			English	Editorial Material							CURRENT SITUATION		[Bolton, Paul] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD 21205 USA; [Bolton, Paul] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bolton, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD 21205 USA.	pbolton@jhsph.edu						Al-Obaidi A, 2010, INTERVENTION, V8, P40, DOI 10.1097/WTF.0b013e3283387adf; Alhasnawi S, 2009, WORLD PSYCHIATRY, V8, P97; Bolton P, TORTURE IN PRESS; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Sadik S, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-26; Sharma S, 2011, INTERVENTION, V9, P332; Webster PC, 2011, LANCET, V378, P863, DOI 10.1016/S0140-6736(11)61399-8; WHO, MENT HLTH ATL 2011 I; WHO Ministry of Health Iraq, 2006, WHO AIMS REP MENT HL	9	17	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					879	881		10.1016/S0140-6736(13)60637-6	http://dx.doi.org/10.1016/S0140-6736(13)60637-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23499027				2022-12-28	WOS:000316069700005
J	McKee, M				McKee, Martin			The future of England's healthcare lies in the hands of competition lawyers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GO		London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1322; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1634	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2013	346								f1733	10.1136/bmj.f1733	http://dx.doi.org/10.1136/bmj.f1733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VT	23502712	Green Submitted			2022-12-28	WOS:000316325000007
J	Mohseni, SM; Sani, SR; Persson, J; Nguyen, TNA; Chung, S; Pogoryelov, Y; Muduli, PK; Iacocca, E; Eklund, A; Dumas, RK; Bonetti, S; Deac, A; Hoefer, MA; Akerman, J				Mohseni, S. M.; Sani, S. R.; Persson, J.; Nguyen, T. N. Anh; Chung, S.; Pogoryelov, Ye.; Muduli, P. K.; Iacocca, E.; Eklund, A.; Dumas, R. K.; Bonetti, S.; Deac, A.; Hoefer, M. A.; Akerman, J.			Spin Torque-Generated Magnetic Droplet Solitons	SCIENCE			English	Article							WAVES; EXCITATION; STATES	Dissipative solitons have been reported in a wide range of nonlinear systems, but the observation of their magnetic analog has been experimentally challenging. Using spin transfer torque underneath a nanocontact on a magnetic thin film with perpendicular magnetic anisotropy (PMA), we have observed the generation of dissipative magnetic droplet solitons and report on their rich dynamical properties. Micromagnetic simulations identify a wide range of automodulation frequencies, including droplet oscillatory motion, droplet "spinning," and droplet "breather" states. The droplet can be controlled by using both current and magnetic fields and is expected to have applications in spintronics, magnonics, and PMA-based domain-wall devices.	[Mohseni, S. M.; Sani, S. R.; Nguyen, T. N. Anh; Chung, S.; Eklund, A.; Bonetti, S.; Akerman, J.] KTH Royal Inst Technol, Sch Informat & Commun Technol, S-16440 Kista, Sweden; [Mohseni, S. M.; Sani, S. R.; Persson, J.; Akerman, J.] NanOsc AB, Electrum 205, S-16440 Kista, Sweden; [Chung, S.; Pogoryelov, Ye.; Muduli, P. K.; Iacocca, E.; Dumas, R. K.; Akerman, J.] Univ Gothenburg, Dept Phys, S-41296 Gothenburg, Sweden; [Muduli, P. K.] Indian Inst Technol Delhi, Dept Phys, New Delhi 110016, India; [Bonetti, S.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Deac, A.] Helmholtz Zentrum Dresden Rossendorf eV, Inst Ion Beam Phys & Mat Res, D-01314 Dresden, Germany; [Hoefer, M. A.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA	Royal Institute of Technology; University of Gothenburg; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Stanford University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of North Carolina; North Carolina State University	Akerman, J (corresponding author), KTH Royal Inst Technol, Sch Informat & Commun Technol, S-16440 Kista, Sweden.	johan.akerman@physics.gu.se	Bonetti, Stefano/U-1333-2019; Chung, Sunjae/B-9998-2012; Deac, Alina M/D-2961-2012; Mohseni, Seyed Majid/AAE-1636-2019; Pogoryelov, Yevgen/A-9693-2009; Hoefer, Mark/AAD-2373-2019; Iacocca, Ezio/Y-5399-2019; Muduli, Pranaba K/B-9334-2008; Dumas, Randy K/E-3077-2010; Eklund, Anders J./L-5152-2016; Åkerman, Johan/B-5726-2008; Bonetti, Stefano/A-9737-2009	Bonetti, Stefano/0000-0001-9352-2411; Chung, Sunjae/0000-0002-9970-0060; Deac, Alina M/0000-0002-8450-7313; Mohseni, Seyed Majid/0000-0001-5626-533X; Pogoryelov, Yevgen/0000-0001-5867-425X; Hoefer, Mark/0000-0001-5883-6562; Iacocca, Ezio/0000-0002-8870-5106; Muduli, Pranaba K/0000-0002-0061-8455; Dumas, Randy K/0000-0001-5505-2172; Eklund, Anders J./0000-0003-1271-1814; Åkerman, Johan/0000-0002-3513-6608; Bonetti, Stefano/0000-0001-9352-2411	European Commission [ICT-257159 "MACALO"]; Swedish Foundation for Strategic Research; Swedish Research Council; Knut and Alice Wallenberg Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the European Commission FP7 contract ICT-257159 "MACALO," the Swedish Foundation for Strategic Research, the Swedish Research Council, and the Knut and Alice Wallenberg Foundation. J.A. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Akhmediev N., 2008, LECT NOTE PHYS, V751, P1; Barland S, 2002, NATURE, V419, P699, DOI 10.1038/nature01049; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; BESPYATYKH YI, 1994, PHYS LETT A, V184, P198, DOI 10.1016/0375-9601(94)90777-3; Bonetti S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.217204; Boulle O, 2011, MAT SCI ENG R, V72, pIII, DOI 10.1016/j.mser.2011.04.001; Hoefer MA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214433; Hoefer MA, 2012, PHYSICA D, V241, P890, DOI 10.1016/j.physd.2012.02.003; Hoefer MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054432; IVANOV BA, 1977, ZH EKSP TEOR FIZ+, V72, P2000; KOSEVICH AM, 1990, PHYS REP, V194, P117, DOI 10.1016/0370-1573(90)90130-T; Kruglyak VV, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/26/264001; LANE SL, 1993, PHYS REV LETT, V70, P830, DOI 10.1103/PhysRevLett.70.830; Manfrini M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3263727; MELO F, 1993, PHYS REV LETT, V71, P3283, DOI 10.1103/PhysRevLett.71.3283; Mohseni SM, 2011, PHYS STATUS SOLIDI-R, V5, P432, DOI 10.1002/pssr.201105375; Muduli PK, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.140408; Pufall MR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1875762; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; Rippard WH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014426; ROTERMUND HH, 1991, PHYS REV LETT, V66, P3083, DOI 10.1103/PhysRevLett.66.3083; Slavin A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237201; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Slonczewski JC, 1999, J MAGN MAGN MATER, V195, pL261, DOI 10.1016/S0304-8853(99)00043-8; Taranenko VB, 1998, PHYS REV LETT, V81, P2236, DOI 10.1103/PhysRevLett.81.2236; Umbanhowar PB, 1996, NATURE, V382, P793, DOI 10.1038/382793a0; ZABUSKY NJ, 1965, PHYS REV LETT, V15, P240, DOI 10.1103/PhysRevLett.15.240	29	211	218	7	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1295	1298		10.1126/science.1230155	http://dx.doi.org/10.1126/science.1230155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493707				2022-12-28	WOS:000316053400031
J	Chhatriwalla, AK; Amin, AP; Kennedy, KF; House, JA; Cohen, DJ; Rao, SV; Messenger, JC; Marso, SP				Chhatriwalla, Adnan K.; Amin, Amit P.; Kennedy, Kevin F.; House, John A.; Cohen, David J.; Rao, Sunil V.; Messenger, John C.; Marso, Steven P.		Natl Cardiovasc Data Registry	Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITION; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; ANTITHROMBOTIC THERAPY; ECONOMIC-EVALUATION; PROGNOSTIC IMPACT; PROPENSITY SCORE; ISCHEMIC EVENTS; RISK; BIVALIRUDIN	Importance Bleeding is the most common complication after percutaneous coronary intervention (PCI) and is associated with increased morbidity and health care costs. The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear. Objectives To describe the association between bleeding events and in-hospital mortality after PCI and to estimate the adjusted population attributable risk (estimated as the proportion of mortality risk associated with bleeding events), risk difference, and number needed to harm (NNH) for bleeding-related in-hospital mortality after PCI. Design, Setting, and Patients Data from 3 386 688 procedures in the CathPCI Registry performed in the United States between 2004 and 2011 were analyzed. The population attributable risk was calculated after adjustment for baseline demographic, clinical, and procedural variables. To calculate the NNH for bleeding-related mortality, a propensity-matched analysis was performed. Main Outcome Measures In-hospital mortality. Results There were 57 246 bleeding events (1.7%) and 22 165 in-hospital deaths (0.65%) in 3 386 688 PCI procedures. The adjusted population attributable risk for mortality related to major bleeding was 12.1% (95% CI, 11.4%-12.7%) in the entire CathPCI cohort. The propensity-matched population consisted of 56 078 procedures with a major bleeding event and 224 312 controls. In this matched cohort, major bleeding was associated with increased in-hospital mortality (5.26% vs 1.87%; risk difference, 3.39% [95% CI, 3.20%-3.59%]; NNH=29 [95% CI, 28-31]; P < .001). The association between major bleeding and in-hospital mortality was observed in all strata of preprocedural bleeding risk (low: 1.62% vs 0.17%; risk difference, 1.45% [95% CI, 1.13%-1.77%], NNH=69 [95% CI, 57-88], P < .001; intermediate: 3.27% vs 0.71%; risk difference, 2.56% [95% CI, 2.33%-2.79%], NNH=39 [95% CI, 36-43], P < .001; and high: 8.16% vs 3.45%; risk difference, 4.71% [95% CI, 4.35%-5.07%], NNH=21 [95% CI, 20-23], P < .001). Although both access-site and non-access-site bleeding were associated with increased in-hospital mortality (2.73% vs 1.87%; risk difference, 0.86% [95% CI, 0.66%-1.05%], NNH=117 [95% CI, 95-151], P < .001; and 8.25% vs 1.87%; risk difference, 6.39% [95% CI, 6.04%-6.73%], NNH=16 [95% CI, 15-17], P < .001, respectively), the NNH was lower for nonaccess bleeding. Conclusions and Relevance In a large registry of patients undergoing PCI, post-procedural bleeding events were associated with increased risk of in-hospital mortality, with an estimated 12.1% of deaths related to bleeding complications. JAMA. 2013;309(10):1022-1029 www.jama.com	[Kennedy, Kevin F.; House, John A.] St Lukes Mid Amer Heart Inst, Dept Biostat, Kansas City, MO 64111 USA; [Chhatriwalla, Adnan K.; Cohen, David J.; Marso, Steven P.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Chhatriwalla, Adnan K.; Cohen, David J.; Marso, Steven P.] Univ Missouri Kansas City, Sch Med, Dept Internal Med, Div Cardiol, Kansas City, MO USA; [Amin, Amit P.] Washington Univ, Sch Med, Dept Internal Med, Div Cardiol, St Louis, MO 63110 USA; [Rao, Sunil V.] Duke Clin Res Inst, Dept Internal Med, Div Cardiol, Durham, NC USA; [Messenger, John C.] Univ Colorado Denver, Dept Internal Med, Div Cardiol, Denver, CO USA; [Messenger, John C.] Denver VA Med Ctr, Denver, CO USA	Saint Luke's Mid America Heart Institute; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Chhatriwalla, AK (corresponding author), St Lukes Mid Amer Heart Inst, 4300 Wornall Rd,Ste 2000, Kansas City, MO 64111 USA.	achhatri-walla@saint-lukes.org			Medtronic; Edwards Lifesciences; Abbott Vascular; Boston Scientific; Eli Lilly; AstraZeneca; Biomet Inc; Daiichii Sankyo; Medicines Company; Novo Nordisk; Amylin Pharmaceuticals; Volcano Corporation; Terumo Medical; American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR)	Medtronic(Medtronic); Edwards Lifesciences; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Biomet Inc; Daiichii Sankyo; Medicines Company; Novo Nordisk(Novo Nordisk); Amylin Pharmaceuticals(Bristol-Myers Squibb); Volcano Corporation; Terumo Medical; American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR)(General Electric)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chhatriwalla reports that he will be receiving speaking honoraria from Edwards Lifesciences to be paid directly to Saint Luke's Hospital Foundation of Kansas City. Mr House reports receiving consulting honoraria from Vita Solutions and KU Medical Center. Dr Cohen reports medical board membership for Medtronic and Abbott Vascular and reports receiving research support from Medtronic, Edwards Lifesciences, Abbott Vascular, Boston Scientific, Eli Lilly, AstraZeneca, Biomet Inc, and Daiichii Sankyo; consultant honoraria from AstraZeneca, Eli Lilly, Merck, and Janssen Pharmaceuticals; and speaking honoraria from St Jude Medical and Eli Lilly. Dr Rao reports receiving research support and consultant honoraria from The Medicines Company. Dr Marso reports that all compensation for research activities, including research grants and consulting fees from The Medicines Company, Novo Nordisk, Abbott Vascular, Amylin Pharmaceuticals, Boston Scientific, Volcano Corporation, and Terumo Medical, was paid directly to the Saint Luke's Hospital Foundation of Kansas City. No other disclosures were reported.; This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR).	[Anonymous], 2010, AHA HOSP STAT 2011 E; Aronow HD, 2001, AM HEART J, V142, P799, DOI 10.1067/mhj.2001.119371; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1202, DOI 10.1002/pds.1673; Bender R, 2007, STAT MED, V26, P5586, DOI 10.1002/sim.3061; Bender R, 2010, CONTEMP CLIN TRIALS, V31, P498, DOI 10.1016/j.cct.2010.07.005; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lindsey JB, 2009, JACC-CARDIOVASC INTE, V2, P1074, DOI 10.1016/j.jcin.2009.09.002; Lopes RD, 2009, J AM COLL CARDIOL, V53, P1021, DOI 10.1016/j.jacc.2008.12.021; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Mehran R, 2009, EUR HEART J SUPPL, V11, pC4, DOI 10.1093/eurheartj/sup011; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Sanborn TA, 2010, CIRC-CARDIOVASC INTE, V3, P57, DOI 10.1161/CIRCINTERVENTIONS.109.896704; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Suh JW, 2011, J AM COLL CARDIOL, V58, P1750, DOI 10.1016/j.jacc.2011.07.021; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459	33	201	211	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1022	1029		10.1001/jama.2013.1556	http://dx.doi.org/10.1001/jama.2013.1556			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483177	Bronze			2022-12-28	WOS:000315938700031
J	Rao, VL; Rangarajan, V				Rao, Vijaya L.; Rangarajan, Vibhav			Chest Pain and an Angiographic Abnormality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-ARTERY DISSECTION; MANAGEMENT		[Rao, Vijaya L.; Rangarajan, Vibhav] Loyola Univ, Med Ctr, Dept Internal Med, Maywood, IL 60153 USA	Loyola University Chicago	Rao, VL (corresponding author), Loyola Univ, Med Ctr, Dept Internal Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	vijaya.l.rao@gmail.com						Adlam D, 2010, J INVASIVE CARDIOL, V22, P549; Almafragi A, 2010, CARDIOL J, V17, P92; Cini Roberto, 2008, Interact Cardiovasc Thorac Surg, V7, P943, DOI 10.1510/icvts.2008.182345; Hofmann U, 2012, HERZ, V37, P338, DOI 10.1007/s00059-011-3522-8; Morrow D. A., 2011, BRAUNWALDS HEART DIS, P1210; Mortensen KH, 2009, CATHETER CARDIO INTE, V74, P710, DOI 10.1002/ccd.22115; Motreff P, 2010, CARDIOLOGY, V115, P10, DOI 10.1159/000244608; Paraskevaidis S, 2010, OPEN CARDIOVASC MED, V4, P178, DOI 10.2174/1874192401004010178; Schmid J, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-22; Shamloo BK, 2010, J INVASIVE CARDIOL, V22, P222	10	0	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1030	1031		10.1001/jama.2013.1865	http://dx.doi.org/10.1001/jama.2013.1865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483178				2022-12-28	WOS:000315938700032
J	Katlama, C; Deeks, SG; Autran, B; Martinez-Picado, J; van Lunzen, J; Rouzioux, C; Miller, M; Vella, S; Schmitz, JE; Ahlers, J; Richman, DD; Sekaly, RP				Katlama, Christine; Deeks, Steven G.; Autran, Brigitte; Martinez-Picado, Javier; van Lunzen, Jan; Rouzioux, Christine; Miller, Michael; Vella, Stefano; Schmitz, Joern E.; Ahlers, Jeffrey; Richman, Douglas D.; Sekaly, Rafick P.			Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs	LANCET			English	Review							ACTIVE-ANTIRETROVIRAL-THERAPY; CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; CHRONIC VIRAL-INFECTION; NF-KAPPA-B; IMMUNE ACTIVATION; LATENT HIV-1; LYMPH-NODES; VALPROIC ACID; MICROBIAL TRANSLOCATION	Antiretroviral therapy for HIV infection needs lifelong access and strict adherence to regimens that are both expensive and associated with toxic effects. A curative intervention will be needed to fully stop the epidemic. The failure to eradicate HIV infection during long-term antiretroviral therapy shows the intrinsic stability of the viral genome in latently infected CD4T cells and other cells, and possibly a sustained low-level viral replication. Heterogeneity in latently infected cell populations and homoeostatic proliferation of infected cells might affect the dynamics of virus production and persistence. Despite potent antiretroviral therapy, chronic immune activation, inflammation, and immune dysfunction persist, and are likely to have important effects on the size and distribution of the viral reservoir. The inability of the immune system to recognise cells harbouring latent virus and to eliminate cells actively producing virus is the biggest challenge to finding a cure. We look at new approaches to unravelling the complex virus-host interactions that lead to persistent infection and latency, and discuss the rationale for combination of novel treatment strategies with available antiretroviral treatment options to cure HIV.	[Katlama, Christine] Univ Paris 06, Dept Infect Dis, Pitie Salpetriere Hosp, Paris, France; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Autran, Brigitte] Univ Paris 06, Lab Immun & Infect, Hosp Pitie Salpetriere, Paris, France; [Martinez-Picado, Javier] ICREA, AIDS Res Inst IrsiCaixa, Badalona, Spain; [Martinez-Picado, Javier] Univ Autonoma Barcelona, Badalona, Spain; [van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Hamburg, Germany; [Rouzioux, Christine] Paris Descartes Univ, Necker Hosp, Dept Virol, Paris, France; [Miller, Michael] Merck Res Labs, Dept West Point Discovery Chem, West Point, PA USA; [Vella, Stefano] Super Hlth Inst, Dept Pharmacol & Therapeut Res, Rome, Italy; [Schmitz, Joern E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Richman, Douglas D.] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, Ctr AIDS Res, San Diego, CA 92103 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Med, Ctr AIDS Res, San Diego, CA 92103 USA; [Ahlers, Jeffrey; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; ICREA; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Merck & Company; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Vaccine & Gene Therapy Institute of Florida	Sekaly, RP (corresponding author), Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA.	rpsekaly@vgtifl.org	Martinez-Picado, Javier/G-5507-2012; VELLA, STEFANO/ABI-3368-2020; Schmitz, Joern/A-4929-2018; Vella, Stefano/GZM-0519-2022; VELLA, STEFANO/V-8440-2019	Martinez-Picado, Javier/0000-0002-4916-2129; Schmitz, Joern/0000-0001-8803-0922; VELLA, STEFANO/0000-0003-2347-5984	ORVACS by Foundation Bettencourt Schuller; European Union [223131]; Spanish Ministry of Science and Innovation [SAF2010-21224]; Catalan HIV Vaccine Development Programme (HIVACAT); Department of Veterans Affairs; National Institutes of Health [AI080193, AI69432, AI047745, AI74621, AI306214, AI096113, K24 AI069994]; Delaney AIDS Research Enterprise (DARE) [U19AI096109]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, P01AI080193, P01AI074621, R56AI047745, U19AI096113, R21AI047745, UM1AI069432, R01AI047745, U19AI096109, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028871] Funding Source: NIH RePORTER	ORVACS by Foundation Bettencourt Schuller; European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan HIV Vaccine Development Programme (HIVACAT); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Delaney AIDS Research Enterprise (DARE); ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for CK was provided through ORVACS by Foundation Bettencourt Schuller. JMP was supported by the European Union's Seventh Framework Programme (CHAIN project; grant agreement 223131), the Spanish Ministry of Science and Innovation (grant SAF2010-21224), and the Catalan HIV Vaccine Development Programme (HIVACAT). DDR was supported by the Department of Veterans Affairs, and by awards AI080193, AI69432, AI047745, AI74621, AI306214 (CFAR), and AI096113 (Collaboratory for AIDS Research on Eradication [CARE]) from the National Institutes of Health. SGD was supported by NIH grant award K24 AI069994, and SGD and RPS were supported by Delaney AIDS Research Enterprise (DARE; U19AI096109). We thank Dr Chomont for helpful discussion and valuable insights.	Ahlers JD, 2010, TRENDS IMMUNOL, V31, P120, DOI 10.1016/j.it.2009.12.003; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Bouchat S, 2012, AIDS, V26, P1473, DOI 10.1097/QAD.0b013e32835535f5; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Descours B, 2012, CLIN INFECT DIS, V54, P1495, DOI 10.1093/cid/cis188; Desimmie BA, 2012, MOL THER, V20, P2064, DOI 10.1038/mt.2012.132; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Gallastegui E, 2012, J VIROL, V86, P3795, DOI 10.1128/JVI.05972-11; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Geleziunas R, 2012, INT S HIV EM INF DIS; Goujard C, 2012, ANTIVIR THER, V17, P1001, DOI 10.3851/IMP2273; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Hatano H, J INFECT DI IN PRESS; Henrich TJ, 2012, 19 INT AIDS C WASH D; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hufert FT, 1997, AIDS, V11, P849, DOI 10.1097/00002030-199707000-00003; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Kovochich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018270; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Kvale D, 2006, AIDS, V20, P813, DOI 10.1097/01.aids.0000218544.54586.f1; Levy Y, 2012, CLIN INFECT DIS, V55, P291, DOI 10.1093/cid/cis383; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034134; Lichterfeld M, 2012, JAIDS-J ACQ IMM DEF, V59, P1, DOI 10.1097/QAI.0b013e3182373b77; Lisziewicz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035416; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Lodi S, 2012, ARCH INTERN MED, V172, P1252, DOI 10.1001/archinternmed.2012.2719; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mencarelli A, 2012, ANTIVIR THER, V17, P669, DOI 10.3851/IMP2039; Mitsuyasu R, 2007, ARCH INTERN MED, V167, P597, DOI 10.1001/archinte.167.6.597; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Paton NI, 2012, JAMA-J AM MED ASSOC, V308, P353, DOI 10.1001/jama.2012.6936; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Perez M, 2010, CURR HIV RES, V8, P418, DOI 10.2174/157016210793499312; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Piconi S, 2011, BLOOD, V118, P3263, DOI 10.1182/blood-2011-01-329060; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Rasmussen T, 2012, 19 C RETR INF SEATTL, P370; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Sahu GK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-400; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shishido T, 2012, J VIROL, V86, P9055, DOI 10.1128/JVI.00793-12; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sneller MC, 2011, BLOOD, V118, P6845, DOI 10.1182/blood-2011-09-377804; Spivak A, 19 C RETR OPP INF SE, P48; Stellbrink HJ, 1998, ANTIVIR THER, V3, P209; Stellbrink HJ, 2001, CURR OPIN INFECT DIS, V14, P17, DOI 10.1097/00001432-200102000-00004; Stellbrink HJ, 1997, AIDS, V11, P1103, DOI 10.1097/00002030-199709000-00004; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Tebas P, 2011, 18 C RETR OPP INF BO, P165; Tenner-Racz K, 1998, J EXP MED, V187, P949, DOI 10.1084/jem.187.6.949; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Van Duyne R, 2011, J MOL BIOL, V411, P581, DOI 10.1016/j.jmb.2011.06.001; van Grevenynghe J, 2008, SEMIN IMMUNOL, V20, P196, DOI 10.1016/j.smim.2008.07.008; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; Vandergeeten C, 2011, 5 INT WORKSH HIV PES, P29; Vanham G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-72; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; von Laer Dorothee, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P119; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Wheeler LA, 2011, J CLIN INVEST, V121, P2401, DOI 10.1172/JCI45876; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Wolschendorf F, 2012, J VIROL, V86, P4548, DOI 10.1128/JVI.06726-11; Wolschendorf F, 2010, J VIROL, V84, P8712, DOI 10.1128/JVI.00523-10; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Ye FC, 2012, CELL CYCLE, V11, P1393, DOI 10.4161/cc.19756; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	113	226	256	4	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2109	2117		10.1016/S0140-6736(13)60104-X	http://dx.doi.org/10.1016/S0140-6736(13)60104-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23541541	Green Accepted			2022-12-28	WOS:000320924800034
J	Davies, SC; Fowler, T; Watson, J; Livermore, DM; Walker, D				Davies, Sally C.; Fowler, Tom; Watson, John; Livermore, David M.; Walker, David			Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance	LANCET			English	Editorial Material									[Davies, Sally C.; Fowler, Tom; Walker, David] Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England; [Fowler, Tom] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Watson, John] Hlth Protect Agcy, Hlth Protect Serv HPA Colindale, London, England; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Health Protection Agency; University of East Anglia	Fowler, T (corresponding author), Dept Hlth, Off Chief Med Officer, London SW1A 2NS, England.	Tom.Fowler@nhs.net	Staves, Peter/C-8219-2014; Fowler, Tom/AGT-1933-2022	Fowler, Tom/0000-0002-7258-2279				Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Davies S. C, 2014, ANN REPORT CHIEF MED; Department of Health. Department for Environment Food and Rural Affairs, 2013, UK ANT RES IN PRESS; Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]	5	144	147	5	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1606	1609		10.1016/S0140-6736(13)60604-2	http://dx.doi.org/10.1016/S0140-6736(13)60604-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23489756				2022-12-28	WOS:000319112400008
J	Pedersen, BP; Kumar, H; Waight, AB; Risenmay, AJ; Roe-Zurz, Z; Chau, BH; Schlessinger, A; Bonomi, M; Harries, W; Sali, A; Johri, AK; Stroud, RM				Pedersen, Bjorn P.; Kumar, Hemant; Waight, Andrew B.; Risenmay, Aaron J.; Roe-Zurz, Zygy; Chau, Bryant H.; Schlessinger, Avner; Bonomi, Massimiliano; Harries, William; Sali, Andrej; Johri, Atul K.; Stroud, Robert M.			Crystal structure of a eukaryotic phosphate transporter	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PIRIFORMOSPORA-INDICA; MOLECULAR-DYNAMICS; FORCE-FIELD; PROTEIN; SPECIFICITY; PREDICTION; MECHANISM; SEQUENCE; CARRIERS	Phosphate is crucial for structural and metabolic needs, including nucleotide and lipid synthesis, signalling and chemical energy storage. Proton-coupled transporters of the major facilitator superfamily (MFS) are essential for phosphate uptake in plants and fungi, and also have a function in sensing external phosphate levels as transceptors(1-5). Here we report the 2.9 angstrom structure of a fungal (Piriformospora indica) high-affinity phosphate transporter, PiPT, in an inward-facing occluded state, with bound phosphate visible in the membrane-buried binding site. The structure indicates both proton and phosphate exit pathways and suggests a modified asymmetrical 'rocker-switch' mechanism of phosphate transport. PiPT is related to several human transporter families, most notably the organic cation and anion transporters of the solute carrier family (SLC22), which are implicated in cancer-drug resistance(6,7). We modelled representative cation and anion SLC22 transporters based on the PiPT structure to surmise the structural basis for substrate binding and charge selectivity in this important family. The PiPT structure demonstrates and expands on principles of substrate transport by the MFS transporters and illuminates principles of phosphate uptake in particular.	[Pedersen, Bjorn P.; Kumar, Hemant; Waight, Andrew B.; Risenmay, Aaron J.; Roe-Zurz, Zygy; Chau, Bryant H.; Harries, William; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kumar, Hemant; Johri, Atul K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Schlessinger, Avner; Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Jawaharlal Nehru University, New Delhi; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	stroud@msg.ucsf.edu	Kumar, Hemant/AAW-6086-2021; Pedersen, Bjørn/H-4128-2017; Kumar, Arun/C-9149-2009; Pedersen, Bjørn/AAT-2409-2021	Pedersen, Bjørn/0000-0001-7860-7230; Kumar, Arun/0000-0001-8422-0219; Pedersen, Bjørn/0000-0001-7860-7230; Bonomi, Massimiliano/0000-0002-7321-0004; HARRIES, WILLIAM/0000-0002-6461-4090; Kumar, Hemant/0000-0001-7698-2301	Carlsberg Foundation; Danish Cancer Society; Woods Whelan foundation; Council of Scientific and Industrial Research, Government of India; Jawaharlal Nehru University, New Delhi; NIH [F32 GM088991, U01 GM61390, U54 GM094625, GM24485, GM073210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094625, F32GM088991, R01GM024485, U01GM061390, P50GM073210, U19GM061390, R37GM024485] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Woods Whelan foundation; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru University, New Delhi; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Giacomini for discussions about SLC transporters; P. Nissen for comments that improved the manuscript; J. Holton, G. Meigs, C. Ogata and N. Venugopalan for assistance with synchrotron data collection at the Advanced Light Source and Advanced Photon Source; and C. Waddling, P. Wassam and M. Tessema for technical assistance. B. P. P. was supported by a postdoctoral fellowship from the Carlsberg Foundation and later by a fellowship from the Danish Cancer Society; H. K. by a fellowship from Woods Whelan foundation, Council of Scientific and Industrial Research, Government of India, and a travel grant from Jawaharlal Nehru University, New Delhi.; A.Sc. by NIH postdoctoral fellowship F32 GM088991; A. Sa. by NIH grants U54 GM094625 and U01 GM61390; A. K. J. by a Research Assistant Professorship to do work at UCSF from the American Society for Microbiology; and R. M. S. by NIH grants U54 GM094625, GM24485 and GM073210.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng B, 2001, BIOCHEMISTRY-US, V40, P5511, DOI 10.1021/bi002841o; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keller S, 2006, ACTA CRYSTALLOGR D, V62, P1564, DOI 10.1107/S0907444906040169; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KRUPKA RM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P105, DOI 10.1016/0005-2728(93)90009-5; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Madej MG, 2012, P NATL ACAD SCI USA, V109, pE2970, DOI 10.1073/pnas.1211183109; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P2169, DOI 10.1107/S0907444904016038; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; van Scheltinga ACT, 2003, ACTA CRYSTALLOGR D, V59, P2017, DOI 10.1107/S090744490302122X; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Varma A, 2012, AGR RES, V1, P117, DOI 10.1007/s40003-012-0019-5; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	63	159	168	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					533	536		10.1038/nature12042	http://dx.doi.org/10.1038/nature12042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23542591	Green Accepted, Green Submitted			2022-12-28	WOS:000317984400047
J	Makary, MA				Makary, Martin A.			The Power of Video Recording Taking Quality to the Next Level	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLONOSCOPY		[Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Makary, Martin A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Makary, MA (corresponding author), Johns Hopkins Univ Hosp, Halsted 614,600 N Wolfe St, Baltimore, MD 21287 USA.	mmakary1@jhmi.edu						Armellino D, 2012, CLIN INFECT DIS, V54, P1, DOI 10.1093/cid/cir773; Bishop T., 2011, BALTIMORE SUN   0713; Hu YY, 2012, J AM COLL SURGEONS, V214, P115, DOI 10.1016/j.jamcollsurg.2011.10.009; Jacobs B, 2010, J VASC INTERV RADIOL, V21, P725, DOI 10.1016/j.jvir.2010.01.030; Makary MA, 2012, NEWSWEEK; Raghavendra M, 2010, WORLD J GASTROENTERO, V16, P458, DOI 10.3748/wjg.v16.i4.458; Rex DK, 2010, AM J GASTROENTEROL, V105, P2312, DOI 10.1038/ajg.2010.245; Rosenstein AH, 2005, AM J NURS, V105, P54, DOI 10.1097/00000446-200501000-00025; Smith M, 2012, BEST CARE LOWER COST	9	54	55	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1591	1592		10.1001/jama.2013.595	http://dx.doi.org/10.1001/jama.2013.595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23546452				2022-12-28	WOS:000317599500019
J	Valentine, DL				Valentine, David L.			MICROBIOLOGY Intraterrestrial lifestyles	NATURE			English	Editorial Material							ABUNDANCE; GROWTH		[Valentine, David L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Valentine, DL (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	valentine@geol.ucsb.edu		Valentine, David/0000-0001-5914-9107	Directorate For Geosciences [0950600] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adams CJ, 2006, APPL ENVIRON MICROB, V72, P1079, DOI 10.1128/AEM.72.2.1079-1085.2006; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Koonin EV, 2011, J COMPUT BIOL, V18, P917, DOI 10.1089/cmb.2010.0185; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Stickland LH, 1934, BIOCHEM J, V28, P1746, DOI 10.1042/bj0281746; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619	9	3	3	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					176	177		10.1038/nature12088	http://dx.doi.org/10.1038/nature12088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23535593				2022-12-28	WOS:000317346300030
J	Smith, EML; Pang, H; Cirrincione, C; Fleishman, S; Paskett, ED; Ahles, T; Bressler, LR; Fadul, CE; Knox, C; Le-Lindqwister, N; Gilman, PB; Shapiro, CL				Smith, Ellen M. Lavoie; Pang, Herbert; Cirrincione, Constance; Fleishman, Stewart; Paskett, Electra D.; Ahles, Tim; Bressler, Linda R.; Fadul, Camilo E.; Knox, Chetaye; Le-Lindqwister, Nguyet; Gilman, Paul B.; Shapiro, Charles L.		Alliance Clinical Trials Oncology	Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; DRUG-INTERACTIONS; RECEIVING TAXANES; KNEE PAIN; PLACEBO; MANAGEMENT; CANCER; EFFICACY; OSTEOARTHRITIS	Importance There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on average pain severity. Design, Setting, and Patients Randomized, double-blind, placebo-controlled crossover trial at 8 National Cancer Institute (NCI)-funded cooperative research networks that enrolled 231 patients who were 25 years or older being treated at community and academic settings between April 2008 and March 2011. Study follow-up was completed July 2012. Stratified by chemotherapeutic drug and comorbid pain risk, patients were randomized to receive either duloxetine followed by placebo or placebo followed by duloxetine. Eligibility required that patients have grade 1 or higher sensory neuropathy according to the NCI Common Terminology Criteria for Adverse Events and at least 4 on a scale of 0 to 10, representing average chemotherapy-induced pain, after paclitaxel, other taxane, or oxaliplatin treatment. Interventions The initial treatment consisted of taking 1 capsule daily of either 30 mg of duloxetine or placebo for the first week and 2 capsules of either 30 mg of duloxetine or placebo daily for 4 additional weeks. Main Outcome Measures The primary hypothesis was that duloxetine would be more effective than placebo in decreasing chemotherapy-induced peripheral neuropathic pain. Pain severity was assessed using the Brief Pain Inventory-Short Form "average pain" item with 0 representing no pain and 10 representing as bad as can be imagined. Results Individuals receiving duloxetine as their initial 5-week treatment reported a mean decrease in average pain of 1.06 (95% CI, 0.72-1.40) vs 0.34 (95% CI, 0.01-0.66) among those who received placebo (P=.003; effect size, 0.513). The observed mean difference in the average pain score between duloxetine and placebo was 0.73 (95% CI, 0.26-1.20). Fifty-nine percent of those initially receiving duloxetine vs 38% of those initially receiving placebo reported decreased pain of any amount. Conclusion and Relevance Among patients with painful chemotherapy-induced peripheral neuropathy, the use of duloxetine compared with placebo for 5 weeks resulted in a greater reduction in pain.	[Smith, Ellen M. Lavoie] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Pang, Herbert; Cirrincione, Constance] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA; [Pang, Herbert] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Fleishman, Stewart] Beth Israel Hosp, Continuum Canc Ctr New York, Canc Support Serv, New York, NY USA; [Fleishman, Stewart] St Lukes Roosevelt, New York, NY USA; [Paskett, Electra D.] Ohio State Univ, Ctr Comprehens Canc, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Ahles, Tim] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA; [Bressler, Linda R.] Alliance Cent Off, Canc & Leukemia Grp B, Chicago, IL USA; [Fadul, Camilo E.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dept Med Hematol Oncol & Neurol, Lebanon, NH 03766 USA; [Gilman, Paul B.] Main Line Hematol & Oncol Associates, Wynnewood, PA USA; [Shapiro, Charles L.] Ohio State Univ, Wexner Med Ctr, Div Oncol, Dept Internal Med, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; Duke University; Duke University; Mount Sinai St. Luke's; Mount Sinai West; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Memorial Sloan Kettering Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University System of Ohio; Ohio State University	Smith, EML (corresponding author), Univ Michigan, Sch Nursing, Room 2151, Ann Arbor, MI 48109 USA.	ellenls@umich.edu		Smith, Ellen/0000-0002-6519-6636	Genentech; NCI; CALGB/Alliance; NATIONAL CANCER INSTITUTE [U10CA031946] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CALGB/Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Smith reported receiving support from CALGB/Alliance for travel to meetings. Dr Paskett reported institutional support from CALGB/Alliance for travel to meetings. Dr Ahles reported receiving support from CALBG/Alliance for travel to meetings. Dr Fadul reported pending institutional grants from Genentech. Dr Gilman reported institutional and direct grants pending from the NCI. No other financial disclosures were made.	Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Atkinson TM, 2010, PAIN MED, V11, P337, DOI 10.1111/j.1526-4637.2009.00774.x; Bakitas MA, 2007, NURS RES, V56, P323, DOI 10.1097/01.NNR.0000289503.22414.79; Barton DL, 2011, SUPPORT CARE CANCER, V19, P833, DOI 10.1007/s00520-010-0911-0; Bril V, 2011, MUSCLE NERVE, V43, P910, DOI 10.1002/mus.22092; Calhoun EA, 2003, INT J GYNECOL CANCER, V13, P741, DOI 10.1111/j.1525-1438.2003.13603.x; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Caraci F, 2011, CURR DRUG METAB, V12, P570; Cavaletti G, 2010, EUR J CANCER, V46, P479, DOI 10.1016/j.ejca.2009.12.008; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Cella D, 2002, J CLIN EPIDEMIOL, V55, P285, DOI 10.1016/S0895-4356(01)00477-2; Chappell AS, 2011, PAIN PRACT, V11, P33, DOI 10.1111/j.1533-2500.2010.00401.x; Chappell AS, 2009, PAIN, V146, P253, DOI 10.1016/j.pain.2009.06.024; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS., BRIEF PAIN INVENTORY; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dodd MJ, 2010, EUR J ONCOL NURS, V14, P101, DOI 10.1016/j.ejon.2009.09.005; Dubois D, 2006, J CLIN ONCOL, V24, P976, DOI 10.1200/JCO.2005.04.0824; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Frakes EP, 2011, CURR MED RES OPIN, V27, P2361, DOI 10.1185/03007995.2011.633502; Frigeni B, 2011, J PERIPHER NERV SYST, V16, P228, DOI 10.1111/j.1529-8027.2011.00351.x; Glueck CJ, 2006, JAMA-J AM MED ASSOC, V295, P1517, DOI 10.1001/jama.295.13.1517; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Griffith KA, 2010, J PERIPHER NERV SYST, V15, P314, DOI 10.1111/j.1529-8027.2010.00292.x; Hall JA, 2010, EXPERT OPIN DRUG SAF, V9, P525, DOI 10.1517/14740338.2010.484418; Hammack JE, 2002, PAIN, V98, P195, DOI 10.1016/S0304-3959(02)00047-7; Hua TC, 2004, BRIT J CLIN PHARMACO, V57, P652, DOI 10.1111/j.1365-2125.2004.02068.x; Huang HQ, 2007, INT J GYNECOL CANCER, V17, P387, DOI 10.1111/j.1525-1438.2007.00794.x; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Kajdasz DK, 2007, CLIN THER, V29, P2536, DOI 10.1016/j.clinthera.2007.12.002; Kaur H, 2011, DIABETES CARE, V34, P818, DOI 10.2337/dc10-1793; Kautio AL, 2011, SUPPORT CARE CANCER, V19, P1991, DOI 10.1007/s00520-010-1043-2; Kautio AL, 2009, ANTICANCER RES, V29, P2601; Kuroi K, 2009, SUPPORT CARE CANCER, V17, P1071, DOI 10.1007/s00520-008-0550-x; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; Marangell LB, 2011, PAIN, V152, P31, DOI 10.1016/j.pain.2010.05.029; Mease PJ, 2011, ARTHRIT CARE RES, V63, P821, DOI 10.1002/acr.20449; Morales-Vidal S, 2012, POSTGRAD MED, V124, P145, DOI 10.3810/pgm.2012.07.2576; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Patroneva A, 2008, DRUG METAB DISPOS, V36, P2484, DOI 10.1124/dmd.108.021527; Postma TJ, 1998, ANN ONCOL, V9, P739, DOI 10.1023/A:1008344507482; Preskorn SH, 2007, J CLIN PSYCHOPHARM, V27, P28, DOI 10.1097/00004714-200702000-00005; Pritchett YL, 2007, PAIN MED, V8, P397, DOI 10.1111/j.1526-4637.2007.00305.x; Rao RD, 2008, CANCER, V112, P2802, DOI 10.1002/cncr.23482; Rao RD, 2007, CANCER-AM CANCER SOC, V110, P2110, DOI 10.1002/cncr.23008; Raskin J, 2005, PAIN MED, V6, P346, DOI 10.1111/j.1526-4637.2005.00061.x; Raskin J, 2006, PAIN MED, V7, P373, DOI 10.1111/j.1526-4637.2006.00207.x; Russell IJ, 2008, PAIN, V136, P432, DOI 10.1016/j.pain.2008.02.024; Saarto T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005454, 10.1002/14651858.CD005454.pub2]; Shimozuma K, 2012, SUPPORT CARE CANCER, V20, P3355, DOI 10.1007/s00520-012-1492-x; Skinner MH, 2003, CLIN PHARMACOL THER, V73, P170, DOI 10.1067/mcp.2003.28; Skljarevski V, 2010, SPINE, V35, pE578, DOI 10.1097/BRS.0b013e3181d3cef6; Smith A Gordon, 2012, Continuum (Minneap Minn), V18, P60, DOI 10.1212/01.CON.0000411568.34085.3e; Smith EML, 2011, J PAIN SYMPTOM MANAG, V42, P822, DOI 10.1016/j.jpainsymman.2011.03.017; Smith EML, 2011, ONCOL NURS FORUM, V38, P133, DOI 10.1188/11.ONF.133-142; Smith EML, 2010, CANCER NURS, V33, P173, DOI 10.1097/NCC.0b013e3181c989a3; Spallone V, 2012, CLIN J PAIN, V28, P726, DOI 10.1097/AJP.0b013e318243075c; Spina E, 2012, CNS DRUGS, V26, P39, DOI 10.2165/11594710-000000000-00000; Stubblefield MD, 2009, J NATL COMPR CANC NE, V7, pS1, DOI 10.6004/jnccn.2009.0078; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Tofthagen C, 2010, J PALLIAT MED, V13, P1389, DOI 10.1089/jpm.2010.0124; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Yang YH, 2012, SUPPORT CARE CANCER, V20, P1491, DOI 10.1007/s00520-011-1237-2	67	555	583	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1359	1367		10.1001/jama.2013.2813	http://dx.doi.org/10.1001/jama.2013.2813			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549581	Bronze, Green Accepted			2022-12-28	WOS:000316934500025
J	Mozaffarian, D; Lemaitre, RN; King, IB; Song, XL; Huang, HY; Sacks, FM; Rimm, EB; Wang, ML; Siscovick, DS				Mozaffarian, Dariush; Lemaitre, Rozenn N.; King, Irena B.; Song, Xiaoling; Huang, Hongyan; Sacks, Frank M.; Rimm, Eric B.; Wang, Molin; Siscovick, David S.			Plasma Phospholipid Long-Chain omega-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; NONFATAL MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE EVENTS; PROPORTIONAL HAZARDS MODEL; CORONARY-HEART-DISEASE; GAMMA-LINOLENIC ACID; ALL-CAUSE MORTALITY; ACUTE LUNG INJURY; FISH CONSUMPTION; EICOSAPENTAENOIC ACID	Background: Long-chain omega-3 polyunsaturated fatty acids (omega 3-PUFAs), including eicosapentaenoic acid (EPA) (20:5 omega-3), docosapentaenoic acid (DPA) (22:5 omega-3), and docosahexaenoic acid (DHA) (22:6 omega-3), have been shown to reduce cardiovascular risk, but effects on cause-specific and total mortality and potential dose-responses remain controversial. Most observational studies have assessed self-reported dietary intake and most randomized trials have tested effects of adding supplements to dietary intake and evaluated secondary prevention, thus limiting inference for dietary omega 3-PUFAs or primary prevention. Objective: To investigate associations of plasma phospholipid EPA, DPA, DHA, and total omega 3-PUFA levels with total and cause-specific mortality among healthy older adults not receiving supplements. Design: Prospective cohort study. Setting: 4 U.S. communities. Participants: 2692 U.S. adults aged 74 years (+/- 5 years) without prevalent coronary heart disease (CHD), stroke, or heart failure at baseline. Measurements: Phospholipid fatty acid levels and cardiovascular risk factors were measured in 1992. Relationships with total and cause-specific mortality and incident fatal or nonfatal CHD and stroke through 2008 were assessed. Results: During 30 829 person-years, 1625 deaths (including 570 cardiovascular deaths), 359 fatal and 371 nonfatal CHD events, and 130 fatal and 276 nonfatal strokes occurred. After adjustment, higher plasma levels of omega 3-PUFA biomarkers were associated with lower total mortality, with extreme-quintile hazard ratios of 0.83 for EPA (95% CI, 0.71 to 0.98; P for trend = 0.005), 0.77 for DPA (CI, 0.66 to 0.90; P for trend = 0.008), 0.80 for DHA (CI, 0.67 to 0.94; P for trend = 0.006), and 0.73 for total omega 3-PUFAs (CI, 0.61 to 0.86; P for trend < 0.001). Lower risk was largely attributable to fewer cardiovascular than noncardiovascular deaths. Individuals in the highest quintile of phospholipid omega 3-PUFA level lived an average of 2.22 more years (CI, 0.75 to 3.13 years) after age 65 years than did those in the lowest quintile. Limitation: Temporal changes in fatty acid levels and misclassification of causes of death may have resulted in underestimated associations, and unmeasured or imperfectly measured covariates may have caused residual confounding. Conclusion: Higher circulating individual and total omega 3-PUFA levels are associated with lower total mortality, especially CHD death, in older adults.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/ABC-2822-2020		National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, N01-HC-85239, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295]; Office of Dietary Supplements of the National Institutes of Health [R01-HL-085710]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085084, N01HC015103, N01HC085079, N01HC085080, N01HC085082, N01HC035129, N01HC055222, N01HC045133, N01HC085083, N01HC085081, N01HC075150, N01HC085086, N01HC085085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295, R01HL085710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023629, R56AG020098, R01AG020098, R01AG015928, R01AG023629, R01AG027058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.; This investigation was supported by the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Dietary Supplements of the National Institutes of Health (R01-HL-085710). The CHS was supported by NHLBI contracts HHSN268201200036C, N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and NHLBI grant HL080295, with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging. See www.chs-nhlbi.org/pi.htm.	Aarsetoey H, 2009, J NUTR, V139, P507, DOI 10.3945/jn.108.096446; Anandan C, 2009, ALLERGY, V64, P840, DOI 10.1111/j.1398-9995.2009.02042.x; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cox D. R., 1984, ANAL SURVIVAL DATA; CUSHMAN M, 1995, CLIN CHEM, V41, P264; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Erkkila AT, 2003, AM J CLIN NUTR, V78, P65, DOI 10.1093/ajcn/78.1.65; Folsom AR, 2004, AM J EPIDEMIOL, V160, P1005, DOI 10.1093/aje/kwh307; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Johnston CS, 2001, J AM COLL NUTR, V20, P623, DOI 10.1080/07315724.2001.10719159; Kumanyika S, 1996, J AM DIET ASSOC, V96, P137, DOI 10.1016/S0002-8223(96)00042-9; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Lee SH, 2009, CIRC J, V73, P2250, DOI 10.1253/circj.CJ-09-0327; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lindberg M, 2008, AM J CLIN NUTR, V88, P722, DOI 10.1093/ajcn/88.3.722; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Mozaffarian D, 2005, J AM COLL CARDIOL, V45, P2015, DOI 10.1016/j.jacc.2005.03.038; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; Mukamal KJ, 2006, J AM GERIATR SOC, V54, P30, DOI 10.1111/j.1532-5415.2005.00561.x; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pontes-Arruda A, 2011, CRIT CARE, V15, DOI 10.1186/cc10267; Pottala JV, 2010, CIRC-CARDIOVASC QUAL, V3, P406, DOI 10.1161/CIRCOUTCOMES.109.896159; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019; ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453; Saini A, 2011, EUR J CLIN MICROBIOL, V30, P393, DOI 10.1007/s10096-010-1099-4; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Siscovick DS, 2003, CIRCULATION, V107, P2632, DOI 10.1161/01.CIR.0000074779.11379.62; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tiesset H, 2011, J NUTR, V141, P1101, DOI 10.3945/jn.110.134585; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACTIV; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254; Zucker DM, 2008, STAT MED, V27, P1911, DOI 10.1002/sim.3159; Zucker DM, 2004, BIOMETRICS, V60, P324, DOI 10.1111/j.0006-341X.2004.00176.x	58	216	222	0	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					515	+		10.7326/0003-4819-158-7-201304020-00003	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00003			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23546563	Green Accepted			2022-12-28	WOS:000317419400002
J	Lamy, A; Devereaux, PJ; Prabhakaran, D; Taggart, DP; Hu, SS; Paolasso, E; Straka, Z; Piegas, LS; Akar, AR; Jain, AR; Noiseux, N; Padmanabhan, C; Bahamondes, JC; Novick, RJ; Vaijyanath, P; Reddy, SK; Tao, L; Olavegogeascoechea, PA; Airan, B; Sulling, TA; Whitlock, RP; Ou, YN; Pogue, J; Chrolavicius, S; Yusuf, S				Lamy, Andre; Devereaux, P. J.; Prabhakaran, Dorairaj; Taggart, David P.; Hu, Shengshou; Paolasso, Ernesto; Straka, Zbynek; Piegas, Leopoldo S.; Akar, Ahmet Ruchan; Jain, Anil R.; Noiseux, Nicolas; Padmanabhan, Chandrasekar; Bahamondes, Juan-Carlos; Novick, Richard J.; Vaijyanath, Prashant; Reddy, Sukesh Kumar; Tao, Liang; Olavegogeascoechea, Pablo A.; Airan, Balram; Sulling, Toomas-Andres; Whitlock, Richard P.; Ou, Yongning; Pogue, Janice; Chrolavicius, Susan; Yusuf, Salim		CORONARY Investigators	Effects of Off-Pump and On-Pump Coronary-Artery Bypass Grafting at 1 Year	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELDERLY-PATIENTS; SURGERY; OUTCOMES; TRANSCATHETER; SMALLER; DESIGN; LIFE	BACKGROUND Previously, we reported that there was no significant difference at 30 days in the rate of a primary composite outcome of death, myocardial infarction, stroke, or new renal failure requiring dialysis between patients who underwent coronary-artery bypass grafting (CABG) performed with a beating-heart technique (off-pump) and those who underwent CABG performed with cardiopulmonary bypass (on-pump). We now report results on quality of life and cognitive function and on clinical outcomes at 1 year. METHODS We enrolled 4752 patients with coronary artery disease who were scheduled to undergo CABG and randomly assigned them to undergo the procedure off-pump or on-pump. Patients were enrolled at 79 centers in 19 countries. We assessed quality of life and cognitive function at discharge, at 30 days, and at 1 year and clinical outcomes at 1 year. RESULTS At 1 year, there was no significant difference in the rate of the primary composite outcome between off-pump and on-pump CABG (12.1% and 13.3%, respectively; hazard ratio with off-pump CABG, 0.91; 95% confidence interval [CI], 0.77 to 1.07; P = 0.24). The rate of the primary outcome was also similar in the two groups in the period between 31 days and 1 year (hazard ratio, 0.79; 95% CI, 0.55 to 1.13; P = 0.19). The rate of repeat coronary revascularization at 1 year was 1.4% in the off-pump group and 0.8% in the on-pump group (hazard ratio, 1.66; 95% CI, 0.95 to 2.89; P = 0.07). There were no significant differences between the two groups at 1 year in measures of quality of life or neurocognitive function. CONCLUSIONS At 1 year after CABG, there was no significant difference between off-pump and on-pump CABG with respect to the primary composite outcome, the rate of repeat coronary revascularization, quality of life, or neurocognitive function. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294.)	[Lamy, Andre; Devereaux, P. J.; Whitlock, Richard P.; Ou, Yongning; Pogue, Janice; Chrolavicius, Susan; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Noiseux, Nicolas] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Novick, Richard J.] London Hlth Sci Ctr, London, ON, Canada; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Jain, Anil R.] SAL Hosp & Med Inst, Ahmadabad, Gujarat, India; [Padmanabhan, Chandrasekar] G Kuppuswamy Naidu Mem Hosp, Coimbatore, Tamil Nadu, India; [Vaijyanath, Prashant] Frontier Lifeline, Dr KM Cherian Heart Fdn, Chennai, Tamil Nadu, India; [Reddy, Sukesh Kumar] Mediciti Hosp, Hyderabad, Andhra Pradesh, India; [Airan, Balram] All India Inst Med Sci, New Delhi, India; [Taggart, David P.] Univ Oxford, Oxford, England; [Hu, Shengshou] Fu Wai Cardiovasc Hosp, Beijing, Peoples R China; [Paolasso, Ernesto] Inst Invest Clin Rosario, Rosario, Santa Fe, Argentina; [Straka, Zbynek] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Piegas, Leopoldo S.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Akar, Ahmet Ruchan] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey; [Bahamondes, Juan-Carlos] Hosp Reg Temuco, Temuco, Chile; [Tao, Liang] Wuhan Asia Heart Hosp, Wuhan, Hubei, Peoples R China; [Sulling, Toomas-Andres] North Estonia Med Ctr, Tallinn, Estonia	McMaster University; Population Health Research Institute; Universite de Montreal; London Health Sciences Centre; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Charles University Prague; Instituto Dante Pazzanese de Cardiologia; Ankara University; Universidad de Chile	Lamy, A (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.	lamya@mcmaster.ca	Olavegogeascoechea, Pablo/Q-2834-2018; Buse, Giovanna Lurati/ABE-6008-2020; Harrer, Jan/M-3637-2017; Gogayeva, Olena/B-8386-2017; Brat, Radim/G-7925-2019; Stevens, Louis-Mathieu/E-6453-2016; Prabhakaran, Dorairaj/B-4147-2011; Akar, Ahmet Ruchan/C-9905-2009; Whitlock, Richard/AAQ-1593-2021; Devereaux, PJ/AAF-2862-2019; Kahraman, Doğan/H-6800-2018; Devereaux, PJ/AAY-1757-2021; Baran, Cagdas/AAM-3369-2020; LAMY, ANDRE/AAS-3855-2021; Hueb, Alexandre/E-6804-2013; Airan, Balram/ABH-1465-2020; Rösler, Álvaro/AAM-4460-2021; Zamvar, Vipin/J-3430-2013; Stocco Guilhen, Jose Cicero/F-2714-2015; Vanek, Tomas/I-7078-2017	Olavegogeascoechea, Pablo/0000-0002-2625-2922; Buse, Giovanna Lurati/0000-0002-8076-5737; Harrer, Jan/0000-0001-7072-2760; Gogayeva, Olena/0000-0002-7338-475X; Brat, Radim/0000-0001-9381-9135; Stevens, Louis-Mathieu/0000-0003-3372-3419; Prabhakaran, Dorairaj/0000-0002-3172-834X; Akar, Ahmet Ruchan/0000-0002-5191-5505; Whitlock, Richard/0000-0002-6863-5884; Kahraman, Doğan/0000-0002-5367-2340; Rösler, Álvaro/0000-0003-4727-3367; Zamvar, Vipin/0000-0003-2447-828X; Stocco Guilhen, Jose Cicero/0000-0001-7502-5585; Morillo, Carlos/0000-0002-8739-2099; Yusuf, Salim/0000-0003-4776-5601; Piegas, Leopoldo/0000-0003-1021-817X; Botto, Fernando/0000-0002-0572-8493; Lanas, Fernando/0000-0003-3595-9759; Devereaux, PJ/0000-0003-2935-637X; Bannon, Paul/0000-0002-3117-7250; Vanek, Tomas/0000-0002-7412-6912	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown PP, 2001, ANN THORAC SURG, V72, pS1009, DOI 10.1016/S0003-4975(01)02937-X; deGuzman BJ, 2004, NEW ENGL J MED, V350, P1791; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; DHAWAN J, 1995, INT J CARDIOL, V49, P267, DOI 10.1016/0167-5273(95)02315-N; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970; Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571; Houlind K, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-47; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Lamy A, 2012, AM HEART J, V163, P1, DOI 10.1016/j.ahj.2011.10.007; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D; Lip GYH, 1999, POSTGRAD MED J, V75, P463, DOI 10.1136/pgmj.75.886.463; Makaryus AN, 2005, AM J CARDIOL, V96, P778, DOI 10.1016/j.amjcard.2005.05.018; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859; Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X; STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497, DOI 10.1001/archneur.1984.04050170043013; Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039; VANDERLINDEN W, 1980, SURGERY, V87, P258; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yusuf, 1994, LANCET, V344, P1446; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	34	297	318	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1179	1188		10.1056/NEJMoa1301228	http://dx.doi.org/10.1056/NEJMoa1301228			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23477676	Bronze, Green Accepted			2022-12-28	WOS:000316869000005
J	Han, DR; Pal, S; Yang, Y; Jiang, SX; Nangreave, J; Liu, Y; Yan, H				Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao			DNA Gridiron Nanostructures Based on Four-Arm Junctions	SCIENCE			English	Article							FOLDING DNA	Engineering wireframe architectures and scaffolds of increasing complexity is one of the important challenges in nanotechnology. We present a design strategy to create gridiron-like DNA structures. A series of four-arm junctions are used as vertices within a network of double-helical DNA fragments. Deliberate distortion of the junctions from their most relaxed conformations ensures that a scaffold strand can traverse through individual vertices in multiple directions. DNA gridirons were assembled, ranging from two-dimensional arrays with reconfigurability to multilayer and three-dimensional structures and curved objects.	[Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Han, Dongran; Pal, Suchetan; Yang, Yang; Jiang, Shuoxing; Nangreave, Jeanette; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Han, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	dongran.han@asu.edu; yan_liu@asu.edu	Pal, Suchetan/R-5525-2019; Yang, Yang/S-4225-2017; Pal, Suchetan/D-3653-2012; Liu, Yan/K-1999-2014	Yang, Yang/0000-0002-2630-6062; Pal, Suchetan/0000-0001-8291-2844; Liu, Yan/0000-0003-0906-2606; Pal, Suchetan/0000-0002-6323-7502	NSF [1104373]; Office of Naval Research [N000140911118]; Army Research Office [W911NF-11-1-0137]; Army Research Office Multidisciplinary University Research Initiative [W911NF-12-1-0420]; National Science Foundation of China [21028005]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001016]; Presidential Strategic Initiative Fund from Arizona State University	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Army Research Office; Army Research Office Multidisciplinary University Research Initiative(MURI); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Presidential Strategic Initiative Fund from Arizona State University	We thank N. Seeman and R. Sha from New York University for helpful discussions. This work is supported by NSF grant 1104373, Office of Naval Research grant N000140911118, Army Research Office grant W911NF-11-1-0137 to H.Y. and Y.L. and Army Research Office Multidisciplinary University Research Initiative award W911NF-12-1-0420 and National Science Foundation of China grant 21028005 to H.Y. H.Y. and Y.L. are part of the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award no. DE-SC0001016. H.Y. is supported by the Presidential Strategic Initiative Fund from Arizona State University. The DNA sequences for the nanostructures and additional data described in this work can be found in the online supplementary materials.	Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244	9	196	211	10	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1412	1415		10.1126/science.1232252	http://dx.doi.org/10.1126/science.1232252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520107				2022-12-28	WOS:000316740700037
J	Hemphill, CS; Sampat, B				Hemphill, C. Scott; Sampat, Bhaven			Drug Patents at the Supreme Court	SCIENCE			English	Editorial Material									[Sampat, Bhaven] Columbia Univ, Columbia Law Sch, New York, NY 10032 USA; Columbia Univ, New York, NY 10032 USA	Columbia University; Columbia University	Sampat, B (corresponding author), Columbia Univ, Columbia Law Sch, New York, NY 10032 USA.	bns3@columbia.edu						Correa C.M., 2007, GUIDELINES EXAMINATI; Dickey Bret, 2010, Ann Health Law, V19, P367; European Commission, 2009, PHARM SECT INQ FIN R; FTC, 2013, AGR FIL FTC MED PRES; Gal A., 2013, WATERTIGHT COMPOSITI; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Hemphill CS, 2009, COLUMBIA LAW REV, V109, P629; IMS Health, 2012, EC AN GEN DRUG US US; Kanter J., 2013, NY TIMES, pB1; Nikhil S., 2007, PREDICTING PARA; PRIEST GL, 1984, J LEGAL STUD, V13, P1, DOI 10.1086/467732; RBC Capital Markets, 2010, PHARM AN LIT SUCC RA	13	24	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1386	1387		10.1126/science.1235857	http://dx.doi.org/10.1126/science.1235857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114KU	23520096				2022-12-28	WOS:000316740700025
J	Richardson, DB; Volkow, ND; Kwan, MP; Kaplan, RM; Goodchild, MF; Croyle, RT				Richardson, Douglas B.; Volkow, Nora D.; Kwan, Mei-Po; Kaplan, Robert M.; Goodchild, Michael F.; Croyle, Robert T.			Spatial Turn in Health Research	SCIENCE			English	Editorial Material							ENVIRONMENT		[Richardson, Douglas B.] AAG, Washington, DC 20009 USA; [Volkow, Nora D.] NIDA, NIH, Rockville, MD 20852 USA; [Kwan, Mei-Po] Univ Illinois, Dept Geog & Geog Informat Sci, Urbana, IL 61801 USA; [Kaplan, Robert M.] NIH, Off Behav & Social Sci Res, Bethesda, MD 20892 USA; [Goodchild, Michael F.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Croyle, Robert T.] NCI, Div Canc Control & Populat Sci, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Richardson, DB (corresponding author), AAG, 1710 16th St NW, Washington, DC 20009 USA.	drichardson@aag.org	KAPLAN, Robert/AAK-7342-2021; Kwan, Mei-Po/S-4162-2016	Kwan, Mei-Po/0000-0001-8602-9258	NCI NIH HHS [R13 CA162823, R13CA162823] Funding Source: Medline; Direct For Social, Behav & Economic Scie [1244691] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R13CA162823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL060081] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); CLINICAL CENTER		Brouwer KC, 2012, ANN ASSOC AM GEOGR, V102, P1190, DOI 10.1080/00045608.2012.674896; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Fang Tianfang Bernie, 2012, Annals of GIS, V18, P279, DOI 10.1080/19475683.2012.727866; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Goodchild MF, 2010, J SPAT INT SCI, P3, DOI 10.5311/JOSIS.2010.1.2; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Kwan MP, 2009, SOC SCI MED, V69, P1311, DOI 10.1016/j.socscimed.2009.07.013; M-P Kwan, 2012, ANN GIS, V18, P245, DOI DOI 10.1080/19475683.2012.727867; Mauney T., 1993, Patent, Patent No. [5214757 US, 5214757]; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; McLafferty S, 2012, ANN ASSOC AM GEOGR, V102, P893, DOI 10.1080/00045608.2012.674901; Mooney P, 2013, J AMB INTEL HUM COMP, V4, P731, DOI 10.1007/s12652-012-0149-4; Pickle Linda Williams, 2006, Int J Health Geogr, V5, P51, DOI 10.1186/1476-072X-5-51; Richardson D., 2006, GEOGRAPHIC INFORM SC, pvii; Scott CA, 2012, ANN ASSOC AM GEOGR, V102, P977, DOI 10.1080/00045608.2012.657511; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Thomas Y. F., 2008, GEOGRAPHY DRUG ADDIC; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	20	140	151	6	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1390	1392		10.1126/science.1232257	http://dx.doi.org/10.1126/science.1232257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	114KU	23520099	Green Accepted			2022-12-28	WOS:000316740700028
J	Frigola, J; Remus, D; Mehanna, A; Diffley, JFX				Frigola, Jordi; Remus, Dirk; Mehanna, Amina; Diffley, John F. X.			ATPase-dependent quality control of DNA replication origin licensing	NATURE			English	Article							RE-REPLICATION; COMPLEX; HELICASE; CDT1; INITIATION; MECHANISM; SEQUENCE; BINDING; CELLS; ORC6	The regulated loading of the Mcm2-7 DNA helicase (comprising six related subunits, Mcm2 to Mcm7) into pre-replicative complexes at multiple replication origins ensures precise once per cell cycle replication in eukaryotic cells. The origin recognition complex (ORC), Cdc6 and Cdt1 load Mcm2-7 into a double hexamer bound around duplex DNA in an ATP-dependent reaction, but the molecular mechanism of this origin 'licensing' is still poorly understood. Here we show that both Mcm2-7 hexamers in Saccharomyces cerevisiae are recruited to origins by an essential, conserved carboxy-terminal domain of Mcm3 that interacts with and stimulates the ATPase activity of ORC-Cdc6. ATP hydrolysis can promote Mcm2-7 loading, but can also promote Mcm2-7 release if components are missing or if ORC has been inactivated by cyclin-dependent kinase phosphorylation. Our work provides new insights into how origins are licensed and reveals a novel ATPase-dependent mechanism contributing to precise once per cell cycle replication.	[Frigola, Jordi; Remus, Dirk; Mehanna, Amina; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk	Frigola, Jordi/N-4602-2015	Frigola, Jordi/0000-0002-7231-3853; Diffley, John/0000-0001-5184-7680; Remus, Dirk/0000-0002-5155-181X	Cancer Research UK; Association for International Cancer Research [10-0270]; European Research Council [249883 - EUKDNAREP]; Cancer Research UK [15669] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We are grateful to N. Cook for help with protein purifications, A. Early and L Drury for help with strain constructions, G. Coster for help with Mcm3 complementation, S. Mochida and B. Pfander for vectors and K. Labib for antibodies. We also thank members of the Diffley laboratory for critical reading of the manuscript This work was funded by Cancer Research UK and grants from the Association for International Cancer Research (10-0270) and the European Research Council (249883 - EUKDNAREP).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Diffley JFX, 2010, COLD SH Q B, V75, P135, DOI 10.1101/sqb.2010.75.062; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Takara TJ, 2011, EMBO J, V30, P4885, DOI 10.1038/emboj.2011.394; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	26	145	147	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					339	343		10.1038/nature11920	http://dx.doi.org/10.1038/nature11920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23474987	Green Accepted			2022-12-28	WOS:000316650500036
J	Alkema, L; Kantorova, V; Menozzi, C; Biddlecom, A				Alkema, Leontine; Kantorova, Vladimira; Menozzi, Clare; Biddlecom, Ann			National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis	LANCET			English	Article							MODEL	Background Expansion of access to contraception and reduction of unmet need for family planning are key components to improve reproductive health, but scarce data and variability in data sources create difficulties in monitoring of progress for these outcomes. We estimated and projected indicators of contraceptive prevalence and unmet need for family planning from 1990 to 2015. Methods We obtained data from nationally representative surveys, for women aged 15-49 years who were married or in a union. Estimates were based on 930 observations of contraceptive prevalence between 1950 and 2011 from 194 countries or areas, and 306 observations of unmet need for family planning from 111 countries or areas. We used a Bayesian hierarchical model combined with country-specific time trends to yield estimates of these indicators and uncertainty assessments. The model accounted for differences by data source, sample population, and contraceptive methods included in the measure. Findings Worldwide, contraceptive prevalence increased from 54.8% (95% uncertainty interval 52.3-57.1) in 1990, to 63.3% (60.4-66.0) in 2010, and unmet need for family planning decreased from 15.4% (14.1-16.9) in 1990, to 12.3% (10.9-13.9) in 2010. Almost all subregions, except for those where contraceptive prevalence was already high in 1990, had an increase in contraceptive prevalence and a decrease in unmet need for family planning between 1990 and 2010, although the pace of change over time varied between countries and subregions. In 2010, 146 million (130-166 million) women worldwide aged 15-49 years who were married or in a union had an unmet need for family planning. The absolute number of married women who either use contraception or who have an unmet need for family planning is projected to grow from 900 million (876-922 million) in 2010 to 962 million (927-992 million) in 2015, and will increase in most developing countries. Interpretation Trends in contraceptive prevalence and unmet need for family planning, and the projected growth in the number of potential contraceptive users indicate that increased investment is necessary to meet demand for contraceptive methods and improve reproductive health worldwide.	[Alkema, Leontine] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Alkema, Leontine] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Kantorova, Vladimira; Menozzi, Clare; Biddlecom, Ann] United Nations Populat Div, Dept Econ & Social Affairs, New York, NY 10017 USA	National University of Singapore; National University of Singapore	Biddlecom, A (corresponding author), United Nations Populat Div, Dept Econ & Social Affairs, DC2-1988, New York, NY 10017 USA.	biddlecom@un.org	Alkema, Leontine/K-1585-2013	Alkema, Leontine/0000-0001-8806-5957; Biddlecom, Ann/0000-0001-9385-2592; Kantorova, Vladimira/0000-0002-2960-5930	United Nations Population Division; United Nations Population Division, Department of Economic and Social Affairs; National University of Singapore	United Nations Population Division; United Nations Population Division, Department of Economic and Social Affairs; National University of Singapore(National University of Singapore)	LA received consulting fees from the United Nations Population Division for the study. We declare that we have no conflicts of interest.; Funding sources were the United Nations Population Division, Department of Economic and Social Affairs, and a research grant from the National University of Singapore. VK, CM, and AB are staff members of the United Nations Population Division, Department of Economic and Social Affairs. LA is a staff member of the National University of Singapore. The views expressed herein are those of the authors and do not necessarily reflect the views of the United Nations. We thank the numerous survey participants and the staff involved in the collection and publication of the data that we analysed; Kyaw Kyaw Lay for research assistance in implementing the programmes and computing regional aggregates; and Akinrinola Bankole, Le Bao, John Casterline, Alex Cook, Trevor Croft, Patrick Gerland, Petra Nahmias, John Ross, Susheela Singh, John Stover, Mary Beth Weinberger, Hania Zlotnik, and four anonymous reviewers for detailed comments on previous versions of the report.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Bongaarts J, 2002, STUD FAMILY PLANN, V33, P24, DOI 10.1111/j.1728-4465.2002.00024.x; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Family Planning Summit Metrics Group, 2012, TECHN NOT DAT SOURC; FishelJoy D, 2012, DHS ANAL STUDIES, V25; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2004, BAYESIAN DATA ANAL; Khan S, 2007, DHS COMP REPORTS, V16; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Marchetti C, 1996, TECHNOL FORECAST SOC, V52, P1, DOI 10.1016/0040-1625(96)00001-7; MAULDIN WP, 1988, STUD FAMILY PLANN, V19, P335, DOI 10.2307/1966628; Moreland RS, 2006, ACHIEVING MILLENNIUM; Plummer M., 2003, P 3 INT WORKSH DISTR; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Ross J, 2011, INT PERSPECT SEX R H, V37, P125, DOI 10.1363/3712511; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Singh S, 2012, ADDING IT COSTS BENE; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; United Nations, 2012, MILLENNIUM DEV GOALS; United Nations Department of Economic and Social Affairs, 2012, WORLD CONTR US 2012; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2010; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	27	303	309	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1642	1652		10.1016/S0140-6736(12)62204-1	http://dx.doi.org/10.1016/S0140-6736(12)62204-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23489750				2022-12-28	WOS:000319112400031
J	Uy, J; Forciea, MA; Cotton, D; Taichman, D; Williams, S				Uy, Joshua; Forciea, Mary Ann; Cotton, Deborah; Taichman, Darren; Williams, Sankey			Hearing Loss	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; OLDER-ADULTS; PREVALENCE; PATIENT											Bagai A, 2006, JAMA-J AM MED ASSOC, V295, P416, DOI 10.1001/jama.295.4.416; Battista RA, 2005, OTOLARYNG HEAD NECK, V132, P902, DOI 10.1016/j.otohns.2005.01.024; Clark JH, 2012, J AM GERIATR SOC, V60, P1936, DOI 10.1111/j.1532-5415.2012.04150.x; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; DorUe CJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004400; KEANE EM, 1995, BRIT J CLIN PRACT, V49, P71; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Lin FR, 2012, JAMA-J AM MED ASSOC, V307, P1147, DOI 10.1001/jama.2012.321; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Middleton A, 2010, J EVAL CLIN PRACT, V16, P811, DOI 10.1111/j.1365-2753.2009.01207.x; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; Popelka MM, 1998, J AM GERIATR SOC, V46, P1075, DOI 10.1111/j.1532-5415.1998.tb06643.x; Roland PS, 2008, OTOLARYNG HEAD NECK, V139, pS1, DOI 10.1016/j.otohns.2008.06.026; Schneider JM, 2010, MED J AUSTRALIA, V192, P20, DOI 10.5694/j.1326-5377.2010.tb03395.x; Shulman A, 2000, Int Tinnitus J, V6, P10; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Wei BPC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003998.pub2; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976; [No title captured]	22	8	8	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					ITC41	ITC416	ITC4	10.7326/0003-4819-158-7-201304020-01004	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-01004			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NM	23546583				2022-12-28	WOS:000209755700001
J	Feero, WG; Wicklund, C; Veenstra, DL				Feero, W. Gregory; Wicklund, Catherine; Veenstra, David L.			The Economics of Genomic Medicine Insights From the IOM Roundtable on Translating Genomic-Based Research for Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Feero, W. Gregory] Maine Dartmouth Family Med Residency, Augusta, ME USA; [Wicklund, Catherine] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Veenstra, David L.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA	Northwestern University; University of Washington; University of Washington Seattle	Feero, WG (corresponding author), 4 Sheridan Dr,Ste 2, Fairfield, ME 04937 USA.	wfeero@mainegeneral.org						Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Department of Health and Human Services, DET CONS PERS HLTH C; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Institute of Medicine, 2013, EC GEN MED WORKSH SU; Kolata G, 2012, NY TIMES, pA1; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; US Department of Health and Human Services, NIH SEEKS PROP STUD	7	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1235	1236		10.1001/jama.2013.113	http://dx.doi.org/10.1001/jama.2013.113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23532238				2022-12-28	WOS:000316625200021
J	Taylor, JP				Taylor, J. Paul			RNA That Gets RAN in Neurodegeneration	SCIENCE			English	Editorial Material							HEXANUCLEOTIDE REPEAT; C9ORF72; FTD; ALS		St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349				Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	14	6	6	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1282	1283		10.1126/science.1236450	http://dx.doi.org/10.1126/science.1236450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23493702				2022-12-28	WOS:000316053400024
J	Darby, SC; Ewertz, M; McGale, P; Bennet, AM; Blom-Goldman, U; Bronnum, D; Correa, C; Cutter, D; Gagliardi, G; Gigante, B; Jensen, MB; Nisbet, A; Peto, R; Rahimi, K; Taylor, C; Hall, P				Darby, Sarah C.; Ewertz, Marianne; McGale, Paul; Bennet, Anna M.; Blom-Goldman, Ulla; Bronnum, Dorthe; Correa, Candace; Cutter, David; Gagliardi, Giovanna; Gigante, Bruna; Jensen, Maj-Britt; Nisbet, Andrew; Peto, Richard; Rahimi, Kazem; Taylor, Carolyn; Hall, Per			Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSE-SPECIFIC MORTALITY; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; SURVIVORS; COHORT	BACKGROUND Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.)	[Darby, Sarah C.; McGale, Paul; Cutter, David; Peto, Richard; Taylor, Carolyn] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Rahimi, Kazem] Univ Oxford, George Ctr Healthcare Innovat, Oxford, England; [Nisbet, Andrew] Royal Surrey Cty Hosp, Dept Med Phys, Guildford, Surrey, England; [Nisbet, Andrew] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Ewertz, Marianne] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Bronnum, Dorthe] Aalborg Hosp, Dept Oncol, Aalborg, Denmark; [Jensen, Maj-Britt] Rigshosp, Danish Breast Canc Cooperat Grp, DK-2100 Copenhagen, Denmark; [Bennet, Anna M.; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Blom-Goldman, Ulla] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Gagliardi, Giovanna] Karolinska Univ Hosp, Dept Med Phys, Stockholm, Sweden; [Taylor, Carolyn] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	University of Oxford; University of Oxford; Royal Surrey County Hospital; University of Surrey; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Darby, SC (corresponding author), Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	sarah.darby@ctsu.ox.ac.uk	Rahimi, Kazem/AAA-4250-2022; Cutter, David/AAU-6599-2021; Gigante, Bruna/I-9252-2012; Rahimi, Kazem/Q-1279-2015; Nisbet, Andrew/AAK-9799-2021; Nisbet, Andrew/A-9651-2013	Cutter, David/0000-0001-7307-7488; Rahimi, Kazem/0000-0002-4807-4610; Nisbet, Andrew/0000-0002-0652-808X; Nisbet, Andrew/0000-0002-0652-808X; Ewertz, Marianne/0000-0002-5965-969X; Bronnum, Dorthe Scavenius/0000-0002-2723-9148; Gigante, Bruna/0000-0003-4508-7990; Bennet-Bark, Anna/0000-0003-2704-2625	Cancer Research UK; British Heart Foundation; U.K. Medical Research Council; European Commission [FI6R-012796]; U.K. Department of Health [RRX 108]; British Heart Foundation Centre for Research Excellence [CRE RE/08/004]; Oxford National Institute for Health Research Biomedical Research Centre; Medical Research Council [MC_U137686858] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); U.K. Department of Health; British Heart Foundation Centre for Research Excellence; Oxford National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by funding to the Oxford University Clinical Trial Service Unit from Cancer Research UK, the British Heart Foundation, and the U.K. Medical Research Council and by grants from the European Commission (FI6R-012796), the U.K. Department of Health (RRX 108), the British Heart Foundation Centre for Research Excellence (CRE RE/08/004, to Dr. Cutter), and the Oxford National Institute for Health Research Biomedical Research Centre (to Dr. Rahimi).	Abe O, 2005, LANCET, V366, P2087; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; American Cancer Society, 2012, BREAST CANC FACTS FI; Ares C, 2010, INT J RADIAT ONCOL, V76, P685, DOI 10.1016/j.ijrobp.2009.02.062; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Aznar MC, 2011, BRIT J RADIOL, V84, P743, DOI 10.1259/bjr/12497075; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Cutter D, 2013, CANC HEART, P88; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Ferlay J, 2010, IARC CANCERBASE; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Gulyban A, 2008, STRAHLENTHER ONKOL, V184, P262, DOI 10.1007/s00066-008-1770-1; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jagsi R, 2010, INT J RADIAT ONCOL, V78, P1594, DOI 10.1016/j.ijrobp.2010.04.072; Jones B, 2001, CLIN ONCOL-UK, V13, P71, DOI 10.1053/clon.2001.9221; Kleinbaum D. G., 1998, APPL REGRESSION ANAL; Lohr F, 2009, INT J RADIAT ONCOL, V74, P73, DOI 10.1016/j.ijrobp.2008.07.018; McGale P, 2008, INT J EPIDEMIOL, V37, P518, DOI 10.1093/ije/dyn067; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; PRESTON D. L., 1993, EPICURE USERS GUIDE; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Schubert LK, 2011, RADIOTHER ONCOL, V100, P241, DOI 10.1016/j.radonc.2011.01.004; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; StataCorp, 2011, STAT STAT SOFTW REL, P173; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Taylor CW, 2008, INT J RADIAT ONCOL, V72, P501, DOI 10.1016/j.ijrobp.2007.12.058; Taylor CW, 2007, INT J RADIAT ONCOL, V69, P1484, DOI 10.1016/j.ijrobp.2007.05.034; Taylor CW, 2011, RADIOTHER ONCOL, V100, P176, DOI 10.1016/j.radonc.2011.01.020; Taylor CW, 2009, RADIOTHER ONCOL, V90, P127, DOI 10.1016/j.radonc.2008.09.029; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050	41	2224	2311	5	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					987	998		10.1056/NEJMoa1209825	http://dx.doi.org/10.1056/NEJMoa1209825			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484825	Green Published, Bronze			2022-12-28	WOS:000315982100005
J	Palomaki, TA; Harlow, JW; Teufel, JD; Simmonds, RW; Lehnert, KW				Palomaki, T. A.; Harlow, J. W.; Teufel, J. D.; Simmonds, R. W.; Lehnert, K. W.			Coherent state transfer between itinerant microwave fields and a mechanical oscillator	NATURE			English	Article							QUANTUM GROUND-STATE; NANOMECHANICAL MOTION; RESONATOR; CIRCUIT	Macroscopic mechanical oscillators have been coaxed into a regime of quantum behaviour by direct refrigeration(1) or a combination of refrigeration and laser-like cooling(2,3). This result supports the idea that mechanical oscillators may perform useful functions in the processing of quantum information with superconducting circuits(4-7), either by serving as a quantum memory for the ephemeral state of a microwave field or by providing a quantum interface between otherwise incompatible systems(8-14). As yet, the transfer of an itinerant state or a propagating mode of a microwave field to and from a storage medium has not been demonstrated, owing to the inability to turn on and off the interaction between the microwave field and the medium sufficiently quickly. Here we demonstrate that the state of an itinerant microwave field can be coherently transferred into, stored in and retrieved from a mechanical oscillator with amplitudes at the single-quantum level. Crucially, the time to capture and to retrieve the microwave state is shorter than the quantum state lifetime of the mechanical oscillator. In this quantum regime, the mechanical oscillator can both store quantum information and enable its transfer between otherwise incompatible systems.	[Palomaki, T. A.; Harlow, J. W.; Lehnert, K. W.] NIST, JILA, Boulder, CO 80309 USA; [Palomaki, T. A.; Harlow, J. W.; Lehnert, K. W.] Univ Colorado, Boulder, CO 80309 USA; [Palomaki, T. A.; Harlow, J. W.; Lehnert, K. W.] Univ Colorado, Dept Phys, Boulder, CO USA; [Teufel, J. D.; Simmonds, R. W.] NIST, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Lehnert, KW (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	konrad.lehnert@jila.colorado.edu	Lehnert, Konrad/B-7577-2009; Lehnert, Konrad W/O-7555-2019; Teufel, John D/A-8898-2010	Lehnert, Konrad/0000-0002-0750-9649; Lehnert, Konrad W/0000-0002-0750-9649; Teufel, John D/0000-0002-1873-9941; Simmonds, Raymond/0000-0003-2217-2965	DARPA QuASAR programme; US NSF Physics Frontier Center; NIST	DARPA QuASAR programme; US NSF Physics Frontier Center(National Science Foundation (NSF)); NIST(National Institute of Standards & Technology (NIST) - USA)	This work was supported primarily by the DARPA QuASAR programme, with additional support from the US NSF Physics Frontier Center and NIST. We would like to thank J. Kerckhoff, M. Holland, C. Regal, J. Thompson and R. Andrews for discussions.	Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Cicak K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304168; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Eichler C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.259903; Fiore V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133601; Gao JS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2906373; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Hertzberg JB, 2010, NAT PHYS, V6, P213, DOI 10.1038/NPHYS1479; Hofer SG, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052327; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; Mallet F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220502; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; McGee S. A., PHYS REV A UNPUB; Novikova I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243602; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Regal CA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012025; Reim KF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053603; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Sillanpaa MA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3173826; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Teufel JD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197203; Tian L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153604; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Wang YD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153603; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901; Zhang J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013808	30	325	332	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					210	214		10.1038/nature11915	http://dx.doi.org/10.1038/nature11915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486060	Green Submitted			2022-12-28	WOS:000316652300045
J	Kim, SY; Adhikari, A; Lee, SY; Marshel, JH; Kim, CK; Mallory, CS; Lo, M; Pak, S; Mattis, J; Lim, BK; Malenka, RC; Warden, MR; Neve, R; Tye, KM; Deisseroth, K				Kim, Sung-Yon; Adhikari, Avishek; Lee, Soo Yeun; Marshel, James H.; Kim, Christina K.; Mallory, Caitlin S.; Lo, Maisie; Pak, Sally; Mattis, Joanna; Lim, Byung Kook; Malenka, Robert C.; Warden, Melissa R.; Neve, Rachael; Tye, Kay M.; Deisseroth, Karl			Diverging neural pathways assemble a behavioural state from separable features in anxiety	NATURE			English	Article							VENTRAL TEGMENTAL AREA; ELEVATED PLUS-MAZE; STRIA TERMINALIS; BED NUCLEUS; ELECTRICAL-STIMULATION; PROJECTIONS; RESPONSES; FEAR; AMYGDALA; BRAIN	Behavioural states in mammals, such as the anxious state, are characterized by several features that are coordinately regulated by diverse nervous system outputs, ranging from behavioural choice patterns to changes in physiology (in anxiety, exemplified respectively by risk-avoidance and respiratory rate alterations)(1,2). Here we investigate if and how defined neural projections arising from a single coordinating brain region in mice could mediate diverse features of anxiety. Integrating behavioural assays, in vivo and in vitro electrophysiology, respiratory physiology and optogenetics, we identify a surprising new role for the bed nucleus of the stria terminalis (BNST) in the coordinated modulation of diverse anxiety features. First, two BNST subregions were unexpectedly found to exert opposite effects on the anxious state: oval BNST activity promoted several independent anxious state features, whereas anterodorsal BNST-associated activity exerted anxiolytic influence for the same features. Notably, we found that three distinct anterodorsal BNST efferent projections-to the lateral hypothalamus, parabrachial nucleus and ventral tegmental area-each implemented an independent feature of anxiolysis: reduced risk-avoidance, reduced respiratory rate, and increased positive valence, respectively. Furthermore, selective inhibition of corresponding circuit elements in freely moving mice showed opposing behavioural effects compared with excitation, and in vivo recordings during free behaviour showed native spiking patterns in anterodorsal BNST neurons that differentiated safe and anxiogenic environments. These results demonstrate that distinct BNST subregions exert opposite effects in modulating anxiety, establish separable anxiolytic roles for different anterodorsal BNST projections, and illustrate circuit mechanisms underlying selection of features for the assembly of the anxious state.	[Kim, Sung-Yon; Adhikari, Avishek; Lee, Soo Yeun; Marshel, James H.; Kim, Christina K.; Mallory, Caitlin S.; Lo, Maisie; Pak, Sally; Mattis, Joanna; Warden, Melissa R.; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Sung-Yon; Kim, Christina K.; Mallory, Caitlin S.; Mattis, Joanna; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lee, Soo Yeun; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Lim, Byung Kook; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Neve, Rachael; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Adhikari, Avishek/N-1284-2015; Core, Vector/CAF-4832-2022; Warden, Melissa R/M-9300-2016; Adhikari, Avishek/AAF-4444-2021; Tye, Kay/J-6158-2013; Kim, Sung-Yon/AAO-8405-2020; Marshel, James/W-2792-2019; Adhikari, Avishek/A-3339-2012	Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Adhikari, Avishek/0000-0002-9187-9211; Tye, Kay/0000-0002-2435-0182; Kim, Sung-Yon/0000-0003-0791-7308; Marshel, James/0000-0003-3517-8493; Adhikari, Avishek/0000-0002-9187-9211; Mallory, Caitlin/0000-0003-2865-0235; Mattis, Joanna/0000-0003-0341-1270; Kim, Christina/0000-0002-1466-7098; Lim, Byungkook/0000-0002-3766-5415	Samsung Scholarship; US National Institute of Mental Health (NIMH); Berry Fellowship; NARSAD; Wiegers Family Fund; NIMH; US National Institute on Drug Abuse (NIDA); DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Tarlton Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH088010] Funding Source: NIH RePORTER	Samsung Scholarship(Samsung); US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Berry Fellowship; NARSAD(NARSAD); Wiegers Family Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Tarlton Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Davis, D. Walker, D. Pare, D. Rainnie, H. Shin, K. Thompson, P. Anikeeva, T. Davidson, I. Goshen, A. Andalman, L. Gunaydin, A. Bryant, C. Lee, J. Mirzabekov and the entire Deisseroth laboratory for discussions. Supported by a Samsung Scholarship (to S.-Y.K.), the US National Institute of Mental Health (NIMH; to R. C. M.), and a Berry Fellowship (to A. A.). K. D. and M. R. W. are NARSAD grant awardees, and K. D. was supported by the Wiegers Family Fund, the NIMH, the US National Institute on Drug Abuse (NIDA), the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Gatsby Charitable Foundation, the Snyder Foundation, the Woo Foundation, the Tarlton Foundation, and the Albert Yu and Mary Bechman Foundation. All tools and methods are distributed and supported freely (http://www.optogenetics.org).	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; Dabrowska J, 2011, PSYCHONEUROENDOCRINO, V36, P1312, DOI 10.1016/j.psyneuen.2011.03.003; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; DUNN JD, 1995, J COMP NEUROL, V352, P227, DOI 10.1002/cne.903520206; DUNN JD, 1987, BRAIN RES, V407, P327, DOI 10.1016/0006-8993(87)91111-5; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; MARTIN B, 1961, PSYCHOL BULL, V58, P234, DOI 10.1037/h0045492; Poulin JF, 2009, PROG NEURO-PSYCHOPH, V33, P1356, DOI 10.1016/j.pnpbp.2009.06.021; Sartor GC, 2012, EUR J NEUROSCI, V36, P3549, DOI 10.1111/j.1460-9568.2012.08277.x; Schwerdtfeger RMH, 2008, PHYSIOL BEHAV, V93, P697, DOI 10.1016/j.physbeh.2007.11.011; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Straube T, 2007, NEUROIMAGE, V37, P1427, DOI 10.1016/j.neuroimage.2007.06.023; SUESS WM, 1980, PSYCHOPHYSIOLOGY, V17, P535, DOI 10.1111/j.1469-8986.1980.tb02293.x; TERREBERRY RR, 1995, SLEEP, V18, P139, DOI 10.1093/sleep/18.3.139; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Walker DL, 2009, PROG NEURO-PSYCHOPH, V33, P1291, DOI 10.1016/j.pnpbp.2009.06.022; WOODS JH, 1992, PHARMACOL REV, V44, P151; Yassa MA, 2012, J PSYCHIATR RES, V46, P1045, DOI 10.1016/j.jpsychires.2012.04.013	30	379	411	4	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					219	223		10.1038/nature12018	http://dx.doi.org/10.1038/nature12018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23515158	Green Accepted			2022-12-28	WOS:000317346300041
J	Spence, D				Spence, Des			Immigrant song	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f2083	10.1136/bmj.f2083	http://dx.doi.org/10.1136/bmj.f2083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SA	23550051				2022-12-28	WOS:000317337200007
J	Meckler, AN; Sigman, DM; Gibson, KA; Francois, R; Martinez-Garcia, A; Jaccard, SL; Rohl, U; Peterson, LC; Tiedemann, R; Haug, GH				Meckler, A. N.; Sigman, D. M.; Gibson, K. A.; Francois, R.; Martinez-Garcia, A.; Jaccard, S. L.; Roehl, U.; Peterson, L. C.; Tiedemann, R.; Haug, G. H.			Deglacial pulses of deep-ocean silicate into the subtropical North Atlantic Ocean	NATURE			English	Article							AFRICAN HUMID PERIOD; SOUTHERN-OCEAN; LAST DEGLACIATION; YOUNGER DRYAS; CIRCULATION; RECORD; TERMINATION; EVENTS; CD/CA; WATER	Growing evidence suggests that the low atmospheric CO2 concentration of the ice ages resulted from enhanced storage of CO2 in the ocean interior, largely as a result of changes in the Southern Ocean(1). Early in the most recent deglaciation, a reduction in North Atlantic overturning circulation seems to have driven CO2 release from the Southern Ocean(2-5), but the mechanism connecting the North Atlantic and the Southern Ocean remains unclear. Biogenic opal export in the low-latitude ocean relies on silicate from the underlying thermocline, the concentration of which is affected by the circulation of the ocean interior. Here we report a record of biogenic opal export from a coastal upwelling system off the coast of northwest Africa that shows pronounced opal maxima during each glacial termination over the past 550,000 years. These opal peaks are consistent with a strong deglacial reduction in the formation of silicate-poor glacial North Atlantic intermediate water(2) (GNAIW). The loss of GNAIW allowed mixing with underlying silicate-rich deep water to increase the silicate supply to the surface ocean. An increase in westerly-wind-driven upwelling in the Southern Ocean in response to the North Atlantic change has been proposed to drive the deglacial rise in atmospheric CO2 (refs 3, 4). However, such a circulation change would have accelerated the formation of Antarctic intermediate water and sub-Antarctic mode water, which today have as little silicate as North Atlantic Deep Water and would have thus maintained low silicate concentrations in the Atlantic thermocline. The deglacial opal maxima reported here suggest an alternative mechanism for the deglacial CO2 release(5,6). Just as the reduction in GNAIW led to upward silicate transport, it should also have allowed the downward mixing of warm, low-density surface water to reach into the deep ocean. The resulting decrease in the density of the deep Atlantic relative to the Southern Ocean surface promoted Antarctic overturning, which released CO2 to the atmosphere.	[Meckler, A. N.; Martinez-Garcia, A.; Jaccard, S. L.; Haug, G. H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Gibson, K. A.; Peterson, L. C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Francois, R.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Roehl, U.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Tiedemann, R.] Alfred Wegener Inst, D-27568 Bremerhaven, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; University of Miami; University of British Columbia; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Meckler, AN (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	nele.meckler@erdw.ethz.ch	Meckler, Anna Nele/AAC-2490-2020; Gibson, Kelly/AAB-6615-2020; Röhl, Ursula/G-5986-2011; Jaccard, Samuel/G-3447-2014; Sigman, Daniel M/A-2649-2008; Martínez-García, Alfredo/A-6244-2010	Meckler, Anna Nele/0000-0002-7225-8276; Röhl, Ursula/0000-0001-9469-7053; Jaccard, Samuel/0000-0002-5793-0896; Sigman, Daniel M/0000-0002-7923-1973; Martínez-García, Alfredo/0000-0002-7206-5079; Tiedemann, Ralf/0000-0001-7211-8049	US NSF [OCE-1060947]; DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; NSERC; CFCAS; Directorate For Geosciences [1003364] Funding Source: National Science Foundation; Division Of Ocean Sciences [1060947] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFCAS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research used samples provided by the ODP, which is sponsored by the US NSF and participating countries under the management of the Joint Oceanographic Institutions. XRF data were acquired at the XRF Core Scanner Lab at MARUM - Center for Marine Environmental Sciences, University of Bremen, with support from the DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam. Further support was provided by the US NSF through grant OCE-1060947 to D. M. S. and by NSERC and CFCAS to R. F. We thank V. Lukies for XRF scanning technical support and T. Westerhold for help in deriving the new composite depth. M. Soon and T. Kane are acknowledged for opal and excess <SUP>230</SUP>Th measurements, respectively, in core MD03-2705.	Adkins J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001200; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bradtmiller LI, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001443; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Came RE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000888; Came RE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001450; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; EGLINTON G, 1992, NATURE, V356, P423, DOI 10.1038/356423a0; Gil IM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001729; Gnanadesikan A, 1999, GEOPHYS RES LETT, V26, P1865, DOI 10.1029/1999GL900379; Harris PG, 1996, NATURE, V383, P63, DOI 10.1038/383063a0; Hayes CT, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002008; Jaccard S. L., 2002, SCIENCE IN PRESS; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Jullien E, 2007, QUATERNARY RES, V68, P379, DOI 10.1016/j.yqres.2007.07.007; Levitus S., 2009, NOAA ATLAS NESDIS, P184; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Marchitto TM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000598; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Oppo D. W., 2012, NATURE ED KNOWL, V3, P1; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Rickaby REM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000858; Romero OE, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001601; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sarnthein M, 1990, PALEOCEANOGRAPHY, V5, P1041, DOI 10.1029/PA005i006p01041; Schlitzer R., 2000, EOS T AGU, V81, P45, DOI DOI 10.1029/00E000028; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman D. M., 2013, GEOPHYS MONOGR SER, P335, DOI [10.1029/173GM21, DOI 10.1029/173GM21]; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; TIEDEMANN R, 1989, P OCEAN DRILLING PRO, V0108; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Xie RFC, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002337	38	62	66	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					495	+		10.1038/nature12006	http://dx.doi.org/10.1038/nature12006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538831				2022-12-28	WOS:000316682800042
J	Stone, JH; Murali, MR				Stone, John H.; Murali, Mandakolathur R.			Case 10-2013: A 30-Year-Old Man with Fever, Myalgias, Arthritis, and Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; MIDLINE DESTRUCTIVE LESIONS; RHEUMATIC MANIFESTATIONS; INFECTIVE ENDOCARDITIS; COCAINE; HEROIN; LEVAMISOLE; VASCULITIS; PURPURA; EARS		[Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Stone, JH (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				Roche; Genentech	Roche(Roche Holding); Genentech(Roche HoldingGenentech)	Dr. Stone reports receiving consulting fees from Roche and Genentech, grant support through his institution from Roche and Genentech, and travel support from Genentech, Biogen-IDEC, and Genzyme. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1381; Barkhuizen A, 1997, J RHEUMATOL, V24, P1238; Calabrese LH, 2005, INFECT DIS CLIN N AM, V19, P963, DOI 10.1016/j.idc.2005.09.002; Chung C, 2011, J AM ACAD DERMATOL, V65, P722, DOI 10.1016/j.jaad.2010.08.024; DIXON FJ, 1958, ARCH PATHOL, V65, P18; GERMUTH FG, 1953, J EXP MED, V97, P257, DOI 10.1084/jem.97.2.257; GERMUTH FG, 1957, B JOHNS HOPKINS HOSP, V101, P149; Graves RJ, 1843, CLIN LECT PRACTICE M; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lee BL, 2010, ARTHRIT CARE RES, V62, P1805, DOI 10.1002/acr.20240; Lovy MR, 1996, J RHEUMATOL, V23, P979; McDonald JR, 2009, INFECT DIS CLIN N AM, V23, P643, DOI 10.1016/j.idc.2009.04.013; O'Connor G, 2008, EUR J EMERG MED, V15, P104, DOI 10.1097/MEJ.0b013e3282f08aa4; PASTAN RS, 1977, ANN INTERN MED, V87, P22, DOI 10.7326/0003-4819-87-1-22; Peikert T, 2008, ARTHRITIS RHEUM, V58, P1546, DOI 10.1002/art.23469; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Schacker T, 1997, ANN INTERN MED, V126, P174, DOI 10.7326/0003-4819-126-2-199701150-00024; Schneider S, 2011, FORENSIC SCI INT, V212, P242, DOI 10.1016/j.forsciint.2011.06.027; Silverman ME, 2007, AM J CARDIOL, V100, P1802, DOI 10.1016/j.amjcard.2007.07.034; Wiesner O, 2004, ARTHRITIS RHEUM-US, V50, P2954, DOI 10.1002/art.20479	21	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1239	1245		10.1056/NEJMcpc1210260	http://dx.doi.org/10.1056/NEJMcpc1210260			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23514249				2022-12-28	WOS:000316869000014
J	Redfield, MM; Chen, HH; Borlaug, BA; Semigran, MJ; Lee, KL; Lewis, G; LeWinter, MM; Rouleau, JL; Bull, DA; Mann, DL; Deswal, A; Stevenson, LW; Givertz, MM; Ofili, EO; O'Connor, CM; Felker, GM; Goldsmith, SR; Bart, BA; McNulty, SE; Ibarra, JC; Lin, G; Oh, JK; Patel, MR; Kim, RJ; Tracy, RP; Velazquez, EJ; Anstrom, KJ; Hernandez, AF; Mascette, AM; Braunwald, E				Redfield, Margaret M.; Chen, Horng H.; Borlaug, Barry A.; Semigran, Marc J.; Lee, Kerry L.; Lewis, Gregory; LeWinter, Martin M.; Rouleau, Jean L.; Bull, David A.; Mann, Douglas L.; Deswal, Anita; Stevenson, Lynne W.; Givertz, Michael M.; Ofili, Elizabeth O.; O'Connor, Christopher M.; Felker, G. Michael; Goldsmith, Steven R.; Bart, Bradley A.; McNulty, Steven E.; Ibarra, Jenny C.; Lin, Grace; Oh, Jae K.; Patel, Manesh R.; Kim, Raymond J.; Tracy, Russell P.; Velazquez, Eric J.; Anstrom, Kevin J.; Hernandez, Adrian F.; Mascette, Alice M.; Braunwald, Eugene		RELAX Trial	Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY-HYPERTENSION; RIGHT VENTRICLE; OXYGEN-UPTAKE; SILDENAFIL; DYSFUNCTION; PREVENTS; 1-YEAR; RATS; HEMODYNAMICS; ASSOCIATION	Importance Studies in experimental and human heart failure suggest that phosphodiesterase-5 inhibitors may enhance cardiovascular function and thus exercise capacity in heart failure with preserved ejection fraction (HFPEF). Objective To determine the effect of the phosphodiesterase-5 inhibitor sildenafil compared with placebo on exercise capacity and clinical status in HFPEF. Design Multicenter, double-blind, placebo-controlled, parallel-group, randomized clinical trial of 216 stable outpatients with HF, ejection fraction >= 50%, elevated N-terminal brain-type natriuretic peptide or elevated invasively measured filling pressures, and reduced exercise capacity. Participants were randomized from October 2008 through February 2012 at 26 centers in North America. Follow-up was through August 30, 2012. Interventions Sildenafil (n=113) or placebo (n=103) administered orally at 20 mg, 3 times daily for 12 weeks, followed by 60 mg, 3 times daily for 12 weeks. Main Outcome Measures Primary end point was change in peak oxygen consumption after 24 weeks of therapy. Secondary end points included change in 6-minute walk distance and a hierarchical composite clinical status score (range, 1-n, a higher value indicates better status; expected value with no treatment effect, 95) based on time to death, time to cardiovascular or cardiorenal hospitalization, and change in quality of life for participants without cardiovascular or cardiorenal hospitalization at 24 weeks. Results Median age was 69 years, and 48% of patients were women. At baseline, median peak oxygen consumption (11.7 mL/kg/min) and 6-minute walk distance (308 m) were reduced. The median E/e' (16), left atrial volume index (44 mL/m(2)), and pulmonary artery systolic pressure (41 mm Hg) were consistent with chronically elevated left ventricular filling pressures. At 24 weeks, median (IQR) changes in peak oxygen consumption (mL/kg/min) in patients who received placebo (-0.20 [IQR, -0.70 to 1.00]) or sildenafil (-0.20 [IQR, -1.70 to 1.11]) were not significantly different (P=.90) in analyses in which patients with missing week-24 data were excluded, and in sensitivity analysis based on intention to treat with multiple imputation for missing values (mean between-group difference, 0.01 mL/kg/min, [95% CI, -0.60 to 0.61]). The mean clinical status rank score was not significantly different at 24 weeks between placebo (95.8) and sildenafil (94.2) (P=.85). Changes in 6-minute walk distance at 24 weeks in patients who received placebo (15.0 m [IQR, -26.0 to 45.0]) or sildenafil (5.0 m [IQR, -37.0 to 55.0]; P=.92) were also not significantly different. Adverse events occurred in 78 placebo patients (76%) and 90 sildenafil patients (80%). Serious adverse events occurred in 16 placebo patients (16%) and 25 sildenafil patients (22%). Conclusion and Relevance Among patients with HFPEF, phosphodiesterase-5 inhibition with administration of sildenafil for 24 weeks, compared with placebo, did not result in significant improvement in exercise capacity or clinical status. Trial Registration clinicaltrials.gov Identifier: NCT00763867 JAMA. 2013; 309(12): 1268-1277 Published online March 11, 2013. doi: 10.1001/jama.2013.2024 www.jama.com	[Redfield, Margaret M.; Chen, Horng H.; Borlaug, Barry A.; Lin, Grace; Oh, Jae K.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Semigran, Marc J.; Lewis, Gregory] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lee, Kerry L.; Anstrom, Kevin J.] Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Velazquez, Eric J.; Hernandez, Adrian F.] Duke Clin Res Inst, Dept Med, Durham, NC USA; [McNulty, Steven E.] Duke Clin Res Inst, Dept Stat, Durham, NC USA; [Ibarra, Jenny C.] Duke Clin Res Inst, Dept Project Management, Durham, NC USA; [LeWinter, Martin M.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol & Biochem, Burlington, VT 05405 USA; [Rouleau, Jean L.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rouleau, Jean L.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Bull, David A.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Mann, Douglas L.] Barnes Jewish Hosp, Dept Med, St Louis, MO 63110 USA; [Deswal, Anita] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA; [Deswal, Anita] Baylor Coll Med, Houston, TX 77030 USA; [Stevenson, Lynne W.; Givertz, Michael M.; Braunwald, Eugene] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ofili, Elizabeth O.] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; [O'Connor, Christopher M.; Felker, G. Michael; Patel, Manesh R.; Kim, Raymond J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC USA; Duke Heart Ctr, Durham, NC USA; [Goldsmith, Steven R.; Bart, Bradley A.] Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA; [Mascette, Alice M.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA	Mayo Clinic; Harvard University; Massachusetts General Hospital; Duke University; Duke University; Duke University; Duke University; University of Vermont; University of Vermont; Universite de Montreal; Universite de Montreal; Utah System of Higher Education; University of Utah; Barnes-Jewish Hospital; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Morehouse School of Medicine; Duke University; Duke University; Duke University; Hennepin County Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Redfield, MM (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW,Guggenheim 9, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu	Patel, Manesh/AAC-5385-2019; Mann, Douglas Lowell/AAQ-3524-2021; Kim, Raymond J/B-1426-2008; Perlini, Stefano/E-2670-2012; Felker, Michael/AAX-2288-2021; Hernandez, Adrian F/A-7818-2016	Perlini, Stefano/0000-0002-0320-8574; Hernandez, Adrian F/0000-0003-3387-9616; Felker, Gary/0000-0002-5931-1239; Mann, Douglas/0000-0002-2516-0145	National Institutes of Health (NIH); Medscape; Medscape, Amgen; GlaxoSmithKline; Atcor Medical and Gilead; National Heart, Lung, and Blood Institute; National Institute on Minority Health and Health Disparities; Roche Diagnostics; Amgen; Novartis; Ikaria; Acetlion Pharma; Heartware; ResMed; Pozen; GE Healthcare; Johnson Johnson; Gilead; Critical Diagnostics; BG Medicine; Otsuka; Astellas; Novella; Novella, Cytokinetics; Capricor; Singulex; Bristol-Myers Squibb; Amylin; National Heart, Lung, and Blood Institute [U10HL084904, U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, U10HL084931]; National Center for Advancing Translational Sciences [UL1TR000454]; National Institute on Minority Health and Health Disparities [8 U54 MD007588]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084931, U10HL084904, U01HL084875, U01HL084861, U01HL084899, U01HL084889, U01HL084877, U01HL084890, U01HL084891, U01HL084907] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medscape; Medscape, Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); Atcor Medical and Gilead; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Roche Diagnostics; Amgen(Amgen); Novartis(Novartis); Ikaria; Acetlion Pharma; Heartware; ResMed; Pozen; GE Healthcare(General ElectricGE Healthcare); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Gilead(Gilead Sciences); Critical Diagnostics; BG Medicine; Otsuka(Otsuka Pharmaceutical); Astellas(Astellas Pharmaceuticals); Novella; Novella, Cytokinetics; Capricor; Singulex; Bristol-Myers Squibb(Bristol-Myers Squibb); Amylin; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Redfield reported receiving financial support from the National Institutes of Health (NIH) and royalties from Annexon. Dr Chen reported receiving funding for patents that his institution has licensed to Nile Therapeutics and Annexon with other patents pending at the US Patent and Trademark Office. He also reported that he has royalties with Nile Therapeutics, Annexon, and Up To Date. Dr Borlaug reported receiving consulting fees from Medscape, Amgen, and GlaxoSmithKline and receiving financial support from Atcor Medical and Gilead. Dr Semigran reported receiving financial support from the NIH for participation in the Heart Failure Network and from Bayer. Dr Lee reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr LeWinter reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Bull reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Deswal reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Stevenson reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Givertz reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Ofili reported receiving financial support from the NIH, receiving consulting fees from Merck, Novartis, and Arbor Pharmaceuticals and lecture fees from Arbor Pharmaceuticals. She is currently employed by the Morehouse School of Medicine and has grants pending from the National Heart, Lung, and Blood Institute and National Institute on Minority Health and Health Disparities. DrO'Connor reported receiving consulting fees from Roche Diagnostics, Amgen, Novartis, Ikaria, Acetlion Pharma, Heartware, ResMed, Pozen, GE Healthcare, Johnson & Johnson, Gilead, Critical Diagnostics, BG Medicine, Otsuka, Astellas, Novella, Cytokinetics, and Capricor; holding stock options with Neurotronik/Interventional Autonomics Corporation; editing American College of Cardiology; and coowning Cardiology Consulting Associates. Dr Felker reported receiving financial support from the NIH; consulting fees from Novartis, Amgen, Trevena, Roche Diagnostics, Merck, Singulex, and BG Medicine; and funding from Amgen, Otsuka, and Roche Diagnostics. Dr Bart reported receiving financial support from the NIH for participation in the Heart Failure Network. Ms Ibarra reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Oh received financial support from the NIH for the Echo Core Lab. Dr Patel has received consulting fees from Genzyme, Baxter, Jensen, and Bayer, and his financial institution receives financial support from AstraZeneca, Johnson & Johnson, and Maquet. Dr Kim reported receiving financial support from the NIH as the Heart Failure Network Data Coordinating Center and MRI Core Lab, and funding for a patent with Northwestern University. His institution has received a grant from Siemens. Dr Tracy reported receiving financial support from the NIH for participation in the Heart Failure Network, and consulting fees fromMerck, Tibotec-Johnson & Johnson, and Abbott. He has also given expert testimony about biomarkers in blood clotting and is the owner of Haematologic Technologies. Dr Velazquez reported receiving financial support from the NIH for participation in the Heart Failure Network.; Dr Anstrom reported receiving financial support from the NIH for participation in the Heart Failure Network. Dr Hernandez reported receiving financial support from the NIH for participation in the Heart Failure Network and consulting fees from AstraZeneca, Corthera, Janseen, and Bristol-Myers Squibb. His institution has received funding from Amylin, Johnson & Johnson, and Bristol-Myers Squibb. Dr Braunwald reported receiving consulting fees from Merck, Daiichi Sankyo, Genzyme, Amorcyte, Medicines Co, MC Communications, Ikaria, CardioRentis, sanofiaventis; funding (or pending funding) from AstraZeneca, Johnson & Johnson, Merck, sanofi-aventis, Daiichi Sankyo, GlaxoSmithKline, Bristol-Myers Squibb, Beckman Coulter, Roche Diagnostics, and Pfizer; compensation for lectures for Eli Lilly, Merck, CVRx (no compensation), CV Therapeutics (now Gilead), Daiichi Sankyo, MC Communications, Manarini International, Medscape, and Bayer; and payment for devel-opment of educational presentations from MC Communications. No other disclosures were reported.; This work was supported by grants U10HL084904 (for the data coordinating center), and U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, and U10HL084931 (for the clinical centers) from the National Heart, Lung, and Blood Institute. This work is also supported by grant UL1TR000454 from the National Center for Advancing Translational Sciences and grant 8 U54 MD007588 from the National Institute on Minority Health and Health Disparities. Pfizer provided study drug (sildenafil and matched placebo).	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Bishu K, 2012, AM HEART J, V164, P763, DOI 10.1016/j.ahj.2012.08.014; Borgdorff MAJ, 2012, EUR J HEART FAIL, V14, P1067, DOI 10.1093/eurjhf/hfs094; Borlaug BA, 2010, J AM COLL CARDIOL, V56, P845, DOI 10.1016/j.jacc.2010.03.077; Chirinos JA, 2010, HYPERTENSION, V56, P91, DOI 10.1161/HYPERTENSIONAHA.110.150250; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; de Medeiros PJ, 2010, ACTA CIR BRAS, V25, P490, DOI 10.1590/S0102-86502010000600006; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Feldman AM, 2006, J AM COLL CARDIOL, V48, P1198, DOI 10.1016/j.jacc.2005.10.079; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Forfia PR, 2012, CIRCULATION, V125, pE408, DOI 10.1161/CIRCULATIONAHA.111.064584; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Guazzi M, 2004, J AM COLL CARDIOL, V44, P2339, DOI 10.1016/j.jacc.2004.09.041; Guazzi M, 2012, EUR J HEART FAIL, V14, P82, DOI 10.1093/eurjhf/hfr147; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Khan MN, 2005, AM J CARDIOL, V96, P1328, DOI 10.1016/j.amjcard.2005.06.082; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lewis GD, 2007, CIRCULATION, V116, P1555, DOI 10.1161/CIRCULATIONAHA.107.716373; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Nagayama T, 2009, J MOL CELL CARDIOL, V46, P560, DOI 10.1016/j.yjmcc.2008.12.008; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Redfield MM, 2012, CIRC-HEART FAIL, V5, P653, DOI 10.1161/CIRCHEARTFAILURE.112.969071; Shah RV, 2010, J CARD FAIL, V16, P260, DOI 10.1016/j.cardfail.2009.11.007; Shah SJ, 2012, CIRC HEART FAIL; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tapia E, 2012, KIDNEY BLOOD PRESS R, V35, P273, DOI 10.1159/000334952; Xie YP, 2012, HYPERTENSION, V59, P355, DOI 10.1161/HYPERTENSIONAHA.111.180968	31	822	845	2	64	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1268	1277		10.1001/jama.2013.2024	http://dx.doi.org/10.1001/jama.2013.2024			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23478662	Bronze, Green Accepted			2022-12-28	WOS:000316625200027
J	Hunter, DJ				Hunter, David J.			Will 1 April mark the beginning of the end of England's NHS? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst Hlth & Wellbeing, Durham, England	Durham University	Hunter, DJ (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst Hlth & Wellbeing, Durham, England.	d.j.hunter@durham.ac.uk						Brown G, 2004, MODERN AGENDA PROSPE; Christie C, 2011, COMMISSION FUTURE DE; Cutcher N, 2013, OPEN DEMOCRACY; Dahlgren G, 2012, 15 TURK NAT PUBL HLT; Gray John, 2013, NEW STATESMAN; Heath I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1004; Hunter DJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2014; Lansley A, 2012, HLTH SERV J, V1, P18; Letwin O., 1988, BRITAINS BIGGEST ENT; Leys C., 2011, PLOT NHS; Mooney G, 2012, INT J HEALTH SERV, V42, P383, DOI 10.2190/HS.42.3.b; Titmuss R., 1970, GIFT RELATIONSHIP HU	12	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2013	346								f1951	10.1136/bmj.f1951	http://dx.doi.org/10.1136/bmj.f1951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117WO	23533190				2022-12-28	WOS:000316984000027
J	Alaei, A; Alaei, K				Alaei, Arash; Alaei, Kamiar			Drug users need more choices at addiction treatment facilities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Alaei, Arash; Alaei, Kamiar] SUNY Albany, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Alaei, A (corresponding author), SUNY Albany, Albany, NY 12222 USA.	aalaei@albany.edu						Amnesty International, 2011, ADD DEATH EX DRUGS O; Mokri A, 2002, ARCH IRAN MED, V5, P184; United Nations Department of Economic and Social Affairs Population Division, 20 MOST POP COUNTR 1	3	0	0	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1520	10.1136/bmj.f1520	http://dx.doi.org/10.1136/bmj.f1520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MQ	23525866				2022-12-28	WOS:000316672500011
J	Berndt, JD; Moon, RT				Berndt, J. D.; Moon, R. T.			Making a Point with Wnt Signals	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION		[Berndt, J. D.; Moon, R. T.] Univ Washington, Sch Med, Dept Pharmacol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Moon, R. T.] Howard Hughes Med Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Berndt, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.	rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Fuchs E, 2013, EMBO REP, V14, P39, DOI 10.1038/embor.2012.197; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Jackson BM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007948; Kim I, 2013, J CELL BIOL, V200, P419, DOI 10.1083/jcb.201206096; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Walston TD, 2006, SEMIN CELL DEV BIOL, V17, P204, DOI 10.1016/j.semcdb.2006.04.005	17	14	19	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1388	1389		10.1126/science.1236641	http://dx.doi.org/10.1126/science.1236641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520097				2022-12-28	WOS:000316740700026
J	Jeong, J; Aetukuri, N; Graf, T; Schladt, TD; Samant, MG; Parkin, SSP				Jeong, Jaewoo; Aetukuri, Nagaphani; Graf, Tanja; Schladt, Thomas D.; Samant, Mahesh G.; Parkin, Stuart S. P.			Suppression of Metal-Insulator Transition in VO2 by Electric Field-Induced Oxygen Vacancy Formation	SCIENCE			English	Article							SUPERCONDUCTIVITY; OXIDES	Electrolyte gating with ionic liquids is a powerful tool for inducing novel conducting phases in correlated insulators. An archetypal correlated material is vanadium dioxide (VO2), which is insulating only at temperatures below a characteristic phase transition temperature. We show that electrolyte gating of epitaxial thin films of VO2 suppresses the metal-to-insulator transition and stabilizes the metallic phase to temperatures below 5 kelvin, even after the ionic liquid is completely removed. We found that electrolyte gating of VO2 leads not to electrostatically induced carriers but instead to the electric field-induced creation of oxygen vacancies, with consequent migration of oxygen from the oxide film into the ionic liquid. This mechanism should be taken into account in the interpretation of ionic liquid gating experiments.	[Jeong, Jaewoo; Aetukuri, Nagaphani; Graf, Tanja; Schladt, Thomas D.; Samant, Mahesh G.; Parkin, Stuart S. P.] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Jeong, Jaewoo] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Aetukuri, Nagaphani] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	International Business Machines (IBM); University of California System; University of California Santa Barbara; Stanford University	Parkin, SSP (corresponding author), IBM Almaden Res Ctr, San Jose, CA 95120 USA.	stuart.parkin@us.ibm.com	Graf, Tanja/G-4510-2011; Schladt, Thomas D/G-4261-2011; Parkin, Stuart/D-2521-2012; Aetukuri, Nagaphani/A-2107-2015	Parkin, Stuart/0000-0003-4702-6139; Aetukuri, Nagaphani/0000-0001-7269-5057	Graduate School "Material Science in Mainz" [Deutsche Forschungsgemeinschaft (DFG)] [GSC 266]; Multidisciplinary University Research Initiative program of the Army Research Office [W911-NF-09-1-0398]; Alexander von Humboldt Foundation; DFG [GR4000/1-1]	Graduate School "Material Science in Mainz" [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); Multidisciplinary University Research Initiative program of the Army Research Office; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG))	We thank V. Deline, A. Kellock, T. Topuria, and P. Rice for sample characterization, B. Hughes for help with device fabrication, and K. Martens and A. Pushp for useful discussions. Supported by the Graduate School "Material Science in Mainz" [Deutsche Forschungsgemeinschaft (DFG) GSC 266] (T.G.), the Multidisciplinary University Research Initiative program of the Army Research Office (grant W911-NF-09-1-0398) (J.J.), a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation (T.D.S.), and a stipend from DFG (GR4000/1-1) (T.G.).	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Cao J, 2009, NAT NANOTECHNOL, V4, P732, DOI [10.1038/nnano.2009.266, 10.1038/NNANO.2009.266]; Cavalleri A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067405; Galinski M, 2006, ELECTROCHIM ACTA, V51, P5567, DOI 10.1016/j.electacta.2006.03.016; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Janotti A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.085212; Kotz R, 2000, ELECTROCHIM ACTA, V45, P2483, DOI 10.1016/s0013-4686(00)00354-6; Lee Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136809; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Moetakef P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3669402; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Mott N.F., 1990, METAL INSULATOR TRAN; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; RESTORI R, 1987, ACTA CRYSTALLOGR B, V43, P251, DOI 10.1107/S0108768187097921; Robertson J, 2000, J VAC SCI TECHNOL B, V18, P1785, DOI 10.1116/1.591472; ROSEVEAR WH, 1973, PHYS REV B, V7, P2109, DOI 10.1103/PhysRevB.7.2109; Silversmit G, 2004, J ELECTRON SPECTROSC, V135, P167, DOI 10.1016/j.elspec.2004.03.004; Takagi H, 2010, SCIENCE, V327, P1601, DOI 10.1126/science.1182541; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]	22	807	816	53	1139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1402	1405		10.1126/science.1230512	http://dx.doi.org/10.1126/science.1230512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520104				2022-12-28	WOS:000316740700034
J	Luty, J				Luty, Jason			Promoting abstinence for drug users is about saving money not science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METHADONE-MAINTENANCE; OPIOID DEPENDENCE		Ipswich Subst Misuse Serv, Ipswich IP1 2NZ, England		Luty, J (corresponding author), Ipswich Subst Misuse Serv, Ipswich IP1 2NZ, England.	jason.luty@yahoo.co.uk						AMATO L, 2003, COCHRANE DB SYST REV, P3409; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005031.pub4; [Anonymous], 2009, BBC NEWS; Easton M., 2008, BBC NEWS; GOSSOP M, 2001, NATL TREATMENT OUTCO; HM Government, 2017, DRUG STRAT 2010 RED; Judd LL, 1998, JAMA-J AM MED ASSOC, V280, P1936; National Treatment Agency for Substance Misuse, 2012, MED REC REOR DRUG DE; Nosyk B, 2012, ADDICTION, V107, P1621, DOI 10.1111/j.1360-0443.2012.03870.x; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; Simpson DD, 1997, DRUG ALCOHOL DEPEN, V47, P227; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	12	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2013	346								f1481	10.1136/bmj.f1481	http://dx.doi.org/10.1136/bmj.f1481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113MQ	23525865				2022-12-28	WOS:000316672500010
J	Chandra, V; Huang, PX; Potluri, N; Wu, DL; Kim, YC; Rastinejad, F				Chandra, Vikas; Huang, Pengxiang; Potluri, Nalini; Wu, Dalei; Kim, Youngchang; Rastinejad, Fraydoon			Multidomain integration in the structure of the HNF-4 alpha nuclear receptor complex	NATURE			English	Article							LIGAND-BINDING DOMAIN; PPAR-GAMMA-RXR; TRANSCRIPTION FACTORS; DNA-BINDING; HYPERINSULINEMIC HYPOGLYCEMIA; PHOSPHORYLATION; IDENTIFICATION; MUTATIONS; ELEMENTS; HNF4A	The hepatocyte nuclear factor 4 alpha (HNF-4 alpha; also known as NR2A1) is a member of the nuclear receptor (NR) family of transcription factors, which have conserved DNA-binding domains and ligand-binding domains(1,2). HNF-4 alpha is the most abundant DNA-binding protein in the liver, where some 40% of the actively transcribed genes have a HNF-4 alpha response element(1,3,4). These regulated genes are largely involved in the hepatic gluconeogenic program and lipid metabolism(3,5,6). In the pancreas HNF-4 alpha is also a master regulator, controlling an estimated 11% of islet genes(7). HNF-4 alpha protein mutations are linked to maturity-onset diabetes of the young, type 1 (MODY1) and hyperinsulinaemic hypoglycaemia(8-11). Previous structural analyses of NRs, although productive in elucidating the structure of individual domains, have lagged behind in revealing the connectivity patterns of NR domains. Here we describe the 2.9 angstrom crystal structure of the multidomain human HNF-4 alpha homodimer bound to its DNA response element and coactivatorderived peptides. A convergence zone connects multiple receptor domains in an asymmetric fashion, joining distinct elements from each monomer. An arginine target of PRMT1 methylation protrudes directly into this convergence zone and sustains its integrity. A serine target of protein kinase C is also responsible for maintaining domain-domain interactions. These post-translational modifications lead to changes in DNA binding by communicating through the tightly connected surfaces of the quaternary fold. We find that some MODY1 mutations, positioned on the ligand-binding domain and hinge regions of the receptor, compromise DNA binding at a distance by communicating through the interjunctional surfaces of the complex. The overall domain representation of the HNF-4 alpha homodimer is different from that of the PPAR-gamma-RXR-alpha heterodimer, even when both NR complexes are assembled on the same DNA element. Our findings suggest that unique quaternary folds and interdomain connections in NRs could be exploited by small-molecule allosteric modulators that affect distal functions in these polypeptides.	[Chandra, Vikas; Huang, Pengxiang; Potluri, Nalini; Wu, Dalei; Rastinejad, Fraydoon] Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Kim, Youngchang] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Argonne National Laboratory	Rastinejad, F (corresponding author), Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL 32827 USA.	frastinejad@sanfordburnham.org		Kim, Youngchang/0000-0002-1610-4889	National Institutes of Health [R01 DK094147, R01 DK097475]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094147, R01DK097475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01 DK094147 and R01 DK097475.	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Flanagan SE, 2010, EUR J ENDOCRINOL, V162, P987, DOI 10.1530/EJE-09-0861; Gineste R, 2008, MOL ENDOCRINOL, V22, P2433, DOI 10.1210/me.2008-0092; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Jiang GQ, 1997, MOL CELL BIOL, V17, P6546, DOI 10.1128/MCB.17.11.6546; Kapoor RR, 2009, ARCH DIS CHILD, V94, P450, DOI 10.1136/adc.2008.148171; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	28	126	131	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					394	398		10.1038/nature11966	http://dx.doi.org/10.1038/nature11966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485969	Green Accepted			2022-12-28	WOS:000316650500048
J	Cooper, KL; Oh, S; Sung, Y; Dasari, RR; Kirschner, MW; Tabin, CJ				Cooper, Kimberly L.; Oh, Seungeun; Sung, Yongjin; Dasari, Ramachandra R.; Kirschner, Marc W.; Tabin, Clifford J.			Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions	NATURE			English	Article							LONGITUDINAL BONE-GROWTH; PLATE CHONDROCYTES; VOLUME INCREASE; FACTOR-I; HYPERTROPHY; PERFORMANCE; MECHANISMS; HINDLIMB; RATS; AGE	The wide diversity of skeletal proportions in mammals is evident upon a survey of any natural history museum's collections and allows us to distinguish between species even when reduced to their calcified components. Similarly, each individual is comprised of a variety of bones of differing lengths. The largest contribution to the lengthening of a skeletal element, and to the differential elongation of elements, comes from a dramatic increase in the volume of hypertrophic chondrocytes in the growth plate as they undergo terminal differentiation(1-7). However, the mechanisms of chondrocyte volume enlargement have remained a mystery(8-11). Here we use quantitative phase microscopy(12) to show that mammalian chondrocytes undergo three distinct phases of volume increase, including a phase of massive cell swelling in which the cellular dry mass is significantly diluted. In light of the tight fluid regulatory mechanisms known to control volume in many cell types(13), this is a remarkable mechanism for increasing cell size and. regulating growth rate. It is, however, the duration of the final phase of volume enlargement by proportional dry mass increase at low density that varies most between rapidly and slowly elongating growth plates. Moreover, we find that this third phase is locally regulated through a mechanism dependent on insulin-like growth factor. This study provides a framework for understanding how skeletal size is regulated and for exploring how cells sense, modify and establish a volume set point.	[Cooper, Kimberly L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Oh, Seungeun; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sung, Yongjin; Dasari, Ramachandra R.] MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Cooper, KL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kcooper@genetics.med.harvard.edu		Oh, Seungeun/0000-0002-4064-9301; Sung, Yongjin/0000-0001-6371-8771	NIH [P01DK056246, R01GM026875, P41RR02594]; National Science Foundation (NSF) [DBI0754339]; Hamamatsu Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Hamamatsu Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank T. J. Mitchison, C. E. Farnum and members of the Developmental Bone Morphogenesis program project grant (National Institutes of Health (NIH)) for helpful discussions. We also thank the Nikon Imaging Center at Harvard Medical School for technical support, A. Luyten and R. Shivdasani for providing mouse megakaryocytes and P. Ramirez for jerboa care. This work was supported by NIH grants P01DK056246 to C.J.T.; R01GM026875 to M.W.K.; and by NIH grant P41RR02594, National Science Foundation (NSF) grant DBI0754339 and support from the Hamamatsu Corporation to R.R.D.	BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Bush PG, 2008, J CELL PHYSIOL, V214, P621, DOI 10.1002/jcp.21249; Bush PG, 2010, J BONE MINER RES, V25, P1594, DOI 10.1002/jbmr.47; Cooper K. L, 2011, COLD SPRING HARB PRO; Farnum CE, 2002, BONE, V30, P574, DOI 10.1016/S8756-3282(01)00710-4; Farnum CE, 2008, CELLS TISSUES ORGANS, V187, P35, DOI 10.1159/000109962; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn JL, 1996, J ORTHOPAED RES, V14, P706, DOI 10.1002/jor.1100140505; Lowe LA, 2000, GENESIS, V26, P118, DOI 10.1002/(SICI)1526-968X(200002)26:2<118::AID-GENE5>3.0.CO;2-S; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Serrat MA, 2007, ANAT REC, V290, P375, DOI 10.1002/ar.20480; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wilsman NJ, 2008, J ORTHOP RES, V26, P1457, DOI 10.1002/jor.20547; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324	23	216	221	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					375	378		10.1038/nature11940	http://dx.doi.org/10.1038/nature11940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23485973	Green Accepted, Green Submitted			2022-12-28	WOS:000316650500044
J	Biller-Andorno, N; Lee, TH				Biller-Andorno, Nikola; Lee, Thomas H.			Ethical Physician Incentives - From Carrots and Sticks to Shared Purpose	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Biller-Andorno, Nikola] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Biller-Andorno, Nikola] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Div Med Eth, Boston, MA USA; [Lee, Thomas H.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Thomas H.] Partners HealthCare Syst, Boston, MA USA; [Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland; [Biller-Andorno, Nikola] Commonwealth Fund, Harkness Fellowship Program, New York, NY USA; [Biller-Andorno, Nikola] Careum Fdn, Zurich, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; University of Zurich; Commonwealth Fund	Biller-Andorno, N (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Biller-Andorno, Nikola/0000-0001-7661-1324				Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Lee TH, 2012, NEW ENGL J MED, V367, P466, DOI 10.1056/NEJMhpr1204386; Pearson SD, 1998, NEW ENGL J MED, V339, P689, DOI 10.1056/NEJM199809033391009; Sabin JE., 2008, SETTING LIMITS FAIRL; Weber M., 1978, EC SOC	5	21	21	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					980	982		10.1056/NEJMp1300373	http://dx.doi.org/10.1056/NEJMp1300373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104HF	23484824	Green Published			2022-12-28	WOS:000315982100003
J	Lee, JT; Bartolomei, MS				Lee, Jeannie T.; Bartolomei, Marisa S.			X-Inactivation, Imprinting, and Long Noncoding RNAs in Health and Disease	CELL			English	Review							CHROMOSOME INACTIVATION; XIST RNA; FACULTATIVE HETEROCHROMATIN; DOSAGE COMPENSATION; PREIMPLANTATION DEVELOPMENT; SEX-DIFFERENCES; TURNER-SYNDROME; STEM-CELLS; MOUSE; GENE	X chromosome inactivation and genomic imprinting are classic epigenetic processes that cause disease when not appropriately regulated in mammals. Whereas X chromosome inactivation evolved to solve the problem of gene dosage, the purpose of genomic imprinting remains controversial. Nevertheless, the two phenomena are united by allelic control of large gene clusters, such that only one copy of a gene is expressed in every cell. Allelic regulation poses significant challenges because it requires coordinated long-range control in cis and stable propagation over time. Long noncoding RNAs have emerged as a common theme, and their contributions to diseases of imprinting and the X chromosome have become apparent. Here, we review recent advances in basic biology, the connections to disease, and preview potential therapeutic strategies for future development.	[Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Bartolomei, Marisa S.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu; bartolom@mail.med.upenn.edu			National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R37GM058839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Lee and Bartolomei labs for many inspirational discussions, and the National Institutes of Health and the Howard Hughes Medical Institute for supporting their research.	Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Azzi S, 2010, EPIGENETICS-US, V5, P373, DOI 10.4161/epi.5.5.11851; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bishop DVM, 2000, NEUROPSYCHOLOGIA, V38, P712, DOI 10.1016/S0028-3932(99)00118-9; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1967, GENETICS, V57, P331; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; COOPER DW, 1971, NATURE, V230, P292, DOI 10.1038/230292a0; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; Fortier AL, 2008, HUM MOL GENET, V17, P1653, DOI 10.1093/hmg/ddn055; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Goto Y, 2000, CHROMOSOME RES, V8, P101, DOI 10.1023/A:1009234217981; Grant J, 2012, NATURE, V487, P254, DOI 10.1038/nature11171; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Kelsey G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002601; Kesler SR, 2004, NEUROPSYCHOLOGIA, V42, P1971, DOI 10.1016/j.neuropsychologia.2004.04.021; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Liao DZJ, 2003, CANCER INVEST, V21, P641, DOI 10.1081/CNV-120022385; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Lyon Mary F., 1999, Results and Problems in Cell Differentiation, V25, P73; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Migeon BR, 1999, GENOMICS, V59, P113, DOI 10.1006/geno.1999.5861; Minkovsky A, 2012, STEM CELLS, V30, P48, DOI 10.1002/stem.755; MOORE K L, 1955, Br J Cancer, V9, P246, DOI 10.1038/bjc.1955.21; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Namekawa SH, 2007, P NATL ACAD SCI USA, V104, P9730, DOI 10.1073/pnas.0700323104; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; Okamoto I, 2006, CYTOGENET GENOME RES, V113, P318, DOI 10.1159/000090848; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Oreland L, 2004, CURR MED CHEM, V11, P2007, DOI 10.2174/0929867043364838; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauler FM, 2012, CURR OPIN GENET DEV, V22, P283, DOI 10.1016/j.gde.2012.02.005; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penaherrera MS, 2012, HUM REPROD, V27, P1745, DOI 10.1093/humrep/des072; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percec I, 2002, SCIENCE, V296, P1136, DOI 10.1126/science.1070087; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; PUCK JM, 1992, AM J HUM GENET, V50, P742; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Riccio A, 2009, ENDOCR DEV, V14, P1, DOI 10.1159/000207461; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Robson JE, 2012, RNA, V18, P135, DOI 10.1261/rna.029561.111; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; SEARLE AG, 1978, CYTOGENET CELL GENET, V20, P282, DOI 10.1159/000130859; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Sleutels F, 2002, ADV GENET, V46, P119; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; SOLTER D, 1988, ANNU REV GENET, V22, P127; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sun BW, 2012, STEM CELLS, V30, P161, DOI 10.1002/stem.793; Sunderam Saswati, 2012, Morbidity and Mortality Weekly Report, V61, P1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, DEV BIOL, V371, P146, DOI 10.1016/j.ydbio.2012.08.009; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1990, DEVELOPMENT, V109, P189; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Thorvaldsen JL, 2012, GENETICS, V192, P1095, DOI 10.1534/genetics.112.144477; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Weksberg R, 2010, AM J MED GENET C, V154C, P317, DOI 10.1002/ajmg.c.30268; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	151	496	527	11	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1308	1323		10.1016/j.cell.2013.02.016	http://dx.doi.org/10.1016/j.cell.2013.02.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498939	Bronze			2022-12-28	WOS:000316192500012
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Hype and the HIV cure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, TELEGRAPH, DOI DOI 10150905/NSA-SURVEILLANCE-US-BUGGED-EU-OFFICES.HTML; Boseley S, 2013, GUARDIAN; Hodgekiss Anna, 2013, DAILY MAIL; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; NIH News National Institutes of Health, 2013, NIH NEWS        0303; Persaud D, 2013, 20 C RETR OPP INF 3; Pollack A., 2013, NY TIMES; Roehr B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1487; Sample I., 2013, GUARDIAN	9	1	1	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2013	346								f1599	10.1136/bmj.f1599	http://dx.doi.org/10.1136/bmj.f1599			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VJ	23479595				2022-12-28	WOS:000316324000006
J	Singh, P; Sachs, JD				Singh, Prabhjot; Sachs, Jeffrey D.			1 million community health workers in sub-Saharan Africa by 2015	LANCET			English	Editorial Material							INTERVENTIONS; MANAGEMENT; PROGRAMS; CHILDREN; CARE		[Singh, Prabhjot] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10015 USA; [Singh, Prabhjot; Sachs, Jeffrey D.] Columbia Univ, Earth Inst, New York, NY 10015 USA	Columbia University; Columbia University	Singh, P (corresponding author), Columbia Univ, Earth Inst, Interchurch Ctr, New York, NY 10015 USA.	psingh@ei.columbia.edu						[Anonymous], LESSONS LEARNED HOME; Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911; Balcazar H, 2006, HEALTH PROMOT PRACT, V7, P68, DOI 10.1177/1524839904266799; Bhutta ZA, GLOBAL EXPERIENCE CO; Brownstein JN, 2007, AM J PREV MED, V32, P435, DOI 10.1016/j.amepre.2007.01.011; Bureau of Health Professions Health Resources and Services Administration US Department of Health and Human Services, 2008, PHYS WORKF PROJ RES; Cherrington A, 2008, DIABETES EDUCATOR, V34, P824, DOI 10.1177/0145721708323643; Clark NM, 2010, AM J PUBLIC HEALTH, V100, P904, DOI 10.2105/AJPH.2009.180869; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Lehmann U., COMMUNITY HLTH WORKE; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Otero-Sabogal Regina, 2010, Qual Prim Care, V18, P363; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Postma J, 2009, J ASTHMA, V46, P564, DOI 10.1080/02770900902912638; Roman LA, 2009, ARCH WOMEN MENT HLTH, V12, P379, DOI 10.1007/s00737-009-0083-4; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Singh P, 1 MILL COMM HLTH WOR; Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106	21	157	159	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					363	365		10.1016/S0140-6736(12)62002-9	http://dx.doi.org/10.1016/S0140-6736(12)62002-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FT	23541538	Green Submitted			2022-12-28	WOS:000322544900034
J	Awasthi, S; Peto, R; Read, S; Richards, SM; Pande, V; Bundy, D				Awasthi, Shally; Peto, Richard; Read, Simon; Richards, Susan M.; Pande, Vinod; Bundy, Donald		DEVTA Deworming Enhanced Vitamin A	Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial	LANCET			English	Article							MORTALITY; GROWTH; HEALTH	Background In north India many pre-school children are underweight, many have intestinal worms, and 2-3% die at ages 1.0-6.0 years. We used the state-wide Integrated Child Development Service (ICDS) infrastructure to help to assess any effects of regular deworming on mortality. Methods Participants in this cluster-randomised study were children in catchment areas of 8338 ICDS-staffed village child-care centres (under-5 population 1 million) in 72 administrative blocks. Groups of four neighbouring blocks were cluster-randomly allocated in Oxford between 6-monthly vitamin A (retinol capsule of 200 000 IU retinyl acetate in oil, to be cut and dripped into the child's mouth every 6 months), albendazole (400 mg tablet every 6 months), both, or neither (open control). Analyses of albendazole effects are by block (36 vs 36 clusters). The study spanned 5 calendar years, with 11 6-monthly mass-treatment days for all children then aged 6-72 months. Annually, one centre per block was randomly selected and visited by a study team 1-5 months after any trial deworming to sample faeces (for presence of worm eggs, reliably assessed only after mid-study), weigh children, and interview caregivers. Separately, all 8338 centres were visited every 6 months to monitor pre-school deaths (100 000 visits, 25 000 deaths at age 1.0-6.0 years [the primary outcome]). This trial is registered at ClinicalTrials.gov, NCT00222547. Findings Estimated compliance with 6-monthly albendazole was 86%. Among 2589 versus 2576 children surveyed during the second half of the study, nematode egg prevalence was 16% versus 36%, and most infection was light. After at least 2 years of treatment, weight at ages 3.0-6.0 years (standardised to age 4.0 years, 50% male) was 12.72 kg albendazole versus 12.68 kg control (difference 0.04 kg, 95% CI -0.14 to 0.21, p=0.66). Comparing the 36 albendazole-allocated versus 36 control blocks in analyses of the primary outcome, deaths per child-care centre at ages 1.0-6.0 years during the 5-year study were 3.00 (SE 0.07) albendazole versus 3.16 (SE 0.09) control, difference 0.16 (SE 0.11, mortality ratio 0.95, 95% CI 0.89 to 1.02, p=0.16), suggesting absolute risks of dying between ages 1.0 and 6.0 years of roughly 2.5% albendazole versus 2.6% control. No specific cause of death was significantly affected. Interpretation Existing ICDS village staff can be organised to deliver simple pre-school interventions sustainably for many years at low cost, but regular deworming had little effect on mortality in this lightly infected pre-school population.	[Awasthi, Shally; Pande, Vinod; DEVTA Deworming Enhanced Vitamin A] King Georges Med Univ, Lucknow 226003, Uttar Pradesh, India; [Peto, Richard; Read, Simon; Richards, Susan M.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard; Read, Simon; Richards, Susan M.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Bundy, Donald] World Bank, Human Dev Network, Washington, DC 20433 USA	King George's Medical University; University of Oxford; University of Oxford; The World Bank	Awasthi, S (corresponding author), King Georges Med Univ, Dept Paediat, Lucknow 226003, Uttar Pradesh, India.	shally07@gmail.com	Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647	UK Medical Research Council; USAID; World Bank; USAID OMNI project; UK Medical Research Council (via CTSU); Helmut Horten cancer research award; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); USAID(United States Agency for International Development (USAID)); World Bank(The World Bank India); USAID OMNI project(United States Agency for International Development (USAID)); UK Medical Research Council (via CTSU); Helmut Horten cancer research award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, USAID, World Bank (albendazole donated by GlaxoSmithKline).; This report is dedicated to its onlie begetter, Kenneth S Warren (1929-96). Our chief acknowledgment is to the AWC workers, communities, and children in the 8338 participating AWCs; the seven district and 72 ICDS officials in the following districts and blocks (Lucknow: Mall, Malihabad, Bakshi Ka Talab, Chinhat, Sarojini Nagar, Kakori, Mohan Lal Ganj, Gosai Ganj; Unnao: Sikandarpur Karan, Sikandarpur Sirosi, Hasan Ganj, Miyan Ganj, Asoha, Auras, Safipur, Bangarmau, Fatehpur Chourasi, Bichhiya, Sumerpur, Bighapur, Purva, Ganjmuradabad; Kanpur: Kanpur Nagar I, Kanpur Nagar II, Sarsoul, Bilhour, Patara, Vidhnu, Choubepur, Kalyanpur; Sitapur: Mishrikh, Sakaran, Khairabad, Godlamau, Hargaon, Kasmanda, Machrehta, Biswan, Pahla; Lakhimpur Kheeri: Lakhimpur Kheeri, Nidyasan, Vijuva, Ishanagar, Dharora, Pasgawan, Mohammadi, Golagokaran Nath, Bakey Ganj, Mitouli, Paliya Kala, Nakha, Phool Behad, Behjam; Raibareli: Singhpur, Dalmau, Unchahar, Maharajganj, Bahadurpur, Salon, Harchanpur, Bachrawana, Khero, Tiloi; Hardoi: Kachhouna, Kothawa, Bilgram, Hariyawan, Pihani, Tadiawan, Sursa, Ahirori, Behinder); the Government of Uttar Pradesh Department of Health and Department of Woman and Child Welfare (responsible for the ICDS); and the Vice-Chancellor of King George's Medical University, M Bhandari. Rajiv Awasthi, Jill Boreham, Frances Davidson, Nilanthi de Silva, Martin Frigg (1943-2010), Andrew Hall, John Horton, Trudie Lang, Penny Nestel, Lorenzo Savioli, and Sarman Singh helped to plan, execute, or comment on the study. Funding was received from the USAID OMNI project, World Bank, and UK Medical Research Council (via CTSU). Albendazole (Zentel) was donated by SmithKlineBeecham (now part of GlaxoSmithKline), and vitamin A by Roche vitamins (now part of DSM) via the Sight and Life Program. We acknowledge the CTSU's computing and other support in Oxford, including funds from the 1991 Helmut Horten cancer research award to Richard Peto and Richard Doll (1912-2005).	Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; Alstead S., 1940, POSTGRAD MED J, P278, DOI 10.1136/pgmj.16.178.278.; Awasthi S, 2008, Indian J Med Sci, V62, P484, DOI 10.4103/0019-5359.48552; Awasthi S, 2000, Indian Pediatr, V37, P19; Awasthi S, 1998, SHORT PROTOCOL DEVTA; Awasthi S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000223; Awasthi Shally, 2001, Indian Journal of Pediatrics, V68, P823, DOI 10.1007/BF02762101; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; Bundy DAP, 2013, TRENDS PARASITOL; Bundy DAP, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1091; Bundy DAP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000362; deSilva NR, 1997, TROP MED INT HEALTH, V2, P519; Gragnolati M, 2006, INDIAS UNDERNOURISHE; Integrated Child Development Service, 2001, INDIAN J PEDIATR, V38, P721; JUKES MCH, 2007, SCH HLTH NUTR ED ALL; KREY W, 1949, Z HYG INFEKTIONSKR, V129, P507, DOI 10.1007/BF02184384; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Nandita Saikia, 2010, Economic and Political Weekly, V45, P62; Nitin Shukla, 2008, Journal of Communicable Diseases, V39, P217; Pawlowski Z. S., 1989, Ascariasis and its prevention and control., P71; PELLETIER DL, 1994, J NUTR, V124, pS2106; Peto R, 2013, LANCET; Registrar General of India, 2006, POP PROJ IND STAT 20; Sommer A., 1995, VITAMIN A DEFICIENCY, V3rd; Sur D, 2005, T ROY SOC TROP MED H, V99, P261, DOI 10.1016/j.trstmh.2004.08.005; Taylor-Robinson DC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub3; Taylor-Robinson D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000358; THEINHLAING, 1987, J TROP MED HYG, V90, P165; World Health Organisation SEARO Parasitological Examination of Faeces, 2006, GUID STAND OP PROC M; World Health Organization Department of Child and Adolescent Health and Development (WHO CAH), 2005, WHO GUID HAND HYG HL, P19	30	55	55	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1478	1486		10.1016/S0140-6736(12)62126-6	http://dx.doi.org/10.1016/S0140-6736(12)62126-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23498850	Green Published			2022-12-28	WOS:000318607300037
J	Jia, JZ; Zhao, SC; Kong, XY; Li, YR; Zhao, GY; He, WM; Appels, R; Pfeifer, M; Tao, Y; Zhang, XY; Jing, RL; Zhang, C; Ma, YZ; Gao, LF; Gao, C; Spannagl, M; Mayer, KFX; Li, D; Pan, SK; Zheng, FY; Hu, Q; Xia, XC; Li, JW; Liang, QS; Chen, J; Wicker, T; Gou, CY; Kuang, HH; He, GY; Luo, YD; Keller, B; Xia, QJ; Lu, P; Wang, JY; Zou, HF; Zhang, RZ; Xu, JY; Gao, JL; Middleton, C; Quan, ZW; Liu, GM; Wang, J; Yang, HM; Liu, X; He, ZH; Mao, L; Wang, J				Jia, Jizeng; Zhao, Shancen; Kong, Xiuying; Li, Yingrui; Zhao, Guangyao; He, Weiming; Appels, Rudi; Pfeifer, Matthias; Tao, Yong; Zhang, Xueyong; Jing, Ruilian; Zhang, Chi; Ma, Youzhi; Gao, Lifeng; Gao, Chuan; Spannagl, Manuel; Mayer, Klaus F. X.; Li, Dong; Pan, Shengkai; Zheng, Fengya; Hu, Qun; Xia, Xianchun; Li, Jianwen; Liang, Qinsi; Chen, Jie; Wicker, Thomas; Gou, Caiyun; Kuang, Hanhui; He, Genyun; Luo, Yadan; Keller, Beat; Xia, Qiuju; Lu, Peng; Wang, Junyi; Zou, Hongfeng; Zhang, Rongzhi; Xu, Junyang; Gao, Jinlong; Middleton, Christopher; Quan, Zhiwu; Liu, Guangming; Wang, Jian; Yang, Huanming; Liu, Xu; He, Zhonghu; Mao, Long; Wang, Jun		Int Wheat Genome Sequencing Consor	Aegilops tauschii draft genome sequence reveals a gene repertoire for wheat adaptation	NATURE			English	Article							NUCLEOTIDE-BINDING SITE; POLYPLOID WHEAT; HEXAPLOID WHEAT; MOLECULAR-BASIS; DNA; DOMESTICATION; HARDNESS; PROGRAM; PROTEIN; ORIGIN	About 8,000 years ago in the Fertile Crescent, a spontaneous hybridization of the wild diploid grass Aegilops tauschii (2n = 14; DD) with the cultivated tetraploid wheat Triticum turgidum (2n = 4x = 28; AABB) resulted in hexaploid wheat (T. aestivum; 2n = 6x = 42; AABBDD)(1,2). Wheat has since become a primary staple crop worldwide as a result of its enhanced adaptability to a wide range of climates and improved grain quality for the production of baker's flour(2). Here we describe sequencing the Ae. tauschii genome and obtaining a roughly 90-fold depth of short reads from libraries with various insert sizes, to gain a better understanding of this genetically complex plant. The assembled scaffolds represented 83.4% of the genome, of which 65.9% comprised transposable elements. We generated comprehensive RNA-Seq data and used it to identify 43,150 protein-coding genes, of which 30,697 (71.1%) were uniquely anchored to chromosomes with an integrated high-density genetic map. Whole-genome analysis revealed gene family expansion in Ae. tauschii of agronomically relevant gene families that were associated with disease resistance, abiotic stress tolerance and grain quality. This draft genome sequence provides insight into the environmental adaptation of bread wheat and can aid in defining the large and complicated genomes of wheat species.	[Jia, Jizeng; Kong, Xiuying; Zhao, Guangyao; Zhang, Xueyong; Jing, Ruilian; Ma, Youzhi; Gao, Lifeng; Xia, Xianchun; Zhang, Rongzhi; Liu, Xu; He, Zhonghu; Mao, Long] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Zhao, Shancen; Li, Yingrui; He, Weiming; Tao, Yong; Zhang, Chi; Gao, Chuan; Li, Dong; Pan, Shengkai; Zheng, Fengya; Li, Jianwen; Liang, Qinsi; Chen, Jie; Gou, Caiyun; He, Genyun; Luo, Yadan; Xia, Qiuju; Lu, Peng; Wang, Junyi; Zou, Hongfeng; Xu, Junyang; Gao, Jinlong; Quan, Zhiwu; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhao, Shancen; Zheng, Fengya] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Zhao, Shancen; Zheng, Fengya] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Appels, Rudi] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Pfeifer, Matthias; Spannagl, Manuel; Mayer, Klaus F. X.] Helmholtz Ctr Munich, MIPS Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Hu, Qun; Kuang, Hanhui] Huazhong Agr Univ, Coll Hort & Forestry, Dept Vegetable Crops, Wuhan 430070, Peoples R China; [Wicker, Thomas; Keller, Beat; Middleton, Christopher] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Liu, Guangming] Natl Supercomp Ctr Tianjin, Tianjin 300457, Peoples R China; [He, Zhonghu] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56130, Mexico; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Chinese University of Hong Kong; Murdoch University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Huazhong Agricultural University; University of Zurich; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Copenhagen; King Abdulaziz University	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	jzjia@mail.caas.net.cn; liuxu01@caas.cn; zhhe@public3.bta.net.cn; maolong@caas.net.cn; wangj@genomics.cn	Wang, Jun/A-7261-2013; Xia, Xianchun/L-2402-2015; Mayer, Klaus FX/M-7941-2015; Keller, Beat/K-3093-2019; Liang, Qinsi/AAK-5234-2020; He, Zhonghu/E-1625-2015; wang, junyi/GYA-3213-2022; Li, Yingrui/K-1064-2015; Wicker, Thomas/Z-1978-2019; Pfeifer, Matthias/GRJ-4579-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Mayer, Klaus FX/0000-0001-6484-1077; Keller, Beat/0000-0003-2379-9225; Wang, Jun/0000-0002-2113-5874; He, Zhonghu/0000-0003-1384-3712; Wang, Jun/0000-0002-8540-8931; Spannagl, Manuel/0000-0003-0701-7035; , Thomas/0000-0002-6777-7135	National 863 Project [2012AA10A308, 2011AA100104]; International S&T Cooperation Program of China [2008DFB30080]; National Natural Science Foundation of China [31171548, 31071415]; National Basic Research Program of China [2010CB125900]; Core Research Budget of the Non-profit Governmental Research [201013]; National Program on R&D of Transgenic Plants [2011ZX08009-001, 2011ZX08002-002]	National 863 Project(National High Technology Research and Development Program of China); International S&T Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Core Research Budget of the Non-profit Governmental Research; National Program on R&D of Transgenic Plants	We thank J. M. Wan for support and encouragement; J. Dvorak and M. C. Luo for the AL8/78 line; C. Y. Jin, X. Y. Li, L. C. Zhang, L. Pan and J. C. Zhang for material preparation; Y. H. Lv for providing helpful palaeogeological information; D. M. Appels for producing the CMap database of molecular genetic maps; K. Edwards for providing the details of the SNP-based map for Avalon x Cadenza; L. Goodman for assistance in editing the manuscript; and M. W. Bevan, Y. B. Xu and C. Zou for critical readings of the manuscript. This work was supported by grants from the National 863 Project (2012AA10A308 and 2011AA100104), the International S&T Cooperation Program of China (2008DFB30080), the National Natural Science Foundation of China (31171548 and 31071415), the National Basic Research Program of China (2010CB125900), the Core Research Budget of the Non-profit Governmental Research (201013) and the National Program on R&D of Transgenic Plants (2011ZX08009-001 and 2011ZX08002-002).	Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; Hu B, 2011, PLANT SIGNAL BEHAV, V6, P927, DOI 10.4161/psb.6.7.15377; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; LI RQ, 2010, GENOME RES, V20, P265, DOI DOI 10.1101/GR.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Luo S, 2012, PLANT PHYSIOL, V159, P197, DOI 10.1104/pp.111.192062; Mao XG, 2011, FUNCT INTEGR GENOMIC, V11, P445, DOI 10.1007/s10142-011-0218-3; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Talbert LE, 1998, GENOME, V41, P402, DOI 10.1139/gen-41-3-402; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Williams M, 2009, PHILOS T R SOC A, V367, P85, DOI 10.1098/rsta.2008.0224; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x	30	572	744	5	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					91	95		10.1038/nature12028	http://dx.doi.org/10.1038/nature12028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23535592	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000316993400031
J	Fowler, VG; Allen, KB; Moreira, ED; Moustafa, M; Isgro, F; Boucher, HW; Corey, GR; Carmeli, Y; Betts, R; Hartzel, JS; Chan, ISF; McNeely, TB; Kartsonis, NA; Guris, D; Onorato, MT; Smugar, SS; DiNubile, MJ; Sobanjo-ter Meulen, A				Fowler, Vance G., Jr.; Allen, Keith B.; Moreira, Edson D., Jr.; Moustafa, Moustafa; Isgro, Frank; Boucher, Helen W.; Corey, G. Ralph; Carmeli, Yehuda; Betts, Robert; Hartzel, Jonathan S.; Chan, Ivan S. F.; McNeely, Tessie B.; Kartsonis, Nicholas A.; Guris, Dalya; Onorato, Matthew T.; Smugar, Steven S.; DiNubile, Mark J.; Sobanjo-ter Meulen, Ajoke			Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORIGINAL ANTIGENIC SIN; METHICILLIN-RESISTANT; MONOCLONAL-ANTIBODY; RISK-FACTORS; SURFACE; IMMUNITY; IMMUNOGENICITY; DISEASE; SAFETY; EPIDEMIOLOGY	Importance Infections due to Staphylococcus aureus are serious complications of cardiothoracic surgery. A novel vaccine candidate (V710) containing the highly conserved S aureus iron surface determinant Bis immunogenic and generally well tolerated in volunteers. Objective To evaluate the efficacy and safety of preoperative vaccination in preventing serious postoperative S aureus infection in patients undergoing cardiothoracic surgery. Design, Setting, and Participants Double-blind, randomized, event-driven trial conducted between December 2007 and August 2011 among 8031 patients aged 18 years or older who were scheduled for full median sternotomy within 14 to 60 days of vaccination at 165 sites in 26 countries. Intervention Participants were randomly assigned to receive a single 0.5-mL intramuscular injection of either V710 vaccine, 60 mu g (n=4015), or placebo (n=4016). Main Outcome Measures The primary efficacy end point was prevention of S aureus bacteremia and/or deep sternal wound infection (including mediastinitis) through postoperative day 90. Secondary end points included all S aureus surgical site and invasive infections through postoperative day 90. Three interim analyses with futility assessments were planned. Results The independent data monitoring committee recommended termination of the study after the second interim analysis because of safety concerns and low efficacy. At the end of the study, the V710 vaccine was not significantly more efficacious than placebo in preventing either the primary end points (22/3528 V710 vaccine recipients [2.6 per 100 person-years] vs 27/3517 placebo recipients [3.2 per 100 person-years]; relative risk, 0.81; 95% CI, 0.44-1.48; P=.58) or secondary end points despite eliciting robust antibody responses. Compared with placebo, the V710 vaccine was associated with more adverse experiences during the first 14 days after vaccination (1219/3958 vaccine recipients [30.8%; 95% CI, 29.4%-32.3%] and 866/3967 placebo recipients[21.8%; 95% CI, 20.6%-23.1%], including 797 [20.1%; 95% CI, 18.9%-21.4%] and 378 [9.5%; 95% CI, 8.6%-10.5%] with injection site reactions and 66 [1.7%; 95% CI, 1.3%-2.1%] and 51 [1.3%; 95% CI, 1.0%-1.7%] with serious adverse events, respectively) and a significantly higher rate of multiorgan failure during the entire study (31 vs 17 events; 0.9 [95% CI, 0.6-1.2] vs 0.5 [95% CI, 0.3-0.8] events per 100 person-years; P=.04). Although the overall incidence of vaccine-related serious adverse events (1 in each group) and the all-cause mortality rate (201/3958 vs 177/3967; 5.7 [95% CI, 4.9-6.5] vs 5.0 [95% CI, 4.3-5.7] deaths per 100 person-years; P=.20) were not statistically different between groups, the mortality rate in patients with staphylococcal infections was significantly higher among V710 vaccine than placebo recipients (15/73 vs 4/96; 23.0 [95% CI, 12.9-37.9] vs 4.2 [95% CI, 1.2-10.8] per 100 person-years; difference, 18.8 [95% CI, 8.0-34.1] per 100 person-years). Conclusions and Relevance Among patients undergoing cardiothoracic surgery with median sternotomy, the use of a vaccine against S aureus compared with placebo did not reduce the rate of serious postoperative S aureus infections and was associated with increased mortality among patients who developed S aureus infections. These findings do not support the use of the V710 vaccine for patients undergoing surgical interventions.	[Fowler, Vance G., Jr.; Corey, G. Ralph] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Fowler, Vance G., Jr.; Corey, G. Ralph] Duke Clin Res Inst, Durham, NC USA; [Allen, Keith B.] St Lukes Mid Amer Heart & Vasc Inst, Kansas City, MO USA; [Moreira, Edson D., Jr.] McGill Univ, Div Canc Epidemiol, Montreal, PQ, Canada; [Moreira, Edson D., Jr.] Brazilian Minist Hlth, Assoc Obras Socials Irma Dulce, Oswaldo Cruz Fdn, Salvador, BA, Brazil; [Moustafa, Moustafa] South Carolina Nephrol & Hypertens Ctr, Orangeburg, NY USA; [Isgro, Frank] Acad City Hosp Ludwigshafen, Ludwigshafen, Germany; [Boucher, Helen W.] Tufts Med Ctr, Boston, MA USA; [Carmeli, Yehuda] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Betts, Robert] Univ Rochester, Sch Med, Rochester, NY USA; [Hartzel, Jonathan S.; Chan, Ivan S. F.; McNeely, Tessie B.; Kartsonis, Nicholas A.; Guris, Dalya; Smugar, Steven S.; DiNubile, Mark J.; Sobanjo-ter Meulen, Ajoke] Merck Sharp & Dohme Ltd, Whitehouse Stn, NJ USA	Duke University; Duke University; Saint Luke's Mid America Heart Institute; McGill University; Fundacao Oswaldo Cruz; Ludwigshafen Hospital; Tufts Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Rochester; Merck & Company	Fowler, VG (corresponding author), Duke Univ, Med Ctr, Hanes Bldg,Room 153,Trent Dr,POB 102359, Durham, NC 27710 USA.	fowle003@mc.duke.edu	Moreira, Edson/W-7437-2019; Fowler, Vance/AAW-2017-2021; Moreira Jr, Edson Duarte/GRF-5620-2022; Moreira, Edson D/J-1758-2012	Moreira, Edson/0000-0002-7081-8348; Moreira Jr, Edson Duarte/0000-0002-7081-8348; Moreira, Edson D/0000-0002-7081-8348	Merck; Cerexa; Pfizer; Novartis; Advanced Liquid Logics; MedImmune; National Institutes of Health; Theravance; Medicines Company; Innoccol; Merck Sharp Dohme Corp	Merck(Merck & Company); Cerexa; Pfizer(Pfizer); Novartis(Novartis); Advanced Liquid Logics; MedImmune(AstraZenecaMedimmune); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Theravance; Medicines Company; Innoccol; Merck Sharp Dohme Corp(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Employees of Merck (Drs Hartzel, Chan, McNeely, Kartsonis, Guris, Smugar, DiNubile, and Sobanjo-ter Meulen and Mr Onorato) may own stock or stock options in the company. All academic authors have been investigators for Merck. Dr Fowler reports that he was compensated by Merck for serving as chair of the V710 Scientific Advisory Committee; has received grant support from Merck, Cerexa, Pfizer, Novartis, Advanced Liquid Logics, MedImmune, and the National Institutes of Health; has been a paid consultant for Merck, Astellas, Cubist, Cerexa, Durata, Pfizer, NovaDigm, Novartis, the Medicines Company, Bio-synexus, MedImmune, Galderma, and Inimex; and has received honoraria from Merck, Astellas, Cubist, Pfizer, Theravance, and Novartis. Dr Moreira reports that he has received research grants from Merck through his institution and honoraria from Merck for speaking engagements and board membership. Dr Moustafa reports consulting fees/honoraria and support for travel from Merck. Dr Boucher reports that she was compensated by Merck for serving on the adjudication committee for this study, is the recipient of a National Institutes of Health grant to study catheter-related bloodstream infections, and has been a paid consultant for Merck, Basilea, Cubist, Durata, Johnson & Johnson, RibX, Targanta/TMC, Wyeth/Pfizer, and Paratek. Dr Corey reports that he has received grant support from Theravance, the Medicines Company, and Innoccol and has served as a consultant and/or advisor for Merck, AstraZeneca, Astellas, Cempra, Cubist Pharmaceuticals, Cerexa/Forest Pharmaceuticals Furiex, PRA International, Inimex, Pfizer, GlaxoSmithKline, Polymedix, Achaogen, Trius, RibX, Nabriva, Seachaid, BioCryst, Durata, and Gilead. Dr Carmeli reports that he has been a paid consultant for Merck, Achaogen, AstraZeneca, Basilea, Intercell, Johnson & Johnson, RibX, and Proteologics. No other disclosures were reported.; The study was sponsored and funded by Merck Sharp & Dohme Corp, a subsidiary of Merck & Co Inc, Whitehouse Station, New Jersey.	Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; [Anonymous], 2013, GENE, DOI DOI 10.1016/j.gene.2013.03.137; Califf RM, 2004, AM HEART J, V147, P599, DOI 10.1016/j.ahj.2003.12.031; Chen LF, 2012, AM J INFECT CONTROL, V40, P963, DOI 10.1016/j.ajic.2012.01.012; Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Deresinski S., 2008, 12 INT S STAPH STAPH; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790; Frodermann V, 2011, J INFECT DIS, V204, P253, DOI 10.1093/infdis/jir276; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Harro CD, 2012, VACCINE, V30, P1729, DOI 10.1016/j.vaccine.2011.12.045; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kanafani ZA, 2009, INFECT CONT HOSP EP, V30, P242, DOI 10.1086/596015; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Kelly-Quintos C, 2005, J INFECT DIS, V192, P2012, DOI 10.1086/497604; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Lee BY, 2010, VACCINE, V28, P2465, DOI 10.1016/j.vaccine.2009.12.075; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moustafa M, 2012, CLIN VACCINE IMMUNOL, V19, P1509, DOI 10.1128/CVI.00034-12; Niebuhr M, 2011, INFECT IMMUN, V79, P1615, DOI 10.1128/IAI.00958-10; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Pan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023910; Pancari G, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00036; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Proctor RA, 2012, VACCINE, V30, P2921, DOI 10.1016/j.vaccine.2011.11.006; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Raedler MD, 2009, CLIN VACCINE IMMUNOL, V16, P739, DOI 10.1128/CVI.00478-08; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Skurnik D, 2010, J CLIN INVEST, V120, P3220, DOI 10.1172/JCI42748; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tang YW, 2004, VIRUS RES, V99, P81, DOI 10.1016/j.virusres.2003.10.009; Yoong P, 2010, P NATL ACAD SCI USA, V107, P2241, DOI 10.1073/pnas.0910344107	43	255	268	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1368	1378		10.1001/jama.2013.3010	http://dx.doi.org/10.1001/jama.2013.3010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549582	Bronze			2022-12-28	WOS:000316934500026
J	Robertson, MC; Gillespie, LD				Robertson, M. Clare; Gillespie, Lesley D.			Fall Prevention in Community-Dwelling Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Robertson, M. Clare; Gillespie, Lesley D.] Dunedin Sch Med, Dept Med, Dunedin 9054, New Zealand	University of Otago	Gillespie, LD (corresponding author), Dunedin Sch Med, Dept Med, POB 913, Dunedin 9054, New Zealand.	lesley.gillespie@otago.ac.nz						CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lamb SE, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-125; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	6	34	34	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1406	1407		10.1001/jama.2013.3130	http://dx.doi.org/10.1001/jama.2013.3130			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23549586				2022-12-28	WOS:000316934500030
J	Griggs, D; Stafford-Smith, M; Gaffney, O; Rockstrom, J; Ohman, MC; Shyamsundar, P; Steffen, W; Glaser, G; Kanie, N; Noble, I				Griggs, David; Stafford-Smith, Mark; Gaffney, Owen; Rockstroem, Johan; Oehman, Marcus C.; Shyamsundar, Priya; Steffen, Will; Glaser, Gisbert; Kanie, Norichika; Noble, Ian			Sustainable development goals for people and planet	NATURE			English	Editorial Material							ANTHROPOCENE		[Griggs, David] Monash Univ, Monash Sustainabil Inst, Clayton, Vic 3800, Australia	Monash University	Griggs, D (corresponding author), Monash Univ, Monash Sustainabil Inst, Clayton, Vic 3800, Australia.	dave.griggs@monash.edu	McGeoch, Melodie A/F-8353-2011; Smith, Mark Stafford/G-1680-2010; Shyamsundar, Priya/AAP-3411-2021; Steffen, Will/C-7651-2011	McGeoch, Melodie A/0000-0003-3388-2241; Smith, Mark Stafford/0000-0002-1333-3651; , Priya/0000-0001-8368-8581; Rockstrom, Johan/0000-0001-8988-2983; gaffney, owen/0000-0001-6244-991X; Griggs, David/0000-0002-9461-9933				Biermann F, 2012, SCIENCE, V335, P1306, DOI 10.1126/science.1217255; Carpenter SR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014009; Glaser G, 2012, NATURE, V491, P35, DOI 10.1038/491035a; Huntingford C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014039; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smakhtin VU, 2005, HYDROL PROCESS, V19, P1293, DOI 10.1002/hyp.5555; Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x; Sutton M.A., 2013, OUR NUTR WORLD; United Nation, 2012, MILL DEV GOALS REP	10	1422	1462	61	619	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					305	307		10.1038/495305a	http://dx.doi.org/10.1038/495305a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EY	23518546	Green Published, Bronze			2022-12-28	WOS:000316650500016
J	Batista, PJ; Chang, HY				Batista, Pedro J.; Chang, Howard Y.			Long Noncoding RNAs: Cellular Address Codes in Development and Disease	CELL			English	Review							INTERGENIC TRANSCRIPTION; SELECTIVE ELIMINATION; HISTONE MODIFICATION; NUCLEAR-BODIES; MESSENGER-RNAS; X-INACTIVATION; ANTISENSE RNA; GENE; CHROMATIN; GENOME	In biology as in real estate, location is a cardinal organizational principle that dictates the accessibility and flow of informational traffic. An essential question in nuclear organization is the nature of the address code-how objects are placed and later searched for and retrieved. Long noncoding RNAs (IncRNAs) have emerged as key components of the address code, allowing protein complexes, genes, and chromosomes to be trafficked to appropriate locations and subject to proper activation and deactivation. IncRNA-based mechanisms control cell fates during development, and their dysregulation underlies some human disorders caused by chromosomal deletions and translocations.	[Batista, Pedro J.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Batista, Pedro J.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	Batista, Pedro J/K-5303-2012		NIH; California Institute for Regenerative Medicine; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Chang lab for discussion and apologize to colleagues whose works are not discussed due to space limitation. We acknowledge support from NIH and California Institute for Regenerative Medicine (H.Y.C.). P.J.B. is the Kenneth G. and Elaine A. Langone Fellow of the Damon Runyon Cancer Research Foundation. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. H.Y.C. is on the Scientific Advisory Board of RaNA Therapeutics, which works on long noncoding RNAs.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bierhoff H, 2010, COLD SH Q B, V75, P357, DOI 10.1101/sqb.2010.75.060; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fradet YF, 2004, UROLOGY, V64, P311, DOI 10.1016/j.urology.2004.03.052; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grimal P., 1983, ROMAN CITIES VILLES; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Martin L, 2012, NAT METHODS, V9, P1192, DOI [10.1038/NMETH.2225, 10.1038/nmeth.2225]; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Mitton-Fry RM, 2010, SCIENCE, V330, P1244, DOI 10.1126/science.1195858; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Shappell Scott B, 2008, Rev Urol, V10, P44; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tycowski KT, 2012, CELL REP, V2, P26, DOI 10.1016/j.celrep.2012.05.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Dijk M, 2012, J CLIN INVEST, V122, P4003, DOI 10.1172/JCI65171; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	103	1920	2029	8	460	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1298	1307		10.1016/j.cell.2013.02.012	http://dx.doi.org/10.1016/j.cell.2013.02.012			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498938	Green Accepted, Bronze			2022-12-28	WOS:000316192500011
J	Savage, N				Savage, Neil			MINE, ALL MINE!	NATURE			English	Editorial Material																			0	3	3	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					S2	S3		10.1038/495S2a	http://dx.doi.org/10.1038/495S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23486098	Bronze			2022-12-28	WOS:000316652300026
J	Clair, C; Rigotti, NA; Porneala, B; Fox, CS; D'Agostino, RB; Pencina, MJ; Meigs, JB				Clair, Carole; Rigotti, Nancy A.; Porneala, Bianca; Fox, Caroline S.; D'Agostino, Ralph B., Sr.; Pencina, Michael J.; Meigs, James B.			Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among Adults With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; MORTALITY; WOMEN; POPULATION; MELLITUS; OUTCOMES	Importance Smoking cessation reduces the risks of cardiovascular disease (CVD), but weight gain that follows quitting smoking may weaken the CVD benefit of quitting. Objective To test the hypothesis that weight gain following smoking cessation does not attenuate the benefits of smoking cessation among adults with and without diabetes. Design, Setting, and Participants Prospective community-based cohort study using data from the Framingham Offspring Study collected from 1984 through 2011. At each 4-year examination, self-reported smoking status was assessed and categorized as smoker, recent quitter (-4 years), long-term quitter (-4 years), and nonsmoker. Pooled Cox proportional hazards models were used to estimate the association between quitting smoking and 6-year CVD events and to test whether 4-year change in weight following smoking cessation modified the association between smoking cessation and CVD events. Main Outcome Measure Incidence over 6 years of total CVD events, comprising coronary heart disease, cerebrovascular events, peripheral artery disease, and congestive heart failure. Results After a mean follow-up of 25 (SD, 9.6) years, 631 CVD events occurred among 3251 participants. Median 4-year weight gain was greater for recent quitters without diabetes (2.7 kg [interquartile range {IQR}, -0.5 to 6.4]) and with diabetes (3.6 kg [IQR, -1.4 to 8.2]) than for long-term quitters (0.9 kg [IQR, -1.4 to 3.2] and 0.0 kg [IQR, -3.2 to 3.2], respectively, P < .001). Among participants without diabetes, age-and sex-adjusted incidence rate of CVD was 5.9 per 100 person-examinations (95% CI, 4.9-7.1) in smokers, 3.2 per 100 person-examinations (95% CI, 2.1-4.5) in recent quitters, 3.1 per 100 person-examinations (95% CI, 2.6-3.7) in long-term quitters, and 2.4 per 100 person-examinations (95% CI, 2.0-3.0) in nonsmokers. After adjustment for CVD risk factors, compared with smokers, recent quitters had a hazard ratio (HR) for CVD of 0.47 (95% CI, 0.23-0.94) and long-term quitters had an HR of 0.46 (95% CI, 0.34-0.63); these associations had only a minimal change after further adjustment for weight change. Among participants with diabetes, there were similar point estimates that did not reach statistical significance. Conclusions and Relevance In this community-based cohort, smoking cessation was associated with a lower risk of CVD events among participants without diabetes, and weight gain that occurred following smoking cessation did not modify this association. This supports a net cardiovascular benefit of smoking cessation, despite subsequent weight gain. JAMA. 2013;309(10):1014-1021 www.jama.com	[Clair, Carole; Rigotti, Nancy A.] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Clair, Carole; Rigotti, Nancy A.; Porneala, Bianca; Meigs, James B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; [Fox, Caroline S.] NHLBI, NIH, Framingham Heart Study, Framingham, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Pencina, Michael J.] Harvard Clin Res Inst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Harvard Medical School	Clair, C (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, 44 Bugnon Ave, CH-1011 Lausanne, Switzerland.	carole.willi@gmail.com	Meigs, James/P-3927-2019; Clair, Carole/AAF-6675-2021; Clair, Carole/D-9786-2014	Meigs, James/0000-0002-2439-2657; Clair, Carole/0000-0001-5281-0943; Clair, Carole/0000-0001-5281-0943; Pencina, Michael/0000-0001-5798-8855	UpToDate Inc; Swiss National Science Foundation [PBLAP3-127728/1]; SICPA Foundation; National Heart, Lung, and Blood Institute (NHLBI) [5K24HL4440-10]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K24 DK080140]; Swiss National Science Foundation; NHLBI Framingham Heart Study [N01-HC-25195]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094] Funding Source: NIH RePORTER	UpToDate Inc; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SICPA Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NHLBI Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rigotti reported serving as an unpaid consultant to Pfizer and Allere Wellbeing Inc; conducting research projects sponsored by Pfizer and Nabi Biopharmaceuticals; and receiving royalties from UpToDate Inc for chapters related to smoking cessation. Dr Pencina reported serving as a data and safety monitoring board member for Thoracos. No other authors reported disclosures.; Dr Clair was supported by a grant from the Swiss National Science Foundation (PBLAP3-127728/1) and by a grant from the SICPA Foundation. Dr Rigotti was supported by National Heart, Lung, and Blood Institute (NHLBI) grant 5K24HL4440-10. Dr Meigs was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant K24 DK080140.; The Swiss National Science Foundation, SICPA Foundation, and NIDDK had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The Framingham Heart Study is supported by the NHLBI Framingham Heart Study (contract N01-HC-25195 [Drs D'Agostino and Pencina]). The NHLBI approved the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Al-Delaimy WK, 2002, ARCH INTERN MED, V162, P273, DOI 10.1001/archinte.162.3.273; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Chaturvedi N, 1997, DIABETES CARE, V20, P1266, DOI 10.2337/diacare.20.8.1266; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; CUPPLES LA, 1987, NIH PUBLICATION, P87; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eliasson B, 1997, EUR J CLIN INVEST, V27, P450, DOI 10.1046/j.1365-2362.1997.1330680.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Feldstein AC, 2008, DIABETES CARE, V31, P1960, DOI 10.2337/dc08-0426; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; MOY CS, 1990, CIRCULATION, V82, P37, DOI 10.1161/01.CIR.82.1.37; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Pisinger C, 2007, PREV MED, V44, P290, DOI 10.1016/j.ypmed.2006.11.015; Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; US Surgeon General, 1990, HLTH BEN SMOK CESS; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	26	162	163	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					1014	1021		10.1001/jama.2013.1644	http://dx.doi.org/10.1001/jama.2013.1644			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23483176	Green Accepted			2022-12-28	WOS:000315938700030
J	Spence, D				Spence, Des			Scrap the royal colleges' fellowships	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2013	346								f1609	10.1136/bmj.f1609	http://dx.doi.org/10.1136/bmj.f1609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VM	23482958				2022-12-28	WOS:000316324300015
J	Asch, DA; Muller, RW; Volpp, KG				Asch, David A.; Muller, Ralph W.; Volpp, Kevin G.			Conflicts and Compromises in Not Hiring Smokers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.; Volpp, Kevin G.] Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Asch, David A.; Muller, Ralph W.; Volpp, Kevin G.] Univ Penn, Ctr Hlth Incent & Behav Econ, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Muller, Ralph W.] Univ Penn, Univ Penn Hlth Syst, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599				Bayer R, 2008, SOC SCI MED, V67, P463, DOI 10.1016/j.socscimed.2008.03.017; Centers for Disease Control and Prevention, TOB REL MORT; Kleinerman E., CUYAHOGA COUNTY SMOK; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	5	21	21	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1371	1373		10.1056/NEJMp1303632	http://dx.doi.org/10.1056/NEJMp1303632			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122QT	23534547				2022-12-28	WOS:000317333600002
J	Tsai, IJ; Zarowiecki, M; Holroyd, N; Garciarrubio, A; Sanchez-Flores, A; Brooks, KL; Tracey, A; Bobes, RJ; Fragoso, G; Sciutto, E; Aslett, M; Beasley, H; Bennett, HM; Cai, JP; Camicia, F; Clark, R; Cucher, M; De Silva, N; Day, TA; Deplazes, P; Estrada, K; Fernandez, C; Holland, PWH; Hou, JL; Hu, SN; Huckvale, T; Hung, SS; Kamenetzky, L; Keane, JA; Kiss, F; Koziol, U; Lambert, O; Liu, K; Luo, XN; Luo, YF; Macchiaroli, N; Nichol, S; Paps, J; Parkinson, J; Pouchkina-Stantcheva, N; Riddiford, N; Rosenzvit, M; Salinas, G; Wasmuth, JD; Zamanian, M; Zheng, YD; Cai, XP; Soberon, X; Olson, PD; Laclette, JP; Brehm, K; Berriman, M				Tsai, Isheng J.; Zarowiecki, Magdalena; Holroyd, Nancy; Garciarrubio, Alejandro; Sanchez-Flores, Alejandro; Brooks, Karen L.; Tracey, Alan; Bobes, Raul J.; Fragoso, Gladis; Sciutto, Edda; Aslett, Martin; Beasley, Helen; Bennett, Hayley M.; Cai, Jianping; Camicia, Federico; Clark, Richard; Cucher, Marcela; De Silva, Nishadi; Day, Tim A.; Deplazes, Peter; Estrada, Karel; Fernandez, Cecilia; Holland, Peter W. H.; Hou, Junling; Hu, Songnian; Huckvale, Thomas; Hung, Stacy S.; Kamenetzky, Laura; Keane, Jacqueline A.; Kiss, Ferenc; Koziol, Uriel; Lambert, Olivia; Liu, Kan; Luo, Xuenong; Luo, Yingfeng; Macchiaroli, Natalia; Nichol, Sarah; Paps, Jordi; Parkinson, John; Pouchkina-Stantcheva, Natasha; Riddiford, Nick; Rosenzvit, Mara; Salinas, Gustavo; Wasmuth, James D.; Zamanian, Mostafa; Zheng, Yadong; Cai, Xuepeng; Soberon, Xavier; Olson, Peter D.; Laclette, Juan P.; Brehm, Klaus; Berriman, Matthew		Taenia Solium Genome Consortium	The genomes of four tapeworm species reveal adaptations to parasitism	NATURE			English	Article							ECHINOCOCCUS-MULTILOCULARIS; TAENIA-SOLIUM; GRANULOSUS; IDENTIFICATION; CULTIVATION; INFECTIONS; BIOLOGY; TARGET; HOX	Tapeworms (Cestoda) cause neglected diseases that can be fatal and are difficult to treat, owing to inefficient drugs. Here we present an analysis of tapeworm genome sequences using the human-infective species Echinococcus multilocularis, E. granulosus, Taenia solium and the laboratory model Hymenolepis microstoma as examples. The 115- to 141-megabase genomes offer insights into the evolution of parasitism. Synteny is maintained with distantly related blood flukes but we find extreme losses of genes and pathways that are ubiquitous in other animals, including 34 homeobox families and several determinants of stem cell fate. Tapeworms have specialized detoxification pathways, metabolism that is finely tuned to rely on nutrients scavenged from their hosts, and species-specific expansions of non-canonical heat shock proteins and families of known antigens. We identify new potential drug targets, including some on which existing pharmaceuticals may act. The genomes provide a rich resource to underpin the development of urgently needed treatments and control.	[Tsai, Isheng J.; Zarowiecki, Magdalena; Holroyd, Nancy; Sanchez-Flores, Alejandro; Brooks, Karen L.; Tracey, Alan; Aslett, Martin; Beasley, Helen; Bennett, Hayley M.; Clark, Richard; De Silva, Nishadi; Huckvale, Thomas; Keane, Jacqueline A.; Lambert, Olivia; Berriman, Matthew] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tsai, Isheng J.] Miyazaki Univ, Div Parasitol, Dept Infect Dis, Fac Med, Miyazaki 8891692, Japan; [Garciarrubio, Alejandro; Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62210, Morelos, Mexico; [Bobes, Raul J.; Fragoso, Gladis] Univ Nacl Autonoma Mexico, Inst Biomed Res, Mexico City 04510, DF, Mexico; [Cai, Jianping] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou 730046, Gansu, Peoples R China; [Cucher, Marcela] Univ Buenos Aires, Inst Microbiol & Parasitol Med, Fac Med, Consejo Nacl Invest Cient Tecnol IMPAM, Buenos Aires, DF, Argentina; [Day, Tim A.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [Deplazes, Peter] Univ Zurich, Inst Parasitol, Vet Fac, CH-8057 Zurich, Switzerland; [Fernandez, Cecilia] Univ Republica, Fac Quam, Montevideo 11600, Uruguay; [Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China; [Parkinson, John] Univ Toronto, Dept Biochem & Mol & Med Genet, Program Mol Struct & Funct, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Parkinson, John] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany; [Riddiford, Nick] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Riddiford, Nick] Natl Univ Ireland Galway, Dept Zool, Sch Nat Sci, Galway, Ireland; [Zamanian, Mostafa] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Soberon, Xavier] Inst Nacl Medicina Genom, Mexico City 14610, DF, Mexico	Wellcome Trust Sanger Institute; University of Miyazaki; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Buenos Aires; Iowa State University; University of Zurich; Universidad de la Republica, Uruguay; University of Oxford; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Wurzburg; Natural History Museum London; Ollscoil na Gaillimhe-University of Galway; McGill University; Instituto Nacional de Medicina Genomica	Berriman, M (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	laclette@biomedicas.unam.mx; kbrehm@hygiene.uni-wuerzburg.de; mb4@sanger.ac.uk	González, Víctor/AAF-7035-2020; Zarowiecki, Magdalena/ABD-2858-2021; Ochoa-Leyva, Adrián/E-5540-2013; Tsai, Isheng J/H-6606-2014; Olson, Peter/D-4643-2009; Zarowiecki, Magdalena/F-5037-2013; YD, Zh/HGA-5541-2022; Paps, Jordi/B-2098-2012; Berriman, Matthew/A-7618-2011; Zamanian, Mostafa/B-7993-2013; Tsai, Isheng Jason/ABB-8273-2021; Parkinson, John/A-4424-2008; Hu, Songnian/C-6509-2013; Sanchez-Flores, Alejandro/L-9454-2016	González, Víctor/0000-0003-4082-0022; Ochoa-Leyva, Adrián/0000-0002-4701-2303; Olson, Peter/0000-0002-4183-4533; Zarowiecki, Magdalena/0000-0001-6102-7731; YD, Zh/0000-0001-6795-9978; Paps, Jordi/0000-0003-2636-6636; Berriman, Matthew/0000-0002-9581-0377; Tsai, Isheng Jason/0000-0002-2123-5058; Parkinson, John/0000-0001-9815-1189; Hu, Songnian/0000-0003-3966-3111; Carrero, Julio/0000-0003-1055-5774; Holland, Peter/0000-0003-1533-9376; Camicia, Federico/0000-0003-1406-0357; Bennett, Hayley/0000-0001-8879-2855; Salinas, Gustavo/0000-0003-3350-3002; Keane, Jacqueline A./0000-0003-0739-6848; Day, Tim/0000-0002-9037-6540; Morett, Enrique/0000-0001-5723-0032; Liu, Kan/0000-0001-5625-8180; Huckvale, Thomas/0000-0001-7066-2577; ying feng, luo/0000-0003-1950-9045; Zamanian, Mostafa/0000-0001-9233-1760; Portillo Bobadilla, Tobias/0000-0002-3448-7959; Sciutto, Edda/0000-0001-5608-5355; Wasmuth, James/0000-0002-9516-212X; Riddiford, Nick/0000-0002-4739-4233; Cucher, Marcela Alejandra/0000-0003-1357-9210; Koziol, Uriel/0000-0002-9699-4964; Sanchez-Flores, Alejandro/0000-0003-0476-3139; De Silva, Nishadi/0000-0003-4802-2375	BBSRC [BBG0038151]; SynTax joint UK Research Council; European Research Council; Canadian Institute for Health Research (CIHR MOP) [84556]; FIRCA-NIH [TW008588]; Universidad de la Republica, CSIC [CSIC 625]; Wellcome Trust through Wellcome Trust Sanger Institute [098051]; Deutsche Forschungsgemeinschaft (DFG) [BR2045/4-1]; Universidad Nacional Autonoma de Mexico; FOGARTY INTERNATIONAL CENTER [R03TW008588] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G003815/1] Funding Source: researchfish; BBSRC [BB/G003815/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SynTax joint UK Research Council; European Research Council(European Research Council (ERC)European Commission); Canadian Institute for Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); FIRCA-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Universidad de la Republica, CSIC; Wellcome Trust through Wellcome Trust Sanger Institute; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Dunn and OpGen for the E. multilocularis optical map; Roche for 20kb 454 libraries; R. Rance, M. Quail, D. Willey, N. Smerdon and K. Oliver for sequencing libraries at WTSI; T. D. Otto for bioinformatics expertise; R. Davies and Q. Lin for help with data release; A. Bateman, M. Punta, P. Cogghill and J. Minstry of Pfam; N. Rowlings from MEROPS database, J. Gough at SUPERFAMILY and C. Dessimoz for OMA; C. Seed and F. Jarero for laboratory assistance; J. Overington and B. Al-Lazikani; and B. Brejova for predicting genes with ExonHunter. P.D.O. and N. P. S. were supported in part by a BBSRC grant (BBG0038151) to P.D.O. P.D.O. and Ma.Z. were supported by a SynTax joint UK Research Council grant. The European Research Council supported P.W.H.H. and J. Paps. J. Parkinson and S. S. H. were supported by an operating grant from the Canadian Institute for Health Research (CIHR MOP#84556). G. S. was supported by FIRCA-NIH (grant TW008588) and the Universidad de la Republica, CSIC (grant CSIC 625). The E. multilocularis, E. granulosus and H. microstoma genome projects were funded by the Wellcome Trust through their core support of the Wellcome Trust Sanger Institute (grant 098051). K. B. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; BR2045/4-1). The Taenia solium Genome Project (IMPULSA 03) was supported by the Universidad Nacional Autonoma de Mexico. The Taenia solium Genome Consortium thanks P. de la Torre, J. Yanez, P. Gaytan, S. Juarez and J. L. Fernandez for technical support; L. Herrera-Estrella and LANGEBIO, CINVESTAV-Irapuato and C. B. Shoemaker for sequencing support and other advice; and J. Watanabe (deceased), S. Sugano and Y. Suzuki for the construction and sequencing of the full-length cDNA library.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Brunetti E, 2012, INFECT DIS CLIN N AM, V26, P421, DOI 10.1016/j.idc.2012.02.001; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000319; Burton JB., 2012, HUMAN PARASITOLOGY, V4; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; DeMarco R, 2010, GENOME RES, V20, P1112, DOI 10.1101/gr.100099.109; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; FRAYHA GJ, 1971, COMP BIOCHEM PHYSIOL, V39, P167, DOI 10.1016/0305-0491(71)90264-1; Garcia HH, 2007, CURR OPIN INFECT DIS, V20, P489, DOI 10.1097/QCO.0b013e3282a95e39; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Grove D.I., 1990, HIST HUMAN HELMINTHO, P848; Hancock K, 2004, MOL BIOCHEM PARASIT, V133, P115, DOI 10.1016/j.molbiopara.2003.10.001; Heath DD, 2003, ACTA TROP, V85, P133, DOI 10.1016/S0001-706X(02)00219-X; Hemphill A, 2010, PARASITOLOGY, V137, P569, DOI 10.1017/S003118200999117X; Holland PWH, 2001, J ANAT, V199, P13; Kaasch AJ, 2000, J BIOL CHEM, V275, P1112, DOI 10.1074/jbc.275.2.1112; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Marks NJ, 2010, ADV EXP MED BIOL, V692, P49; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; Matsumoto J, 2010, GENOME RES, V20, P636, DOI 10.1101/gr.100271.109; McVeigh P, 2012, INT J PARASITOL-DRUG, V2, P76, DOI 10.1016/j.ijpddr.2011.10.004; Obal G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001642; Pakharukova MY, 2012, MOL BIOCHEM PARASIT, V181, P190, DOI 10.1016/j.molbiopara.2011.11.005; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Repasky EA, 2011, ONCOTARGET, V2, P433; Riddiford N, 2011, DEV GENES EVOL, V221, P187, DOI 10.1007/s00427-011-0370-8; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Spakulova M, 2011, ADV PARASIT, V74, P177, DOI 10.1016/B978-0-12-385897-9.00003-3; Spiliotis M, 2010, MOL BIOCHEM PARASIT, V174, P83, DOI 10.1016/j.molbiopara.2010.07.001; Spiliotis Markus, 2009, V470, P245, DOI 10.1007/978-1-59745-204-5_17; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Van Nassauw Luc, 2008, Travel Med Infect Dis, V6, P253, DOI 10.1016/j.tmaid.2008.06.006; Vargas-Parada L, 2001, PARASITOLOGY, V122, P583, DOI 10.1017/S0031182001007764; World Health Organization, 2012, NEGL TROP DIS; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, COORDIN CHEM REV, V255, P1206, DOI 10.1016/j.ccr.2011.02.016; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	47	478	513	8	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					57	63		10.1038/nature12031	http://dx.doi.org/10.1038/nature12031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23485966	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000316993400024
J	Vize, R				Vize, Richard			Goodbye (and good riddance?) to PCTs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com						Pollock A, 2007, BMJ-BRIT MED J, V335, P475, DOI 10.1136/bmj.39303.425359.AD	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2013	346								f2039	10.1136/bmj.f2039	http://dx.doi.org/10.1136/bmj.f2039			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SA	23550049				2022-12-28	WOS:000317337200009
J	Allen, DB; Cuttler, L				Allen, David B.; Cuttler, Leona			Short Stature in Childhood - Challenges and Choices	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC SHORT STATURE; GROWTH-HORMONE THERAPY; GH-DEFICIENT PATIENTS; LONG-TERM MORTALITY; ADULT HEIGHT; FINAL HEIGHT; DOUBLE-BLIND; CHILDREN; PHYSICIAN; PUBERTY	A family seeks evaluation and treatment of short stature in their 11.5-year-old son. He previously was in the 3rd percentile for height, but his growth rate has slowed during the past 2 years, and his height is now just below the 1st percentile (Fig. 1). His mother is 5 ft 0 in. (152 cm), and his father is 5 ft 6 in. (167 cm). The child's size at birth was normal. His medical history and a review of systems are unremarkable. His physical examination is normal and shows prepubertal development. The complete blood count, erythrocyte sedimentation rate, thyrotropin, tissue transglutaminase antibody, and insulin-like growth factor I (IGF-I) levels and growth hormone levels after provocative testing are normal. His skeletal maturation (bone age) is approximately 9 years, and his predicted adult height is 5 ft 5 in. (165 cm) plus or minus 1.3 in. (3.3 cm).(1) How should his condition be managed?	[Allen, David B.] Univ Wisconsin, Sch Med & Publ Hlth, Div Pediat Endocrinol & Diabet, Amer Family Childrens Hosp, Madison, WI 53792 USA; [Cuttler, Leona] Case Western Reserve Sch Med, Ctr Child Hlth & Policy, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Cuttler, Leona] Case Western Reserve Sch Med, Div Endocrinol & Diabet, Rainbow Babies & Childrens Hosp, Cleveland, OH USA	University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Allen, DB (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, H4-448 CSC,600 Highland Ave, Madison, WI 53792 USA.	dballen@pediatrics.wisc.edu			National Institutes of Health [R01HD030053]; Novo Nordisk; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by a grant (R01HD030053) from the National Institutes of Health (to Dr. Cuttler).; Dr. Allen reports receiving grant support through his institution from Novo Nordisk. No other potential conflict of interest relevant to this article was reported.	Allen DB, 2006, PEDIATRICS, V118, P343, DOI 10.1542/peds.2006-0329; Allen DB, 2011, J CLIN ENDOCR METAB, V96, P3042, DOI 10.1210/jc.2011-1739; Allen DB, 2010, J CLIN ENDOCR METAB, V95, P52, DOI 10.1210/jc.2009-2364; Allen DB, 2004, J PEDIATR-US, V144, P648, DOI 10.1016/j.jpeds.2004.02.028; [Anonymous], APPR LETT H IN PRESS; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Blethen SL, 1997, J CLIN ENDOCR METAB, V82, P418, DOI 10.1210/jc.82.2.418; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Child CJ, 2011, J CLIN ENDOCR METAB, V96, pE1025, DOI 10.1210/jc.2010-3023; ChildStats.gov, AM CHILDR BRIEF KEY; Cohen P, 2002, J CLIN ENDOCR METAB, V87, P90, DOI 10.1210/jc.87.1.90; Cohen P, 2008, J CLIN ENDOCR METAB, V93, P4210, DOI 10.1210/jc.2008-0509; Cuttler L, 2005, MED CARE, V43, P1185, DOI 10.1097/01.mlr.0000185731.71972.d4; Cuttler L, 1996, JAMA-J AM MED ASSOC, V276, P531, DOI 10.1001/jama.276.7.531; Cuttler L, 2010, ENDOCRINOLOGY ADULT, P479; Cuttler L, 2006, J CLIN ENDOCR METAB, V91, P3336; Cuttler L, 2010, J CLIN ENDOCR METAB, V95, P3149, DOI 10.1210/jc.2009-2688; Cuttler L, 2009, MED CARE, V47, P858, DOI 10.1097/MLR.0b013e31819e1f04; Deodati A, 2011, BMJ-BRIT MED J, V342, pc7157; Finkelstein BS, 2002, ARCH PEDIAT ADOL MED, V156, P230, DOI 10.1001/archpedi.156.3.230; FRASIER SD, 1981, J CLIN ENDOCR METAB, V53, P1213, DOI 10.1210/jcem-53-6-1213; Geisler A, 2012, HORM RES PAEDIAT, V78, P94, DOI 10.1159/000341151; GOURMELEN M, 1979, PEDIATR RES, V13, P221, DOI 10.1203/00006450-197904000-00002; Grimberg A, 1997, HORM RES, V48, P11, DOI 10.1159/000191323; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; KEENAN BS, 1993, J CLIN ENDOCR METAB, V76, P996, DOI 10.1210/jc.76.4.996; Lagrou K, 2006, HORM RES, V66, P277, DOI 10.1159/000095547; Lee JM, 2006, ARCH PEDIAT ADOL MED, V160, P263, DOI 10.1001/archpedi.160.3.263; Leschek EW, 2004, J CLIN ENDOCR METAB, V89, P3140, DOI 10.1210/jc.2003-031457; Maghnie M, 2004, J ENDOCRINOL INVEST, V27, P496, DOI 10.1007/BF03345298; MARIN G, 1994, J CLIN ENDOCR METAB, V79, P537, DOI 10.1210/jc.79.2.537; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P3653, DOI 10.1210/jc.85.10.3653; Nicol L, 2010, PEDIAT PRACTICE ENDO, P23; Noeker M, 2009, HORM RES, V71, P75, DOI 10.1159/000178044; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Rosenfeld RG, 2012, J CLIN ENDOCR METAB, V97, P68, DOI 10.1210/jc.2011-2294; Ross JL, 2004, J CLIN ENDOCR METAB, V89, P4873, DOI 10.1210/jc.2004-0791; Salehpour S, 2010, HORM RES PAEDIAT, V74, P428, DOI 10.1159/000315482; Sandberg DE, 2004, PEDIATRICS, V114, P744, DOI 10.1542/peds.2003-1169-L; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; SCHROOR EJ, 1995, EUR J PEDIATR, V154, P953, DOI 10.1007/BF01958637; Silvers JB, 2010, PEDIATRICS, V126, P468, DOI 10.1542/peds.2009-3609; Tauber M, 1997, J CLIN ENDOCR METAB, V82, P352, DOI 10.1210/jc.82.2.352; Ulph F, 2004, ARCH DIS CHILD, V89, P17, DOI 10.1136/adc.2002.010694; Visser-van Balen H, 2007, ACTA PAEDIATR, V96, P715, DOI 10.1111/j.1651-2227.2007.00235.x; WILSON DM, 1995, PEDIATRICS, V96, P1095; Wilson TA, 2003, J PEDIATR-US, V143, P415, DOI 10.1067/S0022-3476(03)00246-4; Wit JM, 2012, NAT REV ENDOCRINOL, V8, P135, DOI 10.1038/nrendo.2011.161; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055; ZACHMANN M, 1978, J PEDIATR-US, V93, P749, DOI 10.1016/S0022-3476(78)81071-3	50	48	55	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1220	1228		10.1056/NEJMcp1213178	http://dx.doi.org/10.1056/NEJMcp1213178			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116FU	23534561	Green Accepted			2022-12-28	WOS:000316869000009
J	Cabreiro, F; Au, C; Leung, KY; Vergara-Irigaray, N; Cocheme, HM; Noori, T; Weinkove, D; Schuster, E; Greene, NDE; Gems, D				Cabreiro, Filipe; Au, Catherine; Leung, Kit-Yi; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Weinkove, David; Schuster, Eugene; Greene, Nicholas D. E.; Gems, David			Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism	CELL			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; GUT MICROBIOTA; DIABETES-MELLITUS; ESCHERICHIA-COLI; HOST; GENETICS; MODEL; HOMEOSTASIS	The biguanide drug metformin is widely prescribed to treat type 2 diabetes and metabolic syndrome, but its mode of action remains uncertain. Metformin also increases lifespan in Caenorhabditis elegans co-cultured with Escherichia coli. This bacterium exerts complex nutritional and pathogenic effects on its nematode predator/host that impact health and aging. We report that metformin increases lifespan by altering microbial folate and methionine metabolism. Alterations in metformin-induced longevity by mutation of worm methionine synthase (metr-1) and S-adenosylmethionine synthase (sams-1) imply metformin-induced methionine restriction in the host, consistent with action of this drug as a dietary restriction mimetic. Metformin increases or decreases worm lifespan, depending on E. coli strain metformin sensitivity and glucose concentration. In mammals, the intestinal microbiome influences host metabolism, including development of metabolic disease. Thus, metformin-induced alteration of microbial metabolism could contribute to therapeutic efficacy-and also to its side effects, which include folate deficiency and gastrointestinal upset.	[Cabreiro, Filipe; Au, Catherine; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Schuster, Eugene; Gems, David] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Cabreiro, Filipe; Au, Catherine; Vergara-Irigaray, Nuria; Cocheme, Helena M.; Noori, Tahereh; Schuster, Eugene; Gems, David] UCL, GEE, London WC1E 6BT, England; [Leung, Kit-Yi; Greene, Nicholas D. E.] UCL, Neural Dev Unit, Inst Child Hlth, London WC1N 1EH, England; [Weinkove, David] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	University of London; University College London; University of London; University College London; University of London; University College London; Durham University	Gems, D (corresponding author), UCL, Inst Hlth Ageing, Mortimer St, London WC1E 6BT, England.	david.gems@ucl.ac.uk		Greene, Nicholas D.E./0000-0002-4170-5248; Gems, David/0000-0002-6653-4676; Cocheme, Helena/0000-0001-8637-0042; Cabreiro, Filipe/0000-0002-3696-4843; Schuster, Eugene/0000-0001-5076-2810; Au, Catherine/0000-0002-1923-9121; Weinkove, David/0000-0001-7399-1202	Wellcome Trust (Strategic Award); European Union (LifeSpan); MRC [J003794]; BBSRC [BB/H01974X/1] Funding Source: UKRI; MRC [MR/J003794/1, G0800339] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01974X/1] Funding Source: researchfish; Medical Research Council [MR/J003794/1, G0800339] Funding Source: researchfish	Wellcome Trust (Strategic Award)(Wellcome Trust); European Union (LifeSpan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dan Ackerman, Joy Alcedo, Nazif Alic, Caroline Araiz, Alex Benedetto, Steve Clarke, Goncalo Correia, Monica Driscoll, Michael Murphy, Brian Onken, Matthew Piper, Bhupinder Virk, and Matthias Ziehm for useful discussion and other help. Strains were provided by the CGC and CGSC (DBI-0742708). We acknowledge funding from the Wellcome Trust (Strategic Award), the European Union (LifeSpan) and the MRC (J003794).	Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BRENNER S, 1974, GENETICS, V77, P71; Bytzer P, 2001, ALIMENT PHARM THER, V15, P137, DOI 10.1046/j.1365-2036.2001.00896.x; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2011, CURR DIABETES REP, V11, P154, DOI 10.1007/s11892-011-0191-1; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hannich JT, 2009, DEV CELL, V16, P833, DOI 10.1016/j.devcel.2009.04.012; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242; Maier W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000376; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Martinez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; ORENTREICH N, 1993, J NUTR, V123, P269; Ottaviani E, 2011, BIOGERONTOLOGY, V12, P599, DOI 10.1007/s10522-011-9352-5; Pierotti MA, 2012, ONCOGENE; Proctor WR, 2008, DRUG METAB DISPOS, V36, P1650, DOI 10.1124/dmd.107.020180; Pyra KA, 2012, J NUTR, V142, P213, DOI 10.3945/jn.111.147132; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Venn BJ, 2007, EUR J CLIN NUTR, V61, pS122, DOI 10.1038/sj.ejcn.1602942; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	52	577	596	21	262	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 28	2013	153	1					228	239		10.1016/j.cell.2013.02.035	http://dx.doi.org/10.1016/j.cell.2013.02.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23540700	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000316853700019
J	Inokuma, Y; Yoshioka, S; Ariyoshi, J; Arai, T; Hitora, Y; Takada, K; Matsunaga, S; Rissanen, K; Fujita, M				Inokuma, Yasuhide; Yoshioka, Shota; Ariyoshi, Junko; Arai, Tatsuhiko; Hitora, Yuki; Takada, Kentaro; Matsunaga, Shigeki; Rissanen, Kari; Fujita, Makoto			X-ray analysis on the nanogram to microgram scale using porous complexes	NATURE			English	Article							ABSOLUTE-CONFIGURATION; GUEST EXCHANGE; CRYSTAL; MOLECULES; NETWORK; INCLUSION; FRAMEWORK; SANTONIN; CITRUS	X-ray single-crystal diffraction (SCD) analysis has the intrinsic limitation that the target molecules must be obtained as single crystals. Here we report a protocol for SCD analysis that does not require the crystallization of the sample. In our method, tiny crystals of porous complexes are soaked in a solution of the target, such that the complexes can absorb the target molecules. Crystallographic analysis clearly determines the absorbed guest structures along with the host frameworks. Because the SCD analysis is carried out on only one tiny crystal of the complex, the required sample mass is of the nanogram-microgram order. We demonstrate that as little as about 80 nanograms of a sample is enough for the SCD analysis. In combination with high-performance liquid chromatography, our protocol allows the direct characterization of multiple fractions, establishing a prototypical means of liquid chromatography SCD analysis. Furthermore, we unambiguously determined the structure of a scarce marine natural product using only 5 micrograms of the compound.	[Inokuma, Yasuhide; Yoshioka, Shota; Ariyoshi, Junko; Arai, Tatsuhiko; Fujita, Makoto] Univ Tokyo, Dept Appl Chem, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Hitora, Yuki; Takada, Kentaro; Matsunaga, Shigeki] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Rissanen, Kari] Univ Jyvaskyla, Dept Chem, NanoSci Ctr, Jyvaskyla 40014, Finland	University of Tokyo; University of Tokyo; University of Jyvaskyla	Fujita, M (corresponding author), Univ Tokyo, Dept Appl Chem, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Inokuma, Yasuhide/AAQ-9803-2020; Takada, Kentaro/AAH-7191-2020; Rissanen, Kari T/B-5688-2008	Inokuma, Yasuhide/0000-0001-6558-3356; Takada, Kentaro/0000-0003-3835-1482; Rissanen, Kari T/0000-0002-7282-8419; Hitora, Yuki/0000-0003-4271-2543; Fujita, Makoto/0000-0001-6105-7340	CREST project of the Japan Science and Technology Agency;  [24000009];  [23750146]; Grants-in-Aid for Scientific Research [12J07872] Funding Source: KAKEN	CREST project of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Specially Promoted Research (24000009) and Young Scientists (B) (23750146), and by the CREST project of the Japan Science and Technology Agency. The experiment involving X-ray crystallography with 80 ng of guest molecules was performed using VariMax optics with a RAPID image plate detector system, courtesy of Rigaku Corporation. We thank M. Yamasaki and H. Sato for support for X-ray measurements.	Ahuja S, 2003, HDB ISOLATION CHARAC; [Anonymous], 2009, ISOLATION IDENTIFICA; Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; Biradha K, 2002, ANGEW CHEM INT EDIT, V41, P3392, DOI 10.1002/1521-3773(20020916)41:18<3392::AID-ANIE3392>3.0.CO;2-V; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Chen BL, 2010, ACCOUNTS CHEM RES, V43, P1115, DOI 10.1021/ar100023y; COREY EJ, 1955, J AM CHEM SOC, V77, P1044, DOI 10.1021/ja01609a076; Croue J.-P., 1999, CHARACTERIZATION NAT, P73; Deschamps JR, 2010, LIFE SCI, V86, P585, DOI 10.1016/j.lfs.2009.02.028; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Flack HD, 1999, ACTA CRYSTALLOGR A, V55, P908, DOI 10.1107/S0108767399004262; Freedman TB, 2003, CHIRALITY, V15, P743, DOI 10.1002/chir.10287; FUJITA M, 1994, J AM CHEM SOC, V116, P1151, DOI 10.1021/ja00082a055; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Green CO, 2007, BIOMED CHROMATOGR, V21, P48, DOI 10.1002/bmc.718; Halder GJ, 2005, J AM CHEM SOC, V127, P7891, DOI 10.1021/ja042420k; Han S, 2010, J AGR FOOD CHEM, V58, P9488, DOI 10.1021/jf102730b; Haneda T, 2007, ANGEW CHEM INT EDIT, V46, P6643, DOI 10.1002/anie.200700999; Hitora Y, 2011, TETRAHEDRON, V67, P4530, DOI 10.1016/j.tet.2011.04.085; INAYAMA S, 1980, J CHEM SOC CHEM COMM, P495, DOI 10.1039/c39800000495; Inokuma Y, 2011, J AM CHEM SOC, V133, P19691, DOI 10.1021/ja209290t; Inokuma Y, 2011, NAT CHEM, V3, P349, DOI [10.1038/NCHEM.1031, 10.1038/nchem.1031]; Inokuma Y, 2010, NAT CHEM, V2, P780, DOI [10.1038/nchem.742, 10.1038/NCHEM.742]; Kawano M, 2007, COORDIN CHEM REV, V251, P2592, DOI 10.1016/j.ccr.2007.07.022; Kim H, 2006, CHEM COMMUN, P2759, DOI 10.1039/b604925g; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitaura R, 2002, SCIENCE, V298, P2358, DOI 10.1126/science.1078481; Kondo M, 1997, ANGEW CHEM INT EDIT, V36, P1725, DOI 10.1002/anie.199717251; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Li QW, 2009, SCIENCE, V325, P855, DOI 10.1126/science.1175441; Li-Ling Ooi, 2010, PRINCIPLES XRAY CRYS; Ohara K, 2010, J AM CHEM SOC, V132, P30, DOI 10.1021/ja908794n; Ohashi Y, 2008, MODELS, MYSTERIES AND MAGIC OF MOLECULES, P109, DOI 10.1007/978-1-4020-5941-4_5; Ohmori O, 2004, J AM CHEM SOC, V126, P16292, DOI 10.1021/ja046478a; Seco JM, 2004, CHEM REV, V104, P17, DOI 10.1021/cr000665j; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TAKAYANAGI H, 1991, ANAL SCI, V7, P183, DOI 10.2116/analsci.7.183; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340	40	590	603	14	651	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2013	495	7442					461	+		10.1038/nature11990	http://dx.doi.org/10.1038/nature11990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538828				2022-12-28	WOS:000316682800036
J	Rellergert, WG; Sullivan, ST; Schowalter, SJ; Kotochigova, S; Chen, K; Hudson, ER				Rellergert, Wade G.; Sullivan, Scott T.; Schowalter, Steven J.; Kotochigova, Svetlana; Chen, Kuang; Hudson, Eric R.			Evidence for sympathetic vibrational cooling of translationally cold molecules	NATURE			English	Article							IONS; CHEMISTRY; COLLISIONS	Compared with atoms, molecules have a rich internal structure that offers many opportunities for technological and scientific advancement. The study of this structure could yield critical insights into quantum chemistry(1-3), new methods for manipulating quantum information(4,5), and improved tests of discrete symmetry violation(6,7) and fundamental constant variation(8-10). Harnessing this potential typically requires the preparation of cold molecules in their quantum rovibrational ground state. However, the molecular internal structure severely complicates efforts to produce such samples. Removal of energy stored in long-lived vibrational levels is particularly problematic because optical transitions between vibrational levels are not governed by strict selection rules, which makes laser cooling difficult. Additionally, traditional collisional, or sympathetic, cooling methods are inefficient at quenching molecular vibrational motion(11). Here we experimentally demonstrate that the vibrational motion of trapped BaCl+ molecules is quenched by collisions with ultracold calcium atoms at a rate comparable to the classical scattering, or Langevin, rate. This is over four orders of magnitude more efficient than traditional sympathetic cooling schemes(11). The high cooling rate, a consequence of a strong interaction potential (due to the high polarizability of calcium), along with the low collision energies involved(12), leads to molecular samples with a vibrational ground-state occupancy of at least 90 per cent. Our demonstration uses a novel thermometry technique that relies on relative photodissociation yields. Although the decrease in vibrational temperature is modest, with straightforward improvements it should be possible to produce molecular samples with a vibrational ground-state occupancy greater than 99 per cent in less than 100 milliseconds. Because sympathetic cooling of molecular rotational motion is much more efficient than vibrational cooling in traditional systems, we expect that the method also allows efficient cooling of the rotational motion of the molecules. Moreover, the technique should work for many different combinations of ultracold atoms and molecules.	[Rellergert, Wade G.; Sullivan, Scott T.; Schowalter, Steven J.; Chen, Kuang; Hudson, Eric R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Kotochigova, Svetlana] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rellergert, WG (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	wgr6@ucla.edu		Sullivan, Scott/0000-0002-7294-9069	ARO [W911NF-10-1-0505]; US NSF [PHY-1005453, PHY-1205311]; AFOSR [FA 9550-11-1-0243]; Division Of Physics [1005453] Funding Source: National Science Foundation	ARO; US NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by ARO grant no. W911NF-10-1-0505, US NSF grant nos PHY-1005453 and PHY-1205311, and AFOSR grant no. FA 9550-11-1-0243.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Balakrishnan N, 2001, CHEM PHYS LETT, V341, P652, DOI 10.1016/S0009-2614(01)00515-2; BAND YB, 1992, PHYS REV A, V46, P330, DOI 10.1103/PhysRevA.46.330; Chen K, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.030501; Chin C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055048; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; DeMille D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043202; DeVoe RG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.063001; FERGUSON EE, 1986, J PHYS CHEM-US, V90, P731, DOI 10.1021/j100277a008; Griffith WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.101601; Hudson ER, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063404; Hudson ER, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.032716; Hummon M., 2012, B AM PHYS SOC, V57; KOZLOV MG, 1995, J PHYS B-AT MOL OPT, V28, P1933, DOI 10.1088/0953-4075/28/10/008; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; Krems R. V., 2009, COLD MOL THEORY EXPT; Leanhardt AE, 2011, J MOL SPECTROSC, V270, P1, DOI 10.1016/j.jms.2011.06.007; Lefebvre-Brion H., 2004, SPECTRA DYNAMICS DIA; Levin K, 2012, CONT CONCEPT CONDENS, P1; MAJOR FG, 1968, PHYS REV, V170, P91, DOI 10.1103/PhysRev.170.91; McGuirk JM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033608; Ostendorf A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243005; Rellergert WG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.243201; Schneider T, 2010, NAT PHYS, V6, P275, DOI 10.1038/NPHYS1605; Schowalter SJ, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3700216; Schuster DI, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012311; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; SMITH D, 1992, CHEM REV, V92, P1473, DOI 10.1021/cr00015a001; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Sullivan ST, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.223002; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Vutha AC, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/7/074007	32	93	93	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					490	+		10.1038/nature11937	http://dx.doi.org/10.1038/nature11937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23538830				2022-12-28	WOS:000316682800041
J	Holz, RW				Holz, Ronald W.			Dynamin Flexibility Drives Fission	SCIENCE			English	Editorial Material							MEMBRANE-FUSION; MODEL		Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Holz, RW (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	holz@umich.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073686] Funding Source: NIH RePORTER; NINDS NIH HHS [R21-NS073686] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6	10	2	2	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1392	1393		10.1126/science.1236005	http://dx.doi.org/10.1126/science.1236005			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520100				2022-12-28	WOS:000316740700029
J	Thompson, H; Tucker, AS				Thompson, Hannah; Tucker, Abigail S.			Dual Origin of the Epithelium of the Mammalian Middle Ear	SCIENCE			English	Article							EUSTACHIAN-TUBE; NEURAL CREST; EVOLUTION	The air-filled cavity and ossicles of the mammalian middle ear conduct sound to the cochlea. Using transgenic mice, we show that the mammalian middle ear develops through cavitation of a neural crest mass. These cells, which previously underwent an epithelial-to-mesenchymal transformation upon leaving the neural tube, undergo a mesenchymal-to-epithelial transformation to form a lining continuous with the endodermally derived auditory tube. The epithelium derived from endodermal cells, which surrounds the auditory tube and eardrum, develops cilia, whereas the neural crest-derived epithelium does not. Thus, the cilia critical to clearing pathogenic infections from the middle ear are distributed according to developmental derivations. A different process of cavitation appears evident in birds and reptiles, indicating that this dual epithelium may be unique to mammals.	[Thompson, Hannah; Tucker, Abigail S.] Kings Coll London, Guys Hosp, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tucker, AS (corresponding author), Kings Coll London, Guys Hosp, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England.	abigail.tucker@kcl.ac.uk	Tucker, Abigail S/K-1788-2016	Tucker, Abigail S/0000-0001-8871-6094	Medical Research Council [G1001232]; MRC [G1001232] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Warley and G. Vizcay in the Centre for Ultrastructural Imaging at King's College London for help with the SEM and J. Green for his helpful critique of the manuscript. We also thank H. Lickert and M. A. Basson for the Sox17-2AiCre line. This work was funded by a project grant from the Medical Research Council (G1001232). Sox17-2Aicre transgenic mice are available for noncommercial use subject to a material transfer agreement with Helmholtz Zentrum Munchen, German Research Centre for Environmental Health (GmbH), through H. Lickert.	Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; BUCH NH, 1964, ARCHIV OTOLARYNGOL, V79, P472, DOI 10.1001/archotol.79.5.472; Chai Y, 2000, DEVELOPMENT, V127, P1671; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; GIANNESSI F, 1993, J ANAT, V183, P103; HAYE R, 1974, CELL TISSUE RES, V148, P431; Hilding D A, 1980, Am J Otolaryngol, V1, P97, DOI 10.1016/S0196-0709(80)80002-0; Indra AK, 2000, HORM RES, V54, P296, DOI 10.1159/000053275; Jaisinghani VJ, 1999, AM J OTOLARYNG, V20, P363, DOI 10.1016/S0196-0709(99)90075-3; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; Kaufmann MH, 1992, ATLAS MOUSE DEV; Kontges G, 1996, DEVELOPMENT, V122, P3229; KUIJPERS W, 1984, HISTOCHEM J, V16, P807, DOI 10.1007/BF01002787; Lim D J, 1967, Acta Otolaryngol, V63, P425, DOI 10.3109/00016486709128777; MAROVITZ WF, 1971, ANN OTO RHINOL LARYN, V80, P384, DOI 10.1177/000348947108000313; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; PARK K, 1992, AM J OTOLARYNG, V13, P93, DOI 10.1016/0196-0709(92)90005-E; PROCTOR B, 1964, J Laryngol Otol, V78, P631, DOI 10.1017/S002221510006254X; Richter CA, 2010, HUM MOL GENET, V19, P1551, DOI 10.1093/hmg/ddq028; SADE J, 1966, ARCHIV OTOLARYNGOL, V84, P137; SCHWARZBART A, 1959, J Laryngol Otol, V73, P45, DOI 10.1017/S0022215100054906; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takechi M, 2010, J EXP ZOOL PART B, V314B, P417, DOI 10.1002/jez.b.21347; Varshney S, 2010, INDIAN J OTOLARYNGOL, V62, P421, DOI 10.1007/s12070-010-0116-3; Wittmaack K., 1918, NORMALE PATHOLOGISCH	25	63	65	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1453	1456		10.1126/science.1232862	http://dx.doi.org/10.1126/science.1232862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23520114	Green Published			2022-12-28	WOS:000316740700048
J	McLauchlan, KK; Williams, JJ; Craine, JM; Jeffers, ES				McLauchlan, Kendra K.; Williams, Joseph J.; Craine, Joseph M.; Jeffers, Elizabeth S.			Changes in global nitrogen cycling during the Holocene epoch	NATURE			English	Article							RECENT ENVIRONMENTAL-CHANGES; REGIONAL PALEOLIMNOLOGICAL ASSESSMENT; SEDIMENTARY GEOCHEMICAL RECORD; LACUSTRINE ORGANIC-MATTER; MOUNTAIN NATIONAL-PARK; LAKE-SEDIMENTS; STABLE-ISOTOPES; CLIMATE-CHANGE; ALPINE LAKES; EAST-AFRICA	Human activities have doubled the pre-industrial supply of reactive nitrogen on Earth, and future rates of increase are expected to accelerate(1). Yet little is known about the capacity of the biosphere to buffer increased nitrogen influx. Past changes in global ecosystems following deglaciation at the end of the Pleistocene epoch provide an opportunity to understand better how nitrogen cycling in the terrestrial biosphere responded to changes in carbon cycling. We analysed published records of stable nitrogen isotopic values (delta N-15) in sediments from 86 lakes on six continents. Here we show that the value of sedimentary delta N-15 declined from 15,000 years before present to 7,056 +/- 597 years before present, a period of increasing atmospheric carbon dioxide concentrations and terrestrial carbon accumulation(2). Comparison of the nitrogen isotope record with concomitant carbon accumulation on land and nitrous oxide in the atmosphere suggests millennia of declining nitrogen availability in terrestrial ecosystems during the Pleistocene-Holocene transition around 11,000 years before present. In contrast, we do not observe a consistent change in global sedimentary delta N-15 values during the past 500 years, despite the potential effects of changing temperature and nitrogen influx from anthropogenic sources. We propose that the lack of a single response may indicate that modern increases in atmospheric carbon dioxide and net carbon sequestration in the biosphere have the potential to offset recent increased supplies of reactive nitrogen in some ecosystems.	[McLauchlan, Kendra K.; Williams, Joseph J.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA; [Craine, Joseph M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Jeffers, Elizabeth S.] Univ Oxford, Biodivers Inst, Dept Zool, Oxford OX1 3PS, England	Kansas State University; Kansas State University; University of Oxford	McLauchlan, KK (corresponding author), Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA.	mclauch@ksu.edu	Craine, Joseph/D-4569-2009; Jeffers, Elizabeth S./D-4021-2013	Craine, Joseph/0000-0001-6561-3244; Jeffers, Elizabeth S./0000-0001-9679-5909; Williams, Joseph/0000-0003-4521-4902; McLauchlan, Kendra/0000-0002-6612-1097	National Science Foundation [BCS-0955225, EPS-0903806]; James Martin Fellowship at the University of Oxford	National Science Foundation(National Science Foundation (NSF)); James Martin Fellowship at the University of Oxford	This work was supported by the National Science Foundation (BCS-0955225 and EPS-0903806) and a James Martin Fellowship at the University of Oxford. We thank the many authors who contributed their data for the purpose of this analysis. We appreciate technical assistance from C. Morris, P. Long and S. McConaghy. We thank J. Marlon, S. Enders, C. Baird and S. Perakis for comments.	Abbott MB, 2000, QUATERNARY SCI REV, V19, P1801, DOI 10.1016/S0277-3791(00)00078-0; Alin SR, 2002, GEOLOGY, V30, P1143, DOI 10.1130/0091-7613(2002)030<1143:EOLUCO>2.0.CO;2; Anderson L, 2001, QUATERNARY RES, V55, P313, DOI 10.1006/qres.2001.2219; Bai E., 2009, GLOBAL BIOGEOCHEM CY, V23; Bernal S, 2012, P NATL ACAD SCI USA, V109, P3406, DOI 10.1073/pnas.1121448109; Bertrand S, 2010, PALAEOGEOGR PALAEOCL, V294, P56, DOI 10.1016/j.palaeo.2009.03.012; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Brahney J, 2008, QUATERNARY RES, V70, P213, DOI 10.1016/j.yqres.2008.05.001; Brenner M, 1999, J PALEOLIMNOL, V22, P205, DOI 10.1023/A:1008078222806; Brodie CR, 2011, QUATERNARY SCI REV, V30, P3076, DOI 10.1016/j.quascirev.2011.07.003; Bunting L, 2010, LIMNOL OCEANOGR, V55, P333, DOI 10.4319/lo.2010.55.1.0333; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Choudhary P, 2009, SCI TOTAL ENVIRON, V407, P2783, DOI 10.1016/j.scitotenv.2008.12.020; Choudhary P, 2009, J PALEOLIMNOL, V42, P571, DOI 10.1007/s10933-009-9306-y; Chu GQ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012077; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Davidson E.A., 2012, EXCESS NITROGEN US E, V15; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Drew S, 2008, HYDROBIOLOGIA, V608, P35, DOI 10.1007/s10750-008-9383-3; Enders SK, 2008, LIMNOL OCEANOGR, V53, P1468, DOI 10.4319/lo.2008.53.4.1468; Engstrom DR, 2006, ECOL APPL, V16, P1194, DOI 10.1890/1051-0761(2006)016[1194:AROTCE]2.0.CO;2; Engstrom DR, 2000, NATURE, V408, P161, DOI 10.1038/35041500; Enters D, 2010, J PALEOLIMNOL, V43, P719, DOI 10.1007/s10933-009-9362-3; Fagel N, 2010, J QUATERNARY SCI, V25, P1100, DOI 10.1002/jqs.1364; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Filippi ML, 2005, QUATERNARY SCI REV, V24, P1303, DOI 10.1016/j.quascirev.2004.10.009; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hassan KM, 1997, J PALEOLIMNOL, V18, P121, DOI 10.1023/A:1007993329040; Hastings M. G., 2005, GLOBAL BIOGEOCHEM CY, V19; Heikkila M, 2010, QUATERNARY SCI REV, V29, P2146, DOI 10.1016/j.quascirev.2010.05.010; Herczeg AL, 2001, APPL GEOCHEM, V16, P73, DOI 10.1016/S0883-2927(00)00016-0; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs WO, 2011, CAN J FISH AQUAT SCI, V68, P1480, DOI [10.1139/f2011-058, 10.1139/F2011-058]; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Holmgren SU, 2010, J PALEOLIMNOL, V43, P393, DOI 10.1007/s10933-009-9338-3; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Hu FS, 2001, ECOSYSTEMS, V4, P358, DOI 10.1007/s10021-001-0017-0; Hyodo F, 2008, SCI TOTAL ENVIRON, V403, P139, DOI 10.1016/j.scitotenv.2008.05.010; Janbu AD, 2011, J PALEOLIMNOL, V46, P29, DOI 10.1007/s10933-011-9512-2; Jeffers ES, 2012, NEW PHYTOL, V193, P150, DOI 10.1111/j.1469-8137.2011.03907.x; Jeffers ES, 2011, J ECOL, V99, P1063, DOI 10.1111/j.1365-2745.2011.01816.x; Jeffers ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016134; Pueyo JJ, 2011, PALAEOGEOGR PALAEOCL, V307, P339, DOI 10.1016/j.palaeo.2011.05.036; Keeling CD, 2011, TELLUS B, V63, P1, DOI 10.1111/j.1600-0889.2010.00507.x; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P479, DOI 10.1139/cjfas-58-3-479; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P492, DOI 10.1139/cjfas-58-3-492; Lascu I, 2012, PALAEOGEOGR PALAEOCL, V337, P99, DOI 10.1016/j.palaeo.2012.04.001; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; LEAVITT PR, 1994, CAN J FISH AQUAT SCI, V51, P2411, DOI 10.1139/f94-241; Li L, 2008, GEOCHIM COSMOCHIM AC, V72, P4338, DOI 10.1016/j.gca.2008.06.026; Lobo I, 2001, J PALEOLIMNOL, V26, P119, DOI 10.1023/A:1011145227967; Lucke A, 2004, PALAEOGEOGR PALAEOCL, V211, P139, DOI 10.1016/S0031-0182(04)00259-7; Mayr C, 2009, J PALEOLIMNOL, V42, P81, DOI 10.1007/s10933-008-9249-8; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; McLauchlan KK, 2010, NEW PHYTOL, V187, P1135, DOI 10.1111/j.1469-8137.2010.03322.x; Muggeo V.M., 2008, R NEWS, V8, P20; Muzuka ANN, 2004, J AFR EARTH SCI, V40, P293, DOI 10.1016/j.jafrearsci.2004.12.005; Nadelhoffer KJ, 1994, STABLE ISOTOPES ECOL; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Olsen J, 2010, J PALEOLIMNOL, V43, P323, DOI 10.1007/s10933-009-9334-7; Parplies J, 2008, J PALEOLIMNOL, V40, P471, DOI 10.1007/s10933-007-9176-0; Perakis SS, 2011, OECOLOGIA, V167, P793, DOI 10.1007/s00442-011-2016-y; Perakis SS, 2011, ECOLOGY, V92, P1481, DOI 10.1890/10-1642.1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; PUEYO JJ, 2010, AN ACAD BRAS CIENC, V82, P717; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reuss NS, 2010, ECOSYSTEMS, V13, P393, DOI 10.1007/s10021-010-9326-5; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Routh J, 2004, LIMNOL OCEANOGR, V49, P1560, DOI 10.4319/lo.2004.49.5.1560; Routh J, 2007, J PALEOLIMNOL, V37, P529, DOI 10.1007/s10933-006-9032-7; Routh J, 2009, J PALEOLIMNOL, V42, P325, DOI 10.1007/s10933-008-9279-2; Russell JM, 2009, QUATERNARY RES, V72, P315, DOI 10.1016/j.yqres.2009.06.008; Ryner M, 2007, PALAEOGEOGR PALAEOCL, V248, P440, DOI 10.1016/j.palaeo.2006.12.014; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Saros JE, 2005, CAN J FISH AQUAT SCI, V62, P1681, DOI 10.1139/F05-077; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Schindler DE, 2006, CAN J FISH AQUAT SCI, V63, P1439, DOI 10.1139/F06-069; Schindler DE, 2005, ECOLOGY, V86, P3225, DOI 10.1890/04-1730; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Selbie DT, 2007, T AM FISH SOC, V136, P800, DOI 10.1577/T06-100.1; Selbie DT, 2011, CAN J FISH AQUAT SCI, V68, P675, DOI [10.1139/F11-006, 10.1139/f2011-006]; Street-Perrott FA, 2008, J QUATERNARY SCI, V23, P375, DOI 10.1002/jqs.1187; Talbot MR, 2006, J PALEOLIMNOL, V35, P467, DOI 10.1007/s10933-005-2828-z; Talbot MR, 2002, DEV PALEOENVIRON RES, V2, P401; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Talbot MR, 2000, J PALEOLIMNOL, V23, P141, DOI 10.1023/A:1008029400463; Tareq SM, 2011, QUATERN INT, V229, P47, DOI 10.1016/j.quaint.2010.04.014; TEAM RDC, 2005, R LANGUAGE ENV STAT; Tenzer GE, 1999, ORG GEOCHEM, V30, P133, DOI 10.1016/S0146-6380(98)00209-5; Teranes JL, 2000, LIMNOL OCEANOGR, V45, P801, DOI 10.4319/lo.2000.45.4.0801; Vreca P, 2006, LIMNOL OCEANOGR, V51, P781, DOI 10.4319/lo.2006.51.1_part_2.0781; Wolfe AP, 2006, ARCT ANTARCT ALP RES, V38, P465, DOI 10.1657/1523-0430(2006)38[465:ACROAN]2.0.CO;2; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x; Wolfe BB, 2003, HOLOCENE, V13, P153, DOI 10.1191/0959683603hl605ft; Wolfe BB, 1999, HOLOCENE, V9, P215, DOI 10.1191/095968399669823431; Woodward CA, 2012, J PALEOLIMNOL, V47, P167, DOI 10.1007/s10933-011-9568-z; Wooller M, 2008, J PALEOLIMNOL, V40, P63, DOI 10.1007/s10933-007-9144-8; Xu YP, 2009, APPL GEOCHEM, V24, P411, DOI 10.1016/j.apgeochem.2008.12.002; Xu-Ri, 2008, GLOBAL CHANGE BIOL, V14, P1745, DOI 10.1111/j.1365-2486.2008.01625.x	105	89	93	14	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					352	355		10.1038/nature11916	http://dx.doi.org/10.1038/nature11916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23518563				2022-12-28	WOS:000316650500039
J	Shortell, SM				Shortell, Stephen M.			Bridging the Divide Between Health and Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PUBLIC-HEALTH		Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417 E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu						[Anonymous], 1997, PURCHASING POPULATIO; Asch DA, 2012, NEW ENGL J MED, V367, P888, DOI 10.1056/NEJMp1206862; Bielaszka-DuVernay C, 2011, HEALTH AFFAIR, V30, P435, DOI 10.1377/hlthaff.2011.0162; Braunstein S, 2011, HEALTH AFFAIR, V30, P2042, DOI 10.1377/hlthaff.2011.0838; Committee on Public Health Strategies to Improve Health; Institute of Medicine, 2012, PUBL HLTH INV HLTH F; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P461, DOI 10.1001/jama.2012.8227; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78	8	56	58	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2013	309	11					1121	1122		10.1001/jama.2013.887	http://dx.doi.org/10.1001/jama.2013.887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FF	23512058				2022-12-28	WOS:000316276500024
J	Giannakopoulos, B; Krilis, SA				Giannakopoulos, Bill; Krilis, Steven A.			The Pathogenesis of the Antiphospholipid Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENDOTHELIAL-CELL ACTIVATION; NITRIC-OXIDE SYNTHASE; IN-VIVO; TISSUE FACTOR; FACTOR-XI; BETA(2)-GLYCOPROTEIN I; DOMAIN-I; ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; VENOUS THROMBOSIS		[Giannakopoulos, Bill; Krilis, Steven A.] Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW 2217, Australia; [Giannakopoulos, Bill] Univ New S Wales, St George Hosp, Dept Rheumatol, Sydney, NSW 2217, Australia; [Giannakopoulos, Bill; Krilis, Steven A.] Univ New S Wales, St George Clin Sch, Dept Med, Sydney, NSW 2217, Australia	St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Krilis, SA (corresponding author), Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, 2 South St, Sydney, NSW 2217, Australia.	bill.giannakopoulos@unsw.edu.au; s.krilis@unsw.edu.au						Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Alves JD, 2002, ARTHRITIS RHEUM-US, V46, P2686, DOI 10.1002/art.10542; Ames PRJ, 2010, J RHEUMATOL, V37, P2523, DOI 10.3899/jrheum.100494; Ames PRJ, 1998, THROMB HAEMOSTASIS, V79, P447; Arad A, 2011, BLOOD, V117, P3453, DOI 10.1182/blood-2010-08-300715; Arai T, 2001, BLOOD, V98, P1889, DOI 10.1182/blood.V98.6.1889; Asherson RA, 1998, LUPUS, V7, pS55, DOI 10.1177/096120339800700214; Banzato A, 2011, THROMB RES, V128, P583, DOI 10.1016/j.thromres.2011.04.021; Basu S, 2009, FREE RADICAL RES, V43, P85, DOI 10.1080/10715760802610851; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629; Broder A., 2012, J RHEUMATOL; Bruce IN, 2000, J RHEUMATOL, V27, P2833; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Cervera R, 2009, J AUTOIMMUN, V32, P240, DOI 10.1016/j.jaut.2009.02.008; Charakida M, 2009, JAMA-J AM MED ASSOC, V302, P1210, DOI 10.1001/jama.2009.1346; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; De Groot PG, 2005, J THROMB HAEMOST, V3, P1993, DOI 10.1111/j.1538-7836.2005.01485.x; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; de Laat B, 2007, BLOOD, V109, P1490, DOI 10.1182/blood-2006-07-030148; de Laat HB, 2004, BLOOD, V104, P3598, DOI 10.1182/blood-2004-03-1107; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Devreese K, 2010, BLOOD, V115, P870, DOI 10.1182/blood-2009-09-244426; Edwards MH, 1997, CIRCULATION, V96, P4380; Emsley J, 2010, BLOOD, V115, P2569, DOI 10.1182/blood-2009-09-199182; Fairfax K, 2012, IUBMB LIFE, V64, P595, DOI 10.1002/iub.1046; Ferrara DE, 2003, ARTHRITIS RHEUM-US, V48, P3272, DOI 10.1002/art.11449; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Galli M, 2008, J THROMB HAEMOST, V6, P399, DOI 10.1111/j.1538-7836.2007.02862.x; Galli M, 2003, BLOOD, V101, P1827, DOI 10.1182/blood-2002-02-0441; Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005; Girardi G, 2004, J CLIN INVEST, V113, P646, DOI 10.1172/JCI200418817C1; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gris JC, 2012, BLOOD, V119, P2624, DOI 10.1182/blood-2011-09-381913; HASHIMOTO Y, 1992, J IMMUNOL, V149, P1063; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.x; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; Kobayashi K, 2003, J LIPID RES, V44, P716, DOI 10.1194/jlr.M200329-JLR200; Kolyada A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015345; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lambrianides A, 2010, J IMMUNOL, V184, P6622, DOI 10.4049/jimmunol.0902765; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; Lonze BE, 2010, NEW ENGL J MED, V362, P1744, DOI 10.1056/NEJMc0910965; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Madureira PA, 2011, ONCOTARGET, V2, P1075, DOI 10.18632/oncotarget.375; Marcinkiewicz MM, 2012, J BIOL CHEM, V287, P6187, DOI 10.1074/jbc.M111.291989; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Meroni PL, 2001, ARTHRITIS RHEUM-US, V44, P2870, DOI 10.1002/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Montiel-Manzano G, 2007, ANN NY ACAD SCI, V1108, P540, DOI 10.1196/annals.1422.057; Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61; Nishimura S, 2012, BLOOD, V119, pE45, DOI 10.1182/blood-2011-09-381400; Otomo K, 2012, ARTHRITIS RHEUM-US, V64, P504, DOI 10.1002/art.33340; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Pengo V, 2011, BLOOD, V118, P4714, DOI 10.1182/blood-2011-03-340232; Perez-Sanchez C, 2012, BLOOD, V119, P5859, DOI 10.1182/blood-2011-12-400986; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 2005, ARTHRITIS RHEUM, V52, P2120, DOI 10.1002/art.21157; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prinz N, 2011, BLOOD, V118, P2322, DOI 10.1182/blood-2011-01-330639; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Rand JH, 2010, BLOOD, V115, P2292, DOI 10.1182/blood-2009-04-213520; Rand JH, 1997, NEW ENGL J MED, V337, P1327; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056/NEJM199707173370303; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Reddel SW, 2000, J AUTOIMMUN, V15, P91, DOI 10.1006/jaut.2000.0427; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; Romay-Penabad Z, 2011, BLOOD, V117, P1408, DOI 10.1182/blood-2010-07-299099; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; ROUBEY RAS, 1992, J CLIN INVEST, V90, P1100, DOI 10.1172/JCI115926; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Satta Nathalie, 2011, Blood, V117, P5523, DOI 10.1182/blood-2010-11-316158; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sciascia S, 2012, THROMB HAEMOST; Seshan SV, 2009, BLOOD, V114, P1675, DOI 10.1182/blood-2009-01-199117; Shapira I, 2012, ARTHRITIS RHEUM-US, V64, P2719, DOI 10.1002/art.34440; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Sikara MP, 2010, BLOOD, V115, P713, DOI 10.1182/blood-2009-03-206367; Sorice M, 2007, ARTHRITIS RHEUM-US, V56, P2687, DOI 10.1002/art.22802; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; Urbanus RT, 2008, J THROMB HAEMOST, V6, P1405, DOI 10.1111/j.1538-7836.2008.03021.x; Urbanus RT, 2009, LANCET NEUROL, V8, P998, DOI 10.1016/S1474-4422(09)70239-X; Van Os GMA, 2011, J THROMB HAEMOST, V9, P2447, DOI 10.1111/j.1538-7836.2011.04532.x; Vega-Ostertag M, 2005, ARTHRITIS RHEUM-US, V52, P1545, DOI 10.1002/art.21009; Versteeg HH, 2011, CURR OPIN HEMATOL, V18, P343, DOI 10.1097/MOH.0b013e32834981de; Wahl DG, 1997, LUPUS, V6, P467, DOI 10.1177/096120339700600510; Yang DT, 2006, AM J CLIN PATHOL, V126, P411, DOI 10.1309/QC259F09UNMKVP0R	107	415	441	0	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					1033	1044		10.1056/NEJMra1112830	http://dx.doi.org/10.1056/NEJMra1112830			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104HF	23484830				2022-12-28	WOS:000315982100010
J	Papp, B; Plath, K				Papp, Bernadett; Plath, Kathrin			Epigenetics of Reprogramming to Induced Pluripotency	CELL			English	Review							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; HUMAN SOMATIC-CELLS; SELF-RENEWAL; C-MYC; TRANSCRIPTION FACTORS; REGULATES PLURIPOTENCY; INTERACTION NETWORK; DNA METHYLATION; CHROMATIN	Reprogramming to induced pluripotent stem cells (iPSCs) proceeds in a stepwise manner with reprogramming factor binding, transcription, and chromatin states changing during transitions. Evidence is emerging that epigenetic priming events early in the process may be critical for pluripotency induction later. Chromatin and its regulators are important controllers of reprogramming, and reprogramming factor levels, stoichiometry, and extracellular conditions influence the outcome. The rapid progress in characterizing reprogramming is benefiting applications of iPSCs and is already enabling the rational design of novel reprogramming factor cocktails. However, recent studies have also uncovered an epigenetic instability of the X chromosome in human iPSCs that warrants careful consideration.	[Papp, Bernadett; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Papp, Bernadett; Plath, Kathrin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Papp, Bernadett; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Bioinformat Interdept Degree Program, Los Angeles, CA 90095 USA; [Papp, Bernadett; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372	NIH [DP2OD001686, P01 GM099134]; CIRM [RN1-00564, RB3-05080]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Our work is supported by the NIH (DP2OD001686 and P01 GM099134), by the CIRM (RN1-00564 and RB3-05080), and by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. We apologize to all authors whose work could not be cited due to space limitations. We thank Dr. Sanjeet Patel for critical reading of the manuscript.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gaetz J, 2012, CELL RES, V22, P848, DOI 10.1038/cr.2011.190; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hammachi F, 2012, CELL REPORTS, V1, P99, DOI 10.1016/j.celrep.2011.12.002; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI BY, 1994, J BIOL CHEM, V269, P7756; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lowry WE, 2012, CURR OPIN GENET DEV, V22, P429, DOI 10.1016/j.gde.2012.07.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagamatsu G, 2012, J BIOL CHEM, V287, P36273, DOI 10.1074/jbc.M112.380683; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Pfaff N, 2011, EMBO REP, V12, P1153, DOI 10.1038/embor.2011.176; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Surani M. A., 2012, J CELL SCI; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tiemann U, 2011, CYTOM PART A, V79A, P426, DOI 10.1002/cyto.a.21072; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Trounson A, 2012, CURR OPIN GENET DEV, V22, P509, DOI 10.1016/j.gde.2012.07.004; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WOLFFE AP, 1991, J CELL SCI, V99, P201; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	135	210	219	1	148	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1324	1343		10.1016/j.cell.2013.02.043	http://dx.doi.org/10.1016/j.cell.2013.02.043			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23498940	Green Accepted, Bronze			2022-12-28	WOS:000316192500013
J	D'Silva, J				D'Silva, Jeetha			Union budget 2013: India "could do better," say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], MONEYCONTROL; Barclays Research, BUDG 2013 FISC DISC; Chidambaram P., BUDGET SPEECH 2013 1; Government of India, EC SURV 2012 13; Government of India, BUDG DOC 2013 14; KPMG & ASSOCHAM, 2011, EM TRENDS HEALTHC JO; Medical Council of India, ANN REP 2010 11; Planning Commission, FAST SUST MOR INCL G	8	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2013	346								f1605	10.1136/bmj.f1605	http://dx.doi.org/10.1136/bmj.f1605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108VM	23482957				2022-12-28	WOS:000316324300014
J	Day, JN; Chau, TTH; Wolbers, M; Mai, PP; Dung, NT; Mai, NH; Phu, NH; Nghia, HD; Phong, ND; Thai, CQ; Thai, LH; Chuong, LV; Sinh, DX; Duong, VA; Hoang, TN; Diep, PT; Campbell, JI; Sieu, TPM; Baker, SG; Chau, NVV; Hien, TT; Lalloo, DG; Farrar, JJ				Day, Jeremy N.; Chau, Tran T. H.; Wolbers, Marcel; Mai, Pham P.; Dung, Nguyen T.; Mai, Nguyen H.; Phu, Nguyen H.; Nghia, Ho D.; Phong, Nguyen D.; Thai, Cao Q.; Thai, Le H.; Chuong, Ly V.; Sinh, Dinh X.; Duong, Van A.; Hoang, Thu N.; Diep, Pham T.; Campbell, James I.; Sieu, Tran P. M.; Baker, Stephen G.; Chau, Nguyen V. V.; Hien, Tran T.; Lalloo, David G.; Farrar, Jeremy J.			Combination Antifungal Therapy for Cryptococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HIGH-DOSE FLUCONAZOLE; AMPHOTERICIN-B; RANDOMIZED-TRIAL; AIDS; FLUCYTOSINE; MULTIPLICITY; GUIDELINES; MANAGEMENT	BACKGROUND Combination antifungal therapy (amphotericin B deoxycholate and flucytosine) is the recommended treatment for cryptococcal meningitis but has not been shown to reduce mortality, as compared with amphotericin B alone. We performed a randomized, controlled trial to determine whether combining flucytosine or high-dose fluconazole with high-dose amphotericin B improved survival at 14 and 70 days. METHODS We conducted a randomized, three-group, open-label trial of induction therapy for cryptococcal meningitis in patients with human immunodeficiency virus infection. All patients received amphotericin B at a dose of 1 mg per kilogram of body weight per day; patients in group 1 were treated for 4 weeks, and those in groups 2 and 3 for 2 weeks. Patients in group 2 concurrently received flucytosine at a dose of 100 mg per kilogram per day for 2 weeks, and those in group 3 concurrently received fluconazole at a dose of 400 mg twice daily for 2 weeks. RESULTS A total of 299 patients were enrolled. Fewer deaths occurred by days 14 and 70 among patients receiving amphotericin B and flucytosine than among those receiving amphotericin B alone (15 vs. 25 deaths by day 14; hazard ratio, 0.57; 95% confidence interval [CI], 0.30 to 1.08; unadjusted P = 0.08; and 30 vs. 44 deaths by day 70; hazard ratio, 0.61; 95% CI, 0.39 to 0.97; unadjusted P = 0.04). Combination therapy with fluconazole had no significant effect on survival, as compared with monotherapy (hazard ratio for death by 14 days, 0.78; 95% CI, 0.44 to 1.41; P = 0.42; hazard ratio for death by 70 days, 0.71; 95% CI, 0.45 to 1.11; P = 0.13). amphotericin B plus flucytosine was associated with significantly increased rates of yeast clearance from cerebrospinal fluid (-0.42 log(10) colony-forming units [CFU] per milliliter per day vs. -0.31 and -0.32 log10 CFU per milliliter per day in groups 1 and 3, respectively; P<0.001 for both comparisons). Rates of adverse events were similar in all groups, although neutropenia was more frequent in patients receiving a combination therapy. CONCLUSIONS amphotericin B plus flucytosine, as compared with amphotericin B alone, is associated with improved survival among patients with cryptococcal meningitis. A survival benefit of amphotericin B plus fluconazole was not found. (Funded by the Wellcome Trust and the British Infection Society; Controlled-Trials.com number, ISRCTN95123928.)	[Day, Jeremy N.; Chau, Tran T. H.; Wolbers, Marcel; Mai, Nguyen H.; Phu, Nguyen H.; Nghia, Ho D.; Thai, Cao Q.; Thai, Le H.; Duong, Van A.; Hoang, Thu N.; Diep, Pham T.; Baker, Stephen G.; Hien, Tran T.; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam; [Chau, Tran T. H.; Mai, Pham P.; Dung, Nguyen T.; Mai, Nguyen H.; Phu, Nguyen H.; Nghia, Ho D.; Phong, Nguyen D.; Chuong, Ly V.; Sinh, Dinh X.; Sieu, Tran P. M.; Chau, Nguyen V. V.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Day, Jeremy N.; Wolbers, Marcel; Campbell, James I.; Baker, Stephen G.; Hien, Tran T.; Farrar, Jeremy J.] Univ Oxford, Ctr Trop Med, Liverpool, Merseyside, England; [Lalloo, David G.] Univ Oxford, Liverpool Sch Trop Med, Liverpool, Merseyside, England	University of Oxford; University of Oxford; Liverpool School of Tropical Medicine; University of Oxford	Day, JN (corresponding author), Univ Oxford, Clin Res Unit, 764 Vo Van Kiet, Ho Chi Minh City, Vietnam.	jday@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Thi, Nguyen/AAM-7074-2020	Lalloo, David/0000-0001-7680-2200; Farrar, Jeremy/0000-0002-2700-623X; Loyse, Angela/0000-0001-7853-1344; Jarvis, Joseph/0000-0003-1459-5554; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [077078/Z/05/A, 089276/Z/09/Z]; British Infection Society; MRC [G1100684] Funding Source: UKRI; Medical Research Council [G1100684] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Infection Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants (077078/Z/05/A and 089276/Z/09/Z) from the Wellcome Trust and by the British Infection Society. Dr. Day is a Wellcome Trust Intermediate Fellow and was a British Infection Society Fellow during the first year of the study.	[Anonymous], 2010, R LANG ENV STAT COMP; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bretz F., 2010, MULTIPLE COMP USING; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Dromer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002870; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pitisuttithum P, 2001, J INFECTION, V43, P226, DOI 10.1053/jinf.2001.0916; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; ROZENBAUM R, 1994, CLIN INFECT DIS, V18, P369, DOI 10.1093/clinids/18.3.369; Saag MS, 1999, CLIN INFECT DIS, V28, P291, DOI 10.1086/515110; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sloan D, 2008, COCHRANE DB SYST REV, V4; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; van Buuren S, 2011, J STAT SOFTW; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103	25	330	350	2	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1291	1302		10.1056/NEJMoa1110404	http://dx.doi.org/10.1056/NEJMoa1110404			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23802521	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000316989900006
J	Day, JN; Chau, TTH; Lalloo, DG				Day, Jeremy N.; Chau, Tran T. H.; Lalloo, David G.			Combination Antifungal Therapy for Cryptococcal Meningitis REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Day, Jeremy N.; Chau, Tran T. H.] Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Day, JN (corresponding author), Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.	jday@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Thi, Nguyen/AAM-7074-2020	Lalloo, David/0000-0001-7680-2200; Farrar, Jeremy/0000-0002-2700-623X; Loyse, Angela/0000-0001-7853-1344; Jarvis, Joseph/0000-0003-1459-5554; Baker, Stephen/0000-0003-1308-5755	MRC [G1100684] Funding Source: UKRI; Medical Research Council [G1100684] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Jackson AT, 2012, AIDS, V26, P1363, DOI 10.1097/QAD.0b013e328354b419	2	330	350	2	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2522	2523		10.1056/NEJMc1305981	http://dx.doi.org/10.1056/NEJMc1305981			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802521	Green Published, Green Accepted			2022-12-28	WOS:000320926900019
